Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8242149203018143,1.9080159915860069,0.0,0.197044037196369,0.13,2/7,2.49%,PDE12;TICAM1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.7158238752676979,1.88867760817008,0.0,0.16889488902545916,0.19,2/27,2.47%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.8019358604855746,1.8855888238646252,0.0,0.12667116676909437,0.2,5/24,4.93%,NCOA4;NEDD4;SORL1;LAPTM5;RAB7A
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.9202345840762551,1.8676106605106852,0.0,0.13370845381182184,0.27,3/8,2.31%,ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.832027201422346,1.8481844700209913,0.0,0.131362691464246,0.41,6/13,12.16%,RAP1A;MAP4K4;RAPGEF6;STK26;RAP2A;RAP2C
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.832027201422346,1.8481844700209913,0.0,0.131362691464246,0.41,6/13,12.16%,RAP1A;MAP4K4;RAPGEF6;STK26;RAP2A;RAP2C
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.919530858810114,1.8113843008057113,0.0,0.22117187848572034,0.62,3/7,3.66%,NEDD4;DAB2IP;HHEX
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.6818683442821681,1.810174624130756,0.0,0.19880335895705092,0.62,10/36,13.40%,TNFAIP8L3;PIK3C2B;PTAFR;PI4KB;CSF1R;GAB2;PLCB4;PITPNM2;PLCB3;PLCL2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6349739202393538,1.80446638105343,0.0,0.1907886709361668,0.67,5/29,10.41%,NEDD4;SORL1;PGAP1;PLK3;CEP290
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.8282682333023839,1.8001967022901462,0.0,0.1801545482938231,0.69,5/20,4.93%,NCOA4;NEDD4;SORL1;LAPTM5;RAB7A
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8951470822026745,1.7807607237623342,0.0,0.2187956516920721,0.76,5/8,9.65%,LGALS9;CD274;CBFB;RUNX1;TWSG1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.8568303829945338,1.7730107493953222,0.0,0.22636606654106678,0.79,1/11,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.9380239312416409,1.7631501239028733,0.0,0.23385446172755886,0.82,1/6,1.79%,ITGA5
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.9865348422467209,1.7341047831850451,0.0,0.3307524910081909,0.91,1/6,0.12%,NUFIP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.9014700777282687,1.729827724096534,0.0,0.2999643601962582,0.91,1/7,0.17%,GCLC
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.9014700777282687,1.729827724096534,0.0,0.2999643601962582,0.91,1/7,0.17%,GCLC
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.9316083063675553,1.7217353471797276,0.0,0.3170918749840728,0.93,1/8,0.12%,NUFIP1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.5658865501694168,1.7149295105554534,0.0,0.3307524910081908,0.93,23/84,18.27%,ARHGAP31;RALB;RIN2;RGL2;KRAS;RAPGEF6;MAPK11;TP53;GRAP2;RASGRP2;ABR;SHTN1;CRKL;FGF2;RIT2;USP28;SHOC2;ARHGAP1;MRAS;SETDB1;ARHGAP32;BCR;G3BP1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5988997828367392,1.708634649752077,0.0,0.34371591450795197,0.95,9/25,14.80%,GSN;CTSH;SIRT1;BTRC;EP300;FBXW11;FBXL3;MDM2;PEX2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.9278006805950356,1.708527202519792,0.0,0.32793757619109987,0.95,1/6,0.81%,PUS1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.9070218094530347,1.70204989305659,0.0,0.34516217400044236,0.97,3/9,7.02%,CBFB;TGFBR2;RUNX1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.8257430925293504,1.6972177280845044,0.0,0.34610657182868715,0.97,3/8,12.50%,PLXNA2;PLXNA4;PLXNB2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.855181204838178,1.693262737807784,0.03125,0.3488046621177961,0.99,2/8,4.18%,CX3CR1;ITGAM
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.8443457694231538,1.679653703718165,0.0,0.3952609555665259,1.0,4/9,6.42%,PDPN;FSCN1;TGFB1;DDR1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.7131682005806886,1.6774226318280812,0.0,0.3929621084659016,1.0,4/13,6.42%,LCP1;ARHGAP35;PDPN;DDR1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6997842020668891,1.6677739542975276,0.0,0.4298158393788929,1.0,4/20,9.41%,ZNF703;TGFB1;CYP19A1;NRIP1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.7207320913184007,1.6600427035646097,0.05263157894736842,0.45664173699476,1.0,5/13,16.43%,NSUN2;METTL16;METTL8;ZC3H13;TRMT6
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6952619720389672,1.6529207321189356,0.0,0.4805461723462469,1.0,4/17,11.85%,RAP1A;CBFB;RUNX1;PDLIM5
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.9009813043203168,1.6513370892763326,0.02857142857142857,0.47125556679230124,1.0,3/7,4.88%,GSN;LCP1;FSCN1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.629705418338759,1.6446013380710913,0.0,0.4958941602775287,1.0,9/24,19.01%,CPSF4;WDR33;SNRPB;LSM11;PAPOLA;CSTF1;SCAF8;CPSF1;CPSF7
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.9495802856815632,1.6439779691261533,0.0,0.4808056114998959,1.0,2/7,1.67%,PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.7790651998761445,1.6424636836157944,0.058823529411764705,0.4780956884652972,1.0,5/10,9.61%,GSN;HPN;MYH9;KLKB1;PLGRKT
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",0.9101485888851772,1.641442102152942,0.0,0.46744646053510924,1.0,2/5,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7935918718112948,-1.6393546452350376,0.0,0.14332002381793202,0.14,61/87,17.64%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;SRP14;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;SRPRA;RPS3;RPL27
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.7240948446198807,1.634618612357224,0.0,0.49261009299092257,1.0,2/18,7.37%,ARL2BP;TAF3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.7587369593011094,1.6340925435222151,0.09523809523809523,0.48014404165809105,1.0,2/12,7.89%,ACER2;SPTLC3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7865812671835863,-1.6334171567789757,0.0,0.07166001190896601,0.14,61/84,18.15%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;FTSJ1;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;RPS3;RPL27;TMA7;RPL8
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.7753673866947556,1.6307742230768851,0.0625,0.48791856829577085,1.0,3/12,11.41%,ARV1;TECR;MGST2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.9460003163346208,1.6292281761912737,0.0,0.48462182121269143,1.0,2/6,2.04%,RIN2;RAP1A
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.8020871781721358,1.627262816712326,0.034482758620689655,0.48557280594819513,1.0,2/8,9.68%,SORL1;PGAP1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7787105641547579,1.626201963609788,0.0,0.4799790649655143,1.0,2/15,2.58%,PHLDB2;CRK
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.9484221813127286,1.62589627846134,0.0,0.4697389101020583,1.0,2/5,2.04%,RIN2;RAP1A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7904269294811644,-1.6248927423013753,0.0,0.08061751339758676,0.24,61/84,17.64%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;SRP14;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;SEC61B;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;RPS3;RPL27
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8467480434074119,1.6219362594688924,0.0,0.48299818873744116,1.0,2/8,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.7431399537187922,1.6194891288597995,0.047619047619047616,0.484902588134602,1.0,1/14,0.17%,GCLC
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.737688581732991,1.6155118313127628,0.09090909090909091,0.49555593407857595,1.0,2/10,8.46%,ICAM1;SERPINE1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8725757232435162,1.6133784568557956,0.041666666666666664,0.49324984635844327,1.0,1/8,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.51343830332839,1.6104962306972093,0.0,0.4991782275641348,1.0,20/86,14.70%,PLA2G4C;PIK3C2B;PI4KB;CSF1R;PIP4K2B;OCRL;PLA2G12A;VAC14;INPP5K;PGAP1;PTPN13;PIP4P2;MTMR14;PITPNM2;FGF2;PLCB3;PIK3R6;PIK3R5;MTMR10;PIKFYVE
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7790707939238664,-1.608745581640472,0.0,0.09853251637482827,0.32,61/95,17.64%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;SRP14;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;SRPRA;RPS3;RPL27
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.6578109400242271,1.6062037738093187,0.0,0.5118861401079586,1.0,4/24,4.05%,PHLDB2;RPS6KA6;RBM19;DAG1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.905437417230657,1.6056899040798165,0.05,0.5039895358685244,1.0,2/5,7.02%,CBFB;RUNX1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.9128297491459134,1.6032122366106523,0.0,0.5066846670763775,1.0,3/7,4.28%,SPRED2;ZNF385A;SPRED1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7623087707945427,1.6000276728273564,0.03225806451612903,0.5118549187812385,1.0,2/7,7.57%,IPPK;ISYNA1
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.9325942529640874,1.5992777712673147,0.05128205128205128,0.5075291415215047,1.0,2/5,4.88%,LCP1;FSCN1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.8757945685848674,1.5984159537794886,0.0,0.5022691144221171,1.0,2/8,6.06%,ACTA2;TMEM79
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",0.911715832761196,1.5984107487109713,0.0,0.4928807578771814,1.0,2/5,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.8920843165374371,1.589235838986481,0.0,0.5273981912021414,1.0,3/8,3.70%,SIRPA;CX3CR1;TMEM106A
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.9529505003306159,1.5888684835220044,0.0,0.5215411619443577,1.0,1/7,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.6945127883204846,1.5886531658527063,0.0,0.5125703980575677,1.0,3/14,4.77%,CPA1;MAPKAPK2;ALOX5AP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7811141812934701,-1.5880600463910517,0.0,0.21677153602462218,0.54,62/102,18.31%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;EIF4A3;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;RPS3;RPL27;RPL8;EIF3E
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6746471913578689,1.5846534762996556,0.0,0.5250318797234884,1.0,5/18,14.31%,UCP2;HVCN1;SLC46A1;SLC25A14;SLC25A27
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7035351379418517,1.5829961158726626,0.06666666666666667,0.5239692317427256,1.0,8/18,18.17%,AVIL;WASF2;FSCN1;AUTS2;CDC42;CYFIP1;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.455618666797999,1.57598793219782,0.0,0.5484230591918645,1.0,12/80,13.28%,NUP42;VCPKMT;NUP188;SIRT1;LOXL3;HDAC10;SENP6;NSMCE2;NUP214;RAE1;EP300;UBA2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8490804442749575,1.5685459376336544,0.038461538461538464,0.5842141005979512,1.0,2/7,6.37%,LGALS9;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.9160901902694732,1.560876390750582,0.05405405405405406,0.6249110893941988,1.0,1/6,2.29%,BCL2L1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.8575415822398927,1.558936757066568,0.030303030303030304,0.6268953736095253,1.0,2/7,2.84%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8994543547868877,1.5581983121124376,0.0,0.6213243430950024,1.0,2/8,4.05%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.743463995346935,1.5580828193335963,0.041666666666666664,0.612579081624086,1.0,5/10,22.27%,SUPT16H;BRD4;CDK13;CDC73;LEO1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6441656995563227,1.5566938880037833,0.0,0.6124638879373747,1.0,2/15,2.47%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7502662732885,-1.5511780698041244,0.0,0.5419288400615554,0.92,67/128,17.64%,PCSK1;RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;MRPL43;EEF1A2;COPS5;RPS9;RPL13A;RPS14;RPL27A;DMD;RPL41;RPS15;RPL39;RPL6;RPL21;MRPS7;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;EEF1A1;RPL7;RPLP0;RPS16;DARS1;MRPL51;RPS2;RPS3;RPL27
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.7192090126493377,1.5491834036354133,0.045454545454545456,0.6498122589300038,1.0,7/19,9.65%,ZNF703;BCL9;SMAD7;LATS2;TGFB1;TRIM33;TWSG1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7855701665819836,1.548631035533633,0.10714285714285714,0.6423123809907614,1.0,2/7,2.92%,NRP1;HPN
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.8767893523072638,1.5477924957897498,0.041666666666666664,0.6367169261643865,1.0,1/7,1.34%,PDE12
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.9616112450046895,-1.546388755397353,0.0,0.5195350863400036,0.93,1/8,0.15%,DDIT4
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.7735709163087694,1.5454302938796418,0.09523809523809523,0.6441187434402315,1.0,2/11,3.37%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.8825920565122937,1.5425931086429758,0.11428571428571428,0.650286118614932,1.0,2/7,4.78%,GSN;PDPN
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.9382583586977429,1.5410843500854174,0.0,0.6410869379205808,1.0,2/5,4.05%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.9382583586977429,1.5410843500854174,0.0,0.6410869379205808,1.0,2/5,4.05%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8400510325549793,1.5409897335313993,0.07142857142857142,0.6323784328673152,1.0,2/6,2.47%,GSN;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.7446285480256217,1.5379034634146773,0.0,0.6418391387736914,1.0,4/11,7.82%,GSN;WASF2;WHAMM;WASF3
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7173186280047057,1.5346188219357648,0.03333333333333333,0.6552284827620573,1.0,3/8,12.05%,FER;SYK;UNC13D
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",0.9042671000766183,1.5345202569598118,0.034482758620689655,0.6466797639797025,1.0,2/6,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.8043418369642528,-1.5335041532641402,0.012345679012345678,0.6516582332971597,0.98,8/23,9.21%,CENPF;AGT;GREB1L;VEGFA;TGFB2;SULF2;STAT1;PAX8
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8261098195199121,1.5317098734905397,0.037037037037037035,0.6522453938022666,1.0,2/8,4.18%,TICAM1;ITGAM
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.9303473633118322,1.5316408626179294,0.02857142857142857,0.6441402477551061,1.0,2/5,3.30%,PLEKHJ1;SORL1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6215354844300163,1.5302579530045495,0.07692307692307693,0.6421975534632577,1.0,3/23,6.39%,ZDHHC3;DAB2IP;BID
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.726253997856735,-1.5274222001670277,0.0,0.7146095632032999,0.99,14/41,17.09%,KCNE1;CEMIP;LRP2;NDUFB9;SLC26A5;SOD1;MYO3B;COL11A1;TIMM13;LHFPL5;PIEZO2;USP53;CDH23;ZNF354A
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6592427722097642,1.5259793478823684,0.0,0.6572291620410535,1.0,6/18,8.46%,ACER2;NEXMIF;P2RY12;SYK;CIB1;SERPINE1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.8008599431232719,1.5227297918652378,0.08,0.6699497264676546,1.0,3/9,5.78%,ZNF703;SMAD7;VCL
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.5312828334021921,1.5192879097028198,0.0,0.6814874020142498,1.0,9/46,10.65%,GSN;NRP1;FER;ATP2C1;MCU;MYH9;WHAMM;AUTS2;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.8952454068149194,-1.5178577160008984,0.013333333333333334,0.823194386804247,1.0,3/11,1.54%,GLRA1;NLRP12;HHIP
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.8203144819766446,1.5164319157992818,0.10344827586206896,0.6893108478925243,1.0,4/7,15.18%,P2RY12;SRC;PIEZO1;FERMT2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.8928650948251775,1.5163182466295666,0.0,0.681514617463173,1.0,3/6,9.65%,LGALS9;CD274;TWSG1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.9375193597417915,-1.5162891518568322,0.0,0.7736024012899739,1.0,2/6,3.98%,KCNE1;KCNT2
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.8405408569491023,1.5159675250392972,0.043478260869565216,0.6755795561018366,1.0,4/9,12.14%,GSN;ARFIP1;WHAMM;WASHC5
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.9004813722074351,-1.51361766913474,0.0,0.7569088757884535,1.0,1/11,0.03%,KCNE1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7455424278113965,1.5126246952707256,0.0,0.6873359650438049,1.0,4/11,12.42%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.7743261304989816,1.5076911111029867,0.0,0.7094567286098503,1.0,1/9,4.23%,LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.7771907540710591,1.5074093365129404,0.125,0.7024344905637391,1.0,1/5,4.03%,LPL
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6437428633970067,1.506402195124735,0.038461538461538464,0.7000501224095026,1.0,8/16,13.15%,MAP3K10;DAB2IP;MAP3K5;MAP3K4;MAP3K11;TRAF6;DVL2;DVL3
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.9341829858700073,-1.5035188699404982,0.0,0.8861036087974066,1.0,1/9,0.03%,KCNE1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.8103554217068107,1.5034383425294338,0.034482758620689655,0.7075240950373635,1.0,4/7,14.71%,BIN3;WHAMM;BIN2;FNBP1L
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8692893745979071,1.5021106469155583,0.06666666666666667,0.708107460654888,1.0,3/6,11.93%,ARHGAP35;CXCL12;EPS8
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.6954439740279431,1.501973216098791,0.1,0.7009447225855138,1.0,5/8,24.39%,TMEM119;NOTCH1;HDAC5;HDAC1;BHLHE41
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.8190203711683379,-1.5016116288919432,0.02564102564102564,0.8548015706283802,1.0,4/16,9.03%,KCNE1;KCNT2;SLC11A1;ATP1B3
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7479744165199276,1.5011090699985896,0.10344827586206896,0.6985272312411653,1.0,1/9,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.6300539073967744,1.4982840271488556,0.0,0.7094796055119648,1.0,4/27,10.41%,LCP1;TGFB1;PLK3;CEP290
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8588499352803598,1.4969030205654046,0.16129032258064516,0.7109157208270213,1.0,3/5,12.48%,SMAD7;PMEPA1;SNX25
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.842351122441949,-1.4963788530137816,0.0,0.8987359826916154,1.0,3/16,6.39%,TOP2A;HMGB2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.82585920019665,1.4954500537464321,0.12,0.7102474543754835,1.0,2/8,4.31%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7981652182970796,1.4946454285204964,0.06666666666666667,0.7090066695547921,1.0,6/10,15.78%,SCRIB;MSN;RAB10;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.8531015440214346,1.4933797093396988,0.037037037037037035,0.7089522575415752,1.0,2/7,2.47%,ATRAID;DAB2IP
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7065198086420358,-1.4931850823083568,0.0,0.9069470257228511,1.0,41/133,13.47%,SOCS3;SLC2A3;NAMPT;NR4A3;CCL4;GADD45B;FOSL2;TNC;CEBPD;PLPP3;BHLHE40;NFIL3;PPP1R15A;NR4A1;VEGFA;GPR183;RHOB;FOS;IFIT2;IL7R;NR4A2;CD69;BCL2A1;DUSP1;LITAF;TRIP10;MAP3K8;ID2;TNFAIP8;TGIF1;KDM6B;ATF3;JUNB;IRF1;ETS2;BCL6;SAT1;PDE4B;MXD1;IL18;SPSB1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.8733407284586014,1.4920045923661114,0.06451612903225806,0.7116276999329508,1.0,1/6,5.80%,ABL1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8818464755249629,1.49164867165611,0.0,0.706714219987843,1.0,3/6,7.33%,SMAD7;HHEX;DACH1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.9009070907414132,-1.491254962078493,0.0,0.8878464710779981,1.0,1/10,0.03%,KCNE1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8408115623312866,1.489472216860684,0.0,0.7093585339069284,1.0,2/10,3.23%,PLEKHM2;LYST
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.9160262226069379,-1.485904422480955,0.014925373134328358,0.9300872379017879,1.0,2/7,4.06%,RHOB;RBPJ
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8330903567114452,1.485550518238108,0.034482758620689655,0.7232380148862484,1.0,2/9,3.23%,PLEKHM2;LYST
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.9162295399497773,1.4852607828653,0.0,0.7166993901946364,1.0,1/6,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.8761413296370214,-1.485189003565488,0.015151515151515152,0.894807253968536,1.0,2/15,0.36%,NUDT12;NAMPT
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.7176600055220995,1.4836793540886444,0.09090909090909091,0.717529985657513,1.0,5/13,11.98%,NRP1;SORL1;SERPINE1;TRIB1;PDGFA
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.9107103615105756,1.4830216888421137,0.0,0.7164499539269078,1.0,2/5,6.50%,UBE2E2;UBA7
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.549455198750843,1.482555173784862,0.0,0.7115032309104264,1.0,12/54,9.59%,PHLDB2;NRP1;SERPINF2;ARAP1;LPAR1;WASF2;ALMS1;PPM1F;ABL1;SORBS3;NF2;INPP5K
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7145944822680297,-1.4814921172618003,0.0,0.9244141536256615,1.0,65/153,18.31%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;EIF4A3;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;POLR2G;TENT4B;RPL24;RPLP1;RPL30;RPS9;RPL13A;RPS14;RPL27A;UBA52;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;RPS2;RPS3;RPL27;CNOT8;RPL8;EIF3E
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7347851159802012,1.4811711700929335,0.0,0.713023234329179,1.0,4/11,14.24%,TAL1;CEBPA;EP300;CBFA2T3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.645885212076594,1.4801919368450522,0.07142857142857142,0.7108317603532563,1.0,3/19,4.27%,PHLDB2;ARAP1;WASF2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.620672327226168,1.4801711580505945,0.0,0.7045106250552718,1.0,5/18,6.42%,LCP1;ITGA5;ARHGAP35;PDPN;DDR1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7940403285745297,1.479773632313154,0.037037037037037035,0.7001132173517122,1.0,6/10,15.78%,FSCN1;SCRIB;MSN;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6487456139378968,1.4789460700506785,0.0,0.6983547759855728,1.0,1/29,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7979041425865421,1.4784355023247182,0.10344827586206896,0.6947260487766447,1.0,2/10,4.37%,PKD2;NFKBIE
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.9420451917025084,1.4784265751570969,0.058823529411764705,0.6885231376268532,1.0,1/5,2.95%,SMAD7
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.9319401917355332,-1.4783553623312053,0.0,0.9418172993749818,1.0,1/10,0.08%,TOP2A
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7040117337341804,-1.4780428376965242,0.0,0.9047076503506958,1.0,76/175,19.49%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;FTSJ1;RPL35;RPS21;RPS13;RPL36;RPL10A;RPL9;RPL4;EEF1B2;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;RPL24;RPLP1;RPL30;MRPL43;EEF1A2;COPS5;RPS9;RPL13A;RPS14;RPL27A;UBA52;PPA1;RPL41;RPS15;RPL39;RPL6;RPL21;MRPS7;RPL5;RPL18A;RPL15;RPL34;RPS7;RPL7A;EEF1A1;RPL7;RPLP0;RPS16;DARS1;MRPL51;RPS2;LARS1;RPS3;RPL27;TMA7;RPL8;MRPL27;MRPL47;DRG2;NARS1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.7522638000991588,1.47652178880205,0.043478260869565216,0.6935152965293191,1.0,5/13,13.28%,DESI2;UBA1;UBA7;SENP6;UBA2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6868875887461712,1.4756937237070291,0.0,0.692987581944373,1.0,9/15,24.95%,TMEM119;MAML1;PIEZO1;NOTCH1;HDAC5;HDAC1;MMP14;BHLHE41;HDAC9
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.91308643272542,1.4752113077405014,0.0,0.6891645797843193,1.0,1/5,6.27%,CAP1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.6949767779905816,-1.4738791147967016,0.011363636363636364,0.9502740709667232,1.0,9/41,10.46%,KCNE1;CEMIP;LRP2;NDUFB9;SLC26A5;SOD1;MYO3B;COL11A1;TIMM13
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.8168962295313434,-1.4731874715701914,0.0,0.9222494240992448,1.0,2/19,1.56%,KCNE1;INSIG1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.8416053274732486,-1.4731396353580632,0.013157894736842105,0.8860760472543646,1.0,6/14,8.38%,PRLR;CYP3A5;SLC5A9;TSHR;TG;FMO5
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7196619741562369,1.473118902311851,0.047619047619047616,0.6962060870891412,1.0,6/16,9.36%,ZNF703;BCL9;SMAD7;LATS2;TGFB1;TRIM33
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),0.8810304949772962,1.4729490117828,0.06896551724137931,0.6910976762473383,1.0,2/5,4.18%,CX3CR1;ITGAM
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.7711870209222957,-1.472830402857222,0.03488372093023256,0.8564749500273533,1.0,4/25,7.22%,TOP2A;CENPF;HMGB2;SPON2
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.8727957002681763,1.4718877584150867,0.06896551724137931,0.6903697864967214,1.0,2/6,3.83%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.685054487733777,1.4715862450403407,0.06666666666666667,0.6858693707693542,1.0,10/25,18.17%,FER;AVIL;WASF2;FSCN1;ABI3;AUTS2;CDC42;CYFIP1;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.8539786008231398,1.4705876030946288,0.0,0.6850798936095187,1.0,3/5,10.80%,PGM5;TMOD2;FLII
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.8486802673630612,-1.4699099668414182,0.02631578947368421,0.8808209797143739,1.0,1/13,0.25%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8560143245746198,1.469359967570562,0.06896551724137931,0.6845361032471262,1.0,2/6,10.46%,LPL;TIRAP
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.9154312706178784,1.4685367248377754,0.03125,0.6835397660354136,1.0,3/6,3.02%,ZNF385A;TAL1;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.9067449082459389,-1.466674213596482,0.0136986301369863,0.9171841702812747,1.0,3/9,1.54%,GLRA1;NLRP12;HHIP
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7428325763492782,1.466360266040072,0.045454545454545456,0.6844329172201068,1.0,2/7,17.59%,ABL1;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7428325763492782,1.466360266040072,0.045454545454545456,0.6844329172201068,1.0,2/7,17.59%,ABL1;PRKN
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.9150970834172413,1.4646087627028077,0.027777777777777776,0.6878525847043534,1.0,1/5,2.18%,CX3CR1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8381760722463201,1.463944667170741,0.05555555555555555,0.6861913381503939,1.0,2/6,5.69%,GALNT1;POGLUT3
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.8632336456262704,-1.4638172467653638,0.011764705882352941,0.933124551624941,1.0,2/12,4.35%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.8424430618103012,1.4635248679351043,0.03125,0.6824506080175705,1.0,2/6,4.11%,PGM5;PTCH1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8831838841058772,1.4631514085378006,0.027777777777777776,0.678328496352902,1.0,2/5,7.32%,SIRT1;TP53
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.9019251667561689,-1.462746318854452,0.014705882352941176,0.9268028206892939,1.0,2/8,3.21%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.8619438505690019,1.4626519194864727,0.03225806451612903,0.6753613456508993,1.0,3/8,5.37%,PHLDB2;DAG1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7827321618738093,-1.4621393444896078,0.0379746835443038,0.9081750702817748,1.0,4/18,5.71%,TFRC;GPR183;VAV3;IL7
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.8497732686436594,-1.4615534459978032,0.027777777777777776,0.816668207148252,1.0,1/11,0.39%,CENPF
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.8497732686436594,-1.4615534459978032,0.027777777777777776,0.816668207148252,1.0,1/11,0.39%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.8497732686436594,-1.4615534459978032,0.027777777777777776,0.816668207148252,1.0,1/11,0.39%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.8497732686436594,-1.4615534459978032,0.027777777777777776,0.816668207148252,1.0,1/11,0.39%,CENPF
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6536782807766833,1.4596878938390767,0.0,0.6852152260526481,1.0,1/28,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7498281839261849,1.458798319636157,0.03333333333333333,0.6843895948423503,1.0,4/10,12.92%,TRAF6;ZDHHC21;IRAK1;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6705272107275689,1.4573514974282866,0.05263157894736842,0.685922235543421,1.0,7/19,10.46%,LGALS9;IRF5;LAPTM5;MAPK11;SYK;SCIMP;TIRAP
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.9121125384553788,-1.4560660815614528,0.014705882352941176,0.8835579940581191,1.0,2/8,0.36%,NUDT12;NAMPT
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.8235660146566516,-1.4556052754497972,0.02857142857142857,0.8681513604917301,1.0,1/10,1.18%,CD55
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8685798254375786,1.4555954196689278,0.0,0.6894424824566832,1.0,2/6,0.38%,ACER2;NEXMIF
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.7016048274232578,1.4553953951566752,0.07692307692307693,0.6756830456171709,1.0,2/10,7.96%,PANK1;PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.7016048274232578,1.4553953951566752,0.07692307692307693,0.6756830456171709,1.0,2/10,7.96%,PANK1;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.7016048274232578,1.4553953951566752,0.07692307692307693,0.6756830456171709,1.0,2/10,7.96%,PANK1;PANK3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7780485093926517,1.454298532526932,0.1875,0.6749631513973642,1.0,4/7,15.78%,MSN;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.8497318737362274,1.452830323916479,0.09090909090909091,0.6758855251036943,1.0,3/5,12.26%,RPAP2;RPRD1B;RPRD1A
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6571636052444987,1.4495919799544936,0.0,0.6882365471858789,1.0,5/25,7.18%,ATRAID;TMEM119;FFAR4;ACVR1;IL6ST
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.748748470112701,1.4494942247465126,0.16666666666666666,0.6840243005531095,1.0,2/7,5.54%,NUAK1;NEK6
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7320285382614928,1.449203277127059,0.09523809523809523,0.6803709004713533,1.0,3/9,10.83%,ARHGAP35;CNTN4;EPHB3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.8418695334534603,-1.4489910053194945,0.04,0.9690602268347344,1.0,1/10,0.03%,KCNE1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.8159231850292231,-1.4488725584197757,0.01282051282051282,0.9462796444389102,1.0,4/17,9.78%,KCNE1;ANK3;FHL1;ANK2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7737990217498913,1.4478712174069845,0.06666666666666667,0.6831124267391223,1.0,3/7,12.05%,FER;SYK;UNC13D
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.844271777251806,-1.447592895727846,0.011494252873563218,0.9477036574960754,1.0,2/15,4.35%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.6202940554123051,1.4475598770192057,0.07142857142857142,0.6800086178769799,1.0,4/17,8.46%,LGALS9;PLA2G7;CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.7674937587165777,-1.444640792872267,0.025974025974025976,0.9770230891978536,1.0,8/32,10.88%,CCL4;MYLK;PKP2;CACNB2;ANK3;FHL1;ANK2;CCL3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7886106207307866,-1.4442364391381226,0.0,0.9584526592824203,1.0,8/19,17.93%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.7525955816503483,1.4439230466862574,0.10344827586206896,0.6938569543933649,1.0,1/6,1.80%,PGM2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.7973058114341234,-1.4438525256170673,0.01282051282051282,0.9442873080911132,1.0,2/21,2.22%,TOP2A;KNSTRN
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.6490828403996862,1.4419551538506161,0.0,0.6978076765540379,1.0,4/18,9.54%,PUS1;NSUN2;METTL16;METTL8
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.753010800818211,-1.441628159321407,0.0,0.9610991938131492,1.0,8/28,8.81%,H1-3;H1-4;IL7R;H1-2;H1-0;FIGNL1;RPA2;ZCWPW1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8246829642025886,1.4412464649276269,0.10810810810810811,0.6967878184223852,1.0,2/5,4.88%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.698087543014393,1.4397885094728957,0.1,0.6995159065873041,1.0,3/10,7.73%,CX3CR1;SYK;NMI
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6870778461310421,-1.438704712164837,0.0,0.9855242193369187,1.0,57/137,16.82%,RPL23;RPL37A;RPL38;RPS27;RPL23A;RPS25;RPLP2;RPS24;RPS6;WDR12;RPL3;RPL37;RPL11;RPL12;RPL32;RPL14;NOB1;RPL35;RPL36;RPL10A;RPL9;RPL4;IMP3;RPL28;RPL31;RPL19;MAPT;RPL24;RPLP1;RPL30;UTP3;RPS9;RPL13A;RPS14;RPL27A;NOP53;RRP36;UBA52;RRP1B;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;MPHOSPH6;RPL18A;SBDS;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;WDR46;RPS2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.7967899153640988,-1.4386976127462614,0.0125,0.964099779786116,1.0,3/20,2.84%,NR4A3;RGS2;AGT
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.8328756372769217,-1.4363072513068689,0.024691358024691357,0.9845628231960596,1.0,3/12,10.88%,CCL4;GPR183;CCL3
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8507195493398143,-1.4359815731815175,0.036585365853658534,0.9700227653718887,1.0,1/9,0.37%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9229269394706809,-1.435472311270345,0.0,0.9608291392691973,1.0,1/6,1.07%,ENPP2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.9137477265433107,-1.4347094565378884,0.046875,0.9543322085976548,1.0,1/6,3.96%,RSAD2
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.8317086549974277,1.4346102033926675,0.10344827586206896,0.7235091867712238,1.0,1/6,2.69%,NLRP1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.8055185613575138,1.4343181523026927,0.13333333333333333,0.7201647840772375,1.0,3/7,11.06%,NEDD4;WNK3;COMMD1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6775917093358668,-1.4342964531017615,0.0,0.9412402054415413,1.0,83/233,18.15%,BRIP1;RPL23;RPL37A;RPL38;RPS27A;RPS4X;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;GCNT1;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;NR4A2;RPL36;RPL10A;RPL9;RPL4;RPA2;EEF1B2;RPS8;RPL28;BRCA1;RPS12;RPL31;RPL19;RPS3A;CLSPN;RPS23;POLR2G;RPL24;RPLP1;RPL30;MRPL43;PAX8;EEF1A2;COPS5;RPS9;RPL13A;RPS14;DONSON;RPL27A;RPL41;PTMA;RPS15;RPL39;RPL6;RPA3;RPL21;MRPS7;RPL5;RPL18A;RPL15;RFC4;RPL34;RPS7;ING4;RPL7A;ING5;EEF1A1;RPL7;RPLP0;RPS16;DARS1;MRPL51;RPS2;ORC6;RPS3;RPL27;TIMELESS;RPL8
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.9454651927288539,-1.4334431248950399,0.030303030303030304,0.934336309120749,1.0,1/5,0.03%,KCNE1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.6147606731116437,1.433413740759609,0.0,0.7199613797179713,1.0,9/20,22.27%,SUPT16H;BRD4;THOC5;SCAF8;KAT7;CDK13;SUPT5H;CDC73;LEO1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.9394737070574415,-1.433302525392688,0.012345679012345678,0.9197494924730968,1.0,1/8,1.69%,RGS2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.960317013301819,-1.4306716713288596,0.0,0.9448505273922927,1.0,1/6,0.32%,SLC2A3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.8757863127054071,-1.4303954542385982,0.03225806451612903,0.9327202004605644,1.0,2/8,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6818135970776867,1.43029357948384,0.08333333333333333,0.7306661341449087,1.0,1/11,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.6572937714025915,1.4300744919443482,0.08,0.7266924830437519,1.0,2/8,11.12%,MTPN;LIMA1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7328040892513689,1.4293753788271886,0.12,0.7249785514213745,1.0,3/8,13.48%,ZDHHC3;ADRA1A;BAIAP3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.8194791437619058,1.4275149772564641,0.09375,0.7284049055914013,1.0,1/5,2.24%,COPRS
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7488061407474753,1.4273096686990114,0.19230769230769232,0.7249767709565946,1.0,3/7,14.19%,STK10;MSN;JAM2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.8758590072306234,-1.424763287620326,0.06349206349206349,1.0,1.0,2/7,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6616301452350828,1.4247327790816218,0.08695652173913043,0.7319680740724093,1.0,4/16,6.45%,RING1;DDB2;RYBP;RNF2
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.8464485720552056,-1.4244375306829682,0.028169014084507043,0.9942826652369035,1.0,1/11,0.03%,KCNE1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6019226405325723,1.4239864157277433,0.0625,0.7306227948818961,1.0,5/15,20.25%,RAB33B;MAP2K1;MAP2K2;RBSN;USP6NL
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.8713271085051429,1.4239323932718422,0.06896551724137931,0.7216096097146453,1.0,1/6,0.17%,GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.8713271085051429,1.4239323932718422,0.06896551724137931,0.7216096097146453,1.0,1/6,0.17%,GCLC
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5431658069104557,1.4234782656589622,0.0,0.7192107357667469,1.0,6/36,7.45%,RALB;LCP1;ARHGAP35;PIP4K2B;FSCN1;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7916572808466963,-1.4229900580344041,0.04,1.0,1.0,1/15,0.37%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7956381428545585,1.4225610536902205,0.11538461538461539,0.7191145740804489,1.0,2/7,8.28%,BCL2L1;SERPINB9
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7058960883746439,1.4222074745937763,0.041666666666666664,0.7168475974017816,1.0,2/12,4.95%,LGALS9;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4621330456794231,1.4220599363132989,0.0,0.7133132301837005,1.0,25/91,12.71%,PHLDB2;NEXMIF;DAB2IP;SMAD7;SRGAP2;DAG1;ARHGDIB;JAG1;RECK;VCL;RNF20;STK26;DACH1;SRGAP2B;SRGAP2C;SERPINE1;NF2;DUSP3;TRIB1;RAP2A;FGF2;ADARB1;RAP2C;ADGRG1;MITF
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.8816085201929458,1.4209839419416785,0.06451612903225806,0.71582940516329,1.0,2/5,3.83%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6106419107958331,1.4204429406377035,0.2,0.7130264532140471,1.0,3/24,5.37%,NUP42;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.5753064129692197,1.41852867903574,0.17647058823529413,0.717633705176449,1.0,5/19,9.24%,LGALS9;TRIM38;KPNA6;CHMP2B;TRIM11
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7968052546865594,1.4182907630402315,0.16,0.7150220750958062,1.0,4/8,4.16%,SIRPA;CX3CR1;CD274;MAPKAPK2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6755593103505855,-1.4180077904101969,0.0,1.0,1.0,60/162,16.82%,RPL23;RPL37A;RPL38;RPS27;RPL23A;RPS25;RPLP2;RPS24;GLUL;RPS6;WDR12;RPL3;RPL37;RPL11;RPL12;RPL32;RPL14;NOB1;RPL35;RPL36;RPL10A;RPL9;RPL4;IMP3;RPL28;RPL31;RPL19;RPL24;RPLP1;RPL30;HEATR3;UTP3;RPS9;RPL13A;RPS14;RPL27A;RIOK2;NOP53;RRP36;UBA52;RRP1B;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;MPHOSPH6;RPL18A;SBDS;RPL15;RPL34;RPS7;METTL17;RPL7A;RPL7;RPLP0;RPS16;WDR46;RPS2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.9032483825522254,-1.4169861746537455,0.0,1.0,1.0,1/8,0.52%,HTR2B
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.8513000087396103,-1.4165666526242693,0.0379746835443038,1.0,1.0,4/12,9.14%,SOCS3;CDC37;STAT1;PARP9
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.8193980571888115,-1.4154956698441676,0.012195121951219513,1.0,1.0,3/22,6.87%,KCNE1;CEMIP;ANK3
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5148609235675023,1.4153531024555346,0.0,0.7267674416150091,1.0,10/65,7.49%,GCLC;FKBP9;MYO1D;DAB2IP;HID1;DAG1;TSPAN15;LGR4;DDR1;UNC5B
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6802542217722344,1.4138751098673663,0.0,0.729962377863979,1.0,6/11,25.83%,OCRL;INPP5K;INPP1;SYNJ1;IMPA1;INPP5B
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7350831158824287,1.412020096903158,0.13333333333333333,0.7368453491796993,1.0,2/9,8.21%,SIRT1;TFE3
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8646737926670052,-1.4108611841534286,0.029850746268656716,1.0,1.0,3/7,10.09%,VEGFA;SOD1;EIF2B2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.48080081426653765,1.410679548198639,0.0,0.7384624485070271,1.0,8/50,7.18%,ATRAID;TMEM119;FFAR4;PTCH1;PPARG;SEMA4D;ACVR1;IL6ST
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6198720017574275,1.410661556417146,0.0625,0.7343327200167008,1.0,4/15,3.66%,NEDD4;ITGA5;DAB2IP;HHEX
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.873688021155817,-1.4103282869806906,0.029850746268656716,1.0,1.0,2/7,10.62%,CENPF;CENPE
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.8536320817010814,-1.4096735208094195,0.07246376811594203,1.0,1.0,3/7,6.59%,THBS1;SULF2;SPRY1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.8166042115414467,-1.4089239788556862,0.0375,1.0,1.0,1/13,0.15%,DDIT4
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.9166587853836604,-1.4087417826579336,0.05714285714285714,1.0,1.0,1/5,0.25%,PRLR
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.8606499815402118,-1.408546731288924,0.03614457831325301,1.0,1.0,2/8,1.91%,THBS1;F13A1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7781108416655913,-1.4084392786593454,0.05194805194805195,1.0,1.0,7/20,11.69%,NAMPT;CHI3L1;SH3PXD2B;SULF2;DDRGK1;ARID5B;ITGB8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.8355039719357489,-1.4077126519504062,0.06756756756756757,1.0,1.0,1/12,0.03%,KCNE1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.6979912326619981,1.406916785678746,0.10526315789473684,0.7464405620465259,1.0,2/12,7.96%,PANK1;PANK3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.9404643192918022,-1.406088962910499,0.06349206349206349,1.0,1.0,1/5,0.03%,KCNE1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.7378163192889869,-1.4057122324994513,0.03488372093023256,1.0,1.0,6/29,10.01%,TOP2A;H1-3;H1-4;H1-2;H1-0;TTN
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.8932884536988481,-1.405592197501433,0.06666666666666667,1.0,1.0,1/8,1.56%,INSIG1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.8932884536988481,-1.405592197501433,0.06666666666666667,1.0,1.0,1/8,1.56%,INSIG1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.8418849180434721,-1.4022731439457214,0.08620689655172414,1.0,1.0,1/5,10.31%,GSTM3
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.784896507598517,1.4013502933461326,0.08333333333333333,0.7675496177981714,1.0,2/6,5.33%,SORL1;SIRT1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6462049977619982,-1.400951750920649,0.0,1.0,1.0,91/275,18.73%,RPL23;RPL37A;RPL38;ARAF;RPS27A;RPS4X;TNC;RPS27;RPL23A;RPS25;RPS11;PAPPA2;RPS20;VCAN;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;ERO1A;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;FBXL2;RPL24;RPLP1;RPL30;MRPL43;EEF1A2;COPS5;RPS9;SERP1;RPL13A;LAMB1;RPS14;RPL27A;LTBP1;SPARCL1;UBA52;RPL41;RPS15;LGALS1;RPL39;RPL6;RPL21;MRPS7;RPL5;VGF;CDH2;RPL18A;GPC3;USP6;RPL15;FN1;GGCX;RPL34;RPS7;RPL7A;EEF1A1;SLC35A1;RPL7;RPLP0;RPS16;CHGB;DARS1;MRPL51;RPS2;RPS3;RPL27;PIGH;TMEM132A;RPL8;UBE2M;MRPL27;CPE
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.7041317497691726,1.400884492816479,0.045454545454545456,0.7609066614949072,1.0,6/10,25.83%,OCRL;INPP5K;INPP1;SYNJ1;IMPA1;INPP5B
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7041317497691726,1.400884492816479,0.045454545454545456,0.7609066614949072,1.0,6/10,25.83%,OCRL;INPP5K;INPP1;SYNJ1;IMPA1;INPP5B
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5523043995255636,1.4004093101681145,0.0,0.7592318269374219,1.0,9/30,13.11%,NCOA4;NEDD4;PMEPA1;ARID1A;ZMIZ1;NR3C1;SRC;PLPP1;NR3C2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.7963179856176564,1.4000297819739127,0.15151515151515152,0.7563106804908786,1.0,1/6,3.52%,BAP1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.7569501522688739,-1.3997444664418297,0.037037037037037035,1.0,1.0,6/25,10.12%,PCSK1;FA2H;DEGS2;AANAT;NMRAL1;DMD
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7050454587577454,-1.399120450114378,0.07317073170731707,1.0,1.0,3/31,2.29%,PRLR;LRP2;CYP3A5
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5871652366700886,1.3988441595751366,0.0,0.7571177311108688,1.0,6/24,14.94%,LCP1;ARFIP1;PPM1F;STXBP5;P3H1;RHBDF2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6547747188269928,1.3979900587052219,0.08695652173913043,0.75643016501495,1.0,5/15,24.25%,MED24;MITF;MED4;PAXIP1;SUB1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6644432409119012,-1.396866089609469,0.0,1.0,1.0,59/148,16.82%,RPL23;RPL37A;RPL38;RPS27;RPL23A;RPS25;RPLP2;RPS24;RPS6;WDR12;RPL3;RPL37;RPL11;RPL12;RPL32;RPL14;NOB1;RPL35;RPL36;RPL10A;RPL9;RPL4;IMP3;RPL28;NHP2;RPL31;RPL19;RPL24;RPLP1;RPL30;UTP3;RPS9;RPL13A;RPS14;RPL27A;RIOK2;NOP53;RRP36;UBA52;RRP1B;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;MPHOSPH6;RPL18A;SBDS;RPL15;RPL34;RPS7;RPL7A;MAK16;RPL7;RPLP0;RPS16;WDR46;RPS2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7027212817522976,-1.3966978679108146,0.02040816326530612,1.0,1.0,16/50,17.77%,NDUFA2;CYCS;NDUFB9;COX7C;NDUFS8;NDUFA3;COX4I1;NDUFA1;UQCRC1;NDUFS5;COX6C;UQCR10;UQCRB;NDUFB6;COX5B;NDUFS7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.6920011049307389,1.3962295665809294,0.16666666666666666,0.7592493998363644,1.0,2/9,5.33%,LGALS9;SIRT1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6617371848391211,1.3958581397761731,0.0967741935483871,0.7563150250315891,1.0,3/10,23.13%,RUNX1;NLRC4;RHBDD1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.8024649065283551,-1.3956935642709054,0.027777777777777776,1.0,1.0,3/11,9.78%,KCNE1;PKP2;ANK2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.8640783992131393,-1.3956349076191845,0.057971014492753624,1.0,1.0,2/7,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.8640783992131393,-1.3956349076191845,0.057971014492753624,1.0,1.0,2/7,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.7242170491043168,-1.3950857524389968,0.011904761904761904,1.0,1.0,7/30,9.21%,CENPF;AGT;GREB1L;VEGFA;TGFB2;SULF2;PAX8
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7054081810777132,-1.3943021212819824,0.01020408163265306,1.0,1.0,17/51,17.77%,NDUFA2;CYCS;NDUFB9;COX7C;NDUFS8;NDUFA3;COX4I1;NDUFA1;UQCRC1;NDUFS5;COX6C;UQCR10;UQCRB;COA6;NDUFB6;COX5B;NDUFS7
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.955229247202416,-1.3942710956068933,0.01694915254237288,1.0,1.0,1/5,1.07%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),-0.9195582928950989,-1.3935060528841001,0.0,1.0,1.0,1/5,1.81%,LRP2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.8398859834246932,1.3921077891094351,0.125,0.7693331397639653,1.0,1/5,2.35%,NAA20
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.714534184432234,-1.3918306373068212,0.06097560975609756,1.0,1.0,7/28,12.43%,TFRC;GPR183;VAV3;IL7;FCGR2B;MNDA;TNFSF13B
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.7439878901816447,-1.3917034642205848,0.010869565217391304,1.0,1.0,4/32,4.35%,HTR2B;TGFB2;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.8795884387976272,-1.3915012989418545,0.02857142857142857,1.0,1.0,1/7,3.11%,VEGFA
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.9027018207651051,-1.3914860126585118,0.02631578947368421,1.0,1.0,1/6,0.32%,SLC2A3
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.8259049742301602,-1.3913568078508132,0.06578947368421052,1.0,1.0,2/11,2.62%,THBS1;FGF1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7527565620519063,1.3900450337799386,0.11764705882352941,0.775325450707452,1.0,2/8,7.32%,BCL2L1;TP53
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7681817119328043,-1.3898178788660422,0.02531645569620253,1.0,1.0,5/16,8.82%,HTR2B;CHRM5;TSHR;AGT;HTR7
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.8883549461288367,-1.38959493141396,0.046153846153846156,1.0,1.0,1/6,0.56%,KMO
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5748242400217526,1.3887008946436108,0.0,0.7769164895171122,1.0,23/56,18.17%,NRP1;AVIL;ARAP1;P2RY12;ARHGAP35;WASF2;FSCN1;TAPT1;CDC42EP3;AUTS2;P2RX7;DEF8;EPS8;CDC42;PLEKHM1;FNBP1L;RHOQ;CROCC;CYFIP1;KCTD17;FMR1;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7006900261286818,1.3874668236814458,0.0,0.7777337228511064,1.0,3/12,9.42%,FGL1;LAPTM5;DUSP3
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.6469973080712462,-1.386810080441652,0.010638297872340425,1.0,1.0,49/91,28.50%,PCSK1;FAM13C;SULT4A1;AKAP12;FAIM2;BRINP1;PCDH17;MAP1B;ANK2;ITSN1;KIF1B;NRXN1;GRIA4;MAPK4;PTPRD;RAB3C;LIFR;CHGB;CNTN1;PHYHIPL;LRP4;ERC2;TAGLN3;SNAP25;UNC13A;CPE;KCTD16;SYT4;TTLL7;CLVS2;ASXL3;MAPK10;RGS4;PLPPR4;STMN2;ST8SIA3;CADPS;MAP2;CSRNP3;CDC42BPA;UNC5D;GRIA2;LSAMP;FAM171B;CRMP1;PLD1;CACNA1B;CADM3;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.7962910471103809,-1.386291367220649,0.05952380952380952,1.0,1.0,4/16,3.11%,GLRA1;TACR1;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.9677517878216917,-1.386045347980904,0.015625,1.0,1.0,2/5,3.11%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.9677517878216917,-1.386045347980904,0.015625,1.0,1.0,2/5,3.11%,PRLR;VEGFA
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.6723929867075936,-1.3860149354211722,0.0,1.0,1.0,31/112,19.26%,TOP2A;PRLR;GLA;PRKAR2B;ETFB;ALDH3B1;OVOL2;FOS;XRCC3;TSPAN13;LSR;BLVRB;MAPT;SLC7A5;PAPSS2;ID2;SNX10;COX6C;STIL;OLFM1;RAPGEFL1;SLC16A1;KLF4;SORD;CD44;FKBP5;PDCD4;CPE;ST14;ZFP36;ATP2B4
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.8172443780487384,-1.383759273088719,0.04477611940298507,1.0,1.0,2/8,4.91%,APOLD1;ALOX15B
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.7494646829984675,1.3824933801589387,0.15151515151515152,0.7938210314400702,1.0,2/7,7.81%,GSN;MAGED2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.7276027701329911,-1.3820746331329892,0.024691358024691357,1.0,1.0,7/30,9.44%,ACVR1B;HMGB2;RAB7B;HIF1A;HSPA1B;STAT1;FAXDC2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6878487518721863,1.3819795657858995,0.2,0.7916199275510661,1.0,2/10,3.37%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.73063573926725,-1.3819625158491258,0.03296703296703297,1.0,1.0,4/24,11.11%,KCNE1;ANK3;DMD;SCN9A
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.8099329694172047,1.381420278118006,0.15789473684210525,0.7892187098288431,1.0,1/6,4.74%,GCNA
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7189544570729625,-1.3801350178364444,0.03225806451612903,1.0,1.0,16/37,17.37%,RPS27;RPL23A;RPL3;RPL11;RPL24;RPS14;NOP53;RPS15;RPL6;MRPS7;RPL5;SBDS;TRAF7;MRPL20;RPLP0;C1QBP
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.9097209428959476,-1.379874840248845,0.02702702702702703,1.0,1.0,2/5,5.34%,KMO;AFMID
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.8428818176313402,1.379412043440061,0.03333333333333333,0.7955097426510553,1.0,1/5,0.57%,ZDHHC3
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6744224203485988,1.3782977937114338,0.14285714285714285,0.7962819244367854,1.0,4/16,1.50%,B4GALT7;HPSE;GAL3ST4;HS3ST4
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8524579953309386,-1.3780908866082247,0.05714285714285714,1.0,1.0,2/9,8.48%,GLRA1;SOD1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.4885325143179044,1.3779045082215688,0.0,0.7941138597277774,1.0,13/38,21.67%,NEDD4;TGFB1;ZPR1;EFCAB7;TP53;ANP32B;YWHAE;TCF7L2;BAG3;IL1B;TPR;GSK3B;SMAD3
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.7568859573960695,1.377287891825298,0.038461538461538464,0.792916290316847,1.0,3/6,12.00%,STIM1;CD84;HOMER1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.8493465935565698,-1.3766758145073499,0.04819277108433735,1.0,1.0,1/10,0.28%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.8493465935565698,-1.3766758145073499,0.04819277108433735,1.0,1.0,1/10,0.28%,UAP1L1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.8493465935565698,-1.3766758145073499,0.04819277108433735,1.0,1.0,1/10,0.28%,UAP1L1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7784203807158845,-1.3759433245247008,0.07228915662650602,1.0,1.0,4/15,10.08%,MYLK;PTN;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7648600846747298,-1.3759184205686397,0.0625,1.0,1.0,9/18,20.65%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB;POLE2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.7156819734596893,-1.3752167169730065,0.03614457831325301,1.0,1.0,4/31,8.75%,THBS1;FGF1;HSPA1B;MAPT
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.46658426977486106,1.3746162451774755,0.0,0.8010899332556358,1.0,5/39,3.37%,ST6GALNAC3;B4GALT7;HPSE;GAL3ST4;ST8SIA4
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.7965178307073867,-1.3745890306467785,0.05128205128205128,1.0,1.0,2/13,4.22%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.7286758181001818,-1.3745270106015643,0.03296703296703297,1.0,1.0,10/39,10.08%,GLIPR2;ENPP2;GLUL;TGFB2;HIF1A;PTN;DOCK1;RAB11A;DOCK5;PRKCE
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.7686909149301903,-1.3741817678169703,0.024691358024691357,1.0,1.0,4/20,10.12%,KCNE1;PKP2;ANK2;DMD
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.7454599971131269,1.3739168019815464,0.125,0.7997245172658494,1.0,1/6,1.07%,NEDD4
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.7883665148968998,-1.3728168339009414,0.05128205128205128,1.0,1.0,2/15,4.22%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.9215325536431281,-1.3718318373960847,0.029850746268656716,1.0,1.0,1/5,0.82%,RPL23
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6528396227787624,-1.371530962719489,0.0,1.0,1.0,58/170,16.82%,RPL23;RPL37A;RPL38;RPS27;RPL23A;RPS25;RPLP2;RPS24;RPS6;WDR12;RPL3;RPL37;RPL11;RPL12;RPL32;RPL14;NOB1;RPL35;INTS12;RPL36;RPL10A;RPL9;RPL4;IMP3;RPL28;RPL31;RPL19;SSB;RPL24;RPLP1;RPL30;UTP3;RPS9;RPL13A;RPS14;RPL27A;NOP53;RRP36;UBA52;RRP1B;RPL41;RPS15;RPL39;RPL6;RPL21;RPL5;MPHOSPH6;RPL18A;SBDS;RPL15;RPL34;RPS7;RPL7A;RPL7;RPLP0;RPS16;WDR46;RPS2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.6419042321804718,1.3705257449975967,0.13043478260869565,0.8111550452515248,1.0,3/12,12.10%,PPP1R16B;INPP5K;SRC
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.748176917326544,1.3693957011746873,0.17857142857142858,0.8113956237995514,1.0,2/7,8.28%,RAB7A;SERPINB9
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.49556557979566923,1.369236322070442,0.0,0.8079374194711149,1.0,10/57,10.00%,ACER2;RPS6KA6;SESN2;ZNF385A;PLAGL1;NBN;TP53;PIDD1;TFAP4;PLK3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4879945523345493,1.366708786318303,0.1,0.8137084163475325,1.0,16/49,20.97%,PEX13;ECI1;ACADS;MTLN;ACOX1;EHHADH;AIG1;PEX2;ECHDC1;MMAA;PECR;NUDT19;ABCD3;ACAT2;PCCB;LPIN2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.785589393848781,-1.3666862141536398,0.1506849315068493,1.0,1.0,7/10,18.99%,OPALIN;PTN;TNFRSF1B;CXCR4;DAAM2;PTPRZ1;TNFRSF21
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.7431505129875648,1.3658961251101525,0.14634146341463414,0.8131585177871585,1.0,2/6,6.08%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.9030399820378037,-1.365596129714278,0.05555555555555555,1.0,1.0,1/6,3.11%,VEGFA
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5516628574925035,1.3654321068940252,0.07692307692307693,0.811353681234658,1.0,6/27,6.07%,CPA1;PLA2G4C;MAPKAPK2;ALOX5AP;DAGLB;CYP2S1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6482031463813535,-1.365419094988362,0.07368421052631578,1.0,1.0,32/69,23.73%,PCSK1;FAM13C;DEPP1;AGT;KCNT2;PCDH17;CAMK2N1;SST;PTPRD;RAB3C;PTPRT;CHGB;ALDH1A1;PCSK2;SCG5;PHYHIPL;SH3GL2;SNAP25;CPE;RCAN2;SYT4;MAFB;TSPAN7;ASXL3;MAPK10;RUNX1T1;RGS4;PLPPR4;STMN2;ST8SIA3;CADPS;FGF14
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.7793824377015268,-1.3636146584180269,0.05,1.0,1.0,6/16,17.61%,ALOX12;SH3PXD2B;DUOX1;SOD1;NCF4;NCF2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7060216593019348,-1.363580934479323,0.03260869565217391,1.0,1.0,17/50,16.29%,RPL38;RPS25;RPS24;GLUL;RPS6;WDR12;RPL11;RPL14;HEATR3;RIOK2;RRP36;RPS15;RPL5;RPS7;METTL17;RPL7;RPS16
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.8759309007693842,-1.3634498227764225,0.06666666666666667,1.0,1.0,2/5,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.8759309007693842,-1.3634498227764225,0.06666666666666667,1.0,1.0,2/5,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.8085895722295389,-1.362773717476872,0.10666666666666667,1.0,1.0,1/10,0.56%,KMO
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7412362104535153,-1.3626862033416727,0.09302325581395349,1.0,1.0,8/21,19.74%,CD55;C5AR1;CR1;FCGR2B;C5AR2;C1QBP;SERPING1;CLU
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.4990588302294798,1.3622899535713826,0.1,0.8221780901404365,1.0,11/32,15.18%,NRP1;SERPINF2;LPAR1;PPM1F;ABL1;SORBS3;NF2;FHOD1;CDC42;EVL;FERMT2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.6181408937201467,1.3620719430410404,0.15384615384615385,0.819098612047116,1.0,5/17,11.23%,MCU;MICU3;MAIP1;SMDT1;C19ORF12
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.8845729420514818,-1.36203514248611,0.025974025974025976,1.0,1.0,1/7,0.08%,TOP2A
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.8654778234589797,-1.3606383404723463,0.0,1.0,1.0,1/10,0.25%,PRLR
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.7244803214260405,1.3605236324180996,0.06666666666666667,0.8208098426208692,1.0,1/7,1.19%,PIK3C2B
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.7998884216011977,1.3604123796258603,0.21212121212121213,0.8173551438406874,1.0,5/6,20.04%,ARRB2;GTF2H2;ARRB1;GRK2;ADRB2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.842832128410737,1.3599800641154918,0.12,0.8161203274308696,1.0,4/7,12.42%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.6532454304693572,-1.3591570515960967,0.0,1.0,1.0,42/129,16.66%,DDIT4;SLC2A3;FOSL2;SAP30;PLIN2;BHLHE40;NFIL3;PPP1R15A;VEGFA;MT2A;FOS;RBPJ;PHKG1;AKAP12;FAM162A;RORA;MXI1;NDRG1;ERO1A;NOCT;DUSP1;FBP1;PLAC8;ANKZF1;GAPDH;CXCR4;PGK1;PDK3;ATF3;PPFIA4;BNIP3L;TGFBI;LDHA;TPD52;ENO2;GPC3;PGM1;HSPA5;CDKN1B;PFKFB3;KDM3A;P4HA1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.7815410681821191,-1.3591372485957829,0.037037037037037035,1.0,1.0,2/16,3.11%,GADD45B;VEGFA
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.8465804933401166,-1.3580684031133348,0.0625,1.0,1.0,2/9,2.26%,CD55;MYO1G
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.7835671549474832,1.3571669048297834,0.08333333333333333,0.8242804910046866,1.0,1/8,3.02%,SH2B3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.5068202641259554,1.35707091143656,0.0,0.8211295986874788,1.0,11/29,15.18%,NRP1;SERPINF2;LPAR1;PPM1F;ABL1;SORBS3;NF2;FHOD1;CDC42;EVL;FERMT2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6935251293089659,1.3568479095176,0.14285714285714285,0.8188169679667296,1.0,1/7,5.23%,AGO1
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.9134299092356424,-1.3566221550124276,0.07142857142857142,1.0,1.0,4/5,8.69%,THBS1;SLC11A1;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.8403225593855659,-1.3563847345470343,0.028169014084507043,1.0,1.0,4/10,6.19%,ALOX12;ALOX15B;ACSL1;GSTP1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.779636385237471,1.356269143324392,0.17391304347826086,0.8141240602510779,1.0,2/9,7.89%,ACER2;SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.779636385237471,1.356269143324392,0.17391304347826086,0.8141240602510779,1.0,2/9,7.89%,ACER2;SPTLC3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7262288760234163,-1.3561345801619167,0.06578947368421052,1.0,1.0,3/20,9.78%,KCNE1;PKP2;ANK2
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7303581557825775,1.355429784201198,0.16666666666666666,0.814134443443084,1.0,1/7,0.77%,DCP1B
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8721307250532202,1.3551582058107259,0.13793103448275862,0.8119641613242732,1.0,2/5,11.12%,GSN;LIMA1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.7327480033511075,-1.355022559564557,0.09876543209876543,1.0,1.0,1/15,0.32%,GPR18
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.7244307525844808,-1.354457284604886,0.060240963855421686,1.0,1.0,6/24,13.92%,CENPF;OIP5;CENPV;ITGB3BP;CENPE;CENPI
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6502978219537897,-1.3538426286984073,0.021739130434782608,1.0,1.0,51/79,30.15%,DENND2A;SULT4A1;NEFL;BRINP1;PCDH17;MAP1B;PLP1;ANK2;GPM6B;EFR3B;NRXN1;GRIA4;MAPK4;PTPRD;RAB3C;GDAP1L1;ADGRL3;NEFM;CNTN1;TRPM3;SH3GL2;SNAP25;UNC13A;FMN2;GABRB3;ROBO2;ATP1B2;CLVS2;SCN3B;ASXL3;RUNX1T1;STMN2;ST8SIA3;CADPS;NTRK3;CSRNP3;UNC5D;GRIA2;LSAMP;SRRM4;NOVA1;MAGI2;CRMP1;CACNA1B;B3GAT1;CADM3;NDRG4;TMEM132B;ABI2;NCAN;PNMA2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.672566707250985,1.3537095551152212,0.13043478260869565,0.8139576115962159,1.0,3/11,7.03%,PRKAB2;PPARG;ADIPOR2
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.8688758906804225,-1.352780892187802,0.0410958904109589,1.0,1.0,3/7,9.71%,NAMPT;SH3PXD2B;ARID5B
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7353452491828303,-1.351237987167722,0.011764705882352941,1.0,1.0,4/28,4.39%,NAPA;MX2;RIMS1;MX1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.7376774253708027,-1.3511013846129476,0.0759493670886076,1.0,1.0,5/23,14.79%,KCNE1;ANK3;ANK2;KCNMA1;AKAP6
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.9342126346229866,-1.350795181870249,0.02666666666666667,1.0,1.0,1/5,0.37%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.9342126346229866,-1.350795181870249,0.02666666666666667,1.0,1.0,1/5,0.37%,NR4A3
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8285390596672944,1.3499991425459528,0.09090909090909091,0.8262102303838449,1.0,4/5,17.14%,SPRED2;SPRED1;EP300;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.904108645206132,-1.349768966841335,0.07246376811594203,1.0,1.0,1/5,2.84%,AGT
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8408503861054989,-1.349617482203001,0.027777777777777776,1.0,1.0,4/9,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.7825202884785459,-1.3489753198664345,0.0625,1.0,1.0,1/19,0.03%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8583466710518722,-1.3486714957696286,0.0410958904109589,1.0,1.0,3/10,8.93%,NR4A3;HIF1A;PINK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.7866087199950369,-1.3485612215616347,0.08333333333333333,1.0,1.0,2/10,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7225715161397592,1.3484843810249265,0.1111111111111111,0.8302043908462096,1.0,4/8,11.44%,TAL1;SH2B3;TGFBR2;THOC5
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8760393142503227,-1.348275114639894,0.09090909090909091,1.0,1.0,2/6,10.62%,CENPF;CENPE
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7900872653070533,1.348042341638276,0.15384615384615385,0.8287135165431228,1.0,2/6,1.09%,PTPRM;NRP1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.7595159540640519,-1.347078367430853,0.05063291139240506,1.0,1.0,2/19,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6999547487042077,-1.3468659424975988,0.022727272727272728,1.0,1.0,7/41,9.90%,NR4A3;THBS1;HMGB2;RAB7B;WDR5;FAXDC2;PRKCQ
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.807609249366182,1.3463571911529972,0.21739130434782608,0.8327886749003813,1.0,2/5,18.71%,SIRT1;IL1B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.925218467090758,-1.3459376402546477,0.057971014492753624,1.0,1.0,3/5,4.35%,VEGFA;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.8106774679457689,-1.3458811856941075,0.07575757575757576,1.0,1.0,3/10,6.59%,THBS1;SULF2;SPRY1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.6901602394984916,-1.3455091003204722,0.0625,1.0,1.0,8/44,2.89%,PCSK1;ENPP2;PLPP3;FAM13C;MYLK;FGF1;AGT;DENND2A
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6623180543243739,1.3453594597800522,0.19230769230769232,0.8336775115822893,1.0,2/9,10.73%,SYK;DVL2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5884357886254461,1.3452871021860313,0.13636363636363635,0.8304638463785929,1.0,2/16,0.92%,SLC7A8;SLC25A18
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8625610931068843,-1.345211468554939,0.07894736842105263,1.0,1.0,1/5,5.28%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.8368337428832617,1.3450761813967058,0.13793103448275862,0.8275340075402777,1.0,3/5,12.10%,TP53;ERCC4;SRC
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.65092295088222,1.3450593783575755,0.10526315789473684,0.8238697758580487,1.0,6/12,22.77%,ENPP1;TGFB1;ANKH;NOTCH1;TXLNG;ROCK2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.935723435432399,-1.344968761285665,0.03389830508474576,1.0,1.0,2/5,4.35%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7289774283875323,-1.3444211137181075,0.07058823529411765,1.0,1.0,8/22,19.74%,CD55;C5AR1;CR1;FCGR2B;C5AR2;C1QBP;SERPING1;CLU
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.9003489214243661,-1.3439343274100328,0.02666666666666667,1.0,1.0,1/7,0.08%,TOP2A
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6455931434625751,1.3436879235820278,0.1111111111111111,0.8225457560387969,1.0,2/9,7.44%,VTA1;CHMP2B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6455931434625751,1.3436879235820278,0.1111111111111111,0.8225457560387969,1.0,2/9,7.44%,VTA1;CHMP2B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4770766404694421,1.3436301328696225,0.0,0.818952550785671,1.0,13/45,5.37%,PHLDB2;ZNF703;BCL9L;IL17RD;SPRED2;DAB2IP;HPN;SMAD7;DAG1;SPRED1;PDPN;TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6381038996640847,1.3433121995027277,0.08695652173913043,0.8162007432034175,1.0,1/10,3.30%,SORL1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.6860380980547899,1.3425968039389407,0.23529411764705882,0.8162012918983642,1.0,2/7,2.27%,MAP1S;TAL1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.8845131039024623,-1.3425219807848212,0.07692307692307693,1.0,1.0,1/6,0.37%,NR4A3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7881840128179733,-1.3425038311275088,0.07692307692307693,1.0,1.0,2/15,4.39%,MX2;MX1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6922917595160174,-1.3417064168394848,0.06741573033707865,1.0,1.0,6/37,18.17%,THBS1;VEGFA;BEX3;CARD16;KLF4;CD44
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8564698065206457,-1.3413902773476867,0.07352941176470588,1.0,1.0,2/7,7.10%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.8106120367484534,-1.3411566142159586,0.014084507042253521,1.0,1.0,2/13,2.84%,NR4A3;AGT
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.6966862752626756,1.3404665361073416,0.13513513513513514,0.821325474592008,1.0,1/6,0.25%,FGL1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.864421593318765,-1.3402150091525888,0.05128205128205128,1.0,1.0,2/7,8.74%,SLC2A3;SLC2A9
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.8147453773161765,-1.339999022081956,0.06451612903225806,1.0,1.0,3/8,9.44%,HMGB2;RAB7B;FAXDC2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7884214601868352,-1.3392517521695047,0.038461538461538464,1.0,1.0,2/16,3.92%,MT2A;FOS
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.8594151941844138,-1.3391070982868678,0.06756756756756757,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.8594151941844138,-1.3391070982868678,0.06756756756756757,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6970271357653934,1.3389206285207975,0.19047619047619047,0.8240079247322893,1.0,2/11,9.41%,ZNF703;NRIP1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.6417986497506536,-1.3381752273817786,0.011111111111111112,1.0,1.0,11/85,8.93%,PRLR;TOM1L1;PRKAR2B;CHI3L1;FGF1;VEGFA;TGFB2;ADCY3;SLC11A1;CLSPN;PINK1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.7437521988213288,-1.3378176114717806,0.02564102564102564,1.0,1.0,13/25,16.82%,SLC51A;SLC16A4;ATP8B1;SLCO3A1;SLC16A3;SLCO1A2;ABCC3;ABCB4;SLC10A1;CD36;SLC16A7;SLC16A1;STARD5
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.6538821932295927,-1.3377124728330727,0.02127659574468085,1.0,1.0,36/69,24.81%,PLPP3;FAM13C;VCAN;KCNT2;TGFB2;PTN;BRINP1;MAP1B;ANK2;COL11A1;CCDC3;ADGRL2;COL23A1;MAPK4;PTPRD;LIFR;ADGRL3;RGCC;STOX2;LRP4;FBXL7;CPE;RCAN2;DIO2;THY1;ASXL3;MAPK10;RUNX1T1;PLPPR4;GPRC5B;STMN2;TMEM178A;CRYAB;MPDZ;MAP2;CSRNP3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7094213423510609,1.3377038677373312,0.18181818181818182,0.8258715298143467,1.0,2/8,6.73%,CDC14B;BTRC
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.6850191079357513,1.337473214244343,0.16666666666666666,0.8233930484451858,1.0,3/7,18.60%,USP30;PEX5;PJVK
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.7427976575454386,-1.3370852037432264,0.06329113924050633,1.0,1.0,4/23,9.78%,KCNE1;PKP2;CACNB2;ANK2
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6210606236650261,1.3368799334385109,0.0,0.8232412514638939,1.0,5/15,14.80%,PEX13;PEX16;PEX5;GDAP1;PEX2
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.8925832028580452,-1.3366298804429952,0.04285714285714286,1.0,1.0,1/5,0.37%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7955606197585909,-1.3355020428363613,0.02564102564102564,1.0,1.0,2/15,3.92%,MT2A;FOS
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.6390072502733715,-1.3349868109658973,0.010309278350515464,1.0,1.0,24/89,21.23%,NAMPT;NLRP12;THBS1;VIM;RPS4X;EIF4A3;TGFB2;PRR16;NOD2;NMD3;RBM3;NLRC5;RPL5;ATAD5;RGCC;KLF4;INSR;EIF3E;IRS2;EIF3D;SOX4;TLR2;DNA2;EEF2
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.6666040310905436,-1.3348719924895087,0.11627906976744186,1.0,1.0,10/32,14.39%,RPS27A;DTL;RPA2;TRIM25;UBA52;RFC1;UBC;RPA3;RFC4;USP43
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.7818539977828944,-1.3340842497908791,0.07142857142857142,1.0,1.0,4/16,6.09%,DNAH11;DNHD1;DNAH17;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.5895088585304153,1.3339232594183847,0.11764705882352941,0.8334805718073267,1.0,5/26,4.76%,PHLDB2;ACER2;NEXMIF;MAP4K4;JAG1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7777489833694936,1.3338113226843098,0.16666666666666666,0.8305201665468448,1.0,4/8,14.69%,P2RY12;DEF8;EPS8;PLEKHM1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5605959758676902,1.3336632912710564,0.14285714285714285,0.8243167924116865,1.0,5/18,15.98%,BID;TP53;YWHAG;PPP1R13B;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5605959758676902,1.3336632912710564,0.14285714285714285,0.8243167924116865,1.0,5/18,15.98%,BID;TP53;YWHAG;PPP1R13B;YWHAE
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.8112799203959518,-1.3335605552682073,0.08695652173913043,1.0,1.0,2/11,3.47%,GLRA1;MT2A
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7284451338519629,-1.3333273174641074,0.09523809523809523,1.0,1.0,7/20,19.74%,CD55;C5AR1;CR1;C5AR2;C1QBP;SERPING1;CLU
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.9262949678246969,-1.3331527802160814,0.04285714285714286,1.0,1.0,1/5,0.37%,NR4A3
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.6566007687632833,-1.3327317079976928,0.053763440860215055,1.0,1.0,10/57,11.79%,KCNE1;JPH1;CACNB2;NEFL;ANK3;DAPK1;ANK2;DMD;FGF13;AHNAK
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.7312588596107608,1.3324458985415781,0.2692307692307692,0.8254708007925042,1.0,1/8,2.35%,NAA20
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.8039649806803078,1.3321532339050934,0.14814814814814814,0.8227120784741554,1.0,1/6,0.59%,SLC7A8
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6406680033831859,-1.3321440061402112,0.03296703296703297,1.0,1.0,35/72,24.81%,PCSK1;ENPP2;VEGFA;SULT4A1;CCK;CALY;SST;NRXN1;PAK5;GRIA4;RAB3C;GDAP1L1;CTNND2;PTPRT;CHGB;PCSK2;SCG5;PHYHIPL;SH3GL2;KCNC1;TAGLN3;SNAP25;UNC13A;CPE;SYT4;CLVS2;SYP;GAD2;ASXL3;STMN2;ST8SIA3;CADPS;TMEM59L;LY6H;CSRNP3
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7775480773866795,-1.3314938722555083,0.08450704225352113,1.0,1.0,3/11,8.81%,SYCE2;IHO1;ZCWPW1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7394197861568307,-1.3305696862802312,0.08860759493670886,1.0,1.0,1/18,0.32%,SLC2A3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6669648412763973,-1.329973677142794,0.021739130434782608,1.0,1.0,15/41,16.52%,MX2;IFITM3;RSAD2;MX1;IFIT2;IFIT3;HLA-B;GBP2;STAT1;HLA-F;IRF1;IFIT1;OAS3;STAT2;IFIT5
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6669648412763973,-1.329973677142794,0.021739130434782608,1.0,1.0,15/41,16.52%,MX2;IFITM3;RSAD2;MX1;IFIT2;IFIT3;HLA-B;GBP2;STAT1;HLA-F;IRF1;IFIT1;OAS3;STAT2;IFIT5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.8664960560035744,-1.329854952189862,0.07246376811594203,1.0,1.0,2/5,8.93%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.8615804326110725,-1.3294147334050423,0.031746031746031744,1.0,1.0,2/6,3.47%,GLRA1;MT2A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.826909249824564,-1.3293919070169644,0.1111111111111111,1.0,1.0,3/7,8.93%,ATP5IF1;MAPT;PINK1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.789490764664691,-1.3289031488322658,0.04225352112676056,1.0,1.0,3/9,10.09%,VEGFA;SOD1;EIF2B2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8272825720805603,-1.3287870867178326,0.02702702702702703,1.0,1.0,3/11,6.19%,ALOX12;ALOX15B;GSTP1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6849233867956077,-1.328042746508695,0.09411764705882353,1.0,1.0,10/33,14.39%,RPS27A;DTL;RPA2;TRIM25;UBA52;RFC1;UBC;RPA3;RFC4;USP43
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.8675923955215495,-1.3278241488355504,0.056338028169014086,1.0,1.0,1/7,3.11%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.6237452692474951,1.327529859738289,0.13793103448275862,0.8399988483469839,1.0,1/9,2.52%,CEBPA
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.8815307845654183,-1.3271803222471672,0.05714285714285714,1.0,1.0,3/6,6.80%,NAMPT;GSTP1;NOD2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6913331739600562,-1.3267593197497927,0.053763440860215055,1.0,1.0,18/45,16.27%,RPL23A;WDR12;RPL3;RPL11;RPL14;RPL10A;NHP2;RPL24;HEATR3;NOP53;RPL6;RPL5;TRAF7;RPL7A;MRPL20;MAK16;RPL7;RPLP0
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.8455224117149722,-1.32658013765997,0.04411764705882353,1.0,1.0,3/7,7.16%,THBS1;ANK3;FBP1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.6981016865654402,1.3261859682433468,0.1111111111111111,0.8416595303102048,1.0,2/6,18.44%,APPL2;TREM2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.9032541245828389,-1.3261545201844493,0.1038961038961039,1.0,1.0,1/5,2.62%,FGF1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5779513299071531,1.3258700564004477,0.14285714285714285,0.8396855858949003,1.0,7/32,15.63%,CPSF4;KHDRBS3;RBM23;METTL16;PAPOLA;SAFB2;SON
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4381715693744846,1.325797479614887,0.0,0.8363902889377164,1.0,6/45,5.80%,PHLDB2;NRP1;MAP4K4;PPM1F;VCL;ABL1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7797623477379658,-1.3249583963996858,0.10666666666666667,1.0,1.0,3/12,14.79%,PRKAR2B;AKAP12;AKAP6
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.8588324512941765,-1.3243420888738995,0.0684931506849315,1.0,1.0,3/9,4.06%,TGFB2;ADGRG6;RBPJ
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.6746076269189096,-1.3242016962931658,0.05434782608695652,1.0,1.0,14/39,16.01%,VEGFA;HIF1A;FAM162A;RORA;NDRG1;EGLN3;PINK1;BNIP3;NOP53;PGK1;BNIP3L;CARD16;SUV39H2;RGCC
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7678087410805468,-1.324198735650253,0.07317073170731707,1.0,1.0,8/18,13.70%,SOCS3;CDC37;TXK;STAT1;PARP9;NLRC5;NR1H2;PARP14
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.5796927067558021,1.3240766229866632,0.17391304347826086,0.8406517213016168,1.0,5/11,18.41%,TRAPPC10;SNX1;RAB6A;RBSN;LMAN1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.7395178281721112,-1.323322413841593,0.1,1.0,1.0,2/20,4.37%,TFRC;DNAJB9
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.7243060936177973,-1.3233115322090299,0.022727272727272728,1.0,1.0,3/27,4.35%,HTR2B;GLA;HIF1A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.8495767698581669,-1.3232346822234093,0.11688311688311688,1.0,1.0,2/8,7.14%,XRCC3;DUSP1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.7681096415202393,-1.3230844759251152,0.02666666666666667,1.0,1.0,3/15,8.69%,DNAJB9;CR1;FCGR2B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6620076427233915,1.3230204979719427,0.14285714285714285,0.8410711669672882,1.0,4/10,12.97%,MAP2K1;SRC;MAP2K2;DNAJC13
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.7688274134208093,1.3229270769983719,0.14285714285714285,0.8378680123933067,1.0,3/6,17.02%,NBN;ERCC4;ERCC1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.7552263714478447,-1.3228823992964132,0.06578947368421052,1.0,1.0,3/17,8.47%,PRKAR2B;ADCY3;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7867692692576291,-1.3228110274941423,0.0625,1.0,1.0,2/12,9.76%,PRLR;IL10RA
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6200185624761159,1.3226288240264348,0.25,0.835892387758116,1.0,4/11,22.66%,NFATC3;NFAT5;HRH1;NFATC1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.7867742601696947,-1.322099082296697,0.03614457831325301,1.0,1.0,10/17,16.27%,RPL23A;RPL3;RPL11;RPL24;NOP53;RPL6;RPL5;TRAF7;MRPL20;RPLP0
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.8743661296591273,-1.3220106365929742,0.08823529411764706,1.0,1.0,2/6,6.87%,KCNE1;ANK3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6697212849861837,1.3217041659416524,0.07692307692307693,0.8364399716615097,1.0,4/10,17.14%,IDE;APH1A;APEH;DYRK1A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.7597482559933848,-1.321304078906745,0.11688311688311688,1.0,1.0,2/14,4.22%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6918309059566885,1.321132949053694,0.16129032258064516,0.832265176041118,1.0,2/8,12.92%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6918309059566885,1.321132949053694,0.16129032258064516,0.832265176041118,1.0,2/8,12.92%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6768415534544162,-1.32035706095408,0.031578947368421054,1.0,1.0,19/48,24.32%,NDUFA2;NDUFB9;NDUFS8;DMAC1;NDUFA3;NDUFA1;NDUFS5;TMEM126B;NDUFB6;TIMM21;BCS1L;NDUFS7;TMEM126A;ACAD9;NDUFA10;TIMMDC1;NDUFB4;NDUFAF1;NDUFS6
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6768415534544162,-1.32035706095408,0.031578947368421054,1.0,1.0,19/48,24.32%,NDUFA2;NDUFB9;NDUFS8;DMAC1;NDUFA3;NDUFA1;NDUFS5;TMEM126B;NDUFB6;TIMM21;BCS1L;NDUFS7;TMEM126A;ACAD9;NDUFA10;TIMMDC1;NDUFB4;NDUFAF1;NDUFS6
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.5504356483037851,1.3199487689017253,0.09090909090909091,0.8338903654150337,1.0,5/20,14.80%,PEX13;PEX16;PEX5;GDAP1;PEX2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.7380137082002648,-1.3198823941868512,0.0641025641025641,1.0,1.0,5/24,14.79%,KCNE1;FHL1;ANK2;KCNMA1;AKAP6
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6617065613246201,-1.3192919879861906,0.125,1.0,1.0,8/43,7.22%,SLC51A;CD55;PLIN2;ASPN;CBR1;AQP11;DEGS2;SPON2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5198432625405558,1.3192707547150069,0.06666666666666667,0.8336521630615874,1.0,4/24,4.85%,SIRPA;LGALS9;CD274;ILRUN
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.8243295898725658,1.3191735198938346,0.22857142857142856,0.8305674254952392,1.0,1/5,5.33%,SIRT1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8661241633254187,-1.319081398272701,0.043478260869565216,1.0,1.0,3/7,5.63%,VIM;PKP2;NEFL
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.7759847342155273,1.3186125853987203,0.047619047619047616,0.8293428872172415,1.0,2/10,3.37%,ST6GALNAC3;ST8SIA4
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.693756582588365,1.3184984413923702,0.16129032258064516,0.8266318748299868,1.0,3/9,16.06%,CBFB;RUNX1;SH3RF1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.8133725345477849,-1.3181227775007545,0.07692307692307693,1.0,1.0,1/10,2.69%,IHO1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8548224956798075,-1.317969482600522,0.08974358974358974,1.0,1.0,3/8,8.74%,SLC2A3;SLC5A9;SLC2A9
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7843606915890677,1.3163923274825744,0.2857142857142857,0.8315589536135842,1.0,2/8,0.53%,CPA1;MEP1A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.8931847135633528,-1.3158642957969202,0.09090909090909091,1.0,1.0,1/5,2.62%,FGF1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.5961733149803958,1.3149482261618537,0.13043478260869565,0.8344133238083965,1.0,6/13,12.05%,FER;LGALS9;SYK;GAB2;CD84;UNC13D
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4815885229265454,1.3136367503563995,0.18181818181818182,0.8328547386148853,1.0,2/32,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4815885229265454,1.3136367503563995,0.18181818181818182,0.8328547386148853,1.0,2/32,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.6700545642717616,-1.3135922451693318,0.08045977011494253,1.0,1.0,5/34,6.80%,TFRC;GPR183;VAV3;IL7;NOD2
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.7769832553652638,-1.3135478439666202,0.13157894736842105,1.0,1.0,4/11,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.7525552546309034,1.3133356905998104,0.19230769230769232,0.8313236847849016,1.0,2/8,5.15%,SESN2;SESN3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5029963075014602,1.3132559075421848,0.0,0.8281262859972673,1.0,7/27,9.32%,GSN;LCP1;HTRA1;HPN;EXOC8;KLKB1;ADAM10
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7317935202315906,-1.3127351841334474,0.09210526315789473,1.0,1.0,12/16,22.95%,ENO4;GAPDH;PGK1;LDHA;PKM;ENO2;PGAM1;PGM1;ENO1;HK2;GPI;PFKL
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.8451868730070746,-1.3126276941431039,0.10256410256410256,1.0,1.0,2/7,6.80%,HLA-B;NOD2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.745066024558074,-1.3125307751522934,0.0875,1.0,1.0,1/14,0.33%,GLRA1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.6078017994942329,-1.3115586716210954,0.010101010101010102,1.0,1.0,26/132,19.77%,TOP2A;DIAPH3;TFRC;CKS2;NAA38;HMGB2;RACGAP1;RPA2;PAICS;BRCA1;DONSON;CENPE;PRDX4;CIT;RFC1;RPA3;LMNB1;PNN;CDKN1B;PRPS1;ORC6;TIMELESS;CBX5;ILF3;MCM3;BRCA2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6703887667491872,1.3111506581181196,0.18518518518518517,0.8332040007446903,1.0,5/7,31.82%,RNF168;LIG4;RNF8;EXOSC6;MSH2
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7762567257192565,-1.3110483558518893,0.08974358974358974,1.0,1.0,8/10,22.10%,RPS27A;PGK1;UBA52;UBC;B2M;UBB;TLR2;ENO1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5682520683805733,1.31102852180212,0.13333333333333333,0.8303998710418408,1.0,6/22,7.03%,SIRPA;AVIL;CX3CR1;PRKAB2;SIRT1;ADIPOR2
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.8077140849267296,-1.3109682223428787,0.13253012048192772,1.0,1.0,3/9,10.88%,MYO1G;GPR183;CCL3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8633198320173904,-1.3107943518252696,0.08108108108108109,1.0,1.0,2/8,3.11%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.7200685422234532,-1.310775023209405,0.10975609756097561,1.0,1.0,2/19,6.31%,KCNE1;PPP2R5A
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.826182001501528,1.3104269236449453,0.16129032258064516,0.8297576851520103,1.0,3/5,11.17%,DNMT3A;CTCF;MECP2
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.6921103521611519,-1.3101594401065368,0.08433734939759036,1.0,1.0,5/29,6.50%,JAML;RORA;SELL;IL7R;CD69
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.8162829138823171,-1.3095617144315153,0.06493506493506493,1.0,1.0,3/9,9.21%,AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.6736138642449051,-1.3095326035270196,0.0625,1.0,1.0,15/63,10.08%,GLIPR2;THBS1;ENPP2;FGF1;AGT;SPARC;VEGFA;RHOB;TGFB2;HIF1A;DOCK1;RAB11A;IQSEC1;DOCK5;PRKCE
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.7855262781565823,-1.309095304577467,0.04938271604938271,1.0,1.0,2/13,9.41%,GDPD1;RDH11
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.604986642652303,1.3088466261910405,0.18518518518518517,0.833651950660071,1.0,3/15,6.69%,ARV1;PRKAB2;NPC2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.8239586954202895,-1.3085749466519705,0.17391304347826086,1.0,1.0,1/6,3.11%,VEGFA
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.8408145088611731,-1.3074496517276193,0.15,1.0,1.0,1/6,1.18%,CD55
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.7883212916218784,-1.3074478836061914,0.12698412698412698,1.0,1.0,1/14,0.25%,PRLR
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7005367218178582,-1.3072030600221949,0.175,1.0,1.0,4/19,7.16%,CGNL1;TGFB2;SPRY1;FBP1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.8858753160225477,-1.3070306455703657,0.0547945205479452,1.0,1.0,1/7,0.52%,HTR2B
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6686672295193229,1.3068073509918958,0.2,0.8387383922924689,1.0,2/9,4.37%,PKD2;NFKBIE
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.628453060910281,-1.3061421311210928,0.0425531914893617,1.0,1.0,28/65,23.43%,PTN;FAIM2;PCDH17;PLP1;ANK2;SPARCL1;GPM6B;CCDC3;NRXN1;APOD;DAAM2;MAPK4;PTPRD;ADGRL3;PTPRT;PTPRZ1;CNTN1;ALDH1A1;PHYHIPL;CHL1;GFAP;RCAN2;THY1;TSPAN7;PLPPR4;GPRC5B;STMN2;CRYAB
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7913472140639329,1.3053380016995524,0.22857142857142856,0.8410880814375622,1.0,5/7,18.52%,RUBCNL;PIP4K2B;PLEKHM1;ARL8B;ATP13A2
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.8297146561457521,-1.3039649519911345,0.08823529411764706,1.0,1.0,2/6,6.32%,ATP8B1;MAL
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7165069505959079,1.3023091250830543,0.1935483870967742,0.8501675312742213,1.0,4/9,10.53%,MCU;MICU3;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7437462294674173,-1.3017200401559839,0.06172839506172839,1.0,1.0,4/15,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6860944716647742,-1.300616622908265,0.11904761904761904,1.0,1.0,9/26,17.27%,FOSL2;CD55;BHLHE40;MLANA;ABCC3;PPP1R13L;IL18;KLF4;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7368827038661839,-1.3003686892595112,0.12162162162162163,1.0,1.0,5/22,10.88%,CCL4;MYLK;CACNB2;ANK2;CCL3
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.883695675452077,-1.3002610574931153,0.03125,1.0,1.0,2/5,10.35%,CLDN18;CLDN20
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.639907878158814,1.3002582528312914,0.15151515151515152,0.8546102391515226,1.0,2/7,18.44%,APPL2;TREM2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.6088435791942255,1.2995738549292757,0.13333333333333333,0.8543109504360896,1.0,2/16,0.92%,SLC7A8;SLC25A18
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6710337025191485,-1.2992850541844279,0.12941176470588237,1.0,1.0,13/34,16.33%,NR4A3;ME1;SLC16A3;ENO4;GAPDH;PGK1;LDHA;PKM;ENO2;PGAM1;PGM1;PDHB;SLC16A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8918713451634674,-1.2992165580803547,0.029850746268656716,1.0,1.0,2/5,3.11%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.7836829975493286,-1.2989272723640195,0.09090909090909091,1.0,1.0,3/14,5.14%,NLRP12;AIM2;BEX3
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),0.7982729852537647,1.2987923154250922,0.2,0.8545872872479561,1.0,2/5,1.18%,FER;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.8519125950010648,-1.29849552385825,0.08823529411764706,1.0,1.0,1/5,7.78%,BRCA1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.6423018022677126,1.298484206810274,0.1111111111111111,0.8526283496712679,1.0,4/15,6.45%,RING1;DDB2;RYBP;RNF2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.7173681037859413,-1.2983741961955502,0.08235294117647059,1.0,1.0,7/23,11.59%,HTR2B;FGF1;SVIL;CENPV;RACGAP1;PRKCE;CIT
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.8719527384696497,-1.2982819324573511,0.041666666666666664,1.0,1.0,1/6,5.25%,RBX1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6565996488476318,-1.2980538932748353,0.07368421052631578,1.0,1.0,6/66,3.11%,DDIT4;TFRC;ARAF;PAQR3;MTCP1;VEGFA
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7362506743001035,-1.2978971869788714,0.189873417721519,1.0,1.0,4/14,12.30%,RPS27;RPS14;RPS15;MRPS7
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.7637733876527606,-1.297853300564694,0.13157894736842105,1.0,1.0,2/13,3.21%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7290917643594924,-1.2974928267110235,0.11904761904761904,1.0,1.0,2/16,8.48%,FGF1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7965595135273829,-1.2973285144601605,0.14864864864864866,1.0,1.0,1/9,0.96%,THBS1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6757204909491534,1.2972595563976612,0.19047619047619047,0.8538402462650434,1.0,2/7,5.33%,TMEM106A;SIRT1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.6132326338605094,-1.297073302596197,0.0,1.0,1.0,43/87,28.37%,SPOCK1;SULT4A1;CCDC85C;FAIM2;CCK;BRINP1;TCEAL2;AMER2;PLP1;LRRC4C;SST;NRXN1;PAK5;GRIA4;RAB3C;GABRB1;PHYHIPL;SH3GL2;KCNC1;TAGLN3;SNAP25;GFAP;GABRG2;GRM3;PDE10A;SYT4;CADM2;CLVS2;SCN3B;GAD2;SERPINI1;PLPPR4;STMN2;ST8SIA3;LY6H;CSRNP3;NRGN;CA10;GRIA2;LSAMP;VSTM2B;AQP4;CADM3
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.584479736808636,1.2969685283379127,0.13333333333333333,0.8519499515096802,1.0,2/12,6.23%,GCLC;MSRA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.8287648588052692,-1.2967434811864456,0.1095890410958904,1.0,1.0,1/7,0.96%,THBS1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.6108166782021602,-1.2966332703784285,0.07368421052631578,1.0,1.0,37/86,24.02%,PCSK1;GNRHR;FAM13C;KCNT2;COL11A1;SST;NREP;NRXN1;GRIA4;PTPRD;RAB3C;NEFM;TMEM130;CHGB;PCSK2;TRPM3;CACNA1C;FMN2;KCTD16;SYT4;SEZ6L2;THY1;ROBO2;AMPH;CADM2;CLVS2;GAD2;ASXL3;MAPK10;RUNX1T1;PLPPR4;STMN2;ST8SIA3;JAM3;CADPS;FGF14;MAP1A
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.8406735452544787,-1.2965037656283303,0.1643835616438356,1.0,1.0,1/6,2.43%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.719173375986873,-1.2962943956415982,0.0379746835443038,1.0,1.0,5/23,8.72%,ACVR1B;HMGB2;HIF1A;HSPA1B;STAT1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.7569697970915774,-1.296233054186614,0.17142857142857143,1.0,1.0,2/8,10.34%,GPR183;CXCR4
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7361636442027323,1.2956986132181483,0.2,0.853771882753089,1.0,3/6,8.04%,NPR2;PDE9A;GUCY1A1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.8589653616414635,-1.2956725819157338,0.08108108108108109,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.6553923111166717,-1.295235161463212,0.052083333333333336,1.0,1.0,8/60,4.35%,THBS1;PLPP3;FGF1;AGT;SPARC;VEGFA;RHOB;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.5202497515889873,1.2951842955608597,0.18181818181818182,0.8526121079621588,1.0,5/38,4.49%,SESN2;FER;SPRED2;SPRED1;PPP1R16B
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.696103334607239,-1.2951409335993413,0.06521739130434782,1.0,1.0,6/30,10.11%,NDUFA2;NDUFB9;NDUFS8;NDUFA3;NDUFA1;NDUFS5
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6826726666884051,-1.2947134250857772,0.07058823529411765,1.0,1.0,3/24,5.14%,CCL4;JAML;SELL
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5973514574238761,1.294380518424209,0.15,0.8530925720129549,1.0,3/21,4.27%,PHLDB2;ARAP1;WASF2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.8261834400581816,-1.2941457179352087,0.11290322580645161,1.0,1.0,1/5,1.69%,RGS2
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.7616595711197365,-1.2936450251122782,0.12162162162162163,1.0,1.0,3/10,17.98%,BNIP3;BNIP3L;BMF
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.5679977952196059,1.2927555466077254,0.10526315789473684,0.855754428690368,1.0,3/11,5.33%,DDB2;POLD3;SIRT1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.8669103267503782,-1.2927018993918231,0.14285714285714285,1.0,1.0,1/6,1.10%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.8669103267503782,-1.2927018993918231,0.14285714285714285,1.0,1.0,1/6,1.10%,GLA
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8743623443486706,-1.292643752889673,0.07352941176470588,1.0,1.0,3/6,10.27%,CLDN18;ATP8B1;ABCC3
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.8528855394777768,-1.2922696994159273,0.14084507042253522,1.0,1.0,2/7,7.78%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.7981647702717554,-1.291626097989758,0.09090909090909091,1.0,1.0,2/8,6.80%,VIM;NOD2
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.8430920325468703,-1.2916128238289049,0.15384615384615385,1.0,1.0,2/6,10.88%,GPR183;CCL3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.7453217789904323,-1.2913213078774897,0.0684931506849315,1.0,1.0,2/14,5.28%,KCNE1;PKP2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7094209177864883,-1.2906454612791962,0.12048192771084337,1.0,1.0,5/21,13.19%,CCL4;JAML;TGFB2;CCL3;PDE4B
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.7180481333605968,1.2903448445910708,0.21621621621621623,0.8633080478603505,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.8310648805737604,-1.2897465278884075,0.125,1.0,1.0,2/6,10.01%,HTR2B;TTN
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7874402400236342,1.28923712178072,0.12,0.8644008134561656,1.0,2/8,5.33%,SORL1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.7815735526300216,-1.289149608077012,0.12,1.0,1.0,2/10,11.21%,VEGFA;CTBP1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7149744745685288,-1.2890840950794034,0.06329113924050633,1.0,1.0,8/21,20.61%,H2BC11;HMGB2;GBP2;FGR;RPL39;GSDMD;TLR2;PPP1R11
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7316999350107133,1.2886350355931313,0.25,0.8641285825109132,1.0,5/8,23.64%,ADRA1A;ZDHHC21;PDE4D;ADRB2;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.7331338241018509,-1.2884991373794605,0.12359550561797752,1.0,1.0,2/23,0.40%,SOCS3;SH3BP5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.6766769712037819,-1.288429184651389,0.11627906976744186,1.0,1.0,5/30,14.79%,KCNE1;ATP1B3;ANK2;KCNMA1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7880206252690976,-1.2877443765853602,0.0975609756097561,1.0,1.0,3/12,9.66%,NR4A3;ACSL1;CLIP3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.8620479381919728,-1.2876120255530477,0.07792207792207792,1.0,1.0,2/5,10.45%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.5402011571522584,1.2875582112342479,0.21052631578947367,0.8641087264137667,1.0,5/20,19.10%,UBE2E2;ANAPC4;UBE2E3;PRKN;UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7627483235268827,-1.2872668341018083,0.0684931506849315,1.0,1.0,2/14,2.84%,NR4A3;AGT
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.6097805550542965,-1.286850672120752,0.06593406593406594,1.0,1.0,18/72,18.07%,KCNE1;ANKUB1;OMG;CCDC170;CD163;FMO5;MS4A6A;HSPA2;SMIM14;FAM20A;CCPG1;DNAH12;ALDH1A1;RASSF4;CHL1;HLA-DMB;ABCA1;MGLL
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7723014695091471,-1.286761959345745,0.1728395061728395,1.0,1.0,2/9,3.11%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.7909588846909917,-1.2865373128363664,0.12698412698412698,1.0,1.0,2/7,8.93%,PRELID1;PINK1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.8044507896793334,-1.2864127037576991,0.1375,1.0,1.0,3/7,13.75%,NEK11;MAP3K12;INCENP
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.8570141394632138,-1.2862164599793544,0.06756756756756757,1.0,1.0,1/6,0.39%,CENPF
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.688442442483398,-1.2860643529147742,0.07058823529411765,1.0,1.0,8/26,14.35%,CD55;TRIM5;DHX58;FGR;FCGR2B;APPL1;IRF1;CD36
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.8047330271595772,-1.285919903644713,0.09859154929577464,1.0,1.0,2/9,4.00%,CD55;TGFB2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.7388593085243635,-1.2858627361148296,0.06896551724137931,1.0,1.0,3/16,10.88%,CCL4;MAPT;CCL3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.8544669801416479,-1.2856258874871695,0.12121212121212122,1.0,1.0,2/5,11.73%,BNIP3;BNIP3L
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.6850836409765769,-1.2854987693127196,0.06818181818181818,1.0,1.0,2/30,3.05%,DDIT4;HINT1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.7753501213552196,1.2848413068153075,0.15151515151515152,0.8705772899737246,1.0,3/5,20.63%,RAB10;LIN7B;LIN7A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.7035322828062341,-1.2848366818138492,0.11627906976744186,1.0,1.0,6/20,11.28%,TFRC;PRELID1;MAPT;PINK1;BNIP3;TMEM14A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.7140176793892513,1.2844608812838392,0.16129032258064516,0.8687941155435059,1.0,4/9,16.11%,TRAF6;IRAK1;NFAT5;ALOX5
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.620336256582926,-1.2844299254688105,0.061855670103092786,1.0,1.0,40/83,28.72%,VCAN;PTN;FAIM2;BRINP1;PLP1;CLIP3;ANK2;LRRC4C;APLP1;MAPK4;ADGRL3;CTNND2;PHYHIPL;TAGLN3;SNAP25;GFAP;ADCY8;ATP2B2;LHFPL3;NRXN2;ATP1B2;CLVS2;NKX6-2;PLPPR4;GPRC5B;STMN2;ST8SIA3;TMEM178A;TMEM59L;LY6H;MAP2;CA10;GRIA2;OLIG1;VSTM2B;CRMP1;AQP4;CADM3;NDRG4;LINGO1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.8416170239869031,-1.284291688003731,0.08333333333333333,1.0,1.0,2/6,10.64%,SSB;DDX1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6002456567731208,-1.2840537792695943,0.04040404040404041,1.0,1.0,27/103,13.06%,GADD45B;THBS1;TNFRSF11B;VIM;TNC;MYLK;SPOCK1;SPARC;VEGFA;VCAN;RHOB;ECM2;LAMA2;SNTB1;FBN2;BASP1;ID2;IL15;COL11A1;NOTCH2;TGFBI;LGALS1;SAT1;EMP3;CDH2;APLP1;ENO2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.7170869024880877,1.2837412637829777,0.2608695652173913,0.8688075996201069,1.0,3/9,15.17%,SIRT1;EP300;KAT7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6367880825978693,-1.2837332431976016,0.03125,1.0,1.0,22/68,24.80%,NDUFA2;NDUFB9;NDUFS8;DMAC1;SCO2;NDUFA3;NDUFA1;NDUFS5;TMEM126B;NDUFB6;COX20;TIMM21;BCS1L;NDUFS7;TMEM126A;ACAD9;NDUFA10;TIMMDC1;NDUFB4;NDUFAF1;NDUFS6;SCO1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.6776101681157454,-1.2836239723728105,0.07692307692307693,1.0,1.0,4/41,4.06%,THBS1;ACVR1B;TGFB2;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.7779164646520625,-1.2835448281872182,0.13157894736842105,1.0,1.0,4/8,20.95%,FCGR2B;MNDA;TNFRSF21;CD300A
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7976207037142253,-1.2828242274913952,0.06578947368421052,1.0,1.0,2/10,5.76%,IL7;IL7R
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7976207037142253,-1.2828242274913952,0.06578947368421052,1.0,1.0,2/10,5.76%,IL7;IL7R
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.6793057366809034,-1.2825827591770371,0.08695652173913043,1.0,1.0,5/28,7.10%,HTR2B;SEMA6A;SEMA3A;CENPV;PDXDC1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.6780964955706261,-1.2825258430472113,0.0989010989010989,1.0,1.0,3/36,4.31%,TFRC;FTH1;SLC11A1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7149306697689234,-1.28217937367347,0.11904761904761904,1.0,1.0,9/21,12.92%,PRLR;OVOL2;LSR;RARRES1;BAIAP2L1;BTN2A2;BTN3A1;PPP1R13L;PADI2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.696319269565088,-1.2819049202456547,0.09090909090909091,1.0,1.0,8/26,13.70%,TXK;HIF1A;IL7;HSPA1B;PARP9;CXCR4;NLRC5;PARP14
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6990737272556378,1.2812636055012518,0.18181818181818182,0.8769694267000303,1.0,2/7,8.91%,SORL1;BIN1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.7656436864985903,-1.2793535927043698,0.12345679012345678,1.0,1.0,3/13,6.69%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.8603698262001291,-1.279221886725705,0.09333333333333334,1.0,1.0,2/5,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.8603698262001291,-1.279221886725705,0.09333333333333334,1.0,1.0,2/5,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6902521996638195,1.2790741158966932,0.2413793103448276,0.8819246230260064,1.0,3/9,5.29%,ZNF703;CSF1R;SCRIB
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.6473273110173973,1.2788707479981236,0.17857142857142858,0.8762888469662928,1.0,3/8,9.24%,LGALS9;TRIM38;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.6473273110173973,1.2788707479981236,0.17857142857142858,0.8762888469662928,1.0,3/8,9.24%,LGALS9;TRIM38;TRIM11
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.7979400266376335,-1.2786961836974544,0.1527777777777778,1.0,1.0,6/7,20.13%,RPS27A;UBA52;UBC;B2M;UBB;TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.7979400266376335,-1.2786961836974544,0.1527777777777778,1.0,1.0,6/7,20.13%,RPS27A;UBA52;UBC;B2M;UBB;TLR2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.6904903263574492,-1.2786367269642793,0.11904761904761904,1.0,1.0,9/19,20.97%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB;LIG3
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7815646151553732,-1.2786253472263698,0.12857142857142856,1.0,1.0,4/9,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7815646151553732,-1.2786253472263698,0.12857142857142856,1.0,1.0,4/9,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7815646151553732,-1.2786253472263698,0.12857142857142856,1.0,1.0,4/9,6.39%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7070119018809227,-1.278543221441201,0.10975609756097561,1.0,1.0,5/24,13.19%,CCL4;JAML;TGFB2;CCL3;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.829223244499443,-1.2784309020099143,0.12698412698412698,1.0,1.0,4/5,15.56%,PTN;TNFRSF1B;CXCR4;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.8469223677798816,-1.2780903099453678,0.17142857142857143,1.0,1.0,2/6,5.78%,THBS1;ACSL1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.6405798650352873,-1.2778446505607384,0.12790697674418605,1.0,1.0,11/36,14.39%,RPS27A;DTL;RPA2;BRCA1;TRIM25;UBA52;RFC1;UBC;RPA3;RFC4;USP43
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.7336736603572264,-1.2778316421464062,0.13793103448275862,1.0,1.0,2/19,3.11%,THBS1;VEGFA
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.6158608930801596,-1.2776099953026412,0.06382978723404255,1.0,1.0,48/90,27.98%,PCSK1;HAMP;RIMS1;SULT4A1;TCEAL2;PCDH17;LRRC4C;UBE2QL1;SST;NRXN1;PAK5;GRIA4;MAPK4;RAB3C;CTNND2;PTPRT;CHGB;CNTN1;PCSK2;PHYHIPL;SH3GL2;KCNC1;SNAP25;SYT4;GABRB3;MAFB;ROBO2;CADM2;CLVS2;SYP;SCN3B;GAD2;ASXL3;MAPK10;NKX6-2;STMN2;ST8SIA3;CADPS;LY6H;CSRNP3;ERO1B;CA10;UNC5D;GRIA2;CAMK2B;LSAMP;NOVA1;CACNA1B
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.8653958311630299,-1.277600391447022,0.08333333333333333,1.0,1.0,1/5,9.05%,DAPK1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7982409527363183,-1.2775520788276133,0.09090909090909091,1.0,1.0,2/9,5.16%,NUDT16;ENTPD3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7892325681559585,-1.2773131445122068,0.15942028985507245,1.0,1.0,3/8,18.42%,THBS1;RGCC;PDCD4
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7785251385143004,-1.2772667477286057,0.0875,1.0,1.0,4/11,10.41%,CYCS;COX7C;COX4I1;COX6C
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7050078293004146,-1.2771096509852753,0.1282051282051282,1.0,1.0,7/18,16.82%,SLC51A;ATP8B1;SLCO1A2;ABCC3;SLC10A1;SLC16A1;STARD5
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.7540985947249559,-1.2767624462357992,0.1686746987951807,1.0,1.0,2/12,6.39%,HMGB2;H1-0
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.7855854858638223,-1.2767498256228091,0.15384615384615385,1.0,1.0,2/9,8.49%,RPS21;ERI2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.6274857714273234,-1.2766840694149797,0.010416666666666666,1.0,1.0,42/96,28.72%,TMEM163;CDK14;PIANP;SULT4A1;NEFL;ABLIM3;BRINP1;TCEAL2;CALY;NARF;APLP1;LHFPL5;SRRM3;PAK5;MAPK4;GDAP1L1;NEFM;BSN;GALNTL6;SH3GL2;KCNC1;ERC2;TAGLN3;SNAP25;SYT16;SYT4;CLVS2;KIF5A;STMN2;ST8SIA3;TMEM59L;LY6H;DCTN1;MTUS2;CA10;GRIA2;KCTD8;VSTM2B;CRMP1;CACNA1B;NDRG4;LINGO1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8802086447613064,-1.276032339715137,0.09090909090909091,1.0,1.0,3/5,8.69%,CD55;CR1;FCGR2B
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.6389446345464769,1.2757622592154287,0.20833333333333334,0.8847988303963501,1.0,2/11,6.69%,ARV1;NPC2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.8940712004743357,-1.275673482495367,0.1323529411764706,1.0,1.0,2/5,4.80%,LRP2;PTN
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.782928331289898,1.2756418339271929,0.21212121212121213,0.882281663101673,1.0,1/6,3.05%,EYS
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6390764142322078,-1.2754028233159436,0.03225806451612903,1.0,1.0,27/78,16.30%,TRIM5;TMEM140;IFITM3;RSAD2;MX1;IFIT2;SELL;IL7;IFIT3;GBP2;DHX58;PARP9;OGFR;IL15;TRIM25;IFI44L;PROCR;IRF1;CMPK2;TXNIP;PSMA3;B2M;HERC6;IFI44;PARP14;TAP1;STAT2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6642074557455481,1.275184551313581,0.14285714285714285,0.8811360504770376,1.0,3/9,12.16%,RAP1A;RAP2A;RAP2C
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.49146390703294535,1.274853259640432,0.15384615384615385,0.8797090809371163,1.0,8/33,9.96%,LYL1;TAL1;HHEX;RHOG;FAM110A;EPOR;CNPY3;FAM78A
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.8191085077199098,-1.274825425944183,0.17567567567567569,1.0,1.0,2/7,4.06%,MYLK;RBPJ
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.7003160159347714,-1.2747283024302447,0.1728395061728395,1.0,1.0,4/19,9.78%,KCNE1;FHL1;ATP1B3;ANK2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.7680010263757047,1.2747177820709936,0.0967741935483871,0.8772830939340047,1.0,2/5,2.18%,LGALS9;CX3CR1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.5593213449609202,1.2742533252073316,0.1,0.8759268096652002,1.0,4/17,9.32%,TGFB1;APH1A;TRAF6;ADAM10
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.6555124785707765,1.2739466653080758,0.125,0.8743888788614662,1.0,3/11,19.01%,PKD2;KRT10;CPSF7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8261655451923,-1.2737387532709206,0.10294117647058823,1.0,1.0,2/6,16.01%,ATF5;RGCC
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.799228258091043,-1.2734783249736692,0.15714285714285714,1.0,1.0,2/6,10.85%,SOD1;ADPRS
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),-0.825382491042547,-1.2734398858209792,0.11764705882352941,1.0,1.0,1/5,6.32%,MAL
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.803978485728476,-1.2730983066716925,0.16049382716049382,1.0,1.0,2/7,8.93%,TOMM7;PINK1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.607590589703649,-1.2729579248490512,0.03225806451612903,1.0,1.0,38/80,28.50%,FAM13C;PTN;SPRY1;FAIM2;BRINP1;PCDH17;MAP1B;PLP1;ANK2;LRRC4C;GPM6B;MAPK4;PTPRD;ADGRL3;PTPRZ1;PHYHIPL;LRP4;FBXL7;CPE;GFAP;RCAN2;CLVS2;ASXL3;MAPK10;RUNX1T1;PLPPR4;GPRC5B;STMN2;TMEM178A;LY6H;MAP2;CSRNP3;GRIA2;NOVA1;CRMP1;AQP4;CADM3;NDRG4
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.7238603023446677,-1.2727356038052382,0.17567567567567569,1.0,1.0,2/7,12.94%,FAIM2;AGTPBP1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.5670975243042209,1.2727093301979449,0.14285714285714285,0.8755716459782672,1.0,5/21,6.45%,RING1;DDB2;RYBP;RNF20;RNF2
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.8616992886640805,-1.2726220798122059,0.1323529411764706,1.0,1.0,2/5,7.82%,CD55;CR1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.6632240591241648,-1.2723368333447067,0.10204081632653061,1.0,1.0,8/41,12.29%,DIAPH3;CATIP;COBL;MAPT;HDGFL3;FGF13;MID1IP1;PSTPIP2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.580817247240794,1.2717135457563113,0.15789473684210525,0.8763199460883251,1.0,2/14,4.23%,FGL1;LAPTM5
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.6246175502004231,-1.271598795483504,0.12643678160919541,1.0,1.0,21/36,30.09%,SULT4A1;GRM8;BRCA1;CASKIN1;VGF;APLP1;GDAP1L1;NEFM;KLHL23;UNC13A;SYT4;STMN1;CLVS2;KIF5A;STMN2;TMEM59L;CRMP1;CACNA1B;LINGO1;REEP2;NCAN
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7884219632012213,1.271511473191785,0.18518518518518517,0.8738988063864851,1.0,4/5,20.15%,PHACTR4;ARHGAP12;NOTCH1;LRP6
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.6825538488632926,1.2709141529366195,0.10526315789473684,0.8730472426853932,1.0,2/9,6.08%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.6591051556993527,-1.2707193073829928,0.16666666666666666,1.0,1.0,3/25,5.01%,KMO;GLUL;MTHFD1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6940559962966835,-1.2705776882766706,0.14457831325301204,1.0,1.0,5/23,13.19%,CCL4;JAML;TGFB2;CCL3;PDE4B
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7720810629002719,1.270195574682436,0.21621621621621623,0.870051827269302,1.0,1/6,6.91%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7720810629002719,1.270195574682436,0.21621621621621623,0.870051827269302,1.0,1/6,6.91%,SYK
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5214864040719425,1.2698413308134209,0.18181818181818182,0.8688952293020586,1.0,4/22,6.37%,ACTA2;TPM2;MRC2;CXCL12
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.6982608155516563,-1.2696974860107075,0.14634146341463414,1.0,1.0,7/22,22.92%,CLDN18;LSR;CLDN20;MPP7;ACTG1;PDCD6IP;MICALL2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.7014055417167873,-1.269264717799687,0.14942528735632185,1.0,1.0,4/19,5.28%,LRP2;TGFB2;RBPJ;PKP2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7124374308979883,-1.2692370346244204,0.1411764705882353,1.0,1.0,3/21,10.42%,NR4A3;CLIP3;APPL1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.7406687664225833,-1.2691187603279317,0.15384615384615385,1.0,1.0,1/16,0.28%,UAP1L1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.817936047326538,-1.2689441685220142,0.11267605633802817,1.0,1.0,4/7,17.61%,ALOX12;DUOX1;NCF4;NCF2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.7238336157563696,1.2679484769156266,0.23333333333333334,0.8732739036519891,1.0,3/8,16.82%,INPP5K;TASOR;SETDB1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5851967596417176,1.2676401205356826,0.3125,0.8713272509482295,1.0,4/21,5.37%,ZNRF3;NEDD4;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.7250207433085042,-1.2675605096435196,0.175,1.0,1.0,3/17,3.17%,OMD;OGN;VCAN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.7933379071010075,-1.2670803659291683,0.12857142857142856,1.0,1.0,3/8,13.62%,RSAD2;RAB7B;GRAMD4
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.8522866774339203,-1.2670083420074447,0.09375,1.0,1.0,1/5,0.62%,NLRP12
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6515390384807982,1.2667626187865524,0.18181818181818182,0.8716545242628138,1.0,4/12,15.28%,LPL;SIRT1;FBXW7;MEST
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.671833038045316,-1.2663104944780241,0.09411764705882353,1.0,1.0,5/24,9.21%,TGFB2;SH3PXD2B;MEIS2;SCO2;PAX8
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7631176196424532,-1.2658977214938907,0.15384615384615385,1.0,1.0,4/11,12.07%,H2BC11;RPL30;GAPDH;RPL39
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.8404589908990634,-1.2656516264829374,0.14666666666666667,1.0,1.0,2/7,4.80%,TGFB2;PTN
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7206341106610941,1.265227248919949,0.3225806451612903,0.8745094022442961,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.8568012022293877,-1.2652139166503205,0.1111111111111111,1.0,1.0,2/7,6.06%,KNSTRN;RACGAP1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8143530452414862,1.2647382710223711,0.13636363636363635,0.8734946581438853,1.0,3/6,7.14%,GSN;MCU;WHAMM
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.7588834422173132,-1.2647346133455672,0.26153846153846155,1.0,1.0,1/5,7.44%,HSPA1B
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.7588834422173132,-1.2647346133455672,0.26153846153846155,1.0,1.0,1/5,7.44%,HSPA1B
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6181116545785955,-1.2646753014792336,0.08333333333333333,1.0,1.0,15/62,18.44%,RPS27A;VEGFA;RBPJ;HIF1A;RBX1;EGLN3;LIMD1;UBA52;UBC;PSMA5;PSMA3;PSMD8;UBB;CITED2;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7100421944219109,-1.264139972079075,0.12345679012345678,1.0,1.0,6/21,10.08%,THBS1;PLPP3;MYLK;ENPP4;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.629742391463519,1.2638456942118752,0.11764705882352941,0.8736289200185954,1.0,3/11,11.44%,SLC25A18;ARL6IP5;LRRC8D
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.7479052587106045,-1.2636646740831035,0.2,1.0,1.0,1/10,1.56%,INSIG1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.6833071471509814,-1.2630667324981364,0.09876543209876543,1.0,1.0,3/26,3.75%,FA2H;SLC5A9;OVOL2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.5799155594880866,1.2628524428227357,0.06666666666666667,0.8742633495023364,1.0,6/22,5.58%,NUAK1;CGAS;HMGA1;SIRT1;NEK6;ABI3
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.6951065803664918,-1.262577419442837,0.14285714285714285,1.0,1.0,5/15,16.92%,CD55;RSAD2;B2M;IL18;TRAF2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6438292145320594,1.2623664421936374,0.17391304347826086,0.8731230136689798,1.0,1/7,2.18%,CX3CR1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6742896731514844,1.2621422215966152,0.3448275862068966,0.8682478443036893,1.0,3/8,9.49%,RPS6KA6;TP53;TFAP4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6742896731514844,1.2621422215966152,0.3448275862068966,0.8682478443036893,1.0,3/8,9.49%,RPS6KA6;TP53;TFAP4
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.7257753642207401,-1.2619932558445572,0.1794871794871795,1.0,1.0,2/10,4.00%,RGS2;TGFB2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7308344708453962,1.2617035294274292,0.3,0.8667779235502532,1.0,1/6,10.44%,FBL
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.8473910093836894,-1.2616165947974025,0.08,1.0,1.0,2/6,2.94%,OMD;OGN
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.7766583052714224,-1.2613362917164708,0.1111111111111111,1.0,1.0,1/8,1.66%,TRIM5
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.7784501685604523,1.2612814440145586,0.22857142857142856,0.865944894130267,1.0,2/5,12.10%,CBL;SRC
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.603239475832525,-1.2610160122008582,0.07142857142857142,1.0,1.0,25/90,18.86%,RPS27A;VEGFA;HIF1A;FAM162A;RORA;RBX1;NDRG1;EGLN3;PINK1;BNIP3;LIMD1;NOP53;PGK1;UBA52;BNIP3L;UBC;PSMA5;PSMA3;CARD16;SUV39H2;RGCC;PSMD8;UBB;PSMB4;FMN2
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.7307444517007693,-1.2604540142112122,0.0625,1.0,1.0,2/18,4.44%,PCSK1;SRP14
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.8075778854357796,-1.260263975236758,0.1794871794871795,1.0,1.0,1/6,4.00%,TGFB2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.6192858428678794,-1.2602256613558127,0.07368421052631578,1.0,1.0,8/74,6.35%,NR4A3;INSIG1;PRKAR2B;TSHR;NR4A1;ADCY3;SYAP1;NR4A2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5608318459453959,1.2600293064470505,0.125,0.8676193002900439,1.0,1/14,0.92%,GSN
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.7068318990602673,-1.2599143658911593,0.09302325581395349,1.0,1.0,1/19,0.15%,DDIT4
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.8013511896246153,-1.259839205323568,0.21052631578947367,1.0,1.0,2/6,18.63%,RBX1;FBXL7
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.7129962071467344,-1.2595229855207184,0.13953488372093023,1.0,1.0,2/16,1.79%,NR4A3;CYCS
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7797148855592031,-1.2589427521260577,0.16666666666666666,1.0,1.0,2/10,9.72%,TGFB2;LAMB1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8183405630962792,-1.258724671606834,0.14516129032258066,1.0,1.0,3/6,14.41%,SYAP1;PINK1;PRR5
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.8429133106398148,-1.2585548002676894,0.1506849315068493,1.0,1.0,1/7,2.43%,NUDT16
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5941168786922736,-1.2582288875722418,0.050505050505050504,1.0,1.0,28/120,13.53%,NAMPT;ADGRE1;CD55;TACR1;RGS1;ACVR1B;OSMR;RNF144B;GPR183;HIF1A;C5AR1;SELL;TNFRSF1B;IL7R;CD69;NOD2;IL15;IL10RA;SLC31A2;MARCO;ITGB8;IRF1;KIF1B;EMP3;PDE4B;MXD1;IL18;GPC3
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.6306779598585048,-1.2579524043525636,0.14893617021276595,1.0,1.0,8/54,7.78%,THBS1;CHI3L1;FGF1;VEGFA;RHOB;HIF1A;FLT1;BRCA1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7176757550851276,1.2578302340387681,0.23333333333333334,0.874182485997544,1.0,2/5,18.90%,PGGT1B;PTAR1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.6480718901129782,1.2577788007130106,0.2962962962962963,0.8689057812756328,1.0,1/8,6.81%,MPDU1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.6480718901129782,1.2577788007130106,0.2962962962962963,0.8689057812756328,1.0,1/8,6.81%,MPDU1
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.7822341781883935,-1.2573776104464502,0.18309859154929578,1.0,1.0,3/7,19.63%,SEPSECS;TRNAU1AP;DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.7822341781883935,-1.2573776104464502,0.18309859154929578,1.0,1.0,3/7,19.63%,SEPSECS;TRNAU1AP;DIO2
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.6194576900614149,-1.2573454126910852,0.12903225806451613,1.0,1.0,8/54,11.10%,SLC51A;SLC38A4;SLC16A10;ATP8B1;ACSL1;SLCO1A2;ABCC3;SLC6A15
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.8319410904346924,-1.2571955647815662,0.17567567567567569,1.0,1.0,1/7,1.10%,GLA
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.6380177228736318,-1.2571908267471308,0.11458333333333333,1.0,1.0,12/59,10.79%,GADD45B;SCRG1;TNC;PLPP3;SPARC;VEGFA;ADAMTS2;LAMA2;STAT1;IL10RA;COL11A1;COL10A1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6712938789157211,-1.2569518314248591,0.13636363636363635,1.0,1.0,7/25,14.79%,KCNE1;DUOX1;STAT1;AANAT;VGF;CFTR;AKAP6
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7038862138782467,-1.256506552292693,0.14772727272727273,1.0,1.0,6/22,5.81%,THBS1;SEMA6A;FGF1;VEGFA;GLUL;EPN1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8181114484176211,-1.2557771396416928,0.15,1.0,1.0,2/5,9.21%,ALOX15B;PAX8
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7867468937996475,-1.2555479850531965,0.16455696202531644,1.0,1.0,4/9,18.06%,CACNB2;CALM3;PDE4B;CALM1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.8610173833819135,-1.255071388512591,0.11392405063291139,1.0,1.0,2/5,12.63%,JAML;TCF7
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5298309599788671,1.254742826604834,0.16666666666666666,0.8777857411602691,1.0,5/22,5.78%,ATRAID;TMEM119;TGFB1;PKDCC;ACVR1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.6979042610308005,-1.2545646648476247,0.1411764705882353,1.0,1.0,4/20,6.89%,TGFB2;SH3PXD2B;MEIS2;SCO2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7748236406505589,1.2544615322364028,0.2727272727272727,0.8760982537755523,1.0,3/5,21.67%,TGFB1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.8181327571218285,-1.2544466390839202,0.10256410256410256,1.0,1.0,3/7,15.15%,TFRC;BNIP3;PID1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5311632738342063,1.2539090255229166,0.18181818181818182,0.8760874292880839,1.0,4/19,6.05%,MSH4;POLD3;ABL1;MCM9
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5668288094693782,1.2536915645620736,0.3333333333333333,0.874109728450086,1.0,2/17,7.77%,NDE1;SLAIN2
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7095353999147012,-1.253065020904473,0.17857142857142858,1.0,1.0,3/15,19.11%,POLR2G;TENT4B;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.6663154719435532,-1.2530037173330084,0.12903225806451613,1.0,1.0,5/41,4.35%,HTR2B;NR4A1;VEGFA;HMGB2;HIF1A
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.6694678271345588,-1.2518547117269687,0.10588235294117647,1.0,1.0,5/26,6.89%,TGFB2;SH3PXD2B;MEIS2;FBN2;SCO2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8122717460142495,-1.2511282697595538,0.09090909090909091,1.0,1.0,1/6,2.29%,CYP3A5
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.7464205849931224,1.2511267937924793,0.2857142857142857,0.8806848818610823,1.0,1/5,0.81%,PUS1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6118696926481577,-1.2507452143550155,0.03225806451612903,1.0,1.0,31/71,26.80%,SULT4A1;NR4A2;CASKIN1;MAPT;CALY;APLP1;NRXN1;PAK5;MAPK4;GDAP1L1;CTNND2;BSN;PHYHIPL;KCNC1;ERC2;SNAP25;UNC13A;GABRG2;SYT4;CLVS2;SYP;GAD2;KIF5A;STMN2;ST8SIA3;HS6ST3;TMEM59L;LY6H;CSRNP3;LONRF2;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7174184414160065,-1.2505615498305755,0.12162162162162163,1.0,1.0,2/11,10.86%,HLA-B;HLA-F
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8002169493003811,-1.2502593342284205,0.21739130434782608,1.0,1.0,1/6,8.72%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8002169493003811,-1.2502593342284205,0.21739130434782608,1.0,1.0,1/6,8.72%,STAT1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7175438344188103,-1.249972636892754,0.17073170731707318,1.0,1.0,1/11,0.37%,NR4A3
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8339727560517637,-1.249920885862394,0.13513513513513514,1.0,1.0,2/6,10.01%,MYLK;TTN
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6886707793972189,1.249870356537174,0.1935483870967742,0.8823107229928243,1.0,1/6,5.37%,TGFB1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8493235728755517,-1.2496059422128423,0.1,1.0,1.0,1/6,8.72%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8493235728755517,-1.2496059422128423,0.1,1.0,1.0,1/6,8.72%,STAT1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7487549806902861,-1.2495718449575677,0.14492753623188406,1.0,1.0,2/11,2.26%,CD55;MYO1G
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.5943997881778997,-1.2490440284996127,0.03,1.0,1.0,35/150,15.31%,SOCS3;GPR18;NAMPT;MX2;IFITM3;MT2A;RSAD2;HIF1A;MX1;IFIT2;IL7;IFIT3;CD69;HLA-B;DHX58;STAT1;OGFR;IL15;TRIM25;ARID5B;IL10RA;IFI44L;NLRC5;IRF1;CMPK2;TXNIP;PSMA3;PDE4B;B2M;HERC6;IFI44;PARP14;IFIT1;OAS3;TAP1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6708521453039853,1.2490116574588506,0.25,0.8818911590037052,1.0,3/6,16.64%,RPS6KA1;DDIT3;INO80
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6183212403915536,1.2489856052450703,0.25,0.8765834123069576,1.0,3/10,10.95%,SESN2;SESN3;RRAGD
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6183212403915536,1.2489856052450703,0.25,0.8765834123069576,1.0,3/10,10.95%,SESN2;SESN3;RRAGD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.599111985396387,-1.2484543478787795,0.07291666666666667,1.0,1.0,24/103,23.58%,RPL38;RPS27;RPL23A;RPL3;RPL11;SNRPD2;RPL24;RPS14;NOP53;DDX1;RPS15;RPL6;MRPS7;RPL5;TRAF7;MRPL20;RPLP0;SRSF5;PRPF6;DICER1;EIF2D;RPL10;SRSF9;GCFC2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8113234200004326,1.2479848842859196,0.3055555555555556,0.8775153659986381,1.0,2/5,9.68%,PIGT;PGAP1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7813951993317985,-1.247504792330637,0.18055555555555555,1.0,1.0,4/8,17.93%,RPS27A;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.7058424976109148,-1.247406014892014,0.14457831325301204,1.0,1.0,8/16,18.06%,JPH1;CACNB2;PLN;ANK2;DMD;AHNAK;CAV3;CALM1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8008208040579066,-1.2469858270763812,0.203125,1.0,1.0,3/5,15.02%,HMGB2;NEIL1;OAS3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8389657458602231,-1.2464706111839228,0.136986301369863,1.0,1.0,3/7,5.81%,THBS1;SEMA6A;EPN1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.7151106312847134,1.2462646084569036,0.20689655172413793,0.8814362445492807,1.0,1/8,0.09%,STPG1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6332048935256134,-1.2461477904834217,0.1590909090909091,1.0,1.0,7/39,9.79%,FANCB;H1-3;H1-4;H1-2;H1-0;POLR2G;POLQ
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7755840009781608,-1.2461287607700946,0.1506849315068493,1.0,1.0,2/7,4.55%,GLUL;GLYATL1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.6867840549899267,-1.245136210677831,0.0898876404494382,1.0,1.0,6/38,10.88%,DDIT4;FOS;TGFB2;FCGR2B;MAPT;CCL3
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.6587302787702858,-1.2447716061878604,0.1411764705882353,1.0,1.0,5/26,13.05%,GLRA1;SLC11A1;RACGAP1;SLC13A4;SLC4A10
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.617545072318539,1.2441674667222746,0.2,0.8881909252412088,1.0,6/14,15.99%,SLC25A18;SLC46A1;PDPN;ARL6IP5;FOLR2;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7360805889465281,-1.243865497441083,0.21621621621621623,1.0,1.0,3/9,19.26%,RGS2;CAV3;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.8738764707963147,-1.2435398729724307,0.1388888888888889,1.0,1.0,2/5,3.11%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.8084313562674552,-1.2428790273559744,0.1917808219178082,1.0,1.0,2/7,4.80%,IHO1;PTN
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.726664222944344,-1.2428743617972717,0.17142857142857143,1.0,1.0,2/17,2.84%,THBS1;AGT
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6214102692529276,-1.2426630820855007,0.1368421052631579,1.0,1.0,5/48,9.90%,NR4A3;THBS1;MEIS2;WDR5;PRKCQ
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.5940746686954956,-1.2426353466935691,0.10309278350515463,1.0,1.0,44/81,32.07%,MEIS2;AMER2;DIRAS2;SLC17A7;NRXN1;PAK5;GRIA4;TMEM130;BSN;FRRS1L;TRPM3;PHYHIPL;KCNC1;SNAP25;UNC13A;KCTD16;GABRG2;GRM3;SCN1A;CLVS2;SCN3B;GAD2;STMN2;ST8SIA3;CADPS;GRIN2A;NTRK3;GABRA2;CSRNP3;SLC1A2;CA10;GRIA2;LSAMP;SRRM4;MAGI2;CACNA1B;NDRG4;TMEM132B;NCAN;SCN2A;SLC6A1;PPFIA2;ATCAY;ASIC2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.6057970398943993,-1.2425304867502407,0.07368421052631578,1.0,1.0,10/75,12.51%,THBS1;VIM;RPS4X;EIF4A3;PRR16;POLR2G;RBM3;RPS9;RPL5;PKM
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5991266689618867,1.2422621923266823,0.2413793103448276,0.892438552584677,1.0,1/9,1.15%,FER
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.5736732550251636,-1.2421511028796,0.09278350515463918,1.0,1.0,23/105,16.41%,TFRC;NR4A1;RHOB;FOS;TUBA4A;RXRB;CCK;HTR7;HLA-F;ATF3;JUNB;IRF1;HSPA2;ENO2;OLFM1;DGAT1;MGAT1;RFC4;AP2S1;PTPRD;TAP1;ABCB1;GRINA
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.8547090941829766,-1.2417929636763083,0.16216216216216217,1.0,1.0,1/5,4.57%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.8547090941829766,-1.2417929636763083,0.16216216216216217,1.0,1.0,1/5,4.57%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.6151207158462676,-1.241656098263574,0.08333333333333333,1.0,1.0,18/76,19.90%,THBS1;VIM;RPS4X;EIF4A3;AGT;PRR16;VPS11;RBM3;NR1H2;RPL5;UHRF1;RDX;KLF4;EIF3E;ASPSCR1;EIF3D;ASPH;SOX4
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.44307901415512,1.2416137866883967,0.16666666666666666,0.891954936017987,1.0,2/34,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7439663414278239,1.2412959122203213,0.16,0.8901639784197186,1.0,1/6,3.09%,CSF1R
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7030944309735031,1.2411238628255719,0.25925925925925924,0.8881309084582278,1.0,1/7,2.71%,NUAK1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.7949164577398573,-1.2411151067194959,0.26582278481012656,1.0,1.0,1/5,8.75%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.824802022869008,-1.2409307691402953,0.14285714285714285,1.0,1.0,1/5,1.76%,OSMR
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6407965702590118,-1.2404239393059089,0.20987654320987653,1.0,1.0,13/35,17.93%,RPS27A;FANCB;XRCC3;FANCI;FANCM;RPA2;UBA52;UBC;RPA3;FAN1;SLX4;WDR48;UBB
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.8304872426370418,-1.240416777059566,0.16216216216216217,1.0,1.0,3/6,10.88%,CCL4;MYO1G;CCL3
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.6658017540446675,1.2398160107147707,0.20689655172413793,0.8898912050866294,1.0,2/11,5.26%,SPIN1;RPAP2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.6540589255611393,-1.2396665704782894,0.10112359550561797,1.0,1.0,6/35,18.17%,THBS1;VEGFA;BEX3;CARD16;KLF4;CD44
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5927103297613302,1.2394770421793682,0.15384615384615385,0.8864475814948988,1.0,1/14,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5927103297613302,1.2394770421793682,0.15384615384615385,0.8864475814948988,1.0,1/14,0.02%,PHLDB2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.61142498962072,-1.2393684147719415,0.10101010101010101,1.0,1.0,9/62,13.97%,PRLR;CGNL1;PLPP3;AGT;COBL;SLC13A4;ADGRL2;SLC4A10;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.678934685796016,-1.2392343548665885,0.11764705882352941,1.0,1.0,8/31,13.36%,ARIH2;TOMM7;VPS11;RHOU;ABLIM3;ATP5IF1;PINK1;USP36
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5950985173720669,-1.2391309465913627,0.07142857142857142,1.0,1.0,23/116,16.58%,SH3BP5;RHOBTB3;GLA;BHLHE40;ALDH3B1;OVOL2;THSD4;FOS;SVIL;MINDY1;BLVRB;ENDOD1;GREB1;MAPT;SLC7A5;PAPSS2;UGCG;SYBU;OLFM1;RAPGEFL1;KAZN;SLC16A1;KLF4
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5199808591057435,1.2388718134421997,0.21052631578947367,0.8858237115972861,1.0,6/31,12.10%,TGFA;TGFB1;NCK2;CBL;SLC30A10;SRC
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5661120901415496,1.2386999469660118,0.20833333333333334,0.8838334310653821,1.0,8/17,20.16%,LATS2;AMOTL1;DVL2;WWTR1;YWHAE;MOB1B;MOB1A;STK3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.6685693460113384,-1.2383833749516895,0.15,1.0,1.0,5/24,6.81%,H1-3;H1-4;H1-2;H1-0;ZNF93
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.8554035179424644,-1.2382817890228148,0.11594202898550725,1.0,1.0,4/5,14.49%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.7274648165927194,1.238005957200004,0.23684210526315788,0.8840902315972381,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.6885106280422142,-1.2374947230359132,0.16666666666666666,1.0,1.0,5/23,13.15%,HTR2B;VEGFA;TGFB2;TTN;OLFM1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.7257026854391895,1.2374439970611495,0.3103448275862069,0.8836025865730766,1.0,5/6,26.85%,SETD1B;KMT2B;KMT2A;KMT2D;SETD4
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7610355814255911,-1.2373950432942724,0.19117647058823528,1.0,1.0,1/7,6.52%,CFL1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7566042801550434,-1.2369730751909667,0.23880597014925373,1.0,1.0,2/9,6.53%,PLPP3;DEGS2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7309309791153222,-1.2365829859503177,0.15853658536585366,1.0,1.0,4/11,12.40%,AIM2;STAT1;IRF1;MNDA
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6856136211318566,-1.2365584260961608,0.1724137931034483,1.0,1.0,7/25,13.36%,ARIH2;TOMM7;VPS11;RHOU;ABLIM3;PINK1;USP36
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.6514877537752859,-1.236440385474308,0.1927710843373494,1.0,1.0,6/24,10.31%,ATP8B1;SULF2;MAL;CRYBG1;BRCA1;GSTM3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.7875423876930814,-1.236395962221309,0.1282051282051282,1.0,1.0,1/8,0.29%,SOCS3
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.7923508764610413,-1.2363821836023012,0.17142857142857143,1.0,1.0,1/6,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.7431031193503699,-1.2363640329046317,0.19230769230769232,1.0,1.0,1/12,0.96%,THBS1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7826918449929358,-1.23601264581784,0.17391304347826086,1.0,1.0,4/7,11.82%,FA2H;ALOX12;LSR;UGCG
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7826918449929358,-1.23601264581784,0.17391304347826086,1.0,1.0,4/7,11.82%,FA2H;ALOX12;LSR;UGCG
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.6853001817839994,-1.235752595454338,0.17647058823529413,1.0,1.0,8/23,20.31%,CEMIP;JPH1;ANK2;DMD;CALM3;AKAP6;CALM1;THY1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6421393355097771,-1.235119501006682,0.20454545454545456,1.0,1.0,12/31,21.31%,GRIK1;GRM8;SHANK3;CDH2;DGKI;TSHZ3;NRXN1;NLGN3;SYT1;UNC13A;GRM3;RELN
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7312208655346444,1.2350731175442586,0.16666666666666666,0.8893320058090088,1.0,3/5,23.25%,MAML1;PIEZO1;MMP14
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.4689411774425987,1.2348526010297505,0.07692307692307693,0.8872726397953118,1.0,6/26,9.32%,GSN;LCP1;HTRA1;EXOC8;KLKB1;ADAM10
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.8014231201384018,-1.2344496747832723,0.17647058823529413,1.0,1.0,2/5,8.93%,ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5070358904036719,1.234091078341259,0.2222222222222222,0.8879256011701828,1.0,6/44,13.31%,RALB;LPL;SIRT1;STK26;RRAGD;CLEC16A
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.7454588636204693,-1.2340417463234787,0.21875,1.0,1.0,4/8,20.14%,STEAP2;SLC31A2;ATOX1;CUTC
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5543789967695928,1.2338670273743175,0.15789473684210525,0.8859230459122877,1.0,5/19,10.15%,LYST;VTA1;LAPTM4B;CHMP2B;UBXN6
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.7037717484250312,-1.2334086789223855,0.13580246913580246,1.0,1.0,4/20,14.49%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.6810768435272635,1.2333320700302168,0.2413793103448276,0.8851117269520631,1.0,4/7,20.64%,ACADS;PCK2;MMAA;PCCB
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.6413867037252972,-1.2328522187295072,0.07526881720430108,1.0,1.0,11/53,6.80%,NR4A3;HTR2B;JAML;FGF1;NR4A1;VEGFA;HMGB2;HIF1A;C5AR1;PTN;NOD2
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.6025267795122866,-1.232133991546416,0.08695652173913043,1.0,1.0,31/79,23.45%,PLPP3;FAM13C;AGT;SPARC;VEGFA;GLUL;PTN;BRINP1;PCDH17;PLP1;ANK2;COL11A1;SPARCL1;ADGRL2;PTPRD;LIFR;LRP4;CD44;FBXL7;CPE;RCAN2;CLU;TLR2;THY1;COL5A1;MAPK10;PLPPR4;GPRC5B;TMEM178A;CRYAB;MPDZ
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.4478222557800453,1.2316802554385182,0.18181818181818182,0.8879149893507029,1.0,2/36,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.6412840067480468,1.2316175974106909,0.2777777777777778,0.8854039536746533,1.0,3/15,12.21%,ACER2;SPTLC3;CYB5R3
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.6999050477505355,1.2314933273098778,0.23076923076923078,0.8833912473979664,1.0,6/7,29.45%,SETD1B;KMT2B;KMT2A;KMT2D;SETD4;KMT2C
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.6890827679890614,1.231355579201635,0.17857142857142858,0.8813498292311878,1.0,3/8,13.79%,SLC25A18;LRRC8D;SLC25A14
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6531145424796291,1.2311834875666727,0.21428571428571427,0.8794403385817593,1.0,1/9,4.05%,DAG1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6358361514790466,-1.2310276801766364,0.18681318681318682,1.0,1.0,7/26,16.67%,LRP2;CYP3A5;AKR1B1;RDH11;GPC5;GPC3;ALDH1A1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.6174744767830026,-1.2302361735651917,0.1511627906976744,1.0,1.0,8/45,10.31%,PCSK1;GLRX2;GSTP1;SOD1;TRHDE;DMD;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.7357718582380793,1.2301249982995055,0.23255813953488372,0.877846735522553,1.0,1/5,0.75%,NPR2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.7357718582380793,1.2301249982995055,0.23255813953488372,0.877846735522553,1.0,1/5,0.75%,NPR2
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.5808773383257682,-1.2296837027030556,0.1414141414141414,1.0,1.0,39/82,28.50%,FAM13C;FGF1;AGT;PTN;NDRG1;FAIM2;PLP1;CLIP3;ANK2;SPARCL1;HSPA12A;APOD;DAAM2;MAPK4;MAG;CTHRC1;ASPA;PHYHIPL;LRP4;CPE;GFAP;RCAN2;THY1;SEPTIN9;STMN1;PLPPR4;GPRC5B;TMEM178A;CRYAB;PMP22;MATN2;S100B;SORBS1;GRIA2;OLIG1;AQP4;SEMA3B;CADM3;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.7810339553920319,-1.2295917987401452,0.20270270270270271,1.0,1.0,2/7,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.731671412066352,1.2294108980458855,0.20689655172413793,0.8781102916705017,1.0,3/6,10.15%,LYST;CHMP2B;UBXN6
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.6726029422958472,-1.2294042961939349,0.16666666666666666,1.0,1.0,5/26,8.74%,KCNE1;FA2H;OVOL2;COBL;SLC2A9
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.6524781953501774,1.2286772166787128,0.2903225806451613,0.878689536495599,1.0,2/7,9.32%,APH1A;ADAM10
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6218975056901821,-1.2285670945858997,0.13043478260869565,1.0,1.0,11/48,16.58%,CYCS;CD93;NAPSB;MS4A4A;FGR;FCGR2B;H2AC8;CXCR4;PRDM1;NCF4;KLF4
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5967910680242948,-1.2283069464193481,0.08421052631578947,1.0,1.0,13/73,15.30%,DDIT4;SPOCK1;VEGFA;TGFB2;NR4A2;ID2;RORB;UGCG;MANF;ERCC2;IL1RAPL1;PTPRD;ALK
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6115645326356225,-1.2283057445131984,0.16666666666666666,1.0,1.0,32/60,29.24%,SULT4A1;CASKIN1;MAP1B;ANK2;LRRC4C;EFR3B;APLP1;SRRM3;PAK5;MAPK4;ADGRL3;CTNND2;PTPRZ1;STOX2;PHYHIPL;KCNC1;LRP4;ERC2;TAGLN3;UNC13A;CPE;ATP1B2;CADM2;CLVS2;TMEM59L;CSRNP3;UNC5D;GRIA2;CACNA1B;NDRG4;LINGO1;REEP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6050455111539818,1.228043846136592,0.16,0.878514356047455,1.0,2/8,5.33%,LAPTM5;SIRT1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.6214990834619306,-1.2279743884185257,0.1590909090909091,1.0,1.0,12/42,16.73%,LAMA2;DOCK1;IQSEC1;CKMT2;LAMB1;PRKCQ;TTN;DOCK5;DMD;CXCR4;LDB3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5312109157961883,1.22728072145954,0.1875,0.878773827352354,1.0,5/21,5.78%,ATRAID;TMEM119;TGFB1;PKDCC;ACVR1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5438603952742606,1.2272462020039558,0.15789473684210525,0.8766336674789778,1.0,4/20,5.37%,NEDD4;IDE;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.6838503748687423,-1.227115288932787,0.1686746987951807,1.0,1.0,8/23,23.81%,FGF1;PINK1;IL18;PRR5;INSR;TXN;NRG1;NTRK3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.7607305529976618,-1.2269288688064794,0.19444444444444445,1.0,1.0,1/11,0.58%,TFRC
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.7149758239960154,-1.2268573885438294,0.17333333333333334,1.0,1.0,2/13,2.15%,SRGN;ASPN
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5957245536831548,1.2268054917243156,0.23076923076923078,0.8758776034628094,1.0,4/24,6.08%,DCP1B;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6931791148818676,-1.2266263899674894,0.2077922077922078,1.0,1.0,3/13,10.88%,SRGN;RBPJ;CCL3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.6786824670979474,-1.226626297994838,0.14814814814814814,1.0,1.0,5/20,22.92%,CLDN18;CLDN20;MPP7;PDCD6IP;MICALL2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.6468394953303725,-1.226535223779767,0.19540229885057472,1.0,1.0,6/30,15.13%,GLRA1;ADCY3;ADAM15;BRCA1;CFTR;GRAMD1C
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.6387105490199475,1.225973940596361,0.16666666666666666,0.8757903724674331,1.0,3/10,8.46%,PLA2G7;CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8299291017928576,-1.2258538508164183,0.14285714285714285,1.0,1.0,2/5,10.83%,NLRP12;NLRC5
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7513928035146509,-1.2255712914755756,0.20512820512820512,1.0,1.0,1/8,0.37%,NR4A3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.7968266043678254,-1.2248796620117217,0.22666666666666666,1.0,1.0,2/7,5.01%,EIF4A3;MTHFD1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.7560008412435854,-1.2247465501399069,0.16666666666666666,1.0,1.0,1/10,0.96%,THBS1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7422560076133498,-1.224168349190894,0.13924050632911392,1.0,1.0,3/12,10.88%,CCL4;FLT1;CCL3
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.6323553470599105,-1.2240173381940065,0.17391304347826086,1.0,1.0,3/36,4.35%,THBS1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6552289260028459,1.2239528905452741,0.23333333333333334,0.880772030926627,1.0,4/10,14.80%,PEX13;PEX16;PEX5;PEX2
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6789984677345102,1.2238444321450286,0.3333333333333333,0.8786888793681807,1.0,4/7,20.06%,IPPK;POMK;FGGY;ITPK1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.6253571946446951,-1.223804149278777,0.18681318681318682,1.0,1.0,6/39,14.91%,NUDT12;NUDT16;HSPA1B;SIDT2;RIDA;RNASET2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.5537760858354918,1.2235168250147277,0.17647058823529413,0.8774702097188168,1.0,6/13,12.75%,LGALS9;ITGAM;NMI;SCIMP;TIRAP;IRAK1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.6415214416626285,-1.2234744792218812,0.16279069767441862,1.0,1.0,4/28,14.91%,NUDT16;ENTPD3;SIDT2;RNASET2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.723031467215955,-1.2225206609776416,0.2261904761904762,1.0,1.0,1/10,0.52%,HTR2B
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6957347344805619,-1.2223603192006076,0.13095238095238096,1.0,1.0,1/18,1.07%,ENPP2
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.6886767398767565,1.222244907112672,0.2777777777777778,0.879196883393061,1.0,2/5,9.32%,APH1A;ADAM10
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5066544221562859,1.2222329185965992,0.1111111111111111,0.8767881248084224,1.0,6/22,14.80%,PEX13;PEX16;PEX5;GDAP1;ZFAND6;PEX2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5760762502830673,-1.2222087323778905,0.08163265306122448,1.0,1.0,29/119,20.31%,CCL4;SRGN;GCNT1;TGFB2;HIF1A;IL7;RPL9;GBP2;BRCA1;RPS3A;FGR;FCGR2B;STAT1;IL15;RPS9;RPL39;TPD52;B2M;IL18;TAP1;NCF4;DARS1;TRAF2;HLA-DMB;GPR65;HCLS1;EIF3D;TLR2;THY1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7094474152354563,1.2218528430413027,0.25,0.8762383746206995,1.0,1/5,2.04%,RAP1A
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.8048634697959528,1.2215689427053147,0.22857142857142856,0.8748862632465485,1.0,3/6,15.00%,TMEM79;MAFG;KRT10
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7772938819221941,-1.2213264831194646,0.16901408450704225,1.0,1.0,2/8,12.07%,H2BC11;RPL39
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.6330116666567265,-1.2203401357690395,0.10588235294117647,1.0,1.0,5/32,8.72%,ACVR1B;HMGB2;HIF1A;HSPA1B;STAT1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7093602854836961,-1.2202801026824481,0.18055555555555555,1.0,1.0,3/8,22.98%,HMGB2;KDM1A;EIF2AK2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.6778617669003427,-1.2199152551403036,0.17857142857142858,1.0,1.0,7/25,14.05%,PLPP3;CYP3A5;ALOX12;ALOX15B;DGKI;DGKG;MBOAT2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5671860913018292,1.2198992101464774,0.18518518518518517,0.8787812194605922,1.0,2/10,3.13%,CASP7;RYR1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7110914639715318,-1.2197925425167073,0.2,1.0,1.0,3/10,15.84%,IL7R;IL10RA;GHR
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.5724852795259664,-1.2195878031125489,0.11224489795918367,1.0,1.0,47/104,28.38%,PDE5A;SULT4A1;FAIM2;BRINP1;TCEAL2;AMER2;PLP1;CALY;PDE1A;KCNMA1;NRXN1;PAK5;GRIA4;RAB3C;GDAP1L1;CTNND2;BSN;CPLX1;KCNC1;SNAP25;GABRG2;GRM3;GAD1;SYT4;ATP2B2;NRXN2;ATP1B2;SLC24A2;CADM2;CLVS2;SYP;GAD2;TSHZ1;KIF5A;STMN2;ST8SIA3;CADPS;LY6H;HCN1;CNTNAP2;CA10;SHANK2;GRIA2;SRRM4;VSTM2B;CACNA1B;SLC24A3
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.7998058530514102,1.2195774782262876,0.23076923076923078,0.8776584002881245,1.0,1/5,0.68%,PEX13
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8046618273076296,-1.2192198361900926,0.16417910447761194,1.0,1.0,2/5,15.02%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6546479585853525,-1.2191782031597964,0.18518518518518517,1.0,1.0,5/20,16.92%,CD55;HLA-B;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.811234838814848,-1.219131758235422,0.24324324324324326,1.0,1.0,1/6,3.47%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.7122223501290641,-1.2188974732961462,0.15853658536585366,1.0,1.0,3/16,18.34%,THBS1;SDCBP;CITED2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.7122223501290641,-1.2188974732961462,0.15853658536585366,1.0,1.0,3/16,18.34%,THBS1;SDCBP;CITED2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5731368518379131,1.2187858177571353,0.2,0.878329501711228,1.0,3/16,5.33%,SPRED2;SPRED1;SIRT1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.8422008484317943,-1.218743659951273,0.18571428571428572,1.0,1.0,1/5,1.79%,CYCS
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7952416787179428,-1.218707204828783,0.2,1.0,1.0,1/7,6.80%,NOD2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.729335738990041,-1.21847696239482,0.19444444444444445,1.0,1.0,3/14,12.88%,RGS2;RPGRIP1L;APLP1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.7597287798116772,-1.2184612003232296,0.1917808219178082,1.0,1.0,2/7,13.01%,COBL;CLMP
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7312608018090665,-1.2181333865340949,0.18181818181818182,1.0,1.0,6/13,16.82%,SLC51A;ATP8B1;SLCO1A2;ABCC3;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.7590793710331014,-1.2181132906169247,0.2236842105263158,1.0,1.0,1/7,2.84%,AGT
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.7116689124700997,-1.2175074372004364,0.1927710843373494,1.0,1.0,2/15,6.26%,NUDT16;RPS13
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.6597342796298238,1.2174506351732397,0.3103448275862069,0.8800592173433518,1.0,1/6,6.91%,SYK
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.773122256367351,-1.2166572622578171,0.25,1.0,1.0,2/5,17.37%,DHX58;C1QBP
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5877320289097865,-1.2164152246513384,0.14736842105263157,1.0,1.0,14/72,13.12%,TNFRSF11B;HHIP;CHI3L1;VCAN;TGFB2;SH3PXD2B;SULF2;DDRGK1;PAPSS2;COL10A1;TRPS1;ITGB8;ETS2;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.7248453570059123,-1.216319299881239,0.15384615384615385,1.0,1.0,2/15,1.79%,DDIT4;PAQR3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.8494625832884556,-1.2162617591123268,0.1875,1.0,1.0,2/5,8.06%,GLUL;NMD3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.7666012374397888,-1.2161094691010441,0.16216216216216217,1.0,1.0,1/8,0.96%,THBS1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6398036208694169,-1.2159268047138792,0.18888888888888888,1.0,1.0,6/35,10.87%,THBS1;CBR1;AGT;BRCA1;PINK1;PDK3
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6539225645066721,1.2157763706821743,0.32142857142857145,0.8834443679983136,1.0,2/5,5.33%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.7765667560464908,-1.215219079175747,0.21739130434782608,1.0,1.0,1/11,0.58%,TFRC
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7125157730669868,-1.214973673201689,0.16470588235294117,1.0,1.0,6/16,20.31%,SH3BP5;SH3BP5L;SNX6;CBLB;ERRFI1;THY1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.716386840665684,-1.2144236147383134,0.21875,1.0,1.0,2/8,15.47%,IL7R;PTPRT
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.550397466070074,1.2143441607522154,0.23809523809523808,0.8860189654170704,1.0,4/10,12.72%,PMEPA1;ARID1A;ZMIZ1;PLPP1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7571101495862754,-1.214249066569942,0.2318840579710145,1.0,1.0,2/8,4.91%,ALOX12;ALOX15B
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.5695492649627109,-1.214246557845752,0.07,1.0,1.0,37/100,24.22%,SOCS3;VIM;FGF1;AGT;OPALIN;PTN;FAIM2;BRINP1;TCEAL2;AMER2;PLP1;AANAT;SPARCL1;GPM6B;HSPA2;NRXN1;DAAM2;MAPK4;PTPRZ1;PHYHIPL;SNAP25;GFAP;RCAN2;ADCY8;DIO2;SLC25A28;ATP2B2;ATP1B2;CADM2;BAALC;PLPPR4;GPRC5B;STMN2;TMEM178A;CRYAB;GRIN2A;LY6H
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.7714617315043224,-1.214236140137007,0.2777777777777778,1.0,1.0,1/8,6.91%,VPS11
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.748606825937455,-1.2138661689946377,0.19230769230769232,1.0,1.0,3/9,13.46%,RSAD2;NOD2;IL18
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.622702392538701,-1.2135971441534492,0.12345679012345678,1.0,1.0,2/31,1.56%,PRLR;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5601757997998865,1.2135563347948606,0.2,0.886246576771293,1.0,3/18,4.88%,NRP1;ARAP1;FSCN1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.8181462226503159,-1.2133341919760114,0.21212121212121213,1.0,1.0,3/6,11.51%,TGFB2;ANK2;NOTCH2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.6743990673041187,-1.2132589568595453,0.14942528735632185,1.0,1.0,6/22,16.67%,LRP2;AKR1B1;RDH11;GPC5;GPC3;ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.7511090652233703,-1.2132525478494756,0.2153846153846154,1.0,1.0,2/7,10.88%,SRGN;CCL3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6094688148637002,-1.2132482970896101,0.16129032258064516,1.0,1.0,2/57,0.60%,PCSK1;SRGN
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.7434336517000099,-1.2132403463910024,0.26582278481012656,1.0,1.0,3/10,15.58%,PLTP;ABCB4;ABCB1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.71984581536457,-1.2129402115853858,0.25609756097560976,1.0,1.0,8/14,21.31%,ADGRG6;CDH2;MMP24;METRN;PTPRZ1;SOX4;NFIB;RELN
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7775087288127824,1.2128874221496717,0.26666666666666666,0.8862102488153648,1.0,4/5,21.93%,LRP6;HDAC1;EDA;ANKRD11
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.6840920049023316,-1.212539952795996,0.23076923076923078,1.0,1.0,3/19,8.93%,HIF1A;HSPA1B;PINK1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6127195964844283,-1.2123794098157528,0.15306122448979592,1.0,1.0,2/51,1.26%,DDIT4;ARAF
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6351582673219864,-1.2122955233543624,0.17073170731707318,1.0,1.0,5/34,4.68%,GPR18;HTR2B;TACR1;AGT;C5AR1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.8170679389227735,-1.2122181844583473,0.24242424242424243,1.0,1.0,4/5,18.28%,ADGRG6;BAIAP2L1;PPP1R13L;TRIM16
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6720094993697138,-1.212196673933523,0.2261904761904762,1.0,1.0,2/22,4.00%,HTR2B;TGFB2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.36102983341873535,1.2119295570292417,0.0,0.8872970854298501,1.0,7/85,6.99%,NUP42;CPSF4;NUP188;WDR33;HHEX;FYTTD1;U2AF1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6622707479281326,-1.2113635372076923,0.23595505617977527,1.0,1.0,3/24,6.40%,DIAPH3;CATIP;COBL
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.682554954509881,-1.211115000061612,0.15476190476190477,1.0,1.0,3/22,3.34%,HTR2B;SEMA6A;SEMA3A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7615574924791577,-1.2106668737494137,0.21621621621621623,1.0,1.0,4/9,13.79%,CYCS;UQCRC1;UQCR10;UQCRB
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.673878588676201,1.210531132007758,0.32,0.889423482790128,1.0,5/10,16.82%,HP1BP3;BAHD1;SIRT1;SETD7;SETDB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6632182227867066,-1.2104631227925553,0.25301204819277107,1.0,1.0,9/18,25.52%,PKP2;PLN;ANK2;FGF13;PDE4B;CAV3;CACNA1C;RYR2;AKAP9
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5390400736232493,1.2103766072237077,0.1,0.8875917911351181,1.0,5/45,6.08%,DCP1B;PDE12;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.6659197213915283,-1.2103224085151925,0.21839080459770116,1.0,1.0,1/20,0.03%,KCNE1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7475442475788052,1.2102412227454606,0.3225806451612903,0.8856212210816073,1.0,2/5,14.56%,RPIA;FGGY
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.698754955945589,1.2094604771648636,0.2608695652173913,0.8852907099751152,1.0,3/11,3.41%,DGUOK;ADK;POLD3
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.8195731792473554,-1.2093517929839386,0.18571428571428572,1.0,1.0,2/7,4.06%,TGFB2;RBPJ
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6190842413865698,-1.209297716064618,0.10112359550561797,1.0,1.0,12/39,15.23%,DDIT4;SPOCK1;VEGFA;SEMA3A;NR4A2;CCK;MAP1B;CEP85L;FGF13;ASTN2;GPM6A;ADGRL3
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.7124947658497146,-1.2091757662364784,0.22666666666666666,1.0,1.0,4/12,18.92%,PLPP3;DEGS2;CALM1;PTS
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.5716653032345465,-1.2089707436997228,0.20430107526881722,1.0,1.0,39/81,27.93%,FAM13C;AGT;PCDH17;PPP1R9A;UNC5C;ANK2;SPARCL1;SST;SYBU;ADGRL2;NRXN1;PXK;PAK5;MAPK4;PTPRD;LIFR;PTPRT;STOX2;CNTN1;PHYHIPL;SNAP25;CPE;RCAN2;SYT4;NFIB;ETV1;ASXL3;MAPK10;PLPPR4;STMN2;ST8SIA3;FGF14;MAP2;CSRNP3;LMO3;LONRF2;GRIA2;NOVA1;AQP4
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.7158545829457159,-1.2086653421711697,0.2073170731707317,1.0,1.0,2/13,19.11%,POLR2G;ZFP36
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6889714325047133,-1.2085644933025745,0.18666666666666668,1.0,1.0,3/13,17.27%,FA2H;CAV3;ANXA2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.6762284498509357,-1.2085324629977612,0.22784810126582278,1.0,1.0,2/17,4.00%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6943148572784058,1.2083537839290206,0.2413793103448276,0.8871784021949755,1.0,7/7,30.61%,LYPLA1;ABHD10;PPT1;ABHD17A;ABHD17B;APOE;LYPLAL1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5925914845102868,-1.2080607540321537,0.1595744680851064,1.0,1.0,14/66,22.34%,THBS1;VIM;RPS4X;EIF4A3;PRR16;RBM3;RPL5;EIF3E;SIRT3;EIF3D;CLU;SOX4;EEF2;NSMAF
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7727440352905116,-1.2079520967160622,0.2753623188405797,1.0,1.0,1/8,1.10%,GLA
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.7525444566358176,-1.2078851833261635,0.25,1.0,1.0,2/8,17.58%,RAB11A;LIMK2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.64043169217234,-1.2075729116156304,0.18518518518518517,1.0,1.0,8/29,15.15%,THBS1;CBR1;AGT;GSTP1;SOD1;MAPT;CD36;PID1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.638913045448648,-1.2070230970458362,0.2,1.0,1.0,3/25,3.11%,THBS1;NR4A1;VEGFA
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.8073122167426191,-1.206790403839975,0.23880597014925373,1.0,1.0,2/5,10.67%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.8073122167426191,-1.206790403839975,0.23880597014925373,1.0,1.0,2/5,10.67%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.8371445052868652,-1.2067271225895755,0.2,1.0,1.0,1/5,2.83%,PPP1R15A
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7054312468649871,-1.2065832273394952,0.20833333333333334,1.0,1.0,3/10,4.68%,OR3A2;ADCY3;C5AR1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.5493103836862114,1.206506304948802,0.15,0.8911563439918807,1.0,4/17,8.20%,ICAM1;SEMA4D;SYK;MSN
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.5637793937659965,-1.2062875338385068,0.12121212121212122,1.0,1.0,52/118,27.93%,TMEM163;ENPP2;FA2H;ST18;OMG;OPALIN;CREB5;FAIM2;NFE2L3;AMER2;GALC;PLP1;MOBP;SPARCL1;GPM6B;ANLN;MOG;KIF1B;NRXN1;ERMN;MAPK4;EPHB1;MAG;PTPRT;ASPA;SLC25A19;PHYHIPL;ZDHHC9;GFAP;ADCY8;GRM3;ATP2B2;ATP1B2;NINJ2;NKX6-2;GPRC5B;TF;ST8SIA3;TMEM178A;TTYH1;PEX5L;LY6H;SEC14L5;SLC1A2;ARSG;CA10;SORBS1;GRIA2;OLIG1;MYRF;VSTM2B;AQP4
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7602187979176742,-1.2062262169886053,0.2463768115942029,1.0,1.0,1/5,8.48%,SOD1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7786937026883435,-1.2061090180049503,0.22388059701492538,1.0,1.0,1/5,0.60%,SRGN
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7774744284251898,-1.2059562008456468,0.2537313432835821,1.0,1.0,4/7,20.90%,HLA-B;HLA-F;B2M;HLA-C
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8268547534244444,-1.2053393273047,0.2361111111111111,1.0,1.0,2/6,3.11%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7539946533461359,-1.2052744579039476,0.16883116883116883,1.0,1.0,3/8,16.67%,MT2A;SLC31A2;ATOX1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7877840410078086,1.2051781999727786,0.2962962962962963,0.8933128497214722,1.0,2/5,5.33%,TMEM106A;SIRT1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7670225226692451,-1.2050668625508845,0.20833333333333334,1.0,1.0,5/9,18.42%,TGFB2;RBPJ;SPRY1;OLFM1;PDCD4
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5580490694544529,1.2040790010594988,0.2857142857142857,0.8947250729167716,1.0,3/12,5.37%,JAG1;SLIT3;TGFB1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.6736774652339866,1.20359309156863,0.3157894736842105,0.8941558637821874,1.0,2/6,6.42%,PKD2;SALL1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.7920547022594746,-1.2035880482357284,0.16883116883116883,1.0,1.0,2/5,8.18%,SLC11A1;RPS23
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),0.813977389516958,1.2032135378955369,0.3170731707317073,0.8929332766287715,1.0,5/5,18.63%,SLC46A1;PDPN;FOLR2;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7296974024583784,-1.2029777295233015,0.2328767123287671,1.0,1.0,4/11,14.79%,CEMIP;CACNB2;ANK2;AKAP6
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.6056522850923435,-1.2029058987151202,0.16470588235294117,1.0,1.0,6/40,6.39%,H2BC11;HMGB2;H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.7191221296102842,1.2028859486867998,0.16666666666666666,0.8916442709382392,1.0,2/9,19.12%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7769203317183974,-1.2025171095382667,0.17391304347826086,1.0,1.0,2/8,10.05%,NR4A3;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.8097490132849465,-1.2023897947162787,0.20634920634920634,1.0,1.0,1/5,7.78%,BRCA1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6306974561437578,-1.202169981084226,0.15853658536585366,1.0,1.0,1/25,0.37%,NR4A3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6376643905941503,-1.2015352502061492,0.1744186046511628,1.0,1.0,9/30,19.15%,SLF1;DDX11;FIGNL1;RPA2;ZCWPW1;KDM1A;TIMELESS;FMN2;TERF2IP
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6042975587182446,1.20146701825216,0.21739130434782608,0.893916827803778,1.0,3/11,12.91%,ALG1;MPDU1;ALG3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.6863483410134469,-1.201289253849427,0.2894736842105263,1.0,1.0,1/16,2.31%,NFIL3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.47462662063553496,1.2010183370574967,0.13333333333333333,0.8931384609240488,1.0,3/23,4.85%,SIRPA;LGALS9;ILRUN
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.6159382898854875,-1.200606800701395,0.1111111111111111,1.0,1.0,10/43,12.49%,THBS1;HAMP;MT2A;HIF1A;NDRG1;MAPT;ATP5F1D;TTN;CALM3;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5407205801182198,1.2003893779233934,0.058823529411764705,0.8927249721843555,1.0,1/22,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.6233072428973443,-1.2002580432884509,0.19318181818181818,1.0,1.0,9/34,21.53%,CASP5;BASP1;PLP1;CALM3;PADI2;HSPA5;CALM1;SUDS3;CKB
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.67946767782024,1.2001867578791159,0.2413793103448276,0.8909457370565088,1.0,4/6,27.75%,RFX3;GSK3B;RHEB;AKT1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.5619114139448436,-1.1994023602356705,0.10204081632653061,1.0,1.0,51/114,28.50%,FAM13C;TUB;SULT4A1;FAIM2;CCK;BRINP1;PPP2R5B;PCDH17;MAP1B;ANK2;LRRC4C;ATF5;KIF1B;NRXN1;PAK5;AKAP6;MAPK4;TTBK2;GDAP1L1;ADGRL3;NEFM;MFSD6;CNTN1;PHYHIPL;KCNC1;TOX;TAGLN3;SNAP25;CPE;KCTD16;SYT4;CADM2;CLVS2;TSHZ1;ASXL3;MAPK10;PLPPR4;STMN2;ST8SIA3;TMEM59L;LY6H;MAP2;CSRNP3;CA10;GRIA2;LSAMP;NOVA1;CRMP1;CACNA1B;CADM3;NDRG4
prerank,PanglaoDB_Augmented_2021__Neurons,-0.5577351754052595,-1.1993133501071103,0.08,1.0,1.0,76/199,26.13%,SCRG1;MAP7D2;SLC11A1;SULT4A1;BEX1;AIM2;RORA;PQBP1;IFIT3;FAIM2;CCK;BRINP1;TCEAL2;AMER2;CHN1;NWD2;PPP1R9A;CALY;CAMK2N1;PDE1A;BEX2;KCNMA1;VGF;ENO2;SLC17A7;NRXN1;PAK5;GPR162;GRIA4;RAB3C;GDAP1L1;NEFM;TMEM130;BSN;FRRS1L;PCSK2;B3GAT2;PHYHIPL;CPLX1;SH3GL2;KCNC1;ERC2;TAGLN3;SNAP25;UNC13A;GABRG2;GRM3;ZNF445;GAD1;SCN1A;SYT4;ATP1B2;CADM2;CLVS2;SYP;SCN3B;GAD2;KIF5A;DYNC2I1;RNPC3;GNAI1;STMN2;ST8SIA3;RYR2;CADPS;DGKB;PNMA8A;TMEM59L;DYNC1I1;LY6H;MATN2;CSRNP3;NRGN;CNTNAP2;CA10;VSNL1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4563878634375067,1.1991064409781529,0.2,0.8917248009856088,1.0,11/49,16.30%,CSF1R;CBFB;MED24;AGO1;TP53;MECP2;MED27;MITF;MOV10;MED4;TCF7L2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.7632384489656546,-1.1988095488302266,0.3108108108108108,1.0,1.0,4/7,17.62%,C5AR1;CR1;C5AR2;FPR1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.6570049909070639,-1.1982385165246479,0.2222222222222222,1.0,1.0,3/23,9.97%,BRIP1;CLSPN;DONSON
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.7859917734794171,-1.1982125598120938,0.21739130434782608,1.0,1.0,3/5,16.73%,TTN;CDH2;CAV3
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5481124863124219,1.1981004631438081,0.14285714285714285,0.8927505923720622,1.0,6/22,12.16%,RAP1A;ICAM1;PPP1R16B;RAPGEF6;MSN;RAP2C
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.6564977181683459,-1.1977448593756022,0.3058823529411765,1.0,1.0,6/19,16.73%,VEGFA;ANK2;TTN;DMD;KDM1A;CAV3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6700142320954107,-1.1977287896516728,0.25301204819277107,1.0,1.0,9/18,25.52%,PKP2;ANK2;CALM3;FGF13;CAV3;CALM1;CACNA1C;RYR2;AKAP9
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7163836679850274,-1.1975847091860117,0.2289156626506024,1.0,1.0,7/15,18.85%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;VPS9D1;ATP5MC1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7621309022945362,-1.1975777155206164,0.273972602739726,1.0,1.0,2/8,10.08%,THBS1;PRKCE
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4295809836091853,1.1970814581530322,0.1111111111111111,0.8934496762723686,1.0,15/37,17.55%,NEDD4;MAPK13;TP53;ERCC4;EIF2S1;EIF2AK4;SDE2;ZBTB1;EP300;CASP9;USP28;OPN3;INO80;FMR1;PARP1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.6069641534512907,-1.197061193563521,0.18947368421052632,1.0,1.0,10/47,4.58%,PDE5A;VIM;PLPP3;ASPN;SPARC;VEGFA;ADAMTS2;ECM2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6345966606498429,-1.1968460341498954,0.2777777777777778,1.0,1.0,5/25,11.64%,HTR2B;TXK;C5AR1;FLT1;RASGRP4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5849170993770623,-1.1965364172313149,0.16304347826086957,1.0,1.0,18/51,26.58%,RPS27A;UBA52;UBC;PSMA5;PSMA3;PSMD8;ORC6;UBB;PSMB4;MCM3;MCM6;MCM7;PSMD7;PSMD5;PSMB9;MCM5;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.8136635497604432,-1.1962087086074416,0.22784810126582278,1.0,1.0,1/5,4.31%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.8136635497604432,-1.1962087086074416,0.22784810126582278,1.0,1.0,1/5,4.31%,SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7314230090309835,1.1962036731243653,0.21621621621621623,0.8933613201785469,1.0,3/6,14.25%,CD180;SCIMP;LY86
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.577956200833776,-1.196116607815648,0.09090909090909091,1.0,1.0,18/118,16.92%,PRLR;CENPF;RPL38;COX7A2;CCDC39;VBP1;STXBP6;MAPT;CALY;DMD;CENPE;ANLN;MID1IP1;FCHO2;HIGD1C;AP2S1;NSG2;TRAF2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.6728928374401583,1.1961005126059197,0.28,0.8914963176400656,1.0,1/8,0.96%,DR1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.6487796412373676,-1.1960098377456574,0.2247191011235955,1.0,1.0,2/25,10.19%,OSBPL5;ABCA5
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.6947231583380029,-1.1959528263076984,0.20481927710843373,1.0,1.0,3/17,6.69%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.6856439959615392,1.195675762526689,0.28205128205128205,0.8910233513595435,1.0,3/6,26.45%,TREM2;PRKCI;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7721842765740561,-1.1956369897627261,0.21428571428571427,1.0,1.0,1/7,1.69%,RGS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7297262463229823,-1.1955416903274352,0.19117647058823528,1.0,1.0,4/9,14.35%,AGT;ALOX15B;IL18;CD36
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.6941999777093235,-1.1955367351887272,0.3055555555555556,1.0,1.0,4/17,8.99%,H2BC11;HMGB2;SLC11A1;RPL30
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.712887084687661,1.1954918111944426,0.32432432432432434,0.8894211377469271,1.0,1/5,2.02%,TEX264
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6649300484580805,-1.195442822609692,0.18292682926829268,1.0,1.0,4/21,8.38%,CEBPD;OVOL2;HIF1A;UXT
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.7873723892970919,-1.1951677884294827,0.2857142857142857,1.0,1.0,1/5,4.64%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.7873723892970919,-1.1951677884294827,0.2857142857142857,1.0,1.0,1/5,4.64%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.7873723892970919,-1.1951677884294827,0.2857142857142857,1.0,1.0,1/5,4.64%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.6668346688149124,-1.1950035868576092,0.1951219512195122,1.0,1.0,1/25,0.08%,TOP2A
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7666534091420143,-1.194947477503547,0.3088235294117647,1.0,1.0,1/8,0.29%,SOCS3
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.7284755538181025,-1.1947089050682882,0.26666666666666666,1.0,1.0,1/8,7.78%,BRCA1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.6589495745130872,-1.1946662458194313,0.32051282051282054,1.0,1.0,5/16,18.50%,NAPA;GRIK1;SLC17A7;CDH8;UNC13A
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8098199928609524,-1.1943466074855276,0.22950819672131148,1.0,1.0,1/5,0.84%,CYREN
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6691333286417345,-1.1943390748110736,0.18604651162790697,1.0,1.0,7/26,20.29%,VIM;RPS27A;UBA52;UBC;CFTR;UBB;ATG5
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7951477240850817,-1.1943103561862016,0.2631578947368421,1.0,1.0,2/7,11.07%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.6317164035675723,1.1941965543233894,0.28,0.8915307905658846,1.0,6/9,17.34%,ALOX5AP;MGST2;MGST3;ALOX5;GGT7;LTC4S
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6885739309164943,-1.1941466518556765,0.2222222222222222,1.0,1.0,2/13,3.16%,MX2;IFITM3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.7275404786283172,1.1941261828009317,0.21212121212121213,0.8894778957655379,1.0,3/8,9.62%,SRD5A1;CYP19A1;DHRS9
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7011290854666075,-1.1932830838309036,0.26865671641791045,1.0,1.0,3/6,21.81%,NRXN1;CDH23;TPP1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7598486492991101,-1.193172719685246,0.2602739726027397,1.0,1.0,1/7,0.37%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.7068483839741619,-1.193131501303703,0.25757575757575757,1.0,1.0,5/11,27.49%,WDR5;BRCA1;KDM1A;DNMT1;JARID2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3670253776935861,1.1926189677021564,0.0,0.8930159313122937,1.0,9/92,5.58%,PHLDB2;BCL9L;NEDD4;ARHGAP35;DAG1;ZRANB1;SEMA4D;TGFB1;ABI3
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.623364328615482,1.1925553501798996,0.24,0.8910745896739138,1.0,1/10,5.34%,ITPA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.6815464942025395,1.1923245954743094,0.36666666666666664,0.8895969010042383,1.0,2/5,18.33%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6709751200567157,-1.1919645626858377,0.22535211267605634,1.0,1.0,4/15,19.39%,AGT;PLN;CAV3;PER2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.7225662201347025,-1.1919257035925719,0.24324324324324326,1.0,1.0,1/12,1.73%,NEK11
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6658397447863225,-1.1917079761999099,0.23170731707317074,1.0,1.0,3/19,4.68%,HTR2B;TXK;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.4933020866604566,1.1915308563592542,0.25,0.8911226003263656,1.0,15/49,9.39%,ACER2;NEXMIF;PLXNA2;DSCAM;ARHGDIB;JAG1;SEMA4D;SIPA1;TGFB1;PLXNA4;GCNT2;SERPINE1;CDH13;ADAM10;NF2
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7559140498061143,1.1914536130582845,0.25925925925925924,0.8868714995768312,1.0,2/5,9.59%,ENPP1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7559140498061143,1.1914536130582845,0.25925925925925924,0.8868714995768312,1.0,2/5,9.59%,ENPP1;INPP5K
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.8135489018872735,-1.1911881422364012,0.18181818181818182,1.0,1.0,1/6,10.34%,CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.8135489018872735,-1.1911881422364012,0.18181818181818182,1.0,1.0,1/6,10.34%,CXCR4
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.6646320927360488,-1.1908982365577578,0.2535211267605634,1.0,1.0,6/14,16.75%,TOM1L1;OVOL2;SH2D4A;BAIAP2L1;USP43;ENAH
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7590093662362163,-1.1905182956334293,0.23076923076923078,1.0,1.0,1/12,0.29%,SOCS3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.4952285738996878,1.1903819335118462,0.23076923076923078,0.8876664427507189,1.0,6/22,15.17%,ZMYND11;SUPT16H;WDR43;THOC5;SCAF8;KAT7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4971056954319432,1.1903366630124306,0.3,0.8858012582507641,1.0,7/23,21.00%,BID;TP53;YWHAG;PPP1R13B;YWHAE;BCL2;GSK3B
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.5905249870945642,-1.190112912072268,0.17582417582417584,1.0,1.0,31/69,27.75%,SULT4A1;PTN;RBM3;PLP1;GPM6B;APLP1;IFI44;IFIT1;SRRM3;PAK5;MAPK4;ADGRL3;CTNND2;PTPRZ1;STOX2;PHYHIPL;TAGLN3;INAFM2;S100A6;GFAP;RND3;CLVS2;STMN2;TMEM59L;LY6H;MAP2;CSRNP3;S100B;GRIA2;PARP12;CRMP1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7022141509818813,-1.1900086847259441,0.24358974358974358,1.0,1.0,4/10,18.28%,DUOX1;STAT1;VGF;TRIM16
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.5799985593376342,-1.1899478832032133,0.09183673469387756,1.0,1.0,56/119,30.15%,TMEM163;SULT4A1;NEFL;BRINP1;CHN1;MAP1B;ANK2;GPM6B;KIF1B;LNPK;APLP1;PAK5;MAPK4;GDAP1L1;ADGRL3;NEFM;LINGO2;SH3GL2;KCNC1;SYT1;ERC2;TAGLN3;SNAP25;SYT4;CADM2;CLVS2;KCNH7;RELN;SLC25A36;KIF5A;EPHA7;NRG1;MAP9;SRGAP3;STMN2;ST8SIA3;TMEM59L;DYNC1I1;KIF5C;MAP2;INSYN2A;CSRNP3;CNTNAP2;GRIA2;FAM171B;NOVA1;CRMP1;CACNA1B;NDRG4;LINGO1;RIPOR2;REEP2;ABI2;NCAN;EDIL3;PNMA2
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.6818688117124639,-1.18948606000446,0.18181818181818182,1.0,1.0,3/20,13.19%,NR4A3;APLP1;PDE4B
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6527343587580579,1.1887735565437545,0.25,0.8887284849167701,1.0,2/13,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7840447354218021,-1.1886821050801,0.28,1.0,1.0,3/5,20.05%,CFL1;IGF2R;PPIB
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6914894155698628,-1.1886730390935294,0.1927710843373494,1.0,1.0,5/17,12.40%,IFITM3;AIM2;STAT1;IRF1;MNDA
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.5562118671542142,-1.1881593811853575,0.1717171717171717,1.0,1.0,54/104,28.50%,FAM13C;SULT4A1;FAIM2;BRINP1;TCEAL2;AMER2;MAP1B;PLP1;ANK2;FGF13;SCN9A;KIF1B;NRXN1;PAK5;GRIA4;MAPK4;PTPRD;RAB3C;GDAP1L1;NEFM;PIEZO2;PHYHIPL;CREBRF;SH3GL2;KCNC1;ERC2;TAGLN3;SNAP25;KCTD16;ADCY8;SYT4;CADM2;CLVS2;SCN3B;KIF5A;ASXL3;MAPK10;PLPPR4;STMN2;ST8SIA3;LY6H;KCNAB2;MAP2;CSRNP3;CA10;GRIA2;LSAMP;NOVA1;MAGI2;CRMP1;AQP4;CACNA1B;CADM3;NDRG4
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7109408778778278,1.1880810533781228,0.3333333333333333,0.8864926991488364,1.0,3/6,20.99%,NSUN2;SETD2;TPR
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7109408778778278,1.1880810533781228,0.3333333333333333,0.8864926991488364,1.0,3/6,20.99%,NSUN2;SETD2;TPR
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5565830206142688,-1.1877799810417347,0.04040404040404041,1.0,1.0,68/199,25.41%,TMEM163;TACR1;PIANP;SULT4A1;RORA;PDE4A;CCK;BRINP1;TCEAL2;AMER2;CHN1;PDE1A;RORB;HSPA12A;SST;KCNMA1;VGF;ADGRL2;SLC17A7;NRXN1;PAK5;GRIA4;MAPK4;RAB3C;GDAP1L1;CTNND2;NEFM;BSN;SLC16A1;FRRS1L;PCSK2;PHYHIPL;CPLX1;SH3GL2;KCNC1;SYT1;RAB15;ERC2;TIMELESS;TAGLN3;SNAP25;UNC13A;ADCY8;GABRG2;GRM3;GAD1;SYT4;ETV1;CADM2;CLVS2;SYP;HPCAL4;RELN;GAD2;KIF5A;FAM81A;SRGAP3;STMN2;ST8SIA3;NTNG1;TMEM59L;LY6H;MAP2;CSRNP3;OPRM1;AGAP1;NRGN;LMO3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5814144727099143,1.1875486949076988,0.2608695652173913,0.8861174203946977,1.0,4/14,9.49%,CEBPA;HHEX;LATS2;TFAP4
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5672928464214955,-1.1872679412743306,0.04040404040404041,1.0,1.0,78/291,18.52%,RPL23;RPL37A;RPL38;RPS27A;RPS4X;EIF4A3;RPS27;RPL23A;RPS25;RPS11;RPS20;RPLP2;RPS24;RPS6;RPL3;RPS18;RPL37;RPL11;RPL12;RPL32;RPL14;RPL35;RPS21;RPS13;NR4A2;RPL36;RPL10A;RPL9;RPL4;RPS8;RPL28;RPS12;RPL31;RPL19;RPS3A;RPS23;POLR2G;RBM3;RPL24;RPLP1;RPL30;MRPL43;PAX8;EEF1A2;COPS5;RPS9;RPL13A;RPS14;RPL27A;RPL41;PTMA;RPS15;RPL39;RPL6;RPL21;MRPS7;RPL5;RPL18A;ANGPT2;RPL15;RPL34;TSPAN32;RPS7;RPL7A;EEF1A1;RPL7;RPLP0;RPS16;DARS1;MRPL51;TFIP11;RPS2;AGFG1;RPS3;RPL27;RPL8;SRSF5;MRPL27
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.632822647385006,-1.1870407612921523,0.2261904761904762,1.0,1.0,8/33,14.49%,RPL23;RPL11;DDRGK1;NOP53;CAMLG;RPL5;SDCBP;RPS7
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7136141209031901,-1.1866792198394462,0.2631578947368421,1.0,1.0,2/11,4.00%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.6599695225617751,-1.1865525416054516,0.26506024096385544,1.0,1.0,2/21,8.77%,NUDT16;TENT4B
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.6106053335075897,1.1865450045073076,0.2608695652173913,0.8870389561024367,1.0,5/9,13.03%,SUPT16H;MTA2;TP53;CDAN1;RBBP4
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.6889272034649402,-1.1864760193031127,0.22784810126582278,1.0,1.0,3/17,8.49%,WDR12;RPS21;ERI2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6800305610416079,1.1864004877999685,0.3333333333333333,0.885236315485896,1.0,3/6,18.71%,RPS6KA4;FMR1;IL1B
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.742473358486084,1.1863954905883245,0.30434782608695654,0.8831032159305082,1.0,2/8,1.58%,DGUOK;ADK
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.7614708917625218,-1.1863820595951018,0.21333333333333335,1.0,1.0,1/8,0.96%,THBS1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.477364448934051,1.1860730269348252,0.3333333333333333,0.8820630312064797,1.0,3/14,3.20%,RALB;PDE12;CGAS
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5864675474864555,-1.1859629277489079,0.14583333333333334,1.0,1.0,25/91,15.27%,THBS1;TNC;MMP21;SPARC;VCAN;ADAMTS2;THSD4;ECM2;LAMA2;ADAMTS19;FBN2;ADAM15;LAMB1;COL11A1;COL10A1;ITGB8;TGFBI;ITGAE;APLP1;MMP24;COL23A1;FN1;COL4A5;ITGA2;ITGA6
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6014622405916894,1.1858404794230542,0.22727272727272727,0.8806903156157686,1.0,2/10,6.39%,BCL2L1;BID
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.559282420484725,-1.1858125307676948,0.12244897959183673,1.0,1.0,42/100,28.37%,VIM;OPALIN;RFTN2;FAIM2;AMER2;PLP1;LRRC4C;SPARCL1;GPM6B;KIF1B;NRXN1;METRN;AKAP6;GRIA4;PTPRZ1;TRPM3;PHYHIPL;CHL1;GFAP;ADCY8;GRM3;NRXN3;SCN1A;ATP2B2;ATP1B2;CADM2;CLVS2;BAALC;SEPTIN4;MAPK10;PLPPR4;ST8SIA3;GRIN2A;NTRK3;S100B;SLC1A2;CA10;GRIA2;LSAMP;MAGI2;AQP4;CADM3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6189854687952203,-1.1857252951865707,0.20212765957446807,1.0,1.0,4/49,3.11%,TFRC;ARAF;MTCP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.6098459431165005,-1.1854627220981349,0.14736842105263157,1.0,1.0,12/61,9.25%,HTR2B;RGS2;PAQR3;FGF1;AGT;VEGFA;GSTP1;SPRY1;NOD2;DUSP1;FLT1;DIRAS2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.7889561697114149,-1.1851827346579107,0.22077922077922077,1.0,1.0,2/7,1.81%,NR4A3;LRP2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.523031184022261,1.1850764984497524,0.2857142857142857,0.8808730446162353,1.0,4/20,8.90%,NDE1;TRAK2;KIF1C;KIF3B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.6981833377750606,1.184872233210444,0.3,0.8777172486815131,1.0,4/6,21.97%,LYPLA1;ABHD10;PPT1;ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.6981833377750606,1.184872233210444,0.3,0.8777172486815131,1.0,4/6,21.97%,LYPLA1;ABHD10;PPT1;ABHD17A
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.646810537955139,-1.1845362192250413,0.2564102564102564,1.0,1.0,3/16,6.09%,ANKUB1;ATP5MK;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.7494774346253618,-1.1843337079689196,0.2727272727272727,1.0,1.0,2/8,9.29%,PRKAR2B;PKIA
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.621912721657391,1.1843052840022004,0.21875,0.8775379932757873,1.0,4/8,17.88%,UBE2J1;OS9;YOD1;SVIP
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.7887103360101786,-1.183818098302409,0.2676056338028169,1.0,1.0,1/5,3.40%,ALOX12
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.6645490878753992,-1.1837822713410004,0.2857142857142857,1.0,1.0,2/12,13.77%,GK;DGAT1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5772442189756376,-1.1837074866001127,0.13541666666666666,1.0,1.0,21/70,25.55%,RPS27A;VEGFA;HIF1A;RBX1;EGLN3;LIMD1;UBA52;ATF3;UBC;PSMA5;PSMA3;PSMD8;UBB;PSMB4;IMPACT;ELOB;KLF2;PSMD7;PSMD5;PSMB9;PSMC2
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.81656510021519,-1.1834456380017901,0.22535211267605634,1.0,1.0,1/5,15.31%,TAP1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.61652686708929,1.1830570678223313,0.17391304347826086,0.879894344839981,1.0,4/10,10.95%,SESN2;SESN3;EIF2AK4;RRAGD
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.8398146872580474,-1.1830544999523103,0.208955223880597,1.0,1.0,2/5,8.74%,SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.646796427753425,-1.1829615748349702,0.2159090909090909,1.0,1.0,1/21,0.29%,SOCS3
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6850080040163127,-1.1827950835642427,0.3108108108108108,1.0,1.0,4/11,19.64%,PARP9;PARP14;PARP11;PARP15
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.5710322683701695,-1.1827347929498537,0.16842105263157894,1.0,1.0,10/52,15.70%,TFRC;MACC1;CYP3A5;ATP5MK;COBL;TRHDE;ITGB8;PDZD2;CFTR;SLC16A7
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.7207193133855888,-1.1826768479938154,0.2875,1.0,1.0,3/9,13.20%,HAMP;HIF1A;B2M
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.6598283810002288,1.1826421422502322,0.27586206896551724,0.878779139884043,1.0,3/7,6.02%,PKD2;LOXL3;ZPR1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8147162193579552,-1.1824692717281373,0.23076923076923078,1.0,1.0,1/5,2.69%,SYCE2
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8147162193579552,-1.1824692717281373,0.23076923076923078,1.0,1.0,1/5,2.69%,SYCE2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.662455176382513,1.1823882916945194,0.23529411764705882,0.8777687795794452,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.8303853406746435,-1.1822438897182022,0.27692307692307694,1.0,1.0,2/5,7.60%,P4HA3;EGLN3
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.6760635514595866,-1.181962683050272,0.28378378378378377,1.0,1.0,2/10,10.34%,GPR183;CXCR4
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7266518286956318,-1.181426609018096,0.2891566265060241,1.0,1.0,6/12,21.31%,TGFB2;CDH2;MMP24;METRN;NFIB;RELN
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5552454227234108,-1.1813591501906358,0.17525773195876287,1.0,1.0,29/98,25.55%,RPS27A;H2BC11;HMGB2;RBX1;CENPV;RPA2;UBA52;UBC;PSMA5;RPA3;PSMA3;ERCC2;H2BC9;PSMD8;ORC6;UBB;PSMB4;MCM3;DDB1;H2BC5;MCM6;MCM7;PSMD7;NAP1L2;PSMD5;PSMB9;SART3;MCM5;PSMC2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.6526999150360997,-1.1810237340477512,0.21839080459770116,1.0,1.0,11/26,24.28%,TUBB4A;CLIP3;HDGFL3;FGF13;MID1IP1;APC2;TTBK2;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6969156076560463,1.1808463267221272,0.375,0.8804722381411535,1.0,2/5,14.49%,AGO1;MOV10
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.798128293826667,-1.1801553503603779,0.25675675675675674,1.0,1.0,3/5,12.56%,AANAT;SAT2;SAT1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.6198108544130096,-1.1790111477571137,0.2777777777777778,1.0,1.0,14/26,32.52%,NEFL;DAPK1;GRIA4;RELN;LRRC7;GRIN2A;OPRM1;CRHBP;GRIA2;CAMK2B;APP;ACTN2;MAPK8IP2;DLG4
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4718138585568621,1.1789913134830663,0.18181818181818182,0.883724665816311,1.0,8/25,10.73%,MAP3K10;DAB2IP;MAP3K5;ZNF675;MAP3K4;MAP3K11;TRAF6;DVL2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6939784792735992,-1.178955604120681,0.25925925925925924,1.0,1.0,3/14,10.42%,NR4A3;CLIP3;APPL1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5789893657705145,-1.1783592818361621,0.1797752808988764,1.0,1.0,16/52,22.43%,CENPF;FANCI;WDHD1;PAICS;ZGRF1;SUV39H2;RFC4;ATAD5;KDM1A;MCM3;KIF11;DNA2;LIG3;HK2;KNTC1;POU5F1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6581655952277152,-1.1783060254348534,0.2839506172839506,1.0,1.0,3/21,3.34%,THBS1;SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.6361533189177672,-1.1782885183099086,0.25882352941176473,1.0,1.0,1/20,0.33%,GLRA1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.7911672041951705,-1.1777919851264387,0.2753623188405797,1.0,1.0,2/5,10.05%,NR4A3;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.7566949810689727,-1.177330938423126,0.3148148148148148,1.0,1.0,3/6,12.75%,HS3ST5;PROCR;THBD
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.7285510400193489,-1.17710040557255,0.28169014084507044,1.0,1.0,1/8,3.75%,OVOL2
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.7869475889964153,-1.1770926735873015,0.25,1.0,1.0,3/7,14.27%,DUOX1;CLCA4;CFTR
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5627905112413029,-1.1769117152632307,0.1326530612244898,1.0,1.0,39/127,20.95%,CLEC12A;CCL4;ADGRE1;RGS2;RGS1;JAML;SIRPB2;IFITM3;VCAN;MX1;C5AR1;SELL;TNFRSF1B;IFIT3;CD163;FGR;FCGR2B;TYMP;IL10RA;CXCR4;CCL3;MS4A6A;MNDA;IFIT1;FN1;CD36;LSP1;VNN2;NCF4;PYCARD;NCF2;FPR1;CD44;AIF1;TLR2;S100A4;NFKBIZ;FCGR2C;CD300A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7008807449024402,-1.1767987652326029,0.2676056338028169,1.0,1.0,2/9,8.81%,IHO1;ZCWPW1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.6811132362723493,-1.1766643928789107,0.2222222222222222,1.0,1.0,5/18,11.26%,DNAH11;MMP21;ENKUR;CCDC39;STIL
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6676210632235624,-1.175983616722694,0.2441860465116279,1.0,1.0,5/16,13.46%,NOD2;SLC7A5;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.7038763524451499,-1.1757445229637498,0.2692307692307692,1.0,1.0,6/12,19.74%,AQP11;FCGR2B;NR1H2;EIF2AK3;MANF;CLU
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.563160220951,-1.175677794247927,0.15789473684210525,1.0,1.0,20/76,23.03%,BRIP1;WDHD1;RPA2;BRCA1;CLSPN;DONSON;RFC1;RPA3;RFC4;ING4;ING5;ORC6;TIMELESS;MCM3;POLL;DNA2;POLE2;MCM6;MCM7;POLG2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6296225991858084,-1.17542556574021,0.29545454545454547,1.0,1.0,14/24,33.30%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;MICOS13;ATP5MC1;APOO;ATP5F1C;SPG7;IMMT;AFG3L2;ATP5MC3;ATP5MC2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5261246425282463,1.1753154383809836,0.2631578947368421,0.8933234352786874,1.0,3/11,6.91%,PLXNA2;NRP1;PLXNA4
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.45495322323687726,1.1748990824201446,0.2,0.8907991505087931,1.0,4/47,6.13%,NUP42;NUP188;AGO1;POLR2C
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.45495322323687726,1.1748990824201446,0.2,0.8907991505087931,1.0,4/47,6.13%,NUP42;NUP188;AGO1;POLR2C
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.8233876717856202,-1.174818117094843,0.26666666666666666,1.0,1.0,2/5,8.92%,GLA;GALC
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.601023144321489,-1.17447768514717,0.24096385542168675,1.0,1.0,8/30,20.32%,GLRA1;SLC12A8;CFTR;GABRB1;GABRA3;GABRG2;ANO4;GABRB3
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.7582184800608415,-1.1744375193385381,0.3013698630136986,1.0,1.0,1/6,7.78%,BRCA1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.7449000077978194,-1.1742606116546421,0.22666666666666666,1.0,1.0,4/7,19.74%,SOD1;CXCR4;EPB41L3;CLU
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.6763190869535785,-1.1742394882276295,0.26582278481012656,1.0,1.0,5/18,11.59%,SVIL;CENPV;RACGAP1;PRKCE;CIT
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.3163423842390291,1.1742353637390957,0.0,0.8907241502034536,1.0,20/144,5.80%,ATRAID;ZNF703;BCL9L;RIN2;SERPINF2;RAP1A;ZNF385A;TMEM119;MMD;FFAR4;LPL;PPARG;PDPN;TGFBR2;TGFB1;PKDCC;ZC4H2;MAPK11;ACVR1;ABL1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.5805172251106022,-1.1738707936366928,0.23333333333333334,1.0,1.0,9/35,23.86%,TFRC;WDR5;BAIAP2L1;PRDX4;RPL8;KDELR1;PES1;TRAP1;HNRNPAB
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.4154866018098185,1.173818741221137,0.18181818181818182,0.8901923191867782,1.0,9/39,11.36%,CD276;LCP1;LEPR;SCRIB;NCK2;EIF2AK4;MSN;CHD7;DDOST
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.8010036518105622,-1.173755993292216,0.18309859154929578,1.0,1.0,2/5,17.67%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.4681060081921402,1.173701214282401,0.2631578947368421,0.8885878092747633,1.0,7/27,9.32%,DAG1;CTSH;TGFB1;MYH9;APH1A;TRAF6;ADAM10
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.7757903264448924,-1.173492386364652,0.23943661971830985,1.0,1.0,2/6,5.11%,MDH1;ME1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.554466875812944,-1.173193606827001,0.12244897959183673,1.0,1.0,29/119,22.18%,THBS1;VIM;RPS4X;EIF4A3;HIF1A;PRR16;CNEP1R1;NMD3;RBM3;APPL1;NR1H2;MID1IP1;RPL5;CD36;ATAD5;NR1D1;RGCC;KLF4;INSR;EIF3E;IRS2;EIF3D;CLU;SOX4;DDB1;DNA2;EEF2;MFSD2A;KLF2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6139677159307323,-1.172569431349893,0.2716049382716049,1.0,1.0,4/24,12.14%,RPS27A;NOD2;UBA52;UBC
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.6868906475553574,-1.1724700184586248,0.3108108108108108,1.0,1.0,2/11,13.48%,VEGFA;DGKG
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6273033693045835,-1.1720617025961804,0.29069767441860467,1.0,1.0,7/20,24.93%,OIP5;CENPV;ITGB3BP;CENPI;CENPP;CENPU;CENPK
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6567967597505544,-1.1717913984694097,0.2911392405063291,1.0,1.0,6/19,16.92%,CD55;NOD2;SLC7A5;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6017723897288008,1.1717185391618836,0.15789473684210525,0.8930040966505851,1.0,2/10,8.28%,NCOA4;SERPINB9
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.7072554755375726,-1.171262661611768,0.2608695652173913,1.0,1.0,2/9,13.77%,GK;DGAT1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.8023141933071611,-1.1712321473276484,0.22413793103448276,1.0,1.0,2/5,10.56%,FBN2;LTBP1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.7076673850989759,1.170779565975395,0.32,0.8936705946379759,1.0,2/7,21.02%,GTF2H2;SSBP1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7098760631767641,-1.1707680586012865,0.25316455696202533,1.0,1.0,6/14,18.85%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;ATP5MC1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.6971045940987519,-1.1707302471284655,0.2631578947368421,1.0,1.0,2/11,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.7175924804632011,-1.1706644778978648,0.323943661971831,1.0,1.0,3/9,10.67%,VEGFA;RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.578916243698587,-1.170593662001488,0.20238095238095238,1.0,1.0,20/42,31.91%,GLRA1;SLC12A8;SLC4A10;CFTR;GABRB1;GABRA3;CLIC4;GABRG2;ANO4;GABRB3;TTYH1;GABRA2;BEST1;SLC12A7;GABRB2;GABRA4;LRRC8A;CLIC1;SLC6A1;GLRB
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.7644879655969176,-1.1704597601763984,0.3181818181818182,1.0,1.0,1/5,8.89%,SSB
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6767387056200983,-1.1702567565555402,0.2839506172839506,1.0,1.0,3/12,10.87%,DUOX1;SOD1;PRDX4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.47965874052428936,1.1698143131171657,0.25,0.8947870030649565,1.0,1/15,0.78%,NDE1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.792189358654047,-1.168870584720387,0.2608695652173913,1.0,1.0,3/6,8.93%,TOMM7;ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.7053149073964836,-1.168791943407522,0.3013698630136986,1.0,1.0,2/10,8.29%,AQP11;HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7499740601799759,-1.1686926222878602,0.3108108108108108,1.0,1.0,3/6,19.55%,TXNIP;ORC6;E2F7
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5387614993627826,-1.1686920683949404,0.08080808080808081,1.0,1.0,64/166,29.12%,GLRA1;HTR2B;CHRM5;NAPA;PRKAR2B;GRIK1;RIMS1;CACNB2;HTR7;PLP1;KIF1B;SST;SLC17A7;NRXN1;RAB3A;NLGN3;SDCBP;GRIA4;BSN;HTR1F;GABRB1;GABRA3;CDH8;CPLX1;SYT1;SPG11;ERC2;CALM1;SNAP25;UNC13A;GABRG2;GRM3;GAD1;KCNMB1;GABRB3;AMPH;NRXN2;GAD2;KIF5A;CBLN2;DVL1;RPS6KA2;GRIN2A;GABRA2;UNC13C;PMP22;SLC1A2;NRGN;AKAP9;PRKACB;NLGN2;CRHBP;GRIA2;CHRM3;CHRM2;NOVA1;GABBR2;CACNA1B;SLC12A7;GRIK2;GABRB2;NAAA;GRIK4;HRH2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5448898780720612,-1.1686524775295362,0.11,1.0,1.0,37/238,12.62%,PRLR;HTR2B;TFRC;THBS1;ARAF;RPS27A;NAA38;LRP2;RNF144B;VEGFA;PRELID1;IL7;DDRGK1;GSTP1;FIGNL1;IFIT3;CFL1;BCL2A1;FAIM2;HSPA1B;RPS3A;COPS5;BNIP1;BNIP3;TNFAIP8;ATF5;STIL;TMEM14A;UBA52;NOTCH2;PTMA;BNIP3L;TPT1;BCL2L2;UBC;NUAK2;PIM3
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.44231586275471296,1.1685660701412752,0.0,0.8964470696171637,1.0,6/47,13.28%,NUP42;NUP188;NSMCE2;NUP214;RAE1;UBA2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.7385480548945133,1.1685028214348911,0.30434782608695654,0.8944923251151938,1.0,2/6,8.51%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5133719799405762,1.168468044881584,0.3157894736842105,0.8926107738487832,1.0,1/11,0.59%,SLC7A8
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.6081388393291035,1.1679309264620656,0.2,0.8919881553656653,1.0,5/9,27.83%,RPS6KA4;FMR1;IL1B;AKAP8L;RPS6KA5
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5787978910641671,-1.1670789634421803,0.16666666666666666,1.0,1.0,25/93,15.27%,THBS1;TNC;MMP21;SPARC;VCAN;ADAMTS2;THSD4;ECM2;LAMA2;ADAMTS19;FBN2;ADAM15;LAMB1;COL11A1;COL10A1;ITGB8;TGFBI;ITGAE;APLP1;MMP24;COL23A1;FN1;COL4A5;ITGA2;ITGA6
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6063656066187104,-1.1666774457490572,0.21348314606741572,1.0,1.0,14/42,16.08%,NR4A3;FGF1;NR4A1;VEGFA;TGFB2;C5AR1;AQP11;NOD2;LAMB1;B2M;EPB41L4B;UHRF1;NR1D1;DEAF1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6220602072499516,-1.1665273758141566,0.30337078651685395,1.0,1.0,1/27,0.58%,TFRC
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.6322151782867297,-1.1664773165804758,0.24390243902439024,1.0,1.0,11/26,25.04%,HIF1A;NEFL;SOD1;MAPT;KIF1B;SYBU;AP3M2;KIF3A;RAB21;DCTN1;SPAST
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.8041342521170503,-1.1662960924474286,0.25,1.0,1.0,1/5,0.37%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.8154350189560621,-1.1661408780046756,0.3384615384615385,1.0,1.0,1/5,1.00%,ALG10B
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5857446757392808,-1.1658824206764133,0.26881720430107525,1.0,1.0,5/43,6.52%,DIAPH3;CATIP;SVIL;COBL;CFL1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7147162902384103,1.1650720116568134,0.375,0.8976059622998881,1.0,4/5,18.33%,ENPP1;LRMDA;MITF;MEF2C
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5519836348265065,1.1648390598377485,0.25,0.895985471372022,1.0,6/15,23.81%,LYST;PIKFYVE;RAB32;RAB29;AP1M1;HPS4
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.6420236457557871,1.163739516374964,0.3103448275862069,0.8975566057618058,1.0,3/8,22.80%,ZPR1;SERBP1;ETS1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.7047695569422854,-1.163642761583719,0.3333333333333333,1.0,1.0,2/11,3.34%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.44830115057166564,1.1635433650877018,0.16666666666666666,0.8961659395675559,1.0,4/26,4.23%,FGL1;VSIG4;CD274;LAPTM5
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.5655612978995737,-1.163339900787165,0.2631578947368421,1.0,1.0,7/73,9.85%,OSBPL5;NAPA;FTH1;STEAP2;STXBP6;SCAMP3;CLVS1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6292370970359178,-1.1632806732669343,0.2375,1.0,1.0,4/17,17.95%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6292370970359178,-1.1632806732669343,0.2375,1.0,1.0,4/17,17.95%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.6979566677408092,-1.1630008056454006,0.2839506172839506,1.0,1.0,3/12,13.93%,SVIL;BASP1;MYL6
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.5840204892632123,1.1629114529948015,0.15384615384615385,0.8958276208444962,1.0,1/10,2.31%,TMEM119
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6957644625516437,-1.1626357626138901,0.35443037974683544,1.0,1.0,7/14,25.94%,RIMS1;SHANK3;NRXN1;NLGN3;RELN;RIMS2;NLGN2
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.7796207585598166,-1.162524535172034,0.3055555555555556,1.0,1.0,3/8,12.83%,OMG;PTN;NREP
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.7757762450226752,-1.1624137121995468,0.3125,1.0,1.0,1/7,3.17%,VCAN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.6939722526730591,-1.1623117308065718,0.3037974683544304,1.0,1.0,5/12,13.46%,NOD2;SLC7A5;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.46173804264943374,1.1621593415063955,0.23076923076923078,0.8960285030133441,1.0,3/27,3.85%,NDE1;MAP1S;TRAK2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.7073342360627528,-1.161944250330992,0.3424657534246575,1.0,1.0,1/10,0.32%,GPR18
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.8173618438666828,-1.1617888122502997,0.23333333333333334,1.0,1.0,3/6,13.68%,VEGFA;NR4A2;MANF
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.6958592646382235,-1.1607780536721704,0.2535211267605634,1.0,1.0,2/13,1.07%,GDPD1;ENPP2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.7317823581285718,-1.160221962886333,0.28378378378378377,1.0,1.0,3/10,15.40%,TNFRSF1B;IL18;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.6749647195647424,1.1601669765694589,0.34285714285714286,0.9003624960361314,1.0,3/5,24.72%,TIRAP;MFHAS1;TLR1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6708898120221046,-1.1600331388624947,0.26506024096385544,1.0,1.0,1/15,0.62%,NLRP12
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.7581705718587569,-1.1595984961553634,0.25675675675675674,1.0,1.0,2/7,14.02%,XRCC3;SLX4
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5991958204444995,-1.1594778657618403,0.2391304347826087,1.0,1.0,9/46,8.72%,HTR2B;THBS1;SPARC;NR4A1;VEGFA;HMGB2;HIF1A;ATP5IF1;STAT1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6573363806284908,-1.159164660399575,0.2564102564102564,1.0,1.0,2/13,2.26%,CD55;MYO1G
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.7409868521159761,-1.1590773242122208,0.3055555555555556,1.0,1.0,3/6,23.23%,ACSL1;CD36;ACSL3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.6619040542651984,-1.1587855860391467,0.23333333333333334,1.0,1.0,1/20,0.96%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7256058849876384,1.158752492118737,0.4,0.9022841051292986,1.0,2/5,16.97%,MTLN;AKT2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.6310025677248412,-1.1586192363131342,0.22988505747126436,1.0,1.0,8/35,13.79%,NR4A3;CYCS;ETFB;NDUFS8;UQCRC1;ATP5F1D;UQCR10;UQCRB
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.7135611239112493,-1.1584056418667217,0.3333333333333333,1.0,1.0,1/9,1.07%,ENPP2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7084874164433217,-1.1582973746427419,0.2916666666666667,1.0,1.0,4/9,19.64%,PARP9;PARP14;ZC3HAV1;PARP15
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.7036512933000136,-1.1582905095637464,0.25333333333333335,1.0,1.0,4/8,24.57%,AGTPBP1;NRXN1;TPP1;DCTN1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7416452090231044,-1.15827305150209,0.3108108108108108,1.0,1.0,2/9,6.09%,DNAH17;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5770577068752747,-1.158108044404098,0.22916666666666666,1.0,1.0,16/56,24.28%,TUBB4A;VBP1;CLIP3;HDGFL3;SHANK3;FGF13;MID1IP1;APC2;TTBK2;CAV3;CLU;STMN1;STMN2;CRYAB;EML2;MAP2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.6163793504514951,-1.1580020854569102,0.2857142857142857,1.0,1.0,5/24,10.55%,DTL;BRCA1;CLSPN;DONSON;NOP53
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.637298114597905,-1.1579594135557285,0.25301204819277107,1.0,1.0,9/24,25.16%,RPA2;RPA3;ORC6;MCM3;POLE2;MCM6;MCM7;DBF4;MCM5
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.773832169246846,-1.1578981600382676,0.3492063492063492,1.0,1.0,3/5,20.90%,HLA-B;HLA-F;HLA-C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.773832169246846,-1.1578981600382676,0.3492063492063492,1.0,1.0,3/5,20.90%,HLA-B;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5990808392855438,1.1578525666570674,0.30434782608695654,0.902814811369907,1.0,3/11,14.43%,HMGA1;BANF1;NUTF2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.751302008733726,-1.1577151721444503,0.3283582089552239,1.0,1.0,1/6,8.89%,SSB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6126688526668423,-1.157631311212193,0.25,1.0,1.0,4/29,9.14%,NR4A3;THBS1;STAT1;ID2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.4722119554329006,1.157570103483226,0.25,0.9015877502134849,1.0,1/18,0.78%,NDE1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5759026137871288,-1.1572335266536244,0.22105263157894736,1.0,1.0,10/62,12.51%,THBS1;CHI3L1;FGF1;VEGFA;RHOB;HIF1A;FLT1;BRCA1;ITGB8;PKM
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.6110754104355234,1.157030254397155,0.2916666666666667,0.9014295549264368,1.0,2/8,5.78%,PTCH1;ACVR1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),0.6505616772478771,1.1563914619639313,0.28,0.9009911938385129,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7054229072764322,-1.1561760658094073,0.2948717948717949,1.0,1.0,2/9,10.19%,PLTP;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.7205904194983301,-1.1560795635607333,0.2777777777777778,1.0,1.0,4/10,13.18%,H2BC11;GSTP1;CCDC3;CARD16
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6833030740483734,-1.1560262428000612,0.28,1.0,1.0,3/8,12.33%,LRP2;CBR1;PIAS4
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.36770209093108486,1.155893621678285,0.0,0.9011152642897793,1.0,10/44,7.15%,LGALS9;CEBPA;PIR;CSF1R;PPARG;TGFBR2;SIRT1;MYH9;RUNX1;GAB2
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5734479436098272,-1.1555971898925017,0.25806451612903225,1.0,1.0,16/55,23.15%,SOCS3;ACVR1B;OSMR;TNFRSF1B;IL7;STAT1;MAP3K8;IRF1;CD36;STAT2;CD44;TNFRSF21;TLR2;IL3RA;CD14;IFNGR2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7026523008378305,-1.1555536479531816,0.2839506172839506,1.0,1.0,4/13,16.26%,SCO2;COX20;TIMM21;BCS1L
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6320131850760223,-1.155295397508718,0.275,1.0,1.0,13/25,22.95%,ENO4;GAPDH;ENOSF1;PGK1;LDHA;PKM;ENO2;PGAM1;PGM1;ENO1;HK2;GPI;PFKL
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),-0.791649482702637,-1.1552064988435948,0.2903225806451613,1.0,1.0,2/5,8.69%,CR1;FCGR2B
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6577281681397348,-1.15499826334242,0.27848101265822783,1.0,1.0,4/17,17.93%,RPS27A;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7644833528511422,-1.1547793424045945,0.30303030303030304,1.0,1.0,3/5,23.03%,RFC4;CHTF18;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7644833528511422,-1.1547793424045945,0.30303030303030304,1.0,1.0,3/5,23.03%,RFC4;CHTF18;POLG2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.67535920479127,-1.1546548540253574,0.24096385542168675,1.0,1.0,3/17,4.35%,VEGFA;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.7078852663920052,-1.1545067373758835,0.2777777777777778,1.0,1.0,2/8,17.04%,CHST7;OGA
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.7190350074821396,-1.1539575039462304,0.3611111111111111,1.0,1.0,1/11,0.58%,TFRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6279450177332357,-1.153898240021058,0.32558139534883723,1.0,1.0,9/25,20.35%,RPS27A;RBX1;RPA2;UBA52;UBC;RPA3;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.6220158260067354,-1.1537748815553264,0.26436781609195403,1.0,1.0,2/23,3.11%,GLRA1;VEGFA
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7480368501961795,-1.1537344591962215,0.3333333333333333,1.0,1.0,3/6,13.36%,AGBL3;AGTPBP1;FOLH1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7295220420687781,-1.1536684783315603,0.29411764705882354,1.0,1.0,3/7,18.06%,ANK3;CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.6729289674017762,1.1535035056893126,0.34782608695652173,0.9065206359631754,1.0,1/7,0.54%,ZNF703
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.6340556488275052,-1.1528014482027282,0.2875,1.0,1.0,1/26,0.33%,GLRA1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6812138698440238,-1.1521352934366953,0.3116883116883117,1.0,1.0,2/15,6.51%,PTN;TAF6L
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6540008400428695,1.1517447848147344,0.34375,0.9098251107046945,1.0,1/6,2.62%,NBDY
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7129441010988312,-1.1517426639037238,0.3783783783783784,1.0,1.0,6/7,25.16%,MCMDC2;MCM3;MCM6;MUS81;MCM7;MCM5
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.6713585323479563,-1.1516347243247291,0.3125,1.0,1.0,4/14,17.62%,C5AR1;CR1;C5AR2;FPR1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.6598143076609353,-1.1512982760076165,0.27710843373493976,1.0,1.0,3/18,3.34%,HTR2B;SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5515775147113581,1.1511731811214638,0.29411764705882354,0.9098670816474094,1.0,3/14,16.30%,ICAM1;SERPINE1;TCF7L2
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.6504758697013803,-1.151032462805762,0.2891566265060241,1.0,1.0,12/22,32.42%,OMG;FGF13;DCC;MAG;LRP4;THY1;MAP2;GDI1;ARHGDIA;LINGO1;PTPRS;RUFY3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.5775586088755124,-1.149959118851845,0.23157894736842105,1.0,1.0,14/66,17.93%,DDIT4;FOS;TNFRSF1B;FAIM2;EGLN3;FCGR2B;MAPT;HLA-F;DCC;EPHB1;NSMF;TRAF2;RRAS2;UBB
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7297120664804059,-1.1495853352856291,0.3582089552238806,1.0,1.0,2/6,12.64%,MYLK;EMP3
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.6919212299070125,-1.1495230195876434,0.3375,1.0,1.0,5/10,27.49%,BRCA1;CTBP1;TAF7;SET;JARID2
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.5428696576291152,-1.149288636068411,0.19,1.0,1.0,36/149,22.95%,ENPP2;ARAF;PLIN2;OMD;MYLK;TALDO1;ETFB;DNAJB9;ME1;SOD1;ATP1B3;UQCRC1;ITSN1;SPARCL1;UQCR10;UBC;BCL6;PIM3;PGM1;DGAT1;LIPE;CD36;LIFR;PFKFB3;GPD2;ABCA1;MGLL;PDCD4;CMPK1;VEGFB;GHITM;REEP5;NKIRAS1;SLC66A3;FAH;PFKL
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.6260598729124373,1.149200030583066,0.30303030303030304,0.9137670302629237,1.0,1/5,2.84%,P2RY12
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.5621170408705078,-1.1488934425346942,0.18556701030927836,1.0,1.0,16/93,15.24%,DDIT4;EIF4A3;VEGFA;DNAJB9;ERO1A;IMP3;NHP2;HERPUD1;SLC7A5;SERP1;RPS14;ATF3;EIF2AK3;IFIT1;HSPA5;FKBP14
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.655742632639239,1.1488742691685712,0.36363636363636365,0.912599079431511,1.0,2/10,4.31%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.6826228891302965,-1.1487793815255432,0.32857142857142857,1.0,1.0,3/10,19.71%,GLUL;ASPA;GAD1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5443729250440202,-1.14863500682987,0.1875,1.0,1.0,30/143,15.55%,SLC2A3;CLEC12A;SRGN;THBS1;PRKAR2B;F13A1;JAML;SIRPB2;SPARC;VEGFA;ALOX12;CD93;THEMIS2;SELL;TNFRSF1B;CD69;ERO1A;NOD2;FHL1;FGR;CXCR4;MNDA;OST4;CARD16;PALLD;CD36;LSP1;ITGA2;VNN2;NCF4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.5854666426831785,-1.1484368106679825,0.24175824175824176,1.0,1.0,10/53,13.53%,HS3ST2;CEMIP;OMD;OGN;VCAN;HS3ST5;B4GAT1;GPC5;CHST7;GPC3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6346314870790379,1.1483571659750866,0.2692307692307692,0.9118664559775199,1.0,4/11,7.02%,PDPN;FSCN1;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6911194684536945,-1.148353275551693,0.2839506172839506,1.0,1.0,4/13,14.49%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.6390645769016008,-1.1483024940175115,0.29333333333333333,1.0,1.0,4/19,5.97%,PPP1R15A;TGFB2;SH2D4A;MASTL
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5608924834090447,-1.1482456682806284,0.2631578947368421,1.0,1.0,8/58,10.34%,CCL4;JAML;MYO1G;RORA;SELL;CD69;IL10RA;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.7339685583815019,-1.1481924109023713,0.3793103448275862,1.0,1.0,4/6,25.15%,NOP53;WDR48;TNIP1;SART3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.7699439329593462,-1.1481474817147213,0.234375,1.0,1.0,2/5,13.46%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7484389215864711,-1.1480928819291325,0.37142857142857144,1.0,1.0,1/5,8.77%,TENT4B
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.5483686850755666,-1.1480412756723453,0.1919191919191919,1.0,1.0,29/140,21.16%,TOP2A;CENPF;CKS2;SAP30;MT2A;HIF1A;RACGAP1;MEIS2;RPA2;SLC7A5;POLQ;DMD;CENPE;ATF5;STIL;NOTCH2;HIRA;INCENP;LMNB1;CDKN1B;KIF15;ORC6;ILF3;MCM3;BRCA2;KIF11;SRSF2;LIG3;STMN1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.611477450196487,-1.147943974194949,0.23595505617977527,1.0,1.0,12/32,24.82%,CATIP;ENKUR;PLTP;TMEM232;NME9;HSPA2;PTPRT;DNAH12;GFAP;DNAH7;RFX2;S100B
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7500056255587293,-1.1479125602286724,0.3116883116883117,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7500056255587293,-1.1479125602286724,0.3116883116883117,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.8044903483161527,-1.1478561130012728,0.2711864406779661,1.0,1.0,1/5,6.35%,NR4A2
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.669462504020254,-1.1473861867517134,0.4069767441860465,1.0,1.0,5/18,8.53%,CHI3L1;FGF1;VEGFA;CCDC39;BASP1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.6232525893055297,1.1473585311350716,0.34782608695652173,0.9131914833092228,1.0,1/9,2.07%,CD180
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6484645579858226,-1.1473106460819509,0.375,1.0,1.0,7/22,18.94%,TFRC;FANCB;ZCWPW1;ERCC2;WDR48;TIMELESS;KMT5C
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6961551152380833,-1.147272829128262,0.33783783783783783,1.0,1.0,1/8,0.62%,NLRP12
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.6584646322010695,-1.1472010737435725,0.2976190476190476,1.0,1.0,2/18,6.39%,HMGB2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.6798871038148163,-1.1466975574417342,0.32051282051282054,1.0,1.0,1/9,8.48%,SOD1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.7398467897423957,-1.1466432836844715,0.24324324324324326,1.0,1.0,3/8,19.36%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.612361095253931,-1.1462868645216817,0.28888888888888886,1.0,1.0,13/36,16.29%,RPS27;RPS25;RPS24;RPS6;NOB1;RPS14;RIOK2;RRP36;RPS15;MRPS7;RPS7;METTL17;RPS16
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.7761786390011552,-1.1462217430616783,0.30434782608695654,1.0,1.0,2/7,11.51%,TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7228382413403115,-1.1461204270838599,0.38461538461538464,1.0,1.0,2/7,10.14%,CACNB2;SESTD1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.5293677601646236,1.146026039416311,0.23529411764705882,0.9148473155545706,1.0,2/12,6.30%,SIRT1;HLCS
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.7018484495963464,-1.1458963748697533,0.2898550724637681,1.0,1.0,2/10,24.27%,IL15;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.7018484495963464,-1.1458963748697533,0.2898550724637681,1.0,1.0,2/10,24.27%,IL15;PLCB1
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.7191431155654266,-1.1453650551298233,0.3157894736842105,1.0,1.0,1/8,2.31%,NFIL3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6937825932231454,-1.1451229195134771,0.25316455696202533,1.0,1.0,2/18,6.87%,CEMIP;ANK3
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5261457693215844,1.1448698283256311,0.2962962962962963,0.9160380062038823,1.0,1/12,4.24%,NSUN2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.43237513800630395,1.1445510515601367,0.2,0.9153042822456565,1.0,7/24,16.38%,GSN;P2RY12;RHOG;PDGFA;CDC42;RHOQ;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.7538209872927454,-1.14413060850418,0.3333333333333333,1.0,1.0,1/5,8.48%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.7538209872927454,-1.14413060850418,0.3333333333333333,1.0,1.0,1/5,8.48%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.7538209872927454,-1.14413060850418,0.3333333333333333,1.0,1.0,1/5,8.48%,SOD1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.6363786832834544,1.1439707119426856,0.38461538461538464,0.9154856871653578,1.0,6/8,18.62%,ALOX5AP;MGST2;MGST3;ALOX5;LTC4S;FADS1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.46722040436821366,1.1439098936715846,0.2727272727272727,0.913603657068571,1.0,7/26,8.53%,NRP1;RIN2;MAP4K4;PPM1F;ABL1;CIB1;CDH13
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6104060708108034,-1.14350290177204,0.24096385542168675,1.0,1.0,1/24,0.15%,DDIT4
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7154394860268364,1.1434307986873398,0.4375,0.9135457958004316,1.0,3/5,23.64%,ADRA1A;ADRB2;ADCY9
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5605019523058681,-1.1433150283216165,0.20618556701030927,1.0,1.0,24/114,15.31%,TOP2A;GADD45B;IFITM3;HMGB2;DPYD;RHOB;TGFB2;H1-0;CD69;BRCA1;PPP2R5B;SOD1;ATF3;BNIP3L;IRF1;BCL2L2;SAT1;TXNIP;ENO2;FEZ1;IL18;IGF2R;CDKN1B;TAP1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.5561455884881409,-1.1431836379483842,0.26595744680851063,1.0,1.0,23/83,20.95%,CLEC12A;CLEC4E;MYLK;JAML;SIRPB2;SLC11A1;C5AR1;SELL;CR1;FGR;CCL3;RASGRP4;MNDA;OAS3;VNN2;NCF4;NCF2;FPR1;AIF1;TLR2;S100A4;ARG2;CD300A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6627110863751063,1.143111664798595,0.4,0.9127633120955654,1.0,3/6,15.58%,VEZF1;FGF2;RFX3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.5668133632119269,-1.1431086489500872,0.16666666666666666,1.0,1.0,20/65,19.88%,SLC51A;OSBPL5;PRELID1;ATP8B1;ACSL1;SLCO3A1;SLCO1A2;PLTP;ABCA5;ABCC3;UGCG;PCTP;ABCA9;SLC10A1;CD36;STARD5;ABCA1;PEX3;ABCA8;ABCA6
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.6910462167057603,1.1430878986962638,0.34146341463414637,0.9108389250762718,1.0,3/5,26.45%,TREM2;PRKCI;PRKCA
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6226984473521469,-1.1430750138945838,0.30864197530864196,1.0,1.0,4/23,10.29%,TFRC;FTH1;SLC11A1;SLC31A2
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.6496681909067448,-1.1428614656988885,0.2808988764044944,1.0,1.0,2/19,5.33%,OSBPL5;ABHD12B
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5836348001206321,-1.14254957499809,0.2808988764044944,1.0,1.0,16/34,28.14%,MPG;RPA2;NEIL1;POLQ;ADPRS;RFC1;RPA3;RFC4;POLL;DNA2;LIG3;ERCC6;TDG;XPA;PARG;WRN
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.6437872116560507,-1.1422807938064627,0.32222222222222224,1.0,1.0,3/27,2.03%,DDIT4;CEMIP;CHI3L1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.6194609961569362,1.1418314042378934,0.25925925925925924,0.9121406666919829,1.0,3/8,11.97%,PPARG;TGFB1;ELAVL1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.7547812007808723,-1.1413677475261355,0.3116883116883117,1.0,1.0,2/8,10.47%,RACGAP1;SLC13A4
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.7456322332950449,-1.1413610017301796,0.3116883116883117,1.0,1.0,1/6,7.44%,HSPA1B
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6188949361906609,1.1413318794571723,0.3333333333333333,0.9118163305169779,1.0,5/10,15.99%,SLC46A1;PDPN;ABCG2;FOLR2;SLC19A1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6273745421568753,-1.1413207144415671,0.30864197530864196,1.0,1.0,7/21,20.76%,EYA2;MROH9;KCNMA1;CFTR;DNAH12;ARFGEF3;DNAH7
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.7176659458330532,-1.1411654261325972,0.30434782608695654,1.0,1.0,1/9,4.80%,PTN
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.6574230140826471,-1.141099845229519,0.273972602739726,1.0,1.0,4/16,14.03%,DGKI;DGKG;DGAT1;LIPE
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6397331826145334,-1.1409215651292095,0.3287671232876712,1.0,1.0,2/14,10.86%,HLA-B;HLA-F
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5979691087536507,-1.1407435895031284,0.3176470588235294,1.0,1.0,8/22,19.39%,BHLHE40;HMGB2;PTN;TNFRSF1B;TYMP;PTPRZ1;PRUNE1;PER2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6230430322925596,1.1405818343308431,0.36363636363636365,0.9114334826912899,1.0,6/10,29.60%,PUS10;SMAD2;SRRT;SMAD3;DROSHA;MRPL44
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.587706641755622,1.1403490378510468,0.2962962962962963,0.9104844964113084,1.0,3/9,5.33%,LEPR;MKKS;SIRT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.6765442814752523,-1.1401246875143547,0.3380281690140845,1.0,1.0,6/12,23.38%,ANK2;DMD;CALM3;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5333080939599906,-1.1401125254263333,0.09183673469387756,1.0,1.0,50/124,28.35%,GLRA1;HTR2B;CHRM5;PRKAR2B;GRIK1;CACNB2;HTR7;PLP1;SST;NRXN1;NLGN3;SDCBP;GRIA4;BSN;HTR1F;GABRB1;GABRA3;CPLX1;SYT1;SPG11;CALM1;SNAP25;GABRG2;GRM3;GAD1;KCNMB1;GABRB3;AMPH;NRXN2;GAD2;KIF5A;RPS6KA2;GRIN2A;GABRA2;UNC13C;PMP22;SLC1A2;NRGN;AKAP9;PRKACB;NLGN2;GRIA2;CHRM3;CHRM2;NOVA1;GABBR2;CACNA1B;SLC12A7;GRIK2;GABRB2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.6474580665987415,-1.1400908285015738,0.3037974683544304,1.0,1.0,3/15,14.64%,ATP5IF1;UROS;PPOX
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.7000925205382089,-1.140073287329198,0.3013698630136986,1.0,1.0,1/9,0.96%,THBS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6617885518563288,-1.139946694192989,0.3375,1.0,1.0,7/15,23.38%,ANK2;DMD;CALM3;AKAP6;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.6670830157749865,-1.139802227067623,0.3,1.0,1.0,2/12,9.29%,PRKAR2B;PKIA
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.6368249452428529,1.1394364460559836,0.2727272727272727,0.9114479480847782,1.0,1/10,0.96%,DR1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.6135700170869883,-1.139355398944757,0.34146341463414637,1.0,1.0,3/20,4.80%,TGFB2;RBPJ;PTN
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5902523141894103,-1.1393331338566905,0.23076923076923078,1.0,1.0,17/47,25.40%,GLUL;RIMS1;SLC6A15;PPFIA4;SLC17A7;NRXN1;RAB3A;CPLX1;SYT1;SNAP25;UNC13A;GAD1;NRXN2;GAD2;DVL1;GABRA2;SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.5459998267365727,-1.1392288643257231,0.17,1.0,1.0,58/236,22.98%,NUDT12;SRGN;NLRP12;EIF4A3;NUDT16;RBMS3;VEGFA;OVOL2;TGFB2;SLC11A1;HIF1A;CENPV;ZNF540;DDRGK1;RPS13;NOCT;HSPA1B;FCGR2B;MAPT;SLC7A5;PINK1;DAPK1;ID2;PARP9;RPL13A;GAPDH;CCL3;BTN2A2;NOTCH2;ITGB8;CCDC3;EIF2AK3;OLFM1;PARP14;RIDA;ENC1;BMI1;RGCC;KLF4;SH3GL2;RPS3;CNOT8;CITED2;ILF3;ZFP36;ATP2B4;PARP15;PPP1R11;PTRH2;DICER1;LSM5;PATL2;PUS7;DNMT1;FOXP1;GPNMB;RPS26;EIF2AK2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5788474913340049,-1.139221245245461,0.24175824175824176,1.0,1.0,13/61,14.30%,RPS27A;UVSSA;RBX1;RPA2;POLR2G;COPS5;PPIE;UBA52;RFC1;UBC;RPA3;ERCC2;RFC4
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.5439757068532025,-1.1390353469783416,0.16326530612244897,1.0,1.0,19/95,15.23%,DDIT4;BHLHE40;SPOCK1;HMGB2;SEMA3A;TGFB2;RACGAP1;NR4A2;CCK;MAPT;MAP1B;CEP85L;FGF13;CIT;ASTN2;IL1RAPL1;PTPRD;GPM6A;ADGRL3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6354524655336456,-1.1386861660619017,0.3218390804597701,1.0,1.0,9/20,28.81%,RIMS1;SHANK3;NRXN1;NLGN3;RELN;RIMS2;NLGN2;APP;TMEM108
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7210921259003558,-1.138520317119249,0.30434782608695654,1.0,1.0,6/8,25.16%,DONSON;MCMDC2;MCM3;MCM6;MCM7;MCM5
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.690693510084289,-1.1385006855747013,0.358974358974359,1.0,1.0,5/12,13.19%,CACNB2;GNB5;DMD;AHNAK;PDE4B
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.789385183370194,-1.1383253473963733,0.3181818181818182,1.0,1.0,2/5,12.07%,H2BC11;RPL39
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.601735774336543,-1.138024364188476,0.30337078651685395,1.0,1.0,12/30,22.55%,MDH1;FBP1;AKR1B1;GAPDH;PGK1;ENO2;PGAM1;PGM1;SORD;PER2;ENO1;GPI
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.6407524828198949,1.1379242459435426,0.3333333333333333,0.9122640076528098,1.0,3/7,20.55%,ADAM10;CCL5;WNK1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.6407524828198949,1.1379242459435426,0.3333333333333333,0.9122640076528098,1.0,3/7,20.55%,ADAM10;CCL5;WNK1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.6710766233769508,-1.137629123289799,0.2619047619047619,1.0,1.0,7/15,25.27%,MAPT;HDGFL3;FGF13;STMN3;STMN1;STMN2;CKAP5
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.6917490804210811,-1.1376010600702597,0.3,1.0,1.0,3/10,21.55%,NUDT16;NYNRIN;DICER1
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7679327834583376,-1.1374364741946617,0.3333333333333333,1.0,1.0,2/5,4.91%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.7848715171084079,-1.1371968254874916,0.3,1.0,1.0,3/6,19.26%,GLA;CAV3;ATP2B4
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.6466438043394407,-1.1371503766214495,0.3246753246753247,1.0,1.0,2/15,3.05%,NUDT16;HINT1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6328485627610548,1.1369865328662379,0.375,0.9128620598414642,1.0,3/8,7.47%,SERTAD2;ARID1A;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.657875345537435,1.1368770077907853,0.2682926829268293,0.9112695351673015,1.0,3/5,23.19%,NOTCH1;IL1B;PRKCI
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.6026850218762732,-1.1366814757552641,0.30337078651685395,1.0,1.0,7/27,13.67%,MDH1;FBP1;GAPDH;PGK1;ENO2;PGAM1;PGM1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.5764813322851674,1.1363494162331313,0.3333333333333333,0.9108639455303852,1.0,5/9,22.77%,VCL;ZDHHC21;IL1B;IKBKB;ROCK2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6625029472107307,1.1363313427235262,0.4,0.9090467065695609,1.0,4/9,21.52%,RAPGEF6;RAP2C;AFDN;RAB1B
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.5824405225633548,-1.1359500662143514,0.2872340425531915,1.0,1.0,11/38,16.67%,RBPJ;GSTP1;IL15;BTN2A2;NR1H2;PCTP;CCDC3;ARRDC3;ACOT13;NR1D1;ALDH1A1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.5623286320383132,-1.1356966917706361,0.2604166666666667,1.0,1.0,13/49,16.73%,HAMP;HMGB2;LAMA2;COL21A1;CKMT2;PLN;PDE1A;TTN;DMD;CXCR4;CD36;LDB3;CAV3
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6086133765199743,1.1350464024495155,0.3793103448275862,0.9116739251553446,1.0,4/7,17.59%,RAP1A;SLC30A1;FMR1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.7157706155104302,-1.134998304522103,0.2597402597402597,1.0,1.0,6/11,24.28%,TUBB4A;CLIP3;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.7613724536271658,-1.13482613906185,0.3611111111111111,1.0,1.0,1/5,15.58%,ABCB1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7378480646107419,-1.13474016294012,0.4,1.0,1.0,1/6,8.16%,CLSPN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.6944824792411457,-1.1347287141992184,0.3333333333333333,1.0,1.0,2/7,12.92%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4065332470040559,1.1347030300768486,0.3333333333333333,0.9107422314463127,1.0,8/39,10.46%,PEX13;ECI1;PPARGC1A;ACADS;MTLN;ADIPOR2;ACOX1;EHHADH
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.7551658458599615,-1.1344426275895039,0.2878787878787879,1.0,1.0,2/5,11.16%,PDK3;PDPR
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.7551658458599615,-1.1344426275895039,0.2878787878787879,1.0,1.0,2/5,11.16%,PDK3;PDPR
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.6910226126779812,-1.1340623488700916,0.23684210526315788,1.0,1.0,5/12,22.38%,PPP2R5A;CCDC3;APOD;ALK;ASXL3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5729741083524983,-1.1339801889995127,0.30434782608695654,1.0,1.0,20/42,32.52%,BEGAIN;NEFL;DAPK1;GRIA4;RELN;LRRC7;PRRT1;GRIN2A;OPRM1;AKAP9;NLGN2;CRHBP;GRIA2;CAMK2B;APP;ACTN2;CACNG2;DLGAP1;MAPK8IP2;DLG4
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.7587122088130087,-1.133941836874628,0.34210526315789475,1.0,1.0,3/7,16.57%,DPYD;PAICS;PRPS1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5895662340155494,-1.133774512335605,0.3,1.0,1.0,17/39,26.51%,STXBP6;RAB3A;RAB2B;CFTR;NSF;IL1RAPL1;RAB3C;STXBP5L;CPLX1;SYT1;RAB15;RAB5A;SEPTIN4;RAB21;CADPS;RIMS2;RAB3D
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.5362357244372131,1.1337580936772609,0.2916666666666667,0.9112774651628335,1.0,2/13,6.16%,NCOA4;ARID1A
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.7417572770944751,-1.1336323382960534,0.3424657534246575,1.0,1.0,2/5,12.47%,ANK3;EPB41L3
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.7021243925711227,-1.1334464321623532,0.3918918918918919,1.0,1.0,1/10,1.45%,PLIN2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6128396187047002,-1.1331268618418313,0.2894736842105263,1.0,1.0,4/23,12.14%,RPS27A;NOD2;UBA52;UBC
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6698932939727473,-1.1331135399405252,0.32098765432098764,1.0,1.0,1/13,0.37%,NR4A3
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5901174128281872,1.1330557791890714,0.2692307692307692,0.9117520772702173,1.0,2/9,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7027144016132842,-1.1325913906293683,0.391304347826087,1.0,1.0,2/10,11.89%,NMD3;RPS15
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5378079440527538,1.1323458160317732,0.3,0.9119041851557487,1.0,1/10,11.73%,FGF2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3570523453200506,1.1322974970090602,0.14285714285714285,0.9101073246952127,1.0,10/74,3.68%,EDA2R;SIRPA;SERPINF2;ZMYND11;MAP3K10;DAB2IP;MAP3K5;MAP4K2;MAP4K4;ZNF675
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.6694361670097145,1.1320541371219477,0.45161290322580644,0.9087531700742704,1.0,3/5,32.20%,FTO;ALKBH3;ALKBH5
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5482902155695538,-1.1319059962988687,0.28125,1.0,1.0,16/88,14.30%,BRIP1;RPS27A;UVSSA;RBX1;RPA2;POLR2G;COPS5;PPIE;UBA52;RFC1;UBC;RPA3;FAN1;ERCC2;SLX4;RFC4
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7551612327712398,-1.1316250121127993,0.359375,1.0,1.0,1/5,3.96%,RSAD2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5237093505024006,1.1313821195896279,0.2777777777777778,0.9087077894102981,1.0,3/14,10.90%,SLC30A1;SLC30A5;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7380804041758269,-1.1308679736060832,0.30434782608695654,1.0,1.0,2/6,19.39%,SUV39H2;PER2
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.5530580765752408,-1.1307938737031573,0.26881720430107525,1.0,1.0,35/71,31.55%,SULT4A1;CASKIN1;MAP1B;APLP1;PAK5;MAPK4;GDAP1L1;ADGRL3;ITGA6;NEFM;KCNC1;ERC2;TAGLN3;UNC13A;SYT4;CLVS2;TSHZ1;KIF5A;EPHA7;STMN2;NTNG1;TMEM59L;KIF5C;CSRNP3;UNC5D;EZH2;EPHA4;CRMP1;CACNA1B;LINGO1;REEP2;NCAM1;NCAN;B4GALNT4;PPM1E
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5716653888760969,-1.1303027035540065,0.2631578947368421,1.0,1.0,11/58,18.17%,NLRP12;THBS1;CYCS;VEGFA;BEX3;DAPK1;CARD16;GRAMD4;PYCARD;KLF4;CD44
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6824517601819587,1.130209726901888,0.36666666666666664,0.9104255294455877,1.0,3/5,15.13%,NCK2;SRC;NCK1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5897152051869855,-1.1301565152383983,0.27058823529411763,1.0,1.0,7/37,4.58%,MYLK;ASPN;SPARC;RBMS3;ADAMTS2;ECM2;LAMA2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5623913159409428,1.1300414397700689,0.3684210526315789,0.9091078888271,1.0,3/15,7.82%,ARFIP1;WASF2;WASF3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.66002096731613,-1.1300125472130815,0.3488372093023256,1.0,1.0,4/12,9.37%,VEGFA;RSAD2;TGFB2;IL15
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6213741937965283,-1.1297584911608514,0.3493975903614458,1.0,1.0,3/17,13.18%,NLRP12;GSTP1;CARD16
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.45855974552310125,1.1296479241630213,0.26666666666666666,0.9084288492538415,1.0,1/18,0.78%,NDE1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6842305435653102,-1.1296183715547075,0.2318840579710145,1.0,1.0,4/13,13.93%,VIM;TTN;DMD;MYL6
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6842305435653102,-1.1296183715547075,0.2318840579710145,1.0,1.0,4/13,13.93%,VIM;TTN;DMD;MYL6
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.6339762052162319,-1.1294752772219956,0.43478260869565216,1.0,1.0,2/9,3.18%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.677589400020727,-1.12937502714341,0.3373493975903614,1.0,1.0,1/11,1.16%,CHRM5
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5616593294965473,-1.1289886383763548,0.2857142857142857,1.0,1.0,10/64,6.80%,SOCS3;TNC;OSMR;PLPP3;SPARC;ADAMTS2;HIF1A;LAMA2;C5AR1;NOD2
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5502254795404261,-1.128809937532502,0.24742268041237114,1.0,1.0,5/64,3.93%,CENPF;PRKAR2B;HAUS6;TUBB4A;TUBA4A
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.6576001934168786,-1.1287436693878037,0.3291139240506329,1.0,1.0,1/14,4.06%,RBPJ
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6701254603329461,-1.1285854407026632,0.34210526315789475,1.0,1.0,3/14,17.89%,DDX11;ADCY10;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.5257928307629965,-1.128538133640598,0.1,1.0,1.0,31/236,9.72%,PRLR;NAMPT;NR4A3;HTR2B;RPL23;THBS1;RPS4X;OSMR;TBC1D8;TSHR;FGF1;AGT;VEGFA;RPS6;TGFB2;RBPJ;C5AR1;PTN;IL7;IL7R;DDRGK1;MEIS2;AQP11;NOD2;FLT1;CR1;STAT1;ID2;IL15;RPS9;LAMB1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5829011977419775,-1.1284606640813322,0.25555555555555554,1.0,1.0,7/30,19.74%,OSBPL5;ABCA5;CD36;STARD5;ABCA1;ABCA8;CLU
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.7331209980583486,-1.128406645067972,0.34328358208955223,1.0,1.0,1/5,3.57%,GLUL
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.5460049795598667,1.1283000116043482,0.3333333333333333,0.9107972850524293,1.0,1/10,1.94%,CPSF4
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.714225390907673,-1.128024852445533,0.35294117647058826,1.0,1.0,3/9,16.15%,TGFB2;BRCA1;STOX2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.57503244981634,1.1279388163936719,0.4,0.9098309194955997,1.0,3/12,12.75%,TLR7;TRAF6;IRAK1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.5961165656682503,-1.1276494957876204,0.313953488372093,1.0,1.0,8/31,20.29%,DTL;RNF126;RBX1;TRIM25;UHRF1;ATXN7L3;NEURL1;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.4914418755248593,1.1275204023270753,0.2222222222222222,0.9087254479645555,1.0,3/21,6.47%,TGFB1;ZPR1;EFCAB7
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),0.6285789701222005,1.127496417635118,0.34782608695652173,0.9069678379732611,1.0,1/5,6.19%,IL17RA
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.6263220905542054,-1.127448969003321,0.4027777777777778,1.0,1.0,3/21,7.82%,PRELID1;AIM2;CR1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.7462791117419807,-1.1272122964336602,0.3283582089552239,1.0,1.0,1/5,9.37%,IL15
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.7088995373037866,-1.1270730206038342,0.36363636363636365,1.0,1.0,5/8,26.89%,ACSL1;CD36;ACSL3;SLC27A5;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7343196201639004,-1.1269587265645533,0.3484848484848485,1.0,1.0,3/5,22.46%,BRCA1;KDM1A;DNMT1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.7377478789506298,-1.1268716284602447,0.34328358208955223,1.0,1.0,5/7,24.21%,ALOX12;ALOX15B;SCD;FADS3;SCD5
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.7759049282386838,-1.1268434140909782,0.3472222222222222,1.0,1.0,2/5,14.20%,FGF13;DCC
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.7063304586405184,-1.1266902264370326,0.36363636363636365,1.0,1.0,1/9,3.21%,HMGB2
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7087666370198138,-1.126651163822287,0.4166666666666667,1.0,1.0,1/5,0.96%,THBS1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.5532663825885895,-1.126645210659798,0.24210526315789474,1.0,1.0,47/97,28.65%,AMER2;HSPA12A;KIF1B;KCNMA1;NRXN1;PAK5;GRIA4;RAB3C;GDAP1L1;NEFM;TMEM130;FRRS1L;PCSK2;TRPM3;KCNC1;SNAP25;GABRG2;SCN1A;SYT4;AMPH;ATP1B2;SLC24A2;CADM2;CLVS2;SYP;SCN3B;CACNA2D3;GAD2;RNPC3;STMN2;ST8SIA3;CADPS;NTNG1;NTRK3;HCN1;SLC1A2;CNTNAP2;CA10;SV2B;FRMD3;GRIA2;LSAMP;SRRM4;MAGI2;VSTM2B;CACNA1B;SCG3
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7307805515461185,-1.126343680637352,0.3815789473684211,1.0,1.0,2/9,9.93%,MT2A;ATP5F1D
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5571715418348934,-1.1263419651696356,0.32989690721649484,1.0,1.0,19/64,23.38%,MYOT;TG;RSAD2;TGFB2;MX1;NR4A2;PLAG1;SELENOP;IFI44L;DCC;SLC16A7;MFSD6;STAG3;KCNMB1;ZC2HC1C;BMPR1B;SGK1;ZBTB16;RYR2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.6948573688808213,-1.126322981765548,0.35135135135135137,1.0,1.0,1/8,0.52%,HTR2B
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5844700058498626,-1.1262423927537277,0.30434782608695654,1.0,1.0,6/37,16.73%,KCNE1;FHL1;KCNMA1;CD63;AKAP6;CAV3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.7102521456643336,-1.1261487650771322,0.36764705882352944,1.0,1.0,2/8,18.41%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7444172242380991,-1.125908376028912,0.3561643835616438,1.0,1.0,2/6,12.56%,SAT2;SAT1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.634777640274019,-1.1256246511498056,0.3132530120481928,1.0,1.0,3/19,8.84%,DNAJB9;NOD2;SLC7A5
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6800130707283707,-1.1254265712639502,0.2753623188405797,1.0,1.0,2/10,10.01%,VEGFA;TTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.6799673649205296,-1.124758039777322,0.42857142857142855,1.0,1.0,1/7,3.41%,BEGAIN
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5573553238325327,-1.1246116950371592,0.2631578947368421,1.0,1.0,20/77,16.52%,DDIT4;MX2;TRIM5;IFITM3;RSAD2;MX1;IFIT2;PQBP1;IFIT3;STAT1;BNIP3;IFI44L;NLRC5;BNIP3L;IRF1;IFIT1;OAS3;PYCARD;STAT2;IFIT5
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6815759194559332,-1.1246079928346358,0.36,1.0,1.0,4/9,12.68%,HIF1A;NEFL;MAPT;SYBU
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5183710448844354,-1.1238291892331136,0.11,1.0,1.0,77/368,18.65%,PRLR;SOCS3;CCL4;TNFRSF11B;VIM;RPS27A;MX2;TRIM5;CEBPD;OSMR;F13A1;TALDO1;ST18;VEGFA;IFITM3;MT2A;FOS;RSAD2;HIF1A;MX1;AIM2;RORA;IFIT2;RBX1;TNFRSF1B;IL7;IL7R;IFIT3;CFL1;HLA-B;NOD2;RHOU;DUOX1;GBP2;SOD1;STAT1;MAP3K8;IL15;TRIM25;IL10RA;APPL1;HLA-F;CCL3;UBA52;JUNB;IRF1;UGCG;UBC;PSMA5;BCL6;TNFSF13B;PSMA3;B2M;IL18;TEC;IFIT1;LMNB1;FN1;CD36;CDKN1B;OAS3;LIFR;PTPRZ1;GHR;PYCARD;RPLP0;STAT2;IFIT5;TRAF2;PSMD8;ANXA2;FPR1;UBB;CD44;PDCD4;PSMB4;MCL1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.5468308639250555,-1.1237518852657804,0.18947368421052632,1.0,1.0,42/96,28.50%,SULT4A1;AMER2;ANK2;LRRC4C;GPM6B;KIF1B;EFR3B;EPHA3;NRXN1;PAK5;GRIA4;MAPK4;RAB3C;GDAP1L1;ADGRL3;CTNND2;BSN;PHYHIPL;KCNC1;ERC2;SNAP25;UNC13A;GRM3;SYT4;ROBO2;ATP1B2;CADM2;CLVS2;SCN3B;GAD2;KIF5A;EPHA7;STMN2;ST8SIA3;NTRK3;CSRNP3;GRIA2;LSAMP;SRRM4;NOVA1;CACNA1B;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),0.6700040582464447,1.123535714312213,0.3333333333333333,0.9177534017017697,1.0,4/6,15.03%,FER;MILR1;CD84;CD300LF
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.7140665969685425,-1.1235278139416995,0.4,1.0,1.0,2/8,17.89%,DDX11;TIMELESS
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.5074498401831593,1.12347242136053,0.375,0.9159562213916064,1.0,5/23,5.37%,NEXMIF;ZNF703;PPM1F;JAG1;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.6122621293440209,-1.1234266872289005,0.29347826086956524,1.0,1.0,2/26,2.84%,SH3BP5;AGT
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6637347669814513,-1.1234166329849657,0.36585365853658536,1.0,1.0,2/10,3.16%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.705575534473479,-1.1234081540093661,0.3918918918918919,1.0,1.0,3/7,10.45%,PRELID1;MAPT;BNIP3
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5501787716980356,-1.1228927547946803,0.3157894736842105,1.0,1.0,10/75,12.92%,TOP2A;RPS27A;HMGB2;FAM50A;RBX1;CENPV;COPS5;UBA52;UBC;PADI2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.4351464122132701,1.122782745017193,0.25,0.9163228757409488,1.0,8/33,11.81%,CEBPA;PPARG;RCN3;SIRT1;ABHD8;NR1H3;ACOX1;FBXW7
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.697371424928223,-1.1226072692229747,0.4,1.0,1.0,2/8,15.02%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6276877589044692,-1.122515320100171,0.3333333333333333,1.0,1.0,7/29,14.49%,NR4A3;THBS1;OGN;STAT1;ID2;IL18;APOD
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.709200907784589,-1.1223890141887911,0.32894736842105265,1.0,1.0,3/9,19.36%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7226619941832058,1.1222173565437623,0.4482758620689655,0.9160650352440565,1.0,3/5,23.49%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.795966396670008,-1.1221430844946467,0.323943661971831,1.0,1.0,1/5,9.21%,SFXN3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.4257127293812492,1.122124420708299,0.2857142857142857,0.914451644797148,1.0,9/20,21.97%,SIRT1;HDAC10;LYPLA1;ABHD10;PPT1;HDAC5;HDAC1;SIRT2;ABHD17A
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.7537774177958911,-1.1218032618789078,0.391304347826087,1.0,1.0,1/5,2.13%,MYLK
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7861107444416761,-1.12171701799831,0.3333333333333333,1.0,1.0,1/5,2.13%,MYLK
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.5991052583993095,-1.1209781267256496,0.3333333333333333,1.0,1.0,6/31,10.40%,NLRP12;TOM1L1;VEGFA;PPP2R5A;PPP2R5B;CALM3
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5919369696563144,-1.1209313919327668,0.2903225806451613,1.0,1.0,11/31,23.08%,RIMS1;NRXN1;RAB3A;CPLX1;SYT1;SNAP25;UNC13A;GAD1;NRXN2;GAD2;DVL1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.6934373895584549,1.1208692049780606,0.4,0.9142561834429813,1.0,3/6,11.62%,TMEM119;P2RX7;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6934373895584549,1.1208692049780606,0.4,0.9142561834429813,1.0,3/6,11.62%,TMEM119;P2RX7;UBASH3B
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.7097484732878746,1.120536626080983,0.4,0.9133864815177568,1.0,2/6,10.33%,SLC25A18;ARL6IP5
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5386332439925814,-1.120419467756504,0.29896907216494845,1.0,1.0,16/81,14.35%,SRGN;THBS1;F13A1;SPARC;VEGFA;TUBA4A;TGFB2;F8;ENDOD1;SOD1;TTN;SELENOP;MANF;CD63;FN1;CD36
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7250984280155325,-1.120286584182968,0.36470588235294116,1.0,1.0,4/8,25.65%,EMC7;EMC10;EMC2;EMC3
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6597411796710517,-1.1202683567727119,0.2948717948717949,1.0,1.0,6/13,26.68%,WDR12;RPL35;RPL7;PES1;RPL7L1;URB1
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6808064302075605,-1.119874639176982,0.375,1.0,1.0,4/10,27.17%,PAICS;IMPDH1;GART;PFAS
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.578200055887934,-1.119852747217063,0.2916666666666667,1.0,1.0,14/40,23.61%,MDH1;FBP1;GAPDH;PGK1;ENO2;PGAM1;PGM1;APOD;SORD;PER2;IRS2;ENO1;GPI;GAA
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.7456267901757142,-1.1191993257705461,0.32857142857142857,1.0,1.0,2/6,7.20%,TG;DUOX1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.66533528145333,-1.1190278260952544,0.3611111111111111,1.0,1.0,5/12,26.02%,ADGRG6;GSTM3;SERPINI1;PMP22;UGT8
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6574170827662961,-1.1189718522668948,0.3253012048192771,1.0,1.0,2/11,10.12%,ANK3;DMD
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.6319768231196746,-1.1188633148216607,0.35802469135802467,1.0,1.0,3/16,9.66%,TRIM5;HS3ST5;TRIM25
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5809862139469799,-1.118846290931868,0.32978723404255317,1.0,1.0,14/44,17.97%,P4HA3;ADAMTS2;TGFB2;COL21A1;COLGALT2;COL26A1;COL11A1;COL10A1;COL23A1;COL4A5;ITGA6;P4HA1;PLEC;COL19A1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5838675194548476,-1.1183513599421997,0.3,1.0,1.0,8/52,4.80%,THBS1;FGF1;AGT;SPARC;VEGFA;RHOB;GLUL;PTN
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.570105689929125,1.118287827331585,0.34615384615384615,0.9188005325785727,1.0,2/9,12.10%,NR3C1;SRC
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.5250285967759076,1.1181528846209514,0.3333333333333333,0.9173376477486171,1.0,2/10,2.84%,NRP1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3253664447929831,1.1180689395036798,0.16666666666666666,0.915740939306028,1.0,19/82,13.38%,PLXNA2;DSCAM;NUAK1;ARHGDIB;SEMA4D;SIPA1;ABL1;ZDHHC2;CXCL12;PLXNA4;TFE3;CDH13;ADAM10;EPHB3;ABL2;SRC;ADGRG1;PLXNB2;CD164
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.6618594311961473,-1.1180074193323637,0.345679012345679,1.0,1.0,1/12,1.16%,CHRM5
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6526002194871925,-1.117880053906156,0.391304347826087,1.0,1.0,3/18,10.88%,GLRA1;SOD1;CCL3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6236750960755484,-1.117616293411933,0.345679012345679,1.0,1.0,7/22,19.90%,SPOCK1;NR4A2;FAIM2;MAPT;AGTPBP1;TOX;SOX4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.658035229774572,-1.1174360026599721,0.35443037974683544,1.0,1.0,7/14,19.27%,RPL23;RPS20;RPL37;RPS15;RPS7;UBB;HEXIM1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.7108986744901371,-1.11699749809227,0.37333333333333335,1.0,1.0,2/10,8.81%,MEI1;ZCWPW1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.7297108751836325,-1.1169080271253629,0.3235294117647059,1.0,1.0,4/7,23.01%,ADCY3;CFTR;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.7297108751836325,-1.1169080271253629,0.3235294117647059,1.0,1.0,4/7,23.01%,ADCY3;CFTR;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7229587042212939,-1.1163671928681356,0.2987012987012987,1.0,1.0,3/8,20.64%,ANTKMT;MID1IP1;TMSB4X
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5421795647407996,-1.1158749459667532,0.21649484536082475,1.0,1.0,34/89,27.98%,NR4A2;FAIM2;CCK;BRINP1;TCEAL2;AMER2;CALY;NRXN1;PAK5;GRIA4;RAB3C;KCNC1;TAGLN3;SNAP25;GFAP;ADCY8;GABRG2;GRM3;SYT4;CADM2;CLVS2;GAD2;STMN2;ST8SIA3;PDE2A;GRIN2A;LY6H;MAP2;NRGN;CA10;GRIA2;SRRM4;VSTM2B;CACNA1B
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5379264093428396,-1.1157635610657362,0.29473684210526313,1.0,1.0,31/77,23.38%,PCSK1;FAM13C;AGT;KCNT2;PCDH17;SPARCL1;SST;NRXN1;MAPK4;PTPRD;RAB3C;PTPRT;CHGB;CNTN1;PCSK2;PHYHIPL;SNAP25;CPE;RCAN2;GABRG2;SYT4;GABRB3;ETV1;TSPAN7;GAD2;ASXL3;MAPK10;PLPPR4;STMN2;ST8SIA3;CADPS
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5441173541104899,-1.115587904538843,0.2765957446808511,1.0,1.0,14/56,21.19%,KCNE1;KCNJ13;ATP1B3;KCNMA1;KCNH8;TMEM175;SLC24A1;KCNC1;SLC9A6;KCNK10;NALCN;KCNMB1;SLC24A2;KCNH7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.5879717529836626,-1.115417718059905,0.3493975903614458,1.0,1.0,7/22,18.06%,RGS2;PLN;ANK2;CALM3;PDE4B;CAV3;CALM1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7423935791779148,-1.1153363627114086,0.34782608695652173,1.0,1.0,2/5,24.74%,PRPS1;TKT
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6363674954701432,-1.1149727444785693,0.2988505747126437,1.0,1.0,8/24,16.68%,RPS21;NGDN;RPS8;UTP3;RPS14;RRP36;RPS16;WDR46
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6299906528931307,-1.1148797100959793,0.3411764705882353,1.0,1.0,6/18,15.58%,ANK3;ATP1B3;ANK2;DMD;CFTR;ABCB1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.6874589066636333,-1.1147506433075998,0.4383561643835616,1.0,1.0,1/7,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6130932566126172,-1.1147056975352616,0.3176470588235294,1.0,1.0,1/19,0.96%,THBS1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.7152210498544055,-1.1144074632101502,0.34285714285714286,1.0,1.0,3/6,22.52%,BCL6;IRS2;FOXP1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.5708047381200755,-1.1141814005001118,0.21875,1.0,1.0,30/61,32.07%,PIANP;SULT4A1;FAIM2;BRINP1;CASKIN1;CLIP3;APLP1;SRRM3;BSN;KCNC1;NCDN;TAGLN3;GAD1;CLVS2;CKB;KIF5A;STMN2;TMEM59L;LY6H;NLGN2;GRIA2;VSTM2B;NDRG4;LINGO1;NCAN;SCAMP5;B4GALNT4;CELSR2;STXBP1;ASIC2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5343574451987566,-1.1139564677638285,0.27835051546391754,1.0,1.0,17/92,9.72%,FOSL2;CD55;VIM;HHIP;ASPN;SPARC;NR4A1;VEGFA;ADAMTS2;TNS1;HIF1A;LAMA2;TNFRSF1B;NR4A2;SPON2;FGR;LAMB1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7432125384324872,-1.1138991026849279,0.36363636363636365,1.0,1.0,4/7,21.71%,STAT1;IFIT1;DDB1;DYNLT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5971197870412499,-1.1135800283946553,0.3409090909090909,1.0,1.0,10/30,14.30%,RPS27A;RBX1;RPA2;UBA52;RFC1;UBC;RPA3;FAN1;ERCC2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.5950566127186615,1.1134728598369843,0.25806451612903225,0.9276677196720146,1.0,1/5,2.47%,DAB2IP
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.5881215993458623,-1.1132063063774718,0.3118279569892473,1.0,1.0,13/32,26.58%,RIMS1;NRXN1;RAB3A;CPLX1;SYT1;SNAP25;UNC13A;GAD1;NRXN2;GAD2;DVL1;RIMS2;PIP5K1C
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.759802279384641,-1.1131870957514118,0.36923076923076925,1.0,1.0,2/5,11.22%,TGFB2;KDM6B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5907422555469735,-1.1131470977833071,0.2872340425531915,1.0,1.0,7/43,14.35%,RPL23;VIM;DDX11;NOD2;FCGR2B;SNX6;CD36
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.6694519147332187,-1.1127340284565803,0.36585365853658536,1.0,1.0,5/15,16.26%,SCO2;COA6;COX20;TIMM21;BCS1L
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.7034292017218232,-1.1125435753949187,0.37681159420289856,1.0,1.0,4/6,22.52%,PRKCQ;BCL6;IRS2;FOXP1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.5390806985829062,-1.1124691778093991,0.17,1.0,1.0,35/151,24.86%,THBS1;VIM;MIF4GD;RPS4X;EIF4A3;PRR16;ZNF540;RBM4B;RBM3;DAPK1;RPL13A;GAPDH;EIF2B2;DDX1;RPL5;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;EIF3E;IMPACT;ILF3;EIF3D;SOX4;EIF4A2;EEF2;TRAP1;PATL2;PUS7;EIF2AK2;RPL10;RACK1;MRPL13;UPF3A
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.4195594410281612,1.112300577822464,0.2222222222222222,0.9294781969161302,1.0,11/45,9.36%,FKBP9;CD276;HTRA1;DAB2IP;NUAK1;NXN;DAG1;TENM3;CYP19A1;AMOTL1;RAI14
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7493420186900912,-1.1119885922235782,0.34782608695652173,1.0,1.0,1/5,1.81%,LRP2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6683364787716551,-1.111845368950845,0.3333333333333333,1.0,1.0,2/11,2.30%,DNAH11;MMP21
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.7151533077781902,-1.111575664887534,0.4246575342465753,1.0,1.0,1/7,1.65%,EIF4A3
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5759234268555211,-1.1115668278728066,0.3218390804597701,1.0,1.0,9/37,17.27%,MYLK;SLC16A3;RARRES1;TYMP;BNIP3;TMEM14A;PPP1R13L;ITGA2;ANXA2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7224556339970676,-1.1108279102942986,0.38028169014084506,1.0,1.0,1/8,8.16%,CLSPN
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.7247510005606126,1.1106838036284672,0.37037037037037035,0.9319200237647377,1.0,2/6,8.46%,TP53;SERPINE1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6182305162899746,-1.1105979126627463,0.38095238095238093,1.0,1.0,7/19,20.35%,RPS27A;RBX1;UBA52;UBC;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5997297190621279,-1.110476816080282,0.3125,1.0,1.0,4/19,17.95%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.6024455667548789,-1.110171870935094,0.3333333333333333,1.0,1.0,5/25,22.92%,CLDN18;CLDN20;MPP7;PDCD6IP;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6823087381682192,-1.110094958851665,0.38961038961038963,1.0,1.0,3/12,12.00%,NR4A3;NR1H2;MID1IP1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6204823188753406,-1.110031417470083,0.2891566265060241,1.0,1.0,4/22,17.93%,RPS27A;UBA52;UBC;UBB
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.6236511956488591,-1.1096168341162205,0.34523809523809523,1.0,1.0,11/20,24.10%,FGF1;HSPA12A;VGF;APLP1;SRRM3;ENAH;TMEM132A;SEZ6L2;CKB;RBFOX2;TMEM59L
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.6154743668205254,-1.1095620184780954,0.3333333333333333,1.0,1.0,5/20,16.30%,INF2;MAPT;PINK1;BNIP3;STAT2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.6840847974416453,-1.1094333364897544,0.3108108108108108,1.0,1.0,3/7,23.23%,DGAT1;MFSD2A;ACSL3
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5602645383638744,1.1094088752574633,0.3103448275862069,0.93396435515883,1.0,1/9,1.94%,CPSF4
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.617863803781912,1.1093372085689703,0.4482758620689655,0.9324059688831832,1.0,2/8,4.58%,ZDHHC3;PPARG
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.7281030883003219,-1.1089474032022504,0.3472222222222222,1.0,1.0,1/7,3.05%,HINT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.7029961998890968,-1.1085028743913725,0.37142857142857144,1.0,1.0,3/6,19.05%,DPYD;ALDH6A1;DPYS
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),-0.6842629864071827,-1.1084203217397668,0.4057971014492754,1.0,1.0,1/7,5.70%,TNFRSF1B
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.675249298541639,-1.108355016785864,0.3972602739726027,1.0,1.0,4/11,20.14%,MT2A;SLC31A2;ATOX1;CUTC
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.7209522746284581,-1.108303472025886,0.4155844155844156,1.0,1.0,4/7,20.29%,DDX11;PARP9;MED25;DTX3L
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.6688906132313117,-1.1082843850475552,0.43478260869565216,1.0,1.0,3/9,17.62%,AGT;CD36;FPR1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.5707430839276617,-1.1081443620724785,0.29473684210526313,1.0,1.0,18/70,24.58%,EIF4A3;RTN1;ZNF540;DAPK1;RPL13A;GAPDH;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;ILF3;CLU;PATL2;PUS7;EIF2AK2;RACK1;MRPL13
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6849821144002484,-1.1075676993771002,0.30303030303030304,1.0,1.0,3/11,14.70%,CGNL1;LSR;MPP7
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.7328772825824614,-1.1072922701651344,0.3,1.0,1.0,1/5,2.29%,CYP3A5
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.7221546216762805,1.1071619830285753,0.3,0.9372010508667636,1.0,1/5,1.18%,LGALS9
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7884071690515863,-1.1067301826855096,0.34328358208955223,1.0,1.0,1/5,12.01%,CMPK2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.551571169896627,-1.1067275197944098,0.2872340425531915,1.0,1.0,12/44,19.08%,HTR2B;AGT;ACKR4;PPP1R9A;CXCR4;CCL3;EIF2AK3;CD36;NUDT4;FPR1;MCTP1;RCAN2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.7119031575070109,-1.10666143412133,0.36507936507936506,1.0,1.0,1/5,0.96%,THBS1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5508882153852492,-1.1062453683582436,0.3010752688172043,1.0,1.0,21/82,17.30%,DDIT4;MX2;TRIM5;IFITM3;RSAD2;MX1;IFIT2;PQBP1;IFIT3;STAT1;BNIP3;IFI44L;NLRC5;BNIP3L;IRF1;IFIT1;OAS3;PYCARD;STAT2;IFIT5;ATAD3A
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.5885529268348725,-1.1060469169157878,0.3333333333333333,1.0,1.0,7/24,21.83%,BRCA1;PINK1;BTN2A2;SDCBP;SIRT5;LRPAP1;TRAP1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.7346236618084085,-1.1055158855851688,0.36764705882352944,1.0,1.0,2/5,16.73%,RDX;CAV3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4120194059528772,1.105402220675483,0.30434782608695654,0.9406002055152366,1.0,5/26,5.80%,NRP1;CSF1R;ARHGDIB;ABI3;ABL1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.7128018834690522,-1.105395549027628,0.35135135135135137,1.0,1.0,4/7,23.63%,ACSS3;ACAT1;HMGCL;SLC27A5
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.6256358485215359,-1.1053909420848205,0.4155844155844156,1.0,1.0,2/15,5.11%,MTHFD1;ME1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5519626419217856,-1.1050910082329009,0.34831460674157305,1.0,1.0,11/43,19.48%,TFRC;GPR183;VAV3;IL7;IL15;PDCD1LG2;TNFSF13B;IL18;HLA-DMB;AIF1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6614168468860615,-1.105059701479099,0.3670886075949367,1.0,1.0,2/9,6.80%,AGT;NOD2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.7326496849291184,-1.1049337792884557,0.36363636363636365,1.0,1.0,2/6,18.22%,GLUL;SNAP25
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.5311555135003677,1.1046495881822385,0.35714285714285715,0.9409347585371813,1.0,5/23,10.34%,B4GALT7;GAL3ST4;GLCE;UGDH;FAM20B
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.7231034774429028,-1.1046357920550862,0.39436619718309857,1.0,1.0,1/7,0.62%,NLRP12
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.7435760777742397,-1.104593316095418,0.390625,1.0,1.0,2/5,16.01%,TNFRSF1B;RGCC
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5168249351550747,1.1045780695379677,0.36,0.9391828851721116,1.0,2/10,13.88%,HHEX;POLDIP3
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4885460272962087,1.1044134997441064,0.24,0.9377938001530358,1.0,5/13,11.65%,LPL;PPARG;SYK;CDH13;LDLR
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.4850466199996357,1.1040931432475085,0.3333333333333333,0.9367380608797149,1.0,8/27,12.10%,SMAD7;JAG1;TGFB1;ZDHHC2;TENM3;NF2;EPHB3;SRC
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.627155700616359,1.1040834693856085,0.37037037037037035,0.9349226770408007,1.0,1/6,0.80%,B4GALT7
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6203431017735193,-1.1040637005502978,0.4025974025974026,1.0,1.0,2/13,10.88%,CCL4;CCL3
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.5284057164274871,-1.1038778978017127,0.21212121212121213,1.0,1.0,36/190,15.12%,CENPF;RPL23;GADD45B;THBS1;CKS2;MX2;DTL;PPP1R15A;NR4A1;RHOB;WDR12;TGFB2;ALOX15B;MASTL;FIGNL1;DUSP1;BRINP1;PPP2R3B;BRCA1;ID2;CAMK2N1;NOP53;PRR11;CTBP1;HCFC1;JUNB;NOTCH2;BEX2;IRF1;PIM3;MED25;IQGAP1;CCPG1;SDCBP;CDKN1B;ING4
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5509149633231518,1.1038695900421025,0.3793103448275862,0.9336043398193257,1.0,5/11,26.25%,CDAN1;PDS5A;RAD17;SLFN11;TERF1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.5656385015365053,-1.1038509860741978,0.3372093023255814,1.0,1.0,7/45,10.55%,NEK11;DTL;RPA2;BRCA1;CLSPN;DONSON;NOP53
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.6870430815425213,-1.1037891656358267,0.4155844155844156,1.0,1.0,3/9,17.58%,TCHP;ODF2L;LIMK2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.6509347618527038,-1.103748588907973,0.38461538461538464,1.0,1.0,3/12,8.84%,TNFRSF1B;NOD2;SLC7A5
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5954765535552917,-1.1034518741438801,0.3048780487804878,1.0,1.0,9/26,20.97%,MPG;RPA2;NEIL1;ADPRS;RFC1;RPA3;RFC4;POLL;LIG3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.7274140051333147,-1.1034102971262487,0.38095238095238093,1.0,1.0,3/5,22.52%,BCL6;IRS2;FOXP1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6931322562662701,1.103323214490173,0.34285714285714286,0.9332692484308994,1.0,3/5,20.55%,PIEZO1;CCL5;WNK1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6507337494871874,1.1030759998966722,0.44,0.9323930755416405,1.0,3/7,7.47%,SERTAD2;ARID1A;ZMIZ1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5119577045951055,-1.102915950706032,0.24,1.0,1.0,37/187,21.86%,TFRC;RPS27A;NAPA;MX2;LRP2;RIMS1;MX1;IL7R;EPN1;ANK3;MTCH1;CR1;TRIP10;SERP1;ANK2;ITSN1;UBA52;UBC;FCHO2;CFTR;IGF2R;AP2S1;CAV3;SH3GL2;AGFG1;SYT1;TMEM33;UBB;UBXN2B;EMD;AMPH;ACTG1;SYP;DNM1;CHMP5;RAB5A;PDCD6IP
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.3908422320900073,1.102867148893194,0.14285714285714285,0.9313849401049801,1.0,8/47,12.10%,MATK;TGFA;TGFB1;PTPN12;NCK2;CBL;SLC30A10;SRC
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6506236228989725,1.1028239290082518,0.36363636363636365,0.9296782966926027,1.0,1/7,2.31%,TMEM119
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.7476349775489588,-1.1027454162432413,0.38235294117647056,1.0,1.0,1/5,14.09%,SNX6
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.7185549653157601,-1.1026737440415564,0.375,1.0,1.0,2/8,9.31%,PPP2R5A;EEF1A2
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.7587090068317699,-1.1025787731580468,0.39705882352941174,1.0,1.0,1/5,4.22%,ADCY3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6382605953688774,-1.1024471420242528,0.35135135135135137,1.0,1.0,6/15,23.38%,ANK2;DMD;CALM3;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.7439597254429304,-1.1023295668982116,0.38028169014084506,1.0,1.0,3/5,16.57%,CARMIL1;SLC2A9;PRPS1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.6099878878862791,1.1023259501238578,0.35714285714285715,0.9291645547104643,1.0,4/7,20.72%,SYK;DEF8;PLEKHM1;ATP6AP1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6661144516377082,-1.101518325485081,0.41333333333333333,1.0,1.0,3/12,9.66%,TRIM5;HS3ST5;TRIM25
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6856896876622479,-1.1013062902969335,0.38235294117647056,1.0,1.0,1/5,12.92%,PADI2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.670500306084172,-1.101025189811836,0.34285714285714286,1.0,1.0,4/9,25.39%,SULF2;DEAF1;DYNC2I1;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.561390998517719,1.1009604545798464,0.3448275862068966,0.9312093443193057,1.0,3/9,5.29%,LGALS9;CD274;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.7132443046345353,-1.1008897104468498,0.39436619718309857,1.0,1.0,2/6,14.49%,MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.7132443046345353,-1.1008897104468498,0.39436619718309857,1.0,1.0,2/6,14.49%,MDFIC;APOD
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.7272876340480705,-1.1007003006357436,0.38028169014084506,1.0,1.0,4/8,22.13%,MAPT;SHANK3;ADCY8;LILRB2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.5778199958979443,-1.1000196069568695,0.36585365853658536,1.0,1.0,13/43,15.04%,OSMR;PLPP3;FGF1;ME1;DOCK1;GBP2;NTN4;THBD;ADGRD1;FN1;PALLD;SVEP1;FRAS1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6660262482999626,-1.0997765674816466,0.38571428571428573,1.0,1.0,7/11,29.79%,SHANK3;TSHZ3;NRXN1;NLGN3;RELN;NLGN2;CACNG2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6445217157867172,-1.099704846797109,0.4025974025974026,1.0,1.0,4/14,14.28%,PPP1R15A;DDRGK1;ANK2;HSPA5
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.821806124765122,-1.099691182585136,0.36666666666666664,1.0,1.0,2/5,17.77%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.821806124765122,-1.099691182585136,0.36666666666666664,1.0,1.0,2/5,17.77%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.821806124765122,-1.099691182585136,0.36666666666666664,1.0,1.0,2/5,17.77%,CRYL1;SORD
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.7030801035263293,-1.0996476402588202,0.37662337662337664,1.0,1.0,3/8,17.67%,PPP1R15A;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.6137812326281835,-1.0992777250133876,0.4266666666666667,1.0,1.0,2/16,9.66%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.5843856285869786,-1.0991915481623136,0.3977272727272727,1.0,1.0,7/24,26.09%,LPCAT1;GNPAT;DHDDS;ABCA8;IDI1;MVD;PIP5K1A
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5813065683083003,-1.099020384515757,0.32926829268292684,1.0,1.0,1/25,0.37%,NR4A3
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.6007902160104995,1.0988759874898903,0.3333333333333333,0.9357711575632907,1.0,2/7,4.76%,PKD2;JAG1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.6379106678158146,-1.0987706711170566,0.41025641025641024,1.0,1.0,2/13,8.89%,TENT4B;SSB
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6262367768612582,-1.0987572012402544,0.38961038961038963,1.0,1.0,2/15,9.06%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.6784043656623,1.0987499682135444,0.3684210526315789,0.9345517192742073,1.0,3/6,12.53%,NRP1;ABL1;RIT2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6812311626466269,-1.0985805713600059,0.4027777777777778,1.0,1.0,2/9,8.31%,SEMA3A;CHN1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7184350426113405,-1.098255960217534,0.3972602739726027,1.0,1.0,3/7,11.51%,GPR183;FCGR2B;NOTCH2
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.7311742183620844,-1.0980629027464601,0.3611111111111111,1.0,1.0,1/6,3.43%,GPR183
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5917074396684328,-1.0978731318277473,0.38372093023255816,1.0,1.0,9/28,14.30%,RPS27A;RBX1;RPA2;UBA52;RFC1;UBC;RPA3;ERCC2;RFC4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.6136315470641017,-1.097751547950813,0.41975308641975306,1.0,1.0,4/17,13.01%,TGFB2;CCDC39;COBL;CLMP
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5139293137900801,-1.097677573524786,0.2,1.0,1.0,49/294,15.56%,PRLR;HTR2B;TFRC;THBS1;ARAF;RPS27A;NAA38;LRP2;RNF144B;VEGFA;ALOX12;PRELID1;BEX3;IL7;DDRGK1;GSTP1;NR4A2;FIGNL1;IFIT3;CFL1;BCL2A1;FAIM2;HSPA1B;RPS3A;SOD1;PINK1;COPS5;BNIP1;BNIP3;TNFAIP8;ATF5;STIL;TMEM14A;UBA52;TLE1;NOTCH2;PTMA;BNIP3L;TPT1;BCL2L2;UBC;NUAK2;PIM3;CARD16;SNX6;HSPA5;APIP;MAG;PTPRZ1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.54849692263611,-1.0975691869542623,0.3888888888888889,1.0,1.0,10/38,20.31%,NLRP12;HHIP;AQP11;FCGR2B;NR1H2;PIM3;KLF4;MCTP1;CLU;THY1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.58344479010502,-1.0975004750084505,0.29545454545454547,1.0,1.0,5/30,5.23%,CHRM5;RGS1;ADCY3;AKAP12;GRM8
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.605368318427778,-1.0973918401293616,0.4,1.0,1.0,5/23,15.43%,HTR2B;ADGRG6;CD36;AKAP6;NUDT4
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5694116145179698,1.0970139133945807,0.30434782608695654,0.9379124920976543,1.0,1/9,1.09%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6141508885648435,-1.09694227272859,0.3333333333333333,1.0,1.0,1/19,0.62%,NLRP12
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.6713559897938505,-1.0964449632280593,0.43529411764705883,1.0,1.0,4/15,6.09%,CHI3L1;FGF1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5812682887679074,-1.0959767425816347,0.36666666666666664,1.0,1.0,7/24,15.84%,SOCS3;VEGFA;PARP9;IL15;IL18;PARP14;GHR
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.7363082056504384,-1.095920229213169,0.375,1.0,1.0,1/6,8.93%,PINK1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.5171131677319478,-1.0958292877379159,0.25252525252525254,1.0,1.0,27/162,14.28%,DDIT4;SLC2A3;NAMPT;TFRC;GLA;INSIG1;BHLHE40;NFIL3;PPP1R15A;TUBA4A;ME1;ERO1A;EGLN3;SLC7A5;COPS5;SERP1;RDH11;GAPDH;CXCR4;PGK1;PPA1;TOMM40;LDHA;PSMA3;PGM1;TM7SF2;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.632925371539413,-1.095681110030819,0.375,1.0,1.0,2/16,4.06%,AGT;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6925029124223973,-1.0952294414909336,0.3918918918918919,1.0,1.0,2/8,10.88%,THBS1;CCL3
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.7419193736913424,-1.095179721352052,0.3424657534246575,1.0,1.0,4/5,25.69%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.7419193736913424,-1.095179721352052,0.3424657534246575,1.0,1.0,4/5,25.69%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.7392342897449329,-1.0948159430592062,0.4057971014492754,1.0,1.0,1/5,18.14%,ATG2A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.5876063648171748,1.0948125817808043,0.41379310344827586,0.9423020824613023,1.0,1/7,1.18%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.594521833318122,-1.0945827936465617,0.33707865168539325,1.0,1.0,6/22,24.28%,TUBB4A;CLIP3;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6666572292321191,-1.0945311381127305,0.4189189189189189,1.0,1.0,1/11,0.96%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.7099448503303515,1.0944275649959023,0.45714285714285713,0.9416636442098122,1.0,3/5,23.18%,TRAF6;ATP6AP1;CCR1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5555832662037581,-1.0943981644884575,0.36904761904761907,1.0,1.0,6/39,10.88%,CCL4;MYLK;CACNB2;PLN;ANK2;CCL3
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.615303045770859,-1.094361707898639,0.36585365853658536,1.0,1.0,5/20,17.52%,VAV3;PRR16;RDX;CAV3;LARS1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6651608322922373,-1.0942990714284568,0.3333333333333333,1.0,1.0,5/7,29.07%,SLC24A1;SLC24A2;PRRT1;SHANK2;PLK2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.6293502392328388,-1.093874966502891,0.4230769230769231,1.0,1.0,5/9,27.75%,DPYD;ALDH6A1;DPYS;CTPS1;CRMP1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6648925377798953,-1.0938711634928369,0.36486486486486486,1.0,1.0,3/10,21.81%,TERF2IP;BRCA2;TPP1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.6226340518697002,-1.0936480493930285,0.32894736842105265,1.0,1.0,1/18,1.52%,TOM1L1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6730754514485835,-1.0935092300560076,0.38461538461538464,1.0,1.0,1/10,4.06%,RBPJ
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.588983399385165,1.0930131114677744,0.45,0.9440873097321035,1.0,5/10,17.67%,EFL1;AK3;MFN1;RHOQ;GIMAP7
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.656353179143158,-1.092809752799175,0.35802469135802467,1.0,1.0,1/11,3.11%,VEGFA
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.45104703864028173,1.0925373230639108,0.35294117647058826,0.943740026129995,1.0,10/23,21.03%,BCL9L;BCL9;TLE3;EP300;RBBP5;TCF7L2;TLE2;PYGO2;CDC73;HDAC1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7535516506787041,-1.0920203885086677,0.43478260869565216,1.0,1.0,3/5,18.98%,CCDC39;SPATA6;BBOF1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.7083688919929741,-1.0919651907964834,0.36923076923076925,1.0,1.0,3/6,24.53%,DHX58;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7066786991953569,1.0918046040916445,0.48717948717948717,0.9441627184519588,1.0,2/5,19.56%,PPP1R10;ENG
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5884727023384058,1.0916375468540545,0.3157894736842105,0.9429170958265021,1.0,5/14,15.78%,MSN;RAP2A;CYTH3;CDC42;OPHN1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5202111923348653,-1.0912957397725331,0.31958762886597936,1.0,1.0,18/100,12.40%,CLEC12A;ADGRE1;CLEC4E;JAML;SIRPB2;SLC11A1;C5AR1;TNFRSF1B;MS4A4A;CD163;PLTP;FGR;FCGR2B;TYMP;IL10RA;MARCO;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6599656010629145,-1.0912833863846791,0.43283582089552236,1.0,1.0,1/7,3.40%,ALOX12
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5137542758527822,-1.0911434701590714,0.3229166666666667,1.0,1.0,13/93,9.32%,CYCS;ERMP1;ALDH3B1;FOS;HIF1A;GSTP1;ERO1A;HSPA1B;SOD1;MAPT;PINK1;DAPK1;TMEM161A
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5441828369352368,-1.0910781258951048,0.35555555555555557,1.0,1.0,18/50,23.45%,PLPP3;FAM13C;PTN;MAP1B;LAMB1;ANK2;ADGRL2;SVEP1;LIFR;LRP4;FBXL7;CPE;THY1;ALDH1A2;RUNX1T1;GPRC5B;CRYAB;MPDZ
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.5339402920781037,1.0910601704531424,0.42105263157894735,0.9427588067521799,1.0,6/15,13.93%,METTL16;TFB1M;FBL;BUD23;NSUN4;MTERF4
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5374836121746888,-1.090756231731082,0.35789473684210527,1.0,1.0,15/85,12.63%,CCL4;JAML;MYO1G;TXK;RORA;SELL;IL7R;IFIT3;CD69;IL10RA;CXCR4;TGIF1;CCL3;JUNB;TCF7
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6663807659398893,-1.0907435877390268,0.4166666666666667,1.0,1.0,2/12,8.47%,DTL;RAB11A
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.7744669057026119,-1.0907221798069868,0.296875,1.0,1.0,2/5,13.19%,PLN;PDE4B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.6726407046063244,-1.0905655347511058,0.40789473684210525,1.0,1.0,1/7,18.14%,ATG2A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.6726407046063244,-1.0905655347511058,0.40789473684210525,1.0,1.0,1/7,18.14%,ATG2A
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.35823607552714487,1.0905601965041294,0.14285714285714285,0.9425483967602131,1.0,14/65,15.37%,NUP42;NUP188;SMURF1;TGFB1;U2AF1;PHAX;NUP214;THOC5;RAE1;POLDIP3;NUTF2;THOC7;EIF4E;CCHCR1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.710297499014568,-1.0903374733687414,0.40789473684210525,1.0,1.0,1/7,3.45%,DPYD
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5341343743469198,-1.0900755457644349,0.3655913978494624,1.0,1.0,11/70,10.34%,CCL4;JAML;MYO1G;NR4A1;RORA;SELL;CD69;FGR;MAP3K8;IL10RA;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.5508257955325869,-1.089721164739433,0.32558139534883723,1.0,1.0,8/25,22.10%,HIF1A;PFKFB4;PINK1;PID1;PFKFB3;INSR;TMSB4X;ENO1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3550301249314833,1.0894534984551811,0.0,0.9439172302544353,1.0,24/107,12.53%,RALB;RAP1A;RGL2;KRAS;ARHGDIB;RAPGEF6;PDPN;RHOG;MAPK11;PHACTR4;TP53;GNA12;CDH13;GRAP2;CDC42EP3;RASGRP2;SHTN1;RAP2A;CRKL;FGF2;EPS8;RAP2C;ADGRG1;RIT2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5307801708676595,-1.0894283272405603,0.29591836734693877,1.0,1.0,18/86,13.08%,HTR2B;SRGN;NLRP12;AGT;TXK;SLC11A1;TNFRSF1B;HLA-B;SOD1;FGR;FCGR2B;IL15;GAPDH;BTN2A2;MOG;BTN3A1;BCL6;PLD3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5611428023388253,-1.0892796043674524,0.4,1.0,1.0,6/31,15.84%,TOMM7;PINK1;TIMM13;TOMM40;TOMM20;TIMM21
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5071743528330902,-1.088881512483939,0.32653061224489793,1.0,1.0,37/80,28.50%,GADD45B;SULT4A1;FAIM2;BRINP1;ANK2;UBE2QL1;SST;PAK5;MAPK4;CTNND2;PTPRT;PHYHIPL;SH3GL2;KCNC1;SNAP25;GFAP;KCTD16;GABRG2;GAD1;CADM2;CLVS2;GAD2;PLPPR4;STMN2;ST8SIA3;HS6ST3;TMEM59L;LY6H;MAP2;CA10;GRIA2;CAMK2B;VSTM2B;GABBR2;AQP4;CADM3;NDRG4
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5418393158144815,-1.0888735890514272,0.3225806451612903,1.0,1.0,11/64,12.57%,CCL4;JAML;GPR183;SELL;TNFRSF1B;CD69;GBP2;IL10RA;HLA-F;ITGB8;ITGAE
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6293089688864837,-1.0885961926682066,0.4473684210526316,1.0,1.0,3/16,8.72%,SOCS3;ST18;STAT1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.6331825156731917,-1.088395741232437,0.35443037974683544,1.0,1.0,3/17,14.64%,ATP5IF1;UROS;PPOX
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3749324243971852,1.0883379027461986,0.16666666666666666,0.9457798683020815,1.0,6/69,6.69%,TNFAIP8L3;NFYC;RUBCNL;SC5D;PPARG;NPC2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.45412383936907963,1.0877366202749248,0.3333333333333333,0.9456960561478301,1.0,4/22,5.37%,TNFAIP8L3;DAB2IP;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.45402854087687605,1.0875748956260094,0.25,0.9442783487258285,1.0,6/26,13.31%,SESN2;SESN3;RRAGD;SMCR8;TELO2;CLEC16A
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.5229507364798742,-1.087250216260928,0.3854166666666667,1.0,1.0,13/88,14.25%,DIAPH3;RHOBTB3;SEMA6A;RHOB;ARHGAP4;CFL1;RHOU;FGD6;LIMD1;CCL3;EPB41L3;PAK5;PALLD
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.7232022708602994,-1.087231541638754,0.4117647058823529,1.0,1.0,3/5,25.42%,PAICS;PRPS1;GART
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.6304765377625053,1.087132171565518,0.4375,0.9435187113724361,1.0,3/7,4.18%,EDA2R;SMURF1;ITGAM
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.38939994565140673,1.087020406548739,0.25,0.94205815878645,1.0,4/48,3.30%,ATRAID;DAB2IP;LEPR;SORL1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.5892776280872297,-1.0869879115120902,0.4,1.0,1.0,1/25,0.33%,GLRA1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.37317383864125336,1.0867239932113788,0.25,0.9409932433842972,1.0,13/67,14.80%,PEX13;IPO13;NUP188;APPL2;PEX16;SYK;E2F3;PEX5;NUP214;PPP1R10;GDAP1;NUTF2;PEX2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.6610914245031508,-1.0865916667319933,0.453125,1.0,1.0,1/8,8.49%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.6610914245031508,-1.0865916667319933,0.453125,1.0,1.0,1/8,8.49%,ERI2
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5363999288055984,-1.0862053588808043,0.3191489361702128,1.0,1.0,15/63,21.19%,KCNE1;KCNJ13;KCNT2;ATP1B3;SLC12A8;KCNH8;TMEM175;SLC24A1;KCNC1;SLC9A6;KCNK10;NALCN;ATP1B2;SLC24A2;KCNH7
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6762252988374854,-1.0861192841159457,0.36363636363636365,1.0,1.0,1/10,1.08%,OSBPL5
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.6901709051206981,-1.085802280156983,0.3815789473684211,1.0,1.0,4/9,27.41%,BRCA1;LRIF1;SMCHD1;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.518703769775357,-1.0856812829551639,0.30612244897959184,1.0,1.0,12/115,12.84%,CENPF;PRKAR2B;HAUS6;DTL;TUBB4A;TUBA4A;RBX1;FHL1;RAB11A;TUBA1A;PSMA5;PSMA3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.349834861314181,1.085377302158871,0.3333333333333333,0.9431263029698109,1.0,9/58,12.58%,SESN2;MAP3K5;MIOS;SESN3;EIF2S1;EIF2AK4;LAMTOR1;RRAGD;FAS
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.6475442425896574,-1.0853210512784515,0.42696629213483145,1.0,1.0,4/16,6.09%,CHI3L1;FGF1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.5997886027952524,-1.0852659926133124,0.3253012048192771,1.0,1.0,3/26,9.97%,BRIP1;CLSPN;DONSON
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.524113369627569,1.0852569682351056,0.391304347826087,0.941648622376597,1.0,6/13,16.95%,CRK;SERPINE1;FGF2;CASK;ALOX5;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.647214616060371,-1.0850372725681425,0.39473684210526316,1.0,1.0,5/16,15.09%,HDGFL3;FGF13;MID1IP1;APC2;TTBK2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.556085820081219,1.0848846300901003,0.36666666666666664,0.9406679496304602,1.0,1/8,1.00%,SIRPA
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.4230347646448808,1.0848788297590282,0.3333333333333333,0.938967778299185,1.0,4/26,3.68%,SIRPA;ZMYND11;QARS1;ZNF675
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.6856547813130723,-1.084670621860042,0.4722222222222222,1.0,1.0,3/9,19.76%,ANK3;SCN9A;SCN1A
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.532359924083527,-1.0846361727802403,0.358695652173913,1.0,1.0,16/73,20.95%,CLEC12A;ADGRE1;JAML;SIRPB2;C5AR1;TNFRSF1B;FGR;MNDA;VNN2;NCF4;NCF2;FPR1;GPR65;AIF1;S100A4;CD300A
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5400936656642995,-1.083874523533689,0.3404255319148936,1.0,1.0,6/55,6.39%,H2BC11;HMGB2;H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5716529101795338,-1.0838529557134926,0.39080459770114945,1.0,1.0,4/27,11.10%,SLC38A4;SLC16A10;SLC7A5;SLC6A15
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.6335741520665978,-1.083809502430169,0.4457831325301205,1.0,1.0,2/15,5.04%,PPP1R15A;SH2D4A
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6213124706877,1.0837789878805224,0.32142857142857145,0.9404187029039685,1.0,4/8,15.99%,SLC46A1;PDPN;FOLR2;SLC19A1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6512978010134146,-1.0835734129933883,0.3924050632911392,1.0,1.0,1/11,0.96%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.6542503289093483,-1.0835598718601307,0.358974358974359,1.0,1.0,2/11,13.43%,PINK1;FEZ1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5646370667741057,-1.0826337679617228,0.34523809523809523,1.0,1.0,11/34,27.15%,RHOB;RACGAP1;ANK3;CIT;ANLN;INCENP;STMN1;PDCD6IP;SPAST;MYH10;TTC19
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6588563695201908,-1.082352450717637,0.358974358974359,1.0,1.0,4/14,16.11%,CALY;FCHO2;AP2S1;NSG2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6844204984649247,-1.0823508576181564,0.3888888888888889,1.0,1.0,3/9,10.88%,INSIG1;RORA;CCL3
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.5901018940175312,-1.0821795762194253,0.4457831325301205,1.0,1.0,6/25,14.85%,CFL1;FCGR2B;ZDHHC15;SIPA1L1;SHANK3;IL1RAPL1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.4652650295749643,1.0821200175126184,0.4166666666666667,0.9434853428984669,1.0,3/16,3.20%,RALB;TICAM1;CGAS
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5817023120208911,1.0819464406829407,0.28125,0.9421745907861838,1.0,1/7,8.21%,TFE3
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6920462720144337,1.081400023501702,0.42857142857142855,0.9418940836058545,1.0,2/5,5.33%,BAHD1;SIRT1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.6667418796075247,-1.0813310347134744,0.4189189189189189,1.0,1.0,4/9,25.01%,DPYD;TYMP;DPYS;UPP2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.5779336340266199,-1.081214876676541,0.4069767441860465,1.0,1.0,6/31,12.47%,ADGRG6;MAL;PLP1;EIF2B2;CXCR4;EPB41L3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5840767498827368,1.081208581140088,0.4666666666666667,0.9407189417371067,1.0,2/11,5.33%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.7442943043712063,-1.0811492512064051,0.4057971014492754,1.0,1.0,2/5,13.46%,IL15;IL18
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.7290210163864974,-1.0810145217709362,0.3684210526315789,1.0,1.0,1/8,7.16%,FBP1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5537087412709263,-1.0808683410754554,0.39325842696629215,1.0,1.0,9/42,21.81%,DNAJB9;DDX11;PPP2R5B;SERP1;HSPA5;FKBP14;SRPRA;ARFGAP1;TPP1
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7335452351852071,-1.0808011637194301,0.3918918918918919,1.0,1.0,2/5,13.46%,CCL3;IL18
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.6867397805582607,-1.0806069452529004,0.3888888888888889,1.0,1.0,4/9,25.42%,MTHFD1;PRPS1;AMPD2;GART
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5927222869867993,-1.0805013949875717,0.4268292682926829,1.0,1.0,5/21,19.39%,BHLHE40;HMGB2;NOTCH2;PRUNE1;PER2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.659229209628049,1.0799512997408214,0.5172413793103449,0.9428942889589798,1.0,2/5,11.93%,PPM1F;ADARB1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6303627124901487,-1.0797307495576574,0.39436619718309857,1.0,1.0,5/13,16.92%,CD55;TNFRSF1B;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6354334098591046,-1.079612124748278,0.4305555555555556,1.0,1.0,3/10,24.27%,EIF2AK3;GHR;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5653780077460945,-1.0794409480572267,0.3404255319148936,1.0,1.0,7/42,13.36%,ARIH2;TOMM7;VPS11;RHOU;ABLIM3;PINK1;USP36
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6954082711264307,-1.0794218547838588,0.4426229508196721,1.0,1.0,2/5,3.18%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6954082711264307,-1.0794218547838588,0.4426229508196721,1.0,1.0,2/5,3.18%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.7172379007176867,-1.0789573565617092,0.38961038961038963,1.0,1.0,1/5,14.35%,CD36
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6762851751514788,-1.0788853574993966,0.40789473684210525,1.0,1.0,2/8,3.16%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6788666687834113,-1.0785356053957085,0.4,1.0,1.0,2/9,4.89%,INSIG1;RORA
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5204930351957197,-1.0785033572912357,0.31313131313131315,1.0,1.0,28/167,19.10%,NDUFA2;MDH1;CYCS;COX7C;ETFB;NDUFS8;ATP5ME;COX7A2;ATP5F1E;NDUFA3;COX4I1;NDUFA1;UQCRC1;ATP5F1D;COX6C;TIMM13;UQCR10;ATP5PD;LDHA;UQCRB;NDUFB6;ALDH6A1;ATP5F1A;PDHB;COX5B;NDUFS7;ATP5MC1;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.6062776827871412,1.078378126352518,0.3333333333333333,0.9459031692431286,1.0,4/8,15.03%,HAVCR1;MILR1;CD84;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.5495111666164595,-1.0780810513964312,0.3763440860215054,1.0,1.0,19/55,25.04%,NUDT16;SVIL;XRCC3;DDX11;CENPV;RACGAP1;PRKCE;CIT;RGCC;INSR;GPSM2;UBXN2B;E2F7;PLSCR1;ZNF16;DBF4;CDC25B;WIZ;SPAST
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.48456981331167054,1.0779800278750995,0.3684210526315789,0.945312532878783,1.0,1/17,0.13%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5130631808276922,-1.0777768707481603,0.33,1.0,1.0,16/72,18.90%,CD55;TRIM5;CASP5;NOD2;DHX58;FGR;FCGR2B;CXCR4;APPL1;IRF1;BCL6;CD36;GRK4;CALM1;MGLL;ERAP1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5777243495443117,-1.077257090315175,0.4025974025974026,1.0,1.0,6/14,16.73%,TTN;PKD2L2;CDH2;LHFPL5;PIEZO2;CAV3
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.5786597248910894,-1.0770050762831735,0.40229885057471265,1.0,1.0,5/28,15.77%,SEMA3A;MAPT;OLFM1;MAG;GOLGA4
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.713806857675948,-1.0767064754034505,0.40625,1.0,1.0,3/6,22.46%,UHRF1;ZNF445;DNMT1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6531903496236084,-1.0765754514104617,0.3888888888888889,1.0,1.0,4/9,14.19%,RPL11;HIF1A;RPL5;COPS9
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6749253949158007,-1.0765329116646976,0.43661971830985913,1.0,1.0,5/7,29.45%,ATP1B3;ANK2;ATP1B2;AKAP9;ACTN2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.5796021653529532,1.0763106295115488,0.3076923076923077,0.9483061857180075,1.0,7/14,17.11%,P2RY12;ABI3;DEF8;EPS8;PLEKHM1;EVL;P2RX4
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5297921446017902,-1.0759152857855394,0.37894736842105264,1.0,1.0,14/69,12.92%,PRLR;CD55;PLPP3;AGT;VASN;TNS1;RXRB;SLC16A3;ABLIM3;NTN4;NR1H2;NOTCH2;MRO;PADI2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6842919492350736,-1.075864440538639,0.43478260869565216,1.0,1.0,1/9,1.56%,INSIG1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.534970213716061,-1.0756415848535033,0.33695652173913043,1.0,1.0,17/50,20.99%,CLDN18;CEBPD;ALOX15B;FBP1;MS4A4A;LPCAT1;TYMP;MARCO;SAT1;THBD;CD36;SCD;KLF4;ALDH1A1;ST14;SIGLEC1;CRLF1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6410155330755531,-1.0755710665766245,0.38028169014084506,1.0,1.0,4/13,13.81%,TXK;PRKCQ;THBD;TEC
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7538239599706426,-1.0755241514841647,0.4411764705882353,1.0,1.0,1/5,6.13%,DDRGK1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6834091979038399,-1.0752854740462363,0.4507042253521127,1.0,1.0,3/7,28.14%,DDX11;DNA2;WRN
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.58660684801781,-1.0751826472471488,0.37037037037037035,1.0,1.0,4/21,11.13%,HMGB2;DDX11;DDX1;MTERF1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.6830090894414214,-1.0750931174861276,0.43243243243243246,1.0,1.0,3/10,16.30%,NLRC5;OAS3;STAT2
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.6315355687302844,1.074922843788478,0.391304347826087,0.9508579375389777,1.0,3/5,28.32%,APEH;VPS4B;PEX14
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6592819604854179,-1.0748788165362329,0.4230769230769231,1.0,1.0,1/9,10.45%,BNIP3
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5190453669200337,-1.0748777997469927,0.3617021276595745,1.0,1.0,16/89,15.55%,GPR18;JAML;MYO1G;AIM2;NAPSB;SELL;IL7;CD69;FGR;FCGR2B;IL10RA;ACAP1;MNDA;LSP1;VNN2;NCF4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.7544669282175954,-1.0745819486134018,0.4626865671641791,1.0,1.0,1/7,1.71%,ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5220353334197206,-1.0745141614361484,0.3854166666666667,1.0,1.0,14/56,19.36%,GPR18;CD55;TACR1;JPH1;C5AR1;ACKR4;CXCR4;CD36;CAV3;C5AR2;FPR1;CACNA1C;GPR65;ADCY8
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.709545966675976,-1.0741918588766672,0.40625,1.0,1.0,2/5,9.66%,ANK3;CLIP3
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.5348634839863374,-1.0741567704388302,0.3877551020408163,1.0,1.0,17/73,24.58%,EIF4A3;ZNF540;DAPK1;RPL13A;GAPDH;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;EIF3E;ILF3;PATL2;PUS7;EIF2AK2;RACK1;MRPL13
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.5982077428866912,1.0741010691182684,0.4,0.951603217662629,1.0,2/6,2.84%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5581806922055124,-1.0740478359453844,0.4318181818181818,1.0,1.0,3/37,4.13%,RPL23;ARAF;RPL11
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.6884890909549557,-1.074027107754394,0.4,1.0,1.0,2/6,12.00%,NR1H2;MID1IP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3966885435262036,1.0739528914937806,0.2222222222222222,0.950172727711601,1.0,4/41,3.76%,MAP1S;DAB2IP;MAP4K4;SRGAP2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.5456643971531752,-1.0738697256579903,0.36666666666666664,1.0,1.0,15/48,22.98%,TRIM5;IFITM3;RSAD2;MX1;STAT1;IFIT1;OAS3;IFIT5;ZC3HAV1;ILF3;ZFP36;HEXIM1;PLSCR1;TRIM14;EIF2AK2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.610907041239771,-1.0738208902354802,0.43373493975903615,1.0,1.0,1/21,0.52%,HTR2B
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5412603260750365,-1.0738130343654266,0.3655913978494624,1.0,1.0,8/41,20.64%,THBS1;VEGFA;HIF1A;ANGPT2;ATP5F1A;RGCC;ATP2B4;TMSB4X
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.5210506531111002,-1.0734764104073298,0.3191489361702128,1.0,1.0,16/71,14.94%,PLPP3;MYLK;FGF1;SPARC;FILIP1L;TNS1;LAMA2;AKAP12;PTN;NR4A2;NOCT;ARID5B;ANGPT2;FN1;PALLD;SVEP1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.5976389635142217,-1.073434300578526,0.4024390243902439,1.0,1.0,4/19,16.10%,BRINP1;RORB;EPHA3;PTK7
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.6801390838313541,-1.0733993276893254,0.410958904109589,1.0,1.0,1/8,6.80%,NOD2
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.5037072832667727,-1.0730917188219433,0.27,1.0,1.0,63/291,20.48%,HTR2B;TFRC;RPL23;THBS1;VIM;RPS4X;EIF4A3;FGF1;AGT;RBMS3;VEGFA;RIMS1;OVOL2;RBPJ;RPL11;TXK;SLC11A1;HIF1A;PRR16;DDRGK1;ANK3;HSPA1B;BRCA1;SOD1;RBM3;FGR;TENT4B;ID2;IL15;GAPDH;CAMK2N1;ANK2;TTN;POLR1C;CCL3;HCFC1;TLE1;ITGB8;BTN3A1;RPL5;EIF2AK3;OLFM1;EPB41L4B;FN1;CD36;RPS7;SNF8;PID1;RGCC;RDX;KLF4;TAF1D;RPS3;EIF3E;CITED2;HMGN5;PIK3CB;EIF3D;CLU;SOX4;TLR2;MUSK;CADM1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5063037250085315,1.0730593704183886,0.37037037037037035,0.9504625460360442,1.0,4/12,17.88%,UBE2J1;OS9;YOD1;SVIP
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6626231257985918,-1.0729155489562305,0.3472222222222222,1.0,1.0,1/10,3.11%,VEGFA
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.698183570338947,1.0727444950692688,0.3793103448275862,0.9499204491879134,1.0,2/5,11.09%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.6370158412725914,-1.0727092775739975,0.40540540540540543,1.0,1.0,2/8,18.90%,IMPACT;GPR65
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5988711804569713,-1.0726990173409683,0.39759036144578314,1.0,1.0,3/18,10.42%,THBS1;PRKCE;APPL1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6013984457039988,-1.0725941575996105,0.4146341463414634,1.0,1.0,6/18,24.93%,OIP5;ITGB3BP;CENPI;CENPP;CENPU;CENPK
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6013984457039988,-1.0725941575996105,0.4146341463414634,1.0,1.0,6/18,24.93%,OIP5;ITGB3BP;CENPI;CENPP;CENPU;CENPK
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.714558866507245,-1.0725662870411041,0.42857142857142855,1.0,1.0,2/7,10.21%,VEGFA;RORB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5352585188672153,-1.0725293634760245,0.38202247191011235,1.0,1.0,4/45,10.78%,PRLR;ACSL1;LPCAT1;GNPAT
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.65360230704846,-1.0723657427735713,0.41975308641975306,1.0,1.0,3/11,19.15%,MPG;NEIL1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6064970710297011,-1.0723154941417716,0.4444444444444444,1.0,1.0,5/19,15.09%,HDGFL3;FGF13;MID1IP1;APC2;TTBK2
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6353332876994388,-1.0721822052820547,0.40789473684210525,1.0,1.0,3/10,7.10%,ENPP2;GLA;PDXDC1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5248110055591398,-1.0720234243670166,0.35789473684210527,1.0,1.0,14/81,12.40%,CLEC12A;ADGRE1;JAML;SIRPB2;SLC11A1;C5AR1;CASP5;MS4A4A;CD163;FGR;FCGR2B;MARCO;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6311657469821388,-1.0718396468507858,0.4157303370786517,1.0,1.0,4/12,20.95%,PPP1R15A;CALM3;CALM1;CD300A
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5759749117136518,-1.0717312460936914,0.449438202247191,1.0,1.0,6/33,9.44%,CGNL1;PLPP3;AGT;THSD4;ACSL1;FAXDC2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.6804882451986117,-1.0715363960948352,0.41333333333333333,1.0,1.0,1/8,10.30%,SNAPC1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.7127850031585179,-1.0714322876026425,0.4461538461538462,1.0,1.0,3/5,22.18%,SOD1;KCNMA1;KLF2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4404157306274259,1.07125078353871,0.5,0.9524968012331624,1.0,5/25,5.78%,ATRAID;TMEM119;TGFB1;PKDCC;ACVR1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.5228128887064166,-1.0711777716925364,0.3163265306122449,1.0,1.0,36/128,22.59%,SLC2A3;GLIPR2;GADD45B;PLIN2;BHLHE40;NFIL3;IFITM3;RHOB;RORA;SELL;TNFRSF1B;NDRG1;COCH;MAP3K8;IL10RA;SCN9A;AHNAK;ITGAE;APLP1;MXD1;IGF2R;ITGA6;ABCB1;P4HA1;PLEC;CD44;GPR65;TNFRSF21;CKAP4;NFKBIZ;PTRH2;PLSCR1;IL3RA;HK2;GABARAPL1;FAH
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6534344446294997,-1.0711196703736687,0.4444444444444444,1.0,1.0,4/6,29.81%,TFIP11;TERF2IP;RIF1;APEX1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.6064650707561001,1.0709997704909027,0.4482758620689655,0.9512505365848648,1.0,1/6,2.04%,RAP1A
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6357498876546082,-1.070662654066085,0.40540540540540543,1.0,1.0,1/12,3.75%,OVOL2
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.695943001842465,-1.0706121029376743,0.42857142857142855,1.0,1.0,1/6,1.26%,CLEC4E
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.5245330082696102,-1.0702676098695496,0.38144329896907214,1.0,1.0,10/76,13.09%,SLC38A4;CENPF;LRP2;SLC16A10;SLC11A1;SLC7A5;SCAMP3;SLC6A15;TXNIP;ARRDC3
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6503928397522243,1.0700292672933385,0.4782608695652174,0.9527635169164543,1.0,1/6,3.32%,ARFIP1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6126599415990596,1.0698744455168059,0.36,0.9513962095384695,1.0,2/7,2.18%,SIRPA;CX3CR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5993588127317118,-1.069398993203482,0.4117647058823529,1.0,1.0,5/22,12.14%,RPS27A;RBX1;COPS5;UBA52;UBC
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5995161600233336,-1.069345959814318,0.45555555555555555,1.0,1.0,10/21,30.74%,CYREN;PARP9;TFIP11;KMT5C;DTX3L;ERCC6;SMCHD1;RIF1;HSF1;PRKDC
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6711984336786959,1.0693364499568032,0.4642857142857143,0.9510569024304484,1.0,1/5,10.16%,CHD7
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6764876567836864,-1.0692951035666385,0.4647887323943662,1.0,1.0,4/8,25.01%,DPYD;TYMP;DPYS;UPP2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.6273075117302439,-1.068885958714468,0.425,1.0,1.0,1/12,1.30%,CEMIP
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6615640768753207,-1.0687631851647375,0.4675324675324675,1.0,1.0,3/10,19.07%,INSIG1;HSPA5;KDELR1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5866096362955663,-1.068446890523118,0.45569620253164556,1.0,1.0,3/24,9.79%,CYREN;FANCB;POLQ
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.6610130895246351,-1.0681223707849898,0.38271604938271603,1.0,1.0,5/13,17.46%,LRP2;VEGFA;SMARCD3;KDM1A;TOX
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5278785914014171,-1.0680303270221798,0.40625,1.0,1.0,11/56,19.11%,CCL4;CHI3L1;GBP2;BRCA1;CCL3;PID1;NR1D1;PYCARD;RPS3;TNFRSF21;ZFP36
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.5179626354224841,-1.0677789810236917,0.32978723404255317,1.0,1.0,15/72,20.32%,KCNE1;GLRA1;TSHR;BRCA1;AANAT;CFTR;AKAP6;NSMF;GABRB1;LARS1;IMPACT;RYR3;GABRG2;NEURL1;GABRB3
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.5079451095849663,1.0676251382343005,0.6111111111111112,0.9546297842527502,1.0,4/17,10.53%,MCU;MICU3;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.5937795597495061,-1.0674973686006552,0.41379310344827586,1.0,1.0,2/26,1.81%,ACVR1B;LRP2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.5117159478770303,-1.0673937437952246,0.35,1.0,1.0,29/166,16.45%,GLIPR2;THBS1;ENPP2;CEMIP;ACVR1B;MYLK;SEMA6A;FGF1;VEGFA;SEMA3A;TGFB2;HIF1A;DDRGK1;DOCK1;CARMIL1;FLT1;RAB11A;FGR;LAMB1;DOCK5;PRKCE;CCL3;PLET1;FN1;SDCBP;HSPA5;ITGA6;NSMF;RDX
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5687436658905078,-1.0671549777719316,0.43023255813953487,1.0,1.0,7/28,17.58%,TCHP;BRCA1;PINK1;ODF2L;FEZ1;CAV3;LIMK2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.636719280839513,-1.0670418157975485,0.42857142857142855,1.0,1.0,4/7,31.39%,VMP1;CALM1;SNAP29;ATP2A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6497448948180475,-1.0670034027412274,0.44594594594594594,1.0,1.0,4/12,19.31%,DPYD;TYMP;DPYS;CAD
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6596028906793239,1.0666340093126925,0.4634146341463415,0.9559271678322587,1.0,1/5,7.09%,SNX18
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6136031837184266,-1.0664908233156363,0.4,1.0,1.0,3/17,5.33%,GDPD1;ENPP2;ABHD12B
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5866756908122077,-1.0664768904436868,0.4230769230769231,1.0,1.0,12/18,38.57%,CDC37;SDCBP;PDCD6IP;YBX3;OGT;CYLD;SLC25A4;CFLAR;FLOT2;PELI1;FLOT1;HSP90AA1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.6807491640009578,-1.066455205710796,0.43661971830985913,1.0,1.0,5/8,28.81%,SHANK3;NRXN1;NRXN2;NLGN2;TMEM108
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6376824085102761,-1.0662204074648662,0.4583333333333333,1.0,1.0,3/13,17.37%,DHX58;NOP53;C1QBP
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6574418340983583,-1.0658318162318974,0.43283582089552236,1.0,1.0,5/9,22.66%,CACNB2;ANK2;CACNA1C;SCN3B;KCNJ3
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.7449421939972924,-1.065621361548862,0.4461538461538462,1.0,1.0,2/5,16.62%,SHANK3;FRRS1L
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6337910418246514,-1.0655397345381914,0.36904761904761907,1.0,1.0,4/12,20.95%,PPP1R15A;CALM3;CALM1;CD300A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5411297331271109,-1.0655218131050943,0.3076923076923077,1.0,1.0,13/47,26.58%,RBX1;FHL1;ATF5;PSMA5;PSMA3;PSMD8;PSMB4;FBXL7;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.538943651688062,-1.0653519143425552,0.3870967741935484,1.0,1.0,4/45,3.34%,PAQR3;SPOCK1;OMG;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5512963754373593,-1.0653096399357098,0.4,1.0,1.0,6/31,14.26%,RPL11;DDRGK1;AQP11;NOP53;CAMLG;SDCBP
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.4250042931873289,1.0652380114407414,0.375,0.9583121819101816,1.0,3/37,2.09%,NUP42;NUP188;RUBCNL
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6652090654257381,-1.0650285913802593,0.43283582089552236,1.0,1.0,1/10,5.78%,ACSL1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6093556885817206,1.0648409231614009,0.4642857142857143,0.9579383091014122,1.0,2/9,5.33%,SORL1;SIRT1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.542859540562619,-1.0648381460710936,0.44047619047619047,1.0,1.0,7/30,25.15%,H2BC11;HMGB2;HIRA;H2BC9;H2BC5;NAP1L2;SART3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7362756098295367,-1.064374523182108,0.4,1.0,1.0,1/5,6.19%,GSTP1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.37305672861740163,1.06436712658018,0.16666666666666666,0.9574668079082416,1.0,13/53,16.06%,RNF19B;BFAR;DDB2;RNF122;RNF208;TRAF6;RNF146;SH3RF3;RNF10;MDM2;RNF187;RNF185;SH3RF1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.5910623670053956,-1.063988173692808,0.46511627906976744,1.0,1.0,6/18,21.05%,FAM162A;PINK1;BNIP3;PYCARD;BMF;CIDEB
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6884365299137554,-1.0639697883357546,0.5211267605633803,1.0,1.0,2/7,9.21%,TG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.6860141504964367,-1.0638871970419634,0.4262295081967213,1.0,1.0,2/7,6.87%,PKP2;ANK3
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.6939996474353937,-1.063494483254478,0.4426229508196721,1.0,1.0,3/5,27.22%,ZFP36;MAFB;HSPA9
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4279146102662276,1.0633363411766614,0.2,0.9582068806318667,1.0,4/25,9.67%,ZMYND11;SUPT16H;WDR43;BRD4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5362837283413447,-1.06324363679307,0.4148936170212766,1.0,1.0,2/63,0.60%,PCSK1;SRGN
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.5561625220596348,1.0628075419326874,0.3,0.9580323484752659,1.0,2/8,6.90%,SIRT1;HDAC10
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5812113059918447,-1.0627916481789985,0.4,1.0,1.0,7/23,16.15%,WDR12;RPL35;RPL10A;NHP2;RPL7A;MAK16;RPL7
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3121363382484213,1.0625030167524487,0.0,0.9572678850009415,1.0,18/144,8.90%,BBS9;GSN;EHD4;AVIL;KIF27;PKD2;STK36;EXOC8;CDC14B;MKKS;RAB3IP;WDR35;RTTN;TCTN3;CEP41;OCRL;ABCC4;KIF3B
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.6458143906843564,1.0623260346562247,0.375,0.9560885195501706,1.0,3/6,10.36%,NRP1;P2RY12;SHTN1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6392822244055512,1.0622457722193823,0.4666666666666667,0.9546925819114769,1.0,1/6,12.58%,FAS
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5947580914699911,-1.0619542020089279,0.425,1.0,1.0,2/17,9.06%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6463985190044638,-1.0618285432248744,0.41025641025641024,1.0,1.0,5/11,15.56%,PTN;TNFRSF1B;ID2;CXCR4;PTPRZ1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5647695727614268,-1.0618165792871619,0.5,1.0,1.0,4/31,3.17%,CEMIP;OMD;OGN;VCAN
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.5976147182267694,-1.0617646926188589,0.45121951219512196,1.0,1.0,2/19,3.34%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6280957349022347,-1.0617324090632692,0.44871794871794873,1.0,1.0,3/15,19.15%,CENPV;MAPT;TERF2IP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.5435038267789436,-1.0614153108559905,0.3763440860215054,1.0,1.0,4/41,7.78%,DDIT4;TNFRSF1B;BCL2A1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.5165984589068042,-1.0613466104823233,0.3854166666666667,1.0,1.0,21/78,20.06%,TFRC;PPP1R15A;VEGFA;TGFB2;SLF1;ATP10A;CALY;CLIP3;BNIP3;SHANK3;ABCB4;NRXN1;GPC3;MPP7;FRMPD4;LRP4;RPS3;INSR;BMF;CLU;NEURL1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.6694861366483921,-1.0610076673437983,0.4230769230769231,1.0,1.0,4/9,20.29%,DDX11;PARP9;MED25;DTX3L
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.5714135967114227,-1.0610025936730274,0.4835164835164835,1.0,1.0,4/27,11.41%,CCL4;SAP30;CCL3;RRP1B
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5004348757770779,-1.0609697527988706,0.37894736842105264,1.0,1.0,11/54,19.08%,HTR2B;ACKR4;PPP1R9A;ANK2;CXCR4;CCL3;EIF2AK3;NUDT4;MCTP1;CACNA1C;RCAN2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.5419947129171186,1.0605963457777028,0.39285714285714285,0.9580990936571772,1.0,2/13,2.02%,GCLC;ALDH5A1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7485147797687715,-1.0603376890830674,0.39655172413793105,1.0,1.0,1/5,4.05%,RAB7B
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.7187573159118056,-1.0602044196225706,0.4142857142857143,1.0,1.0,2/6,6.19%,OSMR;GSTP1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.5306293169880446,-1.0601679372387829,0.3958333333333333,1.0,1.0,16/106,10.64%,PAQR3;PPP1R15A;TUB;RPL11;FSIP2;DDRGK1;CNEP1R1;RPA2;GBP2;RAB11A;SSB;SEC61B;SERP1;ANK2;SNX10;DDX1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.6436585979163298,-1.059679375558498,0.46153846153846156,1.0,1.0,2/12,3.34%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.6575173001516439,-1.0596350712341385,0.379746835443038,1.0,1.0,2/9,3.11%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6065284287070795,-1.0595694067371124,0.41025641025641024,1.0,1.0,4/11,21.51%,CACNB2;ANK2;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5644448055040867,-1.0595148669838268,0.42168674698795183,1.0,1.0,5/31,10.55%,DTL;BRCA1;CLSPN;DONSON;NOP53
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6194697365361138,1.0580686796310683,0.38235294117647056,0.9637662345113078,1.0,1/6,3.07%,MCU
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.6769066447075122,-1.0579410334848218,0.44,1.0,1.0,2/7,8.06%,TNFRSF1B;NMD3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.517618837501499,1.057808801695029,0.39285714285714285,0.9628521020366767,1.0,2/9,1.18%,GSN;LGALS9
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5937517909996624,-1.057733578511248,0.4805194805194805,1.0,1.0,2/15,6.17%,HHIP;FBN2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.44472130558815876,1.0575873551178219,0.375,0.961770679330819,1.0,10/49,16.30%,CSF1R;CBFB;MED24;AGO1;TP53;MECP2;MED27;MOV10;MED4;TCF7L2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.5505929820316222,-1.0574621264226813,0.45054945054945056,1.0,1.0,6/39,15.77%,OSBPL5;STEAP2;ANK3;STXBP6;NSF;GOLGA4
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.7140495514426833,-1.057421078856815,0.4383561643835616,1.0,1.0,1/7,0.37%,NR4A3
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.6032759676903943,1.0569443129287173,0.42424242424242425,0.9615924035793197,1.0,1/5,3.53%,CD274
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.582099389477307,-1.0568302747404659,0.52,1.0,1.0,9/22,23.08%,PTN;NRXN1;LRP4;MUSK;THY1;NRXN2;LRRC7;SAV1;DVL1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.688807360235299,-1.0566567171259205,0.4074074074074074,1.0,1.0,2/8,11.07%,PRELID1;ABCB4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6587872559095583,1.056655601319821,0.4411764705882353,0.9591785902127159,1.0,5/5,34.15%,EXOSC9;EXOSC6;EXOSC7;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6587872559095583,1.056655601319821,0.4411764705882353,0.9591785902127159,1.0,5/5,34.15%,EXOSC9;EXOSC6;EXOSC7;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.7007724135009072,-1.0565697863147623,0.4794520547945205,1.0,1.0,1/6,6.09%,CCDC39
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.6599399406322546,-1.0564508678464422,0.4084507042253521,1.0,1.0,2/9,22.17%,BNIP1;VCPIP1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.49501923885116844,-1.056316582520798,0.41,1.0,1.0,21/140,12.57%,NR4A3;CLEC12A;KMO;CCL4;ADGRE1;JAML;VCAN;RAB7B;SLC11A1;TNFRSF1B;HLA-B;CD163;PLAC8;FGR;FCGR2B;IL10RA;CXCR4;MS4A6A;PDCD1LG2;MNDA;ITGAE
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5433541794581369,-1.0560185909618884,0.45454545454545453,1.0,1.0,13/51,19.46%,SLC2A3;TFRC;LRP2;SLCO3A1;SLC7A5;ABCC3;CD36;ABCB1;SLC16A7;SLC16A1;INSR;ATP2B4;SLC13A3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.5761090874497233,-1.0554663637973014,0.43820224719101125,1.0,1.0,3/28,4.35%,TGFB2;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.4154725459065067,1.0553716842844487,0.5714285714285714,0.9614723651022631,1.0,6/56,6.13%,NUP42;NUP188;PPARG;AGO1;TGFB1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.650523827488565,-1.055369895814171,0.45454545454545453,1.0,1.0,6/10,30.90%,CR1;BCL6;LILRB2;IL4I1;DUSP10;HLA-DRA
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5770259754522904,-1.0551914650896206,0.4186046511627907,1.0,1.0,7/26,18.71%,LAMA2;SGCE;FHL1;DMD;POU6F1;CAV3;EMD
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4871578403818676,1.055136339498585,0.4,0.9586616574849764,1.0,2/16,1.65%,GSN;AVIL
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4871578403818676,1.055136339498585,0.4,0.9586616574849764,1.0,2/16,1.65%,GSN;AVIL
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6284800344749499,1.0550752492161204,0.42424242424242425,0.9571432151139375,1.0,4/6,5.33%,CTBP2;FFAR4;PPARG;SIRT1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6066826908911183,-1.0540091186080107,0.45121951219512196,1.0,1.0,6/16,21.80%,RIMS1;SLC17A7;RAB3A;CPLX1;SNAP25;RAB5A
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.5698800314692865,-1.053703195654766,0.375,1.0,1.0,2/17,4.22%,TSHR;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6672727817474277,-1.053504293851074,0.44594594594594594,1.0,1.0,3/9,10.12%,ANK3;ATP1B3;DMD
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.6379482498706315,-1.0534194906509442,0.525,1.0,1.0,3/12,11.51%,TGFB2;TNFRSF1B;NOTCH2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.635619595081381,-1.0533466243641612,0.4225352112676056,1.0,1.0,2/12,8.72%,MX1;STAT1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5517151689316658,-1.0533303632702276,0.46987951807228917,1.0,1.0,3/30,6.50%,JAML;SELL;CD69
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5062939522036534,-1.0533273900024216,0.3958333333333333,1.0,1.0,28/99,25.55%,RPS27A;WDHD1;RPA2;UBA52;RFC1;UBC;PSMA5;RPA3;PSMA3;MCMDC2;RFC4;PSMD8;ORC6;UBB;PSMB4;MCM3;DNA2;POLE2;TEFM;MCM6;MCM7;POLG2;PSMD7;PSMD5;DBF4;PSMB9;MCM5;PSMC2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.6908258200829933,-1.0532978415293077,0.4225352112676056,1.0,1.0,1/6,9.06%,AKR1B1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.41543348620747417,1.0531258374629309,0.38461538461538464,0.9612261595119312,1.0,5/31,8.23%,NRP1;ARAP1;PPP1R16B;FSCN1;SRGAP2C
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5156620825340432,1.053062077382521,0.46153846153846156,0.9598523846489468,1.0,3/10,5.41%,LGALS9;CX3CR1;ARRB2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.534740947505322,-1.0529447780053771,0.43157894736842106,1.0,1.0,15/47,27.20%,MYOT;TGFB2;MAPT;PPFIA4;NLGN3;CTNND2;VMP1;LRP4;ACTG1;CBLN2;APBB2;DVL1;PPFIBP1;NLGN2;APP
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3597865701102877,1.052938060327132,0.36363636363636365,0.9587465823449179,1.0,3/28,3.66%,LYL1;BLNK;HHEX
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6187368261010919,-1.0527747014754965,0.4936708860759494,1.0,1.0,2/12,14.79%,RBPJ;AKAP6
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6733986736518919,-1.0521613952212376,0.4166666666666667,1.0,1.0,4/6,28.95%,GK;GK5;COQ2;GOT1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5476662260522994,-1.0521425811825569,0.3978494623655914,1.0,1.0,12/39,18.96%,FZD6;EMILIN2;OVOL2;BAIAP2L1;BRCA1;FMO5;ANLN;INCENP;BMI1;ITGA2;KIF15;ST14
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.5503042548745983,1.0520732672161985,0.3888888888888889,0.9592933389823228,1.0,3/14,10.90%,SLC30A1;SLC30A5;SLC30A10
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5678687726973488,1.052020515838549,0.4375,0.956118443964204,1.0,3/11,6.16%,SUPT16H;HMGA1;ARID1A
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5678687726973488,1.052020515838549,0.4375,0.956118443964204,1.0,3/11,6.16%,SUPT16H;HMGA1;ARID1A
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.5281519175759042,-1.0516831987470674,0.43010752688172044,1.0,1.0,14/57,23.71%,TGFB2;FAIM2;EGLN3;SOD1;PINK1;CCL3;SNX6;MAG;PTPRZ1;NSMF;CRLF1;EPHA7;RETREG1;NRBP2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.5950364773016629,-1.0516819596530482,0.4177215189873418,1.0,1.0,7/18,17.86%,AGT;ALOX15B;ABCA5;NR1H2;IL18;CD36;ABCA1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.6604853490416993,-1.0512665032167812,0.4189189189189189,1.0,1.0,3/9,23.46%,DGKI;DGKG;DGKB
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5377181007641778,-1.0512657621720485,0.4421052631578947,1.0,1.0,20/65,24.33%,ZPBP;TALDO1;GRM8;MEP1B;PEBP1;CLVS1;GSTM3;HSPA2;DCC;CFTR;RFC4;SPATA6;SCG5;AGFG1;CCT6B;GAD1;ZC2HC1C;SEPTIN4;JAM3;DBF4
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.626824876126676,-1.0511436811621995,0.43661971830985913,1.0,1.0,3/10,24.00%,EPB41L3;DICER1;PMP22
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.6923825560927815,-1.050952569122991,0.45901639344262296,1.0,1.0,1/5,3.45%,DPYD
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.5753593565744047,1.0504064202701804,0.42105263157894735,0.958426191059028,1.0,3/7,7.63%,SIRT1;IL6ST;EIF2AK4
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.6682457017630714,-1.0500039592071404,0.4473684210526316,1.0,1.0,5/8,31.67%,KIF5A;MAP1A;KIF5C;RAB27B;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.6682457017630714,-1.0500039592071404,0.4473684210526316,1.0,1.0,5/8,31.67%,KIF5A;MAP1A;KIF5C;RAB27B;HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.6682457017630714,-1.0500039592071404,0.4473684210526316,1.0,1.0,5/8,31.67%,KIF5A;MAP1A;KIF5C;RAB27B;HSPB1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5065911757578204,-1.0499278305762079,0.3684210526315789,1.0,1.0,25/106,22.44%,MDH1;CBR1;GLUL;ME1;ACSL1;RDH11;UROS;LGALS1;LDHA;ENO2;CD36;PDHB;ALDH1A1;GPD2;MGLL;PTS;PTPRG;CBR3;ECI2;IDI1;BMPR1B;HMGCL;GAD2;ACSM3;GABARAPL1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6203575682977188,-1.0498849592200763,0.4177215189873418,1.0,1.0,2/10,6.17%,VEGFA;FBN2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5480470278926711,-1.0498610225445522,0.4482758620689655,1.0,1.0,5/28,4.58%,MYLK;ASPN;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6638022637934595,-1.0498280824754092,0.4810126582278481,1.0,1.0,1/9,3.11%,VEGFA
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6856604218558442,-1.0497591393684849,0.4634146341463415,1.0,1.0,1/8,6.12%,RPS21
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.6441022337579715,-1.0495333916144511,0.4868421052631579,1.0,1.0,4/11,16.58%,FGF1;VEGFA;PKM;KLF4
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6087897381575411,-1.0495080495707538,0.4225352112676056,1.0,1.0,5/15,17.24%,CD55;TRIM5;CARD16;CD36;SIGIRR
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.6920654741823304,-1.049489527250532,0.5454545454545454,1.0,1.0,1/6,5.16%,ENTPD3
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5764935749134075,-1.049409546554199,0.4157303370786517,1.0,1.0,4/23,7.75%,SEMA6A;NR4A1;VEGFA;FLT1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.6210613450147298,-1.049365501181065,0.46835443037974683,1.0,1.0,3/13,12.94%,VEGFA;FBN2;AGTPBP1
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5136184570035908,-1.0492615592853798,0.41237113402061853,1.0,1.0,19/109,12.40%,CLEC12A;CCL4;OSBPL5;F13A1;JAML;NFIL3;SIRPB2;GPR183;CD93;H1-3;CD69;MS4A4A;INF2;FGR;FCGR2B;PDK3;CCL3;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6882965302815631,-1.0489605799299069,0.5256410256410257,1.0,1.0,6/7,26.95%,RIMS1;SYT1;UNC13A;UNC13C;RIMS2;RIMS3
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5488901186578891,-1.0488692205780392,0.43209876543209874,1.0,1.0,8/26,24.74%,RPS27A;UBA52;UBC;CD36;UBB;TLR2;CD14;TNIP1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.4380163762740836,1.0488482231979948,0.29411764705882354,0.961414456120612,1.0,8/28,12.97%,PLEKHJ1;EXOC8;RAB22A;LAPTM4B;CHMP2B;LAMTOR1;WASHC5;DNAJC13
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.5958599610714788,1.0488224581957877,0.45161290322580644,0.9598669969726923,1.0,1/5,8.13%,PPP1R12B
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5281112852124927,-1.0487058863311074,0.42857142857142855,1.0,1.0,14/50,26.58%,RBX1;FHL1;PSMA5;PSMA3;PSMD8;PSMB4;FBXL7;PSMD7;NABP1;PSMD5;PSMB9;INTS3;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5905302188663918,-1.0486791274076852,0.43243243243243246,1.0,1.0,8/18,28.75%,SOD1;TTN;DMD;SCN3B;RYR2;GAA;SGCZ;SGCD
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.45553242669498595,1.0486693815824406,0.3684210526315789,0.9584430130999375,1.0,3/22,6.47%,TGFB1;ZPR1;EFCAB7
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5698551992296359,1.0486022559012578,0.3939393939393939,0.9570238076965545,1.0,2/7,9.44%,SCRIB;RAB10
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.5982342006475141,-1.0485208596062818,0.4594594594594595,1.0,1.0,3/13,10.42%,CD55;CR1;APPL1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.34375618214762654,1.0481888200782794,0.0,0.9564344992844573,1.0,6/105,4.58%,TNFAIP8L3;NFYC;RUBCNL;SC5D;PRKAB2;PPARG
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.5136085619915972,-1.0480875892163442,0.37777777777777777,1.0,1.0,14/49,27.15%,RHOB;RACGAP1;ANK3;CIT;ANLN;INCENP;SEPTIN9;STMN1;PDCD6IP;SEPTIN4;SEPTIN8;SPAST;MYH10;TTC19
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6158015815140179,-1.047919572151875,0.40476190476190477,1.0,1.0,6/12,17.93%,HIF1A;NEFL;UXT;MAPT;SYBU;UBB
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3068376464390173,1.047830938266253,0.0,0.9557294814181745,1.0,13/111,13.68%,NUFIP1;RNASEL;ELAVL4;AGO1;POLR2C;FASTKD2;PCBP3;PAPOLA;ADARB1;HNRNPC;NOL9;LSM8;RBMX
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5373606985245839,-1.047803558035296,0.4431818181818182,1.0,1.0,12/50,19.46%,SLC2A3;TFRC;LRP2;SLCO3A1;SLC7A5;ABCC3;ABCB1;SLC16A7;SLC16A1;INSR;ATP2B4;SLC13A3
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5676175789659754,-1.0471944660225676,0.4157303370786517,1.0,1.0,9/25,32.05%,OIP5;ITGB3BP;CENPI;CENPP;CENPU;CENPK;ACTR6;NPM1;KNL1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6223701882063217,-1.0465831566466124,0.45454545454545453,1.0,1.0,1/14,0.52%,HTR2B
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.664398299400738,1.0458383644901457,0.46511627906976744,0.9599611423393343,1.0,4/5,18.63%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.5947302453415765,-1.0457315530873679,0.4418604651162791,1.0,1.0,3/16,8.69%,THEMIS2;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.7325481739041289,-1.0453653524509277,0.4647887323943662,1.0,1.0,1/5,5.33%,CACNB2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.5007141871792214,-1.0453453865711704,0.45454545454545453,1.0,1.0,17/120,15.90%,BRIP1;RPL23;RPS20;RPL37;RPL11;RPA2;BRCA1;CHD3;NOP53;RPS15;RPA3;RPL5;PPP1R13L;RFC4;PRR5;PRDM1;ING5
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.546981199257464,-1.0451589280576554,0.4470588235294118,1.0,1.0,6/39,8.27%,CLDN18;OSMR;VEGFA;THSD4;DOCK1;NTN4
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3997757502286301,1.0449856711956844,0.2857142857142857,0.960871172814008,1.0,5/46,4.93%,IDE;DAB2IP;CTSC;CTSH;RAB7A
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6291685913929701,-1.04461478448667,0.41333333333333333,1.0,1.0,3/12,18.60%,RIMS1;CPLX1;MCTP1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.531847017343092,-1.044451245784352,0.4065934065934066,1.0,1.0,7/47,19.61%,HTR2B;PINK1;IL10RA;USP36;BMF;MCL1;TBC1D14
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.6583819500803506,-1.0442326246648035,0.4788732394366197,1.0,1.0,1/10,3.17%,VCAN
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6292110217103355,-1.043965364442565,0.45121951219512196,1.0,1.0,3/13,6.13%,PPP1R15A;DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6795146206035954,-1.043902664607952,0.4246575342465753,1.0,1.0,2/6,8.75%,PRELID1;MAPT
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7408301929874697,-1.0437472609091198,0.4444444444444444,1.0,1.0,4/5,25.94%,SHANK3;NRXN1;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5525639777599578,-1.043346201722054,0.3488372093023256,1.0,1.0,5/24,11.26%,LRP2;TGFB2;MTHFD1;COBL;STIL
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5525639777599578,-1.043346201722054,0.3488372093023256,1.0,1.0,5/24,11.26%,LRP2;TGFB2;MTHFD1;COBL;STIL
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.6712078957955514,-1.0433337576377102,0.5125,1.0,1.0,1/10,3.11%,VEGFA
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.585240096592465,-1.0432872450717658,0.410958904109589,1.0,1.0,2/14,13.32%,ANK3;FAM20A
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.6480343036423468,-1.043263175679864,0.4605263157894737,1.0,1.0,3/8,26.09%,DGKG;DGKB;PIP5K1A
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.4927514393087795,-1.043123278681845,0.4583333333333333,1.0,1.0,9/76,9.32%,CYCS;ERMP1;ALDH3B1;GSTP1;ERO1A;HSPA1B;SOD1;PINK1;TMEM161A
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.6786746822476448,-1.0430065096634002,0.48717948717948717,1.0,1.0,1/6,7.16%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6786746822476448,-1.0430065096634002,0.48717948717948717,1.0,1.0,1/6,7.16%,FBP1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.5225794826942757,-1.0429960883537723,0.45161290322580644,1.0,1.0,4/42,6.53%,FA2H;PLPP3;ALDH3B1;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.6854481710489785,-1.0429608656077662,0.4782608695652174,1.0,1.0,2/7,7.82%,CD55;CR1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.5312632757360628,-1.04290009376072,0.43023255813953487,1.0,1.0,3/39,7.44%,NUDT12;NUDT16;HSPA1B
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5435016522220723,-1.0425243002353974,0.43820224719101125,1.0,1.0,4/36,4.31%,JAML;FGF1;TGFB2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7138125539038029,-1.042485710381303,0.43859649122807015,1.0,1.0,1/6,5.96%,DDX11
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6445772608063531,1.042416598805814,0.4411764705882353,0.9660403587339458,1.0,1/6,0.54%,ZNF703
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6047011870581983,-1.0423219812790554,0.4358974358974359,1.0,1.0,2/12,9.74%,BEGAIN;TYMP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6126527369095773,-1.0423149145658024,0.4583333333333333,1.0,1.0,3/14,14.75%,DTL;RAB11A;ATAD5
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5270041301422739,-1.0421544794324915,0.4659090909090909,1.0,1.0,16/54,20.61%,H2BC11;HAMP;HMGB2;SLC11A1;NOD2;GBP2;FGR;RPL30;RPL39;OAS3;COLEC12;PYCARD;GSDMD;GNLY;TLR2;PPP1R11
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.6246537410669843,-1.0419392273437196,0.47368421052631576,1.0,1.0,3/15,13.77%,ACSL1;HSD17B12;DGAT1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.55717665612324,-1.04185515494679,0.4942528735632184,1.0,1.0,9/36,18.86%,EYA2;SLF1;DDX11;BRCA1;ZCWPW1;TMEM161A;RPS3;TIMELESS;FMN2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.6301276152921168,-1.0416119226869471,0.4861111111111111,1.0,1.0,3/13,11.07%,THBS1;TGFB2;ABCB4
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.4801216797848466,-1.0415695873913866,0.39,1.0,1.0,37/188,19.26%,KCNE1;GLRA1;NR4A3;VIM;INSIG1;TSHR;HMGB2;FOS;RORA;TNFRSF1B;GSTP1;NOD2;BRINP1;MAPT;DAPK1;AANAT;RORB;PDK3;ABCB4;PDCD1LG2;EPHA3;CARD16;PDE4B;CFTR;AKAP6;PID1;NR1D1;PTK7;PYCARD;NSMF;LARS1;RPS3;PDCD4;IMPACT;RYR3;ZFP36;ATP2B4
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.6651809027747433,-1.0414927157321114,0.48,1.0,1.0,4/8,23.63%,ACSS3;ACAT1;HMGCL;SLC27A5
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.48622322358894443,-1.041199968000764,0.37,1.0,1.0,44/198,25.16%,TOP2A;RPS27A;HMGB2;XRCC3;GLRX2;MPG;WDHD1;RPA2;BRCA1;NEIL1;POLQ;NOP53;ADPRS;UBA52;RFC1;UBC;RPA3;FAN1;SLX4;UHRF1;RFC4;ORC6;TIMELESS;UBB;KMT5C;TERF2IP;MCM3;ZNF445;POLL;DDB1;DNA2;POLE2;ZRANB3;LIG3;MCM6;MUS81;DNMT1;MCM7;NABP1;DBF4;FANCL;ENDOV;INTS3;MCM5
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.42796374240803653,1.0410920249747688,0.38461538461538464,0.9680828723528776,1.0,5/15,10.19%,CSF1R;PLD4;TGFB1;TP53;MLF1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6472070824423698,-1.0409356027642624,0.4177215189873418,1.0,1.0,4/9,26.35%,CFL1;IGF2R;PPIB;VAPA
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.5312553302248332,-1.0406821206541699,0.4606741573033708,1.0,1.0,5/52,12.33%,CYREN;HMGB2;BRCA1;POLQ;PIAS4
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.5924158842961977,-1.0404464238078173,0.44,1.0,1.0,4/18,11.11%,OR3A2;C5AR1;NIPSNAP1;SCN9A
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6124495579573753,-1.040397430457269,0.5324675324675324,1.0,1.0,5/14,25.94%,CGNL1;BSN;KIF3A;JAM3;NLGN2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5344575693470843,-1.0402729199024077,0.4606741573033708,1.0,1.0,14/38,27.84%,ATP5ME;ATP5F1E;ATP5F1D;TIMM13;ATP5PD;ATP5F1A;MICOS13;ATP5MC1;GHITM;TIMM29;APOO;HSPA9;ATP5F1C;SPG7
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.6352574960628807,-1.0402552620963448,0.4625,1.0,1.0,1/8,2.84%,AGT
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.46365707387172495,1.039821834195128,0.3333333333333333,0.9704220434110682,1.0,6/25,6.81%,ST6GALNAC3;GAL3ST4;MAN2B2;ST8SIA4;IDUA;MPDU1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6799444276313671,-1.0396673951505937,0.5,1.0,1.0,3/6,29.07%,ZWILCH;NABP1;PLK2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5874082970892611,-1.039515990215669,0.5316455696202531,1.0,1.0,4/21,14.41%,RPS6;SYAP1;PINK1;PRR5
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.5983457568921418,1.039420751222063,0.37037037037037035,0.9699338935976424,1.0,2/6,6.91%,LGALS9;SYK
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.42756436667305653,1.0392145277837004,0.35714285714285715,0.9688424997733158,1.0,4/20,11.43%,NBN;ERCC4;YLPM1;PPP1R10
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7125549591235578,-1.0390790968522958,0.49230769230769234,1.0,1.0,5/6,25.16%,MCMDC2;MCM3;MCM6;MCM7;MCM5
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6433282979695516,-1.0389255351934081,0.43243243243243246,1.0,1.0,6/8,32.74%,FGF13;GABRG2;GABRB3;GABRA2;GABRB2;GABRA1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.6346568750210188,1.0388660883425682,0.46875,0.9681263138252529,1.0,1/5,1.82%,SERPINF2
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.6761062690748221,-1.0385779974790166,0.45,1.0,1.0,2/8,7.55%,SLC11A1;GBP2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6822422482142654,-1.0384999453088142,0.49333333333333335,1.0,1.0,5/9,18.85%,ATP5F1D;ATP5PD;ATP5F1A;VPS9D1;ATP5MC1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6645788233919236,-1.038497680663979,0.5263157894736842,1.0,1.0,3/7,23.03%,DNA2;TEFM;POLG2
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.4981727629491223,-1.0383745643087656,0.4270833333333333,1.0,1.0,15/88,17.86%,GLA;NAPA;TOM1L1;SOD1;GALC;SCAMP3;BNIP3;KIF1B;TPD52;CD63;IGF2R;AP2S1;GOLGA4;SH3GL2;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.5649143246639184,1.038261114310553,0.40625,0.9681312879571659,1.0,1/6,4.58%,PPARG
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.610141395825904,-1.0380410983341952,0.38961038961038963,1.0,1.0,2/14,15.62%,SLC11A1;DMXL2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.5592315325205527,1.0380346818333124,0.30434782608695654,0.9672102869053912,1.0,5/8,31.82%,RNF168;LIG4;RNF8;EXOSC6;MSH2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.5656582464922755,-1.0380084778232024,0.5185185185185185,1.0,1.0,10/21,21.31%,ANK3;ANTKMT;ANK2;CALM3;SHANK3;NLGN3;AKAP6;CALM1;TMSB4X;RELN
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.6742291013462793,1.0379726045619366,0.5185185185185185,0.9657376474694667,1.0,2/5,13.35%,PRCP;PLCB3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.5061946471264765,-1.0376250897853943,0.40625,1.0,1.0,13/125,14.02%,BRIP1;CYREN;HMGB2;XRCC3;RPA2;BRCA1;PARP9;POLQ;DDX1;RPA3;PIAS4;FAN1;SLX4
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5879465141297366,-1.0376179330487338,0.46153846153846156,1.0,1.0,3/17,10.88%,CCL4;DUSP1;CCL3
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.710421076293632,-1.037617037607395,0.49382716049382713,1.0,1.0,1/6,4.68%,C5AR1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.65369079277449,-1.0375474098075494,0.4925373134328358,1.0,1.0,3/7,26.07%,POLQ;POLL;MLH1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4148901862802605,1.0375123987994592,0.42857142857142855,0.9654696361176658,1.0,5/24,5.80%,SIRPA;MAP3K5;MAPK13;SIRT1;ABL1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.684657575629422,-1.037455358868738,0.4864864864864865,1.0,1.0,1/5,13.70%,RAB3A
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6767382620306341,-1.0374143895468975,0.5454545454545454,1.0,1.0,4/8,26.09%,ABCB1;ADCY8;OPRM1;CRHBP
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.6301564915476262,-1.037182305228086,0.5,1.0,1.0,2/13,4.80%,IHO1;PTN
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5359938555740102,-1.0370256906839408,0.4318181818181818,1.0,1.0,1/36,0.82%,RPL23
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7014019533463712,-1.0369718633156642,0.49295774647887325,1.0,1.0,2/6,19.15%,MPG;TERF2IP
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.627887415352671,-1.0363515283180822,0.43209876543209874,1.0,1.0,2/10,8.48%,ADGRG6;SOD1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.5897992933422675,-1.0360013421187295,0.5061728395061729,1.0,1.0,3/15,3.34%,SEMA6A;VEGFA;SEMA3A
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6603884113684653,-1.0359187109209382,0.4142857142857143,1.0,1.0,2/9,18.06%,GRK4;CALM1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.33215843040951987,1.0357869167628266,0.5,0.9688881515684449,1.0,15/138,8.67%,STK32B;RPS6KA6;MAP3K10;GALNT1;CSNK1G1;MAPKAPK2;LATS2;CAB39;TGFBR2;MAPK13;NEK6;POGLUT3;MAST2;MAST3;MKNK1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6113588251816773,-1.0356559079127485,0.49411764705882355,1.0,1.0,3/14,19.15%,MPG;NEIL1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.5932975506113125,1.035596481754524,0.45161290322580644,0.9677879520655464,1.0,2/6,5.41%,LGALS9;ARRB2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5066228709656143,-1.035447215139262,0.43157894736842106,1.0,1.0,32/90,22.62%,CLEC12A;CCL4;SIRPB2;SLC11A1;C5AR1;TNFRSF1B;MS4A4A;FGR;FCGR2B;TRIM25;TYMP;KLHDC4;MARCO;CCL3;MS4A6A;MNDA;PLET1;CD36;NR1D1;NCF4;MPP1;NCF2;FPR1;AIF1;SIGLEC1;TLR2;S100A4;FCGR2C;CD300A;LILRB2;GPNMB;CD14
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7078538959214234,-1.0354118389330982,0.5441176470588235,1.0,1.0,2/5,18.06%,CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.47731577299942535,-1.0353400388702059,0.41,1.0,1.0,94/482,19.38%,TOP2A;PRLR;HTR2B;TFRC;GADD45B;THBS1;ARAF;RPS27A;NAA38;LRP2;RNF144B;PNMA1;AGT;VEGFA;RHOB;RPS6;PRELID1;VAV3;FAM162A;IFIT2;IL7;DDRGK1;NDRG1;GSTP1;FIGNL1;IFIT3;CFL1;BCL2A1;MTCH1;FAIM2;HSPA1B;EGLN3;RPS3A;SOD1;STAT1;PINK1;DAPK1;PAX8;COPS5;CLIP3;ITGB3BP;BNIP1;ITSN1;BNIP3;TNFAIP8;NOP53;DAPK2;ATF5;STIL;TMEM14A;UBA52;RRP1B;NOTCH2;BEX2;PTMA;BNIP3L;TPT1;LGALS1;BCL2L2;UBC;BCL6;NUAK2;MNDA;KCNMA1;PIM3;RASGRF2;OLFM1;USP36;HSPA5;ING4;APIP;ITGA6;ALK;ING5;PYCARD;NSMF;STK17B;TRAF2;CTSB;ATAD3A;C1QBP;RPS3;UBB;BMF;CD44;CITED2;GNA13;PLEKHG5;MCL1;FMN2;TP53INP1;BCL2L14;HMGN5;NGEF
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.663300263106406,-1.0353384806544552,0.4605263157894737,1.0,1.0,2/7,9.90%,SLC11A1;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.6679987682878064,-1.0353037518823547,0.45714285714285713,1.0,1.0,1/6,8.69%,FCGR2B
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6246061209099357,-1.0352565006650079,0.4666666666666667,1.0,1.0,5/11,30.18%,SLIRP;PID1;WASF1;PNPT1;NUBPL
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5541597874875257,1.0350580765884436,0.3611111111111111,0.9678623099482334,1.0,1/6,1.18%,LGALS9
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6337679353541716,-1.0348053229476843,0.5,1.0,1.0,3/8,18.97%,ENTPD3;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5443748120323159,-1.0347510853137487,0.4069767441860465,1.0,1.0,11/33,17.24%,H2BC11;GSTP1;NLRC5;NR1H2;CCDC3;PADI2;CARD16;PARP14;OAS3;STAT2;SIGIRR
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.6210282399937017,-1.0346832383164677,0.4634146341463415,1.0,1.0,2/16,8.69%,THBS1;FCGR2B
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.6725587915025674,-1.0344888270954113,0.4852941176470588,1.0,1.0,2/5,11.51%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5534094340753807,-1.03448702467725,0.4883720930232558,1.0,1.0,4/24,10.02%,DALRD3;FTSJ1;METTL2A;GTPBP3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.5842854593419142,-1.034043896453061,0.47126436781609193,1.0,1.0,6/14,26.03%,JPH1;CACNA1C;ATP2B4;RYR2;GRIN2A;JPH4
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6164211180990816,-1.033955569825115,0.4430379746835443,1.0,1.0,6/14,30.09%,WBP4;WBP11;SRSF12;PRPF39;NCBP2;RBM22
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.6224494350232059,-1.033674141323399,0.47368421052631576,1.0,1.0,3/8,23.38%,PDE4B;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.6224494350232059,-1.033674141323399,0.47368421052631576,1.0,1.0,3/8,23.38%,PDE4B;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.522697406778108,-1.0336433740917093,0.45652173913043476,1.0,1.0,5/36,13.92%,OSBPL5;INSIG1;FAXDC2;ABCA5;TM7SF2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5276970440948276,1.0334103910350705,0.4117647058823529,0.9704120836052915,1.0,10/14,27.75%,TSPAN15;EGFL7;FBXW7;ARRB1;YTHDF2;MMP14;WWP2;EGFR;ZBTB7A;AKT1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.48129440555304076,1.0334086341450974,0.35294117647058826,0.9688570632646089,1.0,3/15,10.87%,DOC2A;SYT17;SYT6
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.6639176071214284,-1.0332951168232847,0.5633802816901409,1.0,1.0,1/6,8.06%,NMD3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6986668930088484,-1.0329969609087937,0.45588235294117646,1.0,1.0,2/6,13.88%,MX1;IFIT1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.6511668571863172,1.0328854767692566,0.46875,0.9685637500917531,1.0,2/5,22.80%,SERBP1;ETS1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.5003206585568525,-1.0328536494991216,0.41414141414141414,1.0,1.0,30/134,23.03%,MX2;CYCS;MX1;IFIT2;TOMM7;COX7A2;PINK1;SLIRP;TYMP;ATP5F1D;BNIP3;TIMM13;MTERF1;HCFC1;BNIP3L;TOMM40;AGTPBP1;HIGD1C;PID1;TOMM20;BCS1L;ATAD3A;SIRT5;SIRT3;CHCHD2;DNM1;SLC25A36;HK2;WASF1;POLG2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5472026166225933,-1.0327901174002867,0.4943820224719101,1.0,1.0,9/28,21.05%,PRELID1;FAM162A;PINK1;BNIP3;PYCARD;BMF;CLU;GHITM;CIDEB
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4889011649589056,-1.0324856164355554,0.44,1.0,1.0,22/114,19.11%,CCL4;TNFRSF11B;CHI3L1;ST18;AIM2;TNFRSF1B;GBP2;BRCA1;STAT1;CCL3;PSMA5;TNFSF13B;PSMA3;PID1;NR1D1;PYCARD;TRAF2;PSMD8;RPS3;PSMB4;TNFRSF21;ZFP36
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5610626551808254,-1.0321611796320933,0.41304347826086957,1.0,1.0,9/42,10.88%,CCL4;IFITM3;SLC11A1;GBP2;STAT1;DAPK1;RPL13A;GAPDH;CCL3
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5082437317866741,-1.0320957694842259,0.43,1.0,1.0,32/139,15.27%,P4HA3;THBS1;TNC;MMP21;SPARC;VCAN;ADAMTS2;THSD4;ECM2;TGFB2;LAMA2;ADAMTS19;SH3PXD2B;COL21A1;FBN2;ADAM15;COLGALT2;LAMB1;COL26A1;COL11A1;COL10A1;GPM6B;ITGB8;TGFBI;ITGAE;APLP1;MMP24;COL23A1;FN1;COL4A5;ITGA2;ITGA6
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5921066852407905,-1.0316515061284042,0.524390243902439,1.0,1.0,5/13,20.95%,FCGR2B;ID2;MNDA;TNFRSF21;CD300A
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6078434664232835,-1.0312387287540767,0.4594594594594595,1.0,1.0,1/9,4.80%,PTN
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5383111116687689,-1.0311456809710327,0.449438202247191,1.0,1.0,6/34,7.14%,RGS2;PAQR3;AGT;GSTP1;SPRY1;DUSP1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.47243749171254423,1.0310726581458651,0.3888888888888889,0.9720808753283249,1.0,3/17,7.45%,ARL2BP;TAF3;TAPT1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.49885183672852434,-1.0310436573926434,0.42424242424242425,1.0,1.0,26/127,14.28%,DDIT4;MDH1;SAP30;TALDO1;VEGFA;VCAN;FAM162A;ME1;PKP2;MXI1;SLC16A3;ERO1A;EGLN3;SOD1;ANKZF1;CXCR4;PGK1;PDK3;PPFIA4;TGFBI;LDHA;PKM;ENO2;PGAM1;GPC3;HSPA5
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.6657734707657856,-1.0308794690240342,0.5352112676056338,1.0,1.0,3/7,21.95%,MCMDC2;MCM3;MCM6
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.36244930377979157,1.0307992192617543,0.2857142857142857,0.9712822582467345,1.0,18/49,17.55%,NEDD4;DDB2;MAPK13;SIRT1;TP53;ERCC4;EIF2S1;EIF2AK4;SDE2;ZBTB1;EP300;CASP9;USP28;OPN3;INO80;ERCC1;FMR1;PARP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6364253056656385,-1.0307798524336553,0.5466666666666666,1.0,1.0,4/12,20.97%,DONSON;TIMELESS;ZRANB3;LIG3
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.4928594993484422,1.0303549655136672,0.41379310344827586,0.9708500231029962,1.0,2/9,3.02%,ZNF703;SH2B3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3652891248727712,1.0303182997661624,0.0,0.9693068368949033,1.0,7/81,6.99%,NUP42;CPSF4;NUP188;WDR33;HHEX;FYTTD1;U2AF1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.4849531260661213,-1.0301117791159742,0.45,1.0,1.0,24/144,18.82%,CENPF;RPS27A;PRKAR2B;NEK11;HAUS6;TUBB4A;TUBA4A;ID2;TUBA1A;RIOK2;APPL1;CENPE;UBA52;ANLN;UBC;PSMA5;PSMA3;ERCC2;RGCC;CEP152;PSMD8;UBB;PSMB4;CEP164
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.617353532760875,-1.029934758971528,0.5205479452054794,1.0,1.0,2/11,7.78%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.5815083258060068,1.0299229640295038,0.3939393939393939,0.9687658529930524,1.0,3/6,12.67%,AMPD3;AK3;NUDT2
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.3976032632026592,1.0298299211403708,0.4,0.9673667471499738,1.0,3/32,4.42%,GSN;FER;PPM1F
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6828749367029537,-1.0298255587532799,0.4696969696969697,1.0,1.0,2/5,14.71%,SHANK3;FRMPD4
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.6320342275609347,-1.0296769407753303,0.4810126582278481,1.0,1.0,4/13,16.53%,VEGFA;PTN;SMARCD3;KDM1A
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.6344912363404754,1.0296739200156344,0.45454545454545453,0.9663110069938423,1.0,1/5,6.49%,STIM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6037634817938392,1.0296330488032348,0.3870967741935484,0.9648300978836861,1.0,2/7,14.21%,SIRT1;DIP2A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.49923337687844527,-1.029473131838733,0.4631578947368421,1.0,1.0,7/52,8.82%,PRKAR2B;TSHR;ADCY3;CD163;FGR;FCGR2B;HTR7
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.6190554357519129,-1.0288429506349264,0.5365853658536586,1.0,1.0,1/14,0.15%,DDIT4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5636431685819359,-1.0279903598590279,0.4823529411764706,1.0,1.0,7/23,20.35%,RPS27A;RBX1;UBA52;UBC;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.6688918254841028,-1.0277189333826215,0.5072463768115942,1.0,1.0,1/7,3.17%,VCAN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.6894777294068617,-1.0277055300095808,0.49230769230769234,1.0,1.0,1/5,8.75%,MAPT
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6556753334857147,-1.0273765665578654,0.4852941176470588,1.0,1.0,3/7,30.60%,FGR;LILRB2;LILRB1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.6590189963171788,-1.0273348706277055,0.5147058823529411,1.0,1.0,1/8,3.17%,VCAN
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.6419154183532139,-1.0269565294180178,0.5614035087719298,1.0,1.0,1/6,16.79%,TFIP11
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.5760924451749279,-1.0269236221940328,0.45977011494252873,1.0,1.0,8/25,18.07%,GLRX2;MTCH1;TYMP;ANK2;UGCG;GRK4;SCG5;MGLL
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.6165363179835872,1.0268990040541288,0.5,0.9689647274135003,1.0,4/8,5.58%,CGAS;HMGA1;SIRT1;ABI3
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.6165363179835872,1.0268990040541288,0.5,0.9689647274135003,1.0,4/8,5.58%,CGAS;HMGA1;SIRT1;ABI3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.35202273633833253,1.0267729576635551,0.25,0.967868278855758,1.0,6/77,5.80%,PHLDB2;CRK;ARHGAP35;FSCN1;RHOG;ABL1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.502395265340426,-1.0266981180734596,0.4838709677419355,1.0,1.0,19/83,19.90%,HTR2B;MMP21;VEGFA;TGFB2;SH3PXD2B;MTHFD1;PKP2;ID2;KDM6B;GPC3;FN1;CDKN1B;LDB3;POU6F1;INSR;CITED2;CACNA1C;MICAL2;SOX4
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5695382046709178,-1.0266658081303999,0.4634146341463415,1.0,1.0,4/18,18.37%,AGT;FN1;BMI1;S100A6
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6525175849090514,-1.0265916367139598,0.5441176470588235,1.0,1.0,2/9,17.89%,DDX11;TIMELESS
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.5716748364401486,1.026571210878868,0.4642857142857143,0.9668425573989263,1.0,6/8,31.44%,SALL1;HDAC1;INTU;CREBBP;WDPCP;MAP3K20
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.6096694490402621,-1.026380958244857,0.5238095238095238,1.0,1.0,2/12,6.09%,DNAH17;CCDC39
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.6554875975645978,-1.026374501079841,0.4675324675324675,1.0,1.0,2/7,3.11%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.4327404077457946,1.0263582411154422,0.4,0.9660662346032292,1.0,3/22,7.03%,AVIL;PRKAB2;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.6607888131264483,1.0262734477702002,0.53125,0.9646891802921099,1.0,2/6,5.60%,ATP2C1;PKDCC
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5724454161027831,1.0262485947865407,0.3548387096774194,0.9632941854652013,1.0,1/6,8.28%,SERPINB9
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.58076813038093,-1.026203792290086,0.4358974358974359,1.0,1.0,2/13,20.29%,ATG2A;ATG5
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5791962104089428,-1.025838384347219,0.5061728395061729,1.0,1.0,4/15,22.46%,WDR5;BRCA1;KDM1A;DNMT1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.525357931721546,-1.0256689038972486,0.45054945054945056,1.0,1.0,3/31,3.21%,LRP2;BHLHE40;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5046642629215643,-1.0254735952138019,0.4725274725274725,1.0,1.0,15/64,19.35%,THBS1;CBR1;AGT;VEGFA;PRELID1;PAX8;NR1H2;CD63;UHRF1;NSF;PID1;KLF4;ANXA2;INSR;CHCHD2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.5029102523207751,-1.0251729655457404,0.425531914893617,1.0,1.0,7/48,19.16%,THBS1;AGT;GSTP1;ITGA6;PYCARD;TRAF2;BCL2L14
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.6063837628471493,-1.0250179307880818,0.4625,1.0,1.0,2/11,3.11%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.6528666347734786,-1.0250157104724502,0.5068493150684932,1.0,1.0,1/7,4.03%,ADGRG6
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.6528666347734786,-1.0250157104724502,0.5068493150684932,1.0,1.0,1/7,4.03%,ADGRG6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.4960162888181331,-1.0248509262224328,0.48484848484848486,1.0,1.0,15/103,11.69%,THBS1;CHI3L1;SEMA6A;FGF1;SPARC;VEGFA;RHOB;GLUL;TGFB2;HIF1A;FLT1;BRCA1;STAT1;PGK1;ITGB8
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4962326479490589,-1.0245720253647812,0.48,1.0,1.0,28/119,20.64%,SRGN;THBS1;F13A1;SPARC;VEGFA;RIMS1;TUBA4A;TGFB2;STEAP2;F8;ENDOD1;SOD1;TTN;SELENOP;MANF;RAB3A;CD63;FN1;CD36;CPLX1;SYT1;CALM1;SNAP25;SERPING1;CLU;SYT4;VEGFB;TMSB4X
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.6180569087534752,1.0244042426000257,0.5666666666666667,0.9670256811909959,1.0,2/6,3.02%,ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.603401336375328,-1.0241661393035597,0.5569620253164557,1.0,1.0,1/14,0.96%,THBS1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.5920560928947153,-1.024091120230923,0.4473684210526316,1.0,1.0,4/19,15.12%,WDR5;HCFC1;MSL3;ING4
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6003211924230931,-1.0238360180023967,0.5205479452054794,1.0,1.0,2/13,10.09%,THBS1;EIF2B2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4741838270942178,-1.0234237137833677,0.43,1.0,1.0,63/277,19.28%,PRLR;SOCS3;CCL4;NLRP12;VIM;RPS27A;CEBPD;OSMR;F13A1;CHI3L1;VEGFA;MT2A;FOS;HIF1A;AIM2;RORA;TNFRSF1B;IL7;RHOU;DUSP1;DUOX1;GBP2;BRCA1;STAT1;DAPK1;RPL13A;GAPDH;IL10RA;CXCR4;CCL3;UBA52;JUNB;IRF1;UBC;BCL6;MNDA;TCF7;IL18;TEC;IFIT1;FN1;CD36;AKAP6;IL1RAPL1;CDKN1B;PID1;LIFR;NR1D1;PTPRT;PTPRZ1;GHR;PYCARD;STAT2;SIGIRR;RPS3;FPR1;UBB;MCL1;HCLS1;TNFRSF21;ZFP36;AIF1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.6705278600415383,-1.0230715734521814,0.484375,1.0,1.0,2/5,9.90%,PRELID1;PRKCQ
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7039635707497017,-1.0229867592633977,0.5223880597014925,1.0,1.0,1/5,8.75%,MAPT
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.6378618305232255,-1.0228961939844692,0.5492957746478874,1.0,1.0,2/11,18.41%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.6388469483047923,-1.0228631225634468,0.5211267605633803,1.0,1.0,3/11,7.08%,TOP2A;SHOC1;FANCM
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5086870204243916,1.0228045126673324,0.4117647058823529,0.9702784580427839,1.0,2/9,9.42%,CRK;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4539763653386584,1.0227852167404092,0.2631578947368421,0.9687702500239238,1.0,8/14,9.45%,IL17RD;SPRED2;DAB2IP;HPN;SMAD7;SPRED1;USF3;SPRY2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.49642550926462103,1.0227645860934231,0.45,0.9673332863173378,1.0,2/12,3.63%,NAA20;NAA35
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5183580928116597,-1.0225044011677349,0.4939759036144578,1.0,1.0,9/36,32.23%,SNRPD2;DDX1;SRSF5;PRPF6;SRSF9;GCFC2;CELF2;RBM5;SRPK1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5312492997519236,-1.021915292491605,0.449438202247191,1.0,1.0,11/36,16.73%,FA2H;ANK3;CR1;SERP1;ANK2;CXCR4;UGCG;EPB41L3;RAB3A;NSF;CAV3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5897925615994495,-1.0218402583538964,0.425,1.0,1.0,5/13,30.18%,SLIRP;PID1;WASF1;PNPT1;NUBPL
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4835948403950318,1.021813359785621,0.46153846153846156,0.9684236423798636,1.0,4/26,6.08%,DCP1B;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6929592509437907,-1.02174043623968,0.5138888888888888,1.0,1.0,2/5,10.27%,SLCO3A1;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6601958277673814,-1.0216158251562675,0.5454545454545454,1.0,1.0,4/8,15.30%,PTN;COBL;ZDHHC15;ALK
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.706938165211681,-1.021406913218415,0.5352112676056338,1.0,1.0,1/5,18.29%,SIRT5
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.5449570526232799,-1.0214055849809425,0.46511627906976744,1.0,1.0,3/19,11.51%,SAP30;RBX1;NOTCH2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.4952780252367354,-1.021384445717608,0.43,1.0,1.0,26/137,24.95%,RPL23;PLPP3;CDC37;RPL11;HSPA1B;PINK1;ATP1B3;GAPDH;ANK2;NOP53;HCFC1;CAMLG;RPL5;USP36;RPS7;GBA3;CLU;SOX4;PPIB;ATP1B2;RAB21;DVL1;CRYAB;IFT46;C10ORF90;WIZ
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.5037982982191596,-1.0213578224984403,0.5,1.0,1.0,16/57,24.53%,VEGFA;HSPA1B;CARMIL1;NOP53;HSPA2;EPHA3;HSPA5;RDX;TFIP11;IMPACT;MCTP1;CLU;CRACD;CRYAB;WASHC2C;RIOK3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.47900688824572296,-1.0212971948610081,0.42105263157894735,1.0,1.0,12/98,10.01%,RHOBTB3;CGNL1;GAS2L3;MYO1G;RHOB;SVIL;COBL;CARMIL1;BAIAP2L1;PPP1R9A;MARCKSL1;TTN
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.48220188698369926,-1.020985843688267,0.4946236559139785,1.0,1.0,24/77,19.57%,SRGN;CD55;MYLK;SPARC;CD93;TNS1;APOLD1;F8;FLT1;PLAC8;SLC7A5;SPARCL1;PROCR;THBD;CD36;GPM6A;LIFR;RGCC;SHROOM4;PLEC;MGLL;CLIC4;HEXIM1;ABCA8
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.6543022305838483,-1.020576476453592,0.5373134328358209,1.0,1.0,4/7,21.01%,ABHD12B;DGAT1;MGLL;FAAH
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5280811810260794,-1.0204346293784075,0.40217391304347827,1.0,1.0,7/30,15.84%,SOCS3;VEGFA;PARP9;IL15;IL18;PARP14;GHR
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6394391378736082,-1.0200231129093593,0.5066666666666667,1.0,1.0,4/10,17.46%,ID2;PTPRZ1;KDM1A;TOX
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6180489917761246,-1.019987031444712,0.5432098765432098,1.0,1.0,3/15,10.40%,CEMIP;CHI3L1;CALM3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.45990357134522986,1.019897637680142,0.38461538461538464,0.9719189401428437,1.0,3/16,4.23%,LGALS9;CD274;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.36285819207072945,1.0198551613198938,0.4444444444444444,0.9704837980679205,1.0,7/47,5.80%,SIRPA;FER;MAP3K5;PKD2;MAPK13;SIRT1;ABL1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5881788122446635,1.0197489698984719,0.4117647058823529,0.9693174590809085,1.0,3/9,15.69%,SIRT1;SLC30A10;CDK6
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5992663991984354,-1.019694641856253,0.42857142857142855,1.0,1.0,3/13,13.36%,NUDT16;RIOK2;USP36
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.491012105082818,-1.0195976004702876,0.47,1.0,1.0,18/102,18.44%,CCL4;RPS27A;ST18;HIF1A;RBX1;NOD2;GBP2;MAP3K8;CCL3;UBA52;UBC;PSMA5;PSMA3;NR1D1;PYCARD;PSMD8;UBB;PSMB4
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5160267107786646,1.0189378602568306,0.42424242424242425,0.9701559934060067,1.0,1/6,2.49%,TICAM1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6215263133816131,-1.0185949223227246,0.5733333333333334,1.0,1.0,4/10,23.38%,PKP2;CACNA1C;ATP1B2;RYR2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.6655185104612287,-1.0183059122331586,0.4788732394366197,1.0,1.0,2/8,7.60%,P4HA3;EGLN3
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5434713008594869,-1.017798685318514,0.5180722891566265,1.0,1.0,1/28,0.33%,GLRA1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.3956542069494045,1.017694443129107,0.4,0.9716725850290749,1.0,12/47,12.57%,LGALS9;TLR7;TMEM106A;LPL;MAPK13;IL17RA;SYK;SCIMP;TIRAP;IL6R;IL1A;LILRA2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.36517760140610805,1.0176221741717775,0.0,0.9702467683800294,1.0,7/83,6.99%,NUP42;CPSF4;NUP188;WDR33;HHEX;FYTTD1;U2AF1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5110500128932394,-1.0176050752257453,0.4943820224719101,1.0,1.0,15/54,19.78%,GLRA1;VIM;MYOT;MYLK;SNTB1;CKMT2;TTN;DMD;LTB4R;MYL6;GNAO1;CAV3;CALM1;EMD;ASPH
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.5894509933892675,-1.0170845441814211,0.5135135135135135,1.0,1.0,1/13,2.98%,ETFB
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.5184454638939964,-1.016945083788333,0.45054945054945056,1.0,1.0,12/31,25.94%,ANK3;UGCG;NRXN1;NLGN3;IL1RAPL1;PTPRD;ANXA2;LRP4;UBXN2B;NRXN2;SPAST;NLGN2
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.48608686298877607,-1.0168262662602963,0.48484848484848486,1.0,1.0,24/152,12.40%,NR4A3;CLEC12A;CCL4;ADGRE1;RGS1;F13A1;JAML;MYO1G;RAB7B;RBPJ;SLC11A1;C5AR1;TNFRSF1B;MS4A4A;EGLN3;CD163;PLTP;FGR;FCGR2B;IL10RA;SELENOP;CCL3;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.545651501500293,1.0167241973970347,0.42857142857142855,0.9710799451432699,1.0,5/18,15.80%,LCP1;FMNL3;STRIP1;FHOD1;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.4891707357249257,-1.016482067816723,0.46464646464646464,1.0,1.0,20/144,15.47%,DDIT4;NLRP12;THBS1;HHIP;RGS2;SEMA6A;AGT;SULF2;NR4A2;SPRY1;PRKCQ;APPL1;RPGRIP1L;TLE1;CARD16;GPC3;DCC;APOD;PID1;PTPRT
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3117829591227313,1.0163624415153787,0.6,0.9705992386787872,1.0,8/66,7.29%,LMO1;TAL1;CBFB;NSUN2;JAG1;ABL1;RUNX1;PSME4
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.6587482366691119,1.0163443670508572,0.6,0.969159896792861,1.0,1/5,5.37%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5958691448348254,-1.0160486307840078,0.48148148148148145,1.0,1.0,4/17,13.88%,ATP5IF1;PARP9;PLN;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5502403155807442,-1.0159763948573226,0.5487804878048781,1.0,1.0,5/21,20.31%,NR4A3;PRKCQ;PYCARD;CD44;THY1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.4943026527691524,1.0156288359791152,0.36,0.9702087594417855,1.0,2/12,13.47%,FFAR4;CAMK2G
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.4975263922985946,-1.0155658590160117,0.4897959183673469,1.0,1.0,46/113,32.08%,SPOCK1;PDE4A;B4GAT1;OSCP1;FLRT1;ENDOD1;CASKIN1;SCN9A;ATF5;HSPA12A;SYBU;APLP1;KCTD1;SRRM3;EPB41L4B;METRN;IFT74;GRAMD1C;IMPDH1;ARFGEF3;CPE;SEZ6L2;CKB;NRG1;FAM81A;RETREG1;TMEM178A;EML2;TMEM59L;MAP2;AGAP1;GNAL;CNPPD1;TTC5;CARNS1;NDRG4;LINGO1;PDE1C;MACROD1;SCAMP5;PKIB;ATP9A;EPB41L1;CELSR2;STXBP1;MAPK8IP2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6242113923163761,-1.0154029059388863,0.5352112676056338,1.0,1.0,2/10,8.88%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6993456120437455,-1.0153584873359716,0.48484848484848486,1.0,1.0,1/5,6.13%,DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6993456120437455,-1.0153584873359716,0.48484848484848486,1.0,1.0,1/5,6.13%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6993456120437455,-1.0153584873359716,0.48484848484848486,1.0,1.0,1/5,6.13%,DDRGK1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.5985071931613932,-1.0149685576379175,0.5301204819277109,1.0,1.0,2/11,10.87%,RORA;PDK3
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5950814385564999,-1.0149313546700873,0.4788732394366197,1.0,1.0,4/12,28.36%,PRPF6;PRPF3;SART3;SRSF12
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5103944149044995,-1.0148315605268472,0.5217391304347826,1.0,1.0,10/46,15.47%,SEMA6A;COBL;ANK3;PPP1R9A;LRRN1;SPARCL1;CFTR;BMI1;SPON1;PTPRT
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.6475645445603903,-1.014688730627197,0.49230769230769234,1.0,1.0,1/6,7.44%,PAICS
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.6803988093449775,-1.0146322899577205,0.45588235294117646,1.0,1.0,1/5,3.40%,ALOX12
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.5872642255959548,-1.0144175830698332,0.45569620253164556,1.0,1.0,1/12,0.16%,GDPD1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.48589208820003893,1.014331658382127,0.45454545454545453,0.9719504948039046,1.0,2/14,3.02%,ZNF385A;SH2B3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.5221016159944639,-1.0142058355316135,0.5172413793103449,1.0,1.0,12/41,21.53%,RPL23A;JPH1;COBL;CXCR4;EPB41L4B;MAPK4;ENAH;LRP4;ARFGEF3;CPE;SEZ6L2;CKB
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.5389421288240197,-1.0140881199293021,0.4943820224719101,1.0,1.0,8/32,19.58%,ANKRD22;CEBPD;FBP1;ABCC3;IL18;KLF4;ST14;RAB20
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.6464537569698695,-1.0139600731574254,0.5616438356164384,1.0,1.0,1/8,11.21%,CTBP1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5281824123601288,-1.0135136098250233,0.4157303370786517,1.0,1.0,5/27,11.26%,LRP2;TGFB2;MTHFD1;COBL;STIL
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.6347358862254532,-1.0135084044227822,0.5194805194805194,1.0,1.0,4/8,29.45%,CARMIL1;CRACD;WASHC2C;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.5252224845522753,-1.0132917007130184,0.4666666666666667,1.0,1.0,3/39,3.34%,PAQR3;SPOCK1;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.5879076455674698,-1.0131830763317162,0.56,1.0,1.0,4/16,21.31%,VEGFA;CRTC3;ADCY8;RELN
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4983836887565067,-1.0130118508846624,0.5161290322580645,1.0,1.0,18/65,26.58%,HLA-B;HLA-F;PSMA5;PSMA3;B2M;CD36;TAP1;NCF4;MFSD6;PSMD8;NCF2;PSMB4;HLA-C;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.652365738052505,-1.0128315898970108,0.525,1.0,1.0,2/7,12.00%,GSTP1;MID1IP1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6025647100606841,-1.0127429885963348,0.49333333333333335,1.0,1.0,4/11,22.80%,NOTCH2;EPB41L4B;ZFP36;PTPRK
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.6335065077213187,-1.0127183922984417,0.5,1.0,1.0,4/9,25.27%,HSPA1B;EML2;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.673076043690706,-1.0123369912872553,0.5223880597014925,1.0,1.0,3/7,23.13%,NREP;APOD;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.42287895386078994,1.0118200039969076,0.4166666666666667,0.9766190573740671,1.0,5/27,6.01%,FGL1;SIRPA;LAPTM5;ABL1;TNFSF8
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.473997286167696,-1.01173548116489,0.5,1.0,1.0,23/142,16.73%,DDIT4;NLRP12;THBS1;CGNL1;RORA;GSTP1;DUSP1;PEBP1;HERPUD1;PPP2R5B;STAT1;PINK1;LIMD1;NOP53;PRDM15;TLE1;CIT;BCL2L2;DGKG;NR1D1;NPRL2;PYCARD;CAV3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5469511815317425,1.0115529979475806,0.5,0.9741337522406868,1.0,2/8,5.33%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5469511815317425,1.0115529979475806,0.5,0.9741337522406868,1.0,2/8,5.33%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5496309188828559,1.0115523914598215,0.5217391304347826,0.9726373870298716,1.0,4/7,22.32%,SIRT1;TDP1;LIG4;APLF
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.46377942692539986,1.0114943072405047,0.4074074074074074,0.9712751325168085,1.0,3/10,5.37%,PKD2;PTCH1;TGFB1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.4756298924021066,1.0114664466604244,0.4090909090909091,0.9697877280259711,1.0,3/13,2.95%,NRP1;PKD2;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4551555169410638,1.0112581708236135,0.45454545454545453,0.9689720155926731,1.0,2/18,7.32%,MED24;TP53
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.5451609332571936,-1.0109088256761505,0.4431818181818182,1.0,1.0,4/27,11.70%,NR4A2;POLR2G;PAX8;PTMA
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.48177394384254885,-1.0108462209288,0.5151515151515151,1.0,1.0,29/160,15.12%,DDIT4;SEMA6A;PPP1R15A;RHOB;MX1;GLRX2;FAM162A;ALOX15B;IFIT2;CASP5;TCHP;MAL;EGLN3;ADAM15;DAPK1;GAPDH;BNIP1;PRKCE;CXCR4;BNIP3;DAPK2;NOTCH2;CIT;IRF1;ERCC2;PAK5;DCC;TRAF7;ING4
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5535670579485519,-1.0107369436670632,0.5060240963855421,1.0,1.0,3/23,4.35%,FOS;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.40331035314990715,1.0103679656089097,0.5,0.9697274105381611,1.0,5/44,5.33%,SESN2;RALB;PIP4K2B;SESN3;SIRT1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.47324714827617204,1.0102765154725069,0.47058823529411764,0.9684851741119443,1.0,3/11,10.83%,ARHGAP35;CNTN4;EPHB3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5166649052952942,-1.0102073347357579,0.5172413793103449,1.0,1.0,7/42,22.39%,OSBPL5;INSIG1;ABCA5;TM7SF2;ABCA1;IDI1;MVD
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6599716733766082,-1.010066774961909,0.5522388059701493,1.0,1.0,1/7,9.14%,ID2
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6907793940504592,-1.0099818200421884,0.5571428571428572,1.0,1.0,2/5,19.48%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.6290414011093602,-1.0096076592838983,0.49230769230769234,1.0,1.0,1/8,11.82%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5652338967943374,-1.0096015548273525,0.42528735632183906,1.0,1.0,4/19,9.14%,AIM2;PQBP1;STAT1;PARP9
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6534709830465862,1.0093463191696077,0.5151515151515151,0.9694746578953772,1.0,1/5,5.07%,SLIT3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.6634679737378155,-1.0093086576426231,0.5217391304347826,1.0,1.0,3/7,24.31%,COPS5;HSPA5;RACK1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.4963103509866946,-1.00889042279446,0.4946236559139785,1.0,1.0,13/51,20.90%,TRIM5;MT2A;HLA-B;GBP2;STAT1;TRIM25;HLA-F;IRF1;B2M;OAS3;CD44;TRIM22;HLA-C
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5593733323429342,-1.008834981823566,0.5324675324675324,1.0,1.0,3/16,8.93%,PRELID1;DDRGK1;PINK1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.6821083303287211,-1.008676774898422,0.5735294117647058,1.0,1.0,2/6,15.08%,KDM6B;ITGA2
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.4905681641576663,-1.0086343873053867,0.4731182795698925,1.0,1.0,18/75,21.52%,CCL4;JAML;MYO1G;TSHR;SELL;CD69;FGR;IL10RA;CXCR4;BCL6;LSP1;VNN2;NCF4;GPR65;HCLS1;GNLY;CD300A;ARHGAP9
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6905546449861907,-1.0086081438090568,0.5666666666666667,1.0,1.0,1/6,4.80%,PTN
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.5822405631482128,1.0084223613745633,0.5555555555555556,0.9707392032221901,1.0,1/5,7.32%,TP53
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5574039807718086,-1.008373651885017,0.5357142857142857,1.0,1.0,10/31,20.29%,FANCB;SLF1;DDX11;ZCWPW1;PARP9;WDR48;TIMELESS;FMN2;KMT5C;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5738047186803893,1.0082999623653564,0.4375,0.969479729075957,1.0,3/10,15.69%,SIRT1;SLC30A10;CDK6
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.6047418324275529,-1.0082537986189404,0.4931506849315068,1.0,1.0,3/9,21.02%,SLC24A1;ATP2B4;SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.6047418324275529,-1.0082537986189404,0.4931506849315068,1.0,1.0,3/9,21.02%,SLC24A1;ATP2B4;SLC24A2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5480622849361271,-1.0081963833103649,0.4625,1.0,1.0,8/30,24.31%,THBS1;EIF2B2;PDK3;ADCY8;IRS2;SOX4;PFKL;RACK1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3000898418859784,1.0081093535633856,0.5,0.968415997528302,1.0,21/133,14.70%,STK32B;RPS6KA6;MAP3K10;CSNK1G1;MAPKAPK2;LATS2;CAB39;TGFBR2;MAPK13;NEK6;MAST2;MAST3;MKNK1;CHUK;RPS6KA4;CAMKV;MAP2K2;RPS6KA1;NLK;TLK2;PIKFYVE
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5175609141977515,1.0079183292423934,0.375,0.9674832416351221,1.0,1/7,3.37%,PDE3A
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5675996464019837,-1.0078998106680541,0.5308641975308642,1.0,1.0,5/21,17.86%,ATP8B1;ATP10A;ABCB4;ABCB1;ABCA1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.661384593404629,-1.0078824316727217,0.532258064516129,1.0,1.0,6/7,32.74%,GABRA3;GABRG2;GABRA2;GABRB2;GABRA4;GABRA1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.622624395556176,-1.0077360692620212,0.4875,1.0,1.0,1/10,1.30%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.646374217258993,-1.0071068719964096,0.5714285714285714,1.0,1.0,1/7,7.68%,DHX58
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5096371597087115,-1.0070976124933542,0.5,1.0,1.0,14/47,20.37%,PRLR;PLPP3;LAMA2;COL21A1;MLANA;SPARCL1;SVEP1;LIFR;ALDH1A1;SH3D19;CPE;SERPING1;ABCA8;MAFB
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.546362878464183,1.0070552945200444,0.42857142857142855,0.9683604620396008,1.0,4/9,21.31%,CHKA;ETNK1;LPIN2;CEPT1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.5053961678372436,-1.0070438929572112,0.4946236559139785,1.0,1.0,2/45,5.01%,SLC2A3;MTHFD1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6055937218433864,-1.0068495773574349,0.5194805194805194,1.0,1.0,1/14,3.47%,MT2A
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.5867701706673163,-1.0068167568492532,0.4444444444444444,1.0,1.0,3/9,18.97%,ME1;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4763414846632148,1.0065109754094679,0.5217391304347826,0.9684283487245376,1.0,3/10,17.14%,APH1A;ADAM10;DYRK1A
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.6923633329981941,-1.0065099801856785,0.4861111111111111,1.0,1.0,3/5,29.52%,FCGR2B;CARD9;FCER1G
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.6707497704659979,-1.0064463155797096,0.5571428571428572,1.0,1.0,2/5,22.40%,MAPT;BEX4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5046273622506061,1.0063195744887397,0.4,0.9674785918409929,1.0,3/10,4.42%,NEXMIF;SERPINF2;PPM1F
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.5979562616986422,1.0061691716474157,0.5142857142857142,0.9664047027307632,1.0,2/6,18.33%,UQCC2;MEF2C
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.48492585926908355,-1.0059812993918564,0.4845360824742268,1.0,1.0,15/79,19.85%,GLRA1;MT2A;FOS;ANK3;FBP1;BNIP3;IQGAP1;B2M;CDKN1B;SYT1;CPNE8;RYR3;CLIC4;ADCY8;SYT4
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.601156119883895,-1.0059560684733002,0.5263157894736842,1.0,1.0,1/12,2.26%,MYO1G
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5557105909402645,-1.0059554959748715,0.5116279069767442,1.0,1.0,6/21,19.09%,OVOL2;UGCG;TXNIP;ERCC2;ST14;CLIC4
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.6065223400687181,-1.0057585768534847,0.5609756097560976,1.0,1.0,2/11,8.69%,GPR183;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5513445472909448,1.0053855489282948,0.6190476190476191,0.9673416729543753,1.0,1/8,3.79%,FFAR4
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.49817637667274,-1.0053767717281628,0.46153846153846156,1.0,1.0,17/62,26.58%,HLA-B;HLA-F;PSMA5;PSMA3;B2M;CD36;TAP1;NCF4;PSMD8;NCF2;PSMB4;HLA-C;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.5860786540216005,-1.0051735436724643,0.4805194805194805,1.0,1.0,11/16,38.57%,CDC37;SDCBP;PDCD6IP;ASAH1;OGT;CYLD;CFLAR;FLOT2;PELI1;FLOT1;HSP90AA1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6081943216846015,1.0051538796162234,0.5483870967741935,0.966524424902815,1.0,1/5,5.72%,LOXL3
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.48314927246530326,1.0051316731768227,0.42857142857142855,0.9650775320511641,1.0,2/11,9.32%,APH1A;ADAM10
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6014539566987109,-1.0051069151515915,0.4935064935064935,1.0,1.0,2/12,14.49%,MDFIC;APOD
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3247876450578103,1.005087575524716,0.5,0.9636980794206786,1.0,6/55,7.29%,LMO1;TAL1;CBFB;ABL1;RUNX1;PSME4
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.503088221993769,-1.004722648503777,0.5161290322580645,1.0,1.0,10/60,18.84%,SOCS3;CDC37;IL7;STAT1;CLIP3;LIFR;PYCARD;TRAF2;SIGIRR;VRK2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.42127417036277526,1.0046496872988198,0.42857142857142855,0.963268051773934,1.0,4/19,10.32%,HMGA1;SIRT1;NSMCE2;MAP2K1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.555742213568991,-1.004562953501121,0.5060240963855421,1.0,1.0,3/18,12.45%,KCNJ13;ATP1B3;SLC12A8
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.5619115789408584,-1.004511921091408,0.48717948717948717,1.0,1.0,3/19,9.09%,SEMA6A;SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.5954979761218924,-1.0044943999906113,0.4788732394366197,1.0,1.0,2/10,11.59%,LIMD1;CIT
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.683368695672448,-1.0043668060843862,0.5972222222222222,1.0,1.0,1/5,4.00%,TGFB2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.6347580805144661,-1.0042799722298614,0.5365853658536586,1.0,1.0,1/8,2.98%,ETFB
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.46817762765486604,1.0040771120282672,0.5263157894736842,0.9634266204456489,1.0,4/16,5.60%,BCL2L1;TGFB1;ABI3;PKDCC
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.49121614406988,-1.0040109787057114,0.5056179775280899,1.0,1.0,5/35,12.84%,SPOCK1;AGT;PRELID1;GAPDH;PSMA3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.48121827686013957,-1.003803555240368,0.5208333333333334,1.0,1.0,10/85,11.75%,ARAF;RNF144B;ARIH2;RPL11;RBX1;DDRGK1;HSPA1B;HERPUD1;NOP53;CAMLG
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6705397163820814,-1.0035791007275068,0.5,1.0,1.0,4/5,31.39%,FGF13;CAV3;AKAP9;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3233677272671033,1.0033679733237122,0.3333333333333333,0.9636894387201671,1.0,12/115,8.61%,SESN2;RALB;MAP3K5;NUAK1;MIOS;SESN3;SIRT1;STK26;TP53;EIF2S1;EIF2AK4;LAMTOR1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.6219972897282164,-1.0032863815305224,0.527027027027027,1.0,1.0,3/12,11.22%,VEGFA;TTN;KDM6B
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.6579666283772346,-1.003262465810218,0.5352112676056338,1.0,1.0,1/7,7.07%,MTCH1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5548632592320878,-1.0030816448392756,0.4666666666666667,1.0,1.0,7/23,15.20%,SPOCK1;TGFB2;BTBD2;MAPT;CXCR4;CIT;EPHB1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6002047705105628,1.0029336824630817,0.46875,0.9633240803838193,1.0,1/6,2.49%,TICAM1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.6787553703135485,-1.00290478802695,0.5679012345679012,1.0,1.0,4/6,27.20%,MAPT;SPG11;DCTN1;APP
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.6037327378441777,-1.002877647734826,0.5068493150684932,1.0,1.0,4/10,31.49%,NEIL1;UPP2;TDG;OGG1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.6014003248042757,1.0028162734840411,0.5,0.9621871663731555,1.0,1/7,7.83%,NMNAT3
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.537794743040116,-1.0027944614427962,0.48863636363636365,1.0,1.0,8/25,22.13%,PPP1R15A;PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1;CD300A;LILRB2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5364696916988589,-1.0020444388563627,0.5581395348837209,1.0,1.0,11/30,22.14%,FA2H;ALOX12;LSR;UGCG;TXNIP;ITGA6;ERRFI1;ST14;CLIC4;STMN1;COL5A1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.3391196666244002,1.0019941672837418,0.5,0.963180445525066,1.0,5/34,9.53%,PANK1;NPR2;PANK3;GUCY1A1;AMPD3
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.491404808106142,1.0019715872574606,0.45,0.9617972631325303,1.0,5/13,9.70%,HPGDS;DAGLB;CYP2S1;PTGS1;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.6433755515594058,1.0017673803064275,0.5,0.960854749012638,1.0,1/5,11.17%,ITM2B
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5252668874213925,-1.0014768023892235,0.5384615384615384,1.0,1.0,8/31,16.67%,RBPJ;IL15;NR1H2;PCTP;ARRDC3;ACOT13;NR1D1;ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5852580336905697,-1.0014635971356958,0.5365853658536586,1.0,1.0,2/13,4.80%,VEGFA;PTN
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4769858954094956,-1.0011706663688864,0.5,1.0,1.0,13/101,11.96%,PCSK1;FA2H;PLPP3;ALDH3B1;GCNT1;GSTP1;DEGS2;LPCAT1;NMRAL1;DMD;GSTK1;GSTM3;PCTP
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.496369535549819,-1.0010499161040463,0.47474747474747475,1.0,1.0,14/66,19.11%,CD55;CTDSP1;NOD2;LITAF;TYMP;UBALD2;HLA-F;JUNB;IRF1;PIM3;TAP1;SIGIRR;ST14;ZFP36
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6443976336737536,-1.0009461262814376,0.5211267605633803,1.0,1.0,4/7,33.56%,KIF3A;DCTN1;BBS4;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5118422004336332,-1.0008924845647003,0.5416666666666666,1.0,1.0,10/74,10.40%,HTR2B;CEMIP;MTCP1;FGF1;VEGFA;SYAP1;NOD2;FLT1;DIRAS2;CALM3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.38376770980013725,1.00008480867655,0.4,0.9641913606889752,1.0,4/21,5.37%,PTPRM;DAB2IP;PPARG;TGFB1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.6007391120168488,-1.0000697168545698,0.5285714285714286,1.0,1.0,6/12,29.07%,TSHZ3;SLC24A1;SLC24A2;GRIN2A;SHANK2;PLK2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3293585968020864,1.0,1.0,0.9545269457021942,1.0,39/189,12.98%,BBS9;GSN;NRP1;EHD4;AVIL;KIF27;RAP1A;P2RY12;STK36;EXOC8;MAP4K4;SRGAP2;CDC14B;MKKS;RAPGEF6;FSCN1;RAB3IP;VCL;WDR35;WHAMM;STK26;TCTN3;CEP41;OCRL;CDH13;ABCC4;KIF3B;INPP5K;P2RX7;SHTN1;CEP290;RAP2A;CILK1;IQCB1;RAP2C;PTPRO;POC1B;CCDC66;DYNLL2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.35055923943699396,1.0,1.0,0.9545269457021942,1.0,8/99,5.37%,PHLDB2;SERPINF2;SMAD7;MOSMO;CBFB;DAG1;NSUN2;TGFB1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.24491730754867927,1.0,1.0,0.9545269457021942,1.0,49/300,13.58%,NUP42;PEX13;KLHL21;RNF25;ZNRF3;NEDD4;DCUN1D4;NUP188;SPSB2;KLHL18;FBXO32;SMURF1;UBE2D1;RFWD3;TRIM38;ZNF598;SIRT1;ARRB2;RNF20;UBA1;UBA7;MARCHF3;BTRC;RNF38;KLHL9;SDE2;CBL;TRIM11;TRIM33;FBXO45;TSPAN17;RNF103-CHMP3;NSMCE2;ELOC;PEX5;COMMD1;NUP214;FBXW7;UBE2E3;AREL1;RAE1;ANAPC16;FBXW11;LZTR1;OS9;UBA2;FBXL3;UFM1;UBE2N
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2728364311165433,1.0,1.0,0.9545269457021942,1.0,8/104,5.80%,NUP42;NUP188;NUAK1;BAG5;MAPKAPK2;SIRT1;NEK6;ABL1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2863997691873865,1.0,1.0,0.9545269457021942,1.0,37/257,12.08%,NUP42;SGSM1;TBC1D22B;RAB5B;IPO13;NUP188;SORL1;ARFIP1;SMURF1;TRAK2;RAB22A;LAPTM5;AP4E1;ARL11;RAB7A;ARL5A;TGFB1;TBC1D8B;TMED4;APPL2;TBC1D10B;SGSM2;SYK;E2F3;SYNDIG1;TBC1D16;MAIP1;EVI5;TBC1D12;TBC1D5;TMED3;SNX1;ARCN1;NUP214;PPP1R10;TBC1D25;TBC1D1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3173075417157389,1.0,1.0,0.9545269457021942,1.0,11/151,6.99%,NUFIP1;RNASEL;RP9;SNRNP35;SCNM1;ELAVL4;LSM6;PPARGC1A;KHSRP;SNRPB;U2AF1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.27070967668279416,1.0,1.0,0.9545269457021942,1.0,25/173,13.14%,NEDD4;GID4;BFAR;SPSB2;SMURF1;RNF122;RCN3;SOCS6;KCTD5;SIRT1;ARRB2;ZFAND2A;BTRC;PSME4;SHARPIN;APPBP2;FBXO45;UBXN6;DNAJB12;KLHL42;FBXW7;AREL1;ATE1;PSME3;FBXW11
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.34058222224978646,1.0,1.0,0.9545269457021942,1.0,16/132,11.73%,PLA2G4C;PIK3C2B;PI4KB;PIP4K2B;ABHD8;SLC44A2;AGPAT2;OCRL;PLA2G12A;VAC14;INPP5K;PTPN13;MTMR14;PITPNM2;AGPAT1;FGF2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6255466299793181,-0.9998834075428166,0.5373134328358209,1.0,1.0,1/5,20.50%,SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5310776422604446,0.9997174791904337,0.4074074074074074,0.9537521426117451,1.0,2/8,7.82%,WASF2;WASF3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6049042325562111,-0.9996730243602799,0.5443037974683544,1.0,1.0,3/9,19.74%,ABCA5;ABCA1;CLU
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6332706334578551,-0.9996639151984404,0.625,1.0,1.0,4/9,27.99%,PLP1;CLU;MYRF;B4GALT5
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.5542285381234637,-0.9995097806757461,0.5131578947368421,1.0,1.0,6/20,15.41%,PRELID1;IL7;CR1;SOD1;TCF7;PRDM1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.5942828262960431,0.9994974305509072,0.5384615384615384,0.9529386773963103,1.0,3/7,10.23%,DNAJB14;DNAJB12;DNAJC18
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.6451389804257077,-0.9994431079920136,0.5526315789473685,1.0,1.0,2/8,9.59%,CLEC4E;GAPDH
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6087408513565427,-0.9991123892234579,0.4375,1.0,1.0,2/7,20.96%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.5208188629028632,0.998887860999434,0.48148148148148145,0.9530059576324077,1.0,4/7,19.56%,SALL1;MDM4;NOTCH1;ENG
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.6348332715434978,-0.9988020944592535,0.5540540540540541,1.0,1.0,2/8,10.01%,VEGFA;TTN
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.6709173717961774,-0.9984048935784824,0.5492957746478874,1.0,1.0,4/6,24.57%,RAB3A;ERC2;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.562403092479065,0.9978390730572584,0.37142857142857144,0.9543989085280445,1.0,1/5,5.25%,ZNF598
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6616354035461331,-0.9978277435080045,0.5151515151515151,1.0,1.0,1/7,3.11%,VEGFA
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.6539837411566599,-0.9978206742750757,0.5616438356164384,1.0,1.0,1/7,1.07%,ENPP2
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6467882693109126,0.9977240197467313,0.4666666666666667,0.9532417759758186,1.0,3/5,23.70%,PRKN;ATP13A2;D2HGDH
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.5462906904434525,0.9976508643911858,0.40625,0.9520066318177586,1.0,4/7,9.70%,HPGDS;CYP2S1;PTGS1;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.6617404197744294,-0.9975717931597574,0.4626865671641791,1.0,1.0,2/5,9.21%,HIF1A;PAX8
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5572462208057716,0.9973619609478482,0.5384615384615384,0.9516483664100457,1.0,4/8,24.72%,TIRAP;MFHAS1;TREM2;TLR1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.5281117721862514,-0.9973586350580805,0.5714285714285714,1.0,1.0,6/30,16.01%,TOM1L1;BRINP1;BCL6;ZWILCH;CDKN1B;RGCC
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.544491664345471,-0.9972611395613574,0.48863636363636365,1.0,1.0,4/24,9.14%,AIM2;PQBP1;STAT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6052113708276681,-0.9972006611919395,0.5542168674698795,1.0,1.0,4/11,14.49%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.6608336494320808,-0.9970011020521584,0.5285714285714286,1.0,1.0,2/6,18.04%,PIAS4;GNL3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.4957589412873464,-0.9969511066254475,0.5257731958762887,1.0,1.0,12/59,16.92%,NLRP12;CYCS;FAM162A;BEX3;CASP5;MTCH1;EGLN3;MAPT;EIF2AK3;KHDC1;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5652418846038628,-0.996898774921835,0.5280898876404494,1.0,1.0,3/17,10.40%,TOM1L1;VEGFA;CALM3
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.6845087641985697,-0.9968351792520767,0.5373134328358209,1.0,1.0,3/5,25.94%,NRXN1;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.31605518090651513,0.9967833676540436,0.25,0.9514736567625411,1.0,16/72,12.84%,SGSM1;TBC1D22B;SIPA1;SCRIB;TBC1D8B;RHOG;TBC1D10B;SGSM2;TBC1D16;EVI5;TBC1D12;TBC1D5;ABR;TBC1D25;TBC1D1;SIPA1L2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.6446748587762553,-0.996385613665932,0.5492957746478874,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6618711166095458,-0.9958222667102131,0.515625,1.0,1.0,3/5,12.49%,SOD1;DOCK5;KCNMA1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4800422860730025,-0.9955735608389301,0.5360824742268041,1.0,1.0,25/92,22.52%,JAML;PIANP;RSAD2;TGFB2;SELL;CLEC2B;HLA-B;DHX58;FGR;FCGR2B;IL15;APPL1;HLA-F;IRF1;BCL6;B2M;COLEC12;ERAP1;KLRF1;FCGR2C;HLA-C;CD300A;PLSCR1;LILRB2;FOXP1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.635214346829334,0.9955353933733941,0.5333333333333333,0.9533043172643243,1.0,3/5,18.67%,CSF1R;FERMT2;MYADM
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.599296892788923,-0.995478051096199,0.5128205128205128,1.0,1.0,1/12,1.30%,CEMIP
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.5628371507470304,-0.9954128047549107,0.5301204819277109,1.0,1.0,4/17,19.36%,PIM3;CFTR;NR1D1;ADCY8
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6394363853026483,-0.9953427475009462,0.5128205128205128,1.0,1.0,2/7,18.65%,HIF1A;MCL1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.5066561458677111,-0.9953319385578602,0.5494505494505495,1.0,1.0,27/65,25.23%,FAM13C;DENND2A;PTN;DZIP1;MAP1B;PLP1;ANK2;ITSN1;HSPA12A;ADGRL2;LIFR;ADGRL3;TUSC3;ENAH;LRP4;FBXL7;CPE;PTPRG;THY1;FIGN;RUNX1T1;RBFOX2;GPRC5B;MPDZ;GULP1;CSRNP3;AGAP1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.49147274257166873,-0.9952741729371793,0.4946236559139785,1.0,1.0,13/71,14.76%,TNC;OSMR;PLPP3;FILIP1L;PTN;SH3PXD2B;SYNC;DOCK1;MLANA;LAMB1;FN1;PALLD;BMI1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.5583261478402858,-0.9952008606078019,0.5,1.0,1.0,2/14,17.20%,USP36;ATXN7L3
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.44305910225879663,0.9951622357062148,0.5384615384615384,0.9527435107214419,1.0,1/10,1.02%,SNAP47
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.655528488726535,-0.995114445989707,0.5633802816901409,1.0,1.0,1/5,4.74%,ASRGL1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.61473083796928,-0.9948315935907235,0.5333333333333333,1.0,1.0,5/9,36.20%,KIF3A;DCTN1;BBS4;HOOK3;BICD1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.6831547743436706,-0.9947491979402425,0.4925373134328358,1.0,1.0,1/5,2.13%,MYLK
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.48799697940323766,-0.9946643277335385,0.5052631578947369,1.0,1.0,19/80,22.10%,FA2H;CYP3A5;ALOX12;ME1;SLC16A3;CKMT2;GNPAT;LDHA;CD36;VNN2;PDHB;BTD;SLC16A1;PNPLA8;ECHDC3;PER2;ALDH1A2;CKB;HACL1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.5868871570421296,-0.9944695952551682,0.5421686746987951,1.0,1.0,3/14,4.00%,LRP2;VEGFA;TGFB2
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5439371795721556,-0.994416419203217,0.5609756097560976,1.0,1.0,7/24,19.64%,PARP9;PARP14;ZC3HAV1;SIRT5;PARP11;SIRT3;PARP15
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.6582794569011285,-0.994363661660228,0.5285714285714286,1.0,1.0,3/5,23.12%,CCL3;MGLL;ACP3
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.3870372762236299,0.9940576482180847,0.46153846153846156,0.9539613040818677,1.0,4/31,4.58%,FKBP9;DAB2IP;CEBPA;PPARG
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.4812753326721935,-0.993576231515769,0.4791666666666667,1.0,1.0,20/86,22.13%,CLEC12A;JAML;MYO1G;C5AR1;TNFRSF1B;CD69;FGR;IL10RA;RASGRP4;MNDA;VNN2;NR1D1;NCF4;FPR1;GPR65;HCLS1;AIF1;CD300A;ARHGAP9;LILRB2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.5871134970074978,-0.9935301697897171,0.5616438356164384,1.0,1.0,3/11,8.75%,GSTP1;SOD1;MAPT
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.6348439977930014,-0.9927837097291056,0.5138888888888888,1.0,1.0,2/7,27.41%,BRCA2;MACROH2A2
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.6673033241728031,-0.9925933388633718,0.582089552238806,1.0,1.0,4/5,25.86%,ALDH1A1;GAD1;GAD2;BCAT1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.6541495464035559,-0.9925869216915287,0.5324675324675324,1.0,1.0,3/6,26.61%,COA6;NDUFB6;NDUFV1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.6624049165995298,-0.9923690551066907,0.5147058823529411,1.0,1.0,3/6,25.94%,TSHZ3;NLGN3;NLGN2
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.48313353762381744,-0.9922710956711891,0.5425531914893617,1.0,1.0,17/72,21.52%,CCL4;JAML;MYO1G;GPR183;SELL;TNFRSF1B;FGR;IL10RA;BCL6;LSP1;VNN2;NCF4;GPR65;HCLS1;GNLY;CD300A;ARHGAP9
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.625500238932945,-0.9920354079228872,0.5189873417721519,1.0,1.0,3/8,28.56%,SIDT2;CKAP5;RTRAF
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5553621746906401,-0.9919617240042431,0.5529411764705883,1.0,1.0,4/20,14.60%,TOM1L1;RNF126;VPS37C;SNF8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6544379572632872,-0.9919381657688942,0.5223880597014925,1.0,1.0,2/6,10.14%,PLN;SESTD1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5802778304961358,-0.9919118659202498,0.5189873417721519,1.0,1.0,1/16,3.47%,MT2A
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.49553949823446375,-0.9918230962195057,0.5652173913043478,1.0,1.0,6/54,11.93%,HTR2B;MT2A;SLC11A1;ANK2;CCL3;TPT1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.5722570169981909,-0.9918181406629857,0.5487804878048781,1.0,1.0,7/18,19.00%,NDUFS8;UQCRC1;ATP5F1D;UQCR10;UQCRB;NDUFS7;SIRT3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5374715591937897,-0.9914025203162535,0.5555555555555556,1.0,1.0,3/29,7.14%,GADD45B;VEGFA;DUSP1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.6293657286144032,-0.9912462481104011,0.5396825396825397,1.0,1.0,4/8,26.99%,CR1;SLC25A5;SLC17A9;SLC25A24
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.5440343315043482,0.9911681475031766,0.5384615384615384,0.9604586143816466,1.0,3/9,9.59%,ENPP1;APPL2;INPP5K
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6559687500181062,-0.9909693976391876,0.5735294117647058,1.0,1.0,4/8,28.34%,DONSON;TIMELESS;ZRANB3;TIPIN
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.4873899033317177,-0.9909116725919928,0.4631578947368421,1.0,1.0,18/82,25.55%,RPS27A;ST18;RBX1;NOD2;MAP3K8;UBA52;UBC;PSMA5;PSMA3;PSMD8;UBB;PSMB4;RIPK2;PSMD7;PSMD5;PLCB1;PSMB9;PSMC2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.4907460071341936,0.9908122494369999,0.36363636363636365,0.9600913326790587,1.0,2/10,8.51%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5360414946292018,0.9907415226409255,0.391304347826087,0.9587800932355977,1.0,2/9,10.33%,MAP3K5;ARL6IP5
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.6768290103489594,-0.9905385321689013,0.5151515151515151,1.0,1.0,3/6,17.88%,RAB3A;BSN;ERC2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.4776006183459627,-0.9903701463134297,0.5463917525773195,1.0,1.0,31/127,22.52%,RBMS3;VEGFA;OVOL2;TGFB2;HIF1A;DDRGK1;NOCT;MAPT;SLC7A5;PINK1;ID2;PARP9;CCL3;NOTCH2;ITGB8;CCDC3;OLFM1;PARP14;SDCBP;KLF4;SH3GL2;CITED2;ATP2B4;PARP15;LRPAP1;PTRH2;DICER1;TET1;LILRB2;DNMT1;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.47308104612738827,0.9902767581042915,0.47368421052631576,0.9585166431378295,1.0,1/11,2.58%,CRK
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.5914339244583334,-0.9899740685648475,0.5416666666666666,1.0,1.0,1/14,3.92%,FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.5914339244583334,-0.9899740685648475,0.5416666666666666,1.0,1.0,1/14,3.92%,FOS
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.46604279958177236,-0.9898636833861209,0.54,1.0,1.0,42/171,30.51%,RPS6;RPL14;SNRPD2;VBP1;EEF1B2;NHP2;SSB;COPS5;PGK1;PRDX4;RPL6;LDHA;RFC4;RPL34;RPLP0;RPS2;PSMD8;C1QBP;RPS3;GNL3;CAD;EIF3D;SNRPA;SRSF2;MCM6;MCM7;PSMD7;TARDBP;RACK1;SRSF3;MCM5;CTPS1;SET;PSMB2;PPM1G;NCBP2;CYC1;APEX1;CLNS1A;TFDP1;HDGF;SLC25A3
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.667492385872865,-0.9895008943102925,0.6025641025641025,1.0,1.0,1/6,8.93%,PINK1
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.6187409211349715,-0.9890154768211538,0.5245901639344263,1.0,1.0,2/5,12.75%,THBS1;THBD
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5157102062194889,-0.9886905609374379,0.5111111111111111,1.0,1.0,6/35,4.80%,MYLK;SPARC;ADAMTS2;TNS1;LAMA2;PTN
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6607365532584458,-0.988537548037046,0.6428571428571429,1.0,1.0,1/6,9.21%,PAX8
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6129136623334603,-0.9885092636307566,0.5394736842105263,1.0,1.0,1/8,7.14%,DUSP1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.6517944248037922,-0.9885091959448232,0.5571428571428572,1.0,1.0,2/6,23.35%,CCL3;JAM3
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.6353999427129523,-0.9883325634518627,0.582089552238806,1.0,1.0,1/7,3.44%,ARIH2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5334138394645406,-0.9878533885868324,0.5168539325842697,1.0,1.0,12/34,25.52%,TUBB4A;MAPT;CLIP3;CAV3;RPS3;PRUNE1;STMN1;STMN2;EML2;MAP2;DCTN1;AKAP9
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.5016200588998647,-0.9877093977697486,0.5681818181818182,1.0,1.0,14/37,25.19%,SLC5A9;ATP1B3;FGF13;SLC6A15;SCN9A;SLC9B2;SLC24A1;NALCN;SCN1A;SLC24A2;SCN3B;SGK1;SLC24A4;HCN1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.6438748342207508,-0.9873357379051263,0.5588235294117647,1.0,1.0,1/7,10.66%,SHANK3
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),-0.6849998842517648,-0.987208877747126,0.5857142857142857,1.0,1.0,1/5,10.85%,ADPRS
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.48327825597972834,-0.9870709630963074,0.5434782608695652,1.0,1.0,11/72,8.13%,PLPP3;ASPN;AGT;ADAMTS2;MT2A;ECM2;TNS1;LAMA2;SYAP1;ACSL1;TRIP10
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6345380464573105,-0.986964624293657,0.5079365079365079,1.0,1.0,3/7,13.19%,PLN;ANK2;PDE4B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.6230283966828851,-0.9867592912232607,0.5633802816901409,1.0,1.0,3/7,23.68%,SOD1;TOX;TESPA1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5812993432803395,-0.9865713983779578,0.5733333333333334,1.0,1.0,1/14,2.26%,MYO1G
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.46354320262229654,-0.9864149409950809,0.5543478260869565,1.0,1.0,18/80,19.02%,ENPP2;CHI3L1;RTN1;GLUL;OPALIN;TNS1;FAIM2;CD163;PLP1;SPARCL1;EPB41L3;NRXN1;PID1;PTPRT;RASSF4;CHL1;GFAP;SERPING1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5059077761384626,-0.9864107592349232,0.5238095238095238,1.0,1.0,8/24,30.43%,WDR83;BCAS2;PRPF6;PRPF3;DBR1;MPHOSPH10;GEMIN2;PRPF4
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.6466473026795505,-0.9861252544370885,0.49333333333333335,1.0,1.0,1/7,7.14%,DUSP1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5127881422648384,-0.9861013278399366,0.5053763440860215,1.0,1.0,5/39,8.48%,TFRC;FTH1;HAMP;SLC11A1;SOD1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.5986310503155035,0.9859801978990812,0.5135135135135135,0.9664207193157821,1.0,2/6,5.77%,NRP1;APPL2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.5986310503155035,0.9859801978990812,0.5135135135135135,0.9664207193157821,1.0,2/6,5.77%,NRP1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.47723412871895476,-0.9856105716204715,0.49473684210526314,1.0,1.0,8/56,9.29%,RGS2;PRKAR2B;PAQR3;AGT;GSTP1;SPRY1;DUSP1;PKIA
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.4861737517692254,-0.9855973844874119,0.5684210526315789,1.0,1.0,16/77,21.61%,TOP2A;ACSL1;SOD1;RDH11;GSTK1;GNPAT;ABCB4;CTBP1;ABCB1;ALDH1A1;SLC25A19;CADM1;ECI2;IDI1;ESR2;HMGCL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.5737750254925331,0.9853958015689015,0.47058823529411764,0.9664874076891303,1.0,3/5,20.62%,TGFB1;MEF2C;EFNB2
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6333600859350579,-0.9851568570903563,0.5131578947368421,1.0,1.0,2/7,18.92%,CALM1;PTS
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5562255398968445,-0.9850847619697756,0.5647058823529412,1.0,1.0,2/15,6.54%,HTR2B;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.5156519048557002,-0.9850580547514088,0.5862068965517241,1.0,1.0,4/32,9.37%,TUB;SLC11A1;FCGR2B;IL15
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.6065479185961067,-0.9850324743548625,0.5375,1.0,1.0,1/10,0.37%,NR4A3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6105699516820515,-0.9849964737299082,0.5694444444444444,1.0,1.0,2/11,11.59%,ACSL1;HSD17B12
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.533022124892891,-0.9846687522279755,0.5116279069767442,1.0,1.0,5/22,19.26%,THBS1;ANGPT2;RGCC;KLF4;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.49597217601523885,0.9846118878088469,0.5,0.9670330413125551,1.0,1/10,2.47%,DAB2IP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5851403601131313,-0.9844761790013743,0.5217391304347826,1.0,1.0,5/12,27.75%,DPYD;TYMP;DPYS;UPP2;CRMP1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6575557965545807,-0.9843310674231058,0.5512820512820513,1.0,1.0,2/5,20.76%,CCDC39;DNAH7
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.5070104108163122,-0.9843269206217812,0.5,1.0,1.0,16/39,27.40%,ZNF382;SV2C;TVP23A;AANAT;FRRS1L;PDE10A;CREM;SLC24A2;SCN3B;MCF2L2;UNC13C;OPRM1;HCN1;XKR4;SV2B;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.5883810659023394,-0.9843151509758092,0.581081081081081,1.0,1.0,3/10,8.75%,GSTP1;SOD1;MAPT
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.400195628825975,0.9840207785384028,0.5,0.9671186091127331,1.0,5/30,9.59%,SORL1;ENPP1;PIP4K2B;SIRT1;INPP5K
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6162955407491856,-0.9836678407200338,0.5416666666666666,1.0,1.0,5/8,29.17%,TYMP;UPP2;UCKL1;PUDP;DCK
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6162955407491856,-0.9836678407200338,0.5416666666666666,1.0,1.0,5/8,29.17%,TYMP;UPP2;UCKL1;PUDP;DCK
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.490237873917912,0.9835146271721963,0.44,0.9671442124746413,1.0,2/10,4.58%,NFATC3;PPARG
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.47185229772828413,-0.9833632026120389,0.5510204081632653,1.0,1.0,14/99,12.40%,GPR18;JAML;MYO1G;LINC00926;NAPSB;SELL;CD69;CR1;FGR;FCGR2B;IL10RA;ABCB4;ACAP1;MNDA
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5102605312822603,-0.9831638719754865,0.5222222222222223,1.0,1.0,6/26,17.93%,RPS27A;UBA52;ANLN;UBC;RGCC;UBB
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.4746920178048057,-0.9830735930474558,0.5151515151515151,1.0,1.0,22/104,26.86%,VIM;RPS27A;CARHSP1;UBA52;UBC;PSMA5;PSMA3;PSMD8;CNOT8;UBB;ZC3HAV1;PSMB4;ZFP36;GTPBP1;PSMD7;PSMD5;PNPT1;PSMB9;PSMC2;SET;PSMB2;EXOSC1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.6578075543308491,-0.9826923670454923,0.582089552238806,1.0,1.0,2/5,22.18%,KLF4;KLF2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.5018417818456095,-0.9826667105542707,0.5121951219512195,1.0,1.0,2/34,5.76%,TOM1L1;IL7R
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.5890152403317264,-0.9825540553454409,0.5542168674698795,1.0,1.0,7/12,34.92%,PLP1;EIF2B2;MYRF;B4GALT5;EIF2B1;EIF2B5;NSUN5
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5764397911947285,-0.9824894273923337,0.55,1.0,1.0,5/13,18.06%,JPH1;DMD;CALM3;AKAP6;CALM1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.49389560953663125,-0.9824246272120012,0.5208333333333334,1.0,1.0,5/41,8.48%,TFRC;FTH1;HAMP;SLC11A1;SOD1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.4278386255881457,0.9824201124663116,0.4666666666666667,0.9687402115230286,1.0,7/18,12.04%,PIR;CSF1R;PPARG;MYH9;THOC5;PDE1B;IKZF1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.5847809663443704,-0.9823995518701671,0.5714285714285714,1.0,1.0,3/15,15.12%,WDR5;HCFC1;ING4
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.5847809663443704,-0.9823995518701671,0.5714285714285714,1.0,1.0,3/15,15.12%,WDR5;HCFC1;ING4
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.6129110516324302,-0.982352395347334,0.484375,1.0,1.0,6/7,38.24%,TTN;OBSCN;ACTN2;FHOD3;CSRP1;WDR1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6797877386193882,-0.9817838194504206,0.5844155844155844,1.0,1.0,4/6,27.20%,INSR;MAP1A;DCTN1;APP
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4250026705088474,0.9813423272915867,0.42105263157894735,0.9700339389079762,1.0,6/17,16.38%,GSN;RHOG;PDGFA;CDC42;RHOQ;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6114851698712578,-0.9811821306242754,0.5428571428571428,1.0,1.0,1/8,1.00%,ALG10B
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.34167647810694723,0.9810622420100932,0.6,0.9693020409246336,1.0,9/49,9.42%,ACER2;NEXMIF;MAP4K4;JAG1;VCL;CIB1;CDH13;NF2;DUSP3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.667150261531171,-0.9809530171068614,0.5147058823529411,1.0,1.0,2/5,3.11%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.46626642984585576,-0.9807213116502977,0.59,1.0,1.0,52/217,22.48%,TOP2A;GADD45B;RPS27A;PNMA1;RHOB;RPS6;TGFB2;VAV3;FAM162A;IFIT2;MTCH1;SOD1;DAPK1;CLIP3;ITGB3BP;ITSN1;BNIP3;TNFAIP8;DAPK2;CCL3;UBA52;RRP1B;BNIP3L;UBC;BCL6;MNDA;KCNMA1;RASGRF2;OLFM1;TRAF7;ING4;ITGA6;ING5;PYCARD;STK17B;C1QBP;RPS3;UBB;BMF;GNA13;PLEKHG5;NGEF;CLU;SOX4;NEURL1;PTRH2;SUDS3;ADAMTSL4;FGD3;EPHA7;ARHGEF4;SEPTIN4
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6094133613508399,0.9804012590768445,0.6285714285714286,0.9693442247771548,1.0,2/6,18.54%,SENP6;SENP5
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.45894921229133934,-0.9802698691169835,0.5555555555555556,1.0,1.0,39/179,21.50%,TFRC;RPS27A;TRIM5;PLPP3;AGT;VEGFA;RAB7B;BEX1;AIM2;SLCO3A1;DDRGK1;NOD2;HSPA1B;COPS5;TRIM25;ARID5B;PRKCQ;CRTC3;UBA52;UBC;CARD16;IL18;CD36;ALK;RGCC;PYCARD;KDM1A;TRAF2;RPS3;UBB;HCLS1;TERF2IP;ADCY8;CLU;TLR2;TRIM22;ESR2;RELN;TRIM14
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4377415857699842,0.9801929341018163,0.47368421052631576,0.9686351190468778,1.0,3/16,5.37%,TNFAIP8L3;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5527700423598401,-0.9801647160979869,0.5394736842105263,1.0,1.0,1/15,0.33%,GLRA1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.6141332953327199,0.9800775672632418,0.46875,0.9675529436165125,1.0,3/5,24.70%,NUTF2;TOR1AIP2;NUP155
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6092664858172309,-0.9799373082128826,0.5714285714285714,1.0,1.0,5/11,25.65%,EMC7;CAMLG;EMC10;EMC2;EMC3
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.45974399924401416,-0.9798224432479624,0.58,1.0,1.0,45/256,22.78%,DDIT4;PRLR;NAMPT;NR4A3;FGF1;VEGFA;VAV3;SULF2;DOCK1;FLRT1;FLT1;CHN1;POLR2G;FGR;ITSN1;SIPA1L1;APPL1;RASGRP4;EPHA3;EIF2AK3;ANGPT2;SDCBP;AP2S1;ANGPTL1;EPHB1;ALK;PTPRT;NCF4;GHR;NCF2;INSR;ATP6V1D;PIK3CB;NGEF;IRS2;PTPRG;VEGFB;MUSK;STMN1;ACTG1;DNM1;EPHA7;NRG1;RBFOX2;ATP6V1E2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.6288124833014658,-0.9797100986597116,0.5714285714285714,1.0,1.0,3/8,14.28%,HERPUD1;EIF2AK3;HSPA5
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5339945366434554,-0.9794620311888157,0.5465116279069767,1.0,1.0,7/28,19.46%,SLC38A4;SLC7A5;ABCB1;SLC16A7;SLC16A1;SLC38A6;SLC13A3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5389058726290655,-0.9793444833051437,0.5402298850574713,1.0,1.0,8/29,21.38%,MX2;MX1;ITSN1;FCHO2;NLGN3;SYT1;AMPH;DNM1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.5935701916982801,-0.9790991065538182,0.5443037974683544,1.0,1.0,1/10,1.45%,PLIN2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.4953723544450342,-0.9790278130293502,0.5529411764705883,1.0,1.0,8/46,16.92%,H2BC11;GSTP1;HSPA1B;CLIP3;CCDC3;CARD16;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.5860826206450088,0.9790210029084389,0.4857142857142857,0.9693715059192319,1.0,2/6,5.77%,ENPP1;APPL2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.633571233339992,-0.9789934962938468,0.5303030303030303,1.0,1.0,5/8,25.94%,ZDHHC15;NRXN1;BSN;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.6225843980433651,-0.9789880394069103,0.59375,1.0,1.0,4/7,24.24%,PRKCQ;NFKBIZ;NFKBID;CARD9
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.5576942911821704,0.9789824632403181,0.4583333333333333,0.9680944804512917,1.0,3/7,16.95%,SORL1;ARHGAP1;INPP5F
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.6305622939760546,-0.9789189350464604,0.5466666666666666,1.0,1.0,1/6,5.05%,RXRB
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5733705164772391,-0.9784903456309983,0.5540540540540541,1.0,1.0,4/10,18.42%,THBS1;PIAS4;RGCC;PDCD4
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6131605762249881,-0.9784761878553414,0.5373134328358209,1.0,1.0,3/8,20.96%,ATP1B3;KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5446402677758562,-0.9784621346967889,0.5647058823529412,1.0,1.0,3/23,12.97%,GTF3C6;SNAPC1;POLR3H
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.6032696084259214,-0.9780483885942856,0.5138888888888888,1.0,1.0,4/8,28.01%,B3GAT2;CSGALNACT2;XYLT2;B3GAT1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5923931149252059,-0.9776893987672225,0.5942028985507246,1.0,1.0,6/9,39.24%,EPHB1;NFIB;EPHA4;SZT2;SPTBN4;EPHB6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.566099972924154,-0.9776865719635378,0.5180722891566265,1.0,1.0,3/11,10.42%,HIF1A;NOD2;APPL1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4800739654082248,-0.977658343584997,0.5729166666666666,1.0,1.0,11/83,10.88%,CCL4;JAML;MYO1G;TXK;SELL;CD69;SPON2;FGR;IL10RA;CXCR4;CCL3
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.37753208142276995,0.9776073737241501,0.5333333333333333,0.9705755523314765,1.0,3/23,12.72%,MAP1S;NCKAP5;CCDC66
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5868029007968698,-0.9773806757180976,0.55,1.0,1.0,2/11,6.80%,VIM;NOD2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4445577680500722,0.9772528120310361,0.42105263157894735,0.9700856021326322,1.0,2/17,0.81%,CTBS;HPSE
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.44866000481015805,0.9771596867497349,0.45454545454545453,0.9690677499840528,1.0,4/18,11.27%,TGFA;ANAPC4;NSMCE2;IL1A
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.4825586469740229,-0.9771051500308011,0.6063829787234043,1.0,1.0,12/62,16.53%,PRLR;TSHR;VEGFA;ACSL1;PLAC8;CXCR4;KDM6B;IL18;CD36;SCD;KDM3A;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5051255700972136,-0.9768015737019294,0.5698924731182796,1.0,1.0,6/43,9.25%,HTR2B;FGF1;VEGFA;NOD2;FLT1;DIRAS2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.5154661007598664,0.9767262794763513,0.5,0.9676269683750265,1.0,3/8,15.51%,HACD4;TECR;HACD2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.5154661007598664,0.9767262794763513,0.5,0.9676269683750265,1.0,3/8,15.51%,HACD4;TECR;HACD2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.6220199367203515,-0.9766594629666243,0.5588235294117647,1.0,1.0,2/8,15.35%,ALK;TYSND1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5795295783747689,-0.9765989144709102,0.5769230769230769,1.0,1.0,1/12,2.03%,CHI3L1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.6080395323096411,0.9763314505642753,0.5,0.9671633468292156,1.0,1/5,2.49%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.546615477011271,-0.9761930533653076,0.4794520547945205,1.0,1.0,5/14,13.12%,HIF1A;RORA;SULF2;BRCA1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.4390191532250328,0.9761837657634643,0.6,0.9661551811957303,1.0,4/17,5.29%,LGALS9;CD274;TMIGD2;SCRIB
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.5000615651884566,-0.9759118738705869,0.5760869565217391,1.0,1.0,8/48,11.78%,CDC37;POLR3F;DHX58;FGR;FCGR2B;PARP9;APPL1;IRF1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5393030804545726,-0.9758870484798242,0.4875,1.0,1.0,7/21,24.21%,TUBA1A;MYO10;KIF1B;KIF5A;TUBA1B;DYNC1I1;KIF5C
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.6018673932042229,-0.9756771931508206,0.5972222222222222,1.0,1.0,3/8,23.80%,LRRC4C;PTPRD;NTNG1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.34768419302794884,0.9756700373396578,0.6666666666666666,0.966239951219302,1.0,6/42,8.26%,RALB;IDE;EPB41;ABL1;CAPRIN2;TRIB3
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.4749070479590186,-0.9755658774037721,0.574468085106383,1.0,1.0,16/72,19.63%,PRLR;TSHR;VEGFA;ACSL1;PLAC8;CXCR4;KDM6B;IL18;CD36;SCD;KDM3A;KDM1A;INSR;PIGA;PER2;DIO2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5449615786101616,-0.9754041949120245,0.6265060240963856,1.0,1.0,6/27,20.97%,DDX11;FANCM;ZGRF1;BRCA2;DNA2;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4995341961741807,-0.9752361423616518,0.5578947368421052,1.0,1.0,7/45,15.00%,DDIT4;FOS;FCGR2B;MAPT;BNIP3;CD36;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.6205112870126601,-0.9749597981529136,0.5454545454545454,1.0,1.0,3/7,25.27%,HSPA1B;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.686279560832759,-0.9746418099988963,0.5492957746478874,1.0,1.0,4/5,28.59%,DMD;ATP2B4;TXN;SNTA1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4186375333369754,0.9746328375337102,0.6111111111111112,0.9674908882388412,1.0,3/22,3.68%,SIRPA;ZMYND11;ZNF675
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.6675605436592367,-0.9744315016229868,0.52,1.0,1.0,2/5,21.49%,MAPT;PLSCR1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.4852077769599853,-0.9742440222081723,0.5111111111111111,1.0,1.0,6/45,8.75%,FOS;HIF1A;GLRX2;GSTP1;SOD1;MAPT
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.4784124045702132,-0.9741775795875662,0.5698924731182796,1.0,1.0,18/65,24.25%,FLT1;SOD1;FGR;MAPT;TTN;NLRC5;EPHA3;CDKN1B;EPHB1;ALK;NPRL2;EEF1A1;INSR;IRS2;MUSK;EPHA7;NTRK3;ZNF16
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.5275390513280684,-0.9737686633203707,0.5662650602409639,1.0,1.0,6/24,20.39%,ERO1A;HSPA1B;HSPA2;HSPA5;DNAJC7;SDF2L1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.6084665102892126,-0.9737335167938473,0.6052631578947368,1.0,1.0,7/10,34.92%,EIF2B2;PTPRZ1;MYRF;EIF2B1;SOX6;EIF2B5;NSUN5
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.535718872642084,-0.9735539741843927,0.5697674418604651,1.0,1.0,7/30,9.71%,TG;ALOX15B;LSR;COBL;SOD1;PAX8;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.6478232315219639,-0.9734637409923749,0.581081081081081,1.0,1.0,2/6,22.13%,FCGR2B;LILRB2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.48783164632206055,-0.9732873875805612,0.5842696629213483,1.0,1.0,3/37,4.39%,TFRC;MX2;MX1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4525935390818886,0.9732383078876705,0.5263157894736842,0.969514902623041,1.0,2/18,5.80%,NEDD4;ABL1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5136166754734379,-0.9732173770264051,0.5604395604395604,1.0,1.0,9/27,18.57%,SEMA3A;FLRT1;MAP1B;IQGAP1;NLGN3;SH3GL2;SPG11;SLC9A6;IMPACT
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.47965214358164787,-0.9731148223769565,0.6020408163265306,1.0,1.0,20/127,16.90%,NLRP12;CD55;HHIP;TRIM5;RGS2;OVOL2;RGS20;GLRX2;RORA;MTCH1;MDFIC;RASGRP4;UGCG;IFT81;CD63;CD36;LIFR;FRRS1L;CAV3;GRK4
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.37679749858548894,0.9730906278077252,0.5555555555555556,0.968567211960625,1.0,3/23,2.36%,CLEC5A;CX3CR1;VEZF1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.4718677944589591,-0.9726586165907972,0.5319148936170213,1.0,1.0,9/71,12.97%,POLR3F;PQBP1;DHX58;GAPDH;TRIM25;POLR1C;NLRC5;IRF1;POLR3H
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6665579380281619,-0.9725407502049948,0.6268656716417911,1.0,1.0,4/5,28.81%,MAPT;SH3GL2;WASF1;TMEM108
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5775922438844171,-0.972490771047726,0.5679012345679012,1.0,1.0,2/19,8.75%,RPS23;MAPT
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.5221517590705729,0.9722057744985595,0.5,0.9698485053438105,1.0,4/5,11.73%,SPRED2;SPRED1;SPRY2;FGF2
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6388487107622678,-0.9721161834207318,0.5671641791044776,1.0,1.0,1/7,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.7056926207628363,-0.9719663142689888,0.53125,1.0,1.0,2/5,21.49%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.7056926207628363,-0.9719663142689888,0.53125,1.0,1.0,2/5,21.49%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.49753180271506947,-0.9719092818720834,0.5888888888888889,1.0,1.0,6/35,16.58%,AGT;RBM4B;RBM3;NR1H2;UHRF1;KLF4
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.4601127606499703,0.9718139703339652,0.5714285714285714,0.9694442897541925,1.0,3/12,9.59%,SIRT1;TP53;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),-0.645493487635336,-0.9717387432310769,0.6119402985074627,1.0,1.0,4/5,33.98%,FCGR2B;CD300A;CD22;GPS2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.4682070917147442,-0.9715609652354779,0.5612244897959183,1.0,1.0,10/94,8.82%,NLRP12;PRKAR2B;TSHR;ADCY3;RORA;TNFRSF1B;GSTP1;CD163;FGR;HTR7
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.5052867426134253,-0.971244409988463,0.5542168674698795,1.0,1.0,8/25,23.46%,GK;DGKI;DGKG;DGAT1;CAV3;MGLL;GK5;DGKB
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.529639117061649,-0.9711713327785939,0.5168539325842697,1.0,1.0,3/21,10.08%,MYLK;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.497642912430351,-0.9709797607740316,0.5632183908045977,1.0,1.0,7/34,18.42%,TALDO1;CFL1;SOD1;LMNB1;RPLP0;ANXA2;PDCD4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6430696599759886,-0.9709049002721287,0.5538461538461539,1.0,1.0,1/5,12.97%,POLR3H
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.643484630685902,-0.970257821634889,0.5789473684210527,1.0,1.0,1/5,20.03%,TRNT1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5718899620823605,-0.9702436537499913,0.4875,1.0,1.0,2/15,7.20%,VEGFA;DUOX1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3723461017810114,0.9700312243807004,0.5,0.9719178793359213,1.0,2/36,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.5846081792547032,0.969833536847873,0.4722222222222222,0.9712034526118096,1.0,1/7,11.17%,ITM2B
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.4918276451951329,-0.9695598855938137,0.5568181818181818,1.0,1.0,12/50,24.29%,FAM50A;TNFRSF1B;PQBP1;RRP1B;AHNAK;USP36;OAS3;METTL4;CLK1;CLK2;AKAP17A;MBNL2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5571835880161551,-0.9690032184570688,0.6265060240963856,1.0,1.0,2/14,6.54%,HTR2B;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.3736771865206086,0.9688846804868732,0.6428571428571429,0.972474128465332,1.0,7/31,9.17%,GSN;FER;VASP;NCK2;WHAMM;BIN1;CDC42EP3
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4959716522549078,-0.968843331102373,0.5402298850574713,1.0,1.0,9/38,26.85%,GRM8;COL11A1;SLC4A10;CDH23;SLC24A1;KIFC3;OAT;EML2;BEST1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.4990041569874592,-0.968661683643571,0.5393258426966292,1.0,1.0,12/40,22.85%,RPS27A;RBX1;DDX11;DDX1;UBA52;UBC;MCMDC2;ERCC2;UBB;DDB1;MCM6;MCM7
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.49249465360164946,-0.9684894612510007,0.5060240963855421,1.0,1.0,5/31,13.92%,INSIG1;ALOX12;ALOX15B;FAXDC2;TM7SF2
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.34599050498094747,0.968450400468434,1.0,0.9719531694258834,1.0,7/85,6.99%,NUP42;CPSF4;NUP188;WDR33;HHEX;FYTTD1;U2AF1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.374744319418222,0.9682489765006974,0.625,0.9710880079096831,1.0,2/35,2.08%,NUP42;NUP188
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5864498726079793,-0.9682211942913646,0.5588235294117647,1.0,1.0,2/10,20.48%,HLA-F;CADM1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5864498726079793,-0.9682211942913646,0.5588235294117647,1.0,1.0,2/10,20.48%,HLA-F;CADM1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.5094938530893557,-0.9681167893574176,0.6162790697674418,1.0,1.0,8/43,19.77%,WDR5;HCFC1;MSL3;ING4;ING5;TRIM16;MORF4L2;BRCA2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.4978185699491263,-0.9680191771937569,0.5578947368421052,1.0,1.0,7/58,10.29%,TFRC;FTH1;HAMP;MT2A;SLC11A1;SOD1;SLC31A2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4559216834355012,-0.9679729360222555,0.574468085106383,1.0,1.0,20/86,17.08%,CLDN18;MYOT;JAML;TGFB2;SELL;EMB;CDH9;CLDN20;LRRC4C;CDH12;CDH2;MMP24;PALLD;IL1RAPL1;PTPRD;ADGRL3;MAG;PTPRT;CDH23;CDH8
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.6089664649283842,-0.9677941596996997,0.6086956521739131,1.0,1.0,3/8,18.76%,EEF1A2;EEF1A1;GFAP
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.39220732656062085,0.9677315135286049,0.4444444444444444,0.9711072615582825,1.0,5/31,4.28%,RPS6KA6;SIRPA;SPRED2;DAB2IP;SPRED1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5973913542670057,-0.9676545392129551,0.5277777777777778,1.0,1.0,2/8,18.60%,PINK1;MCTP1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4720494200419017,-0.9675106874102275,0.6170212765957447,1.0,1.0,8/64,11.17%,KNSTRN;NUDT16;IHO1;RACGAP1;RAB11A;CALM3;KLHL13;ATF5
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.48722784094077776,0.9674467152092953,0.5357142857142857,0.9704945431631856,1.0,1/9,5.33%,SIRT1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5132960155567003,-0.9673979505935695,0.5595238095238095,1.0,1.0,8/27,19.46%,SLC16A4;SLC16A3;SLC7A5;SLC6A15;SLC16A7;SLC16A1;SLC38A6;SLC13A3
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.5004453182361284,-0.9668939699924498,0.5869565217391305,1.0,1.0,14/42,25.02%,SMC1B;CREB5;AQP11;WDR5;BRCA1;GGNBP1;SORD;OSBP2;BCL2L14;CREM;DYNLT1;POU5F1;MOV10L1;DEPDC4
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.47176977518403196,0.9667491153807501,0.39285714285714285,0.9708013967693002,1.0,2/8,5.33%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.4770791633147704,-0.9666652111358727,0.5625,1.0,1.0,8/78,8.92%,ENPP2;GLA;FA2H;PLPP3;ALDH3B1;DEGS2;PDXDC1;GALC
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.46425138036292046,0.9666422519218785,0.46153846153846156,0.9697133282377619,1.0,2/12,2.16%,MEP1A;FCGBP
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5173164838707256,-0.9664194135139286,0.5432098765432098,1.0,1.0,4/21,13.24%,BHLHE40;RBM4B;ID2;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.44625582651125767,-0.9659700982928073,0.5252525252525253,1.0,1.0,26/117,20.70%,TFRC;RPS27A;TRIM5;AGT;RAB7B;AIM2;SLCO3A1;DDRGK1;NOD2;HSPA1B;TRIM25;PRKCQ;UBA52;UBC;CARD16;IL18;CD36;ALK;PYCARD;TRAF2;RPS3;UBB;TERF2IP;CLU;TLR2;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5808162881041946,-0.9657711436191857,0.5714285714285714,1.0,1.0,2/10,6.39%,DDRGK1;H1-0
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4668418239289225,-0.9657635220083827,0.5918367346938775,1.0,1.0,13/106,15.18%,NLRP12;MX2;OSMR;CHI3L1;IFITM3;SLC11A1;MX1;STAT1;CXCR4;AKAP6;IL1RAPL1;PID1;LIFR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.49527608974405507,-0.9657090589585543,0.6236559139784946,1.0,1.0,9/46,17.95%,PRLR;TXK;FLT1;FGR;IL15;EPHA3;TEC;GHR;INSR
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.6370063114508837,-0.9656913965930838,0.5909090909090909,1.0,1.0,2/5,13.20%,ADAM15;B2M
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6370063114508837,-0.9656913965930838,0.5909090909090909,1.0,1.0,2/5,13.20%,ADAM15;B2M
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.46504380744929485,-0.9656771733442399,0.5957446808510638,1.0,1.0,7/63,10.55%,RNF144B;ARIH2;RBX1;DDRGK1;HSPA1B;HERPUD1;NOP53
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.5538789053227539,-0.9655793675322135,0.5421686746987951,1.0,1.0,7/16,32.08%,SHANK3;NLGN3;RELN;PRRT1;NLGN2;CACNG2;MAPK8IP2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5990244648907456,-0.9655445555114383,0.5866666666666667,1.0,1.0,6/9,31.48%,TYMP;UPP2;UCKL1;PUDP;DCK;HPRT1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5312252125459938,-0.9654960617050509,0.5975609756097561,1.0,1.0,7/25,24.93%,OIP5;ITGB3BP;HIRA;CENPI;CENPP;CENPU;CENPK
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5299889972058489,0.9654808369469453,0.5806451612903226,0.9713553955209702,1.0,1/7,2.39%,GALNT1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.6594307272509325,-0.9650364198665439,0.6533333333333333,1.0,1.0,1/6,11.25%,PRDM15
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.47104877466182254,-0.9648205715788362,0.5714285714285714,1.0,1.0,6/52,8.82%,PRKAR2B;TSHR;ADCY3;CD163;FGR;HTR7
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6402981316685615,-0.964517916634588,0.6290322580645161,1.0,1.0,3/5,30.90%,HLA-DMB;TAPBPL;HLA-DRA
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5183304753226899,-0.964409068627251,0.5625,1.0,1.0,4/20,13.24%,BHLHE40;RBM4B;ID2;PPP1CB
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.5711922003520563,-0.964348748077602,0.5714285714285714,1.0,1.0,4/16,31.32%,MSL3;MORF4L2;MEAF6;BRD8
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.43678100754468474,0.964189581673041,0.5454545454545454,0.9731453822332952,1.0,3/17,9.49%,ZNF675;ILRUN;TFAP4
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.3492683379696487,0.9641619830475585,0.5,0.9719063996847932,1.0,9/59,12.58%,SESN2;MAP3K5;MIOS;SESN3;EIF2S1;EIF2AK4;LAMTOR1;RRAGD;FAS
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.4922777363964713,-0.9636639822801011,0.5652173913043478,1.0,1.0,14/41,26.51%,RIMS1;RAB3A;NSF;RAB3C;STXBP5L;SCG5;CPLX1;SYT1;RAB15;MCTP1;SEPTIN4;RAB21;RIMS2;RAB3D
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.4667916645803696,-0.9634450642755369,0.6224489795918368,1.0,1.0,13/76,19.05%,PRKAR2B;HAUS6;TUBB4A;TUBA4A;RAB11A;TUBA1A;RPGRIP1L;CC2D2A;TTBK2;CEP152;SCLT1;CEP164;TCTN1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.46338650376484936,-0.9628971809232952,0.6464646464646465,1.0,1.0,39/201,17.97%,P4HA3;RHOBTB3;VIM;RPS27A;CGNL1;MYO1G;ADAMTS2;RHOB;TGFB2;COL21A1;NEFL;FIGNL1;CARMIL1;PPP1R9A;MAPT;MARCKSL1;COLGALT2;CLIP3;COL26A1;COL11A1;HDGFL3;FGF13;COL10A1;UBA52;TGFBI;UBC;B2M;KATNAL2;ERMN;COL23A1;CD36;COL4A5;ITGA6;SHROOM4;P4HA1;TUBGCP2;PLEC;UBB;COL19A1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.5508475339049057,-0.962736429525911,0.5542168674698795,1.0,1.0,7/19,16.01%,THBS1;SPARC;ATP5IF1;FLT1;STAT1;ATP5F1A;RGCC
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.4694632204271753,-0.9626655163340022,0.5760869565217391,1.0,1.0,21/70,24.10%,VIM;PLPP3;FAM13C;PTN;MAP1B;ANK2;HSPA12A;ADGRL2;SRRM3;LIFR;LRP4;FBXL7;CPE;THY1;FIGN;RBFOX2;PLPPR4;GPRC5B;CRYAB;MPDZ;TMEM59L
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4696520348395197,-0.9625206869690918,0.6530612244897959,1.0,1.0,25/117,20.64%,SRGN;NLRP12;THBS1;SLC11A1;DHX58;CR1;FCGR2B;TRIM25;NLRC5;BTN2A2;PDCD1LG2;FN1;APOD;RGCC;PYCARD;KLF4;C5AR2;SIGIRR;C1QBP;PDCD4;TNFRSF21;ZFP36;MACIR;PPP1R11;TMSB4X
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6306308639514476,-0.96244947297657,0.6,1.0,1.0,1/5,10.78%,GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6306308639514476,-0.96244947297657,0.6,1.0,1.0,1/5,10.78%,GNPAT
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5636989791673472,-0.9623914032927043,0.5930232558139535,1.0,1.0,5/20,14.28%,VEGFA;RBPJ;HIF1A;ATF3;HSPA5
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6078781148702488,-0.9623094824092195,0.5774647887323944,1.0,1.0,2/6,24.94%,PNPT1;TBRG4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5478277655139202,-0.9622444720174264,0.5641025641025641,1.0,1.0,2/21,7.78%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.43202237643314656,0.9619481296148533,0.45454545454545453,0.9758181425644358,1.0,1/15,1.11%,ARV1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.534379046964319,-0.9618295133042823,0.5357142857142857,1.0,1.0,6/20,20.39%,ERO1A;HSPA1B;HSPA2;HSPA5;DNAJC7;SDF2L1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5427443008373755,-0.9617031808774045,0.5205479452054794,1.0,1.0,5/15,13.12%,HIF1A;RORA;SULF2;BRCA1;EIF2AK3
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.4709038322051766,-0.9615940889555328,0.6122448979591837,1.0,1.0,15/78,24.94%,NUDT12;NUDT16;HSPA1B;SSB;HNRNPA0;RIDA;SRSF5;ZFP36;SRSF2;LSM5;SRSF9;U2AF2;PNPT1;PRPF3;TBRG4
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.48950923044016653,-0.9615473886511869,0.5760869565217391,1.0,1.0,9/55,20.29%,VIM;RPS27A;DDRGK1;UBA52;UBC;CFTR;UBB;ATG2A;ATG5
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4787569875942002,-0.961276908641744,0.574468085106383,1.0,1.0,18/67,23.64%,FANCB;XRCC3;FANCM;RPA2;BRCA1;POLQ;RPA3;MCMDC2;FAN1;SLX4;MCM3;POLL;BRCA2;LIG3;MCM6;MUS81;MCM7;NABP1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.6250297501382391,-0.9612216739380812,0.5692307692307692,1.0,1.0,2/5,26.29%,LMO3;PER1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5658657825025224,-0.9607462505401692,0.5875,1.0,1.0,6/11,29.17%,TYMP;CAD;UPP2;UCKL1;PUDP;DCK
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.44565603976980284,0.960442209784904,0.4666666666666667,0.9778035303653857,1.0,3/28,3.85%,NDE1;MYO1D;TRAK2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5411070071504022,-0.9604287483341362,0.6296296296296297,1.0,1.0,3/23,7.78%,DDRGK1;VPS11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.57056400593819,-0.960418096259174,0.5789473684210527,1.0,1.0,5/14,20.31%,CEMIP;CALM3;AKAP6;CALM1;THY1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.36534806057023805,0.9603907371672904,0.5,0.9766201097573545,1.0,2/20,2.49%,SIRPA;TICAM1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.49291898233883297,-0.9597999323446028,0.5888888888888889,1.0,1.0,6/56,7.78%,THBS1;EYA2;GSTP1;FAIM2;HSPA1B;BRCA1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4303323899892286,0.9597611883027339,0.5714285714285714,0.9768397608207476,1.0,2/18,6.37%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.564928565480346,0.9594954282228071,0.5384615384615384,0.9761142199292421,1.0,3/5,28.29%,SPI1;YTHDF2;AKNA
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.5759482692721059,-0.9594871771263203,0.5394736842105263,1.0,1.0,4/10,23.38%,FBN2;ID2;DYNC2I1;RYR2
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.4717871258155148,-0.9594015633840429,0.6326530612244898,1.0,1.0,20/97,16.73%,GADD45B;MYLK;BHLHE40;SPARC;SVIL;LAMA2;ACSL1;FHL1;CKMT2;PKIA;DMD;DAPK2;PPFIA4;CD36;APOD;GNAO1;LSP1;LDB3;SCD;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.6706517370421764,-0.9592853105328927,0.5942028985507246,1.0,1.0,2/5,27.92%,GRM3;GABBR2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.6706517370421764,-0.9592853105328927,0.5942028985507246,1.0,1.0,2/5,27.92%,GRM3;GABBR2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.4716122880209509,-0.9590026788421481,0.5684210526315789,1.0,1.0,16/91,15.55%,CLEC12A;F13A1;JAML;VEGFA;ALOX12;SLC11A1;C5AR1;TNFRSF1B;SPON2;FGR;CXCR4;RASGRP4;MNDA;TSPAN32;VNN2;NCF4
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.6535498881656228,-0.9589676099801759,0.6029411764705882,1.0,1.0,4/6,28.35%,GABRB1;GABRG2;GABRB3;GABRB2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6535498881656228,-0.9589676099801759,0.6029411764705882,1.0,1.0,4/6,28.35%,GABRB1;GABRG2;GABRB3;GABRB2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5665702337256824,-0.9589080011625646,0.5657894736842105,1.0,1.0,3/8,23.23%,NRG1;SGK1;ACSL3
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.5333676797732562,0.9588791831340057,0.5,0.9759943592689935,1.0,1/7,6.10%,PHF8
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.515770093287129,-0.958722563896487,0.627906976744186,1.0,1.0,3/31,7.78%,THBS1;FAIM2;BRCA1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.4430688891559552,-0.9586747462281224,0.65,1.0,1.0,88/400,23.30%,PRLR;NAMPT;NR4A3;HTR2B;TFRC;RPL23;THBS1;FTH1;RPS4X;OSMR;TBC1D8;TSHR;FGF1;ST18;AGT;VEGFA;HMGB2;RPS6;TGFB2;RNF126;PTN;ALOX15B;IL7;IL7R;DDRGK1;MEIS2;IFIT3;AQP11;HSPA1B;EGLN3;FLT1;CR1;STAT1;ID2;IL15;RPS9;CAMK2N1;ATF5;CTBP1;JUNB;IRF1;BCL6;SST;CCPG1;COPS9;FN1;SDCBP;UHRF1;CDKN1B;ING4;LIFR;ALK;ING5;RGCC;STAT2;KLF4;CNOT8;TIMELESS;INSR;GNL3;TP53INP1;HCLS1;AIF1;HMGN5;IRS2;E2F7;CLU;SOX4;NEURL1;MNT;IER5;CRLF1;ALDH1A2;TET1;CAPNS1;MVD;BEX4;GPNMB;NRG1;STAT6;RBFOX2;SPDYA;PTPRK;KITLG;EIF2AK2;SGK1;CLMN;RPS6KA2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.46126250113112655,-0.9584279995198177,0.5888888888888889,1.0,1.0,19/64,23.45%,DENND2A;RBMS3;AKAP12;DZIP1;MAP1B;LAMB1;ANK2;ITSN1;ADGRL2;LIFR;ENAH;FBXL7;PDE10A;PTPRG;THY1;FIGN;RUNX1T1;APBB2;MPDZ
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.6422868759793687,-0.9578107234635748,0.6164383561643836,1.0,1.0,1/6,19.91%,ACAD9
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.45691640279126894,-0.9577188573635906,0.64,1.0,1.0,41/190,20.49%,PRLR;HTR2B;GLIPR2;TFRC;ACVR1B;TSHR;AGT;VEGFA;TGFB2;TXK;SLC11A1;PTN;ACSL1;CFL1;PLAC8;SOD1;FGR;PAX8;IL15;GAPDH;CXCR4;KDM6B;BTN3A1;OLFM1;IL18;SDCBP;CD36;SCD;GHR;RGCC;KDM3A;KDM1A;C1QBP;ABCA1;TRIM16;KMT5C;PER2;DIO2;PPIB;CADM1;LRPAP1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.6267109470142556,-0.9572830413029543,0.5921052631578947,1.0,1.0,2/7,17.27%,RAB3A;ANXA2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5973500673258485,-0.9570695356335435,0.5942028985507246,1.0,1.0,1/7,10.01%,TTN
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.5228154172037849,0.9570557224462952,0.5185185185185185,0.9795865880547353,1.0,1/6,3.56%,GNPDA1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.550407143086655,-0.9568898239261665,0.5526315789473685,1.0,1.0,3/12,20.96%,ATP1B3;KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5569371300149208,-0.956837549518705,0.5538461538461539,1.0,1.0,2/9,3.18%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.33783320974970144,0.9568070670950878,0.5,0.9775158129844665,1.0,4/30,6.45%,RING1;DAB2IP;RYBP;RNF2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.33783320974970144,0.9568070670950878,0.5,0.9775158129844665,1.0,4/30,6.45%,RING1;DAB2IP;RYBP;RNF2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.5354444001426071,-0.956371199516757,0.569620253164557,1.0,1.0,4/23,22.30%,TAF6L;MSL3;MORF4L2;ATAT1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.34748586840368123,0.9561848561849353,0.5333333333333333,0.9778451091610667,1.0,3/41,4.80%,IDE;DAB2IP;SOCS6
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.38853002665442404,0.9560662943052561,0.6666666666666666,0.9768241684182182,1.0,10/31,13.36%,SMAD7;SORL1;SMURF1;UBE2D1;PPARG;SKIL;TRIM33;SKI;SPART;VWC2L
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4808817519607109,-0.9558031044920647,0.59375,1.0,1.0,8/55,12.63%,RPS27A;PLPP3;FZD6;RBX1;NR4A2;UBA52;UBC;TCF7
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5934524931722089,-0.9555320979617552,0.6388888888888888,1.0,1.0,1/12,3.11%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.4766024738978677,-0.9553290827060672,0.5108695652173914,1.0,1.0,8/56,12.06%,THBS1;PRELID1;GSTP1;NR4A2;HERPUD1;PINK1;TMEM14A;BCL2L2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4903766619725277,-0.9552248389675762,0.5647058823529412,1.0,1.0,7/31,16.19%,NLRP12;RORA;GSTP1;STAT1;TLE1;NR1D1;PYCARD
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.4993202150211075,-0.9547658490730495,0.5432098765432098,1.0,1.0,7/34,22.61%,DTL;UVSSA;AANAT;ERCC2;SLC24A1;ZRANB3;MAPK10
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.46718856551608884,-0.9544034643284064,0.6105263157894737,1.0,1.0,11/86,18.63%,NEK11;EYA2;TAF6L;MSL3;MAP3K12;PADI2;USP36;INCENP;UHRF1;ATXN7L3;MORF4L2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5742590432396504,-0.9543028540816128,0.547945205479452,1.0,1.0,2/10,17.95%,LNPK;INSR
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5582949125759706,-0.9542900319450387,0.6375,1.0,1.0,2/17,6.69%,SLC11A1;NOCT
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.5111904334388357,-0.9542865523703764,0.5232558139534884,1.0,1.0,5/24,13.53%,HS3ST2;HS3ST5;B4GAT1;GPC5;GPC3
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.677072180462051,-0.9542362650348872,0.6857142857142857,1.0,1.0,1/5,3.11%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.520177910299256,-0.9542104500381919,0.5176470588235295,1.0,1.0,2/23,6.46%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4846268663528688,0.9540517033923964,0.6,0.9799235045108561,1.0,3/11,6.37%,LRCH1;SH2B3;CXCL12
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.4224473678811947,0.9539397716075149,0.5625,0.9787529846092458,1.0,2/19,3.21%,TLR7;IRF5
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.5739685836026619,0.9539286249066481,0.45,0.9775482364472007,1.0,2/7,6.37%,ARHGAP35;CXCL12
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4778703683206448,-0.9537716100410006,0.6210526315789474,1.0,1.0,12/66,22.02%,NAPA;PLPP3;RACGAP1;BNIP1;CENPE;NSF;KIF15;KDELR1;KIF11;ARFGAP1;KIF3A;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.5752939686465395,-0.9535425247606873,0.6341463414634146,1.0,1.0,6/18,28.26%,RIMS1;ANK3;SYT1;RIMS2;RIMS3;GRIK2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3458306130558404,0.953474035106484,0.375,0.9776143234297053,1.0,8/58,7.71%,BACH2;IPO13;NUP188;APPL2;SNRPB;SYK;E2F3;SNUPN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.49903719425431015,0.9529186755043786,0.5185185185185185,0.976277160704297,1.0,2/11,15.08%,MEPCE;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.49903719425431015,0.9529186755043786,0.5185185185185185,0.976277160704297,1.0,2/11,15.08%,MEPCE;CCT3
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.6684477672428383,-0.9527450020457289,0.6428571428571429,1.0,1.0,2/5,12.49%,SHANK3;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.3520668783101203,0.9527073445134376,0.8,0.9756762135808902,1.0,6/46,4.93%,NEDD4;IDE;DAB2IP;SORL1;SMURF1;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.46709232961030345,-0.9525683234896164,0.6391752577319587,1.0,1.0,15/77,15.90%,ACVR1B;TP53TG5;MT2A;TGFB2;ALOX15B;TCHP;FHL1;FBP1;HSPA1B;ADAM15;NOTCH2;BCL6;CDKN1B;ING4;ING5
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.6664017594330908,-0.9525681166782186,0.6571428571428571,1.0,1.0,3/5,27.99%,PLP1;MYRF;B4GALT5
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.6241873222982737,-0.9525144006738372,0.6216216216216216,1.0,1.0,2/5,16.73%,ANK2;CAV3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.453870840166672,-0.9522466344057322,0.6363636363636364,1.0,1.0,13/119,13.73%,NR4A3;NR4A1;RBPJ;RORA;RXRB;NR4A2;POLR2G;RORB;POLR1C;NR1H2;NOTCH2;POLR3H;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.6546635078364587,-0.9517990554143987,0.6197183098591549,1.0,1.0,1/5,10.55%,NOP53
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.48565027587486065,-0.9517220662196525,0.6344086021505376,1.0,1.0,4/50,6.53%,FA2H;PLPP3;ALDH3B1;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.4457146714400343,-0.9517117177974769,0.66,1.0,1.0,41/204,20.06%,TOP2A;GADD45B;RPS27A;PNMA1;RHOB;RPS6;VAV3;FAM162A;IFIT2;MTCH1;SOD1;DAPK1;CLIP3;ITGB3BP;ITSN1;BNIP3;TNFAIP8;DAPK2;UBA52;RRP1B;BNIP3L;UBC;BCL6;MNDA;KCNMA1;RASGRF2;OLFM1;ING4;ITGA6;ING5;PYCARD;STK17B;C1QBP;UBB;BMF;GNA13;PLEKHG5;NGEF;CLU;SOX4;NEURL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.6177146372019742,-0.9512601872427193,0.6119402985074627,1.0,1.0,3/8,22.44%,NPRL2;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.6177146372019742,-0.9512601872427193,0.6119402985074627,1.0,1.0,3/8,22.44%,NPRL2;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5245394846387534,0.9510805139007436,0.5882352941176471,0.9770347100005674,1.0,2/11,5.10%,SLC37A4;SLC37A2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5245394846387534,0.9510805139007436,0.5882352941176471,0.9770347100005674,1.0,2/11,5.10%,SLC37A4;SLC37A2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6398408819493434,-0.9508971602315274,0.6527777777777778,1.0,1.0,2/5,16.01%,AGT;RGCC
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4577709712240316,-0.9508838324112792,0.6526315789473685,1.0,1.0,27/107,25.27%,CENPF;RPS27;RAB11A;ITGB3BP;CENPE;STIL;ZWILCH;SBDS;INCENP;CENPI;GPSM2;CENPP;KIF11;DSN1;SEH1L;STMN1;CENPU;KNTC1;MAP9;DCTN2;SEC13;ABRAXAS1;NUP133;DYNC1I1;CENPK;SPAST;CKAP5
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4833664678382009,-0.9507481510894472,0.6288659793814433,1.0,1.0,8/66,11.58%,NR4A3;MYO1G;VAV3;DOCK1;FGR;FCGR2B;PRKCE;MYO10
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.440233432197321,0.9506302814708684,0.43478260869565216,0.9767125590707948,1.0,4/10,21.27%,NIPAL2;NIPA1;NIPA2;SLC41A1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5861816764169548,-0.9506170390098916,0.5975609756097561,1.0,1.0,5/10,28.43%,IL1RAPL1;PTPRD;IL1RAPL2;APP;VPS35
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5861816764169548,-0.9506170390098916,0.5975609756097561,1.0,1.0,5/10,28.43%,IL1RAPL1;PTPRD;IL1RAPL2;APP;VPS35
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.4750418530205132,-0.95043737296835,0.6630434782608695,1.0,1.0,14/45,28.14%,EYA2;BRCA1;ZCWPW1;TMEM161A;RGCC;TOX;RPS3;GNL3;ABRAXAS1;STPG4;ERCC6;SMCHD1;NPAS2;WRN
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.49234535360452364,-0.9504117591724068,0.6,1.0,1.0,11/37,24.74%,IFITM3;RSAD2;MX1;IFIT1;OAS3;IFIT5;ZC3HAV1;ILF3;PLSCR1;EIF2AK2;TNIP1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.5730160414679721,-0.9503828677094575,0.5866666666666667,1.0,1.0,4/11,24.70%,INTS12;SSB;TRNT1;INTS8
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.47301586322795547,-0.9502171097008035,0.6,1.0,1.0,6/41,4.80%,PLPP3;MYLK;SPARC;TNS1;LAMA2;PTN
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.506609148199472,-0.9501241642275337,0.5555555555555556,1.0,1.0,3/26,9.21%,SLC38A4;SLC7A5;SFXN3
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5669802327641776,-0.9499233358557151,0.575,1.0,1.0,5/11,26.30%,BRCA1;LRIF1;PCGF5;RLIM;SMCHD1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.5985783258148072,-0.9496089146392721,0.6338028169014085,1.0,1.0,1/8,12.62%,PIM3
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4725214578674479,-0.9496020469954425,0.5319148936170213,1.0,1.0,8/33,17.86%,INSIG1;RORA;ABCA5;NR1H2;IL18;NR1D1;CAV3;ABCA1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4725214578674479,-0.9496020469954425,0.5319148936170213,1.0,1.0,8/33,17.86%,INSIG1;RORA;ABCA5;NR1H2;IL18;NR1D1;CAV3;ABCA1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.4658785904385996,0.9494430309639605,0.45,0.9781644283694517,1.0,3/9,11.73%,IPPK;ITPKB;FGF2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5320542210965808,-0.9494368307960607,0.5487804878048781,1.0,1.0,5/18,19.23%,OGN;APOD;CDKN1B;PDCD4;AIF1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5820949075562191,0.9492759175235708,0.5263157894736842,0.97719601858057,1.0,1/5,3.30%,SORL1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.5237379580270727,-0.9487006607563595,0.5955056179775281,1.0,1.0,5/27,11.10%,CD93;SLC11A1;C5AR1;MAPT;CRTC3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5297929594614488,-0.9482972949490861,0.6086956521739131,1.0,1.0,10/27,27.20%,SEC61B;SERP1;EMC7;CAMLG;EMD;EMC10;EMC2;EMC3;VAPA;APP
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4640390920998223,-0.9479416125308189,0.6145833333333334,1.0,1.0,28/82,26.27%,MYOT;C5AR1;CACNB2;ANK3;MAPT;LRRC4C;SHANK3;PPFIA4;CDH2;NRXN1;NLGN3;PTPRD;GPM6A;ADGRL3;CTNND2;LRP4;UNC13A;MUSK;NRXN2;CBLN2;APBB2;DVL1;NTNG1;UNC13C;DCTN1;PPFIBP1;NLGN2;SHANK2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5425932182465242,0.9477925186446168,0.5625,0.9800066984606624,1.0,2/7,3.83%,GCLC;PSPH
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.6295166001183052,-0.9476934289346332,0.6212121212121212,1.0,1.0,1/7,1.00%,ALG10B
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6539990438150771,-0.9475542007578813,0.5571428571428572,1.0,1.0,3/5,24.53%,DHX58;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.48005537338384235,-0.9474722410655879,0.6304347826086957,1.0,1.0,21/43,33.93%,GLRA1;SLC12A8;CFTR;GABRB1;GABRA3;GABRG2;ANO4;GABRB3;GABRA2;SLC20A2;SLC12A7;GABRB2;GABRA4;LRRC8A;SLC25A3;SLC6A1;GLRB;SLC5A6;GABRA1;SLC37A3;ANO5
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.46529942995287177,0.947355246246325,0.5,0.979755939572198,1.0,5/12,25.18%,TRAK2;MFN1;MARK2;TRAK1;NECTIN2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.5540604865640599,-0.9473085353128607,0.581081081081081,1.0,1.0,5/14,24.21%,RAB11A;SPG11;LIMK2;KIF5A;KIF5C
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.4858534385690083,-0.9471741715265122,0.6153846153846154,1.0,1.0,18/62,22.10%,NUDT12;ACSL1;SLCO1A2;SOD1;ABCA5;GSTK1;GNPAT;ABCA9;LIPE;ALDH1A1;ABCA1;PNPLA8;ABCA8;DIO2;ABCA6;IDI1;PIPOX;HACL1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.40347005551342385,0.9471243693653307,0.6470588235294118,0.9790832307017642,1.0,7/22,13.58%,DCUN1D4;SMAD7;BAG5;ABL1;TRIB3;FBXW7;UBE2N
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5905938852363227,-0.9470284579386923,0.5972222222222222,1.0,1.0,4/11,19.57%,SLC7A5;ABCC3;ABCB1;ABCA8
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.524412796686345,-0.946755366186923,0.6511627906976745,1.0,1.0,4/21,8.27%,TNC;OSMR;MYLK;NTN4
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6435360753842196,-0.9463304356283568,0.6790123456790124,1.0,1.0,2/6,12.56%,SAT2;SAT1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5511695845086042,-0.946141185289083,0.5522388059701493,1.0,1.0,2/11,12.75%,ALOX12;THBD
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6583652814049274,-0.9460985283989396,0.671875,1.0,1.0,3/5,21.01%,ABHD12B;MGLL;FAAH
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5151293316416758,-0.9459500233548445,0.5783132530120482,1.0,1.0,9/19,30.09%,VCAN;CHST7;B3GAT2;CSGALNACT2;XYLT2;CHSY1;CHST12;B3GAT1;NCAN
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4860897057632352,0.9457660946356168,0.4166666666666667,0.9806876960221224,1.0,4/8,5.78%,SMAD7;TGFBR2;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.5481222287520213,0.9454821353143693,0.5161290322580645,0.980345398603289,1.0,1/6,5.33%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.5136226380200855,-0.9453318985103687,0.5747126436781609,1.0,1.0,9/24,29.41%,HSPA1B;MAPT;CAV3;RPS3;DCTN1;CKAP5;AKAP9;PSRC1;FES
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4426117752606016,0.9452693416421108,0.5263157894736842,0.9796196402469308,1.0,4/16,9.49%,CEBPA;HHEX;LATS2;TFAP4
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5248557041096872,-0.9447334286921156,0.6067415730337079,1.0,1.0,3/23,10.34%,THBS1;GPR183;CXCR4
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6003558231872401,-0.9444691796469794,0.6363636363636364,1.0,1.0,1/7,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.46369697891092093,-0.9443504399748123,0.673469387755102,1.0,1.0,14/75,13.20%,CCL4;TRIM5;MT2A;HLA-B;GBP2;STAT1;DAPK1;RPL13A;GAPDH;TRIM25;HLA-F;CCL3;IRF1;B2M
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.5697349533039344,-0.9440492015468576,0.6282051282051282,1.0,1.0,1/11,5.71%,IL7
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.47329470225661263,-0.944015632939653,0.6091954022988506,1.0,1.0,13/52,24.04%,HTR2B;ATP1B3;ANK2;CCL3;TPT1;KCNMA1;SLC24A1;ATP2B4;ATP2B2;ATP1B2;SLC24A2;RYR2;SLC24A4
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5293687587616918,-0.9435583896999145,0.5357142857142857,1.0,1.0,3/18,5.28%,TGFB2;RBPJ;PKP2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5243480031962588,-0.9435018469840818,0.5542168674698795,1.0,1.0,5/20,24.21%,ACSL1;HSD17B12;SCD;ACSL3;SCD5
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.4511137130909459,0.9434532039386618,0.5882352941176471,0.9831546965381355,1.0,4/13,11.73%,IPPK;ISYNA1;ITPKB;FGF2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.50680658149973,-0.9433940308535561,0.5862068965517241,1.0,1.0,3/21,8.72%,NR4A1;VEGFA;STAT1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.4886198285848806,-0.9433928315441847,0.611764705882353,1.0,1.0,7/32,23.19%,IFITM3;POLR2G;MDFIC;ZFP36;HEXIM1;TRIM14;NELFB
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.25837241689200635,0.9431775026790938,1.0,0.9826279816755746,1.0,30/203,10.32%,ATRAID;B4GALT7;CGRRF1;P3H2;DAB2IP;CEBPA;PKD2;HPN;CTBP2;SH2B3;HMGA1;BAP1;PPARG;PDPN;TGFB1;APPL2;TMEM127;NCK2;TP53;E2F3;NMI;ADRA1A;CIB1;CDH13;NF2;TFAP4;ZBTB49;TRIB1;SKI;MAP2K1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5156020603006595,-0.9429395778930311,0.6219512195121951,1.0,1.0,10/28,28.96%,GRIK1;GRM8;GRIA4;GRM3;GRIN2A;PLCB1;GRIA2;APP;GRIK2;GRIK4
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.5712290199457678,-0.9428264252289945,0.5714285714285714,1.0,1.0,1/10,7.78%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.44627114334102214,-0.9427419425958462,0.6105263157894737,1.0,1.0,5/48,6.59%,THBS1;LRP2;AGT;SULF2;SPRY1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.44269097338854274,0.9423974795976673,0.45454545454545453,0.983251204114968,1.0,5/18,11.81%,TGFA;ARAP1;CBL;BCAR3;FBXW7
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6216734968245019,-0.9423604586762011,0.6212121212121212,1.0,1.0,1/5,17.76%,NECAB1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.5172684929933278,0.9415810199065905,0.4864864864864865,0.9837089445211818,1.0,2/8,5.67%,WDR18;NBN
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.6616907918502136,-0.9413557803398754,0.7058823529411765,1.0,1.0,1/5,9.14%,ID2
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.5091618330865154,-0.9412368372529935,0.5977011494252874,1.0,1.0,10/27,26.62%,OMG;PTN;B2M;MAG;LRP4;THY1;DYNLT1;GDI1;ARHGDIA;GORASP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.5661338609801053,-0.9410926953962412,0.6375,1.0,1.0,2/13,10.88%,THBS1;CCL3
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6446421504856019,-0.9410912618075015,0.7083333333333334,1.0,1.0,1/5,5.45%,PPP1R3B
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.599425368832746,-0.9406743368585266,0.625,1.0,1.0,4/9,15.73%,PDK3;CD36;PID1;SCD
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.6196879063114892,-0.9406722451978372,0.6666666666666666,1.0,1.0,3/6,31.49%,NEIL1;TDG;OGG1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.4683075252583036,-0.9405329544039728,0.6458333333333334,1.0,1.0,20/80,20.90%,ANKRD22;FOSL2;CEBPD;BHLHE40;FBP1;MARCKSL1;TYMP;ABCC3;JUNB;SAT1;MGAT1;OAS3;KLF4;CTSB;ST14;ZFP36;RAB20;NFIB;DTX3L;HLA-C
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5697465880191719,-0.9405018590445394,0.5675675675675675,1.0,1.0,3/11,17.89%,FANCB;WDR48;TIMELESS
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.6110950522969518,-0.9404461697771095,0.676923076923077,1.0,1.0,1/7,11.78%,IRF1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.48081733971139773,-0.9403925200531481,0.6129032258064516,1.0,1.0,10/49,15.08%,PLPP3;TXK;PTN;DOCK1;ADAM15;FGR;ITGB8;TEC;FN1;ITGA2
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5856006207216529,-0.9403798191210254,0.5714285714285714,1.0,1.0,1/8,8.77%,TENT4B
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.6273058484307966,-0.939897024635815,0.6153846153846154,1.0,1.0,3/6,29.37%,PRPS1;GUK1;MACROD1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.5370861555378628,-0.9398934155066624,0.5949367088607594,1.0,1.0,6/12,26.19%,ANTKMT;PINK1;PID1;TMSB4X;ENO1;PPARA
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6059865837398152,-0.9398831793072602,0.5714285714285714,1.0,1.0,3/8,12.94%,VEGFA;RORB;AGTPBP1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.55244079763882,-0.9398143881262673,0.5853658536585366,1.0,1.0,6/17,23.35%,LAMA2;LSR;DMD;ACTG1;MFSD2A;JAM3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4860457041702549,0.9397904193215961,0.5789473684210527,0.9867112907299166,1.0,2/12,5.33%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4175327412246974,0.9396644667035078,0.5,0.9857105259822414,1.0,4/17,10.16%,ZNRF3;PTCH1;SALL1;CHD7
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.49958880314231086,-0.939618024874594,0.6022727272727273,1.0,1.0,5/26,12.12%,VEGFA;RTN1;UNC5C;TLE1;ETS2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.4798442672531275,-0.9394702266551704,0.5632183908045977,1.0,1.0,8/27,27.08%,CFL1;ZDHHC15;SIPA1L1;SHANK3;NGEF;RELN;EPHA4;CAMK2B
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6602575008229932,-0.939133794869132,0.6133333333333333,1.0,1.0,1/6,7.98%,ANTKMT
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.48780823219356606,-0.9389794716726324,0.6219512195121951,1.0,1.0,9/34,27.96%,EYA2;BRCA1;TMEM161A;RPS3;ABRAXAS1;ERCC6;SMCHD1;PARG;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.45203769472668354,0.9389687860339214,0.625,0.9861270528687947,1.0,4/15,16.80%,ARHGAP35;TAPT1;CROCC;KCTD17
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.32686833899026607,0.93895369241602,0.5,0.9848579060826056,1.0,6/90,2.22%,NUP42;SESN2;NRP1;FER;NUP188;DSCAM
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4957115493612445,-0.9387867600499885,0.6067415730337079,1.0,1.0,8/33,19.15%,FANCB;FIGNL1;RPA2;POLQ;WDR48;KDM1A;TIMELESS;TERF2IP
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.5569243875493297,-0.9387574779361646,0.6144578313253012,1.0,1.0,2/14,11.26%,VEGFA;STIL
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4590239782120455,-0.9385405657147542,0.574468085106383,1.0,1.0,14/59,26.58%,RPS27A;UBA52;UBC;PSMA5;PSMA3;PSMD8;UBB;PSMB4;PSMD7;PSMD5;PSMB9;PSMC2;ANAPC7;PSMB2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6673789476182392,-0.9384808221650153,0.6129032258064516,1.0,1.0,1/5,16.80%,SLC38A6
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.41545777664478484,0.938265468235377,0.5263157894736842,0.9851659138452689,1.0,4/14,11.81%,TGFA;NCK2;CBL;FBXW7
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6037553303247961,-0.9378691130705012,0.5540540540540541,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4519315855358713,-0.9378592906549351,0.6530612244897959,1.0,1.0,18/124,15.27%,THBS1;CEMIP;MYLK;SEMA6A;FGF1;VEGFA;SEMA3A;DDRGK1;DUOX1;CARMIL1;FLT1;FGR;LAMB1;CCL3;PLET1;SDCBP;HSPA5;ITGA6
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5198221783483528,-0.9378477700406579,0.6125,1.0,1.0,4/25,11.69%,CHI3L1;SULF2;DDRGK1;ITGB8
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4989176343954,-0.9374743922114593,0.5581395348837209,1.0,1.0,1/28,0.29%,SOCS3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.5348328225333084,-0.9373072847122732,0.589041095890411,1.0,1.0,2/17,5.97%,PPP1R15A;MASTL
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.6743955067621856,-0.9372428754701962,0.6521739130434783,1.0,1.0,1/5,4.00%,TGFB2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.6127787077607064,-0.9369694053401725,0.578125,1.0,1.0,3/6,28.75%,SOD1;SGCZ;SGCD
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.5863521549444635,-0.9369131037712101,0.6764705882352942,1.0,1.0,2/7,25.92%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5796477881130708,-0.936860491472842,0.5967741935483871,1.0,1.0,2/9,20.96%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.5796477881130708,-0.936860491472842,0.5967741935483871,1.0,1.0,2/9,20.96%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.43603007024267587,0.936777617898972,0.5882352941176471,0.987189542304457,1.0,4/15,9.02%,DUSP7;PPM1F;DUSP18;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5598297641945453,0.936472685185662,0.6785714285714286,0.9867539536706448,1.0,3/6,23.68%,SMC6;SIRT2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5979565229674221,-0.9363890933358668,0.6285714285714286,1.0,1.0,2/7,27.41%,TRIM16;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5979565229674221,-0.9363890933358668,0.6285714285714286,1.0,1.0,2/7,27.41%,TRIM16;MACROH2A2
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.5865866054947064,-0.9363094224832518,0.581081081081081,1.0,1.0,1/8,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.5839876374331857,-0.9362621448016577,0.547945205479452,1.0,1.0,5/10,31.78%,CLSPN;TIMELESS;DNA2;TIPIN;RAD9A
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.49342941906464444,-0.9358152781390043,0.6363636363636364,1.0,1.0,2/30,3.87%,SPOCK1;ECM2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.5267810614016332,-0.9357585625657732,0.6375,1.0,1.0,6/22,26.54%,CNEP1R1;NR1H2;MID1IP1;MFSD2A;PPARA;SORBS1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.5136210062165805,-0.9357141005759679,0.5679012345679012,1.0,1.0,5/21,19.26%,DDRGK1;ID2;APPL1;CDKN1B;ATP2B4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5036682344346305,-0.9356700990464424,0.6555555555555556,1.0,1.0,11/28,24.85%,HLA-B;HLA-F;B2M;TAP1;SEC24C;MFSD6;ERAP1;HLA-C;SEC13;TAPBPL;HFE
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5669609261736348,-0.9354850135931335,0.5352112676056338,1.0,1.0,2/9,4.00%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.5982237115427287,-0.9352488201650555,0.6212121212121212,1.0,1.0,2/7,23.57%,APPL1;CTNS
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.629906043068698,-0.9351685491499877,0.6101694915254238,1.0,1.0,3/6,22.59%,UBXN2B;KIF11;MAP9
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.5845501446072596,-0.934892166071288,0.6447368421052632,1.0,1.0,3/8,16.58%,RBMS3;DAPK1;KLF4
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6224684856792807,-0.9345718308314217,0.676923076923077,1.0,1.0,4/6,36.83%,RPS15;NUP88;NPM1;XPO1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5659393106069566,-0.9345198566317711,0.6233766233766234,1.0,1.0,1/12,0.37%,NR4A3
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.502416157821959,-0.9345043786655906,0.6627906976744186,1.0,1.0,5/29,22.44%,PINK1;BNIP3;ATG2A;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.5741842704648916,-0.9343912431451659,0.6103896103896104,1.0,1.0,2/14,8.53%,BHLHE40;BASP1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.45698943959537003,-0.9343878519543718,0.6804123711340206,1.0,1.0,14/93,17.05%,DDIT4;CENPF;MEIS2;UTP3;CXCR4;SHANK3;CDH2;ADGRL2;APOD;VPS51;ADGRL3;SHROOM4;POU6F1;TUBGCP2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.44368164623735645,-0.9343850688088062,0.6210526315789474,1.0,1.0,16/63,20.31%,HHIP;MYLK;OGN;VASN;TNS1;LAMA2;SPON2;PLN;OTUD1;DAAM2;SVEP1;FBXL7;HEXIM1;ABCA8;KCNMB1;THY1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.5834658448766958,-0.9334894187923363,0.5753424657534246,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.5646105947083837,-0.9333187281524647,0.5774647887323944,1.0,1.0,3/10,20.28%,BNIP3;INSR;FYCO1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6259867745773361,-0.933232389976663,0.6619718309859155,1.0,1.0,2/6,28.14%,SLX4;WRN
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.48441163077708405,0.9330895387694623,0.6,0.993239629602879,1.0,1/11,2.27%,TAL1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.4436941562501552,-0.9329282046661078,0.7070707070707071,1.0,1.0,19/142,15.00%,TFRC;ACVR1B;TP53TG5;PAPPA2;SPOCK1;AGT;TGFB2;TCHP;FHL1;FBP1;HSPA1B;ADAM15;OGFR;PRKCQ;BCL6;PAK5;SDCBP;AKAP6;CDKN1B
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.5086034244013786,0.9326901519562474,0.5,0.9929594019111871,1.0,2/9,9.25%,SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.6060241844482591,0.9323113981662488,0.6551724137931034,0.9928416667126662,1.0,1/6,5.33%,SIRT1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.505561726356968,0.9322551785954589,0.5185185185185185,0.9918266187158341,1.0,2/7,14.26%,MAN2B2;MAN2B1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.45513395496009623,-0.9320989198186398,0.6559139784946236,1.0,1.0,23/85,25.27%,CENPF;RPS27;ITGB3BP;CENPE;STIL;ZWILCH;SBDS;INCENP;CENPI;GPSM2;CENPP;KIF11;DSN1;SEH1L;STMN1;CENPU;KNTC1;DCTN2;SEC13;NUP133;DYNC1I1;CENPK;CKAP5
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5692907122131782,0.9319944637658742,0.6153846153846154,0.9909755213722032,1.0,2/6,16.11%,SERPINE1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.5301319275668875,-0.931567279411557,0.6235294117647059,1.0,1.0,5/13,26.19%,BRCA1;PINK1;SIRT5;TRAP1;PPARA
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4957539649034904,-0.9314809161990586,0.6590909090909091,1.0,1.0,5/32,22.44%,PINK1;BNIP3;ATG2A;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.45825152355577253,0.9313568534230289,0.5,0.9912726109702468,1.0,2/11,13.42%,ARCN1;CDC42
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.45500822763046006,0.9313430967563469,0.6,0.9900488200391169,1.0,3/16,9.82%,TLR7;IRF5;CHUK
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5225329935669076,-0.9312949013232877,0.56,1.0,1.0,3/16,22.46%,FOS;METTL4;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.5110638087918256,-0.9311614475499957,0.5853658536585366,1.0,1.0,6/22,22.75%,RSAD2;TNFRSF1B;STXBP6;IL1RAPL1;SYT4;PNKD
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4480894544773858,-0.9309411347745762,0.64,1.0,1.0,16/101,17.95%,TFRC;MX2;LRP2;SPARC;MX1;CD163;FCGR2B;MARCO;FCHO2;NLGN3;CD36;IGF2R;AP2S1;COLEC12;GRK4;INSR
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.4357329384701858,0.93062521875185,0.48,0.9904356372926989,1.0,1/9,2.57%,PKD2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4811948392505555,-0.9306247767406494,0.632183908045977,1.0,1.0,16/56,21.17%,PKP2;CDH9;SHANK3;CDH12;CDH2;NRXN1;NLGN3;FN1;GPM6A;ADGRL3;ITGA6;CTNND2;VMP1;CDH8;NRXN2;ACTG1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.5882125665783923,-0.9303995970187598,0.5540540540540541,1.0,1.0,1/8,9.39%,PLN
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5551756250703198,0.9301943669681656,0.5454545454545454,0.9904647040821288,1.0,1/7,4.03%,LPL
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.46319137506331726,-0.9299369504433374,0.6382978723404256,1.0,1.0,20/67,19.69%,ADGRE1;RGS1;TSHR;ADGRG6;ADCY3;AKAP12;GRM8;MARCO;ADGRL2;ADGRD1;GNAO1;ADGRL3;HTR1F;FPR1;ABCA1;GNA13;RXFP1;GPR65;ADCY8;GNA11
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.508830151517988,0.9294979127956483,0.5161290322580645,0.9910638066147935,1.0,3/5,9.45%,SPRED2;SPRED1;SPRY2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.49104612591330865,-0.9288255359066903,0.6363636363636364,1.0,1.0,6/35,16.30%,INF2;MAPT;PINK1;USP36;PID1;STAT2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.6102728944420059,-0.9287517702193809,0.6338028169014085,1.0,1.0,1/5,4.89%,RORA
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5007649180474556,-0.9283782619898379,0.6410256410256411,1.0,1.0,8/23,28.19%,IL7;CR1;BCL6;SOX4;LILRB2;TESPA1;IL4I1;DUSP10
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4702545276567741,0.9278802105621866,0.5909090909090909,0.9937254279702742,1.0,2/13,6.73%,ILRUN;ELMOD2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.5625313373299164,-0.9278688468669747,0.5833333333333334,1.0,1.0,3/9,20.29%,AGTPBP1;FOLH1;ATG5
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.5820585903372704,-0.9278088225557242,0.5897435897435898,1.0,1.0,1/8,5.10%,THEMIS2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5563026897194385,-0.9277406635615326,0.6172839506172839,1.0,1.0,1/13,4.06%,RBPJ
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6047924657579045,-0.9267188463504521,0.6438356164383562,1.0,1.0,2/5,17.25%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.6047924657579045,-0.9267188463504521,0.6438356164383562,1.0,1.0,2/5,17.25%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5306290671334514,-0.9266391239594445,0.6282051282051282,1.0,1.0,6/14,29.42%,MTHFD1;FOLH1;ASPA;NIT2;GOT1;ADI1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.49271639207775253,-0.9264207955159803,0.6025641025641025,1.0,1.0,4/25,12.14%,RPS27A;NOD2;UBA52;UBC
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.565809271569756,0.9264069034642033,0.5151515151515151,0.9955628654234293,1.0,3/6,20.55%,TWSG1;CASK;SLIT2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.5588807221503878,-0.9260916961901001,0.6097560975609756,1.0,1.0,1/11,1.41%,MX2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.3822642273572856,0.9259207274487092,0.5,0.9956208170210337,1.0,10/21,22.90%,TP53;ANP32B;YWHAE;TCF7L2;BAG3;IL1B;SP100;TPR;GSK3B;RANGAP1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.5740019429644095,-0.9257510561953626,0.647887323943662,1.0,1.0,1/10,2.84%,AGT
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4703203090319287,-0.9255730903404102,0.632183908045977,1.0,1.0,11/45,24.04%,HTR2B;ANK2;CCL3;TPT1;FAM20A;SLC24A1;ATP2B4;ATP2B2;SLC24A2;RYR2;SLC24A4
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.6288823615004786,-0.9254974531616712,0.6527777777777778,1.0,1.0,2/5,16.82%,CD36;STARD5
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.6288823615004786,-0.9254974531616712,0.6527777777777778,1.0,1.0,2/5,16.82%,CD36;STARD5
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4848109324777399,-0.9253543874800356,0.6091954022988506,1.0,1.0,6/38,19.48%,GPR18;NOTCH2;RASGRP4;GPR65;PIK3CB;IRS2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.30864195191277194,0.9252653662225561,0.5,0.9958558842831964,1.0,6/59,7.29%,LMO1;TAL1;CBFB;ABL1;RUNX1;PSME4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.4907109946361913,0.9251570006914199,0.65,0.994797977906664,1.0,3/13,6.91%,LGALS9;CD274;SYK
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.5275212801238762,-0.9251195908187599,0.6705882352941176,1.0,1.0,3/23,13.43%,PINK1;USP36;FEZ1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5213989779962972,-0.9250405876436495,0.5862068965517241,1.0,1.0,3/20,19.15%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6570889577414956,-0.9246773047673867,0.6610169491525424,1.0,1.0,2/5,28.81%,PKM;YBX3
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.47968030842602005,-0.9246362842951076,0.55,1.0,1.0,2/22,9.33%,POLR2G;MDFIC
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4597765516401686,0.9245389698887468,0.6086956521739131,0.9949097168848972,1.0,2/14,5.41%,LGALS9;ARRB2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5033953757188553,-0.9243637642311777,0.6375,1.0,1.0,6/17,26.58%,PSMA5;PSMA3;ENC1;PSMB4;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.5786871769810785,-0.9243583192254787,0.5671641791044776,1.0,1.0,1/6,0.96%,THBS1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5464564360240844,-0.9243283999316487,0.5952380952380952,1.0,1.0,4/14,14.19%,DUSP1;LAMB1;COL11A1;FN1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.42996436157846646,-0.9240838031622558,0.73,1.0,1.0,67/336,22.97%,PRLR;NAMPT;HTR2B;RPL23;THBS1;RPS4X;OSMR;TBC1D8;TSHR;FGF1;VEGFA;TUB;RPS6;TGFB2;SLC11A1;PTN;TNFRSF1B;IL7;IL7R;DDRGK1;MEIS2;AQP11;FLT1;CR1;FCGR2B;MAPT;IL15;RPS9;HCFC1;PPP1R13L;EPB41L4B;CCPG1;COPS9;FN1;SDCBP;CD36;AKAP6;CDKN1B;LIFR;COLEC12;PYCARD;C1QBP;FRMD5;CNOT8;INSR;CITED2;HCLS1;ECHDC3;ZFP36;AIF1;HMGN5;IRS2;SOX4;TLR2;IER5;CRLF1;CIDEB;BMPR1B;DICER1;TET1;CAPNS1;MFSD2A;MVD;NRG1;SPDYA;KITLG;RIPK2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.3901068272898032,0.924081937574968,0.5333333333333333,0.994526711129944,1.0,3/32,7.68%,PDE12;KHSRP;METTL16
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.526077190219594,-0.9240619913417257,0.6091954022988506,1.0,1.0,3/19,19.15%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.42728984506682216,0.9237395929798086,0.5454545454545454,0.9940564787347436,1.0,2/20,2.02%,GCLC;ALDH5A1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5602598505678764,-0.9236961243455921,0.6756756756756757,1.0,1.0,5/11,23.00%,SOD1;B2M;ATP1B2;ACTG1;TF
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4386707313760103,-0.9236590897319489,0.68,1.0,1.0,47/215,20.30%,TFRC;RPL23;FGF1;RBMS3;VEGFA;RIMS1;OVOL2;RBPJ;RPL11;SLC11A1;HIF1A;DDRGK1;ANK3;HSPA1B;BRCA1;ID2;CAMK2N1;ANK2;TTN;CCL3;HCFC1;TLE1;ITGB8;RPL5;EIF2AK3;OLFM1;EPB41L4B;CD63;FN1;CD36;RPS7;SNF8;NSF;PID1;RGCC;RDX;KLF4;ANXA2;RPS3;INSR;CITED2;HMGN5;PIK3CB;CLU;TLR2;DTX3L;MUSK
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5322615744243013,0.9235349047621991,0.5675675675675675,0.9934112710253201,1.0,2/5,10.46%,NR1H3;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.4434411318669273,-0.9234281014640021,0.6701030927835051,1.0,1.0,20/98,21.50%,TRIM5;HIF1A;TNFRSF1B;PFKFB4;VPS11;DAPK1;BNIP3;NPRL2;PFKFB3;RDX;CNOT8;INSR;ZC3HAV1;SH3D19;TP53INP1;PIK3CB;IRS2;DTX3L;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5545425546526961,-0.9231715044340978,0.6585365853658537,1.0,1.0,2/15,5.70%,RIMS1;TNFRSF1B
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.4574855305523915,-0.9229265631894918,0.6947368421052632,1.0,1.0,13/91,17.67%,THBS1;PPP1R15A;DNAJB9;DDRGK1;ERO1A;HERPUD1;ATF3;RASGRF2;EIF2AK3;CFTR;HSPA5;TRAF2;TMEM33
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5414420736886012,0.9228861442977889,0.5454545454545454,0.993840862609186,1.0,2/7,25.04%,CLEC16A;CARD11
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6263632534097565,-0.9228450721840139,0.6764705882352942,1.0,1.0,1/6,16.49%,STK17B
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4977760150406999,-0.9227011492709578,0.6623376623376623,1.0,1.0,1/17,8.29%,HERPUD1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.6016017245093752,-0.9225108971374348,0.6515151515151515,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.4500864338232879,-0.9224339614222018,0.625,1.0,1.0,20/77,24.57%,RACGAP1;FCGR2B;CENPE;HLA-F;AP2S1;SEC24C;MFSD6;KIF15;SH3GL2;HLA-DMB;KIF11;KIF3A;DCTN4;ACTR1B;KIF5A;DCTN2;SEC13;DYNC1I1;AP2A2;DCTN1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.43819681893973184,-0.9218920411831067,0.69,1.0,1.0,18/145,13.34%,DDIT4;ACVR1B;PPP1R15A;HINT1;FOS;PVT1;FAM162A;ALOX15B;NDRG1;H1-2;RPL36;RPS12;FGF13;PROCR;ATF3;SAT1;TXNIP;MXD1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5910578328183385,-0.9218857420226262,0.6567164179104478,1.0,1.0,2/9,19.11%,LIMD1;ZFP36
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4913024227869603,-0.9214725132721897,0.6785714285714286,1.0,1.0,3/23,8.72%,SOCS3;ST18;STAT1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.4865103971551232,-0.9210492363635399,0.6162790697674418,1.0,1.0,8/22,29.32%,RIMS1;CPLX1;MCTP1;RAB5A;PNKD;RIMS2;RIMS3;MCTP2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.5614551375219894,-0.9210217390595941,0.625,1.0,1.0,1/12,19.11%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.5614551375219894,-0.9210217390595941,0.625,1.0,1.0,1/12,19.11%,ZFP36
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.4463232492986092,0.9209305523084572,0.6521739130434783,0.9965887870221564,1.0,4/16,5.78%,PKD2;CSF1R;SCRIB;ACVR1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3789100798983135,0.9208563692893748,0.5882352941176471,0.99550410171012,1.0,2/23,2.57%,SLC7A8;PKD2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.4384632349463049,-0.9203248486953872,0.67,1.0,1.0,27/116,20.61%,SRGN;NLRP12;RGS2;OVOL2;VASN;RBPJ;SLC11A1;HS3ST5;SPRY1;FCGR2B;IL15;BTN2A2;NR1H2;PROCR;PCTP;ARRDC3;ACOT13;NR1D1;RGCC;ALDH1A1;LRP4;ATP2B4;BRCA2;NFIB;PTPRG;LRPAP1;PPP1R11
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.49249809191273164,0.9202403214033783,0.5862068965517241,0.9959470095687671,1.0,5/8,29.07%,FAS;ATP6V1G1;ATP6AP1;ATG7;ATP6V0D1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.5496603157658176,0.9201098981863155,0.5294117647058824,0.9951809231144618,1.0,1/6,3.05%,EYS
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5752872876716626,-0.9198168735339185,0.6666666666666666,1.0,1.0,3/8,23.84%,IL18;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.5016159461096716,-0.9198165594955852,0.625,1.0,1.0,3/26,4.80%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.432998460649709,0.919653711260975,0.5384615384615384,0.9951685495279617,1.0,5/12,25.21%,MMS19;YAE1;NFU1;LTO1;GLRX3
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5140947237972353,0.919478052600044,0.5789473684210527,0.9944053298639162,1.0,4/7,30.03%,CDC42;STK25;ARHGAP21;COPG1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.43359139696552756,-0.9194226335391943,0.6632653061224489,1.0,1.0,16/106,15.73%,CD55;JAML;MYO1G;NAPSB;SELL;IFIT3;CD69;FGR;IL10RA;CXCR4;ACAP1;PXK;LSP1;VNN2;NCF4;SCD
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.642082180307997,-0.9190819247172757,0.6521739130434783,1.0,1.0,1/5,1.00%,ALG10B
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.44555165386010137,-0.9186762754057916,0.6428571428571429,1.0,1.0,22/84,23.23%,INSIG1;DNAJB9;AKAP12;NDRG1;H1-0;ARID5B;SELENOP;TNFAIP8;SAT1;TPD52;B2M;LIFR;SCD;MAK;SORD;FKBP5;INPP4B;IDI1;BMPR1B;TMEM50A;SGK1;ACSL3
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4435372970627888,-0.9181085044574798,0.6804123711340206,1.0,1.0,12/99,14.79%,KCNE1;NR4A3;INSIG1;ADCY3;RORA;BRCA1;AANAT;CCL3;ABCB4;IL18;CFTR;AKAP6
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.49219624968608117,-0.918018099216554,0.6941176470588235,1.0,1.0,3/33,4.72%,TRIM5;ARIH2;RNF126
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.5193629596204622,0.9179640368226903,0.5666666666666667,0.9967658712911032,1.0,1/7,0.47%,PFKP
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.47773624233353484,-0.9177226154826077,0.6477272727272727,1.0,1.0,6/31,15.20%,LRP2;NRXN1;NLGN3;IL1RAPL1;PTPRD;EPHB1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.4381763762464278,-0.9177198499397187,0.6326530612244898,1.0,1.0,15/71,23.10%,KCNJ13;LRP2;SLC5A9;FGF13;SCN9A;SLC9B2;KCNMA1;PIEZO2;TRPM3;KCNC1;SCN1A;KCNMB1;SCN3B;KCNJ3;SGK1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.48191278403697757,-0.9173952059093671,0.6511627906976745,1.0,1.0,5/29,23.37%,RACGAP1;RAB11A;KIF11;MAP9;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.5079681618812807,-0.9171209241052919,0.6375,1.0,1.0,8/21,22.64%,PTN;TNFRSF1B;TYMP;EIF2AK3;PTPRZ1;TNFRSF21;DICER1;NKX6-2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5977255521886896,-0.9170589147820083,0.6891891891891891,1.0,1.0,2/7,17.93%,RPS7;UBB
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.4377329991038275,-0.9167949110038413,0.6804123711340206,1.0,1.0,26/81,29.32%,GRIK1;BEGAIN;RIMS1;GRM8;LRRC4C;CDH2;DGKI;NLGN3;PXK;CPLX1;SYT1;UNC13A;MCTP1;GRM3;RELN;IQSEC2;RIMS2;AKAP9;NLGN2;RIMS3;APP;CACNA1B;GRIK2;TMEM108;GRIK4;MCTP2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5739338459109352,-0.9166649023816277,0.6301369863013698,1.0,1.0,5/9,23.38%,CALM3;SYT1;CALM1;KCNMB1;RYR2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3688630804361767,0.9166190180590585,0.5333333333333333,0.9982321993999576,1.0,5/32,8.53%,ZNF703;SMAD7;CDHR3;VCL;CDH13
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.45362171498841836,-0.9164452330607376,0.696969696969697,1.0,1.0,23/100,20.13%,CCL4;THBS1;TACR1;CHI3L1;FOS;SLC11A1;C5AR1;FCGR2B;CXCR4;CCL3;LTB4R;HNRNPA0;IL18;PXK;APOL3;C5AR2;FPR1;MGLL;CD44;AIF1;ADCY8;SIGLEC1;TLR2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5322502672337605,-0.9162437648602179,0.6623376623376623,1.0,1.0,3/17,6.06%,PTN;ALOX15B;RACGAP1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.6147308110384277,-0.9160361819578279,0.6027397260273972,1.0,1.0,3/6,35.17%,TXN;GUCY1B1;MT3
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.49383919499922163,-0.915572817250227,0.6219512195121951,1.0,1.0,10/22,28.26%,SLC4A10;RAB3A;NSMF;NCDN;MCTP1;SYP;RAB5A;CAMK2B;APP;GRIK2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5393693351753832,-0.9154997353989237,0.5925925925925926,1.0,1.0,3/13,18.96%,OVOL2;CFTR;ST14
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.4934277345428491,-0.9152376728036156,0.6666666666666666,1.0,1.0,2/33,3.54%,RHOBTB3;RHOB
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.43729756716855195,-0.9148165912640459,0.6842105263157895,1.0,1.0,17/111,15.55%,CCL4;JAML;MYO1G;GPR183;NAPSB;SELL;GRM8;FGR;FCGR2B;MAP3K8;IL10RA;CXCR4;MNDA;TNFSF13B;LSP1;VNN2;NCF4
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5669422808508683,-0.9148126050691352,0.6438356164383562,1.0,1.0,2/8,18.92%,CALM1;PTS
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.5198007095150302,-0.9147161717503207,0.6133333333333333,1.0,1.0,2/16,13.05%,FHL1;SLC4A10
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.4348846422692306,-0.9146934063361988,0.5869565217391305,1.0,1.0,16/66,18.17%,CLEC12A;THBS1;CD55;RSAD2;CR1;RASGRP4;UROS;MNDA;CD36;TSPAN32;VNN2;NCF4;MPP1;FPR1;UBB;CD44
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3026616399622386,0.9145465556973945,1.0,1.0,1.0,11/48,13.61%,HPN;PPM1F;ZPR1;DDX49;CIB1;SLC25A33;ADAM10;MTPN;CDC42;RPS6KA1;ZNF639
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.40617064154159016,0.9144571317797077,0.5833333333333334,1.0,1.0,4/26,7.32%,ACER2;SESN2;NBN;TP53
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.519150525832331,-0.9142723329716812,0.6746987951807228,1.0,1.0,7/24,21.94%,ATP8B1;ATP10A;ABCB4;ABCB1;ABCA1;PLSCR1;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.45050860417447125,0.9141612390605992,0.7,1.0,1.0,4/13,5.80%,NRP1;MAP4K4;PPM1F;ABL1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.5979203747517915,-0.9141168266666123,0.6875,1.0,1.0,1/5,13.46%,IL18
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.5041780247935594,0.9136696955127513,0.5925925925925926,0.9999014227433973,1.0,2/7,11.65%,TGFB1;LDLR
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.4814570176298638,-0.9136669376195332,0.6190476190476191,1.0,1.0,12/33,28.43%,NRXN1;NLGN3;IL1RAPL1;PTPRD;EPHB1;TLR2;MUSK;ROBO2;IL1RAPL2;NLGN2;APP;VPS35
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5074820535340315,0.9135347637864301,0.6206896551724138,0.9989485220824179,1.0,2/6,3.56%,CTBS;GNPDA1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.5866521643849636,-0.9134316632659853,0.6455696202531646,1.0,1.0,1/8,1.71%,ACVR1B
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5384505364509931,0.9131216335176318,0.4838709677419355,0.9986550066997794,1.0,2/6,11.17%,DNMT3A;MECP2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.4253657504223545,-0.9127910754498131,0.7171717171717171,1.0,1.0,31/214,13.46%,HTR2B;CHI3L1;AGT;RAB7B;TXK;SLC11A1;HIF1A;RORA;ALOX15B;POLR3F;IL7;PQBP1;SULF2;NOD2;HSPA1B;DHX58;BRCA1;SOD1;FGR;SLC7A5;IL15;GAPDH;PRKCQ;POLR1C;APPL1;IRF1;BTN3A1;POLR3H;EIF2AK3;PDE4B;IL18
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.45791321883604663,-0.9126690661995547,0.6129032258064516,1.0,1.0,5/45,11.49%,THBS1;PPP1R15A;ID2;TGIF1;JUNB
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3291009918129079,0.9125397095946047,0.625,0.9986385222571806,1.0,8/40,9.36%,P3H2;CD276;IL17RD;NXN;PDPN;GPR161;TENM3;RAI14
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.47808756403601654,0.9123403757424403,0.6206896551724138,0.9977596655898424,1.0,2/6,6.42%,PKD2;SALL1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6084239084763149,-0.9122144032824846,0.6197183098591549,1.0,1.0,3/6,38.24%,STMN2;CFL2;WDR1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6166441673124918,-0.9120895038181843,0.6438356164383562,1.0,1.0,2/5,20.97%,DNA2;LIG3
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.5112168058535114,0.9120419759663515,0.6060606060606061,0.9972275031636837,1.0,2/6,16.48%,JAM2;CD81
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.48734579627430563,0.9118537931720258,0.6,0.9964729628178932,1.0,2/13,2.74%,DAB2IP;LRCH1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.45413049156532226,-0.9115606372404169,0.6333333333333333,1.0,1.0,3/47,5.25%,ARIH2;RNF126;RBX1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.5441671141947466,-0.911467016979768,0.6883116883116883,1.0,1.0,3/16,16.53%,RORA;DMD;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.4734771488302193,0.9114598318850453,0.5294117647058824,0.9962014470814857,1.0,3/6,7.32%,LGALS9;CD274;TP53
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.5621909547434552,-0.9110602945463162,0.6329113924050633,1.0,1.0,4/10,21.50%,IFITM3;ZFP36;HEXIM1;TRIM14
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5698612033481738,-0.9109813151937416,0.6941176470588235,1.0,1.0,2/11,11.98%,CCDC39;LRGUK
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.4376706108976443,-0.9109443661820371,0.6391752577319587,1.0,1.0,9/77,8.82%,PRKAR2B;TSHR;ADCY3;DHX58;CR1;CD163;FGR;FCGR2B;HTR7
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.6065216335516624,-0.910597977883563,0.7307692307692307,1.0,1.0,4/6,36.32%,TXN;PDE8A;GPR37;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4546699899428534,-0.9105596709390902,0.6631578947368421,1.0,1.0,13/60,20.49%,HTR2B;TNFRSF1B;HSPA1B;PINK1;BNIP3;HLA-F;BNIP3L;TRAF2;IMPACT;CLU;SOX4;ATG5;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5460117185421545,0.9104968577458249,0.6190476190476191,0.9971664098397434,1.0,1/5,7.32%,TP53
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.46793358224416554,0.9102726724448158,0.5555555555555556,0.9965518467254331,1.0,1/8,1.07%,NEDD4
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5033640033453882,-0.9102044631848314,0.6666666666666666,1.0,1.0,5/22,12.05%,TRIM5;IFITM3;HS3ST5;TRIM25;LGALS1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4428551012060752,-0.9101882213367963,0.6836734693877551,1.0,1.0,11/101,10.42%,ACVR1B;LRP2;KNSTRN;SEMA6A;NR4A1;VEGFA;OVOL2;SYAP1;FLT1;MAPT;APPL1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5850525841639596,-0.9101244380945774,0.6027397260273972,1.0,1.0,3/7,32.21%,KDM1A;KDM5C;KDM5B
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.48830135817613257,0.910013343226726,0.6153846153846154,0.9959387788985055,1.0,3/7,14.29%,DAGLB;PTGS1;TBXAS1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5632479186257628,-0.9099532444784163,0.6619718309859155,1.0,1.0,3/9,27.50%,TET1;JARID2;CTR9
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.5380206416442396,0.9092734870735808,0.5555555555555556,0.9966269185638603,1.0,2/7,2.32%,LCP1;MYOM1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.49317369020191415,-0.9088600556450958,0.6153846153846154,1.0,1.0,4/16,21.86%,XRCC3;ATF5;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.5672264463912363,-0.9081649684938765,0.618421052631579,1.0,1.0,1/7,0.96%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6278488688419656,-0.9081322908863088,0.6811594202898551,1.0,1.0,1/5,16.49%,STK17B
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.45155842110687244,0.9074280651207562,0.5882352941176471,0.9993972448300581,1.0,4/17,7.25%,MAP3K10;STK36;PTCH1;TCTN3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.4711455676522841,-0.9073631761524377,0.7023809523809523,1.0,1.0,6/27,10.34%,NR4A1;VEGFA;HMGB2;ACKR4;PRKCQ;CXCR4
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4714426797645309,-0.9071188841125631,0.6046511627906976,1.0,1.0,3/31,10.04%,SRGN;VPS11;SNX10
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.5323361892182561,-0.9070722570343572,0.6630434782608695,1.0,1.0,2/18,9.14%,CDK14;ID2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.5233251870499822,-0.9069704776752274,0.6309523809523809,1.0,1.0,5/13,14.19%,TGFB2;HIF1A;LTBP1;ITGB8;FN1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5534899206777344,-0.9069283270568826,0.6,1.0,1.0,3/9,23.38%,PKP2;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.5211519781585086,-0.9069182338277786,0.6309523809523809,1.0,1.0,6/14,23.38%,ANK2;DMD;CALM3;CAV3;CALM1;RYR2
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.5974509340198235,-0.9064263119980803,0.6515151515151515,1.0,1.0,1/6,14.17%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.5974509340198235,-0.9064263119980803,0.6515151515151515,1.0,1.0,1/6,14.17%,CD63
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.39407490416652236,0.9064229546412387,0.42857142857142855,1.0,1.0,3/22,2.62%,NRP1;EPB41;LEPR
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.47784692473621104,-0.905618754464931,0.6352941176470588,1.0,1.0,9/24,19.46%,LRP2;FBP1;CRYL1;TGFBI;GHR;SORD;GBA3;DPYS;SLC13A3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5792615753129283,0.9052965480366807,0.625,1.0,1.0,3/5,22.77%,TGFB1;NOTCH1;ROCK2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.448103583197982,-0.9050637614847792,0.6979166666666666,1.0,1.0,19/75,25.62%,MRPL33;MRPL19;EEF1B2;MRPL43;EEF1A2;MRPS7;MRPL20;EEF1A1;MRPL51;MRPL45;MRPL27;MRPL47;EEF2;MRPS21;GTPBP1;RACK1;MRPL13;MRPL32;MRPS15
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3208260826986813,0.9050223714248624,0.5555555555555556,1.0,1.0,8/40,14.66%,ZNF385A;PLAGL1;TP53;PIDD1;PLK3;EP300;MDM2;MDM4
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.5483386841104061,-0.9048376178144509,0.6233766233766234,1.0,1.0,2/10,12.19%,HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5114454283298397,-0.9047326855953394,0.6404494382022472,1.0,1.0,4/20,16.30%,CDC37;NLRC5;OAS3;STAT2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3221980380204294,0.9041417249687019,0.7142857142857143,1.0,1.0,10/62,10.53%,PKD2;ATP2C1;MCU;MICU3;CACNA1A;SLC35G1;MAIP1;P2RX7;TRPC1;SMDT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5001283095543804,-0.9038974157871871,0.6741573033707865,1.0,1.0,4/27,18.88%,CDC37;CAMK2N1;CDKN1B;CCNB3
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.579806182826347,-0.903664015849789,0.6811594202898551,1.0,1.0,2/9,9.14%,TGFB2;ID2
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5339091106782183,-0.9036410583283593,0.547945205479452,1.0,1.0,2/10,4.00%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.4979726341982132,-0.9036327123393375,0.65,1.0,1.0,5/20,15.20%,NRXN1;NLGN3;IL1RAPL1;PTPRD;EPHB1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.49177281063097894,-0.9033547210922126,0.6144578313253012,1.0,1.0,3/18,18.97%,ME1;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.3631363757251032,0.9032808978662479,0.75,1.0,1.0,8/25,13.50%,DUSP7;DUSP18;PTPN12;DUSP3;PTPN13;UBASH3B;PTPRO;DUSP6
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.43131166248999103,0.9032142163635324,0.5833333333333334,1.0,1.0,2/13,5.78%,DAG1;VCL
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5126519728763501,-0.9032008766089309,0.6341463414634146,1.0,1.0,1/14,5.62%,INTS12
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.4958716239148391,-0.9031172307139981,0.7,1.0,1.0,2/22,9.06%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.4741457287641146,0.9029918902916302,0.6818181818181818,1.0,1.0,2/9,6.04%,LOXL3;PHACTR4
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.45186764729659196,0.9029144927029379,0.5,0.9998530063952088,1.0,2/9,6.54%,DAGLB;MTLN
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.5248381599832144,-0.9028219802199985,0.6538461538461539,1.0,1.0,2/14,8.48%,NEFL;SOD1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4674599689747906,-0.9027757901216109,0.6559139784946236,1.0,1.0,10/47,18.06%,HTR2B;FGF1;RAB11A;CALM3;KLHL13;PRDM15;TXNIP;PIK3R4;ORC6;CALM1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.39247055124066565,0.9027370745347556,0.6190476190476191,0.9990075238614745,1.0,2/15,6.94%,SNAP47;SYNGR1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.5822772455244114,-0.9025351042014471,0.6901408450704225,1.0,1.0,2/9,17.98%,DAPK2;BMF
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.6268494803712319,-0.9024789061935425,0.6862745098039216,1.0,1.0,3/5,34.29%,WDR48;TNIP1;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5485129746352149,-0.9024139641673214,0.7073170731707317,1.0,1.0,3/11,26.19%,FBP1;CLK2;PPARA
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.5060579655415278,-0.9024122140541561,0.6666666666666666,1.0,1.0,6/15,33.01%,DGAT1;SCD;ACSL3;SCD5;FASN;HSD17B4
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.4712195821478464,0.9019337317503103,0.5384615384615384,0.999514147912757,1.0,2/7,17.14%,APH1A;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.43042426537139816,-0.901690077219564,0.7040816326530612,1.0,1.0,13/107,14.11%,TOM1L1;MTCP1;AGT;VEGFA;TGFB2;SLC11A1;SYAP1;CLSPN;CALM3;CENPE;IQGAP1;INCENP;PAK5
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.49326225932252893,-0.9015572380530213,0.6666666666666666,1.0,1.0,7/25,29.06%,RBM4B;RBM3;PGAM1;RPL10;APP;EIF2A;ROCK1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.40889270789099236,0.9015267333640106,0.5454545454545454,0.9991093465164738,1.0,2/20,0.99%,GCLC;HPGDS
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5368172395894822,-0.9013791049873515,0.647887323943662,1.0,1.0,2/11,9.39%,RGS2;PLN
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.45377879632797263,-0.9010007028393572,0.686046511627907,1.0,1.0,11/36,32.39%,TOMM7;TIMM13;TOMM40;TOMM20;TIMM21;PMPCA;TIMM29;PMPCB;PITRM1;BCAP31;MFN2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.47820039964433286,-0.9009263982341575,0.6626506024096386,1.0,1.0,5/37,9.37%,TUB;SLC11A1;FGR;FCGR2B;IL15
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6228117249577932,-0.9006222886006467,0.6875,1.0,1.0,1/5,5.70%,TNFRSF1B
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.6261188514628486,-0.9005710454802296,0.6865671641791045,1.0,1.0,3/5,28.95%,CALCR;PDCD7;GOT1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5040200942181514,-0.9005650973563265,0.6103896103896104,1.0,1.0,5/14,17.08%,SELL;CDH9;CDH12;CDH23;CDH8
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.5079598887190404,-0.9005413997940335,0.6976744186046512,1.0,1.0,6/17,30.94%,EIF3D;EIF4A2;EIF2D;EIF3A;EIF3I;DHX29
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4769746806352341,-0.9003743714897976,0.6455696202531646,1.0,1.0,4/20,20.48%,JAML;IL1RAPL1;PTPRD;CADM1
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.6016352479358019,-0.9003084885044831,0.676056338028169,1.0,1.0,3/5,34.29%,TOX;STPG4;OTUD4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.6016352479358019,-0.9003084885044831,0.676056338028169,1.0,1.0,3/5,34.29%,TOX;STPG4;OTUD4
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.5321921221805339,-0.9002456203791123,0.6805555555555556,1.0,1.0,2/12,9.39%,RGS2;PLN
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3783430410473101,0.9002114839050543,0.7333333333333333,1.0,1.0,4/31,6.15%,NRP1;FER;SRGAP2;NTNG2
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5581307181775694,-0.9001482002247777,0.6575342465753424,1.0,1.0,2/9,9.90%,CD55;PRKCQ
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.5965409600630583,-0.899917852391786,0.6533333333333333,1.0,1.0,2/6,18.06%,VMP1;CALM1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.5310789959703214,-0.8998403468197873,0.6823529411764706,1.0,1.0,11/16,38.26%,EIF2B2;SOX4;TLR2;APP;MYRF;EIF2B1;EIF2B5;NSUN5;MT3;PICK1;CSPG5
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6400966734087012,-0.8995501270547147,0.6825396825396826,1.0,1.0,3/6,19.90%,TGFB2;NOTCH2;SOX4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.47543630031065676,-0.8992692887851915,0.6363636363636364,1.0,1.0,2/25,7.70%,ENPP2;CARMIL1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.4155078973744384,0.8991331634330048,0.5185185185185185,1.0,1.0,1/11,2.62%,LEPR
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.364943477664754,0.8988954929417341,0.6875,1.0,1.0,4/21,9.59%,ENPP1;PIP4K2B;APPL2;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.6235903221606031,-0.8988095980853029,0.6716417910447762,1.0,1.0,3/5,14.28%,DNAJB9;DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5257280424684042,-0.8985503411805915,0.6962025316455697,1.0,1.0,6/19,19.55%,LSR;CCDC39;COBL;ARID5B;CITED2;E2F7
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31823416533741317,0.8984246189490631,0.7142857142857143,1.0,1.0,18/42,28.04%,KHDRBS3;SAP18;RBMX;SMU1;CELF1;THRAP3;FMR1;FXR2;NSRP1;REST;MBNL3;WTAP;PUF60;RBFOX1;ZBTB7A;RBFOX3;MBNL1;RNPS1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.44013809758394684,-0.8980085540808475,0.711340206185567,1.0,1.0,10/97,11.51%,NR4A3;NR4A1;RBPJ;RORA;RXRB;NR4A2;POLR2G;RORB;NR1H2;NOTCH2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.4463088622786002,-0.8979630441101705,0.6395348837209303,1.0,1.0,6/45,12.92%,H1-3;H1-4;H1-2;H1-0;POLR1C;PADI2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.47889830379946724,-0.8979210437757518,0.6436781609195402,1.0,1.0,8/23,22.53%,CR1;FCGR2B;PDCD1LG2;MNDA;TNFRSF21;CD300A;LILRB2;GPNMB
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.5373165755937092,-0.8977368036687577,0.6388888888888888,1.0,1.0,3/10,23.43%,VBP1;CLU;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5073184816260037,-0.8975980525887245,0.6666666666666666,1.0,1.0,8/21,29.41%,MAPT;CAV3;RPS3;STMN2;DCTN1;AKAP9;PSRC1;FES
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.5611180858016138,-0.8974782191742233,0.6705882352941176,1.0,1.0,1/10,4.68%,C5AR1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.48725911265247707,-0.897358305092694,0.6588235294117647,1.0,1.0,9/24,25.17%,HTR2B;ERO1A;SLC24A1;RYR3;ATP2B4;SLC24A2;RYR2;GRIN2A;IBTK
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5991083295501376,-0.8971727568635403,0.6764705882352942,1.0,1.0,1/6,4.32%,SULT4A1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.49063640616027937,-0.897129243992767,0.6777777777777778,1.0,1.0,4/29,18.86%,FBP1;ALK;AZIN1;FMN2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.46523239638566427,-0.8970616327087257,0.7,1.0,1.0,9/36,21.81%,ENPP2;CYP3A5;PDXDC1;TRHDE;RIDA;PNPLA8;ERAP1;AMDHD2;TPP1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.48656624975146495,-0.8967027729124715,0.7058823529411765,1.0,1.0,10/27,25.04%,NEFL;SOD1;KIF1B;AP3M2;KIF3A;KIF5A;RAB21;MAP1A;KIF5C;SPAST
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.46385266429034056,-0.8965603418423338,0.7111111111111111,1.0,1.0,12/42,19.36%,ADGRE1;TSHR;ADGRG6;ADCY3;ADGRL2;ADGRD1;ADGRL3;ABCA1;GNA13;RXFP1;GPR65;ADCY8
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.46834883110630526,-0.8965347049118189,0.6777777777777778,1.0,1.0,6/33,18.06%,PPP1R15A;PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5256976752668271,-0.8962625825888699,0.7,1.0,1.0,2/16,7.44%,EYA2;HSPA1B
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.4327933044435219,-0.8961545094429022,0.7346938775510204,1.0,1.0,35/82,28.92%,ST18;CACNB2;CCK;AMER2;MOBP;FGF13;MOG;SLC4A10;NRXN1;GRIA4;FRRS1L;PCSK2;ASPA;SCN1A;ATP2B2;ATP1B2;SLC24A2;SYP;SCN3B;GAD2;MCF2L2;ST8SIA3;CADPS;UNC13C;SLC24A4;RPH3A;HCN1;XKR4;SLC1A2;SV2B;GRIA2;SRRM4;B3GAT1;SCG3;UNC80
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.3675629713033725,0.896114545853314,0.47058823529411764,1.0,1.0,2/21,1.28%,NRP1;TGFA
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3147853697793085,0.8957931618281357,0.8333333333333334,1.0,1.0,10/51,10.57%,FKBP9;CD276;DAB2IP;NUAK1;TANC1;LAPTM4B;PKDCC;TENM3;RAI14;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5444290823291225,-0.895272343493709,0.6842105263157895,1.0,1.0,2/13,7.44%,EYA2;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5444290823291225,-0.895272343493709,0.6842105263157895,1.0,1.0,2/13,7.44%,EYA2;HSPA1B
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.4186517065331183,-0.8950449803160815,0.77,1.0,1.0,43/218,23.65%,BRIP1;RPS27A;FANCB;XRCC3;FANCI;MPG;FANCM;WDHD1;RPA2;BRCA1;NEIL1;PARP9;POLQ;NOP53;DDX1;ADPRS;UBA52;UBC;RPA3;PIAS4;FAN1;ERCC2;SLX4;RFC4;WDR48;TIMELESS;UBB;KMT5C;POLL;BRCA2;ACTR5;DTX3L;DDB1;DNA2;POLE2;ZRANB3;LIG3;VCPIP1;MUS81;KDM4B;ABRAXAS1;NABP1;UBXN1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.4386070192286548,-0.8949812115619279,0.7395833333333334,1.0,1.0,16/69,23.63%,FA2H;ALOX12;ALOX15B;ACSL1;GNPAT;CD36;PNPLA8;ECHDC3;PER2;ACAD9;FAAH;ELOVL4;HACL1;ACSM3;ACSL3;SLC27A5
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.6232701412757429,-0.8949018711850588,0.6666666666666666,1.0,1.0,1/5,4.00%,TGFB2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4541996742486885,-0.894571982228326,0.6704545454545454,1.0,1.0,14/50,28.95%,KMO;GLUL;ALDH6A1;ASPA;GAD1;ACAT1;PIPOX;HMGCL;FAH;ECHS1;BCAT1;IL4I1;CARNS1;GOT1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5857893686593105,-0.8942820698366747,0.7121212121212122,1.0,1.0,3/5,21.04%,RIOK2;CENPE;HECW2
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),-0.5972896228988308,-0.8942461364672217,0.6571428571428571,1.0,1.0,1/5,17.27%,ANXA2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.6008495031944379,-0.8942325684917356,0.6818181818181818,1.0,1.0,2/5,19.65%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.5718412332730979,-0.8941369820711914,0.6909090909090909,1.0,1.0,1/5,4.22%,ADCY3
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.522210442884348,-0.8937889100536601,0.6710526315789473,1.0,1.0,3/17,11.51%,TTN;KDM6B;NOTCH2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5382995232417371,-0.8935505662349014,0.7027027027027027,1.0,1.0,3/10,15.84%,TOMM40;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.44532287615212895,-0.8934170880906273,0.6923076923076923,1.0,1.0,16/68,26.58%,RBX1;FHL1;PSMA5;PSMA3;RGCC;KLF4;PSMD8;PSMB4;FBXL7;E2F7;GPNMB;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5766467898627752,-0.8931570555329015,0.6619718309859155,1.0,1.0,1/7,8.75%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.42669325537041175,-0.892213207342238,0.81,1.0,1.0,20/226,10.62%,TFRC;ENPP2;ARAF;CEMIP;TOM1L1;MTCP1;CHI3L1;FGF1;AGT;VEGFA;TGFB2;SLCO3A1;DDRGK1;PINK1;IL15;FAXDC2;CLIP3;CALM3;MARCO;CENPE
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.46751192256684315,-0.8919831520742286,0.7209302325581395,1.0,1.0,3/25,9.59%,SPOCK1;AGT;GAPDH
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.40266774917837644,0.8919105040776483,0.6666666666666666,1.0,1.0,5/17,13.68%,DAG1;MYH9;APH1A;ADAM10;RBMX
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.3292445056055934,0.8918780296047535,0.7333333333333333,1.0,1.0,5/31,12.50%,PLXNA2;SEMA4D;PLXNA4;SHTN1;PLXNB2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.45347809080075746,-0.8918249943761322,0.6774193548387096,1.0,1.0,5/40,14.20%,TFRC;MAPT;PINK1;BNIP3;DCC
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.5674506181986094,-0.8918003773083146,0.6619718309859155,1.0,1.0,4/6,32.00%,THY1;RTN4RL1;EPHA4;PTPRS
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.463865199753543,0.8917769473629001,0.5294117647058824,1.0,1.0,2/11,4.83%,HPN;CTSH
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5534831841912202,-0.8917683111077594,0.6710526315789473,1.0,1.0,1/7,7.73%,NHP2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5887378502378835,-0.8913066258352625,0.6470588235294118,1.0,1.0,1/7,6.87%,ANK3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.49646278840639246,-0.8909172441191437,0.7105263157894737,1.0,1.0,2/21,7.73%,NUDT16;NHP2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.4797690066121074,-0.8907324317127613,0.6075949367088608,1.0,1.0,1/18,4.72%,RNF126
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5462024573097566,-0.8906089561513729,0.6911764705882353,1.0,1.0,8/11,41.89%,RYR2;BCAP31;DMTN;TRPM2;PTPRC;FIS1;PRNP;ADGRL1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4401313419558843,-0.8905015102686282,0.75,1.0,1.0,27/109,20.37%,TNFRSF11B;CEBPD;F13A1;CHI3L1;CD93;TNS1;HIF1A;GRM8;MS4A4A;CD163;SNX10;MARCO;CCL3;TGFBI;LTB4R;KCNMA1;THBD;ITGA2;PID1;EPHB1;CTSB;RASSF4;ABCA1;SERPING1;SIGLEC1;TLR2;MAFB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5139317404958452,0.8903948463078177,0.6,1.0,1.0,2/7,1.18%,GSN;LGALS9
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.4173133078889136,-0.8902919473348415,0.7368421052631579,1.0,1.0,16/90,18.72%,CDC37;RPL11;SRP14;TOMM7;NACA;AQP11;VPS37C;ZDHHC15;TIMM13;TOMM40;SDCBP;AKAP6;TOMM20;ZDHHC9;SRPRA;ZDHHC4
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5629102492306977,-0.8900461072724514,0.7361111111111112,1.0,1.0,2/8,10.99%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.2851041611735262,0.8894514871115532,1.0,1.0,1.0,19/72,12.71%,CRK;SMAD7;SRGAP2;DAG1;JAG1;RECK;VCL;RNF20;STK26;DACH1;SRGAP2B;SRGAP2C;SERPINE1;NF2;DUSP3;RAP2A;ADARB1;RAP2C;MITF
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.5874478069801481,-0.8893732665460344,0.6296296296296297,1.0,1.0,1/5,18.57%,IMPACT
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4662599278279327,-0.8893615820941247,0.6707317073170732,1.0,1.0,5/32,13.53%,HHIP;RORA;PDCL;IFT81;GPC3
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.47254738843895305,-0.8892991921777759,0.6785714285714286,1.0,1.0,5/30,6.19%,FAAH2;ALOX12;ALOX15B;ACSL1;GSTP1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5287097886157872,-0.8891655641856042,0.68,1.0,1.0,2/14,2.84%,HTR2B;AGT
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.4861186547237841,0.8889847185573955,0.6052631578947368,1.0,1.0,2/6,23.76%,IL12RB1;STAT4
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.4780271672242895,0.8886855466639747,0.6666666666666666,1.0,1.0,2/9,7.32%,SIRT1;TP53
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4726572586573101,-0.8885793620580454,0.686046511627907,1.0,1.0,3/30,6.35%,PLPP3;FZD6;NR4A2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4666049123850738,-0.888449808768368,0.6867469879518072,1.0,1.0,5/36,6.19%,FAAH2;ALOX12;ALOX15B;ACSL1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.49025877785651995,-0.888394983866283,0.6363636363636364,1.0,1.0,8/18,28.96%,WDR5;BRCA1;TET1;DNMT1;JARID2;CTR9;RIF1;OGT
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.4591470552609409,0.8879701579627579,0.6086956521739131,1.0,1.0,3/8,13.11%,NR3C1;PLPP1;NR3C2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5533619616810751,-0.8879382941918585,0.7571428571428571,1.0,1.0,3/9,10.55%,COX7A2;PINK1;NOP53
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.4420310463625114,-0.8879088430882092,0.7021276595744681,1.0,1.0,9/70,13.81%,SOCS3;ENPP2;AGT;VEGFA;PARP9;IL15;IL18;PARP14;TEC
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.42853374437301517,-0.8878601561568893,0.6494845360824743,1.0,1.0,13/60,22.57%,TFRC;VEGFA;SLF1;SLX4;SDCBP;SNF8;MPP7;RGCC;RPS3;BMF;CLU;PDCD6IP;NRG1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.6204700665829705,-0.8877990645349002,0.7,1.0,1.0,2/5,10.88%,TGFB2;CCL3
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5661482712855385,-0.8877057312809331,0.7307692307692307,1.0,1.0,3/9,16.53%,VEGFA;SMARCD3;KDM1A
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.41912430852823407,-0.8872826408501457,0.87,1.0,1.0,73/346,23.66%,SLC2A3;CLEC12A;GLA;CD55;FTH1;CHI3L1;ALDH3B1;ENPP4;CD93;SLC11A1;SRP14;C5AR1;CRISPLD2;SELL;TNFRSF1B;GSTP1;HLA-B;HSPA1B;CR1;LPCAT1;PLAC8;FGR;PPIE;PRDX4;PSMA5;PTGES2;MNDA;PKM;IQGAP1;PADI2;B2M;CYSTM1;PGAM1;PGM1;RAB3A;DGAT1;CD63;SDCBP;CD36;IGF2R;RNASET2;IMPDH1;EEF1A1;RAB37;PYCARD;CTSB;ANXA2;FPR1;CD44;SNAP25;ATP6V1D;GSDMD;TLR2;CKAP4;DSN1;GNS;HLA-C;CD300A;EEF2;ACTR1B;ARHGAP9;DYNLT1;LRRC7;LILRB2;GUSB;GPI;CD14;PFKL;FCAR;ACP3;PSMD7;GAA;OSCAR
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.5816747795430482,-0.8871505829334364,0.7285714285714285,1.0,1.0,3/5,22.62%,CD36;TLR2;CD14
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5582541688871708,-0.8871206687383819,0.6666666666666666,1.0,1.0,2/9,9.37%,VEGFA;IL15
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5783740463677931,-0.886151037746951,0.6710526315789473,1.0,1.0,2/6,9.09%,SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4126158345396127,0.8859907519692298,0.631578947368421,1.0,1.0,3/14,5.58%,BCL2L1;TGFB1;ABI3
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4665321700313537,-0.8859196222880384,0.7282608695652174,1.0,1.0,5/44,4.58%,TNC;SPARC;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5020818478619118,-0.8858870614540972,0.625,1.0,1.0,5/14,26.62%,VCAN;CHST7;CSGALNACT2;CHSY1;CHST12
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5106977344714891,-0.8855947314672431,0.675,1.0,1.0,4/13,21.51%,SCN9A;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.5889173774675521,-0.8854515837941802,0.6986301369863014,1.0,1.0,3/7,29.52%,FCGR2B;CARD9;FCER1G
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.42461668218976567,-0.8850352998365539,0.7578947368421053,1.0,1.0,15/104,18.71%,FZD6;RBMS3;LZTS2;RBX1;DKK2;AMER2;LIMD1;TLE1;PSMA5;APC2;PSMA3;PSMD8;LRP4;PSMB4;EMD
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3358411740180839,0.8849837675626052,0.7894736842105263,1.0,1.0,7/23,12.10%,SMAD7;BAG5;ABL1;TP53;ERCC4;INPP5K;SRC
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.4558711292365937,-0.8848988425176209,0.7311827956989247,1.0,1.0,4/52,8.43%,FGF1;NR4A1;FLRT1;POLR2G
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.29097247264491377,0.8847946609452721,0.6666666666666666,1.0,1.0,16/103,10.65%,ZDHHC3;RAMP1;EHD4;RAP1A;SMURF1;TSPAN15;PTCH1;RAPGEF6;ZDHHC2;SLMAP;WNK3;RAB10;INPP5K;TSPAN17;TSPAN33;RAP2A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.4723981454444136,0.8847602128389438,0.5555555555555556,1.0,1.0,3/10,13.03%,SUPT16H;UBN1;RBBP4
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5543236418968392,-0.8847233831372728,0.6973684210526315,1.0,1.0,3/10,21.94%,ACSL1;CD36;MFSD2A
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.4987722837928521,-0.8846251154088466,0.6375,1.0,1.0,3/17,7.16%,TFRC;AIM2;FBP1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.463739935468343,-0.8840886275794521,0.7142857142857143,1.0,1.0,4/26,9.59%,SPOCK1;AGT;CR1;GAPDH
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.35121952790483413,0.8840547129144446,0.7142857142857143,1.0,1.0,12/46,9.51%,FER;TGFA;ARAP1;DAB2IP;EPS15L1;PTPN12;CBL;CDH13;STAM2;DUSP3;SPRY2;BCAR3
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.4976917341011294,0.8839686253883513,0.5833333333333334,1.0,1.0,3/9,16.26%,GNPDA1;ST6GAL1;NPL
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5170576283030864,0.8839285870264637,0.627906976744186,1.0,1.0,1/6,2.95%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.5518677376398688,-0.8836552365231075,0.7402597402597403,1.0,1.0,2/9,12.19%,HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.5324455895617735,-0.8833867709898694,0.7083333333333334,1.0,1.0,5/13,27.17%,PAICS;IMPDH1;AMPD2;GART;PFAS
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.347552183080746,0.883218819684746,0.6111111111111112,1.0,1.0,4/27,10.65%,NEDD4;SEMA4D;CAPRIN2;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4490795987598045,-0.8829837373416098,0.7582417582417582,1.0,1.0,9/42,16.01%,THBS1;SPARC;TGFB2;AQP11;ATP5IF1;STAT1;B2M;ATP5F1A;RGCC
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.5084310907157583,-0.8829343559300624,0.75,1.0,1.0,7/17,33.56%,SNX10;STIL;GOLGB1;DCTN2;CSNK1D;BBS4;HOOK3
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.48731249907897034,-0.8827757830776505,0.6626506024096386,1.0,1.0,3/18,16.91%,RACGAP1;SLC13A4;SLC25A19
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.45447476595115494,-0.882712075729966,0.7209302325581395,1.0,1.0,7/43,11.22%,CBR1;VEGFA;OVOL2;BASP1;GSTK1;PGK1;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.4614207188046499,-0.8826283913655258,0.7555555555555555,1.0,1.0,9/59,17.27%,TUB;SLC11A1;FCGR2B;IL15;CALY;CLIP3;GPC3;PYCARD;ANXA2
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.6392507192343617,-0.882515286647114,0.7580645161290323,1.0,1.0,2/5,4.80%,SEMA3A;PTN
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.4697849965962433,-0.8824928284871284,0.7191011235955056,1.0,1.0,3/26,4.80%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.39064562503554,0.8822663435415902,0.5384615384615384,1.0,1.0,2/19,4.65%,P3H2;PPIL1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.5127696616113722,0.8819504709128931,0.6666666666666666,1.0,1.0,2/8,2.47%,TLR7;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.5561888150782994,-0.8818009627308656,0.6567164179104478,1.0,1.0,1/6,15.84%,GHR
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5527246725458047,-0.8817659590501877,0.6623376623376623,1.0,1.0,3/10,10.95%,NTN4;LAMB1;GPM6B
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.443199748424871,0.8816537909175369,0.6206896551724138,1.0,1.0,1/10,0.81%,PUS1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.479091727311355,-0.8814946184676116,0.7303370786516854,1.0,1.0,6/25,26.58%,ITSN1;FCHO2;AP2S1;SIGLEC1;AP2A2;PIP5K1C
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.5086133593279768,-0.8814034672242068,0.6666666666666666,1.0,1.0,2/16,4.00%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4165330352885214,-0.8811059743831277,0.89,1.0,1.0,73/350,23.66%,SLC2A3;CLEC12A;GLA;CD55;FTH1;CHI3L1;ALDH3B1;ENPP4;CD93;SLC11A1;SRP14;C5AR1;CRISPLD2;SELL;TNFRSF1B;GSTP1;HLA-B;HSPA1B;CR1;LPCAT1;PLAC8;FGR;PPIE;PRDX4;PSMA5;PTGES2;MNDA;PKM;IQGAP1;PADI2;B2M;CYSTM1;PGAM1;PGM1;RAB3A;DGAT1;CD63;SDCBP;CD36;IGF2R;RNASET2;IMPDH1;EEF1A1;RAB37;PYCARD;CTSB;ANXA2;FPR1;CD44;SNAP25;ATP6V1D;GSDMD;TLR2;CKAP4;DSN1;GNS;HLA-C;CD300A;EEF2;ACTR1B;ARHGAP9;DYNLT1;LRRC7;LILRB2;GUSB;GPI;CD14;PFKL;FCAR;ACP3;PSMD7;GAA;OSCAR
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5269506268287897,-0.8809062939791978,0.7397260273972602,1.0,1.0,2/14,9.79%,FANCB;POLQ
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.5578771033935621,-0.8808608557235613,0.7066666666666667,1.0,1.0,3/9,20.47%,TGFB2;NOTCH2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.3894353286054507,0.880720036094262,0.6666666666666666,1.0,1.0,7/25,9.59%,SH2B3;DAG1;SIRT1;ARRB2;CIB1;TRIB3;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5247759407981076,-0.880283232936791,0.7215189873417721,1.0,1.0,4/13,18.06%,GNB5;PLN;CALM3;CALM1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.45386938919776765,-0.8800642425483596,0.7159090909090909,1.0,1.0,1/48,0.36%,NAMPT
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5404247999625814,-0.8798404531250826,0.6578947368421053,1.0,1.0,3/9,17.30%,MX1;IFIT1;ATAD3A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5856580312563089,-0.8796174604666585,0.6962025316455697,1.0,1.0,3/6,30.21%,SYT1;SYT4;SCAMP5
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5715006757737449,-0.879536403952724,0.7162162162162162,1.0,1.0,1/8,11.21%,CTBP1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.49018184785226443,-0.8794136907905238,0.6896551724137931,1.0,1.0,11/30,24.47%,RIMS1;MAPT;GOLGA4;GHR;SYT1;INSR;UNC13A;SYT4;PPIB;PLCB1;RIMS2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4271077736679346,-0.8793265768420885,0.76,1.0,1.0,15/93,12.40%,CCL4;SRGN;GPR183;C5AR1;TNFRSF1B;BCL2A1;MS4A4A;GBP2;FGR;FCGR2B;TYMP;CCL3;MS4A6A;IRF1;MNDA
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.4642299521827201,-0.8792195931997091,0.6555555555555556,1.0,1.0,4/34,9.80%,VEGFA;ATP5IF1;ID2;RPS14
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.42562056444215957,-0.8791671261734314,0.7894736842105263,1.0,1.0,16/134,13.88%,CLEC4E;TRIM5;H2BC11;IFITM3;SLC11A1;MX1;NOD2;ADAM15;DHX58;CR1;FGR;TRIM25;NLRC5;RPL39;B2M;IFIT1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.44319361212470443,-0.8791511521540404,0.7368421052631579,1.0,1.0,15/50,26.19%,IFITM3;RSAD2;MX1;PPIE;IFIT1;OAS3;IFIT5;ZC3HAV1;ILF3;DDB1;PLSCR1;EIF2AK2;TNIP1;PPID;PPARA
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.44282697584871233,-0.8789160373437536,0.7,1.0,1.0,8/48,20.29%,TFRC;DDRGK1;MAPT;PARP9;EIF2AK3;LIMK2;GNL3;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.42813153243036206,-0.8787607838096197,0.8469387755102041,1.0,1.0,20/146,14.35%,HTR2B;GLIPR2;CCL4;TRIM5;CHI3L1;FGF1;VEGFA;GPR183;TGFB2;C5AR1;NOD2;FLT1;DIRAS2;MARCO;CCL3;NOTCH2;MAP3K12;IQGAP1;TRAF7;CD36
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.43661770798995303,-0.8786347602976305,0.7448979591836735,1.0,1.0,10/58,22.19%,MIF4GD;POLR2G;EIF2B2;DDX1;ATF3;EIF2AK3;EIF3E;IMPACT;EIF4A2;RPS6KB2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.5922857312382819,-0.8785745006356158,0.6712328767123288,1.0,1.0,1/7,4.80%,PTN
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4145069044768406,-0.8781913715329689,0.88,1.0,1.0,73/349,23.66%,SLC2A3;CLEC12A;GLA;CD55;FTH1;CHI3L1;ALDH3B1;ENPP4;CD93;SLC11A1;SRP14;C5AR1;CRISPLD2;SELL;TNFRSF1B;GSTP1;HLA-B;HSPA1B;CR1;LPCAT1;PLAC8;FGR;PPIE;PRDX4;PSMA5;PTGES2;MNDA;PKM;IQGAP1;PADI2;B2M;CYSTM1;PGAM1;PGM1;RAB3A;DGAT1;CD63;SDCBP;CD36;IGF2R;RNASET2;IMPDH1;EEF1A1;RAB37;PYCARD;CTSB;ANXA2;FPR1;CD44;SNAP25;ATP6V1D;GSDMD;TLR2;CKAP4;DSN1;GNS;HLA-C;CD300A;EEF2;ACTR1B;ARHGAP9;DYNLT1;LRRC7;LILRB2;GUSB;GPI;CD14;PFKL;FCAR;ACP3;PSMD7;GAA;OSCAR
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.45157205935768935,-0.8781128096889758,0.6875,1.0,1.0,5/36,7.22%,TNC;SPARC;ADAMTS2;LAMA2;SPON2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5827713920357603,-0.8777996460311277,0.6986301369863014,1.0,1.0,1/5,2.41%,SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.46579765631861697,-0.8777946551354657,0.6987951807228916,1.0,1.0,7/31,23.38%,ATP1B3;UHRF1;VMP1;DNAJC9;ATP1B2;PLSCR1;RYR2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.5037287295287978,-0.8775889335982,0.7073170731707317,1.0,1.0,9/17,33.43%,NR1H2;EPHA3;ARF6;MCTP1;CD300A;SCAMP5;LILRB1;SYT11;LRSAM1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.5198186415574897,-0.8774548984216582,0.6666666666666666,1.0,1.0,5/11,30.21%,RAB3A;RAB15;SYT4;RAB3D;SCAMP5
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.5109852122967415,-0.8773588166771277,0.6707317073170732,1.0,1.0,6/18,28.36%,RPS13;C1QBP;RPS26;SRSF9;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.45550385200447374,-0.8772136492261963,0.75,1.0,1.0,10/52,19.24%,ACVR1B;TGFB2;TNFRSF1B;BCL2A1;APPL1;BCL2L2;DCC;TRAF2;MCL1;DEDD
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5456537054018843,-0.8770970597083232,0.6538461538461539,1.0,1.0,3/8,18.00%,SNX6;CBLB;ERRFI1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.41385194439087947,-0.8770181341273626,0.6836734693877551,1.0,1.0,24/85,24.53%,TFRC;NAPA;VEGFA;SLF1;PINK1;NOP53;HCFC1;HSPA5;CD36;MPP7;TFIP11;TRAF2;RPS3;ABCA1;BMF;IMPACT;GFAP;CLU;NRG1;EIF2AK2;CRYAB;SEPTIN8;RACK1;RIOK3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5452993139650715,-0.8769973363177365,0.6987951807228916,1.0,1.0,1/12,0.82%,RPL23
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.45799934050929353,0.8768798151954817,0.6538461538461539,1.0,1.0,1/8,1.05%,ZNRF3
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.4840930217434064,0.8768386239523935,0.6206896551724138,1.0,1.0,2/9,10.09%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4501288130745695,-0.8766248234164394,0.7065217391304348,1.0,1.0,12/53,14.30%,RPS27A;IHO1;RBX1;RPA2;DDX1;UBA52;RFC1;UBC;RPA3;FAN1;ERCC2;RFC4
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.37753503525991383,0.8762140519762824,0.5294117647058824,1.0,1.0,4/22,5.29%,LGALS9;VSIG4;CD274;SCRIB
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.4712595975893082,-0.8756564354097338,0.7789473684210526,1.0,1.0,7/40,16.19%,CCL4;CHI3L1;HIF1A;GBP2;CCL3;NR1D1;PYCARD
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.45900961516358,0.8754784232841634,0.4,1.0,1.0,1/12,2.49%,TICAM1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.4570160677698234,-0.8753396363590812,0.6666666666666666,1.0,1.0,8/42,17.93%,CLEC4E;RPS27A;NOD2;UBA52;UBC;CD36;CTSB;UBB
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5934953741413007,-0.8752536064557468,0.7205882352941176,1.0,1.0,1/5,9.41%,RDH11
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.568451986715092,-0.8751341873409172,0.7301587301587301,1.0,1.0,4/8,33.03%,ZWILCH;CHAMP1;KNL1;IK
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.5134030469486349,0.875052642018133,0.5517241379310345,1.0,1.0,1/6,2.49%,TICAM1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.5600986633588065,-0.8745364675992063,0.7058823529411765,1.0,1.0,2/6,25.75%,ING4;MEAF6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.5051399593035245,-0.8745286326344981,0.6623376623376623,1.0,1.0,6/15,27.50%,MEIS2;ZFP36;MAFB;ZBTB16;HSPA9;CTR9
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),-0.5974622620609801,-0.8744469657706515,0.6962025316455697,1.0,1.0,3/5,36.47%,VNN2;SLC5A6;VNN1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.48378929140613497,-0.8744422419479181,0.6190476190476191,1.0,1.0,3/21,13.81%,VAV3;MNDA;TEC
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.47330964332120035,0.8743809744047248,0.5833333333333334,1.0,1.0,6/8,11.51%,PIR;CSF1R;PPARG;MYH9;THOC5;PDE1B
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.3555709802349322,0.8742877042163356,0.5454545454545454,1.0,1.0,5/27,11.62%,P2RY12;MYH9;VCL;GNAS;UBASH3B
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.5117359779001509,-0.8742621674837725,0.6493506493506493,1.0,1.0,4/12,27.20%,VBP1;CLU;CRYAB;APP
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.4736472479805566,-0.8741965723920687,0.6352941176470588,1.0,1.0,7/25,24.21%,ALOX12;ACSS3;SCD;ACAT1;HMGCL;SLC27A5;SCD5
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.3858589612679264,0.8741635473727033,0.631578947368421,1.0,1.0,1/16,0.92%,GSN
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3962265307377462,0.8741375999657978,0.5,1.0,1.0,8/13,20.15%,PTCH1;TGFBR2;TGFB1;GRAMD1A;SMAD2;OSBPL7;TGFBR1;LRP6
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.43815144589762656,-0.8739964700017907,0.7446808510638298,1.0,1.0,10/58,13.77%,THBS1;CGNL1;PLPP3;TNS1;LAMA2;DOCK1;SPARCL1;SMARCD3;SPSB1;ENC1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.4198297755573934,0.8737709430927829,0.5625,1.0,1.0,7/20,15.30%,TAL1;KLHL18;EIF4EBP1;DUSP3;PPP1R10;MDM2;EIF4E
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.42762247449186297,-0.8737689943855556,0.6739130434782609,1.0,1.0,10/60,12.68%,OMD;OGN;VCAN;GSTP1;B4GAT1;PAPSS2;GSTK1;GSTM3;MAT2A;CHST7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.4699691219529305,0.8736841725286122,0.64,1.0,1.0,2/10,10.19%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4699691219529305,0.8736841725286122,0.64,1.0,1.0,2/10,10.19%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4699691219529305,0.8736841725286122,0.64,1.0,1.0,2/10,10.19%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4773118158599699,-0.8734835492800338,0.6896551724137931,1.0,1.0,4/24,17.95%,TOM1L1;DUSP1;RGCC;INSR
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.533002106227519,-0.8734652638880528,0.7142857142857143,1.0,1.0,4/11,18.57%,HERPUD1;EIF2AK3;HSPA5;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5034775422389117,-0.873458432197422,0.6962025316455697,1.0,1.0,2/17,6.39%,HMGB2;H1-0
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.46885398325428573,-0.8731272830597465,0.6823529411764706,1.0,1.0,4/27,12.14%,RPS27A;MAP3K8;UBA52;UBC
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.4232460647739297,-0.8730262500925203,0.7604166666666666,1.0,1.0,15/61,20.63%,CD55;TACR1;C5AR1;ACKR4;PLN;CXCR4;CD36;CAV3;CDH23;C5AR2;FPR1;CACNA1C;ATP2B4;ADCY8;ATP2B2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.3869033647573326,0.8729610806752993,0.55,1.0,1.0,8/16,25.41%,ZDHHC21;IL1A;LYPLA1;DDAH2;IL1B;NOS1AP;NOSIP;EGFR
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.4083617955080741,-0.872739100933426,0.89,1.0,1.0,38/332,16.19%,DDIT4;BRIP1;NLRP12;ARAF;PRKAR2B;FGF1;VEGFA;RHOB;RPL11;VAV3;AKAP12;ARHGAP4;RACGAP1;RHOU;RPA2;BRCA1;CHD3;TRIP10;CHN1;PPP2R5B;FBXL2;MAPT;ITSN1;NOP53;DAPK2;RPA3;RPL5;RASGRF2;PPP1R13L;ARAP2;PAK5;RFC4;PRR5;ARHGAP23;AKAP6;PRDM1;ING5;PYCARD
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.4811133020246438,-0.8726148728443534,0.7411764705882353,1.0,1.0,4/18,17.58%,TCHP;RAP1GAP;ODF2L;LIMK2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5471387825162631,-0.8725625491632507,0.6842105263157895,1.0,1.0,6/10,32.38%,ASPH;CIDEB;RIPK2;GRIN2A;TBC1D10A;CYFIP2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.4620726330544913,-0.871646579702331,0.7111111111111111,1.0,1.0,9/32,29.06%,STAT1;EIF2B2;STAT2;TRIM16;STAT6;GNAI1;EIF2B1;OGT;ROCK1
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),-0.5946791257802865,-0.8716070246207978,0.7246376811594203,1.0,1.0,2/6,13.81%,TXK;TEC
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.357408882239032,0.8715834446455283,0.5384615384615384,1.0,1.0,3/27,6.56%,VCPKMT;SETD3;SNRPB
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4075836312731663,-0.8715458378192845,0.86,1.0,1.0,37/226,20.52%,SOCS3;TNC;DTL;ASB14;VCAN;ASB16;HIF1A;RBX1;WDR5;RAB11A;COPS5;LAMB1;LTBP1;KLHL13;SPARCL1;LGALS1;PSMA5;VGF;CDH2;PSMA3;SPSB1;GPC3;RAB3A;FN1;CHGB;PSMD8;FBXL13;SUMF2;TMEM132A;UBE2M;PSMB4;FBXL7;SPSB3;ATG5;DDB1;ELOB;CKAP4
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.42973408334198404,-0.8715065893160677,0.6526315789473685,1.0,1.0,17/40,37.24%,PSMA5;PSMA3;AZIN1;PSMD8;PSMB4;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2;PSMB6;PSME2;ODC1;PSMC6;PSMD14;PSME1;PSMA4
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.44335535735369586,-0.871433830940098,0.7325581395348837,1.0,1.0,11/41,20.37%,NR4A3;NR4A1;NR4A2;CLIP3;ATF5;CTBP1;PID1;KLF4;ERAP1;PER2;MAFB
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.4485019286962631,-0.8713858514097562,0.7444444444444445,1.0,1.0,9/34,20.95%,FTH1;AGT;GSTP1;MED25;FN1;BMI1;S100A6;EMD;CD300A
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.43164752220076663,-0.8707857222038861,0.7419354838709677,1.0,1.0,3/44,4.39%,TFRC;MX2;MX1
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.5781312322925523,-0.870444725279221,0.7076923076923077,1.0,1.0,3/5,41.73%,CRHBP;DLG4;CARF
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.5781312322925523,-0.870444725279221,0.7076923076923077,1.0,1.0,3/5,41.73%,CRHBP;DLG4;CARF
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5438941146200904,-0.8704442450100512,0.6901408450704225,1.0,1.0,1/8,9.06%,AKR1B1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5215603747156676,-0.8703253444409603,0.6842105263157895,1.0,1.0,3/10,18.99%,FCGR2B;PDCD1LG2;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.5554003451066404,-0.8703075579493241,0.6721311475409836,1.0,1.0,1/6,7.78%,BRCA1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3184543312967452,0.8701750836865351,0.7857142857142857,1.0,1.0,10/52,9.59%,CEBPA;LEPR;MCU;PPARGC1A;PPARG;SIRT1;APPL2;ADIPOR2;MBD5;INPP5K
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5110308961966515,-0.8701308928299013,0.7073170731707317,1.0,1.0,8/16,34.33%,UBXN2B;EMD;TARDBP;DCTN1;SPAST;NEMP1;CHMP4B;NSFL1C
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.413603709806525,0.8700521181398929,0.7333333333333333,1.0,1.0,1/12,0.59%,SLC7A8
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5323387618525679,-0.8693262559485647,0.7160493827160493,1.0,1.0,2/11,13.81%,TXK;TEC
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.5071475812765172,0.8692863243672759,0.6571428571428571,1.0,1.0,1/5,9.53%,AMPD3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5354040679902372,-0.869124028700697,0.6911764705882353,1.0,1.0,4/6,40.60%,WARS1;KAT2B;PNKP;HPF1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.3145455840145258,0.8690608149346141,1.0,1.0,1.0,15/71,9.96%,P2RX1;LYL1;TAL1;SH2B3;HHEX;ARHGDIB;SIPA1;RHOG;RPIA;VASP;EPOR;NMI;STK10;GRAP2;FAM78A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5192477401166813,-0.8682079179532044,0.6842105263157895,1.0,1.0,5/8,26.19%,PINK1;PID1;TMSB4X;ENO1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5192477401166813,-0.8682079179532044,0.6842105263157895,1.0,1.0,5/8,26.19%,PINK1;PID1;TMSB4X;ENO1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.542410765304637,-0.8682037479235546,0.7439024390243902,1.0,1.0,2/9,14.28%,ATF3;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.4448356552009628,0.8681523712086647,0.5588235294117647,1.0,1.0,1/8,1.07%,NEDD4
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.510972724442999,-0.8681474153578977,0.675,1.0,1.0,2/11,22.85%,PGAM1;MCM7
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.5346542568030969,-0.8680146839910642,0.6891891891891891,1.0,1.0,2/8,16.73%,GPM6B;CAV3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.4220677616950494,-0.8676840421301525,0.7628865979381443,1.0,1.0,15/65,20.36%,PRLR;RORA;ME1;PEBP1;GAPDH;ADGRL2;PGAM1;EPB41L4B;ZDHHC9;ERRFI1;FKBP5;SH3D19;CPE;GNA11;RND3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5357870818924453,-0.8675879066171523,0.6707317073170732,1.0,1.0,3/8,19.28%,SEMA6A;CD63;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.5440932645043967,0.8674238640742085,0.6551724137931034,1.0,1.0,2/5,7.53%,PPARG;E2F3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.41004089228777557,0.8673656149436223,0.6296296296296297,1.0,1.0,1/13,0.30%,ACER2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5263345598901633,-0.8672239672167088,0.6835443037974683,1.0,1.0,5/11,17.67%,DNAJB9;DDRGK1;COPS5;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.4187361289373221,-0.8668346104813213,0.8144329896907216,1.0,1.0,6/99,5.97%,PRKAR2B;HAUS6;CDK14;TUBB4A;TUBA4A;MASTL
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.46810217480018207,0.8667649175792336,0.65625,1.0,1.0,1/9,6.09%,RNF20
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.47628766933152067,0.8667273420176422,0.6190476190476191,1.0,1.0,4/11,15.49%,UBIAD1;COQ9;COQ5;PDSS2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4615974973861439,-0.8666568151302068,0.7142857142857143,1.0,1.0,3/31,4.35%,FOS;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.41670052810070707,-0.8663993568726392,0.7291666666666666,1.0,1.0,16/81,21.43%,NLRP12;ACVR1B;LRP2;CXCR4;CCL3;IL18;AKAP6;IL1RAPL1;PID1;GHR;KLF4;SIGIRR;EMD;HCLS1;ROBO2;BMPR1B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4852657714596866,-0.8659588024080769,0.6966292134831461,1.0,1.0,5/16,18.65%,BCL2A1;APPL1;BCL2L2;DCC;MCL1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.539162216898384,-0.8658241676708188,0.7361111111111112,1.0,1.0,4/11,25.66%,SLC11A1;BTN3A1;CADM1;CTPS1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.46346207898620345,0.865777151524156,0.5833333333333334,1.0,1.0,3/9,12.03%,PKDCC;TAPT1;SOX5
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.4683742281931864,-0.8655623808316737,0.7037037037037037,1.0,1.0,4/27,9.76%,LRP2;GLUL;SLC7A5;IL10RA
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.5253224862780391,-0.8654636714405518,0.6753246753246753,1.0,1.0,5/9,34.72%,PLCB1;RIPOR2;LRRC8A;BTG1;RANBP3L
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5509763809201251,0.8654118560692637,0.5757575757575758,1.0,1.0,1/5,4.79%,ZRANB1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.3053733506208699,0.8653182523344723,0.8,1.0,1.0,15/67,13.45%,LGALS9;TLR7;TICAM1;UBE2D1;MAPKAPK2;ITGAM;CNPY3;NMI;SCIMP;TRAF6;CHUK;TIRAP;IRAK1;TAB2;TLR10
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.40089192336700474,0.8650445065632669,0.5172413793103449,1.0,1.0,3/13,7.97%,SIRPA;APPL2;CHID1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.43742698049610146,0.8649938598444091,0.625,1.0,1.0,2/10,1.18%,SIRPA;LGALS9
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.4134598666320854,-0.8648504987921898,0.7676767676767676,1.0,1.0,35/116,24.78%,F13A1;PPP1R15A;AKAP12;TSPAN13;TNFRSF1B;IL7R;ERO1A;ID2;IL10RA;CXCR4;SPARCL1;PDCD1LG2;EPB41L3;APOD;SPON1;ITGA2;PRDM1;ABCB1;DNMBP;KLF4;GABRA3;SCG5;SNAP25;CPE;MAFB;ETV1;TSPAN7;RELN;ALDH1A2;GPNMB;CDADC1;GPRC5B;NAP1L2;KIF5C;MAP4K1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.429951391306019,-0.8646398149664586,0.6881720430107527,1.0,1.0,3/44,8.93%,ARAF;DDRGK1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.5140259776365845,-0.8642131753247856,0.6790123456790124,1.0,1.0,2/10,11.21%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4170345486078635,-0.8639914487207803,0.7263157894736842,1.0,1.0,12/82,18.44%,TNFRSF11B;ST18;AIM2;TNFRSF1B;STAT1;PSMA5;TNFSF13B;PSMA3;PYCARD;TRAF2;PSMD8;PSMB4
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.46544037669059257,-0.8637642167079663,0.7441860465116279,1.0,1.0,2/27,7.98%,MX2;ANTKMT
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.5730486917933353,-0.8636913224664776,0.6956521739130435,1.0,1.0,3/6,20.74%,MAPT;FYCO1;KIF3A
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.522209001613363,-0.8635667937433147,0.7058823529411765,1.0,1.0,1/9,0.96%,THBS1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.4763587272458325,-0.8632772238598144,0.7,1.0,1.0,5/19,23.61%,TTN;DMD;SCN3B;RYR2;GAA
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.4195304009087231,-0.8630600682147327,0.8247422680412371,1.0,1.0,6/98,5.97%,PRKAR2B;HAUS6;CDK14;TUBB4A;TUBA4A;MASTL
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.5902704206132888,-0.8630052529984852,0.7575757575757576,1.0,1.0,4/5,40.11%,ANXA2;FLOT2;FLOT1;RFTN1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.5448490070631603,-0.8629564552858034,0.7746478873239436,1.0,1.0,2/9,7.77%,GAS2L3;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.5086945844866828,0.8629515267075353,0.6363636363636364,1.0,1.0,2/5,2.22%,NRP1;DSCAM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.448538648030098,-0.8628849288050617,0.7263157894736842,1.0,1.0,9/41,19.52%,NLRP12;AIM2;NOD2;CCL3;MNDA;CD36;PYCARD;TRIM16;GSDMD
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.4197595330298507,-0.8625657302638468,0.7391304347826086,1.0,1.0,6/64,9.66%,DNAJB9;RNF175;HERPUD1;ANKZF1;SEC61B;TRIM25
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.4709010618108235,0.8624913604610767,0.5,1.0,1.0,1/11,2.49%,TICAM1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.4380429529029987,-0.8623987931246558,0.6989247311827957,1.0,1.0,8/55,23.37%,HAUS6;RAB11A;GOLGA8B;TUBGCP2;RPS3;KIF11;MAP9;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4246360362976081,-0.862339139746858,0.71875,1.0,1.0,8/52,12.31%,CASP5;NOD2;DHX58;FGR;FCGR2B;APPL1;IRF1;BCL6
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.5272846889046356,-0.8620427567221632,0.6764705882352942,1.0,1.0,1/7,6.87%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.40279613837453493,0.8616898766489539,0.6428571428571429,1.0,1.0,8/19,19.72%,TP53;DACH1;ERCC4;SRC;HNRNPC;GNL3L;DCP2;CTC1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.4527311860125306,-0.8615821713419218,0.7272727272727273,1.0,1.0,3/27,6.53%,FA2H;PLPP3;DEGS2
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.516394644935536,-0.8615585754689946,0.7205882352941176,1.0,1.0,4/10,28.26%,SLC4A10;RAB3A;SYP;GRIK2
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.5759979130421737,-0.8614024916129556,0.7164179104477612,1.0,1.0,4/5,42.37%,VIPAS39;PLOD1;PLOD3;PLOD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.42110852858485864,-0.8613441673955008,0.7083333333333334,1.0,1.0,18/73,24.57%,RACGAP1;FCGR2B;CENPE;AP2S1;SEC24C;KIF15;SH3GL2;HLA-DMB;KIF11;KIF3A;DCTN4;ACTR1B;KIF5A;DCTN2;SEC13;DYNC1I1;AP2A2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.46377385285747275,-0.8613422853439577,0.7647058823529411,1.0,1.0,5/27,14.26%,RPL11;DDRGK1;NOP53;CAMLG;SDCBP
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4864291626790871,0.8612649723345249,0.6206896551724138,1.0,1.0,2/8,10.09%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.5298233343912654,-0.8611637782471241,0.7435897435897436,1.0,1.0,1/11,4.57%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3937648220508366,0.8609735886201537,0.6296296296296297,1.0,1.0,8/14,21.00%,TP53;ANP32B;YWHAE;TCF7L2;BAG3;IL1B;TPR;GSK3B
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.49309037483823726,-0.8609728125595836,0.7,1.0,1.0,2/14,9.90%,ALOX12;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.4257457166955703,-0.8606838966550507,0.7835051546391752,1.0,1.0,13/79,15.38%,ACVR1B;TP53TG5;TGFB2;TCHP;FHL1;FBP1;HSPA1B;ADAM15;FGF13;BCL6;DCC;CDKN1B;MAG
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.4430298994462154,-0.8604472893185837,0.6853932584269663,1.0,1.0,7/26,20.31%,PLPP3;ANK3;CD44;CITED2;DENND6A;RNASE10;THY1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.5602113790804488,-0.8604186651760145,0.7083333333333334,1.0,1.0,1/7,3.11%,VEGFA
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4417913357846543,-0.8601752355358813,0.7023809523809523,1.0,1.0,3/28,18.06%,FZD6;GNAO1;CALM1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.540459880040238,-0.8600476872202091,0.6891891891891891,1.0,1.0,2/9,17.51%,GSTP1;RNF13
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4626519600508485,-0.8599627151902647,0.6941176470588235,1.0,1.0,3/25,12.14%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4626519600508485,-0.8599627151902647,0.6941176470588235,1.0,1.0,3/25,12.14%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.420309519078504,-0.859837927308172,0.75,1.0,1.0,14/63,24.36%,VAV3;CHN1;ITSN1;SIPA1L1;EPHA3;SDCBP;AP2S1;EPHB1;NGEF;ACTG1;DNM1;EPHA7;ANKS1B;AP2A2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.5078778313354368,-0.8597114178772306,0.7402597402597403,1.0,1.0,2/10,18.57%,CITED2;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4239860656859388,-0.859665006405701,0.7878787878787878,1.0,1.0,8/115,8.93%,CEMIP;ARIH2;TOMM7;ANK3;VPS11;RHOU;ABLIM3;PINK1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4758221376473251,-0.8594054517987127,0.654320987654321,1.0,1.0,3/17,10.62%,DUSP1;RIOK2;CENPE
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.4356553776555929,-0.8587709255475438,0.7526881720430108,1.0,1.0,15/70,18.33%,HAMP;MYRIP;COBL;ANK3;PPP1R9A;SPARCL1;RAP1GAP;SYBU;EPB41L4B;BMI1;MAPK4;PTPRT;PHYHIPL;PLEKHA7;ARFGEF3
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.573652008085491,-0.8586610216954077,0.704225352112676,1.0,1.0,2/7,20.97%,DNA2;LIG3
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.60431654676259,-0.8586471665336024,0.7971014492753623,1.0,1.0,5/5,39.60%,PPIB;VAPA;YTHDC2;NUCKS1;TBC1D20
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5284442472978835,0.8583559346719357,0.7105263157894737,1.0,1.0,1/5,2.35%,EPB41
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.5284442472978835,0.8583559346719357,0.7105263157894737,1.0,1.0,1/5,2.35%,EPB41
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5446095621144007,-0.8581381974672466,0.7313432835820896,1.0,1.0,1/8,8.93%,PINK1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.3704463201676636,0.8580510583666084,0.6,1.0,1.0,2/20,5.89%,SLC7A8;SLC12A6
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.26367640622742305,0.8580349239603605,1.0,1.0,1.0,9/57,15.47%,ELOA;SUPT16H;POLR2C;GTF2H2;ELOC;ELP4;MNAT1;GTF2F1;CDK13
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5420780437992054,-0.8578862816650056,0.7142857142857143,1.0,1.0,6/8,28.22%,BRCA1;KDM1A;DNMT1;JARID2;ZNF274;RIF1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.4323681785421975,-0.8575688722908302,0.7472527472527473,1.0,1.0,9/59,19.77%,YEATS2;TAF6L;WDR5;MSL3;ING4;ING5;TRIM16;MORF4L2;BRCA2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.42982405588403005,0.8567974345419594,0.65625,1.0,1.0,2/8,4.31%,DAB2IP;PIP4K2B
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.4890329701697058,-0.8566514854609822,0.6973684210526315,1.0,1.0,4/14,20.96%,ATP1B3;SLC12A8;KCNMA1;ATP1B2
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.43533877521426045,-0.8564629454478891,0.75,1.0,1.0,13/48,15.84%,HAMP;RHOB;GLUL;ABCC3;BNIP3;SAT2;GPC3;SLC10A1;TM7SF2;EPB41L4B;ALDH6A1;SCD;GHR
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.43794742322469826,-0.8559372649369605,0.7526881720430108,1.0,1.0,5/47,12.91%,RHOBTB3;RHOB;GPM6B;IQGAP1;EPHA3
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.5526547460810339,-0.8554548378968958,0.7464788732394366,1.0,1.0,2/7,17.58%,DDX11;RPS3
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.4983874082173615,-0.8550034890081276,0.7307692307692307,1.0,1.0,6/15,33.56%,SNX10;STIL;DCTN2;CSNK1D;BBS4;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4473555827560477,-0.8549608782463354,0.7526881720430108,1.0,1.0,7/43,10.82%,THBS1;SEMA6A;SPARC;TGFB2;EPN1;STAT1;PGK1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.5645014588715702,-0.8549169555433467,0.7857142857142857,1.0,1.0,2/6,11.26%,COBL;STIL
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.45505690463934195,-0.8546849186736395,0.6829268292682927,1.0,1.0,7/27,21.57%,PPP1R15A;MASTL;CALM3;CALM1;PPP1R11;CD300A;PPP4R4
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.5911949047540488,-0.8546432647376594,0.7428571428571429,1.0,1.0,2/5,9.21%,FGF1;PAX8
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3781434773309123,0.8546216601090435,0.6470588235294118,1.0,1.0,9/25,12.50%,NEXMIF;DAB2IP;SRGAP2;NTNG2;IGSF10;SRGAP2C;SHTN1;ADGRG1;PLXNB2
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.4136448364403812,-0.8544119958475896,0.6888888888888889,1.0,1.0,13/56,22.97%,RBX1;FANCI;FANCM;BRCA1;PINK1;ARRDC3;BMI1;KDM1A;RPS2;UBB;SEPTIN4;PRICKLE1;RIPK2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.4145214132607773,-0.8538958261506518,0.74,1.0,1.0,14/120,19.11%,VIM;RPS27A;SLC11A1;CARHSP1;NOCT;UBA52;UBC;PSMA5;PSMA3;RIDA;PSMD8;UBB;PSMB4;ZFP36
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.5450927232766,-0.8537886283818382,0.6933333333333334,1.0,1.0,3/9,20.46%,XRCC3;SLX4;DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.5450927232766,-0.8537886283818382,0.6933333333333334,1.0,1.0,3/9,20.46%,XRCC3;SLX4;DNA2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.5450927232766,-0.8537886283818382,0.6933333333333334,1.0,1.0,3/9,20.46%,XRCC3;SLX4;DNA2
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5555331008898721,-0.8537066882189326,0.6764705882352942,1.0,1.0,2/5,25.86%,ALDH6A1;BCAT1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.4994639144551486,-0.8535539736783165,0.7283950617283951,1.0,1.0,2/15,7.20%,THBS1;DUOX1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.45612057393979355,0.8535443507540448,0.6666666666666666,1.0,1.0,2/12,9.42%,LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4315852368923204,-0.8533408660353152,0.6781609195402298,1.0,1.0,10/39,22.53%,TFRC;TNFRSF1B;CR1;IL15;PDCD1LG2;HLA-DMB;TNFRSF21;AIF1;LILRB2;GPNMB
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.45742771518208214,-0.8532951782398146,0.6976744186046512,1.0,1.0,2/26,4.45%,PPP1R15A;VAV3
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5009769904316214,-0.85326267262524,0.7530864197530864,1.0,1.0,6/20,15.09%,MAP1B;HDGFL3;FGF13;MID1IP1;APC2;TTBK2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.4639895517469702,-0.8532466373095018,0.7241379310344828,1.0,1.0,3/29,6.80%,TGFB2;RBPJ;NOD2
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.5588352259476164,-0.8531510604140591,0.7419354838709677,1.0,1.0,1/5,18.34%,CITED2
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5336704931992144,-0.8528938280592947,0.6626506024096386,1.0,1.0,3/8,29.37%,TYMP;UPP2;MACROD1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.2926983408153199,0.852830583107384,1.0,1.0,1.0,16/101,10.65%,ZDHHC3;RAMP1;EHD4;RAP1A;SMURF1;TSPAN15;PTCH1;RAPGEF6;ZDHHC2;SLMAP;WNK3;RAB10;INPP5K;TSPAN17;TSPAN33;RAP2A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5569754508681961,-0.8523186115438911,0.7777777777777778,1.0,1.0,3/8,17.84%,IQSEC1;EPB41L4B;ARF6
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.46351284636343015,-0.8519560848410681,0.7674418604651163,1.0,1.0,6/23,23.61%,FBP1;PGM1;APOD;SORD;IRS2;GAA
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4564397997860113,-0.8518448696196472,0.6626506024096386,1.0,1.0,2/22,6.53%,FA2H;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5569996068695491,-0.8515963792321687,0.7397260273972602,1.0,1.0,3/7,17.84%,IQSEC1;EPB41L4B;ARF6
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.4852254941369366,0.8514784115966522,0.6206896551724138,1.0,1.0,1/5,13.31%,CLEC16A
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.2985345489083122,0.8514290379329154,0.9090909090909091,1.0,1.0,17/57,13.58%,LGALS9;MAP3K10;MAP3K5;MAP4K2;MAPK13;MAPK11;BTRC;MAP3K11;TRAF6;TRIB1;CHUK;CRKL;MAP4K3;IRAK1;FBXW11;TAB2;UBE2N
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.502339017572305,0.8513993994553581,0.7058823529411765,1.0,1.0,1/6,3.90%,RAB22A
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.5626404614492492,-0.8513409727312499,0.782051282051282,1.0,1.0,4/6,43.30%,THBS4;ROCK1;ITGB1BP1;MEGF10
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4224971497694828,-0.8512273082548639,0.7628865979381443,1.0,1.0,14/77,21.05%,PPP1R15A;HINT1;TNFRSF1B;ERO1A;BCL2A1;BRCA1;BNIP3;BCL2L2;PYCARD;TRAF2;C1QBP;MCL1;GSKIP;CIDEB
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.5576572447519506,-0.8509288643928284,0.6666666666666666,1.0,1.0,1/7,8.69%,FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.42144250506535663,0.8506726455866496,0.75,1.0,1.0,4/14,6.37%,ZNF385A;BCL2L1;SIRT1;CXCL12
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.5769065263101898,-0.8503764854641163,0.7246376811594203,1.0,1.0,1/6,16.92%,TRAF2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.42854325806273647,-0.8501093778089736,0.7878787878787878,1.0,1.0,4/77,4.72%,RHOBTB3;DENND2A;RAB7B;RNF126
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.45719517965808204,-0.849866900382263,0.7108433734939759,1.0,1.0,6/20,23.61%,PHKG1;PGM1;NR1D1;CALM1;PER2;GAA
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.5304645257417275,-0.8498272341183694,0.6973684210526315,1.0,1.0,3/8,22.79%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.4286246658576264,-0.8495757096232865,0.7446808510638298,1.0,1.0,8/47,18.34%,NUDT16;TGFB2;MEIS2;HCFC1;CCPG1;CDKN1B;RGCC;CITED2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.41191556422311865,0.8494469702793518,0.5882352941176471,1.0,1.0,2/18,2.47%,PTPRM;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.49265029258696125,-0.849306078651696,0.7567567567567568,1.0,1.0,5/16,27.08%,IL1RAPL1;PTPRD;SS18L1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4655249059225819,-0.8491314814086675,0.7976190476190477,1.0,1.0,6/23,24.85%,SLC11A1;B2M;CUTC;TF;FBXL5;HFE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.49648173082264,-0.8491145873162964,0.7317073170731707,1.0,1.0,2/14,10.45%,PINK1;BNIP3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.40333047488131435,-0.8488134272507022,0.7777777777777778,1.0,1.0,22/113,16.19%,VIM;INSIG1;HMGB2;ADCY3;RORA;TNFRSF1B;GSTP1;NOD2;BRINP1;ADAM15;RORB;PDK3;ABCB4;PDCD1LG2;EPHA3;CARD16;PDE4B;CFTR;PID1;NR1D1;PTK7;PYCARD
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.45975847511354284,-0.8487423348093615,0.6455696202531646,1.0,1.0,2/25,7.30%,SLF1;RPA2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.489616710589158,-0.8485168185143267,0.7058823529411765,1.0,1.0,7/13,35.22%,LPCAT1;PNPLA8;ABCA3;LPCAT4;PLA2G4A;PGS1;CDS2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.41469588874904045,-0.8484798473798252,0.8105263157894737,1.0,1.0,20/66,23.55%,HTR2B;TNFRSF1B;HSPA1B;BNIP3;BNIP3L;DCC;CD36;CDKN1B;EPHB1;RRAS2;UBB;IMPACT;CLU;SOX4;ATG5;LRPAP1;CIDEB;RIPK2;CRYAB;ACER3
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.3145701914301592,0.848374776479965,0.7692307692307693,1.0,1.0,8/41,9.59%,CEBPA;LEPR;MCU;PPARG;APPL2;ADIPOR2;MBD5;INPP5K
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.510340149794042,-0.8481938210370366,0.7142857142857143,1.0,1.0,2/13,15.41%,PRELID1;PRDM1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5425243180395736,-0.8481081725073324,0.7625,1.0,1.0,1/8,6.19%,GSTP1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.5383898295307855,-0.8478876424056969,0.7428571428571429,1.0,1.0,2/8,4.91%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5213544645800723,-0.8476099763289161,0.7432432432432432,1.0,1.0,2/12,16.73%,ANK2;CAV3
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.5361912388628552,-0.8472734019270359,0.7164179104477612,1.0,1.0,7/10,42.15%,ZWILCH;CHAMP1;KNL1;IK;MTBP;MIS12;CENPT
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.3917391348223761,0.8472385462505346,0.7333333333333333,1.0,1.0,3/18,4.54%,MEP1A;RAP1A;LGR4
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.412785821431794,-0.8471513012195067,0.6881720430107527,1.0,1.0,8/50,11.59%,SVIL;CENPV;RACGAP1;RAB11A;PRKCE;CALM3;KLHL13;CIT
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.31978415218075434,0.8471415167914078,1.0,1.0,1.0,7/62,5.37%,ACER2;FER;LGALS9;MAPKAPK2;PPARG;CTSH;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.5573373879252943,0.8470543243345484,0.6388888888888888,1.0,1.0,2/5,5.07%,SH2B3;SLIT3
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.41651094678827766,-0.8470380911393882,0.7802197802197802,1.0,1.0,12/58,19.50%,ARAF;ERO1A;FBXL2;SERP1;UBA52;USP6;GGCX;SLC35A1;PIGH;UBE2M;CPE;DUSP12
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.5463989732558562,-0.8469614451420805,0.7464788732394366,1.0,1.0,1/8,1.32%,VIM
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.45797005205475755,-0.8467988596219299,0.6790123456790124,1.0,1.0,5/28,8.93%,PRELID1;ATP5IF1;SOD1;MAPT;PINK1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.5086383365226104,0.8466981435942283,0.6428571428571429,1.0,1.0,2/6,7.53%,PPARG;E2F3
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.56496412054943,-0.8464687446528174,0.6666666666666666,1.0,1.0,1/5,16.58%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.56496412054943,-0.8464687446528174,0.6666666666666666,1.0,1.0,1/5,16.58%,KLF4
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.32355285189193905,0.8464111876052344,0.9,1.0,1.0,4/48,6.15%,NRP1;FER;SRGAP2;NTNG2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.324770130939667,0.8461214587686897,0.7333333333333333,1.0,1.0,4/33,7.32%,SESN2;NUAK1;SESN3;TP53
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.42000322647245514,-0.8457896018800469,0.8229166666666666,1.0,1.0,11/94,11.88%,HTR2B;GLIPR2;CCL4;CHI3L1;GPR183;C5AR1;NOD2;MARCO;CCL3;NOTCH2;MAP3K12
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.44944943678487953,0.8457257046679768,0.5769230769230769,1.0,1.0,1/9,1.28%,TGFA
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.429977206283493,-0.8456609698458689,0.7525773195876289,1.0,1.0,10/60,11.25%,RGS2;PAQR3;SEMA6A;AGT;GSTP1;SPRY1;DUSP1;PEBP1;CAMK2N1;PRDM15
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5012988359134399,-0.8453860979902379,0.7125,1.0,1.0,6/16,31.48%,MTHFD1;PRPS1;GUK1;GART;GDA;HPRT1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5188834251012283,-0.8453210812447527,0.7674418604651163,1.0,1.0,1/12,8.89%,SSB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.45185479284127633,-0.8449874859689622,0.7717391304347826,1.0,1.0,9/38,19.52%,NLRP12;AIM2;NOD2;CCL3;MNDA;CD36;PYCARD;TRIM16;GSDMD
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.5777398711843719,-0.8448420002838147,0.7761194029850746,1.0,1.0,1/5,1.10%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.5777398711843719,-0.8448420002838147,0.7761194029850746,1.0,1.0,1/5,1.10%,GLA
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.5507392918279812,-0.8446645312394824,0.7534246575342466,1.0,1.0,2/7,22.40%,MAPT;BEX4
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.5321739295183877,-0.8444249877588431,0.7763157894736842,1.0,1.0,1/8,3.11%,VEGFA
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.40850395948144974,-0.8441809167346084,0.711340206185567,1.0,1.0,9/55,22.17%,SEC61B;SERP1;BNIP1;LNPK;EIF2AK3;TMEM33;EMD;REEP5;VCPIP1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.4029755251464724,-0.8440920409816413,0.7857142857142857,1.0,1.0,11/97,19.28%,NR4A3;FOS;VAV3;PRKCQ;PSMA5;PSMA3;TEC;PSMD8;CALM1;PSMB4;PIK3CB
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5147874790623772,-0.8437480657617079,0.7142857142857143,1.0,1.0,1/7,1.18%,CD55
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3260159729841418,0.8436915445601818,0.875,1.0,1.0,10/51,15.02%,CPSF4;WDR33;SNRPB;GTF2H2;LSM11;PAPOLA;CSTF1;TAF1A;MNAT1;SCAF8
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.43499401268581367,0.8435591503619396,0.5555555555555556,1.0,1.0,5/17,11.89%,RAP1A;ICAM1;PPP1R16B;MSN;COL15A1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.42156473601664873,-0.8434921677903202,0.7395833333333334,1.0,1.0,16/71,20.74%,CENPF;LRP2;SLCO1A2;PLTP;SCAMP3;ABCA5;PCTP;ABCA9;TXNIP;ARRDC3;TAP1;ABCA1;PEX3;ABCA8;ABCA6;KIF3A
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5264933310596427,-0.843441889800285,0.7108433734939759,1.0,1.0,2/10,15.76%,CCDC39;ADCY10
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.5809119199939801,-0.8434188344618122,0.7894736842105263,1.0,1.0,2/6,21.59%,NOD2;CRACD
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.42662467161695494,-0.8431921066573803,0.7415730337078652,1.0,1.0,6/47,9.37%,RSAD2;TGFB2;POLR3F;NOD2;FCGR2B;IL15
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.4440122635129242,0.842975066825986,0.5517241379310345,1.0,1.0,3/8,7.63%,LCP1;ICAM1;EIF2AK4
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3767432951689981,0.84294012287556,0.88,1.0,1.0,8/24,20.91%,SCRIB;MSN;RAP2A;CDC42;OPHN1;LIN7B;LIN7A;MARK2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5549281869600345,-0.8428296612786272,0.7027027027027027,1.0,1.0,2/7,20.64%,DDRGK1;TMSB4X
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5272781070938479,-0.8428070460194569,0.6712328767123288,1.0,1.0,5/9,37.32%,PNPLA8;PLA2G4A;PGS1;HADHA;TAMM41
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.47902239971179966,-0.842650889374897,0.7246376811594203,1.0,1.0,3/14,8.53%,LRP2;TGFB2;BASP1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.4665707478434127,-0.842555828950054,0.6883116883116883,1.0,1.0,3/12,10.31%,GSTP1;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.4665707478434127,-0.842555828950054,0.6883116883116883,1.0,1.0,3/12,10.31%,GSTP1;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.5556775575960852,-0.8423674503169065,0.7647058823529411,1.0,1.0,3/6,22.39%,DHDDS;IDI1;MVD
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3550267525073422,0.8423196693231291,0.6923076923076923,1.0,1.0,5/27,14.43%,BACH2;SNRPB;SNUPN;PHAX;NUTF2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.47638850742955324,0.8422799404609752,0.6363636363636364,1.0,1.0,4/10,15.49%,UBIAD1;COQ9;COQ5;PDSS2
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.47638850742955324,0.8422799404609752,0.6363636363636364,1.0,1.0,4/10,15.49%,UBIAD1;COQ9;COQ5;PDSS2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.48565760121542634,-0.8413590630607874,0.7468354430379747,1.0,1.0,3/17,11.26%,MMP21;CCDC39;STIL
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.4004118017858087,-0.841340018113095,0.8383838383838383,1.0,1.0,40/162,24.21%,DOK6;SEMA6A;SEMA3A;LAMA2;EMB;ANK3;CCK;NTN4;MAP1B;UNC5C;PRKCQ;CXCR4;SHANK3;NOTCH2;RAP1GAP;EPHA3;NRXN1;FEZ1;RAB3A;NLGN3;DCC;PALLD;EPHB1;ENAH;SPG11;SLC9A6;S100A6;SPTBN5;PIK3CB;IRS2;NRXN3;ROBO2;RELN;PTPRA;KIF5A;EPHA7;PLPPR4;NTNG1;MAP1A;KIF5C
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.49401101869691755,0.8412789812479158,0.6333333333333333,1.0,1.0,2/6,7.78%,RYR1;P2RY6
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.33371705219873693,0.841276479168599,0.9090909090909091,1.0,1.0,8/41,15.25%,LRP10;ABHD11;TMEM79;DENND1C;ANXA11;PIEZO1;RHBDF2;SCAMP2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4435993546471984,-0.8407483521980781,0.7439024390243902,1.0,1.0,10/31,21.94%,PTN;COBL;ZDHHC15;RTN4IP1;DCC;ALK;NSMF;HECW2;CSMD3;MFSD2A
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3122220789968798,0.84070452740003,0.8333333333333334,1.0,1.0,6/33,13.51%,MAP3K4;TP53;ERCC4;SRC;NVL;NAF1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5447790957136621,-0.8405197113576419,0.7164179104477612,1.0,1.0,3/6,36.31%,KLF4;SLC25A37;PRMT1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.41393236212957596,-0.8404500079223097,0.8367346938775511,1.0,1.0,14/90,25.68%,TFRC;DDX11;INCENP;CD36;DHX16;TIMELESS;ILF3;MCM3;EIF3D;DDB1;PDCD11;TBRG4;GART;EIF3A
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.39644260044530183,-0.8403508233192376,0.8247422680412371,1.0,1.0,19/161,15.69%,TFRC;THBS1;FGF1;VEGFA;HIF1A;SLCO3A1;PFKFB4;FLT1;PINK1;FAXDC2;CLIP3;MARCO;EPHA3;FAM20A;SDCBP;EPHB1;ITGA6;ALK;PFKFB3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.46419453226557106,-0.8403362451237151,0.7468354430379747,1.0,1.0,1/16,2.13%,MYLK
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.4077959225262476,-0.8397480414301136,0.7551020408163265,1.0,1.0,9/90,19.48%,NAMPT;INSIG1;SYAP1;APPL1;PKM;RAB15;INSR;ATP6V1D;IRS2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.41033998627657464,0.839735926843084,1.0,1.0,1.0,13/60,7.32%,SELPLG;LYL1;TAL1;CEBPA;SH2B3;CSF1R;JAG1;TGFBR2;PLD4;TGFB1;WNT2B;RUNX1;TP53
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4936375277912489,-0.8395479098720858,0.7303370786516854,1.0,1.0,4/19,22.32%,TGFB2;CCL3;MCL1;EPHA7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4731675948959343,0.8395227845794709,0.6,1.0,1.0,5/11,28.90%,CEP290;TREM2;CEP120;SCFD1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.4840647693168345,-0.839331759417891,0.7073170731707317,1.0,1.0,3/14,16.45%,VPS11;ATP5IF1;RDX
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4816895979747609,-0.8388509640230222,0.7738095238095238,1.0,1.0,4/18,13.73%,RBX1;RPA2;RPA3;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4816895979747609,-0.8388509640230222,0.7738095238095238,1.0,1.0,4/18,13.73%,RBX1;RPA2;RPA3;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.5625181079563564,-0.8386771360236303,0.7246376811594203,1.0,1.0,1/5,4.00%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5441042752279486,-0.8384266378395702,0.7631578947368421,1.0,1.0,2/7,11.21%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.46246595248705746,-0.8382950612446697,0.7375,1.0,1.0,5/23,20.49%,VEGFA;CD63;SDCBP;INSR;LRPAP1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.4694566136023183,-0.8381167120591881,0.725,1.0,1.0,5/14,24.98%,INTS12;ZCCHC8;INTS10;INTS8;INTS3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.35320193144937867,0.8379068199505324,0.6875,1.0,1.0,21/21,64.74%,RNF185;TOR1A;UFD1;CUL3;YME1L1;STUB1;NGLY1;KLHL15;POMT2;VCP;BAG6;UGGT1;ZYG11B;HDAC6;ZER1;FBXL17;ATXN3;AUP1;LONP1;UGGT2;DERL1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.43187213291919413,0.8378858473945331,0.75,1.0,1.0,2/15,14.16%,MCM9;TASOR
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.48273286977654534,-0.8378671075369347,0.7,1.0,1.0,5/13,22.85%,MCMDC2;RFC4;MCM3;LIG3;MCM7
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.3801287841829508,0.8378635982261096,0.5882352941176471,1.0,1.0,3/17,5.33%,HMGA1;BAHD1;SIRT1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.32714199350469997,0.8374359471792123,0.8181818181818182,1.0,1.0,2/36,2.47%,IDE;DAB2IP
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4114060431696063,-0.8372590804042848,0.8315789473684211,1.0,1.0,7/74,12.14%,RPS27A;ACVR1B;FOS;TGFB2;APPL1;UBA52;UBC
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.44503821969336066,-0.8372506060190634,0.7261904761904762,1.0,1.0,3/29,7.16%,TGFB2;SPRY1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.49531863539268794,-0.8371134696310426,0.7088607594936709,1.0,1.0,6/16,33.90%,APPL1;INSR;IRS2;SORBS1;CLTCL1;CAPN10
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5126501940327073,-0.8359547194322721,0.7375,1.0,1.0,2/10,9.14%,PKP2;ID2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.4019696796334035,0.8356423229321629,0.6363636363636364,1.0,1.0,2/16,2.59%,EDA2R;ATP2C1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5693704181330469,-0.8354153579795064,0.7391304347826086,1.0,1.0,1/5,4.00%,TGFB2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.5153230257587499,-0.8353006828583672,0.7567567567567568,1.0,1.0,1/9,8.93%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.5416271444861624,-0.8351526727208363,0.7142857142857143,1.0,1.0,3/8,21.49%,NOD2;UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.36079512573520056,0.835130949217128,0.88,1.0,1.0,8/18,18.48%,LCP1;FSCN1;LIMA1;EPS8;PLS1;ADD1;MICAL1;BAIAP2L2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.5124868593993414,0.8351154675139606,0.6666666666666666,1.0,1.0,1/5,0.59%,SLC7A8
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.5696160041833103,-0.8350083774609511,0.7571428571428571,1.0,1.0,2/5,22.36%,SLX4;MUS81
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5591935600063096,-0.8348269908812311,0.7580645161290323,1.0,1.0,3/5,40.18%,CACNG2;DLG4;CACNG8
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5591935600063096,-0.8348269908812311,0.7580645161290323,1.0,1.0,3/5,40.18%,CACNG2;DLG4;CACNG8
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.32627104169145865,0.8346485633619931,0.7692307692307693,1.0,1.0,6/35,8.24%,IPPK;PLD4;ISYNA1;OCRL;ITPKB;PLCB4
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.4533676574064071,-0.8345872228344086,0.7888888888888889,1.0,1.0,9/33,16.68%,NOB1;NGDN;RPS8;UTP3;RPS14;RIOK2;RRP36;RPS16;WDR46
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.5011066534801807,-0.8344548829089012,0.72,1.0,1.0,1/13,1.08%,OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.42855829635421183,-0.8344378771070536,0.7441860465116279,1.0,1.0,8/36,19.23%,TFRC;IL15;PDCD1LG2;IL18;PYCARD;RPS3;HLA-DMB;AIF1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.5132398363773087,0.8343875519083137,0.7,1.0,1.0,1/6,4.23%,LAPTM5
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.44933618472681536,0.8343105109043699,0.64,1.0,1.0,1/8,3.56%,GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.46220487779418884,-0.834233878516544,0.7317073170731707,1.0,1.0,6/21,22.13%,PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1;LILRB2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4863921597189321,-0.834146986956769,0.7037037037037037,1.0,1.0,1/15,7.73%,NHP2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5334925414333351,-0.8341003780217391,0.7777777777777778,1.0,1.0,3/7,34.85%,TERF2IP;H3-3A;DAXX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5334925414333351,-0.8341003780217391,0.7777777777777778,1.0,1.0,3/7,34.85%,TERF2IP;H3-3A;DAXX
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.43677761925253766,0.8340198888745296,0.6451612903225806,1.0,1.0,2/10,4.78%,FER;PDPN
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5136140390822568,-0.8339917686602648,0.7631578947368421,1.0,1.0,2/10,10.99%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.5110580806471922,0.8335340785375945,0.7037037037037037,1.0,1.0,1/5,3.94%,DPH5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4055081513277532,-0.8335141354863451,0.782608695652174,1.0,1.0,6/64,10.55%,RNF144B;ARIH2;RBX1;DDRGK1;HSPA1B;NOP53
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.527877761233255,-0.8333049279669476,0.717948717948718,1.0,1.0,2/7,14.28%,SEC61B;HSPA5
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.2659502505875358,0.8330677206612304,1.0,1.0,1.0,24/97,18.52%,RUBCNL;PRKAB2;VTA1;PIP4K2B;ILRUN;TOMM70;HDAC10;CHMP2B;STAM2;TBC1D5;UBXN6;MTMR14;SRC;DYNLL2;EI24;YOD1;PLEKHM1;MFN1;PRKAB1;ARL8B;TECPR1;PRKN;VPS37A;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5004065739777779,-0.8327700729652665,0.6973684210526315,1.0,1.0,3/12,17.95%,VEGFA;CD63;INSR
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4202457670816067,0.8324479082333309,0.7333333333333333,1.0,1.0,3/7,9.89%,ENPP1;ITPA;AK3
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.406238812428616,-0.8322427945609987,0.8260869565217391,1.0,1.0,6/69,10.55%,RNF144B;ARIH2;RBX1;DDRGK1;HSPA1B;NOP53
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.40790064743542875,-0.8321479253389925,0.7604166666666666,1.0,1.0,18/75,24.57%,RACGAP1;FCGR2B;CENPE;AP2S1;SEC24C;KIF15;SH3GL2;HLA-DMB;KIF11;KIF3A;DCTN4;ACTR1B;KIF5A;DCTN2;SEC13;DYNC1I1;AP2A2;DCTN1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5025757092076667,-0.8317193878833934,0.7341772151898734,1.0,1.0,3/14,9.71%,LSR;COBL;ARID5B
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.4124550980144009,-0.8316732750930277,0.7634408602150538,1.0,1.0,5/46,4.58%,PLPP3;SPARC;VEGFA;ADAMTS2;LAMA2
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.5400880870089472,-0.8315082577789793,0.8192771084337349,1.0,1.0,2/10,12.56%,SAT2;SAT1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.27584247121489447,0.831078218318512,1.0,1.0,1.0,12/92,13.31%,SESN2;NEDD4;EXOC8;PRKAB2;SESN3;SIRT1;UBQLN2;LAMTOR1;RRAGD;TBC1D25;SMCR8;CLEC16A
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.47675550385529447,-0.8309953111409307,0.7631578947368421,1.0,1.0,5/16,27.17%,PAICS;IMPDH1;AMPD2;GART;PFAS
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.44701136139573105,-0.8309623130710628,0.7303370786516854,1.0,1.0,6/36,10.82%,THBS1;SEMA6A;SPARC;TGFB2;STAT1;PGK1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.31999329249201175,0.8308346431817053,0.75,1.0,1.0,8/36,13.35%,IPPK;PLD4;ISYNA1;OCRL;ITPKB;PLCB4;FGF2;PLCB3
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4799700262153223,-0.8303628120336998,0.7532467532467533,1.0,1.0,4/16,11.59%,FAM162A;GAPDH;BNIP3;CIT
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.4001555490205338,-0.8301152340523059,0.84375,1.0,1.0,24/111,20.66%,INSIG1;PRKAR2B;PLPP3;BHLHE40;GCNT1;DUSP1;MAP1B;COL11A1;PRKCE;SIPA1L1;LTBP1;NOTCH2;KCNMA1;ADGRL2;CDKN1B;RASA2;ANXA2;MGLL;CITED2;INPP4B;ATP2B4;NFIB;RND3;AMPH
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5672835445950951,-0.8300331067933898,0.7868852459016393,1.0,1.0,1/5,9.93%,ATP5F1D
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.4420914449576474,-0.8299897129455289,0.7241379310344828,1.0,1.0,13/31,28.72%,SEMA6A;ADAMTS19;COL26A1;GPC3;FRAS1;GABRB3;EPHA7;POU5F1;CNTNAP2;UNC5D;CRMP1;CACNA1B;LINGO1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.416467463533562,-0.8295725443749187,0.7555555555555555,1.0,1.0,1/47,0.32%,GPR18
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4812092351978532,-0.8295339377769824,0.7922077922077922,1.0,1.0,5/22,19.11%,KNSTRN;SYAP1;IQGAP1;EEF1A1;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.43863088257545635,-0.8295283092195075,0.8255813953488372,1.0,1.0,5/28,16.45%,SH2D4A;ATP5IF1;NEIL1;RRP1B;RDX
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5100688335975938,-0.8294315082134116,0.7407407407407407,1.0,1.0,4/9,37.49%,AP2S1;AP2A2;AP2M1;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5100688335975938,-0.8294315082134116,0.7407407407407407,1.0,1.0,4/9,37.49%,AP2S1;AP2A2;AP2M1;VLDLR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.44849947728338296,0.8293908777733626,0.7,1.0,1.0,1/6,3.67%,NFATC3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4946248002440644,-0.8291764820917725,0.7391304347826086,1.0,1.0,1/11,1.18%,CD55
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5195912857527187,-0.8286918397165176,0.676056338028169,1.0,1.0,1/9,3.11%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.45639613404430524,0.828502432791433,0.6,1.0,1.0,1/9,4.76%,JAG1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.3891048009222495,0.8284565317139455,0.631578947368421,1.0,1.0,2/11,3.20%,RALB;CGAS
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.391582077416717,0.8278636724123013,0.6111111111111112,1.0,1.0,3/13,12.91%,ALG1;MPDU1;ALG3
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.393239165017114,-0.827505183266908,0.7878787878787878,1.0,1.0,22/141,20.30%,TFRC;ALG10B;FGF1;VEGFA;SLCO3A1;PPP2R5A;CNEP1R1;PINK1;FAXDC2;CLIP3;CALM3;MARCO;FAM20A;NSMF;LIMK2;INSR;CALM1;TERF2IP;ASPSCR1;TXN;VEGFB;MUSK
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4165808060189422,-0.8274835673550565,0.8020833333333334,1.0,1.0,11/37,25.68%,HERPUD1;PINK1;DAPK2;BCL2L2;EIF2AK3;PYCARD;BMF;MCL1;SEPTIN4;RACK1;SIAH1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.4347361266951809,-0.8273931121631715,0.7195121951219512,1.0,1.0,5/20,22.54%,KDM6B;KDM3A;KDM1A;KDM5C;KDM4B
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.39586683016162205,0.827392426836851,0.5625,1.0,1.0,2/16,6.85%,MKKS;BBS10
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.322642990914684,0.8273306879760667,0.8571428571428571,1.0,1.0,5/39,5.78%,ZNF703;SMAD7;FSCN1;CDHR3;VCL
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.3759380613253045,0.8270365555940306,0.625,1.0,1.0,1/16,0.59%,SLC7A8
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.43165500939963175,-0.8267849084691324,0.797752808988764,1.0,1.0,7/44,11.96%,OSBPL5;PRELID1;ATP8B1;PLTP;ATP10A;ABCB4;PCTP
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.5060661455140738,0.826707600812268,0.6764705882352942,1.0,1.0,2/5,30.04%,IDH2;IDH3A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5107435401092885,-0.8266876265798627,0.7866666666666666,1.0,1.0,5/10,33.18%,TYMP;SLC25A19;SLC19A2;DCK;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4668000419006689,-0.8266592235952144,0.7721518987341772,1.0,1.0,8/28,20.79%,RSAD2;TGFB2;FCGR2B;IL15;B2M;ECHDC3;IER5;ARG2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.43372780677250744,-0.826439202051528,0.7586206896551724,1.0,1.0,4/32,6.95%,RHOB;ARHGAP4;CFL1;RHOU
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.4136407016305275,-0.826436629418578,0.7741935483870968,1.0,1.0,6/49,9.77%,NR4A1;RHOB;ALOX15B;DUSP1;BRINP1;CAMK2N1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3855259309244649,-0.8261577236223276,0.9393939393939394,1.0,1.0,33/209,19.48%,HTR2B;ARAF;RPS27A;PAQR3;FGF1;WDR83;RBX1;NEFL;PEBP1;MAP3K8;PRKCQ;SHANK3;FGF13;CCL3;UBA52;RASGRP4;UBC;PSMA5;RASGRF2;PSMA3;PPP1CB;IL18;RASA2;ZDHHC9;PSMD8;NRG4;UBB;CALM1;PSMB4;SPTBN5;ZFP36;PIK3CB;IRS2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.5312937687171135,-0.8260539405501601,0.8142857142857143,1.0,1.0,1/8,17.73%,AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.5312937687171135,-0.8260539405501601,0.8142857142857143,1.0,1.0,1/8,17.73%,AP3M2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4985522966153337,-0.8260285135876632,0.7101449275362319,1.0,1.0,1/8,4.35%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5368732626843752,-0.8253533679029491,0.7466666666666667,1.0,1.0,3/6,19.28%,SEMA6A;ATP2B4;PIK3CB
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5508170851405937,-0.8253098970858506,0.7941176470588235,1.0,1.0,2/6,36.83%,NPM1;XPO1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.32858353237202154,0.8252086222638544,0.875,1.0,1.0,4/39,6.90%,MIER3;SIRT1;MTA2;HDAC10
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.5363405595277132,-0.8250615886561911,0.7432432432432432,1.0,1.0,1/8,1.32%,VIM
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3557903196061406,0.8250568528551038,0.8,1.0,1.0,8/19,18.48%,LCP1;FSCN1;LIMA1;EPS8;PLS1;ADD1;MICAL1;BAIAP2L2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.287449684353513,0.825040669167065,1.0,1.0,1.0,7/77,7.01%,TIFA;EHD4;PKD2;RYR1;ALOX5AP;APPL2;ALDH9A1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.5673241717753399,-0.8248943593905542,0.8,1.0,1.0,2/7,27.92%,GRM3;GABBR2
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.38588033745541706,-0.8247928479635822,0.9,1.0,1.0,20/128,21.51%,KCNE1;SLC11A1;ATP1B3;SLC6A15;SCN9A;KCNH8;TMEM175;TRPM3;SLC24A1;KCNC1;SLC9A6;KCNK10;RYR3;CACNA1C;ATP2B4;NALCN;SCN1A;SLC24A2;KCNH7;SCN3B
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.5177381247819032,-0.8247790345384628,0.759493670886076,1.0,1.0,6/9,47.59%,PSMD5;OTUD6B;POMP;PSMG1;ADRM1;PSMD4
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.4534615217800949,-0.8245847461978697,0.6835443037974683,1.0,1.0,1/19,1.56%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.3693492883589955,0.8244866982842177,0.6363636363636364,1.0,1.0,6/18,18.33%,MAPK11;ABL1;CDON;CDC42;TCF3;MEF2C
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.4440535146944731,-0.824347107708586,0.7640449438202247,1.0,1.0,2/23,6.69%,SLC11A1;NOCT
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4060210192715553,-0.824254090755507,0.87,1.0,1.0,8/112,10.40%,DDIT4;NLRP12;PAQR3;PLPP3;GSTP1;CAMK2N1;DMD;CALM3
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.42612931791661496,-0.8241648837672082,0.7777777777777778,1.0,1.0,7/43,16.26%,TOMM7;BNIP3;TIMM13;TMEM14A;TOMM40;TOMM20;BCS1L
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.4636015525083184,-0.8238048867048178,0.7027027027027027,1.0,1.0,7/14,28.19%,CR1;IRF1;BCL6;LILRB2;IL4I1;FANCA;DUSP10
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.4531484105624024,-0.8237905311414236,0.717391304347826,1.0,1.0,11/24,26.95%,RIMS1;STX19;RAB3A;CPLX1;SYT1;SNAP25;UNC13A;UNC13C;RIMS2;PIP5K1C;RIMS3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.5529474019516164,-0.823699396803115,0.71875,1.0,1.0,3/5,36.31%,KLF4;SLC25A37;PRMT1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5122844897426783,-0.8235569448627379,0.6753246753246753,1.0,1.0,3/7,25.66%,PRPS1;CAD;CTPS1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4814529657575657,-0.8232105419830147,0.7162162162162162,1.0,1.0,2/9,8.93%,COX7A2;PINK1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.47147622279463064,0.8228317446575532,0.6764705882352942,1.0,1.0,5/6,34.15%,EXOSC9;EXOSC6;XRN1;EXOSC7;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.40211792563854243,-0.8227483206136859,0.826530612244898,1.0,1.0,16/83,17.58%,NLRP12;CYCS;ST18;FAM162A;BEX3;CASP5;MTCH1;EGLN3;MAPT;DAPK1;EIF2AK3;GRAMD4;KHDC1;PYCARD;TRAF2;RPS3
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.47750465248491963,-0.8225624242003825,0.7368421052631579,1.0,1.0,4/14,7.77%,TOM1L1;ADGRG6;PKP2;BAIAP2L1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.5404025807987396,-0.8225337877547803,0.75,1.0,1.0,1/6,7.14%,DUSP1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.5475584961925696,-0.8222486234164756,0.7857142857142857,1.0,1.0,1/7,1.32%,VIM
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5353090923365051,-0.821458207261949,0.7230769230769231,1.0,1.0,4/8,40.46%,AP1AR;KANK1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5353090923365051,-0.821458207261949,0.7230769230769231,1.0,1.0,4/8,40.46%,AP1AR;KANK1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.41495167173465475,-0.8214572831208335,0.8041237113402062,1.0,1.0,14/56,24.85%,IFIT2;DDX11;ADAM15;CARD16;B2M;IFIT1;TTBK2;KDM1A;TFIP11;LRPAP1;DVL1;MAP2;RACK1;HFE
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.473492404799374,-0.8211435110257282,0.7105263157894737,1.0,1.0,2/18,5.97%,PPP1R15A;MASTL
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.4424209943332574,-0.8208501837073603,0.759493670886076,1.0,1.0,1/28,1.90%,PLPP3
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.34678235017406256,0.8206453441380829,0.76,1.0,1.0,4/18,8.93%,ARV1;OSBPL6;LAMTOR1;NR1H3
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.5180089790021734,-0.8205179593588959,0.7222222222222222,1.0,1.0,4/8,36.20%,UBXN2B;CEP250;NSFL1C;BICD1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.4406667564785999,-0.8204583405559133,0.7738095238095238,1.0,1.0,1/26,1.34%,NAPA
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.45748748750406604,0.8202631070002232,0.55,1.0,1.0,1/6,1.29%,MAP1S
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.38534988921443475,-0.8202039609849632,0.8585858585858586,1.0,1.0,29/122,23.85%,AGT;PRELID1;NDRG1;STAT1;PINK1;DAPK1;PAX8;BNIP3;NOP53;DAPK2;BEX2;BNIP3L;TPT1;LGALS1;BCL6;USP36;ALK;TRAF2;CTSB;RPS3;TP53INP1;BCL2L14;CLU;SRA1;CIDEB;SEPTIN4;SGK1;ACER3;TARDBP
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.3962155375414601,0.8200810272905779,0.7916666666666666,1.0,1.0,4/11,21.00%,DVL2;DVL3;LRP6;GSK3B
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4581498050086614,-0.8193488525882763,0.7317073170731707,1.0,1.0,7/20,22.10%,ENO4;ENO2;NPRL2;ANXA2;TBC1D14;RAB5A;ENO1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4992746486046221,-0.8191749532555997,0.7702702702702703,1.0,1.0,2/14,10.55%,DDX11;NOP53
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.4244499095520877,0.8190691400610846,0.7407407407407407,1.0,1.0,5/12,13.39%,ELAVL4;MAPKAPK2;TIRAP;ELAVL1;HNRNPC
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4756789429060302,-0.8190587509938955,0.7777777777777778,1.0,1.0,2/17,13.36%,PINK1;USP36
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.48037534037369456,-0.8187628364172144,0.7468354430379747,1.0,1.0,2/11,22.15%,PINK1;HK2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.3995471553317128,-0.818561374986599,0.8247422680412371,1.0,1.0,32/114,22.91%,CLEC12A;F13A1;TGFB2;CD93;TNS1;MS4A4A;CD163;CXCR4;PROCR;NOTCH2;MS4A6A;MNDA;THBD;CDH2;TXNIP;CD36;BMI1;ITGA6;ABCB1;ALDH1A1;GNL3;CD44;SERPING1;AIF1;SIGLEC1;TLR2;THY1;BAALC;IL3RA;LILRB2;CD14;KITLG
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.4339581422964851,-0.8184084019720292,0.7529411764705882,1.0,1.0,5/21,17.59%,SEMA3A;MAP1B;NLGN3;SPG11;SLC9A6
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.4134549958896771,-0.818378269502608,0.7872340425531915,1.0,1.0,16/53,23.01%,NFIL3;PDK3;ATF5;ATF3;ANTXR2;TM7SF2;SCD;ERRFI1;TP53INP1;CLU;IDI1;ACTG1;PLSCR1;GUSB;MVD;GNAI1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4123038907710478,-0.818356964148047,0.8297872340425532,1.0,1.0,13/62,25.62%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS21;MRPL13;MRPL32;MRPS15
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.445768661549594,-0.8182512776152148,0.8241758241758241,1.0,1.0,16/31,30.21%,CALY;COL26A1;RAP1GAP;PHYHIPL;CPLX1;SYT1;KLC4;SYT4;FAAH;STMN2;ST8SIA3;PCSK1N;SLC12A7;LINGO1;PTOV1;SCAMP5
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.4955420910001047,-0.8182179437201832,0.6984126984126984,1.0,1.0,2/9,17.88%,KIF1B;ERC2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.5432352554303943,-0.8181476760052451,0.7230769230769231,1.0,1.0,2/5,26.45%,PMPCA;PMPCB
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.44890121166523256,-0.8180151981746041,0.813953488372093,1.0,1.0,8/31,18.76%,AGT;VPS11;PINK1;HCFC1;CD36;RDX;TRAF2;GFAP
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.4139003538505154,0.8177006731393738,0.7222222222222222,1.0,1.0,4/13,6.42%,NRP1;PKD2;TGFBR2;SALL1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.45146671285992845,-0.8176509514379787,0.7375,1.0,1.0,5/30,20.97%,DDX11;FANCM;DONSON;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.44002266981503857,-0.8176460624710715,0.7721518987341772,1.0,1.0,2/20,10.86%,HLA-B;HLA-F
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.5034037674751163,0.8176101213376091,0.6060606060606061,1.0,1.0,2/5,30.29%,SVIP;RAB3GAP1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.36024612020174873,0.8175433611040331,0.7619047619047619,1.0,1.0,4/13,12.99%,LPL;PPARG;NR1H3;TTC39B
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.4278845781044228,0.8175262339506307,0.6333333333333333,1.0,1.0,3/10,23.35%,RNF185;TOR1A;UFD1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.3291369212754824,0.8173808064214813,0.8461538461538461,1.0,1.0,13/35,19.69%,RIOK1;TGFB1;ZPR1;TP53;WDR43;MAP2K1;BUD23;MAP2K2;ZC3H18;DYRK1A;IL1B;GRSF1;HNRNPLL
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.5522089048341835,-0.8173385104566687,0.7857142857142857,1.0,1.0,2/5,35.17%,GUCY1B1;MT3
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.5522089048341835,-0.8173385104566687,0.7857142857142857,1.0,1.0,2/5,35.17%,GUCY1B1;MT3
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.5046313607225253,-0.8169428529304067,0.717948717948718,1.0,1.0,5/12,24.47%,RIMS1;SYT1;UNC13A;SYT4;RIMS2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5046313607225253,-0.8169428529304067,0.717948717948718,1.0,1.0,5/12,24.47%,RIMS1;SYT1;UNC13A;SYT4;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.47840433376324265,0.816531921796332,0.6666666666666666,1.0,1.0,2/6,9.65%,CD274;TWSG1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.4707231334772388,-0.8164408125239984,0.725,1.0,1.0,4/13,24.98%,INTS12;INTS10;INTS8;INTS3
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.42141826138727506,0.816058433986829,0.6470588235294118,1.0,1.0,1/7,5.77%,APPL2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.4607580985167139,0.8157015947684872,0.6470588235294118,1.0,1.0,3/6,25.55%,ST6GAL1;CSGALNACT1;EXTL2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.38976116731140814,0.8154897024997335,0.7894736842105263,1.0,1.0,4/20,7.73%,FER;PKD2;SOCS6;NMI
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.4020525998252543,-0.8153660645184212,0.71875,1.0,1.0,17/41,37.24%,PSMA5;PSMA3;AZIN1;PSMD8;PSMB4;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2;PSMB6;PSME2;ODC1;PSMC6;PSMD14;PSME1;PSMA4
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.49540348094892067,-0.8153201156630979,0.7671232876712328,1.0,1.0,4/11,21.01%,ABHD12B;LIPE;MGLL;FAAH
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.4621257810566171,-0.8153053824736204,0.85,1.0,1.0,4/29,13.12%,TFRC;GLUL;PARP9;EIF2AK3
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.39719802308239693,-0.8152320747970209,0.8229166666666666,1.0,1.0,15/65,19.11%,VIM;HMGB2;TNFRSF1B;GSTP1;NOD2;PRKCE;CCL3;PDCD1LG2;CARD16;PDE4B;IL18;NR1D1;PYCARD;PDCD4;ZFP36
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.41092188320421363,-0.8151085269233458,0.85,1.0,1.0,29/74,28.50%,SH3PXD2B;DOCK1;DZIP1;MAP1B;CAMK2N1;SLC13A4;HSPA12A;APLP1;SRRM3;KAZN;LIFR;LRP4;TMEM132A;CPE;GFAP;TNFRSF21;NGEF;GNA11;SEZ6L2;RBFOX2;GPRC5B;MPDZ;TMEM59L;AGAP1;NLGN2;NR2F1;APP;SEMA3B;NDRG4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3791754827631885,0.8144541270205174,0.64,1.0,1.0,2/12,6.49%,CAP1;STIM1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.4003038165638087,0.8142550170278503,0.6129032258064516,1.0,1.0,2/10,6.91%,ZNF703;SYK
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.460019785003695,0.8141557047826173,0.6451612903225806,1.0,1.0,2/7,19.57%,PPT1;GRN
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4266494046123337,-0.8140449342908165,0.7608695652173914,1.0,1.0,3/28,12.00%,NOD2;SOD1;MID1IP1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.40420137091849584,-0.8140364691880569,0.7934782608695652,1.0,1.0,13/44,20.96%,AGT;TGFB2;ATP1B3;PLN;ANK2;CALM3;CAV3;CALM1;RYR3;ATP2B4;ASPH;ATP2B2;ATP1B2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.4316808793818773,-0.8138874785969826,0.7590361445783133,1.0,1.0,8/28,27.61%,CLVS1;ABCA1;CLVS2;TPP1;ACP3;GAA;MBTPS1;ATP10B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.5107688193679243,-0.8138276457299459,0.7317073170731707,1.0,1.0,2/9,18.93%,NOD2;HCLS1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.40986066647363373,0.8136108940559511,0.6451612903225806,1.0,1.0,1/5,1.15%,FER
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.47538333216316436,0.813388039986879,0.59375,1.0,1.0,1/5,2.74%,LRCH1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4085984105119573,0.8133500044660957,0.7352941176470589,1.0,1.0,2/9,10.46%,ACOX1;EHHADH
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.38471995034172046,0.8131014630892809,0.7142857142857143,1.0,1.0,1/9,3.51%,DOCK10
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5406577305061399,-0.8128160606497578,0.8169014084507042,1.0,1.0,1/6,8.09%,LPCAT1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.4735707900146775,-0.812715074225036,0.7236842105263158,1.0,1.0,2/12,11.48%,SULT4A1;PPA1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.5613177071514125,-0.8124451545299123,0.8243243243243243,1.0,1.0,1/5,3.11%,VEGFA
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.5613177071514125,-0.8124451545299123,0.8243243243243243,1.0,1.0,1/5,3.11%,VEGFA
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.46861478130709516,-0.8124338712631702,0.7792207792207793,1.0,1.0,6/15,20.88%,SHANK3;NRXN1;NLGN3;LRP4;MUSK;NRXN2
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.4100433946078802,0.812415002900357,0.75,1.0,1.0,3/10,18.00%,SETD1B;TET2;KMT2A
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.42099439186760473,-0.8123487458837778,0.7872340425531915,1.0,1.0,15/44,23.08%,CBR1;VEGFA;MTHFD1;STAT1;PAX8;GSTK1;PGK1;STIL;CTSB;TIMELESS;ERRFI1;ALDH1A2;TPP1;MFSD2A;DVL1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.4495445707327986,0.812326847033901,0.72,1.0,1.0,1/11,2.11%,ZNF385A
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.30556845697174556,0.812294271074872,0.8888888888888888,1.0,1.0,1/35,0.81%,PUS1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.39537501733431724,-0.8121240434715409,0.8315789473684211,1.0,1.0,17/60,22.62%,VIM;HMGB2;TNFRSF1B;GSTP1;NOD2;FCGR2B;PDCD1LG2;CARD16;PDE4B;NR1D1;PYCARD;PDCD4;ZFP36;TLR2;CHMP5;LILRB2;CD14
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.4119910734346115,-0.8118164172198038,0.7865168539325843,1.0,1.0,9/39,22.66%,KCNJ13;ATP1B3;SLC12A8;SLC24A1;SLC9A6;ATP2B4;ATP1B2;SLC24A2;KCNJ3
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3199705784234811,0.8118012502466223,0.6666666666666666,1.0,1.0,4/38,6.90%,MIER3;SIRT1;MTA2;HDAC10
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.37623931326484694,0.8115476251983273,0.7586206896551724,1.0,1.0,4/10,14.49%,SEMA4D;NTNG2;SPRY2;MOV10
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.5410674124652761,-0.8114430896331342,0.7792207792207793,1.0,1.0,2/6,14.20%,FGF13;DCC
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.38251425413999673,-0.8113456789714992,0.9175257731958762,1.0,1.0,29/180,20.30%,TFRC;PAQR3;PLPP3;FGF1;VEGFA;SLCO3A1;PPP2R5A;PPP2R5B;SOD1;FGR;PINK1;FAXDC2;CLIP3;TTN;NOP53;MARCO;ATF3;EIF2AK3;FAM20A;FN1;PID1;STAT2;SH3GL2;LIMK2;INSR;IMPACT;TERF2IP;VEGFB;MUSK
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.431309728833193,-0.811146950550345,0.8488372093023255,1.0,1.0,7/34,19.77%,YEATS2;TAF6L;WDR5;ING4;ING5;TRIM16;BRCA2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4186207635269168,0.8111380281554535,0.6538461538461539,1.0,1.0,4/10,10.00%,RFWD3;TP53;SDE2;PLK3
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.406356039350583,-0.8109992637003384,0.7526881720430108,1.0,1.0,6/53,13.46%,NLRP12;OSMR;AGT;IL15;CCL3;IL18
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4969823120444216,-0.8106013017761866,0.7313432835820896,1.0,1.0,3/8,29.34%,CENPE;SEH1L;CHAMP1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.48317603988637736,-0.8104535180012026,0.7590361445783133,1.0,1.0,1/11,2.97%,HAMP
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4876324374269139,-0.8103619666033446,0.7439024390243902,1.0,1.0,4/11,26.25%,RIOK2;CENPE;HECW2;ANAPC7
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.38731823645420654,-0.8099670286107027,0.9052631578947369,1.0,1.0,29/128,23.81%,PAQR3;SPOCK1;SEMA3A;PTN;CFL1;CHN1;ZDHHC15;SIPA1L1;LRRC4C;SHANK3;RTN4IP1;CDH2;EPHA3;DCC;IL1RAPL1;ITGA6;MAG;PTK7;TOX;ATP1B2;RELN;CSMD3;SERPINI1;LRRC7;MFSD2A;RTN4RL1;STMN2;NTNG1;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5624132793595238,-0.8098356402637586,0.7692307692307693,1.0,1.0,1/5,6.19%,GSTP1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5552465032640639,-0.8093375285992008,0.7857142857142857,1.0,1.0,3/5,34.97%,HOOK3;AKTIP;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.47377359280046616,0.8092148152519898,0.7142857142857143,1.0,1.0,1/8,6.09%,RNF20
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.4338747693292419,-0.8090893169365367,0.8452380952380952,1.0,1.0,9/40,21.07%,TGFB2;PKP2;CDH9;CDH12;CDH2;CTNND2;CDH8;CADM1;CADM2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.4651341117716199,-0.8088256356543627,0.7922077922077922,1.0,1.0,4/12,27.20%,CLIP3;SPG11;DYNC1I1;APP
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.483762529400543,-0.8085190649457986,0.7564102564102564,1.0,1.0,2/12,15.40%,TNFRSF1B;NR1D1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5077268913612314,-0.8083002550457526,0.7428571428571429,1.0,1.0,4/9,31.33%,PMPCA;PMPCB;SPG7;AFG3L2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.47757634375572977,0.8081189894406577,0.631578947368421,1.0,1.0,1/5,6.09%,RNF20
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.3265552569799443,0.808028466727931,1.0,1.0,1.0,9/47,10.09%,NRP1;FER;ABL1;VASP;NCK2;SORBS3;BIN1;CDC42EP3;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.44748216901352267,-0.8080207797648837,0.7727272727272727,1.0,1.0,4/22,15.38%,FGF13;DCC;CDKN1B;MAG
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.3659748706613777,0.8079229552404709,0.7391304347826086,1.0,1.0,2/14,2.69%,GSDMB;NLRP1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.5601000658482398,-0.8078999609724289,0.7540983606557377,1.0,1.0,1/5,21.31%,RELN
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.2874829070811448,0.8074783344272041,0.9090909090909091,1.0,1.0,3/42,7.63%,EHD4;RAB7A;DENND1C
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.39130077160018334,-0.807421140450012,0.8556701030927835,1.0,1.0,10/75,14.80%,JAML;MYO1G;SELL;IL7R;CD69;IL10RA;ACAP1;ITGAE;TCF7;LSP1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.47806378415580014,0.8072207998426291,0.6,1.0,1.0,2/5,11.35%,METTL16;BUD23
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.40806126786209085,-0.8071816964137455,0.7582417582417582,1.0,1.0,10/46,14.09%,RPS27A;ASPN;VASN;FBN2;SPRY1;PEG10;LTBP1;UBA52;UBC;SNX6
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.28067270014199036,0.8069838964088301,1.0,1.0,1.0,13/63,9.71%,GSN;TBC1D22B;ALMS1;TBC1D10B;UBQLN2;MSN;TBC1D16;TRAPPC12;SDCCAG8;SENP6;EVI5;TBC1D12;TBC1D5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.48043019315124624,0.8068718162671107,0.75,1.0,1.0,1/5,3.67%,NFATC3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.36106623093547957,0.8068067648117795,0.7,1.0,1.0,6/22,12.48%,SMAD7;TGFB1;PMEPA1;ACVR1;TWSG1;SNX25
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.42364890178756315,-0.8067597578362993,0.7471264367816092,1.0,1.0,8/28,26.09%,LPCAT1;GK;GNPAT;ITPKC;NFS1;GK5;TKT;PIP5K1A
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.4250241499900016,0.8066645440162091,0.6,1.0,1.0,2/9,4.93%,RAB33B;RAB7A
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.5442951975693429,-0.8066240656720256,0.7972972972972973,1.0,1.0,1/5,3.34%,SEMA3A
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.5050431794720557,-0.8064465962707975,0.7397260273972602,1.0,1.0,1/8,4.57%,XRCC3
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.5589889728059637,-0.8062872063337242,0.8076923076923077,1.0,1.0,3/6,23.38%,RBPJ;CPE;RYR2
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.48511144901824754,0.80608283036987,0.6129032258064516,1.0,1.0,1/5,5.78%,ACVR1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.3417393560453671,0.8058827019287734,0.7058823529411765,1.0,1.0,5/20,8.53%,P2RY12;SRGAP2;VCL;WHAMM;CDH13
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.49586892100262503,-0.8057849575510212,0.7352941176470589,1.0,1.0,4/5,44.21%,GMFB;GMFG;PICK1;CTNNA2
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.4334020195685029,-0.8057225535287621,0.7848101265822784,1.0,1.0,3/24,17.55%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4632842009676004,-0.8054748461541995,0.7325581395348837,1.0,1.0,5/14,23.50%,AGTPBP1;GGCX;TPGS1;TTLL7;TTLL5
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4029335826321667,-0.8054512434379864,0.7857142857142857,1.0,1.0,9/64,22.34%,PLPP3;NIT1;MTHFD1;ACOT13;VNN2;BTD;CPE;ACSM3;NSMAF
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.41100410030956896,-0.8054425454292666,0.797752808988764,1.0,1.0,5/42,4.58%,PLPP3;MYLK;ASPN;TNS1;LAMA2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.3256995299939878,0.8052329378278388,0.7272727272727273,1.0,1.0,11/42,12.58%,LGALS9;KLHDC10;DAB2IP;QARS1;MAP4K4;SCIMP;MAP2K1;ARL6IP5;RAP2A;MAP2K2;FAS
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.4372990629259318,-0.8051670587011597,0.8023255813953488,1.0,1.0,4/21,4.91%,FAAH2;CBR1;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.5114584018758542,-0.8051225962804924,0.7307692307692307,1.0,1.0,3/7,35.21%,GRIA2;APP;GRIN3A
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.3790915158532698,-0.8048281670843673,0.826530612244898,1.0,1.0,22/115,22.59%,CBR1;MT2A;TGFB2;MTHFD1;FBP1;BLVRB;PAPSS2;PINK1;ID2;ABCC3;ETS2;RAP1GAP;CD36;ADH5;PTS;SSR3;NFS1;GAD1;ARG2;HACL1;GABARAPL1;FAH
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.40422069722358334,-0.8047259402843562,0.8315789473684211,1.0,1.0,13/61,25.62%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS21;MRPL13;MRPL32;MRPS15
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.39953036229837846,-0.8045947573347494,0.84375,1.0,1.0,13/66,25.62%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS21;MRPL13;MRPL32;MRPS15
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.55541963611901,-0.8044932236982689,0.8115942028985508,1.0,1.0,1/6,3.11%,VEGFA
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.5045526206553654,-0.8042627825975592,0.75,1.0,1.0,1/7,11.51%,NOTCH2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4015301322719071,-0.803993616814465,0.8620689655172413,1.0,1.0,14/65,24.34%,FAM50A;PQBP1;RPS13;RRP1B;AHNAK;C9ORF78;METTL4;CLK1;CLK2;RPS26;U2AF2;AKAP17A;MBNL2;SRSF3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.4811343782634503,-0.8039157762427942,0.8095238095238095,1.0,1.0,1/15,3.28%,RTN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.45378003972542547,-0.8038789457610963,0.8505747126436781,1.0,1.0,3/22,10.87%,RORA;FBP1;PDK3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.4249636420364582,-0.8037476753062684,0.7816091954022989,1.0,1.0,5/32,14.31%,RBPJ;DTX3;STAT1;NOTCH2;TRAF7
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.356520214417247,0.8033178333956895,0.7857142857142857,1.0,1.0,4/30,5.78%,SMAD7;SMURF1;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.356520214417247,0.8033178333956895,0.7857142857142857,1.0,1.0,4/30,5.78%,SMAD7;SMURF1;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.34052310253300877,0.8030244970156469,0.6818181818181818,1.0,1.0,3/15,5.37%,JAG1;SLIT3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3859335440544275,-0.8028568968575563,0.8829787234042553,1.0,1.0,15/118,18.71%,FZD6;RBMS3;LZTS2;RBX1;DKK2;AMER2;LIMD1;TLE1;PSMA5;APC2;PSMA3;PSMD8;LRP4;PSMB4;EMD
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4745558066961627,-0.8027199597872817,0.759493670886076,1.0,1.0,3/11,20.77%,PRELID1;CLU;GHITM
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4184343199197704,-0.8026773101440654,0.8045977011494253,1.0,1.0,4/39,9.97%,BRIP1;NDRG1;CLSPN;DONSON
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3050213112781738,0.8025108199552078,0.8333333333333334,1.0,1.0,7/40,10.51%,SMAD7;NXN;BAG5;ARRB2;ABL1;SPRY2;SVBP
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.45282673820688685,-0.802446780159104,0.759493670886076,1.0,1.0,1/19,3.96%,RSAD2
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.3726487139709212,-0.8022841996291399,0.88,1.0,1.0,27/124,16.75%,ENPP2;CD55;RGS1;PLPP3;SPARC;TNS1;LAMA2;SGCE;MEIS2;COBL;DUSP1;SLC7A5;PAPSS2;CDH9;RIOK2;SLC31A2;CXCR4;SPARCL1;EPB41L3;DGKI;ENO2;ARMCX3;GPM6A;PID1;SHROOM4;ALDH1A1;ENAH
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3769159131723975,-0.80224823378937,0.865979381443299,1.0,1.0,23/123,23.56%,CLDN18;TNFRSF11B;INSIG1;VCAN;ALOX15B;SGCE;ADAM15;TGFBI;NLGN3;DHX16;ITGA2;CNTN1;CDH8;PIK3CB;ADAM23;THY1;NRXN2;CADM2;ACTG1;MVD;GNAI1;JAM3;CERCAM
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.5580402652196039,-0.8021836688240995,0.8823529411764706,1.0,1.0,4/5,40.07%,ABCA1;ABCG1;APOC1;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.40386141733428993,-0.8021053736715968,0.7916666666666666,1.0,1.0,11/52,20.47%,LRP2;VEGFA;SHANK3;SMARCD3;METRN;IL1RAPL1;PTPRD;KDM1A;SS18L1;NEURL1;ROBO2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.38344558958604213,0.8016178152434716,0.6666666666666666,1.0,1.0,5/40,7.66%,GCLC;PFKP;HHEX;MSRA;PRDX6
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.4553993055962859,0.8014468273408333,0.7142857142857143,1.0,1.0,2/7,3.83%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.4907079206871608,0.8013867664871903,0.71875,1.0,1.0,1/5,4.23%,LAPTM5
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.5450945543462976,-0.8012748299956916,0.7435897435897436,1.0,1.0,3/5,39.21%,PRUNE1;ATCAY;BNIP2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4460526968184395,-0.8012021245376759,0.8275862068965517,1.0,1.0,2/22,8.89%,TENT4B;SSB
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.45956523571750163,0.8008545541489803,0.6363636363636364,1.0,1.0,1/6,8.16%,CYP19A1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.39696459453820043,0.8006252102096527,0.7619047619047619,1.0,1.0,3/12,13.42%,ALMS1;FHOD1;CDC42
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.516256873803931,-0.8005760306516728,0.726027397260274,1.0,1.0,3/6,37.32%,PGS1;CDS2;TAMM41
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5029506329211932,-0.8002802031808484,0.7692307692307693,1.0,1.0,5/9,31.82%,CD36;EIF2AK2;NLRC3;DHX33;GBP5
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.46935083974767355,-0.8001653214032256,0.7764705882352941,1.0,1.0,1/17,3.28%,RTN1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.3768697644763208,-0.799870274155474,0.8163265306122449,1.0,1.0,6/76,9.66%,DNAJB9;RNF175;HERPUD1;ANKZF1;SEC61B;TRIM25
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4133147889673192,0.7996643584725517,0.7777777777777778,1.0,1.0,2/14,5.29%,FSCN1;SCRIB
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.5200766304076828,-0.7996259211929332,0.7941176470588235,1.0,1.0,3/6,35.59%,INSR;RAC1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.38391735180904135,0.7996137576878016,0.75,1.0,1.0,3/15,8.46%,PLA2G7;CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.44523005056919224,-0.7989753087527304,0.7341772151898734,1.0,1.0,1/16,1.71%,PRKAR2B
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.34833733830021973,0.7989347987656282,0.8235294117647058,1.0,1.0,6/19,20.21%,RHOG;CDH13;EPS8;CYFIP1;ELMO1;TIAM1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.4410026622911598,-0.798534973109235,0.7619047619047619,1.0,1.0,5/24,19.10%,TUB;FSIP2;SNX10;TCTN1;ATP6V1D
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.42549027337623163,0.7984913544871868,0.7037037037037037,1.0,1.0,1/8,13.31%,CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.48008961341170503,-0.7978250150441747,0.8433734939759037,1.0,1.0,2/9,19.36%,CFTR;ADCY8
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.4742103165623379,-0.7977465494932902,0.7468354430379747,1.0,1.0,2/12,11.26%,BRCA1;STIL
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.386429021908731,-0.7975474244926892,0.8105263157894737,1.0,1.0,15/103,17.30%,TFRC;PAPPA2;SPOCK1;AGT;PINK1;OGFR;PRKCQ;ATF5;HCFC1;ERMN;PAK5;CD36;AP2S1;TRAF2;ATAD3A
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.3759672686526804,0.7973903885219858,0.8421052631578947,1.0,1.0,1/15,2.57%,PKD2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3813184218410509,0.7972951963402903,0.7391304347826086,1.0,1.0,2/12,5.80%,NRP1;ABL1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.38686351299474975,-0.7969045547689069,0.9183673469387755,1.0,1.0,37/160,22.32%,DDIT4;SPOCK1;VCAN;GRIK1;LSR;MEIS2;GSTP1;MAL;NR4A2;UTP3;PAX8;MARCKSL1;EIF2B2;CXCR4;MOG;CDH2;ADGRL2;APOD;ADGRL3;PTPRZ1;BTD;SHROOM4;POU6F1;TUBGCP2;SH3GL2;TAGLN3;PTS;ADAM23;SOX4;NFIB;ROBO2;HPCAL4;RELN;SERPINI1;TPP1;MFSD2A;EPHA7
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.49679960378907895,-0.7964553357597882,0.7972972972972973,1.0,1.0,3/7,42.45%,FES;HLA-DRB1;ACIN1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.41820105378927325,-0.7963916217130205,0.75,1.0,1.0,8/29,24.85%,B2M;ARF6;PIK3CB;CLU;LRPAP1;RAB21;TF;HFE
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.47426776809169835,0.796380824368504,0.71875,1.0,1.0,2/5,4.42%,NEXMIF;PPM1F
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.40538314934151404,-0.7958637573403889,0.8023255813953488,1.0,1.0,10/44,20.47%,OMG;CHN1;SIPA1L1;LRRC4C;CDH2;METRN;MAG;LRP4;THY1;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3985581237148701,-0.7953751760781529,0.8673469387755102,1.0,1.0,13/90,18.10%,CCL4;RGS1;HMGB2;GNB5;PINK1;CALM3;CCL3;RAP1GAP;ITGA6;LARS1;RPS3;CALM1;GBA3
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5287385080814198,-0.7953152211093056,0.7878787878787878,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.43151968743565733,-0.7951726740618443,0.7875,1.0,1.0,7/24,26.67%,CLVS1;ABCA1;CLVS2;TPP1;ACP3;GAA;MBTPS1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.43463088644418096,0.7949034838463782,0.7272727272727273,1.0,1.0,1/8,5.23%,AGO1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.43463088644418096,0.7949034838463782,0.7272727272727273,1.0,1.0,1/8,5.23%,AGO1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.43837015756865516,-0.794860616581959,0.8314606741573034,1.0,1.0,6/29,19.02%,DHX58;CR1;NLRC5;OAS3;STAT2;SERPING1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4940229523633096,-0.7947982501164732,0.7906976744186046,1.0,1.0,6/11,30.74%,PARP9;KMT5C;DTX3L;SMCHD1;RIF1;PRKDC
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.5147109961326535,-0.794529783937692,0.8181818181818182,1.0,1.0,2/9,10.02%,TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5122581897150207,-0.7943859368730019,0.7428571428571429,1.0,1.0,1/6,4.43%,APOLD1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.5469079156584398,-0.7939889499570134,0.7714285714285715,1.0,1.0,1/6,6.80%,NOD2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.3622147098337408,0.7939832296432416,0.8333333333333334,1.0,1.0,4/12,10.51%,RCN3;CTSH;CST7;SVBP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.41429047285297266,-0.7939360916902733,0.8636363636363636,1.0,1.0,7/47,20.29%,TFRC;NMD3;PARP9;EIF2AK3;LIMK2;HCLS1;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.41769331498767337,-0.7937420354423309,0.7802197802197802,1.0,1.0,7/37,15.20%,AGT;VEGFA;NRXN1;NLGN3;IL1RAPL1;PTPRD;EPHB1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.4727194062317798,-0.7936278625068715,0.7692307692307693,1.0,1.0,3/9,26.54%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.37763082770023354,-0.7934612618358077,0.8484848484848485,1.0,1.0,24/123,25.55%,TXK;THEMIS2;PRKCQ;EIF2B2;BTN2A2;MOG;PSMA5;BTN3A1;PSMA3;PDE4B;TEC;PSMD8;PSMB4;TNFRSF21;PIK3CB;THY1;NFKBIZ;BTN2A1;RIPK2;PSMD7;NFKBID;PSMD5;PSMB9;PSMC2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3939828706491666,-0.7934523974422251,0.7916666666666666,1.0,1.0,11/48,25.04%,FIGNL1;RAB11A;MAPT;CLIP3;KATNAL2;TUBGCP2;LIMK2;STMN3;FIGN;DCTN1;SPAST
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.44547162675177115,-0.7934444270551982,0.8235294117647058,1.0,1.0,7/25,28.26%,RIMS1;NSF;ANXA2;SYT1;RIMS2;RIMS3;GRIK2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.4814067151334633,-0.7933350598772912,0.7916666666666666,1.0,1.0,3/11,24.52%,KLF4;TMSB4X;OTUD7B
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.37188588465892625,0.7933289539413247,0.7272727272727273,1.0,1.0,2/18,1.58%,DGUOK;ADK
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4137705328321814,-0.793308475814202,0.8229166666666666,1.0,1.0,12/41,25.71%,CYCS;AIM2;DAPK1;GRAMD4;PYCARD;ASPH;CIDEB;RIPK2;GRIN2A;UACA;CARD9;CASP1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.29950912478776887,0.7931002046222055,0.9,1.0,1.0,2/42,0.92%,SLC7A8;SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.38510171767777973,-0.793093198590309,0.8064516129032258,1.0,1.0,10/49,19.48%,AGT;TGFB2;FLT1;FGR;IL18;FN1;INSR;HCLS1;PIK3CB;IRS2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3092682108660294,0.792903145449703,1.0,1.0,1.0,5/73,5.33%,NUP42;NUP188;BAG5;MAPKAPK2;SIRT1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.371607052755784,-0.7925998169705653,0.89,1.0,1.0,26/138,25.55%,TXK;VAV3;THEMIS2;PRKCQ;EIF2B2;BTN2A2;MOG;PSMA5;BTN3A1;MNDA;PSMA3;PDE4B;TEC;PSMD8;PSMB4;TNFRSF21;PIK3CB;THY1;NFKBIZ;BTN2A1;RIPK2;PSMD7;NFKBID;PSMD5;PSMB9;PSMC2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4386823072983156,-0.7923506857943594,0.7564102564102564,1.0,1.0,1/16,5.04%,SH2D4A
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.5307605353972911,-0.7923102014530841,0.8387096774193549,1.0,1.0,1/6,21.12%,METTL4
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.4828569216749073,-0.7920791800417614,0.8227848101265823,1.0,1.0,2/13,14.18%,DUSP1;PPP2R2B
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.45605477145750417,-0.791928441113501,0.8243243243243243,1.0,1.0,2/13,11.59%,LIMD1;CIT
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.3789984521041258,0.7914658225506014,0.8125,1.0,1.0,3/18,5.37%,TNFAIP8L3;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.4046574652767037,-0.7913444580243923,0.7840909090909091,1.0,1.0,7/36,18.42%,TALDO1;CFL1;SOD1;LMNB1;RPLP0;ANXA2;PDCD4
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.45870098576518026,-0.7911883189044623,0.7777777777777778,1.0,1.0,2/13,17.67%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4947369668393786,-0.7911572367857542,0.7397260273972602,1.0,1.0,2/9,10.55%,PRELID1;NOP53
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.5090317712130279,-0.791085161796473,0.7857142857142857,1.0,1.0,2/7,20.48%,CNEP1R1;VRK1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5320542640439634,-0.7909802642237039,0.8529411764705882,1.0,1.0,1/7,5.70%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.4474971738638001,-0.7908078320119211,0.7530864197530864,1.0,1.0,7/20,27.20%,PTN;SHANK3;ADCY8;RELN;LILRB2;EPHA4;APP
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4175243387421184,-0.7904452643000102,0.7764705882352941,1.0,1.0,9/30,24.85%,VEGFA;B2M;CD63;ANXA2;INSR;CLU;RAB21;TF;HFE
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.26513219175438496,0.7903802505124532,0.8333333333333334,1.0,1.0,15/98,14.30%,BET1;PLEKHM2;BAG5;GOLPH3L;TMED4;LYSMD3;BLZF1;TRAPPC12;PLK3;TMED3;VTI1A;ATP8B4;CDC42;COG1;UBXN2A
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5097274233016771,-0.7901606201512368,0.8356164383561644,1.0,1.0,1/7,22.87%,EIF2D
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.42894066809517084,-0.7900661494504373,0.7682926829268293,1.0,1.0,5/22,24.46%,MAPT;PRUNE1;HCLS1;MAP2;ARHGAP18
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.31164643865235486,0.7897643154613155,0.9285714285714286,1.0,1.0,5/35,8.25%,NRP1;CRK;PDPN;ABL1;CIB1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.4774313201524896,-0.7896727781509448,0.8108108108108109,1.0,1.0,3/11,12.50%,DUOX1;STAT1;VGF
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3987454679086971,-0.789657845282221,0.8020833333333334,1.0,1.0,11/61,19.48%,PAQR3;PLPP3;FBP1;MAPT;CDKN1B;PID1;NPRL2;SH3GL2;IMPACT;TERF2IP;IRS2
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.29977586575376186,0.7896354733502942,1.0,1.0,1.0,4/42,5.22%,SIRPA;TLR7;IRF5;TOMM70
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5063576950026718,-0.7893686877552922,0.7945205479452054,1.0,1.0,1/7,10.87%,PRDX4
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.41664262240922373,-0.7892973922059721,0.8387096774193549,1.0,1.0,15/51,29.37%,RGS2;RGS20;RPGRIP1L;RASGRP4;GRK4;CALM1;MGLL;SYP;DYNLT1;RGS4;PLCB1;CALCR;KCTD8;ROCK1;RGS3
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.42830725739251313,-0.7889553981221279,0.7777777777777778,1.0,1.0,9/25,33.16%,LIMD1;CNOT8;ZFP36;DICER1;PRKRA;CNOT6;AGO4;ZC3H7B;ADAR
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.5420985437192497,-0.7887257489427922,0.7808219178082192,1.0,1.0,2/5,27.37%,ERCC2;XPA
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.4294865547462179,-0.7886553602595627,0.8068181818181818,1.0,1.0,12/34,27.59%,GLA;GALC;UGCG;ST8SIA1;SUMF2;GBA3;ST8SIA3;SUMF1;STS;UGT8;ESYT2;ASAH1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5382354034525786,-0.7885086705100517,0.8133333333333334,1.0,1.0,3/5,45.40%,NCBP2;DHX9;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5382354034525786,-0.7885086705100517,0.8133333333333334,1.0,1.0,3/5,45.40%,NCBP2;DHX9;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.5084052231027925,-0.788218466311745,0.7922077922077922,1.0,1.0,3/6,31.82%,CD36;DHX33;GBP5
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.5320886978915492,-0.7881998004242623,0.7575757575757576,1.0,1.0,1/5,4.80%,PTN
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.395443457539002,-0.7876620169958087,0.7872340425531915,1.0,1.0,17/60,20.36%,PLPP3;SH3PXD2B;SPRY1;DOCK1;NTN4;LAMB1;DMD;CXCR4;HSPA12A;PALLD;BMI1;LIFR;ENAH;ERRFI1;SH3D19;GNA11;RND3
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.5360134618225979,-0.7872383104421412,0.8235294117647058,1.0,1.0,1/5,13.46%,IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.5360134618225979,-0.7872383104421412,0.8235294117647058,1.0,1.0,1/5,13.46%,IL18
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.44786954958472924,0.7871261969596514,0.6333333333333333,1.0,1.0,1/5,2.02%,ALDH5A1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.39167340590335453,-0.7871071477956176,0.7659574468085106,1.0,1.0,5/49,16.58%,NLRP12;AIM2;NLRC5;PYCARD;KLF4
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.5024901250705129,0.7870140533037069,0.75,1.0,1.0,1/5,1.79%,ITGA5
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3921631265052337,-0.7869128317173804,0.8791208791208791,1.0,1.0,9/65,15.02%,POLR3F;PQBP1;DHX58;STAT1;GAPDH;POLR1C;IRF1;POLR3H;OAS3
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.362016175964813,-0.7866748857194604,0.99,1.0,1.0,98/716,19.00%,SOCS3;THBS1;ALG10B;PP2D1;ARAF;TNC;ACVR1B;NEK11;F13A1;DTL;ASB14;CDK14;VCAN;CTDSP1;TGFB2;ASB16;TXK;HIF1A;RBX1;HS3ST5;PPP2R5A;ERO1A;WDR5;DUSP1;PPP2R3B;EGLN3;PPP2R5B;RAB11A;FBXL2;FGR;PINK1;DAPK1;PARP9;COPS5;SERP1;LAMB1;PRKCE;LTBP1;DAPK2;KLHL13;SPARCL1;PDK3;CTBP1;UBA52;UGCG;MAP3K12;LGALS1;PSMA5;NIM1K;NUAK2;VGF;PIM3;CDH2;PSMA3;EIF2AK3;PPP1CB;FAM20A;SPSB1;GPC3;RAB3A;PARP14;USP6;TEC;MTMR7;MGAT1;LIPE;PXK;PAK5;FN1;GGCX;PTPRD;ST8SIA1;PTPRT;PTPRZ1;SLC35A1;CHGB;STK17B;GRK4;OGA;PIK3R4;PSMD8;MAK;LIMK2;FBXL13;PIGH;SUMF2;INSR;TMEM132A;ZC3HAV1;SIRT5;UBE2M;PSMB4;FBXL7;CPE;VRK2;ILF3;SPSB3;SIRT3
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.4192993739213987,-0.7862776281651929,0.813953488372093,1.0,1.0,7/35,14.35%,RPS27A;MAPT;UBA52;TGFBI;UBC;B2M;CD36
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.36894640101578957,-0.78467272424961,0.99,1.0,1.0,115/645,21.55%,TFRC;RPL23;SAP30;TRIM5;ACVR1B;BHLHE40;NFIL3;FGF1;RBMS3;HINT1;VEGFA;RIMS1;OVOL2;TGFB2;RBPJ;RPL11;FAM50A;TXK;SLC11A1;HIF1A;GLRX2;RORA;PQBP1;APBB3;DDRGK1;TAF6L;NOCT;ANK3;HSPA1B;BRCA1;CHD3;MAPT;SLC7A5;PINK1;ID2;PARP9;PLAG1;CAMK2N1;ANK2;PRKCQ;TTN;RORB;DRAP1;LIMD1;PPIE;CCL3;BTN2A2;ATF5;KDM6B;HCFC1;TLE1;MSL3;RRP1B;NOTCH2;ITGB8;AHNAK;MOG;RPL6;BTN3A1;BCL6;RPL5;TCF7;CGGBP1;CCDC3;EIF2AK3;OLFM1;USP36;PARP14;EPB41L4B;FN1;CD36;RPS7;SNF8;BMI1;PID1;MLX;PRDM1;ZNF100;RGCC;ZNF519;ZKSCAN5;RDX;KLF4;SH3GL2;RPS3;INSR;CITED2;HCLS1;CIAO3;TERF2IP;AIF1;HMGN5;ATP2B4;PIK3CB;PARP15;CLU;BRCA2;ACTR5;SOX4;CREM;TLR2;MUSK;MAFB;NFKBIZ;TRIM22;PTRH2;ZNF143;METTL4;ESR2;ACTG1;BTN2A1;CLK1;PLSCR1;TRIM14;DICER1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.2784398552647419,0.7841943178839867,0.8,1.0,1.0,8/44,12.94%,PKD2;RYR1;ALOX5AP;ITPKB;SYT17;RASGRP2;SYT6;CPNE4
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.5322495866976077,-0.7837419149120733,0.8095238095238095,1.0,1.0,2/5,17.24%,CARD16;SIGIRR
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.36824150508738573,-0.7836934956200008,0.96,1.0,1.0,43/304,22.05%,DIAPH3;CYCS;SEMA6A;CATIP;ATP8B1;ARHGAP4;CFL1;VPS11;RHOU;PINK1;BNIP1;FGD6;LIMD1;CCL3;MTERF1;HCFC1;LNPK;AGTPBP1;EIF2AK3;PAK5;PALLD;GOLGA8B;VPS51;BCS1L;VMP1;GOLGB1;ATAD3A;PEX3;SIRT5;SH3D19;SPTBN5;UBXN2B;SIRT3;CHCHD2;MICAL2;THY1;KIF3A;FAM174B;REEP5;CHMP5;PDCD6IP;SLC25A36;FGD3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.4288783284762494,-0.783677150141985,0.7974683544303798,1.0,1.0,3/26,17.55%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.5115406992598892,-0.7835139655346915,0.8115942028985508,1.0,1.0,3/5,32.00%,RTN4RL1;EPHA4;PTPRS
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2999741456057464,0.7833296624771211,1.0,1.0,1.0,10/48,14.66%,ZNF385A;PLAGL1;RFWD3;TP53;SDE2;PIDD1;PLK3;EP300;MDM2;MDM4
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.47992118640096193,-0.7830803833420477,0.7894736842105263,1.0,1.0,1/9,8.72%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3928827024775573,-0.7830686342963191,0.8571428571428571,1.0,1.0,12/59,23.71%,TNFRSF1B;SOD1;PINK1;HLA-F;SNX6;MAG;PTPRZ1;TRAF2;CRLF1;GPNMB;RETREG1;NRBP2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4358119893218536,-0.7830034839443063,0.782051282051282,1.0,1.0,4/25,24.31%,PDK3;ADCY8;SOX4;RACK1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.43888656785153557,-0.7828454507770557,0.7631578947368421,1.0,1.0,5/13,18.06%,ANK2;CALM3;AKAP6;VMP1;CALM1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.35152920498428064,0.782839118015116,0.8571428571428571,1.0,1.0,3/22,8.53%,NRP1;ABL1;CDH13
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.4624680437535362,-0.7828313611237411,0.8292682926829268,1.0,1.0,5/16,23.66%,GPR183;SNX10;ANXA2;FOXP1;OSCAR
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.33939956586873116,0.7827552249433695,0.7727272727272727,1.0,1.0,5/25,7.09%,GSN;ITGAM;HAVCR1;MYH9;SNX18
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.5214797236132256,-0.7824817378170139,0.8157894736842105,1.0,1.0,1/7,7.47%,GTF3C6
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.38346203185025374,-0.7822586627043557,0.8947368421052632,1.0,1.0,21/91,22.53%,CCL4;JAML;NAPSB;MS4A4A;FGR;FCGR2B;IL10RA;HLA-F;MS4A6A;MNDA;LSP1;NCF4;NCF2;HLA-DMB;AIF1;SIGLEC1;TLR2;FCGR2C;CD300A;LILRB2;GPNMB
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.4853635377230491,-0.78203852868498,0.7808219178082192,1.0,1.0,3/8,15.47%,CHI3L1;PID1;PTPRT
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.43515035777252276,-0.7818771812178669,0.7682926829268293,1.0,1.0,5/17,19.46%,SLCO1A2;SLC13A4;SLC17A7;LRRC8B;SLC13A3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.25978979842819927,0.7817758934907022,1.0,1.0,1.0,9/58,15.47%,ELOA;SUPT16H;POLR2C;GTF2H2;ELOC;ELP4;MNAT1;GTF2F1;CDK13
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.41251743905555216,-0.7817677662595466,0.8260869565217391,1.0,1.0,3/44,8.43%,FGF1;FLRT1;POLR2G
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.4118915339485782,0.7817443928311176,0.6764705882352942,1.0,1.0,1/6,7.63%,EIF2AK4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.3836905510674074,-0.7816374163166144,0.8350515463917526,1.0,1.0,17/70,26.58%,NEK11;PSMA5;PSMA3;ERCC2;CDKN1B;PSMD8;PSMB4;ATP2B4;DDB1;PSMD7;PSMD5;ZNF16;DBF4;PSMB9;PSMC2;ANAPC7;PSMB2
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.3744724113202449,-0.781397190406629,0.8315789473684211,1.0,1.0,24/83,23.82%,SH3PXD2B;ADGRA3;DOCK1;LAMB1;BNIP3;MYO10;ADGRL2;COL4A5;FRAS1;LIFR;ITGA6;PTK7;KLF4;ENAH;LRP4;SH3D19;PTPRG;THY1;RND3;POU5F1;RBFOX2;KITLG;GULP1;UACA
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.4282507867054913,-0.7813018521802931,0.8488372093023255,1.0,1.0,4/23,15.90%,MAPT;AANAT;ING4;ING5
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.40442710714910285,-0.781205437905558,0.8181818181818182,1.0,1.0,7/29,24.28%,PTN;SHANK3;EPHB1;CTNND2;LRP4;DVL1;MAP2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.43083038087392433,-0.7811135107089415,0.8235294117647058,1.0,1.0,2/23,6.54%,PPP1R15A;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.32623774088629265,0.7808960626714689,0.9230769230769231,1.0,1.0,4/25,4.23%,DAB2IP;CTSC;SMURF1;LAPTM5
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.43518772183636534,-0.7808395289623338,0.8658536585365854,1.0,1.0,5/23,9.39%,TBC1D8;SOD1;STAT1;HTR7;PLN
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.41724632357705704,0.7807635197030025,0.72,1.0,1.0,3/9,4.83%,PKD2;PTCH1;CTSH
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.4608773026565923,-0.7806736696981941,0.8108108108108109,1.0,1.0,2/15,8.93%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.2766145368750423,0.7798312966983609,1.0,1.0,1.0,8/84,6.99%,RP9;SNRNP35;SCNM1;LSM6;PPARGC1A;KHSRP;SNRPB;U2AF1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49035510332269233,-0.7798119167732505,0.7638888888888888,1.0,1.0,2/8,11.51%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.4488533713869466,-0.7797116793561756,0.8292682926829268,1.0,1.0,4/14,29.40%,B4GAT1;SDF2L1;POMT1;CRPPA
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.49138086851405377,-0.779662381852808,0.8405797101449275,1.0,1.0,1/8,4.05%,RAB7B
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.30216099457767753,0.7795399711736638,0.8333333333333334,1.0,1.0,4/67,3.07%,TIFA;EHD4;PKD2;MCU
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3951448037529771,-0.779324709515847,0.8021978021978022,1.0,1.0,8/42,20.25%,VEGFA;ECM2;TGFB2;EPB41L4B;C1QBP;FRMD5;CITED2;RNASE10
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.31353962976973254,0.7789593065576287,0.8823529411764706,1.0,1.0,7/24,21.67%,AGO1;PUS10;SMAD2;SRRT;TUT7;PUM1;SMAD3
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.47695954832645676,-0.7786816127398963,0.8133333333333334,1.0,1.0,4/11,29.07%,ZWILCH;NABP1;INTS3;PLK2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4437728439115867,-0.7784392406651739,0.7721518987341772,1.0,1.0,2/16,6.80%,TGFB2;NOD2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.38792488349953647,-0.7782800221792397,0.8333333333333334,1.0,1.0,13/47,27.72%,PSMA5;PSMA3;AZIN1;PSMD8;SIRT5;PSMB4;PSMD7;PSMD5;PSMB9;PSMC2;PPARA;PSMB2;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.42130928563295866,-0.7782702914975127,0.7764705882352941,1.0,1.0,5/23,24.99%,POLR3F;NLRC5;PLSCR1;RIOK3;IFI35
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.3389844571603622,0.7780820126945623,0.7777777777777778,1.0,1.0,6/18,11.90%,NRP1;MAP4K4;PPM1F;ABL1;DUSP3;COL16A1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.44573265569216014,-0.7780231420805429,0.8192771084337349,1.0,1.0,1/18,7.73%,NHP2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.46945383422769305,-0.7779483832575411,0.775,1.0,1.0,3/11,18.06%,GNB5;CALM3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.47063559955088174,-0.7776660659761854,0.821917808219178,1.0,1.0,1/12,9.90%,PRKCQ
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.45639202153509134,-0.7772767456877482,0.8051948051948052,1.0,1.0,4/15,20.43%,WDR12;MPHOSPH6;MAK16;PES1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3955171687012542,0.7772548395332792,0.6666666666666666,1.0,1.0,1/8,6.49%,STIM1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.35048232289951275,0.7768330712428118,0.8148148148148148,1.0,1.0,2/15,9.33%,PKD2;CCNYL1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.5218186467622244,-0.7768037701433268,0.8289473684210527,1.0,1.0,1/6,7.47%,GTF3C6
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.5218186467622244,-0.7768037701433268,0.8289473684210527,1.0,1.0,1/6,7.47%,GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.39547946304426335,-0.7767627560453778,0.8947368421052632,1.0,1.0,17/69,24.58%,EIF4A3;ZNF540;DAPK1;RPL13A;GAPDH;CAMK2N1;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;ILF3;PATL2;PUS7;EIF2AK2;RACK1;MRPL13
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3318030509791132,0.7767242716852687,0.7692307692307693,1.0,1.0,6/39,6.91%,FER;CSF1R;ABI3;PKDCC;ABL1;SYK
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5327774668318517,-0.7766695255109307,0.8591549295774648,1.0,1.0,1/7,9.73%,SLIRP
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.3471480004600476,0.7766452735730734,0.7368421052631579,1.0,1.0,2/20,6.24%,GSN;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.5145219155403341,0.7765979141329646,0.696969696969697,1.0,1.0,1/5,4.53%,MKKS
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4189084532774852,-0.7763459849819776,0.8072289156626506,1.0,1.0,6/22,24.31%,AQP11;HERPUD1;NR1H2;CLU;UBXN1;RACK1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.3905678417366005,-0.7762033335623004,0.8723404255319149,1.0,1.0,13/53,23.69%,ECM2;SGCE;ADAM15;OTOA;ITGB8;CD63;FN1;ITGA2;CD44;SIGLEC1;THY1;PTPRK;PARVG
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.4094883421134794,-0.7761791926081408,0.8351648351648352,1.0,1.0,7/38,24.66%,POLR2G;RIDA;CNOT8;ZC3HAV1;ZFP36;GTPBP1;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.44155209316429855,-0.7759686274444759,0.7857142857142857,1.0,1.0,2/16,22.19%,POLR2G;RPS6KB2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.49689087771326196,-0.7759602396515523,0.8142857142857143,1.0,1.0,1/5,2.29%,CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.49689087771326196,-0.7759602396515523,0.8142857142857143,1.0,1.0,1/5,2.29%,CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.49689087771326196,-0.7759602396515523,0.8142857142857143,1.0,1.0,1/5,2.29%,CYP3A5
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.4853245099010616,-0.7758508870612179,0.8024691358024691,1.0,1.0,4/11,23.12%,TRPS1;MBOAT2;BMPR1B;ZBTB16
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.47608403945008704,0.7755887503581405,0.7272727272727273,1.0,1.0,1/6,4.85%,ILRUN
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5332310414411278,-0.7755411661025315,0.8260869565217391,1.0,1.0,4/5,45.91%,ASAH1;MT3;SLC6A6;HEBP2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.4560101527809524,-0.7754818078436418,0.8181818181818182,1.0,1.0,6/19,32.29%,PDK3;ADCY8;SOX4;RACK1;PRKAA2;SLC2A5
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.4732225559557979,-0.775449300838468,0.8311688311688312,1.0,1.0,2/12,10.01%,PKP2;TTN
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.40895880432313464,-0.7751028282857836,0.8452380952380952,1.0,1.0,9/30,23.38%,RAB3A;RAB2B;SDCBP;CFTR;SNF8;RAB15;RAB5A;PDCD6IP;CADPS
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.5205994742781787,-0.7750905598991873,0.8,1.0,1.0,1/5,14.43%,COA6
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.36461815084103666,-0.7750050277562904,0.8829787234042553,1.0,1.0,21/125,20.48%,ACVR1B;TXK;FLT1;FGR;PINK1;DAPK1;RIOK2;DAPK2;MAP3K12;PIM3;EIF2AK3;TEC;EPHB1;ALK;STK17B;MAK;INSR;VRK2;CAD;MUSK;VRK1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4117422063660571,-0.7748740660487754,0.8021978021978022,1.0,1.0,5/29,14.35%,THBS1;DOCK1;FCGR2B;MARCO;CD36
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.3481930199818349,0.774847562620854,0.8181818181818182,1.0,1.0,2/18,5.77%,LGALS9;APPL2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.49562207716002593,-0.7747544059662471,0.8472222222222222,1.0,1.0,4/9,26.19%,GSTP1;TRAP1;ASXL3;PPARA
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3824458689470407,-0.7744087688791484,0.9175257731958762,1.0,1.0,20/136,15.21%,HTR2B;GLIPR2;CCL4;CHI3L1;SEMA6A;GPR183;C5AR1;GSTP1;SPRY1;NOD2;CAMK2N1;MARCO;CCL3;NOTCH2;MAP3K12;FN1;TRAF7;CD36;EPHB1;APIP
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.36845348919024873,-0.7742401292225483,0.96,1.0,1.0,80/254,27.96%,SCRG1;ACVR1B;SEMA6A;SPOCK1;VEGFA;VCAN;GRIK1;ADGRG6;PTN;GSTP1;MAL;BTBD2;PAX8;MARCKSL1;EIF2B2;CXCR4;SHANK3;MOBP;FGF13;GPM6B;STIL;NOTCH2;C3ORF70;MOG;APC2;CDH2;APLP1;NRXN1;FEZ1;RAPGEFL1;NLGN3;FN1;GPM6A;EPHB1;ADGRL3;PTPRZ1;NRSN1;BTD;PRPS1;SH3GL2;TAGLN3;PTS;ADAM23;NEURL1;CRIM1;ROBO2;NRXN2;STMN3;HPCAL4;RELN;ALDH1A2;SERPINI1;TPP1;NINJ2;NRG1;RBFOX2;DVL1;ZBTB16;PMP22;SCD5;LY6H;DCTN1;S100B;BTBD6;NRGN;SIAH1;IL1RAPL2;ERCC6;NLGN2;UGT8;SHANK2;CHRM3;SLC2A1;CHRM2;LSAMP;SRRM4;JARID2;CRMP1;SPG7;NPAS2
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.4563402587849758,-0.7740762418305499,0.7857142857142857,1.0,1.0,5/16,26.95%,RIMS1;SYT1;SYT4;RIMS2;RIMS3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.49176640698224927,-0.7740006769488695,0.7721518987341772,1.0,1.0,2/9,10.02%,TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.48726228397413623,-0.7739045752610307,0.8461538461538461,1.0,1.0,2/12,8.72%,RBPJ;STAT1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.4667096579575075,-0.7737656437886047,0.775,1.0,1.0,2/12,13.93%,SVIL;MYL6
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.418127400513682,0.7736351790540034,0.7777777777777778,1.0,1.0,1/9,2.99%,CTBP2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.34789247354907255,0.7733663950847776,0.7333333333333333,1.0,1.0,6/22,13.58%,DCUN1D4;CDC14B;BTRC;TRIB3;FBXW7;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.37437338242999135,-0.7732721745001288,0.8297872340425532,1.0,1.0,10/87,13.46%,NLRP12;THBS1;AGT;PTN;POLR3F;DHX58;IL15;CCL3;THBD;IL18
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.35141171723101783,0.7731901774998852,0.7142857142857143,1.0,1.0,1/10,2.29%,BCL2L1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35291591971672376,0.7728040724701697,0.782608695652174,1.0,1.0,2/17,6.24%,ZDHHC3;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35291591971672376,0.7728040724701697,0.782608695652174,1.0,1.0,2/17,6.24%,ZDHHC3;ZDHHC2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.35579347168844516,-0.7727900012107574,0.9381443298969072,1.0,1.0,21/144,21.40%,SRGN;ATP8B1;ANK3;VPS11;CR1;SERP1;BNIP1;SNX10;LNPK;EIF2AK3;GOLGA8B;VPS51;CAV3;VMP1;GOLGB1;SPTBN5;UBXN2B;FAM174B;SYP;DNM1;REEP5
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.38240453709225397,-0.7724768725313772,0.8865979381443299,1.0,1.0,15/86,20.35%,TFRC;VEGFA;SLF1;RBX1;RPA2;RPA3;MED25;ERCC2;CD36;MPP7;RPS3;ABCA1;BMF;CLU;DDB1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.42082393334437646,-0.7724276714692644,0.8333333333333334,1.0,1.0,4/21,11.96%,OSBPL5;PRELID1;PLTP;PCTP
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.3672498288448983,-0.7723155209871007,0.8787878787878788,1.0,1.0,14/109,15.56%,PP2D1;EYA2;PPP1R15A;CTDSP1;PPP2R5A;DUSP1;PPP2R3B;PPP2R5B;PPP1CB;MTMR7;PPP2R2B;PTPRD;PTPRT;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.4323881774144055,-0.7722799491911643,0.8,1.0,1.0,8/23,27.20%,SOD1;OLFM1;GHR;INSR;MUSK;MFSD2A;PLCB1;APP
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.45920938149108204,-0.7722377156908901,0.7777777777777778,1.0,1.0,2/11,13.93%,SVIL;MYL6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.4536883801499015,-0.7720852297162114,0.7746478873239436,1.0,1.0,2/10,10.86%,FGR;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.436561029026091,-0.7720773027462402,0.8433734939759037,1.0,1.0,2/27,7.78%,GLA;BRCA1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4676484823393663,-0.7720594425234432,0.8076923076923077,1.0,1.0,4/14,27.99%,MTCH1;APP;SRRM4;B4GALT5
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.39300967083028326,-0.7720066504571294,0.8709677419354839,1.0,1.0,2/47,4.93%,GDPD1;PIGL
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.44970484673668903,-0.7719650096695162,0.7974683544303798,1.0,1.0,4/11,18.90%,HLA-F;B2M;TAP1;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.46966847479865015,-0.7718840127955177,0.810126582278481,1.0,1.0,2/11,10.86%,TGFB2;HLA-F
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.5041721931774328,-0.7716345319333666,0.8289473684210527,1.0,1.0,1/8,3.11%,VEGFA
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3642644760856114,0.7710685632251556,0.7727272727272727,1.0,1.0,2/12,10.03%,CPSF4;TRPT1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.4035802383959538,0.7710168365543445,0.7083333333333334,1.0,1.0,3/10,8.28%,LGALS9;ARRB2;SERPINB9
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.37400486059909127,-0.7710089459215983,0.9081632653061225,1.0,1.0,26/106,24.82%,LRP2;ANK3;CCK;FLRT1;MAP1B;SHANK3;EPB41L3;IQGAP1;RAB3A;DCC;GPM6A;EPHB1;CTNND2;LRP4;SLC9A6;UBB;S100A6;IMPACT;DICER1;PLPPR4;DVL1;SGK1;NTNG1;MAP1A;MAP2;S100B
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3605441226074309,-0.770587915200501,0.94,1.0,1.0,21/168,16.92%,HTR2B;TFRC;NLRP12;TRIM5;RORA;GSTP1;NOD2;LITAF;STAT1;PINK1;GAPDH;TRIM25;DDX1;TLE1;LGALS1;CARD16;NR1D1;APOL3;PYCARD;IFIT5;TRAF2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5186643546604617,-0.7704008890138946,0.8,1.0,1.0,3/5,38.57%,CLU;HSP90AB1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.4896891580211823,-0.7700957910962534,0.7887323943661971,1.0,1.0,2/7,20.96%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.4521802949081445,-0.7700634226361474,0.75,1.0,1.0,3/10,18.14%,RORA;IL18;PNPLA8
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.41575256903763613,-0.7696146044320393,0.8481012658227848,1.0,1.0,3/28,17.55%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.4242605462837671,-0.7695737905167985,0.8314606741573034,1.0,1.0,3/22,19.15%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3703544345149501,0.7695033963860268,0.7777777777777778,1.0,1.0,3/8,11.35%,RIOK1;WDR43;BUD23
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.3337538747813242,0.7694484423779161,0.8421052631578947,1.0,1.0,2/17,6.97%,NBN;MAP3K4
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.5181989212702529,-0.7694313403374134,0.8484848484848485,1.0,1.0,1/5,9.14%,ID2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.3990966734618562,-0.7692973563874625,0.8295454545454546,1.0,1.0,3/38,5.11%,MDH1;MTHFD1;ME1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.43448447875478785,0.7692896756209027,0.75,1.0,1.0,1/8,0.32%,ACTA2
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35687018498974266,0.7692457870808914,0.76,1.0,1.0,2/13,10.03%,CPSF4;TRPT1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4399950293503595,-0.7691703738171033,0.825,1.0,1.0,1/18,0.96%,THBS1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.35681769715164297,-0.7681826620117763,0.9591836734693877,1.0,1.0,17/163,14.25%,TOP2A;CENPF;TUBA4A;ARHGAP4;RACGAP1;UXT;ITSN1;FGD6;CENPE;NOTCH2;ANLN;MID1IP1;RFC1;KIF1B;INCENP;LMNB1;PALLD
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.4920880916057844,-0.7674473558367085,0.7580645161290323,1.0,1.0,2/5,22.62%,TLR2;CD14
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.4920880916057844,-0.7674473558367085,0.7580645161290323,1.0,1.0,2/5,22.62%,TLR2;CD14
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3770478188608273,-0.7673645059014363,0.8152173913043478,1.0,1.0,3/55,7.78%,RHOB;FIGNL1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.4557554269848826,0.767185612098058,0.8518518518518519,1.0,1.0,2/7,8.93%,WNK3;NR1H3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.3375942753992202,0.7671557359271224,0.8333333333333334,1.0,1.0,5/23,6.42%,SMAD7;TGFBR2;SLIT3;ACVR1;SALL1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.5453286674167255,-0.7668500094554066,0.8714285714285714,1.0,1.0,2/5,16.19%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.449470048536338,0.7667200803320322,0.6296296296296297,1.0,1.0,2/6,8.20%,SORL1;MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.449470048536338,0.7667200803320322,0.6296296296296297,1.0,1.0,2/6,8.20%,SORL1;MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.449470048536338,0.7667200803320322,0.6296296296296297,1.0,1.0,2/6,8.20%,SORL1;MSN
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.4129391714289934,-0.7664306733611783,0.7926829268292683,1.0,1.0,10/18,37.81%,SLC24A1;SLC24A2;PNKD;PRRT1;SHANK2;PLK2;STXBP1;SYT11;NLGN4X;PICK1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.4946184394196641,-0.7661900680984522,0.8307692307692308,1.0,1.0,1/6,4.05%,RAB7B
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4197603173811488,-0.7657448864561894,0.8426966292134831,1.0,1.0,9/27,28.47%,PIGL;ST8SIA1;PIGG;PIGH;PIGA;ST8SIA3;MPPE1;SCCPDH;PIGF
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.3864416948499787,-0.7657317399257534,0.8734177215189873,1.0,1.0,6/32,16.91%,SLCO3A1;SLCO1A2;SLC4A10;CFTR;SLC35A1;SLC25A19
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.4901666040904737,-0.7656957006138293,0.7692307692307693,1.0,1.0,1/8,4.68%,C5AR1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4668045209459445,-0.7656459130554364,0.810126582278481,1.0,1.0,1/14,8.69%,FCGR2B
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.3656295746189412,0.7656006452587422,0.7222222222222222,1.0,1.0,2/16,6.56%,VCPKMT;SNRPB
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.4936471080967485,-0.765551892452326,0.7721518987341772,1.0,1.0,1/9,6.57%,MPG
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.4936471080967485,-0.765551892452326,0.7721518987341772,1.0,1.0,1/9,6.57%,MPG
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.3696655141895796,0.7654766359329288,0.8,1.0,1.0,1/11,1.67%,PLA2G7
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.494670464213223,-0.7653031812088675,0.75,1.0,1.0,3/6,35.77%,SNX17;MT3;CYP27A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.494670464213223,-0.7653031812088675,0.75,1.0,1.0,3/6,35.77%,SNX17;MT3;CYP27A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.494670464213223,-0.7653031812088675,0.75,1.0,1.0,3/6,35.77%,SNX17;MT3;CYP27A1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.43784122002039505,-0.765290887945686,0.7674418604651163,1.0,1.0,1/17,1.81%,LRP2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.3578824276884747,0.7648229655481896,0.76,1.0,1.0,4/15,17.28%,MRPS27;FASTKD2;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.4625037186401608,-0.7643279183805691,0.7763157894736842,1.0,1.0,3/14,14.49%,SOD1;NREP;APOD
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.38735656680728425,-0.7643189740524176,0.8426966292134831,1.0,1.0,11/39,26.29%,KCNJ13;ANK3;B2M;SNX6;PXK;SYT1;SYT4;KCNJ3;TF;HFE;PER1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3777780487906522,-0.7642334010093265,0.8709677419354839,1.0,1.0,6/57,12.14%,RPS27A;FOS;TGFB2;APPL1;UBA52;UBC
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.3998131535631521,-0.764174327944785,0.8901098901098901,1.0,1.0,14/39,26.27%,SHANK3;FGF13;CDH2;NRXN1;NLGN3;GPM6A;ADGRL3;GABRG2;GABRB3;NRXN2;DVL1;GABRA2;NLGN2;SHANK2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.45323192652041044,-0.7641281090285631,0.8148148148148148,1.0,1.0,2/15,17.95%,BNIP3;INSR
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4849437780234645,-0.7639750926733979,0.8,1.0,1.0,6/10,27.20%,SHANK3;NEURL1;SYP;RAB5A;CAMK2B;APP
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.4749512674337973,-0.7627537701620435,0.7662337662337663,1.0,1.0,3/9,12.05%,HLA-B;FCGR2B;LGALS1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4366544828591674,-0.7626037787948864,0.7866666666666666,1.0,1.0,1/14,5.82%,PQBP1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.4425081437149193,-0.7625229700736363,0.7307692307692307,1.0,1.0,3/10,19.98%,CHST7;OGA;AMDHD2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.3863632437362966,-0.7623686323866812,0.875,1.0,1.0,2/55,2.77%,ACVR1B;CDK14
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.39898789464133844,-0.7623256425360361,0.8068181818181818,1.0,1.0,7/30,23.57%,C5AR1;GPR155;TUSC3;SHROOM4;CBR3;MFSD2A;CTNS
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.46722968701011813,-0.7622875738723501,0.7894736842105263,1.0,1.0,3/10,22.13%,PLN;CAV3;LILRB2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.37965068478166897,-0.7619753308138233,0.8736842105263158,1.0,1.0,5/80,7.20%,ENPP2;FGF1;RHOB;TMSB10;DUOX1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4863589545612067,-0.76195515063536,0.8059701492537313,1.0,1.0,2/6,12.92%,HIF1A;PADI2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.2677448903182102,0.7612478420608045,1.0,1.0,1.0,8/80,7.53%,ARL2BP;IPO13;NUP188;HHEX;APPL2;SYK;TAF3;E2F3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3485208044381556,0.7609195515278094,0.8571428571428571,1.0,1.0,6/26,12.58%,BCL2L1;FAIM;ICAM1;SERPINE1;TNFRSF10A;FAS
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.5037668740489696,-0.7608996932649597,0.8169014084507042,1.0,1.0,1/8,8.01%,STXBP6
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.36330790436055876,-0.7608982880657278,0.7835051546391752,1.0,1.0,13/64,26.04%,KNSTRN;RAB11A;TTN;CENPE;TEX14;DSN1;SEH1L;CHMP5;PDCD6IP;DCTN2;SMC4;CENPK;SET
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.4216787836642876,0.7608577818561352,0.6666666666666666,1.0,1.0,2/5,17.52%,SERPINB9;IRAK4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.39294564186812364,-0.7607691309208144,0.8764044943820225,1.0,1.0,5/33,10.95%,SRGN;PTN;FBN2;CCL3;GPM6B
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.4202574412509215,-0.7607500566046786,0.8313253012048193,1.0,1.0,1/20,4.50%,MINDY1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.4549326768783782,-0.7606944891196085,0.8194444444444444,1.0,1.0,3/9,21.51%,FHL1;CAV3;SCN3B
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.3975914879898908,-0.7605675838029806,0.8241758241758241,1.0,1.0,12/26,33.48%,HSPA1B;GPSM2;CHMP5;PDCD6IP;MAP9;GNAI1;DCTN1;PSRC1;TACC3;DRG1;CHMP4B;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3750867863758649,-0.7605658253053166,0.8681318681318682,1.0,1.0,5/45,16.58%,PRKCQ;RFC4;CHTF18;RGCC;KLF4
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.4197636874919851,-0.7602413880871339,0.8620689655172413,1.0,1.0,3/24,16.01%,VIM;CD36;RGCC
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.37225962064598883,-0.7599214380999253,0.9139784946236559,1.0,1.0,7/71,12.14%,RPS27A;OVOL2;FOS;TGFB2;APPL1;UBA52;UBC
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4628658250753105,-0.7597535512196371,0.7468354430379747,1.0,1.0,1/10,1.10%,GLA
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.3805061705889565,-0.7593409979312462,0.9354838709677419,1.0,1.0,17/76,20.30%,ACVR1B;PTN;FLT1;FGR;GP6;RASGRP4;EPHA3;PTPRD;ANGPTL1;LIFR;EPHB1;ALK;PTPRT;INSR;PIK3CB;PTPRG;MUSK
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.45799629310694384,-0.7591992595622453,0.8695652173913043,1.0,1.0,2/11,10.99%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.48320118620569275,-0.7582680512626823,0.8656716417910447,1.0,1.0,3/8,17.58%,IL18;PYCARD;RPS3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.38739013985450604,-0.7582609375186793,0.8804347826086957,1.0,1.0,10/56,20.97%,XRCC3;RPA2;BRCA1;POLQ;RPA3;FAN1;SLX4;POLL;BRCA2;LIG3
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.403884188647941,0.7582162074367955,0.8421052631578947,1.0,1.0,2/11,7.63%,EIF4EBP1;EIF2AK4
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3993396324838151,-0.7580899008564889,0.813953488372093,1.0,1.0,7/27,18.28%,RXRB;BRINP1;TMEM161A;RORB;EPHA3;PTK7;TRIM16
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.32768457460572886,0.7580529636655589,0.7777777777777778,1.0,1.0,6/22,10.53%,MCU;MICU3;SLC35G1;ADRA1A;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3339730606737278,0.7579612050763634,0.8,1.0,1.0,2/16,9.33%,PKD2;CCNYL1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.444107552399211,-0.75764609340293,0.8375,1.0,1.0,5/12,30.45%,ABCA5;ABCA1;ABCA8;STX12;ABCG1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.5128593535971289,-0.7576265524307935,0.8235294117647058,1.0,1.0,2/7,16.19%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.4799536841675116,-0.7575941260076976,0.8533333333333334,1.0,1.0,2/11,18.04%,DDX11;GNL3
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.46624128122986386,-0.7573750354042199,0.8181818181818182,1.0,1.0,2/8,15.40%,RAB7B;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.457749203228096,-0.7573695249857507,0.7974683544303798,1.0,1.0,1/12,6.81%,ZNF93
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.36543174258947486,-0.7572289867073568,0.8709677419354839,1.0,1.0,14/67,19.90%,TGFB2;SH3PXD2B;MTHFD1;PKP2;ID2;KDM6B;FN1;CDKN1B;LDB3;POU6F1;CITED2;CACNA1C;MICAL2;SOX4
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.3557352243193865,-0.7571411233676606,0.99,1.0,1.0,54/347,20.70%,HTR2B;TFRC;CCL4;NLRP12;RPL23;THBS1;TRIM5;LRP2;CHI3L1;FGF1;RPS20;AGT;VEGFA;RPL37;TGFB2;NOD2;DHX58;FLT1;LITAF;FGR;PINK1;GAPDH;TRIM25;DDX1;CCL3;RPS15;LGALS1;IQGAP1;CARD16;IL18;FN1;TRAF7;APOL3;IFIT5;TRAF2;NRG4;C1QBP;RNF13;LARS1;RPS3;INSR;BMF;PDCD4;PLEKHG5;HCLS1;TERF2IP;HEXIM1;PIK3CB;IRS2;TXN;TLR2;S100A4;SEH1L;TRIM22
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5015429652204225,-0.7566184190486626,0.8714285714285714,1.0,1.0,2/8,9.36%,PAX8;MYO3B
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5177384068236421,0.7564667267136225,0.7586206896551724,1.0,1.0,1/5,6.76%,PTPN12
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.4407718889185467,0.7562700654726484,0.7692307692307693,1.0,1.0,2/7,8.91%,CAB39;BIN1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3579775557847344,-0.7561974295591878,0.99,1.0,1.0,69/426,20.11%,NR4A3;RPL23;RPS27A;SAP30;BHLHE40;NFIL3;HAMP;VEGFA;RBPJ;MXI1;MEIS2;NR4A2;YEATS2;H1-0;FBP1;CHD3;UXT;STAT1;ID2;PARP9;ARID5B;RPS14;DRAP1;NOP53;TGIF1;TRPS1;NR1H2;CTBP1;HCFC1;UBA52;ATF3;ETS2;UBC;BCL6;MED25;CGGBP1;ZNF550;KCTD1;MXD1;SUV39H2;MAX;SDCBP;UHRF1;BMI1;ZNF266;MLX;NR1D1;PRDM1;DEAF1;ZNF20;KDM1A;KLF4;POU6F1;NFIX;C1QBP;UBB;ZNF778;CBX5;CITED2;IMPACT;ZFP36;HEXIM1;PER2;E2F7;PARP15;ZNF558;NFIB;MNT;CREM
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5019977670070603,-0.756166643677363,0.7746478873239436,1.0,1.0,1/5,23.12%,ACP3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.4218870761795205,-0.7560745848975825,0.8588235294117647,1.0,1.0,1/18,1.49%,KCNJ13
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.46000635095986175,-0.7558897365582842,0.8481012658227848,1.0,1.0,1/9,7.44%,HSPA1B
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.39287522551417514,-0.7554775554112586,0.9069767441860465,1.0,1.0,12/39,33.03%,GRM8;COL11A1;SLC4A10;SLC24A1;KIFC3;OAT;EML2;BEST1;CABP4;CEP250;RGS16;BBS2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.4022198623049398,-0.7554525935147661,0.8024691358024691,1.0,1.0,7/31,24.31%,HIF1A;PDK3;NR1D1;ADCY8;SOX4;HK2;RACK1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.49835024725812876,-0.7554070460821987,0.8,1.0,1.0,2/8,16.48%,APOD;CBLB
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.4781524544929493,0.7552230100875587,0.8108108108108109,1.0,1.0,2/5,16.97%,PLEKHM1;ARL8B
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.37996854964476257,0.7549551565185164,0.8571428571428571,1.0,1.0,2/13,4.83%,IDE;CTSH
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.45818970062953135,-0.7547681143538213,0.8311688311688312,1.0,1.0,1/10,4.31%,SLC11A1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.4671502458189054,0.7547262005670509,0.7567567567567568,1.0,1.0,2/5,23.74%,SRC;FYN
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.4237232865959847,-0.7546805959097496,0.8192771084337349,1.0,1.0,1/15,3.60%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.4113287348238285,-0.75442531502792,0.8390804597701149,1.0,1.0,5/23,19.90%,MYRIP;CFTR;ADCY8;IRS2;SOX4
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.37152450682212934,0.7543404994721129,0.782608695652174,1.0,1.0,1/11,5.41%,ARRB2
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.37602061958347616,0.7540550958493479,0.7407407407407407,1.0,1.0,3/11,7.02%,LEPR;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.46621927924846684,-0.7540083201799914,0.7878787878787878,1.0,1.0,5/6,47.45%,GMFB;GMFG;PICK1;CTNNA2;CORO1A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.27093436890046035,0.7539231460289001,0.7222222222222222,1.0,1.0,3/23,4.54%,DAB2IP;TICAM1;LGR4
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.40005796467193966,0.7537170057414065,0.7916666666666666,1.0,1.0,2/7,7.98%,EIF2AK4;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.37198168026067113,-0.7535329600328428,0.8913043478260869,1.0,1.0,6/66,8.69%,GADD45B;VEGFA;SEMA3A;TGFB2;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.4296831173619877,-0.7533172474783772,0.8205128205128205,1.0,1.0,9/16,22.95%,GAPDH;PGK1;PKM;ENO2;PGAM1;ENO1;HK2;GPI;PFKL
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.3575033064213807,-0.7532549349604793,0.9292929292929293,1.0,1.0,16/152,18.88%,PRKAR2B;ACVR1B;HAUS6;CDK14;TUBB4A;TUBA4A;MASTL;TUBA1A;PPP1CB;MAX;CDKN1B;ABCB1;CEP152;FBXL7;CEP164;CCNB3
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.43091074469657054,-0.7531578066495074,0.8202247191011236,1.0,1.0,2/21,11.96%,LPCAT1;PCTP
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4884746427926684,-0.752943440601432,0.8142857142857143,1.0,1.0,4/7,35.49%,DBF4;WIZ;TIPIN;CDC7
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.33882026824385664,0.7527251009646729,0.8181818181818182,1.0,1.0,1/12,1.34%,PDE12
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.4430028238749939,0.7522611044859269,0.7419354838709677,1.0,1.0,2/7,7.53%,PPARG;E2F3
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.3523483772096378,-0.7522284004390155,0.99,1.0,1.0,35/252,19.23%,THBS1;ENPP2;CEMIP;MYLK;SEMA6A;FGF1;VEGFA;SEMA3A;RHOB;ALOX15B;TMSB10;ARHGAP4;DDRGK1;ADAM15;CARMIL1;FLT1;FGR;LAMB1;APPL1;CCL3;SST;PLET1;SDCBP;HSPA5;TTBK2;ITGA6;PTPRT;RDX;FRMD5;INSR;CITED2;MCTP1;TP53INP1;CLIC4;AIF1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.48622801401361726,-0.7521315691036647,0.8571428571428571,1.0,1.0,3/9,24.57%,CNEP1R1;VRK1;DCTN1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.4422837451735659,-0.7517611195618662,0.8493150684931506,1.0,1.0,2/15,19.15%,POLR2G;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.4422837451735659,-0.7517611195618662,0.8493150684931506,1.0,1.0,2/15,19.15%,POLR2G;TERF2IP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.4048806397280015,0.7516783628629159,0.8333333333333334,1.0,1.0,5/17,11.68%,HPSE;HS3ST4;GLCE;UGDH;HS6ST1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.46935890107643524,-0.7513788608232129,0.8333333333333334,1.0,1.0,1/6,8.72%,STAT1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.41653491490253947,-0.7511228518272738,0.7926829268292683,1.0,1.0,6/17,29.16%,SRP14;SRPRA;RYR2;MAN1A1;SRP54;SPCS2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4048330710406087,0.7510876688832141,0.8,1.0,1.0,2/8,10.23%,IGF2BP3;PCBP3
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.3657941817425594,0.7507830706249946,0.8181818181818182,1.0,1.0,3/8,8.09%,USP14;UBQLN2;SGTA
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.42640174873604897,-0.7507809049780705,0.8372093023255814,1.0,1.0,3/15,8.38%,CYP3A5;SLC5A9;FMO5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.3688280025339561,0.7506740150496158,0.875,1.0,1.0,2/14,3.79%,CX3CR1;FFAR4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.43358717046700135,-0.7506175434076391,0.8333333333333334,1.0,1.0,1/14,5.71%,IL7
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.2689708152696248,0.7505631559423918,1.0,1.0,1.0,15/113,11.89%,ATRAID;SIRPA;TRIM38;HMG20A;KHSRP;IGF2BP3;ZNF711;TBC1D16;LAMTOR1;TRIM11;PCBP3;TOB2;CTCF;LDLR;PRDM10
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.5117423676077973,-0.7504307793957427,0.8714285714285714,1.0,1.0,2/6,12.91%,BASP1;IQGAP1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.46566668311258363,-0.7504148100123244,0.810126582278481,1.0,1.0,1/8,4.80%,PTN
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.41384507358474903,-0.7503939871824996,0.8607594936708861,1.0,1.0,3/27,13.73%,POLR2G;RNMT;ERCC2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.41384507358474903,-0.7503939871824996,0.8607594936708861,1.0,1.0,3/27,13.73%,POLR2G;RNMT;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.4929040011611088,-0.7500439535973831,0.8,1.0,1.0,4/6,38.15%,CD300A;HMOX1;CD200;SLAMF8
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3508039798599137,-0.7500037499008407,0.8484848484848485,1.0,1.0,12/98,19.28%,SOCS3;PIGL;ITPKC;EFR3B;MTMR7;INPP4A;PIGG;PIK3R4;PIGH;PIGA;INPP4B;PIK3CB
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.358294379490236,0.7499077573084691,0.7916666666666666,1.0,1.0,1/11,3.54%,ARHGAP35
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.43249296323726727,-0.749665649718191,0.7951807228915663,1.0,1.0,3/19,10.87%,RORA;FMO5;PDK3
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.3852549909685945,0.749520559714507,0.7272727272727273,1.0,1.0,3/8,26.78%,CDK13;CDK7;GTF2H5
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.38307387667923715,0.7492494664186076,0.8666666666666667,1.0,1.0,5/11,14.94%,FER;PTPN12;CDH13;MVB12B;RHBDF2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.36616602829917844,-0.7489057950308919,0.9375,1.0,1.0,31/133,22.32%,DOK6;SEMA6A;VEGFA;SEMA3A;LAMA2;EMB;NTN4;CHN1;UNC5C;PRKCQ;CXCR4;SHANK3;NOTCH2;RAP1GAP;EPHA3;NRXN1;FEZ1;DCC;PALLD;EPHB1;ENAH;SPTBN5;PIK3CB;IRS2;NRXN3;NFIB;ROBO2;RELN;PTPRA;KIF5A;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4222628593668172,-0.7484531487607506,0.8352941176470589,1.0,1.0,1/18,3.96%,RSAD2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4091054639511098,-0.7483059057061451,0.9166666666666666,1.0,1.0,5/28,16.08%,VEGFA;SULF2;BRCA1;STIL;DEAF1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.48846790675056895,-0.7480249977359072,0.8051948051948052,1.0,1.0,1/7,3.34%,SEMA3A
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4236744650119051,-0.7478476310352122,0.8333333333333334,1.0,1.0,3/17,20.46%,BRCA1;SLX4;DNA2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.4298584528771241,-0.7476436380759259,0.8690476190476191,1.0,1.0,6/19,20.49%,VEGFA;VCAN;THBD;TNFRSF21;S100A4;LRPAP1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.43180272657031654,-0.7476021042296804,0.8266666666666667,1.0,1.0,9/15,22.95%,GAPDH;PGK1;PKM;ENO2;PGAM1;ENO1;HK2;GPI;PFKL
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.43180272657031654,-0.7476021042296804,0.8266666666666667,1.0,1.0,9/15,22.95%,GAPDH;PGK1;PKM;ENO2;PGAM1;ENO1;HK2;GPI;PFKL
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.35856241577522446,0.7474970333973248,0.84,1.0,1.0,4/12,18.60%,USP30;PEX5;TRAPPC8;PJVK
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.3043372776416628,0.7474264078077502,0.8666666666666667,1.0,1.0,8/32,17.25%,RALB;PIP4K2B;UBQLN2;TBC1D12;SMCR8;PIKFYVE;SH3GLB1;IFT88
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.47715447345105866,-0.7473866000640345,0.7777777777777778,1.0,1.0,3/9,24.95%,E2F7;DBF4;WIZ
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.5095310318565114,-0.7465767615277222,0.8115942028985508,1.0,1.0,1/5,27.41%,MACROH2A2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.46826354060631215,-0.746390006778433,0.8987341772151899,1.0,1.0,4/11,14.10%,ATP5IF1;PLN;IFIT1;PXK
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.49662502084161175,-0.746232731459966,0.8309859154929577,1.0,1.0,2/7,25.90%,DICER1;PRKRA
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3422030281452757,-0.7460146404065225,0.91,1.0,1.0,20/162,20.61%,RPS27A;RNF144B;DTL;ARIH2;RNF126;RBX1;HERPUD1;PINK1;TRIM25;UBA52;UBC;SPSB1;UHRF1;RNF149;RNF13;UBB;FBXL7;DTX3L;DDB1;PPP1R11
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.4579795171405185,-0.745930746512823,0.7746478873239436,1.0,1.0,3/9,24.21%,SPG11;KIF5A;KIF5C
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3742282355843107,-0.7459215845818761,0.8863636363636364,1.0,1.0,12/70,15.40%,PLPP3;ENPP4;TAMALIN;DOCK1;STXBP6;NTN4;PROCR;THBD;FN1;PALLD;SVEP1;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.3143923300850298,0.7457485962196152,0.8461538461538461,1.0,1.0,4/17,8.93%,PTCH1;PPARG;SIRT1;NR1H3
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.29341480644341666,0.7456713303699983,1.0,1.0,1.0,3/37,4.42%,RALB;LCP1;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.36980406553788936,0.745444576081426,0.8333333333333334,1.0,1.0,2/15,4.23%,VSIG4;LAPTM5
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.4873043054424284,-0.7450179867115913,0.782608695652174,1.0,1.0,2/6,14.35%,UGCG;CD36
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3957122333833427,-0.7446939297301262,0.8809523809523809,1.0,1.0,3/36,9.32%,EYA2;BRCA1;TMEM161A
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.45781098953176314,-0.7446735982103233,0.8055555555555556,1.0,1.0,4/9,37.70%,MFSD2A;ABCA3;MTMR4;DNAJC19
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.49282371019295046,-0.7446494544195184,0.8676470588235294,1.0,1.0,3/9,35.71%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.45736158626987755,-0.7445806900032013,0.7777777777777778,1.0,1.0,1/7,19.95%,GARS1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.36970899677337926,0.7445327693565237,0.7619047619047619,1.0,1.0,2/13,11.99%,ARHGAP35;ABL2
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),0.4543794250595887,0.7443835190170253,0.8076923076923077,1.0,1.0,3/5,18.71%,SEMA4D;JAM2;IL1B
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.44738489306018403,-0.743956874034047,0.810126582278481,1.0,1.0,5/12,27.66%,TGFB2;IQCE;BMPR1B;PCSK5;ZNF141
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.49215541292738346,-0.7438523775211648,0.8852459016393442,1.0,1.0,1/5,10.42%,APPL1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.4517656418097523,-0.7438068210191509,0.8169014084507042,1.0,1.0,1/9,10.34%,CXCR4
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5084403856505068,-0.7436486806421222,0.8709677419354839,1.0,1.0,3/5,41.43%,MAN1A1;MAN1B1;EDEM1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5084403856505068,-0.7436486806421222,0.8709677419354839,1.0,1.0,3/5,41.43%,MAN1A1;MAN1B1;EDEM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5084403856505068,-0.7436486806421222,0.8709677419354839,1.0,1.0,3/5,41.43%,MAN1A1;MAN1B1;EDEM1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.41526558649309414,0.743104121870265,0.775,1.0,1.0,1/7,3.99%,HVCN1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3879357683401774,-0.7425933956854602,0.8735632183908046,1.0,1.0,4/37,8.96%,RHOB;GLRX2;SOD1;ANKZF1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.359280980100238,-0.7425388182396129,0.8969072164948454,1.0,1.0,14/63,26.58%,FZD6;PSMA5;PSMA3;AP2S1;PSMD8;PSMB4;PRICKLE1;DVL1;PSMD7;PSMD5;AP2A2;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.48971563085913805,-0.7421271374543545,0.8260869565217391,1.0,1.0,2/6,20.96%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.3785214461578212,-0.7419114609721463,0.8426966292134831,1.0,1.0,10/44,20.31%,TFRC;IL7;NOD2;IL15;PRKCQ;PDCD1LG2;PYCARD;HLA-DMB;AIF1;THY1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.33286103513620546,0.7416968631111021,0.6666666666666666,1.0,1.0,7/52,5.29%,SIRPA;LGALS9;CD276;TLR7;CD274;LAPTM5;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.46210971606169027,-0.7414601742566693,0.782051282051282,1.0,1.0,1/10,5.96%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4600391809308865,-0.7408410337490139,0.7945205479452054,1.0,1.0,2/11,20.13%,DHX58;TLR2
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.4146870612729991,0.740798746523191,0.7241379310344828,1.0,1.0,4/6,18.44%,P2RY12;CRKL;P2RX4;TREM2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.4252781372860011,-0.7403452499799734,0.8170731707317073,1.0,1.0,4/13,16.54%,OVOL2;ID2;CFTR;PIEZO2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.3411640171037382,0.7399203876419547,0.7083333333333334,1.0,1.0,3/15,11.32%,LGALS9;SYK;NLRP3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.32683371252445337,0.7397757203489908,0.8695652173913043,1.0,1.0,2/12,9.58%,PHF8;WDR43
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.2809437065075114,0.739689919071177,1.0,1.0,1.0,6/37,8.25%,ATP2C1;RHOG;ZDHHC2;WNK3;STAC3;CIB1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.38092089834344517,0.7395993147836158,0.7333333333333333,1.0,1.0,4/15,13.61%,HPN;TFAP4;EP300;ZNF639
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.3491354863865428,0.7389722457217462,0.8636363636363636,1.0,1.0,3/12,9.18%,ZNF675;TGFB1;TRAF6
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.3976812815618086,-0.7387633950343572,0.8433734939759037,1.0,1.0,2/26,10.10%,PAQR3;ZDHHC15
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.42401851057695483,-0.7384715301150274,0.8552631578947368,1.0,1.0,3/11,35.02%,PARP11;PARP12;PARP10
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),-0.4428330425553043,-0.7379597375983159,0.8846153846153846,1.0,1.0,7/14,25.94%,NLGN3;IL1RAPL1;PTPRD;BSN;LRP4;DVL1;NLGN2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.41787313009014415,-0.7377495690539554,0.8850574712643678,1.0,1.0,1/17,6.91%,VPS11
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.4900319601183656,-0.7376573507034951,0.7761194029850746,1.0,1.0,2/5,27.68%,RPS3;RNF169
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.4153505985521628,-0.7376506096288421,0.8295454545454546,1.0,1.0,4/22,11.07%,PLTP;ABCA5;NR1H2;ABCB4
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.3804196945317734,-0.7375735581275019,0.8539325842696629,1.0,1.0,4/38,14.28%,HSPA1B;HERPUD1;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4379177639452914,0.7374429075354793,0.7777777777777778,1.0,1.0,3/6,20.48%,SMPD3;SGMS1;SAMD8
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4908190709366054,-0.7373962566848155,0.828125,1.0,1.0,2/5,19.55%,SOD1;E2F7
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.35445323779309396,-0.7373141970070334,0.90625,1.0,1.0,10/86,17.24%,NLRP12;BHLHE40;FZD6;AIM2;ID2;NLRC5;PYCARD;KDM1A;KLF4;SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.39900410017165905,-0.7371526406904517,0.8953488372093024,1.0,1.0,4/31,11.86%,SYAP1;NOCT;ID2;AAMDC
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.3675678083669512,-0.7371078214849184,0.9080459770114943,1.0,1.0,19/38,33.13%,ATP1B3;SLC6A15;SCN9A;SLC24A1;SLC9A6;NALCN;SCN1A;ATP1B2;SLC24A2;SCN3B;SLC24A4;HCN1;SLC9A7;SLC24A3;TRPM4;SCN2A;SLC6A1;ASIC2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4488645232103146,-0.7369967641919517,0.7866666666666666,1.0,1.0,4/12,33.44%,HEXIM1;NELFB;RECQL5;NELFA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3587186490475573,-0.7368585444322864,0.8602150537634409,1.0,1.0,9/51,20.15%,NACA;AQP11;RAB11A;VPS37C;ZDHHC15;SDCBP;ZDHHC9;ZDHHC4;ZDHHC19
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.35442443801789547,-0.7366907457852562,0.9560439560439561,1.0,1.0,16/76,24.04%,HTR2B;HERPUD1;PLN;ANK2;CCL3;TPT1;CAV3;CDH23;SLC24A1;ATP2B4;ADCY8;ATP2B2;SLC24A2;TMEM178A;RYR2;SLC24A4
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4093694313398919,-0.7365102686222597,0.7654320987654321,1.0,1.0,3/17,15.31%,AQP11;PLTP;TAP1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.3057858765692476,0.7364576416971228,0.8823529411764706,1.0,1.0,8/31,13.99%,ZDHHC3;HHAT;ZDHHC2;ZDHHC13;ZDHHC21;EP300;GTF2B;ZDHHC5
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.28896025029306205,0.7359372386583274,1.0,1.0,1.0,1/25,2.09%,RUBCNL
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.4448161764735677,-0.7359361664679382,0.8205128205128205,1.0,1.0,4/11,23.12%,TRPS1;MBOAT2;BMPR1B;ZBTB16
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.46106096428682,-0.7355538154662843,0.8676470588235294,1.0,1.0,1/6,10.99%,NR1H2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.4344061447232752,-0.7354946598336111,0.8461538461538461,1.0,1.0,7/16,30.61%,UGCG;TXNIP;ST14;CLIC4;PIP5K1A;ASAH1;CASP3
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.38095020611793795,-0.7353595830134707,0.8953488372093024,1.0,1.0,5/36,12.14%,RPS27A;NOD2;UBA52;MAP3K12;UBC
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.40685546219025986,-0.7350093670892206,0.8641975308641975,1.0,1.0,5/19,23.23%,ACSL1;MID1IP1;CD36;MFSD2A;ACSL3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.3772954531646273,-0.7348674532009914,0.8842105263157894,1.0,1.0,11/52,19.52%,NLRP12;AIM2;GSTP1;NOD2;CCL3;MNDA;CARD16;CD36;PYCARD;TRIM16;GSDMD
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.3107646307333281,0.7348281548075302,0.8888888888888888,1.0,1.0,4/21,8.26%,ENPP1;SIRT1;TGFB1;TRIB3
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.39345597511252034,-0.7346855187732981,0.8481012658227848,1.0,1.0,3/23,13.92%,INSIG1;FAXDC2;TM7SF2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.37348611162009815,-0.7337731234028727,0.8764044943820225,1.0,1.0,7/52,20.13%,THBS1;NOD2;CCL3;OAS3;PYCARD;CLU;TLR2
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.3468880089468794,-0.7336157587681527,0.9263157894736842,1.0,1.0,14/59,25.40%,GLRA1;AQP11;SLC17A7;GABRB1;PIEZO2;TRPM3;SLC24A1;SLC9A6;SLC24A2;CTNS;SLC20A2;SLC24A4;MCOLN1;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.44563667300551835,-0.7336058800915197,0.8108108108108109,1.0,1.0,1/9,4.00%,TGFB2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.3466297190718463,-0.7332920299582607,0.9696969696969697,1.0,1.0,16/134,12.40%,CLEC12A;CCL4;JAML;GPR183;FOS;CD93;C5AR1;TNFRSF1B;MS4A4A;CD163;FGR;FCGR2B;IL10RA;CCL3;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.26850947094197136,0.7331056934483137,1.0,1.0,1.0,15/75,12.97%,NRP1;RAB5B;RAB33B;STON2;ABL1;SYK;CDH13;RAB10;MAP2K1;STXBP5;ABL2;SRC;MAP2K2;RIT2;DNAJC13
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.4826018367711572,-0.732817944393756,0.8169014084507042,1.0,1.0,2/6,12.34%,CBR1;PTGES2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.43055915950642787,-0.7327296069017898,0.8441558441558441,1.0,1.0,3/10,26.54%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.38204399879005735,-0.7325824556352762,0.8681318681318682,1.0,1.0,11/58,22.97%,ENPP2;AGT;VEGFA;IL15;TEC;GHR;CD44;HCLS1;RELN;EPHA7;RIPK2
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.3463656550195271,-0.7325618914912646,0.9595959595959596,1.0,1.0,13/107,15.56%,PP2D1;PLPP3;CTDSP1;PPP2R5A;DUSP1;FBP1;PPP2R3B;PPP2R5B;PPP1CB;MTMR7;PTPRD;PTPRT;PTPRZ1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.43904932174439,-0.7321581851191159,0.8227848101265823,1.0,1.0,1/10,5.70%,TNFRSF1B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.47387662079033865,-0.7321341581690174,0.8783783783783784,1.0,1.0,2/10,7.70%,COBL;CARMIL1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.4603580936538508,0.7319851026923597,0.8823529411764706,1.0,1.0,3/6,29.63%,CD81;C1S;C1QC
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3430350664484944,-0.7319211837311931,1.0,1.0,1.0,63/564,17.11%,NAMPT;NR4A3;FOSL2;MACC1;RPS27A;FGF1;ST18;NR4A1;VEGFA;HMGB2;FOS;TGFB2;RBPJ;TXK;SLC11A1;HIF1A;BEX1;RORA;RXRB;DDRGK1;MEIS2;NR4A2;TAF6L;NOD2;BRCA1;LITAF;PLAC8;STAT1;PAX8;COPS5;PLAG1;RORB;DRAP1;NLRC5;NR1H2;CRTC3;ATF5;KDM6B;PRDM15;HCFC1;UBA52;RRP1B;ATF3;JUNB;IRF1;SMARCD3;UBC;MED25;IL18;PAXBP1;MAX;HSF2;UHRF1;PID1;ITGA6;MLX;NR1D1;RGCC;KDM1A;KLF4;NFIX;CCNC;CREBRF
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.41032322537780375,0.7319064012445257,0.8076923076923077,1.0,1.0,2/6,14.60%,PEX16;ZFAND6
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.41032322537780375,0.7319064012445257,0.8076923076923077,1.0,1.0,2/6,14.60%,PEX16;ZFAND6
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.40084123380570946,-0.731639202735126,0.8333333333333334,1.0,1.0,1/19,4.00%,TGFB2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.5050684194967303,-0.7316111526808124,0.8793103448275862,1.0,1.0,1/5,28.96%,OGT
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.49226253945058884,-0.7312704772128222,0.8513513513513513,1.0,1.0,2/5,10.88%,ANK2;CCL3
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.40942891048428903,-0.7308802918816393,0.8170731707317073,1.0,1.0,3/21,13.40%,SH3PXD2B;SULF2;SBDS
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3593762107277091,-0.7308310373397598,0.8936170212765957,1.0,1.0,10/64,22.35%,TGFB2;SPRY1;FBP1;NOTCH2;RASGRP4;RDX;ARF6;IRS2;ARFGAP1;STARD8
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.36878898456315956,-0.7307404228446075,0.9069767441860465,1.0,1.0,9/40,23.71%,HIF1A;SOD1;PINK1;SNX6;MAG;PTPRZ1;CRLF1;RETREG1;NRBP2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4404461764038904,-0.7305456772785467,0.8378378378378378,1.0,1.0,2/15,14.26%,TGFB2;SDCBP
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.41601781299540364,-0.730280570227298,0.8314606741573034,1.0,1.0,6/15,24.74%,TALDO1;HK2;GPI;RBKS;PGLS;TKT
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.44917676103665927,-0.729776855183065,0.8285714285714286,1.0,1.0,3/9,21.10%,PDCL;TXNDC15;TTC23
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3947872404894795,-0.7296013857482551,0.8313253012048193,1.0,1.0,6/17,25.26%,DAPK2;C5AR2;MPP1;C1QBP;JAM3;THBS4
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.33215584796980097,0.7293583186994833,0.8695652173913043,1.0,1.0,7/21,20.10%,OCRL;INPP5K;PIP4P2;MTMR10;INPP5F;MTMR2;SYNJ1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3599833522284042,-0.7291622157639546,0.9111111111111111,1.0,1.0,6/62,12.91%,RHOBTB3;RHOB;GPM6B;NOTCH2;IQGAP1;EPHA3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4151735329166976,-0.7291382601635442,0.8837209302325582,1.0,1.0,1/14,8.77%,TENT4B
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.4238296432187139,-0.7291348512987129,0.8051948051948052,1.0,1.0,3/12,35.71%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.4536687499507379,-0.729102282511054,0.7948717948717948,1.0,1.0,1/7,8.62%,FGR
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.36893629857256605,-0.7289586083914671,0.9263157894736842,1.0,1.0,10/65,19.26%,PAQR3;PLPP3;PPP1R15A;MAPT;DMD;PID1;SH3GL2;IMPACT;TERF2IP;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.39409960384646053,-0.7289183397995775,0.8777777777777778,1.0,1.0,11/34,34.31%,VBP1;AZIN1;FMN2;CLU;LILRB2;CRYAB;ROCK1;HSP90AB1;FLOT2;PFDN6;PFDN2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.3885840720364698,0.7287519040423643,0.8333333333333334,1.0,1.0,4/10,17.28%,MRPS27;FASTKD2;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.4511838105923215,-0.728611764527006,0.8472222222222222,1.0,1.0,1/10,6.80%,NOD2
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.4719008507568022,-0.7282593764503018,0.8658536585365854,1.0,1.0,1/10,2.40%,TALDO1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.3216818575244075,0.7282469143675611,0.8571428571428571,1.0,1.0,1/14,1.79%,ITGA5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.351045418860482,-0.7279917456550837,0.9278350515463918,1.0,1.0,15/65,27.56%,FZD6;PSMA5;PSMA3;AP2S1;PSMD8;PSMB4;PRICKLE1;DVL1;PSMD7;PSMD5;AP2A2;PSMB9;PSMC2;PSMB2;MAGI2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.49294206025086135,-0.7278988671782756,0.8571428571428571,1.0,1.0,2/5,21.49%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4665826065485591,-0.7273878705963164,0.8939393939393939,1.0,1.0,1/9,5.23%,GRM8
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4632186831240666,-0.7273656490971919,0.8533333333333334,1.0,1.0,3/7,25.66%,CMPK1;CAD;CTPS1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.3566375681199809,0.7271557361976314,0.9,1.0,1.0,3/13,9.33%,HPN;TMEM106A;MTPN
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.3746330734335766,-0.7271318168172042,0.9101123595505618,1.0,1.0,7/50,20.13%,THBS1;NOD2;CCL3;OAS3;PYCARD;CLU;TLR2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.34925995160129286,-0.7270341583689133,0.9166666666666666,1.0,1.0,15/97,18.84%,TRIM5;GSTP1;DUSP1;PEBP1;FLT1;PRDM15;IQGAP1;PAK5;FN1;TRAF7;EPHB1;APIP;CAV3;INSR;VRK2
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.4570253376110254,-0.7268972992877825,0.8695652173913043,1.0,1.0,2/8,15.40%,THBD;NR1D1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.362410985138186,-0.7267943016242362,0.896551724137931,1.0,1.0,6/31,23.15%,RAB11A;CENPE;SEH1L;CHMP5;PDCD6IP;DCTN2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.35630651927683143,-0.7267611930160359,0.9285714285714286,1.0,1.0,13/75,25.62%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS21;MRPL13;MRPL32;MRPS15
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.2936818787126155,0.7266797875359425,0.8888888888888888,1.0,1.0,6/33,13.31%,MIOS;LAMTOR1;RRAGD;SMCR8;TELO2;CLEC16A
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.4622013500662262,0.7266629337748804,0.7096774193548387,1.0,1.0,2/5,17.59%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3645059212854203,-0.7263401677747724,0.9139784946236559,1.0,1.0,11/68,14.26%,THBS1;RPS27A;ASPN;VASN;SPRY1;PEG10;UBA52;UBC;NREP;SNX6;SDCBP
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.44054402493112244,-0.7262912849733997,0.8055555555555556,1.0,1.0,5/9,34.53%,CLMN;SYNE3;DCTN1;DYNC1H1;SUN2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4259464949560621,-0.7262151607744443,0.8452380952380952,1.0,1.0,3/15,23.81%,FLT1;GNA13;NTRK3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.36595908525276255,-0.7262099968676522,0.898876404494382,1.0,1.0,9/53,15.55%,RGS2;JAML;CASP5;FGR;MS4A6A;MNDA;NREP;MXD1;NCF4
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.34358195492514293,-0.7259366653965199,1.0,1.0,1.0,69/369,23.58%,CENPF;EIF4A3;BHLHE40;NFIL3;HMGB2;RBPJ;ATP8B1;ZNF540;YEATS2;ZNF93;L3MBTL3;BRCA1;BASP1;DAPK1;ID2;MDFIC;RPL13A;GAPDH;ARID5B;RORB;LIMD1;NR1H2;ATF5;CTBP1;HIC2;TLE1;IRF1;BCL6;PIAS4;EIF2AK3;KCTD1;TSHZ3;RIDA;ENC1;SUV39H2;SNX6;CDKN1B;ING4;MLX;NR1D1;DEAF1;KDM1A;KLF4;RPS3;CNOT8;TIMELESS;CBX5;CITED2;PDCD4;ILF3;HEXIM1;PER2;SUDS3;PATL2;KDM5C;LANCL2;ENO1;PUS7;FOXP1;NRG1;NKX6-2;RUNX1T1;RBFOX2;PTPRK;PRICKLE1;EIF2AK2;ZBTB16;CRYAB;GCFC2
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3661287580997207,0.7256834145676762,0.7333333333333333,1.0,1.0,1/12,4.76%,JAG1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.4607180559579943,-0.7254882747064548,0.8888888888888888,1.0,1.0,2/7,9.72%,NTN4;LAMB1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.3094598037195085,0.725309400095485,0.7142857142857143,1.0,1.0,4/22,9.82%,LGALS9;TOMM70;MAPK11;CHUK
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3456043801800858,-0.7251403464338001,1.0,1.0,1.0,26/310,12.63%,SAP30;TOM1L1;ACVR1B;BHLHE40;NFIL3;HINT1;HIF1A;GLRX2;RORA;PQBP1;APBB3;TAF6L;RBM4B;CHD3;RBM3;PLAG1;PRKCQ;RORB;DRAP1;LIMD1;PPIE;ATF5;HCFC1;MSL3;RPL6;TCF7
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.4827948679603845,-0.7246949230393316,0.8611111111111112,1.0,1.0,3/5,26.09%,ARF6;AIF1;PIP5K1A
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.3699542452594362,-0.7246594168074899,0.8709677419354839,1.0,1.0,7/28,26.36%,MRPS7;MRPL51;MRPL47;TEFM;MRPS21;MRPS15;TFAM
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.4719117600741141,-0.7243811999347961,0.8153846153846154,1.0,1.0,1/5,13.12%,EIF2AK3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.4462949794668541,-0.7242919157502414,0.8414634146341463,1.0,1.0,1/13,7.75%,FLT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.41492385480003846,-0.723893705291726,0.8705882352941177,1.0,1.0,1/19,5.44%,POLR3F
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.4110114927230234,0.72389274344872,0.7307692307692307,1.0,1.0,1/7,5.23%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4220573704546916,-0.7238810029169598,0.8026315789473685,1.0,1.0,2/10,13.46%,HLA-F;IL18
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.4875814359563615,-0.7238205765751323,0.9193548387096774,1.0,1.0,1/5,17.71%,KCNK10
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.3608891701605884,0.723817968120825,0.8571428571428571,1.0,1.0,13/13,63.95%,IKBIP;LIG4;BRCC3;MSH2;NIPBL;XRRA1;ATM;XRCC5;ANXA1;BLM;XRCC4;XRCC6;NUCKS1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.2918363843357751,0.7233471767782055,1.0,1.0,1.0,4/30,7.01%,PKD2;RYR1;APPL2;ALDH9A1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3827995502584151,-0.723230716063794,0.9444444444444444,1.0,1.0,10/38,15.44%,CACNB2;TMEM266;GREB1;CKMT2;MAPT;ZNF483;FGF13;PREX2;SYCP2L;LDB3
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3966156480931637,-0.7229437914665992,0.9146341463414634,1.0,1.0,10/19,31.79%,GCNT1;GK;GK5;ALG11;TKT;TNIP1;SCCPDH;B4GALT5;GOLPH3;RRM1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.4374865553102623,-0.7226984975798195,0.8026315789473685,1.0,1.0,2/9,29.54%,MUS81;DNASE1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.36897672855943286,-0.7226522337972147,0.9333333333333333,1.0,1.0,19/48,29.79%,RIMS1;SHANK3;TSHZ3;NRXN1;NLGN3;SLC24A1;SYT1;ADCY8;SLC24A2;RELN;GRIN2A;RIMS2;NLGN2;SHANK2;RIMS3;APP;GRIK2;PLK2;CACNG2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.3942125174888913,-0.7224401269122466,0.8333333333333334,1.0,1.0,1/20,1.56%,INSIG1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.37285989150584375,0.7224125940761523,0.875,1.0,1.0,5/12,17.67%,EFL1;AK3;MFN1;RHOQ;GIMAP7
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.4945813910889137,-0.7223732927611943,0.855072463768116,1.0,1.0,1/6,11.51%,NOTCH2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.4792868408324582,-0.7223050038662667,0.8688524590163934,1.0,1.0,1/5,7.78%,BRCA1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.47554269390704573,-0.7220094419696351,0.7945205479452054,1.0,1.0,1/6,4.00%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.3401609880138552,0.7219458392642768,0.9230769230769231,1.0,1.0,6/12,23.25%,TGFB1;MAML1;PIEZO1;MEF2C;EFNB2;MMP14
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.2749836338748558,0.7219114871504838,1.0,1.0,1.0,6/38,8.25%,EPB41;RHOG;EFCAB7;WNK3;STAC3;CIB1
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),0.40538800585537754,0.7218147424407604,0.71875,1.0,1.0,1/5,2.84%,P2RY12
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.42385251102347077,-0.7216450022470831,0.8767123287671232,1.0,1.0,1/12,4.16%,PHKG1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.36015142811053125,-0.7214752337617176,0.9139784946236559,1.0,1.0,16/62,25.89%,NLRP12;AGT;POLR3F;IL15;CCL3;IL18;PDCD4;TLR2;NFKBIZ;PLSCR1;GPRC5B;PDE2A;RIOK3;TNIP1;IFI35;PTGER4
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.3669144393484107,0.7211077768838696,0.8666666666666667,1.0,1.0,8/8,63.33%,PRKN;BECN1;SQSTM1;PHB2;AMBRA1;ATG13;ATG14;MAP1LC3B
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.35326694051184143,-0.7209973963331017,0.9787234042553191,1.0,1.0,31/96,29.06%,TGFB2;PQBP1;RAB11A;PPP1R9A;MAPT;PLP1;LAMB1;HDGFL3;GPM6B;UGCG;MANF;GPM6A;ALK;SH3GL2;NCDN;ETV1;STMN3;STMN1;MICALL2;STMN2;MAP2;CNTNAP2;ERCC6;VAPA;APP;SRRM4;ATP8A2;B4GALT5;TMEM108;RASGRF1;ROCK1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.42226010198049113,-0.7209290431237746,0.8461538461538461,1.0,1.0,3/13,16.19%,FCGR2B;IRF1;PYCARD
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.43243754581344335,-0.7209005135227248,0.8354430379746836,1.0,1.0,4/12,18.35%,PIGL;PIGG;PIGH;PIGA
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.4400486892899792,-0.7207306134832628,0.8372093023255814,1.0,1.0,1/10,8.75%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.4836192429838251,-0.7207151213336028,0.8714285714285714,1.0,1.0,1/6,9.14%,ID2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.4504279425225311,-0.7206224897258776,0.8888888888888888,1.0,1.0,1/7,3.34%,SEMA3A
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.4504279425225311,-0.7206224897258776,0.8888888888888888,1.0,1.0,1/7,3.34%,SEMA3A
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.4734872846354556,-0.7204600646470429,0.8507462686567164,1.0,1.0,4/6,36.19%,EZH2;RIF1;EZH1;DOT1L
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.4724278118718424,0.72040569732154,0.8787878787878788,1.0,1.0,1/5,5.77%,APPL2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4843927139544707,-0.7203148771503889,0.8767123287671232,1.0,1.0,2/5,24.24%,IL18;CARD9
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.3762401255088511,-0.7202327015856183,0.8863636363636364,1.0,1.0,7/29,30.19%,SNRPD2;PRPF6;PRPF3;SART3;GEMIN2;SRSF12;CLNS1A
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.47926486724248346,-0.720070816952492,0.8676470588235294,1.0,1.0,1/6,3.11%,VEGFA
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.49983269886817516,-0.7197814303951459,0.8857142857142857,1.0,1.0,1/5,11.90%,ANTXR2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.381345248417309,0.7197501796244344,0.6666666666666666,1.0,1.0,4/9,25.08%,HDAC1;SIRT2;HDAC9;REST
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.3528397150589956,-0.7196016824789768,0.8947368421052632,1.0,1.0,23/83,26.35%,CATIP;PQBP1;CARMIL1;RAB11A;PPP1R9A;MAPT;PLP1;LAMB1;HDGFL3;GPM6B;MANF;GPM6A;SH3GL2;NCDN;ATP1B2;STMN3;STMN1;MICALL2;STMN2;MAP2;CNTNAP2;ERCC6;VAPA
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.363864424098181,-0.7191359115507457,0.9032258064516129,1.0,1.0,7/40,23.19%,HINT1;SULT4A1;ACOT13;ACAT1;ACSM3;AMPD2;GTPBP1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3648306481741654,-0.7189083912744975,0.9021739130434783,1.0,1.0,5/49,10.02%,TRMT9B;FTSJ1;METTL2A;SSB;GTPBP3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.43333250458728484,-0.7188061859337239,0.8352941176470589,1.0,1.0,2/13,8.38%,RORA;FMO5
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.4821962355789562,-0.7186994992858405,0.855072463768116,1.0,1.0,1/5,10.34%,CXCR4
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3345323598979012,-0.7184950983989161,0.99,1.0,1.0,38/274,22.85%,TOP2A;DTL;PPP1R15A;VAV3;XRCC3;SLF1;TNFRSF1B;DDX11;MASTL;BCL2A1;WDHD1;BRCA1;POLQ;NOP53;ADPRS;BCL2L2;BCL6;MNDA;FAN1;SLX4;RFC4;WDR48;RPS3;TIMELESS;CBX5;MCL1;FMN2;KMT5C;DTX3L;DDB1;POLE2;ZRANB3;CIDEB;VCPIP1;MUS81;FOXP1;SPDYA;MCM7
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.3367622883375263,-0.7183620408256325,0.99,1.0,1.0,50/306,23.83%,HTR2B;ACVR1B;NEK11;CDK14;TGFB2;TXK;FGR;PINK1;DAPK1;PRKCE;GK;LIMD1;DAPK2;PGK1;PDK3;CTBP1;MAP3K12;NIM1K;NUAK2;PIM3;DGKI;EIF2AK3;FAM20A;DGKG;TEC;LIPE;PXK;PAK5;ALK;STK17B;GRK4;PIK3R4;MAK;LIMK2;INSR;VRK2;ILF3;PIK3CB;VRK1;GK5;BMPR1B;CLK2;EPHA7;MAPK10;PRRT1;EIF2AK2;SGK1;DGKB;NRBP2;STRADB
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.42875183009618084,0.7182931227948791,0.8421052631578947,1.0,1.0,1/6,3.09%,CSF1R
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.48164370864224654,-0.7181314073007031,0.8714285714285714,1.0,1.0,1/5,2.81%,SLC16A10
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.41861016681160557,0.7180353100053576,0.6923076923076923,1.0,1.0,5/5,58.16%,RHOA;FGFR1;FGFR3;PDPK1;FGFR2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.38190434761593006,-0.7178666179858897,0.8505747126436781,1.0,1.0,10/27,22.98%,HIF1A;ALOX15B;IL7;IL18;PYCARD;SIGIRR;AIF1;TLR2;FOXP1;EIF2AK2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.3665337405491707,-0.7177945192482968,0.8958333333333334,1.0,1.0,7/64,11.58%,MYO1G;VAV3;DOCK1;FGR;FCGR2B;PRKCE;MYO10
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.4372807759419114,-0.7174111122246091,0.8518518518518519,1.0,1.0,8/14,25.94%,NRXN1;ASTN2;NLGN3;NCAM2;NRXN3;NRXN2;NINJ2;NLGN2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.40527848625035534,0.7173828190742825,0.8125,1.0,1.0,2/5,7.68%,ELAVL4;METTL16
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.3314082988227302,0.7173091374011438,0.9523809523809523,1.0,1.0,3/13,17.36%,AGO1;CELF1;HENMT1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.3752465813757451,-0.7169407501128935,0.8539325842696629,1.0,1.0,4/36,15.15%,PINK1;PDK3;BTN2A2;PID1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.4091003352552426,0.7166757108583749,0.7777777777777778,1.0,1.0,1/6,8.16%,CYP19A1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.39853909366396234,0.7165472184452198,0.8214285714285714,1.0,1.0,3/6,26.89%,SLC30A10;ROCK2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.38531895131354943,-0.7163740180906565,0.9302325581395349,1.0,1.0,3/35,7.44%,CHI3L1;NOD2;HSPA1B
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.33745438069074757,-0.7159952411893759,0.99,1.0,1.0,24/171,20.03%,FZD6;CDK14;RBMS3;LZTS2;RBX1;DKK2;AMER2;LIMD1;PRDM15;TLE1;GPC5;PSMA5;APC2;PSMA3;GPC3;DAAM2;CTNND2;PTK7;PSMD8;LRP4;PSMB4;EMD;SOX4;GSKIP
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.36108854337139756,0.7158780656213833,0.7894736842105263,1.0,1.0,2/14,5.33%,BAG5;SIRT1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.4729776753436372,-0.7157983205736803,0.875,1.0,1.0,1/5,11.22%,KDM6B
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.43655402945885013,-0.7156016660334332,0.8625,1.0,1.0,3/12,19.02%,ATP8B1;CFTR;SERPING1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.40619811842833425,0.7155384360374387,0.7567567567567568,1.0,1.0,5/5,59.40%,SRPK2;DDX23;PRIMPOL;SIRT7;DDX21
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.4836290868366411,-0.7155300151069673,0.8450704225352113,1.0,1.0,1/6,6.13%,DDRGK1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4298453385886459,0.7153884318878357,0.8709677419354839,1.0,1.0,2/7,10.06%,ALDH9A1;CPT1C
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.36264029440129975,-0.7150075080685296,0.8969072164948454,1.0,1.0,7/65,11.58%,MYO1G;VAV3;DOCK1;FGR;FCGR2B;PRKCE;MYO10
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.38537873579491855,0.7149574597198389,0.8,1.0,1.0,1/10,1.20%,P3H2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.3364401994672198,-0.7147857204496711,1.0,1.0,1.0,112/599,23.58%,NR4A3;CENPF;RPL23;RPS27A;SAP30;BHLHE40;NFIL3;HAMP;VEGFA;HMGB2;RBPJ;ATP8B1;MXI1;ZNF540;MEIS2;NR4A2;YEATS2;H1-0;ZNF93;FBP1;L3MBTL3;BRCA1;CHD3;UXT;BASP1;STAT1;ID2;PARP9;MDFIC;ARID5B;RPS14;RORB;DRAP1;LIMD1;NOP53;TGIF1;TRPS1;NR1H2;ATF5;CTBP1;HIC2;HCFC1;UBA52;TLE1;ATF3;IRF1;ETS2;UBC;BCL6;PIAS4;MED25;CGGBP1;ZNF550;KCTD1;TSHZ3;MXD1;SUV39H2;SNX6;MAX;SDCBP;UHRF1;BMI1;CDKN1B;ING4;ZNF266;MLX;NR1D1;PRDM1;DEAF1;ZNF20;KDM1A;KLF4;POU6F1;NFIX;C1QBP;TIMELESS;UBB;ZNF778;CBX5;CITED2;PDCD4;IMPACT;ILF3;ZFP36;HEXIM1;PER2;E2F7;PARP15;ZNF558;MNT;CREM;SUDS3;ESR2;DICER1;KDM5C;LANCL2;ENO1;KLF2;POU5F1;FOXP1;NRG1;NKX6-2;RUNX1T1;RBFOX2;PTPRK;PRICKLE1;ZNF589;ZBTB16;RPL10;CRYAB;PDE2A;GCFC2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.34395427743412665,0.7147606514491939,0.875,1.0,1.0,4/9,27.71%,CDK13;OBSL1;DAPK3;BORA
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.2752136215231207,0.714343093763887,0.9333333333333333,1.0,1.0,8/25,20.40%,ZPR1;PRDX6;RBMX;THRAP3;DYRK1A;TRA2A;HNRNPLL;NUP98
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3377305030274407,-0.7142377237539982,0.9270833333333334,1.0,1.0,12/114,10.66%,TFRC;ENPP2;ACVR1B;VEGFA;PTN;COBL;CFL1;BASP1;PINK1;ZDHHC15;BNIP3;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.37290548576046734,-0.7140894855932082,0.9139784946236559,1.0,1.0,9/47,17.84%,CARMIL1;BAIAP2L1;MAPT;PINK1;PRKCE;PYCARD;CAV3;RPS3;ARF6
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.4310222151948771,0.7140728196003728,0.75,1.0,1.0,5/5,56.91%,EXOSC9;EXOSC7;EXOSC2;EXOSC8;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.4310222151948771,0.7140728196003728,0.75,1.0,1.0,5/5,56.91%,EXOSC9;EXOSC7;EXOSC2;EXOSC8;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.4310222151948771,0.7140728196003728,0.75,1.0,1.0,5/5,56.91%,EXOSC9;EXOSC7;EXOSC2;EXOSC8;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.4310222151948771,0.7140728196003728,0.75,1.0,1.0,5/5,56.91%,EXOSC9;EXOSC7;EXOSC2;EXOSC8;EXOSC10
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.4374171694001576,-0.7140390727232019,0.8095238095238095,1.0,1.0,4/8,25.27%,STMN3;STMN1;STMN2;CKAP5
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.42491118723562493,-0.7139456450521665,0.8470588235294118,1.0,1.0,1/13,8.52%,RBM3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.28923001972172063,0.7138054080149057,1.0,1.0,1.0,8/42,9.47%,MOSMO;MMD;ZC4H2;EIF2AK4;BRINP3;CNTN4;BIN1;YWHAG
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.3433570506146381,-0.7136584205667567,0.9595959595959596,1.0,1.0,28/178,21.95%,HTR2B;TRIM5;DEPP1;FBXL2;MAPT;PINK1;DAPK1;EEF1A2;GAPDH;IL10RA;BNIP3;DAPK2;USP36;SNX6;NPRL2;EEF1A1;BMF;MCL1;GFAP;TP53INP1;ATP6V1D;PIK3CB;TBC1D14;DRAM1;TRIM22;TRIM14;CAPNS1;UCHL1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.332206501784389,-0.7133869866863449,0.98,1.0,1.0,39/208,26.64%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;POLR2G;WBP4;PPIE;BCAS2;WBP11;HNRNPA0;DHX16;PNN;TFIP11;SNRNP27;SRSF5;ZCCHC8;SNRPA;PRPF6;FRG1;SRSF2;PRPF40B;LSM5;MFAP1;RNPC3;DDX46;CSTF2T;SRSF9;GCFC2;U2AF2;SRSF3;PRPF3;SART3;SNU13;DBR1;ZCRB1;SRSF8;PDCD7
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.44737109180313844,-0.7130079917711661,0.8717948717948718,1.0,1.0,2/9,30.94%,EIF2D;DHX29
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.43627154552802,-0.7129634817145926,0.8961038961038961,1.0,1.0,4/10,17.42%,NLGN3;IL1RAPL1;PTPRD;LRP4
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.44856433862939493,-0.7129044376436313,0.8028169014084507,1.0,1.0,2/6,29.66%,ARFGAP2;TMED2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.44856433862939493,-0.7129044376436313,0.8028169014084507,1.0,1.0,2/6,29.66%,ARFGAP2;TMED2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.44856433862939493,-0.7129044376436313,0.8028169014084507,1.0,1.0,2/6,29.66%,ARFGAP2;TMED2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.4071879025429173,-0.7128479892598817,0.8604651162790697,1.0,1.0,2/23,3.34%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.41753565485561345,-0.7127059518986864,0.8765432098765432,1.0,1.0,4/18,18.35%,PIGL;PIGG;PIGH;PIGA
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.4407215419975229,-0.7119732688037109,0.8933333333333333,1.0,1.0,1/10,3.11%,VEGFA
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3552817243961131,-0.7119290177377808,0.9213483146067416,1.0,1.0,2/40,4.06%,LRP2;RBPJ
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.27021933279243743,0.711775597044181,1.0,1.0,1.0,4/43,11.95%,NUP188;CHMP2B;CC2D1B;BANF1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.27021933279243743,0.711775597044181,1.0,1.0,1.0,4/43,11.95%,NUP188;CHMP2B;CC2D1B;BANF1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.4170955426830517,-0.7117093375212641,0.92,1.0,1.0,1/12,4.16%,PHKG1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.33599948384651473,-0.7115558409103453,0.9583333333333334,1.0,1.0,9/98,13.80%,HMGB2;FAM50A;DDX11;TAF6L;KDM6B;HCFC1;SMARCD3;PADI2;SUV39H2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.4826830431452073,-0.7114909706906598,0.9054054054054054,1.0,1.0,1/6,10.99%,NR1H2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.4400564359275362,-0.7111755256438362,0.8732394366197183,1.0,1.0,5/8,46.58%,MBTPS1;SREBF1;LPCAT3;MBTPS2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.35964740177530063,-0.7111533935156436,0.9247311827956989,1.0,1.0,7/61,13.20%,HMGB2;RPL11;DDX11;NMD3;PARP9;MED25;B2M
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.4015366799650005,-0.7107421940817263,0.8625,1.0,1.0,5/18,26.62%,VCAN;CHST7;CSGALNACT2;CHSY1;CHST12
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.36922822057323024,-0.7104962265637511,0.9318181818181818,1.0,1.0,7/35,19.48%,AQP11;TENT4B;ABCB4;VGF;SLC4A10;PNPLA8;IRS2
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.4738731715173094,-0.7102685521646299,0.855072463768116,1.0,1.0,1/6,7.30%,RPA2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.3772329732164173,0.7101334957574861,0.7894736842105263,1.0,1.0,3/12,13.67%,CBFB;RUNX1;MAFG
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.35648312906232116,0.709322818765113,0.9333333333333333,1.0,1.0,4/18,5.78%,PKD2;MKKS;TGFBR2;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.3938985337971549,-0.7092869048092625,0.9146341463414634,1.0,1.0,3/18,10.52%,NOCT;RORB;LIMD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.3699056373875369,0.7091745484860794,0.7692307692307693,1.0,1.0,3/12,11.32%,LGALS9;SYK;NLRP3
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.42823715375431987,0.7091289450360946,0.8076923076923077,1.0,1.0,1/6,5.23%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.45336756540157486,-0.7090900280956604,0.8133333333333334,1.0,1.0,1/7,4.00%,TGFB2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.33797430461071293,-0.7087884223765842,0.98,1.0,1.0,24/238,16.61%,NR4A3;CEBPD;NR4A1;RBPJ;C5AR1;RORA;RXRB;INTS12;NR4A2;NOCT;NFE2L3;POLR2G;RORB;SNAPC1;DRAP1;NR1H2;NOTCH2;RNMT;EAF1;ERCC2;BTF3;NR1D1;DEAF1;NFIX
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.4001337328025203,0.7087028404738029,0.7894736842105263,1.0,1.0,1/7,3.02%,SH2B3
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.27953492740081837,0.7086171326698162,1.0,1.0,1.0,10/57,15.40%,PDE12;ENPP1;MMS19;POLR2C;HNRNPC;LSM8;RBMX;GTF2F1;DNASE2;LSM1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3738140899724503,-0.7085456992322899,0.8863636363636364,1.0,1.0,6/30,19.78%,TNFRSF1B;ATP5IF1;PINK1;WDR48;SH3D19;ASPH
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.4056855638706122,-0.7084443564098502,0.8765432098765432,1.0,1.0,5/17,27.35%,ADGRG6;AKAP6;PDE2A;RIMS2;RAPGEF3
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.44318389021168747,-0.7082753410373644,0.8227848101265823,1.0,1.0,3/9,26.85%,ABCB1;SLC1A2;BEST1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.44665136396473304,-0.7081675319236478,0.8831168831168831,1.0,1.0,1/9,4.00%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.375711636163597,-0.7081554712497414,0.8863636363636364,1.0,1.0,8/36,24.85%,CALY;CLIP3;B2M;GPC3;CLU;RAB21;TF;HFE
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4075981794114103,-0.7080985224805273,0.8933333333333333,1.0,1.0,3/12,15.39%,SHANK3;EPHB1;CTNND2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.4118139203499696,-0.7080382229756085,0.8888888888888888,1.0,1.0,4/18,19.74%,C5AR1;MAPT;AIF1;CLU
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.47295642116860837,-0.7079423667982679,0.9014084507042254,1.0,1.0,1/5,3.11%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.48661238081463687,-0.7079178699741153,0.8656716417910447,1.0,1.0,2/5,38.70%,NUCKS1;XRCC6
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.34188344422802336,-0.7078473017253354,0.9595959595959596,1.0,1.0,28/105,24.06%,PLPP3;VEGFA;THSD4;SH2D4A;DOCK1;NTN4;MAPT;EMC7;LAMB1;DOCK5;HSPA12A;ADGRL2;PALLD;COL4A5;LIFR;ENAH;SH3D19;CPE;NFIB;PTPRG;RND3;MAFB;RBFOX2;KITLG;APBB2;MPDZ;UACA;EMC2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.36112342970202543,-0.7077975289003151,0.9574468085106383,1.0,1.0,4/46,10.64%,TRMT9B;FTSJ1;SSB;DDX1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.4069328403130893,0.707639550921388,0.8,1.0,1.0,3/6,25.53%,RABEP1;RAB29;ARL3
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.37042701693228514,0.707573901152884,0.8333333333333334,1.0,1.0,3/11,18.17%,WHAMM;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4482166400408482,-0.7071445931598082,0.8714285714285714,1.0,1.0,2/9,18.42%,GSTP1;PDCD4
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.37979747081834603,-0.70705233078258,0.8571428571428571,1.0,1.0,3/20,17.93%,ATP5IF1;PINK1;UBB
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.37504118132682707,-0.7069993734633684,0.8735632183908046,1.0,1.0,3/16,15.40%,RAB7B;APPL1;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3853068456644953,0.7068671731559286,0.8372093023255814,1.0,1.0,1/6,3.67%,NFATC3
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3590952857729289,-0.706623896367211,0.9347826086956522,1.0,1.0,12/52,25.48%,TGFB2;APBB3;TTN;RAB3A;RAB2B;CFTR;RGCC;ARF6;RAB5A;CADPS;MYH10;PPID
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.3392712452272278,-0.706622380604096,0.9595959595959596,1.0,1.0,13/84,16.19%,VIM;HMGB2;SLC11A1;TNFRSF1B;GSTP1;NOCT;NOD2;PDCD1LG2;HNRNPA0;CARD16;PDE4B;NR1D1;PYCARD
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.3726397679710826,0.706321132646851,0.88,1.0,1.0,5/10,31.43%,VTI1A;STX6;TMED5;TRIP11;GCC2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.36128073201307886,-0.7060984479198377,0.9010989010989011,1.0,1.0,3/44,8.89%,TRMT9B;FTSJ1;SSB
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.3733390395924063,-0.7058306655197318,0.8651685393258427,1.0,1.0,5/38,12.82%,HMGB2;SLC11A1;NOCT;FCGR2B;HNRNPA0
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.4477498315685202,-0.7055978957537455,0.8787878787878788,1.0,1.0,1/6,8.29%,HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.34518020258585114,-0.7055749732450128,0.9361702127659575,1.0,1.0,4/89,2.62%,THBS1;LRP2;CHI3L1;FGF1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.43464797592324345,-0.7055186364972096,0.8695652173913043,1.0,1.0,2/12,5.14%,GCNT1;SELL
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.4340184046377147,0.7053713951386443,0.8,1.0,1.0,3/5,27.81%,CEP120;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.35634370349323174,-0.7053061883333508,0.8924731182795699,1.0,1.0,8/45,20.13%,TGFB2;MYRIP;APBB3;TTN;ARF6;IRS2;SOX4;TLR2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3495335554339991,-0.7051146660501654,0.9361702127659575,1.0,1.0,12/61,21.04%,DTL;TNFRSF1B;VPS11;APC2;GPC3;SNF8;NSF;CDKN1B;RDX;SH3D19;DDB1;HECW2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.35109657920669496,-0.7048905912127942,0.9148936170212766,1.0,1.0,10/39,24.14%,RPL11;HSPA1B;CAMLG;RPL5;COPS9;RPS3;PER2;SOX4;UBXN1;U2AF2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.29832223161785365,0.7047263674989501,1.0,1.0,1.0,3/20,9.59%,ENPP1;PIP4K2B;INPP5K
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.47536856873853817,-0.7044984960102184,0.9076923076923077,1.0,1.0,1/5,8.47%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3577140857523498,0.7041276167237356,0.75,1.0,1.0,1/12,2.29%,BCL2L1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3997412395776787,-0.7037049446602399,0.8552631578947368,1.0,1.0,3/14,20.31%,KLF4;CD44;THY1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.48396171386393394,-0.7035940048792247,0.828125,1.0,1.0,3/5,33.18%,PRPS1;DCK;ENPP3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.38887187693942166,-0.7035185984044818,0.8674698795180723,1.0,1.0,9/20,25.60%,CACNB2;ANK3;LRP4;UNC13A;MUSK;DVL1;UNC13C;DCTN1;PPFIBP1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3416469144751349,-0.7034788613283007,0.9473684210526315,1.0,1.0,12/96,10.99%,OVOL2;VASN;RORA;PKP2;MEIS2;SPRY1;NOCT;ID2;ABCA5;RORB;LIMD1;NR1H2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.337166408211216,0.7034148016632653,0.9444444444444444,1.0,1.0,5/19,10.53%,MCU;MICU3;CACNA1A;MAIP1;SMDT1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.3566588130167472,-0.7032970313648436,0.978021978021978,1.0,1.0,11/58,21.52%,JAML;MYO1G;SELL;IL10RA;LSP1;VNN2;GPR65;HCLS1;GNLY;CD300A;ARHGAP9
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3686887787022997,-0.7030291029517433,0.978021978021978,1.0,1.0,3/48,7.68%,NLRP12;RORA;DHX58
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.329522792912084,-0.7027563721571267,1.0,1.0,1.0,63/332,23.43%,HTR2B;FTH1;ACVR1B;TP53TG5;ST18;NR4A1;RHOB;TGFB2;ALOX15B;TNFRSF1B;TCHP;IFIT3;AQP11;FHL1;DUSP1;FBP1;BRINP1;HSPA1B;ADAM15;CR1;FCGR2B;CAMK2N1;BNIP3;BTN2A2;NR1H2;ATF5;CTBP1;BNIP3L;IRF1;TGFBI;BCL6;SST;TXNIP;EIF2AK3;CDKN1B;ING4;ING5;RGCC;KLF4;ORC6;PDCD4;IMPACT;TP53INP1;TNFRSF21;E2F7;CLU;SOX4;NEURL1;MNT;TLR2;ATG5;LRPAP1;ESR2;ALDH1A2;PLSCR1;ENO1;GPNMB;PTPRK;EIF2AK2;APBB2;CLMN;RPS6KA2;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.36695015446577195,-0.702728066420532,0.9069767441860465,1.0,1.0,7/36,16.19%,TXK;SLC11A1;SLC7A5;BTN3A1;PDE4B;IL18;PYCARD
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3857324824721748,-0.7026089987281836,0.8313253012048193,1.0,1.0,6/24,24.37%,RAB11A;VPS37C;SNF8;CHMP5;PDCD6IP;MVB12A
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.35334603120077257,-0.7022519564515699,0.9139784946236559,1.0,1.0,10/61,25.52%,CENPV;VPS11;MAPT;PINK1;RDX;TMEM33;CLIC4;STMN3;PDE2A;AKAP9
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3499319986821487,-0.7022246840980059,0.9444444444444444,1.0,1.0,1/46,0.52%,HTR2B
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4943526684321047,-0.702071393048485,0.9264705882352942,1.0,1.0,2/5,27.50%,POU5F1;CTR9
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.44666564490648997,-0.7019570885505577,0.835820895522388,1.0,1.0,1/6,6.49%,AQP11
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.41090816639685523,-0.7018254941186827,0.8414634146341463,1.0,1.0,3/17,14.19%,LAMB1;COL11A1;FN1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.43339145176908167,-0.7015787874393775,0.8714285714285714,1.0,1.0,2/13,5.14%,GCNT1;SELL
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.3651083793843539,0.7014889207367447,0.8620689655172413,1.0,1.0,1/7,7.32%,TP53
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.37392870583095694,-0.7011532854610549,0.8444444444444444,1.0,1.0,11/35,27.95%,GLA;GALC;UGCG;SUMF2;GBA3;SUMF1;STS;UGT8;ESYT2;ASAH1;SCCPDH
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.4170292990090716,0.7011366121551079,0.8285714285714286,1.0,1.0,2/5,14.34%,TENM3;PTPN23
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.36780425128241656,-0.7011269175393066,0.9302325581395349,1.0,1.0,5/43,10.78%,ENPP2;PLPP3;ALOX15B;LPCAT1;GNPAT
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.34741622719137155,0.7006621064898539,0.9545454545454546,1.0,1.0,7/13,26.85%,NPC2;LDLR;NPC1;LRP6;LDLRAP1;OSBP;STARD4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4386771060596031,-0.7006521935747766,0.8648648648648649,1.0,1.0,4/9,19.74%,TMEM161A;TPT1;RPS3;CLU
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.4140225881666533,0.7003036273385354,0.7714285714285715,1.0,1.0,1/6,2.54%,PLEKHM2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.33267229335045145,0.7000804703723864,0.9629629629629629,1.0,1.0,2/13,4.91%,NEDD4;CAB39
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.4448303218016898,-0.6995402351656639,0.922077922077922,1.0,1.0,4/13,31.98%,ASPA;PIPOX;GOT1;CRYM
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.4393821666858725,-0.6995371667858026,0.8717948717948718,1.0,1.0,1/10,9.38%,COPS5
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.32182320868942604,0.6994062329197152,0.7916666666666666,1.0,1.0,3/13,17.06%,KPNA6;KPNA4;KPNA3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.3855931078893319,-0.6993994519752234,0.8780487804878049,1.0,1.0,4/20,21.64%,GPM6B;EPHA3;ACTG1;PTPRA
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.41892076755571805,-0.699333073350295,0.8933333333333333,1.0,1.0,4/12,26.36%,MTERF1;TEFM;PNPT1;TFAM
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.44297881695261565,-0.6993002538545156,0.9027777777777778,1.0,1.0,4/9,17.42%,NLGN3;IL1RAPL1;PTPRD;LRP4
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.42419233191812944,-0.6990723775451096,0.9014084507042254,1.0,1.0,2/8,18.37%,RBX1;UBE2M
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3459604657706567,-0.6990703910746837,0.9263157894736842,1.0,1.0,8/67,16.73%,SH3BP5;GSTP1;CAMK2N1;SH3BP5L;CDKN1B;PTPRT;PYCARD;CAV3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4433710079491481,-0.6987562424778693,0.8208955223880597,1.0,1.0,1/8,14.79%,AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4433710079491481,-0.6987562424778693,0.8208955223880597,1.0,1.0,1/8,14.79%,AKAP6
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.37794147995586536,-0.698628993558725,0.8850574712643678,1.0,1.0,1/29,3.28%,RTN1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.328419115119744,0.6984153654338187,0.7727272727272727,1.0,1.0,1/15,4.39%,OSBPL6
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.35242426039882147,-0.6974149398501625,0.9230769230769231,1.0,1.0,9/48,22.62%,CHI3L1;NOD2;HSPA1B;PYCARD;KLF4;C5AR2;TLR2;TMSB4X;CD14
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.4670407002447792,-0.6972481409098281,0.8985507246376812,1.0,1.0,1/5,20.47%,ROBO2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.36234048523209483,-0.6972418661919723,0.8481012658227848,1.0,1.0,5/21,23.63%,GK;DGAT1;CAV3;GK5;SLC27A5
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.4017058768177166,0.6971178002500598,0.64,1.0,1.0,4/6,20.15%,PTCH1;GRAMD1A;OSBPL7;LRP6
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.38743703823194003,-0.6969564522072954,0.9285714285714286,1.0,1.0,5/28,22.78%,SLC11A1;DMXL2;ATP6V1D;RAB20;ATP6V1E2
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.42974698426649854,-0.696898035955604,0.8701298701298701,1.0,1.0,3/8,18.96%,DUOX1;ALDH1A1;ST14
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.3816181013037796,-0.6965728615063945,0.8170731707317073,1.0,1.0,6/25,24.37%,RAB11A;VPS37C;SNF8;CHMP5;PDCD6IP;MVB12A
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4182406520490739,-0.6963796900556086,0.8641975308641975,1.0,1.0,2/10,14.28%,SEC61B;HSPA5
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4288691058811133,0.6963726528124532,0.7931034482758621,1.0,1.0,1/7,4.77%,ALOX5AP
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4288691058811133,0.6963726528124532,0.7931034482758621,1.0,1.0,1/7,4.77%,ALOX5AP
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.46591650778780824,-0.696296676859425,0.8428571428571429,1.0,1.0,1/5,10.87%,PDK3
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.3682969339301115,-0.6957324241727012,0.9294117647058824,1.0,1.0,2/36,6.46%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.37143408932859034,-0.6953854002604177,0.8924731182795699,1.0,1.0,8/30,27.98%,FCGR2B;SNX6;CD36;GRIN2A;CALCR;EPHA4;APP;CACNA1B
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.3739784658592016,-0.6952316349984992,0.8641975308641975,1.0,1.0,4/21,17.95%,SHANK3;EPHB1;CTNND2;INSR
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.4526379978197042,-0.6952187652111134,0.8225806451612904,1.0,1.0,2/5,8.84%,SLC16A10;SLC7A5
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.33153919893986017,0.6952172209499625,0.9285714285714286,1.0,1.0,4/19,5.78%,SMAD7;TGFBR2;SLIT3;ACVR1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.445776892984854,-0.6950387974799083,0.9102564102564102,1.0,1.0,4/11,27.20%,INSR;MAP1A;DCTN1;APP
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.40546448479541763,-0.694938682164747,0.8846153846153846,1.0,1.0,1/13,10.42%,APPL1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3385088468755298,-0.6947747654149811,0.956989247311828,1.0,1.0,13/74,19.48%,AGT;TGFB2;FLT1;PPP2R5B;FBXL2;FGR;NOP53;IL18;FN1;INSR;HCLS1;PIK3CB;IRS2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.4235259604186866,-0.6947447393193473,0.8947368421052632,1.0,1.0,4/11,16.73%,TTN;DMD;CDH2;CAV3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.4003475355578683,-0.6945736590244829,0.9302325581395349,1.0,1.0,5/22,12.77%,VEGFA;RBPJ;FLT1;ITGB8;CDH2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.39367557498425165,-0.6944225095447926,0.9069767441860465,1.0,1.0,8/21,24.28%,MAPT;MAP1B;PRUNE1;STMN3;STMN1;STMN2;MAP1A;MAP2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.308304982887435,0.6940507929352452,1.0,1.0,1.0,10/50,13.98%,CEBPA;PKD2;HHEX;LATS2;CCNG2;CCNYL1;TFAP4;MNAT1;CCNI;CCNG1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.42665543213321233,-0.6940254162129186,0.8611111111111112,1.0,1.0,3/10,22.57%,KDM6B;PLD3;NRG1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.35948948414502585,-0.6938490382599534,0.9247311827956989,1.0,1.0,2/45,4.37%,GPR183;DNAJB9
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.3804995609850032,-0.6935209088662873,0.8571428571428571,1.0,1.0,4/22,22.15%,IFIT2;BNIP3;CLU;HK2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.43521159638090595,-0.6932115166918305,0.875,1.0,1.0,4/8,26.19%,TYSND1;IRS2;MFSD2A;PPARA
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.38068168622874227,-0.6931912210332085,0.8354430379746836,1.0,1.0,8/26,23.73%,ANK3;PRKCE;DMD;FGF13;CAV3;HECW2;SCN3B;FGF14
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.4061392628255295,-0.6931618334637464,0.9324324324324325,1.0,1.0,1/13,4.16%,PHKG1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.4259782531092494,-0.6928370316666963,0.8904109589041096,1.0,1.0,3/13,31.19%,SEH1L;NUP133;AHCTF1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.36129835696747,0.6927490316353385,0.8484848484848485,1.0,1.0,1/8,3.28%,PRKAB2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3491218069553151,-0.6927225879247365,0.9042553191489362,1.0,1.0,14/55,22.05%,VAV3;ATP5IF1;CHN1;SOD1;FGD6;SIPA1L1;RAP1GAP;EPHA3;RDX;TBC1D15;NGEF;STMN3;ARHGAP9;FGD3
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.3882664300839408,-0.6923883760667919,0.9156626506024096,1.0,1.0,6/18,19.74%,TMEM161A;TPT1;KDM1A;RPS3;CD44;CLU
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.35386807942699533,-0.6917019893174137,0.9361702127659575,1.0,1.0,10/51,20.31%,GSTP1;PPP2R5A;MAPT;CAMK2N1;CDKN1B;NPRL2;CAV3;IRS2;GSKIP;THY1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.4354009529734948,-0.6913898342624637,0.8904109589041096,1.0,1.0,4/8,19.76%,COL11A1;LHFPL5;PIEZO2;SCN1A
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.336799962244458,-0.6913686651017645,0.9148936170212766,1.0,1.0,9/68,14.09%,RPS27A;LRP2;ASPN;VASN;SPRY1;PEG10;UBA52;UBC;SNX6
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.40498099880666216,-0.6910822114968971,0.8142857142857143,1.0,1.0,2/10,14.75%,SHANK3;VPS51
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.4190419635270747,-0.6910653373713477,0.8840579710144928,1.0,1.0,6/12,34.53%,CLMN;SYNE3;DCTN1;DYNC1H1;HOOK3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.2565411899570058,0.6908078309300709,1.0,1.0,1.0,16/88,13.15%,PLXNA2;AVIL;RAP1A;DAB2IP;ARHGAP35;PLXNA4;CAPRIN2;TENM3;ARSB;DVL2;ABL2;PLXNB2;RIT2;EP300;P3H1;DVL3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.39829801226000155,-0.6906703213667292,0.9047619047619048,1.0,1.0,4/18,32.59%,CAMK2N1;EPHA4;ROCK1;CSTB
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.35024852560381975,-0.6906448430781825,0.9292929292929293,1.0,1.0,5/71,12.91%,CEMIP;ANK3;CLIP3;PRKCE;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.33655321396758137,-0.6901259290827085,0.9693877551020408,1.0,1.0,15/78,22.18%,DTL;AGT;NR1H2;APC2;IL18;GPC3;UHRF1;SNF8;NSF;CDKN1B;KLF4;CLU;DDB1;HECW2;KLF2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.39122896534950224,-0.6901089399464176,0.9418604651162791,1.0,1.0,1/19,1.49%,KCNJ13
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3113312270741593,0.6897810190367981,0.875,1.0,1.0,6/17,18.13%,WHAMM;TRIP6;SRC;TAOK2;FERMT2;BCR
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3076211443675661,0.6891890044217738,0.9285714285714286,1.0,1.0,5/25,10.85%,NRP1;CRK;ABL1;CIB1;CRKL
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.40863626760806937,-0.6890273498674315,0.8611111111111112,1.0,1.0,1/13,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.32877362220289397,0.6889940610935468,0.8333333333333334,1.0,1.0,7/7,67.14%,GSPT1;UPF1;OGFOD1;ETF1;GLE1;MTRF1;SHFL
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.36476518712009776,0.6887345685309643,0.8695652173913043,1.0,1.0,2/11,11.22%,SETD3;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.32666298190958504,-0.6887099592165282,0.9393939393939394,1.0,1.0,11/126,13.18%,HTR2B;TFRC;TRIM5;NOD2;LITAF;PINK1;GAPDH;TRIM25;DDX1;LGALS1;CARD16
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3512878036245866,-0.6886466763662595,0.8586956521739131,1.0,1.0,3/47,11.88%,ACVR1B;CIT;MAP3K12
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.43236404355982605,-0.6885456980522142,0.8955223880597015,1.0,1.0,2/8,25.83%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.3654621649403019,0.6883436861892951,0.8857142857142857,1.0,1.0,7/7,63.47%,EXOSC9;EXOSC6;XRN1;EXOSC7;EXOSC8;EXOSC10;PCID2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.3635052930429741,-0.687981981406742,0.9036144578313253,1.0,1.0,5/30,17.86%,TVP23A;RAB3A;RAB3C;RAB15;ABCA1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.37726776971042314,-0.6878280851623984,0.8780487804878049,1.0,1.0,6/25,29.45%,GPM6B;CAV3;MAP1A;KCNAB2;HFE;ACTN2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.37842880891522956,0.6876277541167376,0.88,1.0,1.0,3/7,23.49%,ST6GAL1;PARP1;SETD5
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.42274569166465165,-0.6873223347202596,0.8939393939393939,1.0,1.0,1/6,10.42%,APPL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.39867485035311007,-0.6873115516628422,0.9024390243902439,1.0,1.0,4/11,26.71%,DDRGK1;ATAD5;ZNF16;EZH2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.3389317351557373,-0.6870582015793444,0.9387755102040817,1.0,1.0,7/62,16.79%,IFIT2;DDX11;PLN;CARD16;IFIT1;KDM1A;TFIP11
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.3389429709005246,-0.6870120366431135,0.8947368421052632,1.0,1.0,12/49,25.41%,RORA;SYAP1;NOCT;ID2;AAMDC;NR1D1;ZFP36;RUNX1T1;ZBTB16;ANKRD26;ZFPM2;LMO3
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3300760842829962,-0.6869900761036052,0.9368421052631579,1.0,1.0,13/67,20.16%,THBS1;TTN;CALM3;KCNMA1;IQGAP1;SYT1;CALM1;CPNE8;RYR3;CLIC4;ADCY8;SYT4;KCNMB1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.4756898238097642,-0.6868562283680062,0.875,1.0,1.0,1/5,21.49%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3499761708000523,-0.6865745921135036,0.9111111111111111,1.0,1.0,2/43,9.90%,TENT4B;PRKCQ
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3764525223220604,-0.6865710302474597,0.8837209302325582,1.0,1.0,1/25,4.57%,XRCC3
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.4035030262708476,-0.686450336852593,0.8513513513513513,1.0,1.0,2/12,14.27%,SLC4A10;CFTR
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.4365214394406802,-0.6864473239331933,0.8701298701298701,1.0,1.0,2/9,26.67%,HSPA5;MBTPS1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.3749696423425152,-0.6862961277045727,0.9404761904761905,1.0,1.0,5/24,18.99%,NOD2;FCGR2B;PDCD1LG2;PYCARD;TNFRSF21
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.34983360644918815,-0.6861593623826745,0.927710843373494,1.0,1.0,9/44,20.29%,GLUL;PIGL;ZDHHC15;UGCG;PIGG;ZDHHC9;PIGH;PIGA;ATG5
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.3012403923083511,0.6858166244534583,0.9473684210526315,1.0,1.0,6/16,20.99%,ADAM10;TSPAN33;P2RX7;AFDN;NUP98;TPR
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.4143824616824787,-0.6858051019863293,0.875,1.0,1.0,5/13,28.96%,ARF6;PIK3CB;STMN3;RASGRF1;OGT
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.2220827597410752,0.6850338628312923,1.0,1.0,1.0,16/85,16.13%,RALB;ITPR2;CAB39;DAPP1;TRIB3;PLA2G12A;MKNK1;DUSP3;RPS6KA1;UBE2N;SMAD2;PIKFYVE;NCK1;EIF4E;DDIT3;MAP3K7
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.44068403833746167,-0.684804796950987,0.8676470588235294,1.0,1.0,4/7,24.89%,NIPSNAP1;SCN9A;RETREG1;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.38757395441540715,-0.6842660549032992,0.9620253164556962,1.0,1.0,4/21,17.37%,DHX58;CARD16;SIGIRR;C1QBP
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.25975563396637347,0.6842370678434178,1.0,1.0,1.0,7/37,16.64%,MTA2;ARID1A;GATAD2B;RBBP4;HNRNPC;ARID1B;INO80
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.43905096665363086,-0.6838743546302107,0.9285714285714286,1.0,1.0,1/7,8.47%,RAB11A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.34680367770854226,-0.6835385849486286,0.8901098901098901,1.0,1.0,10/50,20.84%,TBC1D8;TCHP;TBC1D13;ODF2L;TBC1D2B;TBC1D15;LIMK2;TBC1D14;ATG5;DYNC2LI1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.3076962639091827,0.6830406730078722,0.9473684210526315,1.0,1.0,2/14,5.77%,SORL1;APPL2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.40831704707103766,-0.683039189681651,0.8902439024390244,1.0,1.0,7/13,33.48%,GPSM2;MAP9;GNAI1;DCTN1;PSRC1;TACC3;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.3878428865809161,-0.6830291278823061,0.8974358974358975,1.0,1.0,3/20,12.00%,BRCA1;NR1H2;MID1IP1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.34492098109474484,-0.6828365515353848,0.967391304347826,1.0,1.0,14/58,24.82%,ANK3;CCK;MAPT;MAP1B;PLP1;NREP;RAB3A;DCC;S100A6;PLPPR4;RTN4RL1;NTNG1;MAP1A;S100B
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3227846263722352,-0.6827009206183743,1.0,1.0,1.0,59/305,23.58%,CENPF;BHLHE40;NFIL3;HMGB2;RBPJ;ATP8B1;ZNF540;YEATS2;ZNF93;L3MBTL3;BRCA1;BASP1;ID2;MDFIC;ARID5B;RORB;LIMD1;NR1H2;ATF5;CTBP1;HIC2;TLE1;IRF1;BCL6;PIAS4;KCTD1;TSHZ3;SUV39H2;SNX6;CDKN1B;ING4;MLX;NR1D1;DEAF1;KDM1A;KLF4;TIMELESS;CBX5;CITED2;PDCD4;ILF3;HEXIM1;PER2;EIF4A2;SUDS3;KDM5C;LANCL2;ENO1;FOXP1;NRG1;NKX6-2;NIF3L1;RUNX1T1;RBFOX2;PTPRK;PRICKLE1;ZBTB16;CRYAB;GCFC2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.41814058136538557,0.6826702644421141,0.7619047619047619,1.0,1.0,1/5,3.51%,DOCK10
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.353705381826374,0.6824443186340887,0.9166666666666666,1.0,1.0,1/9,3.30%,SORL1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.2802443166733259,0.6821207019076715,0.9545454545454546,1.0,1.0,5/18,21.68%,PEX16;TMEM135;PEX2;ABCD3;PEX11B
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3092395726706271,0.6821113636828052,0.95,1.0,1.0,4/21,12.42%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.38951773089971264,-0.6819700012309544,0.8607594936708861,1.0,1.0,1/11,8.29%,HERPUD1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.4225858370428691,-0.681531177806772,0.8589743589743589,1.0,1.0,5/10,46.58%,MBTPS1;SREBF1;LPCAT3;MBTPS2;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.41511118403223424,0.6814188193734534,0.9047619047619048,1.0,1.0,2/7,8.91%,CAB39;BIN1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.3556276837976102,0.6810313043025767,0.75,1.0,1.0,5/15,15.35%,SPIN1;GTF3C2;GTF3C3;GTF3C5;GTF3C4
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.36599101264073725,-0.6807609806511802,0.9302325581395349,1.0,1.0,4/30,11.26%,TGFB2;RBPJ;COBL;STIL
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.32878023900615405,0.6804927131354149,0.85,1.0,1.0,2/12,4.93%,SMPD3;RAB7A
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.4666982962763128,-0.6804347767389072,0.9420289855072463,1.0,1.0,1/6,14.35%,CD36
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.3255256383130751,0.6803640666912932,0.875,1.0,1.0,4/14,14.49%,NTNG2;DVL2;DVL3;MOV10
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4308549340203176,-0.6801767262199818,0.88,1.0,1.0,3/9,17.86%,ABCA5;NR1H2;ABCA1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.4342464585601471,-0.6801068843335877,0.8767123287671232,1.0,1.0,1/6,5.71%,IL7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.3678937833088618,-0.6800457800384013,0.8941176470588236,1.0,1.0,9/28,29.45%,MAPT;GPM6B;TTBK2;CAV3;UBXN2B;MAP1A;OTUD7B;RIPOR2;ACTN2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3230777065618541,0.6799753941289616,0.9130434782608695,1.0,1.0,4/13,24.04%,MSN;MEF2C;BCL2;PIK3CG
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.3840556319584326,0.6796220130836726,0.8666666666666667,1.0,1.0,1/7,5.78%,ACVR1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.38227221683128065,0.6794815788464653,0.9629629629629629,1.0,1.0,4/9,19.83%,CD81;SH3GLB1;ATP13A2;LAMTOR4
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.3046014767216339,0.6793726634487743,0.9,1.0,1.0,1/18,4.39%,OSBPL6
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.2740551551467869,0.6791564111776968,1.0,1.0,1.0,11/27,21.00%,PPARGC1A;SORBS3;P2RX7;SMCR8;AKT2;LMAN1;TREM2;LIG4;ADRB2;SYNJ1;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3753174917764985,-0.6790948110064161,0.9425287356321839,1.0,1.0,2/19,14.02%,TENT4B;SLX4
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.3909808489646635,-0.6789645656463119,0.922077922077922,1.0,1.0,3/17,13.80%,CSKMT;ANTKMT;SUV39H2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3389072471376189,0.6788110399163041,0.8928571428571429,1.0,1.0,2/10,11.65%,EIF2AK4;LDLR
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.37745967671279146,-0.6784948776135167,0.926829268292683,1.0,1.0,3/23,14.28%,HSPA1B;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.32416557329156803,0.6783877526544354,0.9,1.0,1.0,3/17,7.73%,PKD2;SOCS6;NMI
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.46170437046857576,-0.677920814061437,0.8923076923076924,1.0,1.0,2/5,13.70%,NR1H2;PARP14
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.46170437046857576,-0.677920814061437,0.8923076923076924,1.0,1.0,2/5,13.70%,NR1H2;PARP14
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.45160008131153884,-0.6776162240416718,0.9066666666666666,1.0,1.0,1/7,11.50%,DMGDH
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3173394659744427,-0.6775693580879737,1.0,1.0,1.0,80/739,17.20%,NAMPT;NR4A3;FOSL2;MACC1;RPS27A;NFIL3;FGF1;ST18;AGT;NR4A1;VEGFA;HMGB2;FOS;RBPJ;TXK;SLC11A1;HIF1A;BEX1;H1-3;RORA;RXRB;H1-4;CREB5;DDRGK1;MEIS2;H1-2;NR4A2;H1-0;TAF6L;NOD2;BRCA1;LITAF;PLAC8;STAT1;ID2;PARP9;PAX8;MDFIC;COPS5;PLAG1;RORB;DRAP1;NLRC5;NR1H2;CRTC3;ATF5;KDM6B;PRDM15;HCFC1;UBA52;RRP1B;ATF3;JUNB;IRF1;SMARCD3;MAP3K12;ETS2;UBC;MED25;PADI2;EIF2AK3;IL18;PAXBP1;MAX;HSF2;UHRF1;PID1;ITGA6;MLX;NR1D1;ING5;RGCC;DEAF1;KDM3A;KDM1A;KLF4;NFIX;CCNC;CREBRF;ATXN7L3
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.2975151770079315,0.6775684206391602,0.9666666666666667,1.0,1.0,3/19,9.99%,MMS19;HSCB;ABCB7
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.3964188621453285,-0.6775495070845771,0.8846153846153846,1.0,1.0,1/12,9.06%,AKR1B1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.42834128591604614,0.6773016119302488,0.8571428571428571,1.0,1.0,2/5,7.03%,APPL2;ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.4059609455292908,0.6771370868986017,0.9166666666666666,1.0,1.0,5/5,59.42%,LRRK2;SNX12;SERPINE2;TMEM59;PRNP
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.32529047379076453,0.6767122187409632,0.8695652173913043,1.0,1.0,1/11,1.79%,ITGA5
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.4574340582797274,-0.6763261213495528,0.8783783783783784,1.0,1.0,2/6,33.17%,ANAPC7;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.4574340582797274,-0.6763261213495528,0.8783783783783784,1.0,1.0,2/6,33.17%,ANAPC7;TACC3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.39963253148793476,-0.6761328285673149,0.9210526315789473,1.0,1.0,4/11,36.63%,TERF2IP;RAPGEF3;PRKAA2;CAMK1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.44656746076628756,-0.67554415874537,0.873015873015873,1.0,1.0,1/7,4.35%,HIF1A
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.38594129770259755,0.6753631861542867,0.8787878787878788,1.0,1.0,1/9,0.92%,GSN
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3410225918565801,-0.6753242687301688,0.9565217391304348,1.0,1.0,14/57,24.82%,ANK3;CCK;MAP1B;RAB3A;DCC;LRP4;S100A6;MFSD2A;PLPPR4;DVL1;NTNG1;MAP1A;MAP2;S100B
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.39228056860814636,-0.6752385230532314,0.9012345679012346,1.0,1.0,3/16,15.77%,VEGFA;MAPT;GOLGA4
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.30369833477499986,0.6742591443202002,1.0,1.0,1.0,3/18,9.99%,MMS19;HSCB;ABCB7
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.43244979040346454,-0.6738883480504487,0.9166666666666666,1.0,1.0,4/9,25.94%,C5AR1;NLGN3;DVL1;NLGN2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.32397596077811164,0.6738507145611524,0.9583333333333334,1.0,1.0,8/8,67.62%,TRAPPC8;WIPI1;STX17;ATG13;WIPI2;PACS2;WDR45B;MFN2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.38683792010384843,-0.6738368301320853,0.9036144578313253,1.0,1.0,10/20,42.38%,CMPK1;NUDT13;GUK1;CTPS1;RRM1;AK2;AK5;NME4;TXNRD1;NME3
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3822943832064162,0.6737585154945797,0.8695652173913043,1.0,1.0,2/10,18.78%,BOD1;PDS5A
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3189669282885457,-0.6734025091995854,0.99,1.0,1.0,18/168,16.61%,CEBPD;NR4A2;NOCT;NFE2L3;GTF3C6;POLR2G;PAX8;POLR1C;DRAP1;MTERF1;PTMA;RNMT;POLR3H;EAF1;ERCC2;BTF3;DEAF1;NFIX
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.311168977591688,-0.6732211513879223,0.98989898989899,1.0,1.0,25/137,27.23%,CD55;NAPA;F8;ANK3;CNIH4;ANK2;NSF;SEC24C;GOLGB1;SPTBN5;KDELR1;ARFGAP1;DCTN4;DCTN2;SEC13;NRBP2;DYNC1I1;DCTN1;CNIH1;SPAST;MPPE1;VAPA;ARFGAP2;GORASP1;MCFD2
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.4302036781026363,0.6731961715288333,0.8275862068965517,1.0,1.0,3/5,12.68%,PPARG;TGFB1;EP300
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.4302036781026363,0.6731961715288333,0.8275862068965517,1.0,1.0,3/5,12.68%,PPARG;TGFB1;EP300
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.4089670080702447,-0.6730945636838236,0.8933333333333333,1.0,1.0,2/12,21.92%,TYMP;SLC25A36
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.2632247790670103,0.6723530199969658,1.0,1.0,1.0,9/36,18.71%,RAP1A;ITPR2;CACNA1A;CHD7;RFX3;CCL5;ALOX5;UQCC2;IL1B
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.4082357471354821,-0.6723136957798014,0.8987341772151899,1.0,1.0,5/12,27.20%,SOD1;GHR;PPIB;MFSD2A;APP
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.3590530199359502,-0.6719902044875092,0.9230769230769231,1.0,1.0,4/20,23.35%,PKP2;RNASE10;LILRB2;JAM3
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.323008642569021,0.6717375599561458,0.8636363636363636,1.0,1.0,3/14,8.57%,MKKS;CIB1;CDYL
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3342790595183115,-0.6715310002370094,0.9578947368421052,1.0,1.0,8/57,21.86%,RPS27A;UBA52;UBC;NR1D1;CTSB;UBB;DDB1;PDCD6IP
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.36593085899065086,0.6707044015355161,0.7727272727272727,1.0,1.0,1/7,3.56%,GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.344629403408339,-0.6705239389915889,0.9318181818181818,1.0,1.0,2/38,6.80%,NLRP12;NOD2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.42708739558097364,-0.6704596346201456,0.927536231884058,1.0,1.0,3/7,28.14%,CARD16;IMPACT;WRN
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.3702740150461111,-0.6703808669661443,0.9186046511627907,1.0,1.0,3/23,15.77%,ANK3;NSF;GOLGA4
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.335652723966158,0.6703163587335682,0.8648648648648649,1.0,1.0,7/7,66.45%,CEP120;NUMBL;AKNA;PCM1;NUMB;DOCK7;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.35771121783406046,-0.6703026619280869,0.8901098901098901,1.0,1.0,7/31,18.00%,RNF126;EPN1;SPRY1;SNX6;CBLB;SH3GL2;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3515949542410422,-0.6702488020307243,0.9662921348314607,1.0,1.0,7/43,17.37%,ECM2;DOCK1;CARMIL1;DOCK5;FN1;CD36;C1QBP
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.3334395506350828,0.669896013815239,0.9,1.0,1.0,3/15,4.95%,PKD2;MKKS;TGFBR2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.3118477736128809,-0.6697046622692764,1.0,1.0,1.0,50/226,30.43%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;POLR2G;WBP4;DDX1;PPIE;BCAS2;WBP11;HNRNPA0;DHX16;PNN;TFIP11;SNRNP27;SRSF5;ZCCHC8;SNRPA;PRPF6;FRG1;SRSF2;PRPF40B;LSM5;MFAP1;RNPC3;DDX46;CSTF2T;SRSF9;GCFC2;U2AF2;SRSF3;PRPF3;SART3;SNU13;DBR1;ZCRB1;SRSF8;PDCD7;NOVA1;U2SURP;GEMIN2;SRSF12;BUD31;NCBP2;RBM22;CLNS1A;RBM5;PRPF4
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.45002930607052327,-0.6696761599596173,0.9242424242424242,1.0,1.0,3/6,35.49%,DBF4;WIZ;CDC7
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3960368319707729,-0.6696398032210263,0.8970588235294118,1.0,1.0,2/11,22.46%,TET1;DNMT1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.40064662609547264,-0.6695921021001278,0.9078947368421053,1.0,1.0,2/11,20.18%,B4GAT1;CSGALNACT2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.3015985361995618,0.6695082079212406,0.9333333333333333,1.0,1.0,3/14,10.80%,PGM5;TMOD2;FLII
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.38107899113683663,0.6694655853698841,0.8214285714285714,1.0,1.0,1/7,6.42%,DDR1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37072963948728677,-0.6694414183131893,0.9540229885057471,1.0,1.0,2/27,4.00%,GLIPR2;TGFB2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3153588317769029,-0.6694193875536296,1.0,1.0,1.0,32/200,24.97%,RPS27A;HIF1A;MINDY1;BRCA1;CLSPN;COPS5;HCFC1;UBA52;OTUD1;UBC;PSMA5;PSMA3;USP36;USP6;CFTR;TOMM20;WDR48;TRAF2;PSMD8;ATXN7L3;UBB;PSMB4;ACTR5;SUDS3;UCHL1;VCPIP1;PSMD7;ABRAXAS1;PSMD5;OTUD7B;TNIP1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.3446493520486992,0.6693361291341567,0.9166666666666666,1.0,1.0,4/11,20.55%,SERPINE1;TRIB1;MEF2C;SLIT2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.3241461364942683,0.6690405071802775,0.95,1.0,1.0,6/17,13.93%,THUMPD1;TFB1M;FBL;BUD23;NSUN4;MTERF4
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.33537628676555836,-0.6687463977810136,0.9565217391304348,1.0,1.0,13/62,27.87%,CHI3L1;PSMA5;PSMA3;TRAF2;PSMD8;PSMB4;DICER1;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2;REL
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.33407317233328204,-0.6686680902809053,0.9456521739130435,1.0,1.0,8/45,22.10%,HERPUD1;PINK1;TMEM161A;TPT1;BCL2L2;MCL1;CLU;ENO1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.3595613056982452,-0.6685061706351314,0.9318181818181818,1.0,1.0,9/26,28.88%,NOD2;STAT1;EIF2B2;STAT2;STAT6;GNAI1;CALCR;CACNA1B;EIF2B1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.3638953016079443,0.6684075796228603,0.8,1.0,1.0,1/6,3.78%,SMURF1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.34904589447965945,-0.6682778072707859,0.946236559139785,1.0,1.0,7/43,19.55%,TOM1L1;BRCA1;UXT;MAX;BMI1;CBX5;E2F7
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3725368350610199,-0.6682027267023575,0.9012345679012346,1.0,1.0,4/20,21.31%,NOTCH2;RASGRP4;IRS2;RELN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.3620894029302037,-0.6681875338968022,0.881578947368421,1.0,1.0,3/28,7.62%,THBS1;SPOCK1;ADAM15
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.47252122063887936,-0.6681398809012603,0.8840579710144928,1.0,1.0,1/5,19.28%,PIK3CB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.3530249110320285,0.6678133736546716,0.8484848484848485,1.0,1.0,9/9,64.72%,MMAA;ABCC1;MMAB;ABCD4;LMBRD1;MTR;MTRR;MMADHC;MMUT
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.3530249110320285,0.6678133736546716,0.8484848484848485,1.0,1.0,9/9,64.72%,MMAA;ABCC1;MMAB;ABCD4;LMBRD1;MTR;MTRR;MMADHC;MMUT
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.38966032330193257,0.6670376066737428,0.8611111111111112,1.0,1.0,2/6,9.79%,SLC35D1;UGDH
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.37577702859293266,-0.6670233409284236,0.8571428571428571,1.0,1.0,3/16,22.11%,ACOT13;ACAT1;ACSM3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.37577702859293266,-0.6670233409284236,0.8571428571428571,1.0,1.0,3/16,22.11%,ACOT13;ACAT1;ACSM3
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3968858038812115,-0.6669571702307134,0.875,1.0,1.0,4/13,33.44%,HEXIM1;NELFB;RECQL5;NELFA
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.37651263982311917,-0.6665245529410813,0.9102564102564102,1.0,1.0,3/19,26.94%,CNOT8;ZFP36;CNOT6
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.4099630112106635,-0.6663975898153942,0.9090909090909091,1.0,1.0,2/10,15.40%,CCL3;NR1D1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.34786850333433583,-0.6660837238075421,0.9204545454545454,1.0,1.0,9/30,26.26%,IFT81;IFT74;IFT52;KIF3A;DYNC2LI1;DYNC2I1;IFT46;DYNC2H1;IFT122
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.4066071774424092,-0.6659468103310193,0.9459459459459459,1.0,1.0,3/15,12.66%,FTH1;GSTP1;MED25
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.33483187623286564,-0.6656379360558156,0.9574468085106383,1.0,1.0,11/69,20.31%,MTCP1;CDC37;SYAP1;CALM3;INCENP;SNF8;CDKN1B;PYCARD;CALM1;CCNB3;THY1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.35766363686938163,-0.66552402603959,0.9647058823529412,1.0,1.0,5/32,15.84%,SEC61B;TOMM40;HSPA5;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.42808380244247835,-0.6652566141602547,0.9285714285714286,1.0,1.0,2/8,21.49%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.4002793568529774,0.6650560279125068,0.9166666666666666,1.0,1.0,1/6,5.33%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.40572603742540786,-0.6648026748768465,0.8450704225352113,1.0,1.0,4/12,24.66%,CNOT8;ZC3HAV1;GTPBP1;PNPT1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.3073222675345482,0.6646533565911347,0.9333333333333333,1.0,1.0,2/17,9.10%,ST8SIA4;GANC
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.3159796101822219,0.6645631134691794,1.0,1.0,1.0,1/13,0.75%,NPR2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.34974138590492365,-0.6642841547800068,0.946236559139785,1.0,1.0,6/41,21.05%,FAM162A;PINK1;BNIP3;PYCARD;BMF;CIDEB
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.31799133792059747,-0.6641420827539923,1.0,1.0,1.0,44/281,23.08%,SAP30;ACVR1B;BHLHE40;NFIL3;HINT1;HIF1A;GLRX2;RORA;PQBP1;APBB3;TAF6L;CHD3;PLAG1;PRKCQ;RORB;DRAP1;LIMD1;PPIE;ATF5;HCFC1;MSL3;RPL6;TCF7;MLX;ZNF100;ZNF519;ZKSCAN5;INSR;HCLS1;TERF2IP;HMGN5;BRCA2;ACTR5;SOX4;CREM;MAFB;TRIM22;ZNF143;ESR2;POU5F1;NKX6-2;NIF3L1;APBB2;DVL1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.43507333107765295,0.664117680304387,0.8571428571428571,1.0,1.0,1/5,0.92%,GSN
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.300649328682521,0.6639547884826063,1.0,1.0,1.0,4/24,13.55%,STAMBPL1;ZRANB1;ABRAXAS2;YOD1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.32238879042649116,-0.6637852136807528,0.9560439560439561,1.0,1.0,15/58,26.28%,RAB11A;PINK1;HEATR3;IL10RA;ZDHHC15;APPL1;HK2;PRICKLE1;SEC13;RANBP17;RYR2;NUP50;NUP133;FAM53C;TNPO2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.43438021899856083,-0.6634893561570091,0.8813559322033898,1.0,1.0,1/5,26.88%,EPHA4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.3596379951637858,-0.6630449911215133,0.9090909090909091,1.0,1.0,4/18,20.13%,APPL1;IRF1;CD36;TLR2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.43474174010474687,-0.6629856497778813,0.8783783783783784,1.0,1.0,2/6,37.40%,CHAMP1;MID1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4069068688287967,-0.6627409352276076,0.8714285714285714,1.0,1.0,3/8,29.16%,SEC11A;PCSK5;SPCS2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.335041370924047,-0.6625234970560566,0.9368421052631579,1.0,1.0,4/69,6.80%,NLRP12;RAB7B;HLA-B;NOD2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3635204749041521,-0.6622630545127435,0.8571428571428571,1.0,1.0,5/23,24.48%,XRCC3;STIL;CHMP5;PDCD6IP;C10ORF90
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.3568651535954357,-0.6615968085092812,0.946236559139785,1.0,1.0,11/37,24.31%,HAMP;FCGR2B;NR1H2;EPHA3;PXK;MCTP1;TLR2;PLSCR1;NRG1;CRYAB;RACK1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.39661747344836074,-0.6615407519878592,0.8860759493670886,1.0,1.0,3/13,19.90%,TGFB2;OLFM1;SOX4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.4279244760886105,-0.6610193404874185,0.8970588235294118,1.0,1.0,1/6,8.47%,RAB11A
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.32874740332925895,0.6608394563229161,0.9545454545454546,1.0,1.0,2/13,17.13%,UBQLN2;SCYL2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.4000311287516929,-0.6608367076673777,0.9473684210526315,1.0,1.0,2/11,18.04%,PIAS4;GNL3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.3986077202625927,-0.660809118242747,0.9154929577464789,1.0,1.0,1/14,5.01%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3527926728106041,-0.660650044910841,0.9651162790697675,1.0,1.0,5/24,32.16%,SHANK3;CAV3;TWF1;IQCJ-SCHIP1;KANK1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.37178961615112127,-0.6606010523645885,0.891566265060241,1.0,1.0,1/20,1.54%,HHIP
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3203691697410712,-0.6601304735972803,0.9310344827586207,1.0,1.0,11/54,24.74%,FANCI;BRCA1;PINK1;PIAS4;WDR48;UBB;GNL3;SEPTIN4;PRICKLE1;RIPK2;TNIP1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.3532201059123127,-0.6600325868140619,0.9186046511627907,1.0,1.0,7/29,19.16%,NR4A2;DAPK2;TRAF7;ING5;PYCARD;RPS3;BCL2L14
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.31241461833102,-0.6598575088522554,0.9791666666666666,1.0,1.0,17/89,26.58%,FZD6;PSMA5;PSMA3;GNAO1;AP2S1;PSMD8;CALM1;PSMB4;PRICKLE1;DVL1;PSMD7;PSMD5;PLCB1;AP2A2;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.39559530655942327,-0.659715696587659,0.875,1.0,1.0,1/11,7.78%,BRCA1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.3738825158512781,-0.6594226266553074,0.9404761904761905,1.0,1.0,6/23,25.90%,MAPT;TENT4B;ZCCHC8;DICER1;MOV10L1;PRKRA
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.3149348820681403,-0.6594195024026762,0.979381443298969,1.0,1.0,4/144,2.65%,PCSK1;SRGN;ERMP1;PAPPA2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3738621546893185,-0.6591847302673386,0.95,1.0,1.0,4/21,22.53%,FHL1;KLF4;E2F7;GPNMB
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.3834110856329564,0.6584876266895783,0.8461538461538461,1.0,1.0,7/7,61.68%,EIF4E2;TNRC6B;DDX6;AGO2;STAT3;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.3834110856329564,0.6584876266895783,0.8461538461538461,1.0,1.0,7/7,61.68%,EIF4E2;TNRC6B;DDX6;AGO2;STAT3;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.42104599577183216,-0.6582298225636873,0.8875,1.0,1.0,2/10,23.76%,PLSCR1;GPR137B
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.34165686362155107,-0.658125153199864,0.9310344827586207,1.0,1.0,7/40,22.44%,TMEM41B;VMP1;ATG2A;UBXN2B;TP53INP1;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.41013758580636955,-0.6577719678151319,0.9459459459459459,1.0,1.0,1/8,5.16%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.3392829596777586,-0.6576764003509892,0.9680851063829787,1.0,1.0,3/50,6.80%,TGFB2;RBPJ;NOD2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.39920883180776295,0.6574140080566524,0.9166666666666666,1.0,1.0,1/5,6.49%,STIM1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.33676808925642193,-0.6573838254597002,0.9347826086956522,1.0,1.0,7/40,17.98%,AGT;TRAF7;ING5;PYCARD;TRAF2;RPS3;BMF
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.23819810807031597,0.6569812700480622,1.0,1.0,1.0,13/61,15.50%,POU2F1;RPAP2;RPRD1B;POLR2C;INTS7;TAF13;PHAX;GTF2E1;RPRD1A;GTF2B;INTS9;GTF2F1;SRRT
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.305631350938404,-0.6569093934915948,1.0,1.0,1.0,162/1260,20.13%,BRIP1;NAMPT;NR4A3;RPL23;FOSL2;MACC1;RPS27A;SAP30;CEBPD;BHLHE40;ZNF793;NFIL3;ZNF382;FGF1;ST18;NR4A1;HAMP;VEGFA;HMGB2;CTDSP1;OVOL2;FOS;RBPJ;TXK;SLC11A1;HIF1A;BEX1;RORA;RXRB;MXI1;CREB5;ZNF540;DDRGK1;MEIS2;ZNF789;NR4A2;YEATS2;H1-0;TAF6L;NOD2;ZNF93;FBP1;NFE2L3;ZNF549;BRCA1;ZNF260;CHD3;LITAF;PLAC8;UXT;STAT1;ZNF483;ID2;PARP9;PAX8;COPS5;PLAG1;ARID5B;RPS14;ZNF814;RORB;HDGFL3;DRAP1;NOP53;TGIF1;NLRC5;TRPS1;NR1H2;CRTC3;ZNF235;ATF5;CTBP1;KDM6B;HIC2;PRDM15;HCFC1;TSHZ2;UBA52;RRP1B;ATF3;JUNB;IRF1;SMARCD3;ETS2;UBC;ZNF805;BCL6;PIAS4;ZNF518A;TCF7;MED25;CGGBP1;PPP1R13L;ZNF550;KCTD1;TSHZ3;MXD1;ZNF654;IL18;PAXBP1;HIRA;SUV39H2;MAX;HSF2;SDCBP;UHRF1;ZNF41;SNF8;BMI1;ZNF850;PID1;ZNF266;ITGA6;MLX;NR1D1;PRDM1;ZNF213;RGCC;DEAF1;STAT2;KDM3A;ZNF20;ZKSCAN5;KDM1A;KLF4;POU6F1;NFIX;TEF;CCNC;ZNF354A;CREBRF;ZNF449;ATXN7L3;C1QBP;TOX;UBB;ZNF778;CBX5;SS18L1;CITED2;SP110;HBP1;IMPACT;HCLS1;ZFP36;KLF13;ATP2B4;HEXIM1;ZNF197;CHCHD2;PER2;E2F7;PARP15;ZNF445;ZNF558;ZNF565;SOX4;PRPF6;NFIB;MNT;CREM;TLR2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.45527808726197033,-0.6568856783545024,0.92,1.0,1.0,1/5,10.66%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3685891279553334,-0.6566791538934036,0.8701298701298701,1.0,1.0,2/11,23.68%,RPS3;TESPA1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.38130841135919324,0.6565624913748691,0.8928571428571429,1.0,1.0,1/7,3.68%,ZNF675
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3896222255789276,-0.6564957065883237,0.9397590361445783,1.0,1.0,1/14,3.96%,RSAD2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.4384260896001372,-0.6559849971036609,0.9102564102564102,1.0,1.0,1/6,18.00%,ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.3731768306416221,0.6558948018840667,0.8148148148148148,1.0,1.0,1/5,7.02%,RUNX1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.39857221687070454,-0.6558478653447889,0.8292682926829268,1.0,1.0,4/7,29.64%,TPGS1;TTLL7;TTLL5;TTLL4
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.4238834975807168,-0.6557946753737739,0.9295774647887324,1.0,1.0,1/7,8.48%,SOD1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.30512876820425655,0.6556873613226816,0.9444444444444444,1.0,1.0,5/15,16.11%,SLC25A33;ABCB7;SLC30A10;PIKFYVE;ALOX5
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3296914566294057,0.6555473070098589,0.875,1.0,1.0,3/13,8.61%,SCRIB;TBC1D16;LAMTOR1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3143737421002324,-0.65539872071795,0.9583333333333334,1.0,1.0,22/109,22.83%,CGNL1;RHOB;VAV3;ARHGAP4;RACGAP1;RHOU;TRIP10;CHN1;ITSN1;RASGRF2;ARAP2;ARHGAP23;GNA13;PLEKHG5;NGEF;FAM13A;RELN;ARHGAP9;FGD3;STARD8;ARHGEF4;SRGAP3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.3482257350391159,-0.6551544530345368,0.9222222222222223,1.0,1.0,7/31,28.10%,LPCAT1;GNPAT;DGKG;DGKB;PLD1;DDHD2;LPCAT4
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.3800371807828229,-0.6547630429774971,0.9358974358974359,1.0,1.0,5/14,27.72%,MID1IP1;CD36;SLC27A5;SLC2A1;PRKAG2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.41075826249519476,-0.6546571423436597,0.875,1.0,1.0,2/13,11.69%,VEGFA;ITGB8
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.31894594313769054,-0.6542142984973395,0.9666666666666667,1.0,1.0,11/60,20.15%,SRP14;NACA;AQP11;VPS37C;ZDHHC15;SDCBP;ZDHHC9;SRPRA;PEX3;ZDHHC4;ZDHHC19
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3541057987735986,-0.6541806231809889,0.8961038961038961,1.0,1.0,3/17,23.68%,RPS3;FOXP1;TESPA1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.34515497581004706,-0.6540611066157377,0.9101123595505618,1.0,1.0,3/29,6.59%,RNF126;EPN1;SPRY1
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.4303173068004867,0.6538725240956395,0.896551724137931,1.0,1.0,2/5,20.64%,MMAA;PCCB
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.3497940452334176,-0.6538648697895342,0.9550561797752809,1.0,1.0,2/30,6.63%,THBS1;HLA-B
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.3473937511359913,-0.6538082269895443,0.9625,1.0,1.0,6/24,20.15%,GLUL;CLIP3;ZDHHC15;ZDHHC9;ZDHHC4;ZDHHC19
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.33571725410213127,-0.6537765898961067,0.9795918367346939,1.0,1.0,11/57,25.27%,EIF4A3;SIDT2;SRSF5;ZFP36;SRSF2;SRSF9;U2AF2;KIF5C;SRSF3;PNPT1;CKAP5
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.29251942223389144,0.6533511407534426,0.8947368421052632,1.0,1.0,3/14,12.57%,SYK;NMI;LILRA2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.33586854663631605,-0.6524410879218904,0.9767441860465116,1.0,1.0,4/48,8.69%,GADD45B;SEMA3A;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.3209774067984775,-0.6522558790597616,0.9696969696969697,1.0,1.0,16/124,17.52%,CCL4;RGS1;VAV3;GNB5;CHN1;SOD1;FGD6;SIPA1L1;CCL3;RRP1B;RAP1GAP;EPHA3;ITGA6;RDX;TBC1D15;LARS1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.35202005343895576,-0.65224888380422,0.9230769230769231,1.0,1.0,6/27,27.20%,FCGR2B;SNX6;CD36;GRIN2A;EPHA4;APP
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.4091310277053271,0.6521717200244268,0.8928571428571429,1.0,1.0,2/5,14.00%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.31950762388127285,0.6514706402680208,0.9565217391304348,1.0,1.0,2/11,14.49%,KHSRP;MOV10
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.3469799069639723,-0.6512318637509442,0.8690476190476191,1.0,1.0,5/19,23.35%,ANK2;ARF6;PTPRK;PRRT1;JAM3
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.2910714003287016,0.6510484521429077,0.9565217391304348,1.0,1.0,1/14,5.33%,SIRT1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.3793432197303473,-0.6508845886662435,0.8809523809523809,1.0,1.0,2/16,13.80%,CSKMT;SUV39H2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.3050435512609925,-0.6504903633452154,1.0,1.0,1.0,40/272,23.26%,CENPF;TFRC;NAPA;LRP2;TBC1D8;ANK3;TVP23A;SCAMP3;STX19;TBC1D13;IL10RA;TXNIP;ARRDC3;RAB3A;USP6;SNX6;CD36;NSF;RAB3C;GOLGA4;TBC1D2B;TBC1D15;VMP1;SCG5;RAB15;ARF6;ABCA1;ATP6V1D;RAB20;TBC1D14;CLU;KIF3A;ARL17A;RAB5A;ARL4C;ATP6V1E2;RAB21;EIF2D;TF;SEC13
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.34609086531436695,-0.650256138621149,0.9438202247191011,1.0,1.0,7/32,28.10%,LPCAT1;GNPAT;DGKG;DGKB;PLD1;DDHD2;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3660228350589585,-0.6501898176680214,0.9014084507042254,1.0,1.0,5/15,30.67%,LARS1;SEH1L;GPR137B;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.3594170558467987,-0.6486660316055466,0.9176470588235294,1.0,1.0,3/16,19.48%,PPP1R3B;INSR;IRS2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3223383080530404,-0.6485357969703471,0.9340659340659341,1.0,1.0,5/52,12.14%,AZI2;RPS27A;PRDX4;UBA52;UBC
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.3204127758970133,-0.647761300000182,0.98989898989899,1.0,1.0,3/101,4.72%,RHOBTB3;DENND2A;RNF126
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3944975887421929,0.6475603758947535,0.8222222222222222,1.0,1.0,5/5,60.57%,C17ORF75;TBC1D23;TRIP11;FAM91A1;WDR11
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.31548997867054523,-0.6470969091663372,0.9587628865979382,1.0,1.0,10/65,21.50%,TRIM5;PINK1;DAPK1;BNIP3;BNIP3L;NPRL2;TP53INP1;PIK3CB;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.34964962432611585,0.6467371555665695,0.8333333333333334,1.0,1.0,1/6,5.33%,SIRT1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.3786200324782662,-0.6465360145819603,0.9397590361445783,1.0,1.0,4/16,25.48%,PPIE;FKBP5;PPIB;PPID
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.31175104226322664,-0.6464218567827466,0.9897959183673469,1.0,1.0,11/121,15.00%,CKS2;NEK11;MEIS2;BRINP1;PSMA5;PIM3;PSMA3;IQGAP1;ERCC2;SDCBP;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.2825921152917133,0.6459670773311235,0.95,1.0,1.0,3/16,11.81%,SORL1;APPL2;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.3583424197883138,0.6459133364384808,0.8695652173913043,1.0,1.0,1/8,2.47%,DAB2IP
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.3623211321053047,0.6457842539451359,0.8823529411764706,1.0,1.0,5/5,63.78%,RAB11B;SELENOT;PTPRN;RAB11FIP2;PTPRN2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.30856380072169165,0.645364086701856,1.0,1.0,1.0,2/18,3.70%,PKD2;TMEM106A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.36230964386725295,-0.6452180267633331,0.925,1.0,1.0,1/15,6.27%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3141235843007904,-0.6452117349598834,1.0,1.0,1.0,19/113,20.64%,NLRP12;AGT;RORA;CASP5;TNFRSF1B;NOD2;IL15;CCL3;BCL6;IL18;SNX6;NR1D1;KLF4;MGLL;PDCD4;MACIR;TLR2;NFKBIZ;TMSB4X
prerank,MSigDB_Hallmark_2020__Complement,-0.31417366895092125,-0.6448957007300531,0.9896907216494846,1.0,1.0,22/137,22.17%,CD55;ME1;CASP5;F8;CR1;CALM3;IRF1;AKAP10;DGKG;FN1;HSPA5;CD36;CBLB;ATOX1;CTSB;GPD2;CALM1;SERPING1;CLU;HPCAL4;PLSCR1;VCPIP1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.42844327606060506,-0.6447332028905488,0.9285714285714286,1.0,1.0,1/6,11.78%,IRF1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3102174606477403,-0.6445900378350746,0.978021978021978,1.0,1.0,12/53,21.80%,TBC1D8;ATP8B1;TBC1D13;MYO10;TBC1D2B;RDX;TBC1D15;ARF6;TBC1D14;ATG5;DYNC2LI1;RAB5A
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.3631307716437405,-0.6445086420598412,0.8846153846153846,1.0,1.0,4/14,30.17%,SCD;ACAT1;SCD5;FASN
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.29692001627276143,0.6444507327155566,1.0,1.0,1.0,3/17,12.47%,SLC9C2;SLC9A9;SLC9A8
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.31847639632909774,-0.6440069552171619,0.9381443298969072,1.0,1.0,14/69,26.58%,RBX1;FBXL2;PSMA5;PSMA3;PSMD8;FBXL13;PSMB4;FBXL7;PSMD7;FBXL5;PSMD5;PSMB9;PSMC2;PSMB2
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.2438179023237445,0.643949369156988,0.9565217391304348,1.0,1.0,6/25,16.47%,DNMT3A;EED;RBBP4;TASOR;AEBP2;CREBZF
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.37134233118807086,0.6433076946483156,0.8333333333333334,1.0,1.0,2/5,13.33%,LHFPL2;CFAP69
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.3156208431630484,-0.6430659919475802,0.9795918367346939,1.0,1.0,15/71,24.25%,FLT1;MAPT;EEF1A2;CENPE;IQGAP1;EPHA3;EPHB1;ALK;INSR;MUSK;RELN;EPHA7;SPDYA;NTRK3;ZNF16
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.4195556379792011,-0.6429506250964773,0.9014084507042254,1.0,1.0,1/9,7.30%,RPA2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2988178717738684,-0.6426282555626951,1.0,1.0,1.0,48/248,28.36%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;POLR2G;WBP4;PPIE;BCAS2;WBP11;RNMT;HNRNPA0;ERCC2;DHX16;PNN;TFIP11;SNRNP27;SRSF5;ZCCHC8;SNRPA;PRPF6;FRG1;SRSF2;PRPF40B;LSM5;MFAP1;RNPC3;DDX46;CSTF2T;SRSF9;GCFC2;U2AF2;SRSF3;PRPF3;TBRG4;SART3;SNU13;DBR1;ZCRB1;SRSF8;PDCD7;SRRM4;NOVA1;U2SURP;GEMIN2;KIN;SRSF12
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.33842976852623735,-0.6425318736903886,0.9204545454545454,1.0,1.0,5/31,16.75%,HS3ST2;HS3ST5;GPC5;GPC3;B3GAT2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.30846940758984354,-0.6418275008086775,0.9560439560439561,1.0,1.0,2/50,6.09%,NAPA;F8
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.30846940758984354,-0.6418275008086775,0.9560439560439561,1.0,1.0,2/50,6.09%,NAPA;F8
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.30846940758984354,-0.6418275008086775,0.9560439560439561,1.0,1.0,2/50,6.09%,NAPA;F8
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.33229345416641914,-0.6413521120120763,0.945054945054945,1.0,1.0,10/48,24.27%,FHL1;ID2;APPL1;RGCC;RDX;KLF4;AIF1;E2F7;GPNMB;PLCB1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.365115388112477,-0.6406817076323593,0.925,1.0,1.0,3/15,21.86%,HSPA1B;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.3216701826307953,0.64039265310963,0.9166666666666666,1.0,1.0,3/15,15.24%,USP30;GDAP1;MFN1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.34909319346316875,-0.6401492945504585,0.9195402298850575,1.0,1.0,4/20,21.86%,HSPA1B;GPSM2;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.41937809928950553,-0.6400066158358861,0.9076923076923077,1.0,1.0,3/7,37.32%,YBX3;SLC25A4;PELI1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.41937809928950553,-0.6400066158358861,0.9076923076923077,1.0,1.0,3/7,37.32%,YBX3;SLC25A4;PELI1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3397801749582244,-0.6397062170951499,0.9213483146067416,1.0,1.0,3/25,18.04%,PRKCQ;SLX4;GNL3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.33057671223931995,-0.6396501539148943,0.967741935483871,1.0,1.0,8/43,20.86%,NR4A3;PAX8;GHR;NSMF;RDX;CTSB;ROBO2;SRA1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.39044524062786645,-0.6395249557727811,0.8765432098765432,1.0,1.0,1/12,4.00%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.35175690312471153,-0.639453161352113,0.9080459770114943,1.0,1.0,5/17,22.18%,CD36;KLF4;INSR;CLU;KLF2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.309602303444503,-0.6394095435713869,0.946236559139785,1.0,1.0,11/58,26.28%,RPL23;HEATR3;APPL1;CBLB;PRICKLE1;SEC13;RANBP17;NUP50;NUP133;FAM53C;TNPO2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.4199614068565489,0.6391339465539518,0.8378378378378378,1.0,1.0,1/5,13.03%,RBBP4
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.4199614068565489,0.6391339465539518,0.8378378378378378,1.0,1.0,1/5,13.03%,RBBP4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.32579883535714504,-0.6387761694496567,1.0,1.0,1.0,16/60,29.41%,CARMIL1;BAIAP2L1;MAPT;PRKCE;PYCARD;CAV3;RPS3;ARF6;CLU;CRACD;STMN2;DCTN1;AKAP9;APP;PSRC1;FES
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3035352155608527,-0.6385377294776206,0.9897959183673469,1.0,1.0,29/148,23.30%,PTN;SH3PXD2B;PKP2;CACNB2;ANK3;RAB11A;ATP1B3;ANK2;ZDHHC15;SHANK3;FGF13;FCHO2;EPB41L3;EFR3B;NRXN1;RAB3A;TSPAN32;RAB3C;RDX;CAV3;RAB15;CPE;THY1;NRXN2;SCN3B;LRRC7;SAV1;DVL1;SYNE3
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.36202118045446374,-0.6382034450056753,0.8846153846153846,1.0,1.0,2/16,19.26%,AKAP6;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.386298174109302,-0.6378765098223037,0.9036144578313253,1.0,1.0,4/10,27.20%,SHANK3;ADCY8;RELN;APP
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.31968382833724723,0.6377022852692439,0.8823529411764706,1.0,1.0,3/14,18.17%,WHAMM;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.35829788733765294,-0.6373479425514774,0.9204545454545454,1.0,1.0,8/22,29.45%,FN1;ITGA6;PLEC;THY1;PTPRK;PIP5K1A;SORBS1;ACTN2
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.4096358856591442,-0.6372325859616612,0.8947368421052632,1.0,1.0,2/5,21.92%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.3307892762471051,-0.6368470201252864,0.9438202247191011,1.0,1.0,9/27,23.38%,AGT;ATP1B3;ANK2;RYR3;ATP2B4;ASPH;ATP2B2;ATP1B2;RYR2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.3252037773482833,-0.6368437191720838,0.9361702127659575,1.0,1.0,11/41,21.95%,LRP2;VEGFA;ANK2;SST;RAB3A;CTNND2;SCG5;SH3GL2;CPE;SEZ6L2;UCHL1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.3187477636253121,0.6367612477076412,0.8260869565217391,1.0,1.0,3/11,13.31%,TBC1D25;SMCR8;CLEC16A
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.34854776548505684,-0.6366845495873842,0.9041095890410958,1.0,1.0,5/23,29.86%,SRSF5;SRSF9;SRSF12;PRPF39;CELF2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.4327682063415308,-0.6361465627839309,0.9027777777777778,1.0,1.0,3/5,29.65%,CCL3;CALCR;PDGFB
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.38992844720220615,-0.6361342349792466,0.9210526315789473,1.0,1.0,3/9,26.36%,MTERF1;TEFM;TFAM
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.3864188798623359,-0.6359085834755341,0.881578947368421,1.0,1.0,3/8,15.02%,GSTP1;APOD;OAS3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.3340066160842898,-0.6358604811266417,0.9186046511627907,1.0,1.0,10/28,28.96%,GRIK1;LRRC4C;NLGN3;PXK;RELN;IQSEC2;NLGN2;CACNA1B;GRIK2;GRIK4
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.34401837955207937,0.6356952957204696,1.0,1.0,1.0,4/13,14.62%,TMEM109;TP53;TLK2;MDM2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.3588724333233359,0.6356291782237607,0.9523809523809523,1.0,1.0,3/15,7.02%,SH2B3;CBFB;RUNX1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.44064442867259956,-0.6354937151741488,0.9230769230769231,1.0,1.0,4/5,35.41%,ROBO2;APP;ROBO1;GAP43
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3064638513805674,-0.6354377689477201,0.9795918367346939,1.0,1.0,19/97,24.25%,FLT1;PINK1;PRKCQ;EPHA3;ARRDC3;RFC4;BMI1;EPHB1;ALK;CHTF18;KLF4;RPS2;INSR;DTX3L;MUSK;EPHA7;POLG2;NTRK3;ZNF16
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.37682836171174006,-0.6354290104657494,0.948051948051948,1.0,1.0,3/15,25.90%,TENT4B;DICER1;PRKRA
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3315871814668048,-0.6348158191089367,0.9529411764705882,1.0,1.0,8/29,19.42%,HIF1A;NOD2;APPL1;PLD3;APOD;PYCARD;PDCD4;MACIR
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.23579900397892106,0.6347071116161662,1.0,1.0,1.0,13/62,15.50%,POU2F1;RPAP2;RPRD1B;POLR2C;INTS7;TAF13;PHAX;GTF2E1;RPRD1A;GTF2B;INTS9;GTF2F1;SRRT
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.39702441822482754,-0.6344304549552819,0.8873239436619719,1.0,1.0,3/9,40.46%,HMOX1;ERN1;ITGB1BP1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3179715810470136,-0.6341293706220339,0.9659090909090909,1.0,1.0,8/40,26.51%,TVP23A;RAB3A;RAB3C;RAB15;ABCA1;RIMS2;PCSK5;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.3527970655374528,-0.6340153629295815,0.9090909090909091,1.0,1.0,4/18,27.08%,SHANK3;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.2897996329483491,0.6338157283353272,0.9047619047619048,1.0,1.0,2/15,4.93%,SMPD3;RAB7A
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.391321902502929,-0.6335086694421471,0.8933333333333333,1.0,1.0,3/10,18.14%,CBR1;PTGES2;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.38724373358055075,0.6333533318903817,0.8235294117647058,1.0,1.0,1/5,8.93%,NR1H3
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.33061778986278734,-0.6332965702808024,0.9302325581395349,1.0,1.0,7/31,24.53%,POLR3F;DHX58;IRF1;OAS3;TLR2;RIPK2;RIOK3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3075610302752798,0.6331099520491315,0.9166666666666666,1.0,1.0,2/16,9.81%,SLIT3;NR3C1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.3125049434469668,0.6330792145638464,0.8076923076923077,1.0,1.0,11/11,68.78%,DIS3L;EXOSC9;EXOSC6;XRN1;EXOSC7;EXOSC2;EXOSC8;DIS3;EXOSC10;DEDD2;TRIR
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.36427678446948075,-0.6328282763345776,0.9367088607594937,1.0,1.0,3/15,13.46%,PRKCE;CCL3;IL18
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.32305864613875857,-0.6326611860458903,0.9651162790697675,1.0,1.0,4/48,15.59%,ALG10B;OST4;MGAT1;TUSC3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.3827959252620613,0.632643660754402,0.8846153846153846,1.0,1.0,1/7,10.90%,SLC30A10
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.35913167266256624,-0.6324092127199076,0.9156626506024096,1.0,1.0,4/17,26.94%,LIMD1;CNOT8;MOV10L1;CNOT6
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.3789029855523143,-0.6322866774902915,0.9294117647058824,1.0,1.0,2/12,21.84%,LIMD1;PATL2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.36707235352015954,-0.6322255572207528,0.8961038961038961,1.0,1.0,1/12,2.98%,ETFB
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.40383872626836614,-0.6316738743155252,0.9285714285714286,1.0,1.0,5/9,25.94%,NRXN1;NLGN3;LRP4;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.28943591728005086,0.6315479541442796,0.9411764705882353,1.0,1.0,6/17,21.07%,TGFB1;PLK3;CCL5;IL1B;TSC2;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3236459993969418,-0.6312766003190339,0.9897959183673469,1.0,1.0,10/67,21.94%,RIMS1;TGFB2;MAPT;SDCBP;AKAP6;GOLGA4;SYT1;UNC13A;SYT4;MFSD2A
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.342472572406494,-0.6307369737171779,0.9540229885057471,1.0,1.0,7/34,25.89%,CASP5;BNIP3;IRF1;PIEZO2;PDE2A;CASP1;PTGER4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.31352226181360066,0.6298703386805188,0.9090909090909091,1.0,1.0,4/12,17.55%,NBN;ERCC4;ERCC1;PARP1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32315067825358196,-0.6297956371081818,0.967032967032967,1.0,1.0,4/53,7.75%,VEGFA;VAV3;DOCK1;FLT1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.42830815137794787,-0.6287729118946673,0.9552238805970149,1.0,1.0,1/5,9.06%,SEC61B
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.3746693060129682,-0.6286731175146738,0.9210526315789473,1.0,1.0,3/12,18.14%,RORA;IL18;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.3766400955999524,-0.6283428593490954,0.9135802469135802,1.0,1.0,2/11,15.40%,FCGR2B;NR1D1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.38473869127001403,-0.6281174059193542,0.8513513513513513,1.0,1.0,2/9,29.33%,GOT1;GPT2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.3600063256108167,0.6280581124329131,0.8387096774193549,1.0,1.0,7/7,64.02%,LIG4;MR1;ZFP36L2;ZFP36L1;RABL3;ADAM17;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.330464610611794,-0.6274885758721132,0.9404761904761905,1.0,1.0,13/37,31.03%,RPL13A;NOP53;HSPA5;TFIP11;IMPACT;CLU;JAM3;CRYAB;RIOK3;PTGER4;NLRC3;HSF1;THRA
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.321895605551275,-0.6274520773414476,0.896551724137931,1.0,1.0,8/34,20.13%,HIF1A;ALOX15B;IL7;IL18;OAS3;PYCARD;AIF1;TLR2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.3068387467843096,-0.627311914656372,0.9690721649484536,1.0,1.0,13/75,21.04%,DTL;EEF1A2;APC2;GPC3;SNF8;NSF;CDKN1B;EEF1A1;AZIN1;GFAP;FMN2;DDB1;HECW2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.38965975876959186,-0.6267951248653654,0.8701298701298701,1.0,1.0,1/10,8.75%,MAPT
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2879981786648835,0.6260514590077626,0.9545454545454546,1.0,1.0,3/14,17.55%,ERCC4;NAF1;PARP1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.3322545506202915,-0.6255613906179873,0.9879518072289156,1.0,1.0,3/27,12.82%,SLC11A1;NOCT;HNRNPA0
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.35315480236868496,0.6250457727038345,1.0,1.0,1.0,1/9,1.80%,PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.35315480236868496,0.6250457727038345,1.0,1.0,1.0,1/9,1.80%,PGM2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3513632062282128,-0.6244957923809701,0.8888888888888888,1.0,1.0,4/14,33.02%,AP1AR;VPS13A;VPS13C;KIF16B
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.3451852686717601,-0.6241259593459958,0.9259259259259259,1.0,1.0,4/18,21.43%,SULF2;EIF2AK3;NFIB;BMPR1B
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.3443978323990572,-0.6238968213772149,0.9404761904761905,1.0,1.0,1/22,3.52%,CDC37
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.3862426144775563,-0.6236025834036467,0.9459459459459459,1.0,1.0,3/7,18.90%,B2M;TAP1;ERAP1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.2992120820953552,-0.6233314276868368,0.979381443298969,1.0,1.0,25/120,23.14%,OMG;PQBP1;RAB11A;PPP1R9A;MAPT;PLP1;LAMB1;HDGFL3;SHANK3;GPM6B;EPB41L3;MANF;GPM6A;EPHB1;CTNND2;SH3GL2;SLC9A6;NCDN;UBB;STMN3;STMN1;DICER1;MICALL2;SGK1;STMN2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.3378362746927326,0.6230737342347441,0.8620689655172413,1.0,1.0,3/9,15.18%,SRC;PIEZO1;FERMT2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.3890714328847926,0.6228421211191222,0.8928571428571429,1.0,1.0,1/5,10.46%,TIRAP
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.38851898816252245,-0.6226088587219932,0.9625,1.0,1.0,3/10,26.35%,FBXL2;PPIB;VAPA
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.4088164943237969,-0.622412543067018,0.9178082191780822,1.0,1.0,2/6,17.84%,IQSEC1;ARF6
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.4088164943237969,-0.622412543067018,0.9178082191780822,1.0,1.0,2/6,17.84%,IQSEC1;ARF6
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.39220615168462414,-0.6222864627601791,0.88,1.0,1.0,1/10,7.78%,BRCA1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.39229641058740194,-0.6220598230900587,0.9516129032258065,1.0,1.0,1/8,17.76%,NECAB1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.33316885374230687,-0.6210565939695285,0.975609756097561,1.0,1.0,3/35,9.14%,RBM4B;RBM3;PARP9
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3137925472570756,-0.6206945375784351,0.9789473684210527,1.0,1.0,8/57,19.26%,PPP2R5A;CLIP3;PRKCE;APPL1;EPHA3;PID1;ARF6;ATP2B4
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.3670186549740525,-0.6204713049327771,0.9156626506024096,1.0,1.0,3/12,21.94%,PLTP;SLC25A19;MFSD2A
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3130101945860588,-0.6204455195314365,0.989010989010989,1.0,1.0,11/54,24.99%,NLRP12;NOD2;RPS3;PDCD4;TERF2IP;TLR2;TMSB4X;CD14;EIF2AK2;UACA;IFI35
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.3450572862705491,0.620441993170976,0.84,1.0,1.0,1/10,5.33%,SIRT1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.3323415041712248,-0.6203370140681734,0.9411764705882353,1.0,1.0,5/29,20.76%,ITGB8;PDZD2;PTPRT;TCTN1;DNAH7
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.3611378384902404,-0.619971545591979,0.927710843373494,1.0,1.0,1/13,7.78%,BRCA1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.31221560739523135,-0.6198495295731422,0.967032967032967,1.0,1.0,12/62,20.13%,CDK14;SULF2;AMER2;MDFIC;TLE1;GPC3;DAAM2;CTNND2;PTK7;EMD;GSKIP;TLR2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.38491665449805357,-0.6196936709760792,0.9459459459459459,1.0,1.0,2/9,14.49%,PADI2;APOD
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.37593087129511804,-0.6195059404224914,0.9411764705882353,1.0,1.0,1/12,9.14%,ID2
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.35711943227525045,0.6190775941979525,0.9393939393939394,1.0,1.0,2/5,20.72%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.356550176713103,0.6190676890462112,0.8571428571428571,1.0,1.0,2/6,12.03%,PKDCC;SOX5
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.3820393905215097,-0.6190146264801185,0.9393939393939394,1.0,1.0,4/7,27.99%,CFL1;PLCB1;RACK1;B4GALT5
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.32175344986172455,-0.618991921685484,0.9893617021276596,1.0,1.0,9/44,24.31%,TRIM5;TRIM25;KDM1A;TRIM22;TRIM14;DVL1;DZIP1L;MAP2;RACK1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.4195156120407857,-0.6179386711130151,0.9375,1.0,1.0,1/5,20.97%,LIG3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.33185298285730985,-0.6177924568773012,0.975609756097561,1.0,1.0,5/29,23.04%,DDRGK1;ATG2A;VRK1;EIF2D;RETREG1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.30368047516225516,-0.6173420008589176,0.9893617021276596,1.0,1.0,8/67,17.37%,NLRP12;RORA;DHX58;CARD16;NR1D1;KLF4;SIGIRR;C1QBP
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3328184093618351,-0.6173177171650122,0.9444444444444444,1.0,1.0,3/28,13.46%,CCL3;ABCB4;IL18
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.4126925507318098,-0.6173017501300699,0.9583333333333334,1.0,1.0,2/8,24.12%,ADCY10;DYNC1I1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.33425194956262655,-0.6173000640610654,0.946236559139785,1.0,1.0,4/25,17.05%,MAPT;HDGFL3;FGF13;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.31538687723325637,-0.6169708980881254,0.9550561797752809,1.0,1.0,5/43,13.49%,HIF1A;COX7A2;ATP5IF1;PINK1;PGAM1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.324381837401877,-0.6165080568862426,0.968421052631579,1.0,1.0,2/44,4.37%,NFIL3;DNAJB9
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.3888443508806734,-0.6164086852377912,0.9032258064516129,1.0,1.0,3/7,30.50%,MAT2A;SPAST;LRRC8A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.30852241579888706,-0.6162389669456343,0.9887640449438202,1.0,1.0,15/45,23.45%,KIAA1549;DZIP1;MAP1B;HSPA12A;CDH2;ADGRL2;LIFR;TUSC3;ENAH;LRP4;PTPRG;SEZ6L2;FIGN;RBFOX2;MPDZ
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.4220054625652737,-0.6161512741248675,0.9117647058823529,1.0,1.0,1/5,3.43%,GPR183
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.33101445777016325,0.6158028247630829,1.0,1.0,1.0,2/10,8.93%,LPL;NR1H3
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.3930354972309903,-0.615785600809385,0.9014084507042254,1.0,1.0,4/6,30.16%,NHP2;METTL4;NOP10;DKC1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3544534316665354,-0.6148151965443657,0.9518072289156626,1.0,1.0,6/24,26.71%,DDRGK1;RGCC;RDX;AIF1;PLCB1;EZH2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.3851075652426581,-0.6146576238075763,0.9354838709677419,1.0,1.0,1/6,10.46%,TIMM13
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.2891228603712214,-0.6144995639585669,0.98989898989899,1.0,1.0,20/144,17.99%,TFRC;TNS1;MXI1;H1-0;BLVRB;SIDT2;ENDOD1;PPP2R5B;NARF;UROS;BNIP3L;RAP1GAP;MBOAT2;SDCBP;PPOX;ALDH6A1;NUDT4;CTSB;MPP1;OSBP2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.4079920470288175,-0.6144912905281521,0.9393939393939394,1.0,1.0,1/9,6.88%,CSKMT
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4087688443844456,-0.6143304154034112,0.9125,1.0,1.0,1/7,15.76%,ADCY10
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.3604121344013479,-0.6137138943215963,0.9436619718309859,1.0,1.0,2/14,9.78%,PLN;ANK2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.4041520329859335,-0.6136100166006214,0.9705882352941176,1.0,1.0,5/8,25.94%,NRXN1;NLGN3;LRP4;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.4036323670480969,-0.6134485612456487,0.9230769230769231,1.0,1.0,1/6,19.26%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.4036323670480969,-0.6134485612456487,0.9230769230769231,1.0,1.0,1/6,19.26%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.37778657941057026,-0.6131608045379429,0.8701298701298701,1.0,1.0,1/8,13.15%,OLFM1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.401441475319239,-0.6129420118685873,0.9078947368421053,1.0,1.0,2/7,16.95%,CD36;VMP1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3057175631064713,-0.6122787447563698,0.9894736842105263,1.0,1.0,14/76,22.62%,THBS1;GSTP1;NOD2;CCL3;OAS3;PYCARD;C5AR2;ZFP36;CLU;TLR2;ARG2;DICER1;FOXP1;CD14
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3362375994559398,-0.6113649368779266,0.9390243902439024,1.0,1.0,4/23,22.53%,FHL1;KLF4;E2F7;GPNMB
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.3695923486364649,-0.6113128520425847,0.95,1.0,1.0,1/11,8.47%,RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.3695923486364649,-0.6113128520425847,0.95,1.0,1.0,1/11,8.47%,RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.3695923486364649,-0.6113128520425847,0.95,1.0,1.0,1/11,8.47%,RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.3695923486364649,-0.6113128520425847,0.95,1.0,1.0,1/11,8.47%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3770727470138518,0.6109065752604235,0.8529411764705882,1.0,1.0,2/5,15.13%,EIF2AK4;NCK1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.33631805200814086,-0.6107685351717117,0.9883720930232558,1.0,1.0,7/26,22.18%,GLA;CD36;KLF4;INSR;ATP2B4;CLU;KLF2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.41503541691009943,-0.6102814586494322,0.958904109589041,1.0,1.0,1/6,5.45%,PPP1R3B
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2861088986812957,-0.6100674303290737,1.0,1.0,1.0,157/1271,20.11%,BRIP1;NR4A3;CENPF;FOSL2;SAP30;ACVR1B;CEBPD;BHLHE40;ZNF793;NFIL3;ZNF382;ST18;CDK14;AGT;NR4A1;HINT1;VEGFA;HMGB2;CTDSP1;OVOL2;FOS;RBPJ;HIF1A;GLRX2;ATP8B1;RORA;RXRB;POLR3F;MXI1;CREB5;PQBP1;APBB3;ZNF540;MEIS2;ZNF789;NR4A2;YEATS2;TAF6L;ZNF93;NFE2L3;ZNF549;L3MBTL3;BRCA1;ZNF260;CHD3;LITAF;UXT;BASP1;STAT1;ZNF483;ID2;PARP9;PAX8;MDFIC;PLAG1;ARID5B;PRKCQ;ZNF814;RORB;HDGFL3;DRAP1;LIMD1;TGIF1;PPIE;TRPS1;NR1H2;ZNF235;ATF5;CTBP1;HIC2;PRDM15;HCFC1;TSHZ2;TLE1;MSL3;ATF3;JUNB;IRF1;SMARCD3;MAP3K12;RPL6;ETS2;ZNF805;BCL6;PIAS4;ZNF518A;TCF7;PPP1R13L;ZNF550;KCTD1;TSHZ3;MXD1;ZNF654;HIRA;SUV39H2;SNX6;MAX;HSF2;ZNF41;SNF8;CDKN1B;ZNF850;ING4;ZNF266;MLX;NR1D1;PRDM1;ZNF213;ZNF100;ING5;DEAF1;STAT2;KDM3A;ZNF20;ZNF519;ZKSCAN5;KDM1A;KLF4;POU6F1;NFIX;TEF;CCNC;ZNF354A;CREBRF;ZNF449;ATXN7L3;TOX;TIMELESS;ZNF778;INSR;CBX5;SS18L1;TRIM16;CITED2;PDCD4;SP110;HBP1;ILF3;TP53INP1;HCLS1;TERF2IP;KLF13;HMGN5;ATP2B4;HEXIM1;ZNF197;PER2;E2F7;ZNF445;ZNF558;BRCA2;ACTR5;ZNF565;SOX4;NFIB;MNT;CREM
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.2740387502428104,0.6095375554528448,1.0,1.0,1.0,10/35,20.12%,BCAR3;CDAN1;ZBTB38;KAT7;ANKRD17;PDS5A;BRPF3;RAD17;CTC1;RBBP6
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.38714522887184766,0.609484241903295,0.9259259259259259,1.0,1.0,5/5,61.30%,SLC39A12;SLC39A8;SLC39A10;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.41066945700594093,-0.6089856492569188,0.9230769230769231,1.0,1.0,2/5,19.39%,PID1;PER2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.38422518890709323,-0.6086670806423344,0.9113924050632911,1.0,1.0,2/7,23.38%,ANK2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.378488642107359,-0.6085736208191183,0.9571428571428572,1.0,1.0,2/8,20.31%,CD44;THY1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.29006872532765116,-0.6080934070720541,1.0,1.0,1.0,12/79,26.58%,CLEC4E;PSMA5;PSMA3;PSMD8;PSMB4;PSMD7;PSMD5;CARD9;PSMB9;PSMC2;PRKACB;PSMB2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.29006872532765116,-0.6080934070720541,1.0,1.0,1.0,12/79,26.58%,CLEC4E;PSMA5;PSMA3;PSMD8;PSMB4;PSMD7;PSMD5;CARD9;PSMB9;PSMC2;PRKACB;PSMB2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.32432916442602144,-0.6078651036071523,0.9655172413793104,1.0,1.0,6/28,32.59%,CAMK2N1;ASPH;OGT;TBC1D10A;CYFIP2;CSTB
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.3277613103143451,-0.6071334672436565,0.926829268292683,1.0,1.0,3/14,34.53%,EMD;NEMP1;SUN2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.31286005641781184,-0.6071105475884463,0.978494623655914,1.0,1.0,5/42,14.05%,ENPP2;LPCAT1;NR1H2;PCTP;MBOAT2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.28456415223922904,-0.6070306589363754,1.0,1.0,1.0,27/254,21.50%,RPS27A;TRIM5;RNF144B;DTL;ARIH2;RNF126;RBX1;BRCA1;UBA52;UBC;PSMA5;UBE2QL1;PSMA3;HERC6;SPSB1;DZIP3;TRAF2;PSMD8;FBXL13;UBB;PSMB4;FBXL7;TRIM69;DTX3L;TRIM22;HECW2;TRIM14
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.3450268125692135,-0.607003038058757,0.975609756097561,1.0,1.0,6/13,30.60%,CCL3;MAFB;TMEM178A;GPR137B;LILRB3;LILRB1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.3892806262302294,-0.6068354646513356,0.9523809523809523,1.0,1.0,1/5,20.48%,VRK1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.3538003391232124,0.6065278874714038,0.90625,1.0,1.0,1/6,11.89%,COL15A1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.36323233816127987,-0.6060247655825909,0.926829268292683,1.0,1.0,8/21,26.58%,FCHO2;RAB3A;NLGN3;SYT1;AMPH;RAB5A;NLGN2;PIP5K1C
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.3676950867087393,0.6056260779560287,0.9444444444444444,1.0,1.0,1/5,17.50%,FMR1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.35070559617072317,-0.6055970789892906,0.9753086419753086,1.0,1.0,2/17,13.12%,HERPUD1;EIF2AK3
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.31594614448228603,-0.605379479709745,0.9431818181818182,1.0,1.0,6/35,20.44%,PPA1;DARS1;LARS1;NARS1;GARS1;HARS2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3440449241240702,-0.6052074322898103,0.9759036144578314,1.0,1.0,9/18,38.93%,SDCBP;ARF6;LRPAP1;APP;DLG4;RAC1;ANKRD13D;ITGAV;APOC1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.3529132737765833,0.60514013135696,0.8787878787878788,1.0,1.0,5/5,64.72%,MPST;MTHFR;MTRR;BLMH;MMUT
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.29492767506297063,-0.6048367945835906,0.9887640449438202,1.0,1.0,2/57,6.09%,NAPA;F8
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.30164504903511524,0.6044438976932166,0.8518518518518519,1.0,1.0,10/10,69.86%,CCT3;TERF1;CCT2;CCT4;TCP1;CCT5;CCT6A;CCT7;CCT8;DKC1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.3363049783665369,0.6042538590562792,0.9473684210526315,1.0,1.0,4/10,18.63%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.413859881064108,-0.6040417762027188,0.9295774647887324,1.0,1.0,1/6,10.99%,NR1H2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.28534894688029877,-0.604028907690768,1.0,1.0,1.0,35/165,27.90%,SYCE2;RIMS1;PKP2;ANK3;RHOU;BAIAP2L1;GPM6B;LRGUK;NLGN3;BSN;DARS1;TRAF2;VMP1;TUBGCP2;STAG3;AIF1;ELOB;ACTG1;VCPIP1;KNTC1;WASF1;DVL1;NDUFAF1;PARVG;REPS2;HFE;PPID;NEDD9;NLGN2;PARVB;SLC2A1;CALD1;FANCA;SPG7;ABCA3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.32554448987978585,-0.6039213089004045,0.9629629629629629,1.0,1.0,8/19,36.63%,SHANK3;ARF6;NEURL1;CAMK2B;PPFIA2;PTPRS;GRIN3A;CAMK1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.4157775202882437,-0.6036463989437901,0.9393939393939394,1.0,1.0,2/5,28.79%,SRSF12;PRPF39
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.3952764240706763,-0.6035660114748694,0.9264705882352942,1.0,1.0,2/5,17.59%,SH3GL2;SLC9A6
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.3884541278249468,-0.6035543725201284,0.9180327868852459,1.0,1.0,2/8,17.27%,NSF;ANXA2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.32239183738036853,0.6032176996259326,0.9032258064516129,1.0,1.0,11/11,67.79%,SAFB2;IWS1;CDK11B;SAFB;SRPK2;PTCD2;SLTM;SUPT6H;NCBP1;DHX9;SRPK1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.38128363339958793,0.6030925038195682,0.96,1.0,1.0,3/7,15.18%,CXCL12;COL16A1;FERMT2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.3455431164684751,-0.6028082347628679,0.9512195121951219,1.0,1.0,6/14,24.31%,FCGR2B;APPL1;TLR2;CD300A;PLSCR1;RACK1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.29463970162695113,-0.6026360572254553,0.979381443298969,1.0,1.0,14/84,23.08%,C5AR1;GSTP1;SOD1;FGR;CAMK2N1;TTN;CENPE;IQGAP1;CAV3;GSKIP;THY1;RELN;SPDYA;DVL1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.2924746303381641,0.602483236948954,0.9375,1.0,1.0,2/17,7.02%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.35795709717124913,0.6024784277078444,0.8888888888888888,1.0,1.0,1/6,7.43%,SLC35G1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.26157189879997916,0.6016054461698284,0.875,1.0,1.0,3/24,7.75%,MMD;ZC4H2;BRINP3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.4148135915667792,-0.6010941351583233,0.9420289855072463,1.0,1.0,3/6,19.90%,SEMA3A;FN1;SOX4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.3361337021320112,-0.6009197332595512,0.9523809523809523,1.0,1.0,9/22,26.95%,RIMS1;RAB3A;SYT1;RAB15;SYT4;RAB5A;RIMS2;RAB3D;RIMS3
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.3435568681467865,-0.6008028248626013,0.9425287356321839,1.0,1.0,5/18,23.72%,PGK1;ASPH;CIDEB;RIPK2;GRIN2A
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.30767014916230834,0.6006279074262731,0.9130434782608695,1.0,1.0,1/9,2.95%,SMAD7
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.36568038716827245,-0.6006187691767078,0.9634146341463414,1.0,1.0,6/18,27.20%,TXNIP;IL18;PYCARD;TXN;CASP1;APP
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.324609030907993,-0.6005483371597875,0.963855421686747,1.0,1.0,5/26,25.15%,BRCA1;CTBP1;KDM1A;TET1;SART3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.2599679731152367,0.6002882893115786,0.8928571428571429,1.0,1.0,2/17,10.44%,SETD6;FBL
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.3934348616745866,-0.5995210282931596,0.9384615384615385,1.0,1.0,3/5,35.02%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.28410654162399657,-0.5990285807770737,0.98989898989899,1.0,1.0,28/136,23.12%,HTR2B;PLPP3;ALOX15B;PFKFB4;FBP1;GK;LIMD1;PGK1;ITPKC;PPA1;PTPRD;INPP4A;ALK;NUDT4;PFKFB3;GPD2;LIMK2;CALM1;INPP4B;PIK3CB;DUSP12;GK5;HK2;EPHA7;GPI;PLPPR4;PFKL;ACP3
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.2907886192060628,-0.5990277566049609,0.9895833333333334,1.0,1.0,16/114,19.99%,THBS1;LRP2;CHI3L1;FGF1;PPP2R5B;PINK1;NOP53;CCL3;IL18;NRG4;C1QBP;INSR;HCLS1;PIK3CB;IRS2;TXN
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3180579978263137,-0.5989549933883832,0.978494623655914,1.0,1.0,8/28,25.68%,SOD1;RPS7;RPS3;UBB;BMF;SEPTIN4;RACK1;SIAH1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.3862622718977582,-0.5987326678176104,0.9253731343283582,1.0,1.0,1/9,13.08%,PLD3
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.3571652033272955,-0.598595612767205,0.9195402298850575,1.0,1.0,1/17,8.52%,RBM3
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.27201767150290423,0.5984442704448777,0.9166666666666666,1.0,1.0,3/13,16.72%,ITGB5;SRC;ARRB1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.27201767150290423,0.5984442704448777,0.9166666666666666,1.0,1.0,3/13,16.72%,ITGB5;SRC;ARRB1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.3555938989019888,0.5983678060507762,1.0,1.0,1.0,3/8,18.63%,ABCB7;SLC40A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.36612703507131233,-0.5983469262578246,0.9466666666666667,1.0,1.0,1/10,7.75%,FLT1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.3313211208409341,-0.5983447834292264,0.9753086419753086,1.0,1.0,7/18,30.52%,ATP5IF1;SCN9A;SCN1A;SCN3B;CACNA1B;CACNG2;SCN2A
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.23050415945393957,0.5981378808015995,1.0,1.0,1.0,5/46,14.30%,NUP188;CHMP2B;CC2D1B;BANF1;UBXN2A
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.41718242462463007,-0.5980333138740559,0.9253731343283582,1.0,1.0,1/5,15.94%,PDHB
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.33355231011831404,-0.5976678317744117,0.9325842696629213,1.0,1.0,5/18,24.28%,MAPT;MAP1B;PRUNE1;MAP1A;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3224489039055123,-0.597486924075894,0.9883720930232558,1.0,1.0,7/37,18.16%,DOCK1;CARMIL1;DOCK5;IL1RAPL1;PTPRD;C1QBP;SS18L1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.2938810983980286,-0.5974218136886756,0.9574468085106383,1.0,1.0,6/59,19.48%,INSIG1;SYAP1;PKM;RAB15;INSR;IRS2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.32064072463083837,-0.5970634529822229,0.9102564102564102,1.0,1.0,2/25,6.52%,SPARC;CFL1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.32246347064550684,-0.5970179882431305,1.0,1.0,1.0,1/32,1.90%,PLPP3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3094718436897657,-0.5966106602531364,0.9647058823529412,1.0,1.0,11/26,33.42%,BNIP3;MICOS13;GHITM;SLC25A5;RCC1L;APOO;HSPA9;SPG7;IMMT;MFN2;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3081507131587978,-0.5962421123887431,0.9468085106382979,1.0,1.0,5/41,19.23%,DTL;RAB11A;RGCC;RDX;AIF1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.3724051151454265,-0.595972655340342,0.9583333333333334,1.0,1.0,1/10,9.37%,IL15
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.27490701317392857,0.5959636640453392,0.8888888888888888,1.0,1.0,6/19,18.71%,PPARGC1A;TADA2B;RPS6KA4;KAT7;ARRB1;IL1B
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.33994782196221063,0.5956025930570558,0.8846153846153846,1.0,1.0,5/5,66.02%,HDHD5;CPNE1;FAR1;CPNE3;AGK
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.35570180838212173,0.5944431499778553,0.9285714285714286,1.0,1.0,2/7,14.00%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28166384571217695,-0.5943300895820491,0.989247311827957,1.0,1.0,12/80,26.58%,CLEC4E;PSMA5;PSMA3;PSMD8;PSMB4;PSMD7;PSMD5;CARD9;PSMB9;PSMC2;PRKACB;PSMB2
prerank,MSigDB_Hallmark_2020__Coagulation,-0.2956689333095266,-0.5943108130419775,1.0,1.0,1.0,9/66,19.74%,THBS1;SPARC;F8;THBD;FN1;ITGA2;CTSB;SERPING1;CLU
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.3532448518977568,-0.5942290287579923,0.935064935064935,1.0,1.0,4/11,22.85%,MCMDC2;RFC4;MCM3;MCM7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2458989540803413,0.5939308946969628,0.9615384615384616,1.0,1.0,6/18,18.71%,PPARGC1A;TADA2B;RPS6KA4;DIP2A;ARRB1;IL1B
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.2954117096227374,-0.593426208887797,0.9887640449438202,1.0,1.0,5/48,15.24%,ALG10B;GCNT1;SERP1;MGAT1;ST8SIA1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.28304293751856263,-0.5932380435922732,1.0,1.0,1.0,16/96,26.58%,FOS;VAV3;PRKCQ;PSMA5;PSMA3;TEC;PSMD8;CALM1;PSMB4;PIK3CB;MAPK10;PSMD7;PSMD5;PSMB9;PSMC2;PSMB2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.3885471185123996,-0.5931902401555055,0.9466666666666667,1.0,1.0,1/5,25.89%,PTGER4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.26685889236973115,0.5929885833565536,0.9375,1.0,1.0,5/23,21.03%,SIRT1;EP300;SAFB2;PKN1;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.31559625437725375,-0.5928136542706114,0.9761904761904762,1.0,1.0,1/24,2.84%,AGT
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.30287323024639795,0.5920887284813989,0.9130434782608695,1.0,1.0,1/13,3.52%,BAG5
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3033974236675679,-0.5916053939782437,0.9875,1.0,1.0,13/44,23.82%,SYNC;LAMB1;TTN;ANGPT2;FN1;PALLD;FBXL7;MUSK;RND3;COL5A1;ZBTB16;CRYAB;UACA
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2225259182289134,0.5909324968754388,1.0,1.0,1.0,4/46,7.01%,PKD2;RYR1;APPL2;ALDH9A1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.31246189840143057,-0.5908688514639721,0.9886363636363636,1.0,1.0,6/36,24.21%,ALOX12;SCD;FADS3;ELOVL4;ACSM3;SCD5
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.25378442539254714,0.5905206866536558,1.0,1.0,1.0,9/21,23.00%,WDR33;PAPOLA;MTPAP;SCAF8;CPSF1;GRSF1;CDC73;LEO1;CPSF2
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.25378442539254714,0.5905206866536558,1.0,1.0,1.0,9/21,23.00%,WDR33;PAPOLA;MTPAP;SCAF8;CPSF1;GRSF1;CDC73;LEO1;CPSF2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.3314017487364643,-0.5904276547609444,1.0,1.0,1.0,2/22,9.40%,SEC61B;SERP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.344087727659785,-0.5903944164162855,0.9662921348314607,1.0,1.0,2/19,13.12%,DDX11;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.30662577640338995,-0.5902345524480476,0.9560439560439561,1.0,1.0,5/52,10.60%,DEPP1;FBXL2;MAPT;DAPK1;DAPK2
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.32422025840390156,-0.5900326443055215,0.9629629629629629,1.0,1.0,7/17,25.27%,CFL1;MICAL2;STMN3;STMN1;DSTN;STMN2;CKAP5
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.3316527051367565,-0.5899855325764218,0.9875,1.0,1.0,2/18,8.99%,B4GAT1;DPY19L2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.4015337180804806,0.5898156439317644,0.9166666666666666,1.0,1.0,5/5,59.86%,PEX11B;DNM1L;ACOT8;MFF;FIS1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.3183502355147881,0.589580452308952,0.8636363636363636,1.0,1.0,1/16,0.92%,GSN
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.28885980849111553,-0.5895253381369567,0.98989898989899,1.0,1.0,18/135,20.31%,CCL4;RGS1;TBC1D8;GNB5;TBC1D13;SIPA1L1;CCL3;APC2;RAP1GAP;USP6;ITGA6;TBC1D2B;TBC1D15;LARS1;GPR65;NGEF;TBC1D14;THY1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.41418157821767054,-0.5891706372570137,0.9459459459459459,1.0,1.0,2/6,29.06%,LRPAP1;ROCK1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.3246024042623229,-0.5889148302346325,0.9555555555555556,1.0,1.0,2/23,12.77%,ID2;CDH2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.33981657179000635,0.5878949200007195,0.9393939393939394,1.0,1.0,6/6,66.03%,TRIP12;OTUB1;UBR5;PARP10;PLAA;GPS2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.4065401348796691,-0.5877236032593529,0.974025974025974,1.0,1.0,4/6,28.50%,CITED2;RYR2;IFT122;NDRG4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.2856748049574645,-0.587685849247373,1.0,1.0,1.0,8/86,17.04%,ALG10B;AQP11;B4GAT1;SERP1;MGAT1;ST8SIA1;TUSC3;OGA
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.3903148121318879,-0.587150540694254,0.9333333333333333,1.0,1.0,1/6,11.22%,KDM6B
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3651801245680711,-0.5868522738018478,0.9078947368421053,1.0,1.0,2/6,18.06%,CALM3;CALM1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3651801245680711,-0.5868522738018478,0.9078947368421053,1.0,1.0,2/6,18.06%,CALM3;CALM1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.32910999855133505,0.5867811807378482,0.9230769230769231,1.0,1.0,3/6,25.25%,CTTNBP2NL;WWP2;PPIF
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.28089233977719136,-0.5863895151179914,1.0,1.0,1.0,20/96,26.58%,DKK2;PRDM15;GPC5;PSMA5;PSMA3;GPC3;DAAM2;PTK7;PSMD8;PSMB4;SOX4;GSKIP;GPRC5B;PSMD7;PSMD5;PSMB9;PLEKHA4;PSMC2;CSNK1G2;PSMB2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.37865323184958355,-0.5862401815321662,0.9466666666666667,1.0,1.0,2/7,37.40%,CHAMP1;MID1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.3516146184236886,-0.5861862295789337,0.9722222222222222,1.0,1.0,2/11,22.39%,ACAT1;MVD
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.30499606451885214,0.585925246456416,1.0,1.0,1.0,1/10,7.32%,TP53
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.2643049388199235,0.5858464579497288,1.0,1.0,1.0,4/17,14.62%,TMEM109;TP53;TLK2;MDM2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.398284010370084,-0.5858336721706902,0.9855072463768116,1.0,1.0,2/5,25.66%,CAD;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3502589190575345,-0.5843259532862822,0.9466666666666667,1.0,1.0,2/10,18.42%,CDKN1B;PDCD4
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.2647730218331863,0.5843089193879576,1.0,1.0,1.0,2/23,10.16%,LEPR;CHD7
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.27866157954463644,0.5842748325146089,1.0,1.0,1.0,2/20,5.33%,BAG5;SIRT1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.3677263738200989,-0.5831667134861012,0.9850746268656716,1.0,1.0,3/8,22.54%,KDM3A;KDM1A;KDM4B
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.30162119414788474,0.5829256671412817,0.8620689655172413,1.0,1.0,9/9,69.86%,CCT3;CCT2;CCT4;TCP1;CCT5;CCT6A;CCT7;CCT8;DKC1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.35565976555420215,-0.5829123954625575,0.9459459459459459,1.0,1.0,4/8,40.18%,OGA;MAN2A2;MAN2A1;AGA
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),-0.363721547375689,-0.5826295462085337,0.8918918918918919,1.0,1.0,1/7,12.45%,SLC12A8
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),-0.363721547375689,-0.5826295462085337,0.8918918918918919,1.0,1.0,1/7,12.45%,SLC12A8
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2760592960394025,-0.5825830918897593,1.0,1.0,1.0,38/207,24.57%,PRKAR2B;HAUS6;TUBB4A;TUBA4A;CCDC39;ABLIM3;DZIP1;RAB11A;TUBA1A;SNX10;RPGRIP1L;LRGUK;CC2D2A;IFT81;IFT74;TTBK2;SPATA6;CEP152;MAK;IFT52;SCLT1;CEP164;BBOF1;TCTN1;ATP6V1D;MACIR;TXNDC15;KIF3A;DYNC2LI1;DYNC2I1;ATAT1;DCTN2;DZIP1L;IFT46;RFX2;TMEM138;DYNC2H1;DCTN1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.2144415587043999,0.5824177936935637,1.0,1.0,1.0,2/36,4.39%,LPL;OSBPL6
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.28657943808430086,-0.5821989058249495,0.989010989010989,1.0,1.0,9/58,18.61%,LRP2;SLC11A1;CCL3;TPT1;TUSC3;CDH23;SLC24A1;RYR3;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.27547813860936743,-0.5818680872680757,1.0,1.0,1.0,39/316,20.37%,NFIL3;AGT;HMGB2;FOS;HIF1A;RORA;RXRB;CREB5;BRCA1;STAT1;ID2;PARP9;PAX8;MDFIC;RORB;NR1H2;ATF5;HCFC1;IRF1;SMARCD3;MAP3K12;ETS2;NR1D1;ING5;DEAF1;KDM3A;KLF4;ATXN7L3;SS18L1;TRIM16;CITED2;ILF3;TP53INP1;HMGN5;BRCA2;SOX4;NFIB;DTX3L;MAFB
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.350361289681366,-0.5817061857533274,0.9473684210526315,1.0,1.0,2/10,29.41%,FOXP1;FES
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.28656603218415005,-0.5813506905914791,0.98989898989899,1.0,1.0,25/156,22.18%,FGF1;RIMS1;TGFB2;RBPJ;HIF1A;IL7;IL7R;PDCL;SULF2;NOD2;SHANK3;NRXN1;NLGN3;CD63;TRAF7;ING5;RPS3;TRIM16;CITED2;TLR2;TXNDC15;TTC23;RELN;LANCL2;KLF2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.2872234056985036,-0.5811094579279358,0.9893617021276596,1.0,1.0,16/83,27.84%,RIMS1;DARS1;TRAF2;TUBGCP2;ELOB;SEH1L;KNTC1;WASF1;NDUFAF1;NUP133;REPS2;HFE;PPID;SLC2A1;FANCA;SPG7
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.32574919140324987,-0.5810447605289611,0.9647058823529412,1.0,1.0,7/17,26.39%,SNX6;CBLB;ERRFI1;HFE;CRHBP;PPARA;CALCR
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3036662453750605,-0.5800745060789368,0.9523809523809523,1.0,1.0,1/30,9.90%,PRKCQ
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.3545718664306288,-0.5800251655512058,0.987012987012987,1.0,1.0,1/10,9.44%,AANAT
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.34263768319476207,-0.579779201227884,0.9523809523809523,1.0,1.0,5/14,32.42%,RACK1;ROCK1;RIPOR2;KANK1;RUFY3
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.35583939309786855,-0.5794959648083593,0.9342105263157895,1.0,1.0,2/9,24.38%,TMEM14A;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.34241665039712094,0.5793004455341689,0.8846153846153846,1.0,1.0,1/6,4.91%,CAB39
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.27395884772649665,0.579103112557416,0.9615384615384616,1.0,1.0,6/14,22.77%,METTL16;CELF1;ZC3H18;PUM1;YTHDF2;ROCK2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.29324318789830345,-0.5790450554152086,1.0,1.0,1.0,3/47,10.02%,FTSJ1;METTL2A;GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.2871120675142267,0.5790011826513103,1.0,1.0,1.0,4/14,16.03%,CXCL12;ADAM10;DOCK8;CCL5
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.3164208788009836,-0.5789630038633159,0.9888888888888889,1.0,1.0,3/24,10.99%,PLTP;ABCA5;NR1H2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.34387343683713734,-0.5784477381296201,0.9493670886075949,1.0,1.0,1/12,11.43%,ATF3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3134884515262141,-0.5782960727878372,0.9512195121951219,1.0,1.0,2/20,18.93%,ID2;HCLS1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3472750330837988,-0.5782820013981544,0.9577464788732394,1.0,1.0,4/11,27.17%,PAICS;IMPDH1;GART;PFAS
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.32675678836455657,-0.57775350993279,0.9759036144578314,1.0,1.0,3/17,22.79%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.3214087176535513,0.5773757516745719,0.9259259259259259,1.0,1.0,2/7,19.31%,TCF3;LIG4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.33742804350160716,-0.576961594347653,0.9358974358974359,1.0,1.0,4/14,28.36%,C1QBP;SRSF9;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.3735596021003045,-0.5769235237232354,0.9436619718309859,1.0,1.0,1/7,17.95%,INSR
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.31948385077205765,-0.57679821136204,0.96,1.0,1.0,3/13,19.02%,F8;THBD;SERPING1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.31799165346002756,-0.576437251065172,0.9885057471264368,1.0,1.0,2/26,12.63%,RBPJ;TCF7
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.32697243227454964,0.5762558178313125,1.0,1.0,1.0,1/8,7.18%,CAPRIN2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.24529608068552228,0.5757618275140438,1.0,1.0,1.0,3/21,12.69%,TAF13;HELB;GTF2B
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.34452832327220007,-0.5754273310189373,0.922077922077922,1.0,1.0,3/14,26.54%,EEF1A2;PPARA;SORBS1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.3219440046163631,-0.5749577341867791,0.9411764705882353,1.0,1.0,1/21,6.74%,WDR5
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.30750172568588935,-0.5747554817591186,0.9629629629629629,1.0,1.0,1/28,9.90%,PRKCQ
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.30003655653736605,-0.5746800171815518,0.9550561797752809,1.0,1.0,5/35,20.46%,XRCC3;RPA2;RPA3;TERF2IP;DNA2
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.35116075621977666,0.5743863493990965,0.9333333333333333,1.0,1.0,1/7,4.95%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.33790614614359893,0.5733579984035949,0.96,1.0,1.0,1/7,7.02%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.3182336246862155,-0.573038978364192,0.9534883720930233,1.0,1.0,4/16,16.73%,PLN;GPM6B;PXK;CAV3
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.314842383716411,-0.5726693886759011,0.9767441860465116,1.0,1.0,6/24,27.72%,APPL1;PID1;INSR;IRS2;SORBS1;PRKAG2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.27142417318382894,-0.57243914701466,1.0,1.0,1.0,30/210,24.97%,RPS27A;HIF1A;BRCA1;CLSPN;COPS5;HCFC1;UBA52;OTUD1;UBC;PSMA5;PSMA3;USP36;USP6;CFTR;TOMM20;WDR48;TRAF2;PSMD8;UBB;PSMB4;ACTR5;SUDS3;UCHL1;VCPIP1;PSMD7;ABRAXAS1;PSMD5;OTUD7B;TNIP1;PSMB9
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.32334334967578665,0.5724000037212057,0.9259259259259259,1.0,1.0,8/8,67.69%,ATP6V1G1;ATP6AP1;ATP6V0D1;ATP6V1A;CPEB4;PICK1;NDUFS2;ATP6V0A2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.2819879595042135,-0.5718234944670273,0.9893617021276596,1.0,1.0,15/57,28.96%,HIF1A;PFKFB4;FBP1;PGAM1;PFKFB3;INSR;SEH1L;SEC13;NUP50;NUP133;PPARA;APP;PRKAG2;NUP88;OGT
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.2658743514982324,-0.5717034555557337,1.0,1.0,1.0,21/69,28.38%,CACNB2;ANK2;CCL3;TPT1;TRPM3;CDH23;SLC24A1;RYR3;CACNA1C;ATP2B4;NALCN;ATP2B2;SLC24A2;RYR2;SLC24A4;MCOLN1;MCUR1;CACNA1B;TRPC4;ORAI2;SLC24A3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.340531355968235,-0.5714144332378119,0.9615384615384616,1.0,1.0,4/13,28.36%,C1QBP;SRSF9;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.33973930921121737,-0.5708501859318682,0.935064935064935,1.0,1.0,3/13,23.04%,DDRGK1;ATG2A;RETREG1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.3643215041260218,-0.5708096822022456,0.9444444444444444,1.0,1.0,4/7,42.90%,PLEKHA4;CSNK1D;MLLT3;NKD1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.26745216165425956,0.5704421751795952,0.96,1.0,1.0,1/15,5.23%,AGO1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.30663160569452247,-0.5704103215989127,1.0,1.0,1.0,1/30,3.21%,HMGB2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.35997338382712046,0.5702938349686092,0.875,1.0,1.0,1/5,8.45%,IVD
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.3401296349184121,-0.5699762116576379,0.9746835443037974,1.0,1.0,1/16,5.78%,ACSL1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.37715647760924276,-0.5694934343990146,0.9333333333333333,1.0,1.0,2/6,24.24%,IL18;CARD9
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.2702871073429699,-0.5692783699599819,1.0,1.0,1.0,12/113,14.30%,RBX1;MPG;RPA2;POLR2G;POLR1C;CMPK2;RPA3;RNMT;PDE4B;ERCC2;SDCBP;RFC4
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.33972184082209556,-0.5691686051805125,0.972972972972973,1.0,1.0,1/9,19.11%,ZFP36
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.3573102469622973,-0.5686782574858492,0.9436619718309859,1.0,1.0,2/10,14.25%,EMB;PALLD
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.3741803913110606,-0.5684698466311527,0.9523809523809523,1.0,1.0,1/6,19.07%,KDELR1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.2772198940460188,0.5684615068602459,0.9142857142857143,1.0,1.0,7/7,72.29%,PHKG2;GSK3B;UGP2;PHKB;PYGL;GBE1;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.30178825763570194,0.5680665817137737,1.0,1.0,1.0,16/16,69.86%,CCT3;TREM2;CEP120;CEP135;CEP295;CCT2;CCT4;TCP1;CCT5;CCT6A;CCT7;CHP1;CORO2B;TNF;CCT8;DKC1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.34065048516868146,-0.5676697103300239,0.9875,1.0,1.0,3/11,22.79%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.36339405946194964,-0.5665845429297174,0.9493670886075949,1.0,1.0,2/8,25.52%,AKAP6;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.35702079884342997,-0.5663176373047676,0.9342105263157895,1.0,1.0,3/9,24.31%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.35702079884342997,-0.5663176373047676,0.9342105263157895,1.0,1.0,3/9,24.31%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),-0.35928045189269164,-0.5662883679208601,0.987012987012987,1.0,1.0,2/7,22.57%,CDH2;NRG1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.29752021847908505,0.5662290736508537,0.9583333333333334,1.0,1.0,3/11,13.60%,WDR35;CILK1;TTC21B
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.3602891931801555,-0.5658685987970725,0.972972972972973,1.0,1.0,2/9,20.10%,PDHB;ACAT1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.29803053072846636,0.5657536077902451,1.0,1.0,1.0,11/11,70.22%,GLUD1;IREB2;IDH2;IDH3A;ACO2;IDH3G;IDH1;ACLY;IDH3B;SIRT4;ACO1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.30798687064650987,-0.5656589311772285,0.9605263157894737,1.0,1.0,2/23,6.87%,PKP2;ANK3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.359223947708194,-0.5654641389328365,0.96,1.0,1.0,3/9,22.48%,FGD6;FGD3;ARHGEF4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.2902648335443839,-0.5650208825462081,0.9662921348314607,1.0,1.0,1/36,2.98%,ETFB
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.3762390381390527,-0.5647881416985354,0.9523809523809523,1.0,1.0,1/5,22.52%,FOXP1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.35032756387441555,0.5647321035180962,0.9714285714285714,1.0,1.0,1/5,10.13%,CD53
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.27522354989317066,0.5644244847870248,1.0,1.0,1.0,17/17,72.51%,RNF20;CPSF7;SUPT5H;NUDT21;ZC3H14;RNF40;VIRMA;CCNT1;CPEB3;CPSF6;NCBP1;CDK9;NELFE;HSF1;ZC3H3;NCBP2;CTR9
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.31198102016607354,0.5643778914831238,1.0,1.0,1.0,9/9,68.82%,NUP98;TPR;NUP153;NUP93;NUP107;NUP205;RTN4;NDC1;AHCTF1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.3397897066961816,0.5642926882014315,0.9210526315789473,1.0,1.0,5/5,66.03%,BECN1;SQSTM1;AMBRA1;ATG14;GPS2
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.31947948589282016,-0.5639484754673343,0.975609756097561,1.0,1.0,2/26,16.58%,PRKCQ;KLF4
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.2871287676810068,-0.5633298881032189,0.9886363636363636,1.0,1.0,9/50,25.04%,KNSTRN;RAB11A;KIF11;DSN1;MAP9;ABRAXAS1;SMC4;CENPK;SPAST
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.24489421772254055,0.563061440183731,1.0,1.0,1.0,3/19,14.34%,RAB7A;WDR91;PTPN23
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.20258583419503504,0.5628600206942607,1.0,1.0,1.0,10/73,15.63%,KHDRBS3;RBM23;PRDX6;METTL16;SAP18;RBMX;SMU1;CELF1;THRAP3;SON
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.38240759091567267,-0.5628284501376769,0.9523809523809523,1.0,1.0,1/5,11.21%,CTBP1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.3205568783801245,-0.5628252550422688,0.9506172839506173,1.0,1.0,4/22,18.35%,PIGL;PIGG;PIGH;PIGA
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.29611482546833107,0.5627989317577797,0.8947368421052632,1.0,1.0,2/13,6.37%,LRCH1;CXCL12
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.28052661273982266,0.5623394063030399,1.0,1.0,1.0,1/11,5.23%,AGO1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.37442454856021473,-0.5620421773387233,0.9857142857142858,1.0,1.0,1/6,8.03%,BLVRB
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.37442454856021473,-0.5620421773387233,0.9857142857142858,1.0,1.0,1/6,8.03%,BLVRB
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.3864321180308808,-0.5618578724170935,0.9545454545454546,1.0,1.0,2/5,20.74%,FYCO1;KIF3A
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.32013657296821535,-0.5614158241312839,0.9873417721518988,1.0,1.0,5/16,27.90%,CCL3;MAFB;TMEM178A;GPR137B;LILRB3
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3061017388096975,-0.5612919022750258,0.9605263157894737,1.0,1.0,2/15,17.98%,TIMM13;BMF
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3478121246293474,-0.5606184235401506,0.9759036144578314,1.0,1.0,2/9,18.17%,KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.3029326113776971,-0.5587887368318692,0.9883720930232558,1.0,1.0,4/23,17.59%,SLC4A10;CFTR;SLC9B1;SLC9A6
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.2868063704142235,-0.5584543972881807,1.0,1.0,1.0,5/52,19.31%,ACVR1B;CIT;MAP3K12;GALNTL6;CAD
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.3142895561579509,-0.5584210793292994,0.975609756097561,1.0,1.0,5/18,25.94%,MYRIP;IRS2;SOX4;HFE;NLGN2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.29487012188669887,-0.5583992835240004,0.9770114942528736,1.0,1.0,3/23,15.59%,OST4;MGAT1;TUSC3
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.3198803214381854,-0.5581637877155005,0.987012987012987,1.0,1.0,3/13,19.23%,CARMIL1;ARF6;AIF1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.3497367857451583,-0.5578653229801225,0.9230769230769231,1.0,1.0,4/6,27.08%,NRXN1;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.32324123357539825,-0.5573183580652921,0.9875,1.0,1.0,4/15,24.53%,DDX11;TIMELESS;ATP2B4;RIOK3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3001571002036091,-0.5571597093743849,1.0,1.0,1.0,8/31,30.12%,RPA2;MAPT;MCL1;PARG;NPAS2;WDR76;ETAA1;IER3
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.26328583436049857,-0.5567303686776042,1.0,1.0,1.0,14/83,24.14%,FANCI;HSPA1B;BRCA1;PINK1;CAMLG;RPS3;UBB;PER2;SOX4;SEPTIN4;PRICKLE1;RIPK2;UBXN1;U2AF2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.3044078990291117,0.5562779322264907,1.0,1.0,1.0,2/7,11.65%,CST7;LDLR
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.38033020417555247,-0.5561661232360917,0.9264705882352942,1.0,1.0,2/5,31.93%,PTPRK;KLF9
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.2935748715940994,-0.5558641950036453,0.9885057471264368,1.0,1.0,4/34,16.19%,DHX58;TRIM25;NLRC5;PYCARD
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3291436955029218,-0.5556078864102929,0.9466666666666667,1.0,1.0,3/11,22.52%,OAS3;KLF4;FOXP1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3024481294895374,-0.5550975018230264,0.9876543209876543,1.0,1.0,2/23,14.85%,FCGR2B;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.3486575444329892,-0.5542552636029412,0.9710144927536232,1.0,1.0,4/7,27.08%,NRXN1;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.24834972593994123,0.553933195125036,1.0,1.0,1.0,5/15,18.61%,SYT17;SYT6;SYT13;PRKN;GRK2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.29780834513905086,-0.5538625409367854,0.987012987012987,1.0,1.0,2/22,11.42%,GCNT1;GALNT8
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.24472039863956346,0.5534401577062901,1.0,1.0,1.0,11/11,75.55%,CAMK2G;CYB5R4;RAB11B;SELENOT;ANXA1;PTPRN;RAB11FIP2;SNX19;PARK7;PTPRN2;RIMS2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.3462326334918095,-0.5522856013910402,0.9625,1.0,1.0,2/9,22.17%,VRK1;VCPIP1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.28240875236654667,0.5516175815091113,1.0,1.0,1.0,1/8,7.24%,STK26
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.3469046872427538,-0.5512558199180284,0.9428571428571428,1.0,1.0,3/8,22.18%,KLF4;ABCA1;KLF2
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.34679179185132386,0.5511254505277322,0.8571428571428571,1.0,1.0,1/5,5.87%,KHSRP
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.29495476511147073,-0.5509750424801001,0.9880952380952381,1.0,1.0,3/22,15.59%,OST4;MGAT1;TUSC3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3041934870381014,-0.5508739474745082,0.9761904761904762,1.0,1.0,8/20,26.51%,BRCA1;TRIM25;GSTM3;CITED2;SRA1;CRHBP;WBP2;TRIM24
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.28209424442141495,-0.550701776814269,0.9772727272727273,1.0,1.0,1/44,1.71%,ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.36951785777853524,-0.5506556272638167,0.9305555555555556,1.0,1.0,1/5,21.99%,CLK2
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.3518696590312642,-0.5505835774138976,0.948051948051948,1.0,1.0,2/10,17.03%,RDX;CTSB
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.2929825718969238,-0.55032915133134,0.9883720930232558,1.0,1.0,2/30,7.68%,POLR3F;DHX58
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.3390602292454213,-0.5502812574703816,0.9873417721518988,1.0,1.0,3/9,26.19%,PRKCE;IRS2;PPARA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.3594899413092782,-0.5501678696325789,0.9746835443037974,1.0,1.0,2/8,10.86%,FCGR2B;HLA-F
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.35257476934955756,-0.549609591228756,0.9861111111111112,1.0,1.0,1/8,13.12%,EIF2AK3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3204100697644615,-0.549392586930672,0.95,1.0,1.0,5/18,27.50%,UHRF1;ATXN7L3;DTX3L;UBR2;CTR9
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2929452704840241,0.5485724227871103,0.9615384615384616,1.0,1.0,10/10,70.73%,PAPOLA;CDC73;LEO1;AHCYL1;ZFP36L1;DHX36;BARD1;NCBP1;ZC3H3;NCBP2
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.30922913649479017,-0.5481259542143294,1.0,1.0,1.0,3/20,15.84%,TOMM40;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2606537518667176,-0.5475261131646597,1.0,1.0,1.0,48/285,24.55%,CENPF;HAUS6;SH3PXD2B;ABLIM3;DZIP1;RPS23;RAB11A;VPS37C;MAPT;SNX10;LIMD1;CENPE;ANLN;TMEM41B;CC2D2A;IFT81;GOLGA8B;SNF8;IFT74;TTBK2;VMP1;TUBGCP2;MAK;RPS3;ATG2A;IFT52;UBXN2B;SCLT1;CEP164;TP53INP1;TCTN1;ATP6V1D;MACIR;ATG5;TXNDC15;KIF3A;CHMP5;PATL2;PDCD6IP;DYNC2I1;ATAT1;GABARAPL1;DZIP1L;IFT46;RFX2;TMEM138;MVB12A;DYNC2H1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.2933478118495018,0.5472849189623551,1.0,1.0,1.0,1/10,4.03%,LPL
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.3598422591390173,-0.5469811873396817,0.9552238805970149,1.0,1.0,2/7,21.65%,CACNA1C;ISCU
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.334493326826193,-0.5469593801403988,0.961038961038961,1.0,1.0,2/10,20.46%,ATAD5;DNA2
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.3554640281141258,-0.5458671125129434,0.9452054794520548,1.0,1.0,3/7,31.61%,SYT4;KIF5A;PPFIA2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.3488431810797227,-0.545783581548,1.0,1.0,1.0,2/7,22.57%,CDH2;NRG1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.3341811716305154,-0.5457746176392165,0.9736842105263158,1.0,1.0,3/13,16.73%,PLN;CCL3;CAV3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3421950509335563,-0.5457544252241608,0.9743589743589743,1.0,1.0,4/10,40.60%,ROCK1;FLOT2;ABCA7;PRNP
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.2765352332869031,0.5450869900016704,0.9629629629629629,1.0,1.0,1/8,5.61%,RHOG
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.2879267695282839,0.544966571236126,0.9545454545454546,1.0,1.0,1/8,6.30%,HLCS
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.29527376250419496,-0.5449499311336549,0.9764705882352941,1.0,1.0,7/26,25.89%,ADCY3;ADAM15;CFTR;ADCY8;GNAI1;MAP4K1;PTGER4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.2693650955749692,-0.5448958852554117,1.0,1.0,1.0,15/88,24.85%,RPL11;IFIT2;DDX11;NMD3;CARD16;B2M;IFIT1;KDM1A;TFIP11;DTX3L;LRPAP1;RIPK2;DVL1;RACK1;HFE
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2536090008105986,-0.5448283218208358,1.0,1.0,1.0,44/390,21.04%,RPS27A;TRIM5;RNF144B;DTL;H2BC11;ARIH2;UVSSA;HIF1A;RNF126;DTX3;RBX1;VPS11;BRCA1;FBXL2;PINK1;TRIM25;KLHL13;UBA52;UBC;PSMA5;UBE2QL1;PSMA3;HERC6;SPSB1;ENC1;UHRF1;TRAF7;DZIP3;H2BC9;TRAF2;PSMD8;RNF13;FBXL13;UBB;PSMB4;FBXL7;TRIM69;NEURL1;DTX3L;DDB1;ELOB;H2BC5;TRIM22;HECW2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.2922826451696612,-0.5445797314481813,1.0,1.0,1.0,3/27,14.28%,HSPA1B;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.26146080865097066,0.5445554547387068,1.0,1.0,1.0,2/13,14.62%,ZDHHC2;MDM2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.3686254741010702,-0.5438700559248291,0.958904109589041,1.0,1.0,3/5,31.48%,AMPD2;PFAS;HPRT1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.28399990842860195,-0.5437113470808483,0.9893617021276596,1.0,1.0,9/49,21.80%,CALY;CLIP3;EPHA3;GPC3;AP2S1;MCTP1;ARFGAP1;LRPAP1;RAB5A
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.3072653058582549,-0.5434796720658612,0.9518072289156626,1.0,1.0,5/18,29.06%,SHANK3;RDX;ACTG1;PTGER4;ROCK1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.31975640620056955,0.5434281316376655,1.0,1.0,1.0,10/10,68.05%,RPS6KB1;PRKAA1;MEAK7;ATF4;ULK1;RPTOR;KCNB1;MTOR;EIF4G1;PRKAA2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.30013339429709995,0.5429605573787785,1.0,1.0,1.0,1/9,6.58%,SLC44A2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.2691498239902042,-0.5426352001343621,1.0,1.0,1.0,15/55,30.58%,GCNT1;B4GAT1;GALNT8;GALNTL6;OGA;SDF2L1;TET1;GALNT6;GALNT18;B4GALT5;POMT1;OGT;CRPPA;PLOD1;POMGNT1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.32446908005215486,-0.5426001592534911,0.9714285714285714,1.0,1.0,2/9,20.49%,SDCBP;LRPAP1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.35861028252288907,-0.542396709582815,0.9714285714285714,1.0,1.0,2/5,19.23%,FMN2;AIF1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.2640748169553041,-0.5421442835892119,1.0,1.0,1.0,14/64,23.81%,PTN;COBL;ZDHHC15;EPHA3;ITGA6;ALK;PTK7;TOX;ATP1B2;RELN;SERPINI1;LRRC7;STMN2;NTRK3
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.3367493587124006,0.5419024363631275,1.0,1.0,1.0,1/5,2.95%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3187864790631788,-0.5411153175772354,0.9634146341463414,1.0,1.0,3/17,20.95%,FCGR2B;THY1;CD300A
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.255696086987982,-0.5406683252441632,1.0,1.0,1.0,27/201,24.85%,NAPA;RIMS1;AIM2;SH3PXD2B;RBX1;F8;DMD;TLE1;TCF7;FN1;NSF;SEC24C;DARS1;TRAF2;TUBGCP2;PLEKHA7;FBXL7;ADCY8;GSDMD;ELOB;KNTC1;WASF1;SEC13;NDUFAF1;REPS2;CNIH1;HFE
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.31261231837064274,0.540511239663368,0.9428571428571428,1.0,1.0,1/5,5.55%,LAPTM4B
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.2973824362222053,-0.5404820248934564,0.975,1.0,1.0,2/26,11.21%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.3202839101789954,-0.5399466481260904,0.96,1.0,1.0,2/11,22.59%,FAAH;FAH
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.30943157561862616,0.5396029189167574,0.9259259259259259,1.0,1.0,5/5,69.07%,PRKN;SNCA;HDAC6;MT3;OXA1L
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.2598628243634664,-0.5373857191523846,0.989247311827957,1.0,1.0,13/67,29.68%,POLR1C;CGGBP1;BMI1;TAF1D;DNMT1;ERCC6;WBP2;EZH2;TDG;MACROH2A2;JARID2;GLMN;H3-3A
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.32930107526881713,0.5366671079435827,0.9545454545454546,1.0,1.0,6/6,67.09%,HNMT;AMD1;SMS;OAZ2;SRM;ODC1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.2425305025735255,0.5363970159327893,1.0,1.0,1.0,2/21,7.71%,RAB7A;RAB39A
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.3025257739185695,0.5359649973275045,1.0,1.0,1.0,1/8,3.53%,CD274
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.27643684714084304,-0.5358314361831095,0.9759036144578314,1.0,1.0,5/36,19.11%,CR1;PDE4B;TRAF2;RPS3;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.29615536821467026,-0.5349170269272264,1.0,1.0,1.0,4/17,30.61%,CLU;EPHA4;ABCG1;CASP3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.28124725611183254,-0.5342472427586461,0.9885057471264368,1.0,1.0,5/36,15.47%,MYOT;EMB;CDH2;PALLD;PTPRT
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.33298685846551523,-0.5339523866996825,0.9333333333333333,1.0,1.0,3/7,31.71%,BCS1L;TTC19;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.33298685846551523,-0.5339523866996825,0.9333333333333333,1.0,1.0,3/7,31.71%,BCS1L;TTC19;UQCRFS1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.24840275591252894,-0.5337539988893754,1.0,1.0,1.0,33/240,23.35%,NAPA;TBC1D8;SH3PXD2B;STX19;TBC1D13;ANK2;ITSN1;ZDHHC15;DMD;EPB41L3;ARMCX3;USP6;SNX6;CD63;NSF;TBC1D2B;TBC1D15;SCG5;ARF6;CPE;RAB20;TBC1D14;SEPTIN9;ARL17A;RAB5A;ARL4C;SEPTIN4;RAB21;PTPRK;EIF2D;PRRT1;SEC13;JAM3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.28355816370445763,0.532968811824876,0.9666666666666667,1.0,1.0,2/6,16.81%,CYB5R3;DDAH2
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.28355816370445763,0.532968811824876,0.9666666666666667,1.0,1.0,2/6,16.81%,CYB5R3;DDAH2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.3523325057616594,-0.5328049815518628,0.987012987012987,1.0,1.0,1/6,14.17%,CD63
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.30664276373988447,-0.5324374802561038,0.972972972972973,1.0,1.0,4/14,30.61%,CLU;EPHA4;ABCG1;CASP3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.3067305732062315,0.5318317133916787,0.9333333333333333,1.0,1.0,1/9,6.09%,RNF20
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3505297088023549,0.5315686386196331,1.0,0.9994293954338275,1.0,2/6,10.90%,ABCB7;SLC30A10
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.24641891346455874,-0.5313717361248964,1.0,1.0,1.0,57/366,23.83%,ACVR1B;NEK11;CDK14;TGFB2;TXK;MASTL;FLT1;CLSPN;FGR;PINK1;DAPK1;PRKCQ;PRKCE;RIOK2;DAPK2;PRDX4;PDK3;CTBP1;CIT;MAP3K12;NIM1K;NUAK2;PIM3;EPHA3;EIF2AK3;FAM20A;INCENP;TEC;LIPE;PXK;PAK5;TTBK2;EPHB1;ALK;STK17B;GRK4;PIK3R4;MAK;LIMK2;INSR;VRK2;ILF3;CAD;TLR2;MUSK;VRK1;RELN;BMPR1B;CLK2;RPS6KB2;MAPK10;PRRT1;EIF2AK2;SGK1;RPS6KA2;NRBP2;STRADB
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.34025887301388347,-0.5310717509970393,0.9705882352941176,1.0,1.0,2/6,24.44%,BMI1;PCGF5
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.29357031482051826,-0.5307243107645061,0.9882352941176471,1.0,1.0,2/23,7.70%,ABLIM3;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.25251620727783236,-0.5303714314828606,1.0,1.0,1.0,22/109,26.58%,SULF2;DKK2;PRDM15;GPC5;PSMA5;PSMA3;GPC3;DAAM2;PTK7;PSMD8;PSMB4;SOX4;GSKIP;TLR2;GPRC5B;PSMD7;PSMD5;PSMB9;PLEKHA4;PSMC2;CSNK1G2;PSMB2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.25555497989772946,0.5293475761786459,1.0,0.9989017888584482,1.0,3/17,12.49%,BCKDHB;IVD;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.25555497989772946,0.5293475761786459,1.0,0.9989017888584482,1.0,3/17,12.49%,BCKDHB;IVD;SLC25A44
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.29717688022023186,-0.5279130321610613,1.0,1.0,1.0,4/22,18.94%,CSKMT;ANTKMT;SUV39H2;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.3259378034832856,0.5278358052165689,0.9210526315789473,0.9989744136674108,1.0,1/5,6.09%,RNF20
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2448880605709925,-0.527311784364477,1.0,1.0,1.0,24/258,18.95%,RPS27A;DNAJB9;RNF126;RBX1;KCTD2;RNF175;HERPUD1;FBXL2;ANKZF1;SEC61B;TRIM25;UBA52;UBC;PSMA5;PSMA3;SPSB1;HSPA5;PSMD8;FBXL13;UBB;PSMB4;FBXL7;UBXN2B;SPSB3
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.28339618352674945,0.5262912878240033,0.9166666666666666,0.998850734619263,1.0,2/6,20.15%,SKI;LRP6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.2901572627610819,0.5261531842495422,0.9615384615384616,0.9981700323727879,1.0,4/9,16.03%,CXCL12;DOCK8;JAM2;CCL5
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.2774219058916571,0.5259048963138371,0.9722222222222222,0.997552193751958,1.0,9/9,72.28%,UBE2N;SETD5;MTHFR;AKAP8L;PARK7;AKAP8;CDK9;HPF1;PARG
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.27375523167427074,-0.5257112841249252,1.0,1.0,1.0,7/42,22.44%,TMEM41B;VMP1;ATG2A;UBXN2B;TP53INP1;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.2622778226983968,-0.5256361505095501,1.0,1.0,1.0,7/71,17.98%,DTL;UVSSA;TMEM161A;ERCC2;COPS9;KDM1A;BMF
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.2729883435576963,-0.524652995623978,0.9887640449438202,1.0,1.0,9/30,30.74%,RPA2;RPA3;TERF2IP;DNA2;WRN;RIF1;H3-3A;APEX1;PRKDC
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3067324446048023,-0.5235993523411543,0.9444444444444444,1.0,1.0,8/12,37.22%,SNF8;CHMP5;TMEM50A;VPS28;CHMP4B;CHMP6;VPS36;STAM
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.33587168770507053,-0.5233866605385878,0.9354838709677419,1.0,1.0,3/6,28.19%,PTPRT;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.2561355768139396,0.5229588599579954,1.0,0.9981098581494177,1.0,4/11,17.59%,SYT17;SYT6;SYT13;PRKN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.3121324419254373,-0.5221320392228864,0.972972972972973,1.0,1.0,2/16,14.49%,MDFIC;APOD
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.33389852320599395,-0.5214758160068215,1.0,1.0,1.0,3/11,29.06%,CLU;LRPAP1;ROCK1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.3233514167209982,-0.520671560647778,1.0,1.0,1.0,2/9,17.49%,PPP1R13L;PLEC
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.2722866402676295,-0.520136201894131,1.0,1.0,1.0,3/29,15.77%,ANK3;NSF;GOLGA4
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.34774274040153397,-0.5196699861008646,0.9850746268656716,1.0,1.0,2/5,28.64%,FYCO1;CALCOCO2
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.3590804197766658,-0.5195862313879702,0.9726027397260274,1.0,1.0,3/5,35.67%,SERINC5;ZCCHC3;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.2991436665379943,0.5188880505412637,0.9259259259259259,0.9989549934653834,1.0,1/8,7.44%,CHMP2B
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.3238281753559261,-0.5184758013172228,0.9605263157894737,1.0,1.0,2/6,20.79%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.31099077815765797,-0.5183414239470266,1.0,1.0,1.0,3/11,28.24%,SLC12A8;SLC9A7;SLC12A7
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.23636340099990824,-0.5181640465768158,1.0,1.0,1.0,26/288,21.04%,TOM1L1;RNF144B;DTL;ARIH2;RNF126;RBX1;KCTD2;HERPUD1;VPS37C;PINK1;TRIM25;PSMA5;PSMA3;SPSB1;UHRF1;RNF149;PSMD8;RNF13;PSMB4;FBXL7;UBXN2B;SPSB3;DTX3L;DDB1;PPP1R11;HECW2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.249713928291671,0.5178501642540511,1.0,0.998656877323661,1.0,3/12,20.99%,TASOR;SETDB1;TPR
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.2540759792633039,-0.517835496317874,1.0,1.0,1.0,9/73,19.39%,RSAD2;TGFB2;APBB3;TTN;STXBP5L;ARF6;SNAP25;CACNA1C;PER2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.2781413204544072,-0.5173573256166877,0.9743589743589743,1.0,1.0,3/22,17.58%,PDE4B;TRAF2;RPS3
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.33037320706821477,-0.5172564567383324,0.9428571428571428,1.0,1.0,1/6,21.86%,PDCD6IP
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.33037320706821477,-0.5172564567383324,0.9428571428571428,1.0,1.0,1/6,21.86%,PDCD6IP
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.2648319702410413,-0.5172040139849786,1.0,1.0,1.0,3/53,10.01%,TGFB2;APBB3;TTN
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.3437947978778459,-0.5165657101558567,0.9861111111111112,1.0,1.0,2/6,25.75%,ING5;MEAF6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.3276282648049704,-0.5162151652504238,0.9736842105263158,1.0,1.0,2/10,20.95%,FCGR2B;CD300A
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.25708176886778006,-0.5156275698281833,0.9891304347826086,1.0,1.0,7/47,21.59%,CARMIL1;BAIAP2L1;PRKCE;PYCARD;ARF6;HCLS1;CRACD
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.2928989403764037,0.5151169704901343,0.95,0.9990891417461101,1.0,8/8,70.73%,CDC73;LEO1;NUDT21;DHX36;CPEB3;NCBP1;HSF1;NCBP2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.3250186879118738,-0.514844290987324,0.963855421686747,1.0,1.0,1/11,8.75%,MAPT
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.2664883812852921,-0.5138999837382032,1.0,1.0,1.0,6/38,20.44%,PPA1;DARS1;LARS1;NARS1;GARS1;HARS2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.31006753561949324,-0.5137039314239686,0.9634146341463414,1.0,1.0,2/13,18.17%,KDM1A;CD44
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.30667591586560256,-0.5126491300894859,0.9863013698630136,1.0,1.0,3/11,34.34%,GNL3;DKC1;CCT8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.3162305320578703,0.5126401605687392,0.9459459459459459,0.999192025949888,1.0,5/5,68.39%,MTMR2;MTMR1;MTMR3;MTMR9;MTMR4
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.30665895564231216,-0.5123176244360935,0.9879518072289156,1.0,1.0,7/16,28.81%,MAPT;SH3GL2;WASF1;STMN2;NTRK3;MAGI2;TMEM108
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.2568555142178478,-0.5120622566667511,1.0,1.0,1.0,9/53,24.66%,EIF4A3;TENT4B;SRSF5;SRSF2;CSTF2T;SRSF9;U2AF2;SRSF3;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.2581981856787123,0.5107636272336834,0.9459459459459459,0.998986782516196,1.0,2/10,16.82%,TASOR;SETDB1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.31432365150802405,-0.5089755631058155,0.9508196721311475,1.0,1.0,5/11,35.63%,ZWILCH;CHAMP1;KNL1;IK;RB1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2735468564650059,0.5089681595628248,0.96,0.9989459732459405,1.0,9/9,72.66%,CD53;TREM2;TYROBP;MAPK14;ADAM9;FLOT1;CAMK1;RIPOR2;RAPGEF3
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.31051676783175886,-0.5084908589765966,1.0,1.0,1.0,3/11,24.21%,SPG11;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.3159255617329167,0.5082698637447525,0.9354838709677419,0.9984541809886348,1.0,2/5,15.32%,AK3;DHODH
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.3085619416554667,0.5060936335184892,0.9642857142857143,0.9984547927638013,1.0,5/5,69.16%,RAB32;HPS4;RAB38;HPS1;TRAPPC6A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.30872005692149573,0.5058548094231543,1.0,0.9978412404162931,1.0,5/5,69.14%,GBF1;LRRK2;SEC16A;MIA3;BCAP31
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.2842821026774038,-0.5058008665318294,1.0,1.0,1.0,8/21,36.35%,RPGRIP1L;DCTN1;IFT122;CSNK1D;CEP250;BBS4;ARL13B;IFT57
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.28574717180679704,-0.5040288112598508,0.9871794871794872,1.0,1.0,2/14,23.26%,SEC24C;SEC13
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3273277731964951,-0.5026329909300252,0.9848484848484849,1.0,1.0,2/6,35.63%,VCPIP1;RB1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.348980411839399,-0.501335323688164,0.9850746268656716,1.0,1.0,1/5,10.05%,DOCK5
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.30541893065267345,0.50065041719397,1.0,0.9987935579378036,1.0,2/7,13.15%,DVL2;DVL3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.3312927889135867,-0.5001868572306281,0.9855072463768116,1.0,1.0,1/6,28.82%,DENND3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.2882113070354696,-0.5001541598120416,1.0,1.0,1.0,7/16,36.14%,CAV3;ATP2B4;SCN3B;SNTA1;FXYD7;UTRN;FGF12
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.2616894875384892,-0.5001414141358178,0.9883720930232558,1.0,1.0,3/27,18.93%,MDFIC;APOD;HCLS1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.25589421694225045,-0.49949021336411675,1.0,1.0,1.0,5/36,23.59%,USP36;SEH1L;CHMP5;PDCD6IP;NUP133
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.2773780343164386,0.4986488398638398,0.9411764705882353,0.9986099405584218,1.0,7/7,72.28%,CSGALNACT1;UGP2;EXTL2;GMDS;FUT8;GFPT1;PARG
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.29612519632490486,-0.4978368690161688,0.9855072463768116,1.0,1.0,4/8,31.39%,SCN3B;RYR2;TRPM4;ATP2A2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.32201761850107696,0.49730312146956485,0.9655172413793104,0.998263169368729,1.0,2/5,17.79%,PLK3;GBF1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.3013294784609453,-0.4965380869884832,0.9878048780487805,1.0,1.0,3/17,21.99%,FBP1;DDB1;CLK2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.264607994483562,-0.4964325984778289,1.0,1.0,1.0,2/23,13.80%,WDR5;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.28113344680057106,-0.4957779940674,0.9764705882352941,1.0,1.0,4/13,29.22%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.28113344680057106,-0.4957779940674,0.9764705882352941,1.0,1.0,4/13,29.22%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.2622147018992078,-0.495669140230409,1.0,1.0,1.0,1/43,3.11%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.24287380156167476,-0.4954647662992891,1.0,1.0,1.0,4/52,13.88%,POLR2G;MDFIC;PPIE;IFIT1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.26855159689367336,-0.4938513078596652,1.0,1.0,1.0,3/17,22.52%,FCGR2B;CD300A;FOXP1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.28503584821196926,0.4936238961951261,0.9411764705882353,0.998886505561558,1.0,1/6,9.53%,AMPD3
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.29169835493529916,-0.49351019059926376,1.0,1.0,1.0,2/11,19.15%,TFIP11;TERF2IP
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.24712689527899126,-0.492670472616421,1.0,1.0,1.0,13/46,29.45%,TTN;CIT;EPB41L3;EPB41L4B;FRMD5;OBSCN;CDC42BPA;FAM171A1;MYH10;SORBS1;FRMD3;ROCK1;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.28072607177804676,-0.4926592656002405,0.9761904761904762,1.0,1.0,4/14,29.22%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.2633163187126453,-0.492059839936317,0.9885057471264368,1.0,1.0,4/26,21.51%,FHL1;ANK2;CAV3;SCN3B
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.23190300216464188,-0.4910654656882129,1.0,1.0,1.0,6/79,13.80%,TAF6L;CHD3;KDM6B;HCFC1;SMARCD3;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.2991398733334788,-0.49008834299246884,0.987012987012987,1.0,1.0,1/9,16.53%,KDM1A
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.3056226834499053,0.4894138666103224,0.967741935483871,0.9994579435349574,1.0,2/5,20.19%,SRC;BCL2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.29674196855062296,-0.48889497932051074,0.9873417721518988,1.0,1.0,6/18,26.58%,FCHO2;NLGN3;SYT1;AMPH;NLGN2;PIP5K1C
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.310605151307324,-0.48592624896347514,0.9696969696969697,1.0,1.0,3/7,25.26%,PLEKHA7;KIFC3;THBS4
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.3381397831923944,-0.48561257699193705,1.0,1.0,1.0,2/5,37.25%,PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.324329619310332,-0.48459519328376255,0.987012987012987,1.0,1.0,2/5,24.28%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2521642758639785,-0.4840558449602781,1.0,1.0,1.0,2/28,16.53%,DDRGK1;KDM1A
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.33298513010800457,-0.4830452501657928,1.0,1.0,1.0,1/5,19.50%,NFS1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.24381178331356276,0.4824498098168349,0.9583333333333334,1.0,1.0,9/9,75.64%,CAMKK2;PRKN;VDAC1;VPS13D;HTT;PARK7;FBXO7;SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.3095119622289205,-0.48160302109581415,0.9863013698630136,1.0,1.0,2/5,33.42%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.2632266898297356,-0.48151680680932973,1.0,1.0,1.0,5/18,31.77%,TTN;SMC4;SET;SMC2;TENT4A
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.24540343506461942,-0.48081183583887954,0.9886363636363636,1.0,1.0,10/34,34.87%,SNF8;KLF4;LILRB2;KLF2;APP;VPS35;ODC1;HSP90AB1;CNDP1;CHMP6
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.26205413673621064,0.48043057716754,1.0,1.0,1.0,4/11,18.63%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.2675347865075099,0.4803467931372033,0.967741935483871,0.999691656950404,1.0,2/8,13.55%,USP30;YOD1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.2504745333755143,0.4776854921226186,1.0,0.9995083193561689,1.0,10/10,74.97%,EPS8;CLASP1;CHMP2A;PPP2R2D;CTDP1;CHMP7;SIRT7;CHMP4B;CLASP2;SPAST
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.3002932963747012,-0.47736347735220985,0.9876543209876543,1.0,1.0,1/7,13.70%,RAB3A
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.31916216652198864,-0.47659551030883707,1.0,1.0,1.0,2/6,31.59%,MOV10L1;MYBL1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.28321821277230863,-0.47427663587113056,0.971830985915493,1.0,1.0,4/11,34.87%,CHMP5;PDCD6IP;CHMP4B;CHMP6
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.31107504824513327,-0.4732392276192985,1.0,1.0,1.0,2/6,34.50%,NDST3;NDST1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.2861886315123725,0.471572623432082,1.0,1.0,1.0,5/5,71.39%,SRC;AHCYL1;CAMK2A;ACTN2;CA2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.2832642890061,0.4711418787896297,1.0,0.9995790948973092,1.0,4/6,27.75%,OPN3;CCND1;EGFR;AKT1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.25588271422048825,-0.47107548439292485,1.0,1.0,1.0,2/21,22.11%,ACOT13;ACSM3
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.29073797295076403,-0.4686046830326237,1.0,1.0,1.0,3/12,24.31%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.2692747401980364,-0.46658278785280055,1.0,1.0,1.0,4/13,34.87%,CHMP5;PDCD6IP;CHMP4B;CHMP6
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.31420947854815623,-0.4665791764967643,1.0,1.0,1.0,1/5,24.28%,MAP2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.23900140827243851,-0.4657074071816622,1.0,1.0,1.0,9/61,24.34%,EIF4A3;TENT4B;PAPOLG;SRSF5;SRSF2;CSTF2T;SRSF9;U2AF2;SRSF3
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.2673521965297219,0.46431274467312766,1.0,1.0,1.0,3/6,26.24%,SKI;COL5A2;INTU
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.19127197845715188,0.4613140749875009,1.0,1.0,1.0,28/28,80.92%,RAB7A;RAB39A;PIKFYVE;RAB32;ATP6V1G1;TCIRG1;ATP6V0E1;ATP6V0D1;ATP6V1H;RAB38;ATP6V1A;RAB14;ATP6V1B2;CORO1A;ATP6V0E2;ATP6V0B;RAB31;ATP6V1F;SLAMF8;ATP6V0A1;ATP6V1C1;ATP6V0A2;MREG;ATP6V1E1;MCOLN1;ATP6V1E2;RAB20;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.27377658312910125,0.45936278711380324,0.9428571428571428,0.9998318028509783,1.0,5/5,72.63%,CLCN3;ATP6AP1;SLC9A1;PDK4;SLC9A7
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.28754546354783045,-0.4578424766701229,0.9855072463768116,1.0,1.0,1/6,22.52%,FOXP1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.2884678843940937,-0.4573282604590782,1.0,1.0,1.0,5/11,30.79%,MCMDC2;MCM6;MCM7;WRN;RECQL5
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.293536860357247,-0.4573016597126677,0.9855072463768116,1.0,1.0,3/6,40.17%,ERCC6;XRCC6;ERCC8
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.2535863536061003,-0.4572595663131056,1.0,1.0,1.0,5/19,27.90%,CCL3;MAFB;TMEM178A;GPR137B;LILRB3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.31630826190813366,-0.4566635987682694,1.0,1.0,1.0,2/5,36.20%,CEP250;BICD1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.29087663921109497,-0.4558441926587727,0.987012987012987,1.0,1.0,4/10,31.33%,CASP1;MYRF;HTRA2;AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.2687381404174574,0.45554258474316983,1.0,0.999598527853317,1.0,6/6,73.14%,GRN;ROCK2;PICALM;AGER;LYN;EPHA4
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.2781247529448968,0.4530971283436022,1.0,0.999345351634825,1.0,5/5,72.20%,ATP11B;SCARB2;TMEM30A;ATP8A1;ATP8A2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.26646555915279335,0.4526188874846339,1.0,0.9987184305250077,1.0,1/6,8.23%,SRGAP2C
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.28283398979763974,-0.45165369717527426,0.9746835443037974,1.0,1.0,1/8,27.20%,APP
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.30027484266870136,-0.4504969816014268,1.0,1.0,1.0,1/6,26.19%,PPARA
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.22101709097567704,-0.4488574521756562,1.0,1.0,1.0,7/56,19.90%,MYRIP;NR1D1;SNAP25;CACNA1C;PER2;IRS2;SOX4
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3003460532040959,-0.4486190190055791,0.9615384615384616,1.0,1.0,1/8,14.49%,APOD
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.2297391344520533,-0.44525663647573227,1.0,1.0,1.0,3/38,11.64%,ATP5IF1;RPS14;RASGRP4
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.2772551189817378,0.44308148764780597,0.9642857142857143,0.9992442411366272,1.0,5/5,72.29%,FBXO38;HMGB1;HSPD1;HLA-DRB1;IL4I1
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.2905368013281683,0.4427806592552354,1.0,0.9986182920158471,1.0,5/5,70.96%,IKBKB;ROCK2;NCKAP1L;TNF;ROCK1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.2883294200664106,-0.43527628551370606,1.0,1.0,1.0,3/7,34.39%,UBR2;MYBL1;SMYD5
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.25269847532991535,-0.4351198356541981,1.0,1.0,1.0,7/15,34.72%,SRA1;PLCB1;RIPOR2;LRRC8A;BTG1;FLOT2;RANBP3L
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.2588801406740076,-0.4317812847866549,0.9866666666666667,1.0,1.0,8/11,41.33%,ENO1;CHRM2;MYBPC3;ATP1A2;KCNB2;ANXA6;SRI;PLCE1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.2850625913743829,-0.4310443904012908,0.9859154929577465,1.0,1.0,2/7,27.90%,MFSD2A;ABCA3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.2532333697925618,-0.4289220017107403,0.9866666666666667,1.0,1.0,5/10,44.95%,MAP1A;HSP90AB1;ABCA7;TNF;RIC3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.27868040786307663,-0.4243418144178313,0.9859154929577465,1.0,1.0,1/6,26.81%,CHRM3
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.2511995639599135,-0.42417964269016395,1.0,1.0,1.0,4/14,33.63%,GPNMB;HTATIP2;WARS1;HMOX1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.27061606809972116,-0.4214877541266499,1.0,1.0,1.0,2/9,17.86%,NR1H2;ABCA1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.2219028464491317,0.4174212221110311,1.0,1.0,1.0,3/8,19.28%,MOCS1;ALOX5;MOCS2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.2396375629946014,-0.4173975844408016,1.0,1.0,1.0,4/20,24.27%,RGCC;RDX;AIF1;PLCB1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.23922610624619145,0.4164372536073631,1.0,0.9994964015298424,1.0,2/11,16.31%,NR3C1;PCK2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.2502465812238576,-0.4162549886304737,1.0,1.0,1.0,6/12,42.76%,METTL4;PARG;MLLT3;HPF1;ALKBH4;CDK9
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.23584756483238445,0.40828371461098606,1.0,0.9992645354987557,1.0,6/6,76.43%,RAE1;NUP155;NUP107;LDB1;PCID2;NUP133
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.2568859565181201,-0.4044978382889963,1.0,1.0,1.0,2/10,31.98%,PIPOX;CRYM
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.2568859565181201,-0.4044978382889963,1.0,1.0,1.0,2/10,31.98%,PIPOX;CRYM
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.25869433732542013,-0.40361497251664646,0.9859154929577465,1.0,1.0,3/6,31.59%,MOV10L1;TDRD1;MYBL1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.2738293462110428,-0.39439729801276563,1.0,1.0,1.0,2/7,31.44%,FOXP1;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.22666303228671236,-0.39065606259698576,1.0,1.0,1.0,2/16,17.86%,NR1H2;ABCA1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.2262356563392466,-0.38552581120575313,1.0,1.0,1.0,3/15,34.61%,PNPLA8;NAAA;SELENOI
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.25047153459712035,-0.3825589523137645,1.0,1.0,1.0,2/7,33.45%,SPAST;CHMP4B
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.2104273093892149,-0.3792730466482022,1.0,0.9998495177740169,1.0,4/25,23.68%,RPS3;THY1;CD300A;TESPA1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.24011658706954733,-0.3738391980474458,1.0,0.9996700546214263,1.0,2/7,25.86%,HMGCL;BCAT1
